Citrus Sinensis ID: 011628
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 481 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SN43 | 489 | CBL-interacting serine/th | yes | no | 0.979 | 0.963 | 0.785 | 0.0 | |
| Q9FJ55 | 483 | CBL-interacting serine/th | no | no | 0.950 | 0.946 | 0.756 | 0.0 | |
| Q9LP51 | 520 | CBL-interacting serine/th | no | no | 0.964 | 0.892 | 0.738 | 0.0 | |
| O22971 | 502 | CBL-interacting serine/th | no | no | 0.966 | 0.926 | 0.686 | 0.0 | |
| Q68Y49 | 508 | CBL-interacting protein k | yes | no | 0.933 | 0.883 | 0.665 | 0.0 | |
| Q5JLS2 | 540 | CBL-interacting protein k | no | no | 0.904 | 0.805 | 0.661 | 1e-178 | |
| Q5QNM6 | 511 | Putative CBL-interacting | no | no | 0.948 | 0.892 | 0.584 | 1e-159 | |
| Q9LWM4 | 461 | CBL-interacting protein k | no | no | 0.912 | 0.952 | 0.602 | 1e-156 | |
| Q7X996 | 443 | CBL-interacting protein k | no | no | 0.875 | 0.950 | 0.577 | 1e-145 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.898 | 0.945 | 0.585 | 1e-144 |
| >sp|Q9SN43|CIPKC_ARATH CBL-interacting serine/threonine-protein kinase 12 OS=Arabidopsis thaliana GN=CIPK12 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/485 (78%), Positives = 422/485 (87%), Gaps = 14/485 (2%)
Query: 10 TSTTSSSKDQN--QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS 67
T TS K+++ Q+ +LGRYE+GKLLGHGTFAKVY ARNVK+ ESVAIKVIDKEK+LK
Sbjct: 6 TRETSLPKERSSPQALILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKG 65
Query: 68 GLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLA 127
GL+AHIKREISILRRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLKE++A
Sbjct: 66 GLIAHIKREISILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVA 125
Query: 128 RKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187
RKYFQQLISAV FCHARGVYHRDLKPENLLLDENG+LKVSDFGLSAVSDQIRQDGLFHTF
Sbjct: 126 RKYFQQLISAVTFCHARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTF 185
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS 247
CGTPAYVAPEVL+RKGYDAAKVDIWSCGVILFVLMAGYLPF D+N+M MYKKIY+GEFR
Sbjct: 186 CGTPAYVAPEVLARKGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRC 245
Query: 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHT 307
PRWFS +L RLL+KLL+TNP+KR T PEIMEN WF+KGFKHIKFY+EDDK+CNV D D
Sbjct: 246 PRWFSTELTRLLSKLLETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDEL 305
Query: 308 DDVGPCSD-DHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGE 366
+ SD D + SE E E LE +R++ LPRPASLNAFD+ISFS GFDLSGLF++ GE
Sbjct: 306 ESDSVESDRDSAASESEIE-YLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDDDGE 364
Query: 367 GARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPK 426
G+RFVSGAPVSKII+KLEEIAKVVSFTVRKKDCRVSLEGSR+GVKGPLTIA EIFELTP
Sbjct: 365 GSRFVSGAPVSKIISKLEEIAKVVSFTVRKKDCRVSLEGSRQGVKGPLTIAAEIFELTPS 424
Query: 427 LVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDE--SESAVVAAVDDAL--------HL 476
LVVVEVKKKGGDK EYE+FCN ELKP L+NL D+ +E V+AVD+ L
Sbjct: 425 LVVVEVKKKGGDKTEYEDFCNNELKPKLQNLTADDVVAEPVAVSAVDETAIPNSPTISFL 484
Query: 477 PSDTE 481
PSDTE
Sbjct: 485 PSDTE 489
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FJ55|CIPKJ_ARATH CBL-interacting serine/threonine-protein kinase 19 OS=Arabidopsis thaliana GN=CIPK19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 724 bits (1869), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/460 (75%), Positives = 400/460 (86%), Gaps = 3/460 (0%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
MA + + +Q+ +LG+YE+G+LLGHGTFAKVY ARN +SGESVAIKVID
Sbjct: 1 MADLLRKVKSIKKKQDQSNHQALILGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVID 60
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG 120
KEK+LKSGL+AHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV+GGELFNKVAKG
Sbjct: 61 KEKVLKSGLIAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAKG 120
Query: 121 RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180
RLKE++ARKYFQQLISAV FCH RGVYHRDLKPENLLLDENG+LKVSDFGLSAVSDQIRQ
Sbjct: 121 RLKEEMARKYFQQLISAVSFCHFRGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQ 180
Query: 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI 240
DGLFHTFCGTPAYVAPEVL+RKGYD AKVDIWSCGVILFVLMAG+LPF D+N+M MYKKI
Sbjct: 181 DGLFHTFCGTPAYVAPEVLARKGYDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKI 240
Query: 241 YKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDD-KMC 299
Y+G+FR PRWF ++ RLL ++L+T P++R T+P+IME WF+KGFKHIKFY+EDD ++C
Sbjct: 241 YRGDFRCPRWFPVEINRLLIRMLETKPERRFTMPDIMETSWFKKGFKHIKFYVEDDHQLC 300
Query: 300 NVEDVDHTDDVGPCSDDHS-LSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLS 358
NV D D + + S S +SEPE + +R+ S+PRPASLNAFDLISFSPGFDLS
Sbjct: 301 NVADDDEIESIESVSGRSSTVSEPEDFESFDGRRRGGSMPRPASLNAFDLISFSPGFDLS 360
Query: 359 GLFEEGGEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREG-VKGPLTIA 417
GLFE+ GEG+RFVSGAPV +II+KLEEIA++VSFTVRKKDC+VSLEGSREG +KGPL+IA
Sbjct: 361 GLFEDDGEGSRFVSGAPVGQIISKLEEIARIVSFTVRKKDCKVSLEGSREGSMKGPLSIA 420
Query: 418 TEIFELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENL 457
EIFELTP LVVVEVKKKGGDK EY+EFCNKELKP L+NL
Sbjct: 421 AEIFELTPALVVVEVKKKGGDKMEYDEFCNKELKPKLQNL 460
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP51|CIPKI_ARATH CBL-interacting serine/threonine-protein kinase 18 OS=Arabidopsis thaliana GN=CIPK18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 692 bits (1785), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/475 (73%), Positives = 402/475 (84%), Gaps = 11/475 (2%)
Query: 9 STSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG 68
S + S + + L+G+YE+GKLLGHGTFAKVY A+N+KSG+ VAIKVIDKEKI+KSG
Sbjct: 55 SPQSPRSPRSPRNNILMGKYELGKLLGHGTFAKVYLAQNIKSGDKVAIKVIDKEKIMKSG 114
Query: 69 LVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLAR 128
LVAHIKREISILRRVRHP IV LFEVMATKSKIYFVMEYV GGELFN VAKGRL E+ AR
Sbjct: 115 LVAHIKREISILRRVRHPYIVHLFEVMATKSKIYFVMEYVGGGELFNTVAKGRLPEETAR 174
Query: 129 KYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188
+YFQQLIS+V FCH RGVYHRDLKPENLLLD G+LKVSDFGLSAV++Q+RQDGL HTFC
Sbjct: 175 RYFQQLISSVSFCHGRGVYHRDLKPENLLLDNKGNLKVSDFGLSAVAEQLRQDGLCHTFC 234
Query: 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP 248
GTPAY+APEVL+RKGYDAAK D+WSCGVILFVLMAG++PF D+NIMVMYKKIYKGEFR P
Sbjct: 235 GTPAYIAPEVLTRKGYDAAKADVWSCGVILFVLMAGHIPFYDKNIMVMYKKIYKGEFRCP 294
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTD 308
RWFS DL+RLLT+LLDTNPD RITIPEIM+NRWF+KGFKH+KFYIEDDK+C ++ + +
Sbjct: 295 RWFSSDLVRLLTRLLDTNPDTRITIPEIMKNRWFKKGFKHVKFYIEDDKLCREDEDEEEE 354
Query: 309 DVGPCSDDHSLSEPEPEPELETKRK-LTSLPRPASLNAFDLISFSPGFDLSGLF-EEGGE 366
S S + E + E + KR + S+PRP+SLNAFD+ISFS GFDLSGLF EEGGE
Sbjct: 355 ---ASSSGRSSTVSESDAEFDVKRMGIGSMPRPSSLNAFDIISFSSGFDLSGLFEEEGGE 411
Query: 367 GARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPK 426
G RFVSGAPVSKII+KLEEIAK+VSFTVRKK+ + LEG REG KGPLTIA EIFELTP
Sbjct: 412 GTRFVSGAPVSKIISKLEEIAKIVSFTVRKKEWSLRLEGCREGAKGPLTIAAEIFELTPS 471
Query: 427 LVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDESESAVVAAVDDALHLPSDTE 481
LVVVEVKKKGGD+ EYEEFCNKEL+P LE L+ +E V++AL+LPSDTE
Sbjct: 472 LVVVEVKKKGGDREEYEEFCNKELRPELEKLIHEE------VVVEEALYLPSDTE 520
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22971|CIPKD_ARATH CBL-interacting serine/threonine-protein kinase 13 OS=Arabidopsis thaliana GN=CIPK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 651 bits (1679), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/475 (68%), Positives = 387/475 (81%), Gaps = 10/475 (2%)
Query: 8 TSTSTTSSSKDQNQ-SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK 66
TST + S Q S L+ +YEIGKLLGHG+FAKVY ARN+ SGE VAIKVIDKEKI+K
Sbjct: 36 TSTPESPRSPRTPQGSILMDKYEIGKLLGHGSFAKVYLARNIHSGEDVAIKVIDKEKIVK 95
Query: 67 SGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDL 126
SGL HIKREISILRRVRHP IV L EVMATK+KIY VMEYVRGGEL+N VA+GRL+E
Sbjct: 96 SGLAGHIKREISILRRVRHPYIVHLLEVMATKTKIYIVMEYVRGGELYNTVARGRLREGT 155
Query: 127 ARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT 186
AR+YFQQLIS+V FCH+RGVYHRDLK ENLLLD+ G++KVSDFGLS VS+Q++Q+G+ T
Sbjct: 156 ARRYFQQLISSVAFCHSRGVYHRDLKLENLLLDDKGNVKVSDFGLSVVSEQLKQEGICQT 215
Query: 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR 246
FCGTPAY+APEVL+RKGY+ AK DIWSCGVILFVLMAGYLPF D+NI+VMY KIYKG+F+
Sbjct: 216 FCGTPAYLAPEVLTRKGYEGAKADIWSCGVILFVLMAGYLPFDDKNILVMYTKIYKGQFK 275
Query: 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDH 306
P+WFSP+L RL+T++LDTNPD RITIPEIM++RWF+KGFKH+KFYIE+DK+C +D +
Sbjct: 276 CPKWFSPELARLVTRMLDTNPDTRITIPEIMKHRWFKKGFKHVKFYIENDKLCREDDDND 335
Query: 307 TDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGE 366
DD S S + E + E + KR + S+PRPASLNAFD++SFS DLSGLFEEGG+
Sbjct: 336 DDDSSSLSSGRSSTASEGDAEFDIKR-VDSMPRPASLNAFDILSFS---DLSGLFEEGGQ 391
Query: 367 GARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPK 426
GARFVS AP++KII+KLEEIAK V F VRKKD V LEG REG KGPLTI EIFELTP
Sbjct: 392 GARFVSAAPMTKIISKLEEIAKEVKFMVRKKDWSVRLEGCREGAKGPLTIRVEIFELTPS 451
Query: 427 LVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDESESAVVAAVDDALHLPSDTE 481
LVVVEVKKKGG+ EYEEFCNKEL+P LE LM +++ V++ + LP + E
Sbjct: 452 LVVVEVKKKGGNIEEYEEFCNKELRPQLEKLMHYQADE-----VEEVMCLPPEIE 501
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q68Y49|CIPKJ_ORYSJ CBL-interacting protein kinase 19 OS=Oryza sativa subsp. japonica GN=CIPK19 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 650 bits (1677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/485 (66%), Positives = 378/485 (77%), Gaps = 36/485 (7%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
LLGRYE+G+LLGHGTFAKVY AR+ SGE VAIKV+DKEK ++ GLV HIKREI+ILRRV
Sbjct: 33 LLGRYELGRLLGHGTFAKVYQARSADSGEPVAIKVLDKEKAMRHGLVPHIKREIAILRRV 92
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
RHPNIV+LFEVMATKSKIYFVME VRGGELF +VAKGRLKED AR+YFQQL+SAVGFCHA
Sbjct: 93 RHPNIVRLFEVMATKSKIYFVMELVRGGELFGRVAKGRLKEDTARRYFQQLVSAVGFCHA 152
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
RGV+HRDLKPENLL+DE+GDLKVSDFGLSAV+DQ DGL HTFCGTP+YVAPEVL+R+G
Sbjct: 153 RGVFHRDLKPENLLVDEHGDLKVSDFGLSAVADQFHPDGLLHTFCGTPSYVAPEVLARRG 212
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
YD AK DIWSCG+ILFVLMAGYLPF DQN+M MY+KIY+GEFR PRWFS DL LL ++L
Sbjct: 213 YDGAKADIWSCGIILFVLMAGYLPFHDQNLMAMYRKIYRGEFRCPRWFSKDLSSLLNRIL 272
Query: 264 DTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDH----------------- 306
DTNP+ RIT+ E+ME+RWF+KGF+ ++FY+EDD++ ++ D D+
Sbjct: 273 DTNPETRITVKEVMESRWFQKGFRPVRFYVEDDQVHSLADGDNDMPELEPSEPPPPPPFP 332
Query: 307 -----TDDVGPCSDDHSLSEPEPEP-----ELETKRKLTSLPRPASLNAFDLISFSPGFD 356
DD G S S S P E +R L SL RPASLNAFD+ISFS GFD
Sbjct: 333 PPPPQQDDDGEESGWESDSSVASCPATLSSEERRQRPLGSLTRPASLNAFDIISFSKGFD 392
Query: 357 LSGLFEEGGEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTI 416
LSGLFEE G RF+S P+ IITKLEEIAKV SF VR+KD RVS+EG+REG+KGPLTI
Sbjct: 393 LSGLFEERGSEVRFISAEPMQTIITKLEEIAKVKSFFVRRKDWRVSIEGTREGLKGPLTI 452
Query: 417 ATEIFELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDESESAVVAAVDDALHL 476
EIFELTP LVVVEVKKK GDK EY++FCN+ELKPG+++L V + ++
Sbjct: 453 GAEIFELTPSLVVVEVKKKAGDKEEYDDFCNRELKPGMQHL---------VHHMGSVPNI 503
Query: 477 PSDTE 481
PSDTE
Sbjct: 504 PSDTE 508
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5JLS2|CIPKC_ORYSJ CBL-interacting protein kinase 12 OS=Oryza sativa subsp. japonica GN=CIPK12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1608), Expect = e-178, Method: Compositional matrix adjust.
Identities = 305/461 (66%), Positives = 362/461 (78%), Gaps = 26/461 (5%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
+LG+YE+G++LG G+FAKVY AR++++ E VAIKV+DKEK +K G+V +KREI++LRRV
Sbjct: 42 VLGKYELGRVLGQGSFAKVYQARHLETDECVAIKVLDKEKAVKGGMVHLVKREINVLRRV 101
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
RHPNIVQLFEVMA+K+KIYFVMEYVRGGELF++V+KGRL+ED AR+YFQQL+SAV FCHA
Sbjct: 102 RHPNIVQLFEVMASKTKIYFVMEYVRGGELFSRVSKGRLREDTARRYFQQLVSAVDFCHA 161
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
RGV+HRDLKPENLL+DENGDLKVSDFGL+A DQ DGL HTFCGTPAYVAPEVL R+G
Sbjct: 162 RGVFHRDLKPENLLVDENGDLKVSDFGLAAGPDQFDPDGLLHTFCGTPAYVAPEVLRRRG 221
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
YD AK DIWSCGVILF LMAGYLPF D NIMV+Y+KIY GEFR PRWFS D RL+T+LL
Sbjct: 222 YDGAKADIWSCGVILFALMAGYLPFHDHNIMVLYRKIYNGEFRCPRWFSKDFTRLITRLL 281
Query: 264 DTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVED----VDHTDDVGPCSDDHSL 319
D NP RIT+PEI+E+ WF+KG+K +KFYIEDDK+ N+ D ++ D V P
Sbjct: 282 DANPKTRITVPEIIESDWFKKGYKPVKFYIEDDKLYNLSDDVLNLEPADPVPPPLGLAPP 341
Query: 320 SE----------------------PEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDL 357
P E++R SLPRPASLNAFD+ISFS GF+L
Sbjct: 342 VPPPPQGDDPDGSGSESDSSVVSCPATLSTGESQRVRGSLPRPASLNAFDIISFSKGFNL 401
Query: 358 SGLFEEGGEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIA 417
SGLFEE G RFVSG P+S I+ KLEEIAKV SFTVR+KD RVS+EG+REGVKGPLTI
Sbjct: 402 SGLFEERGNEIRFVSGEPMSDIVKKLEEIAKVKSFTVRRKDWRVSIEGTREGVKGPLTIG 461
Query: 418 TEIFELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENLM 458
EIFELTP LVVVEVK+K GD EYE+FCN ELKPG+++L+
Sbjct: 462 AEIFELTPSLVVVEVKRKAGDNEEYEDFCNMELKPGMQHLV 502
|
Involved in drought stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5QNM6|CIPKD_ORYSJ Putative CBL-interacting protein kinase 13 OS=Oryza sativa subsp. japonica GN=CIPK13 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1445), Expect = e-159, Method: Compositional matrix adjust.
Identities = 290/496 (58%), Positives = 351/496 (70%), Gaps = 40/496 (8%)
Query: 6 APTSTSTTSSSKDQNQSPLL-GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI 64
A S S K+ + PLL GR+E+GKLLG G FAKVYHARNV +GE VAIKV++KEKI
Sbjct: 2 ARMGISKGGSGKEAKKPPLLLGRFEVGKLLGQGNFAKVYHARNVATGEEVAIKVMEKEKI 61
Query: 65 LKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKE 124
KSGL AHIKREI++LRRVRHP+IVQL+EVMATK +IYFVMEYVRGGELF +VA+GRL E
Sbjct: 62 FKSGLTAHIKREIAVLRRVRHPHIVQLYEVMATKLRIYFVMEYVRGGELFARVARGRLPE 121
Query: 125 DLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184
AR+YFQQL+SAV FCHARGV+HRD+KPENLL+D+ GDLKVSDFGLSAV+D +R+DGLF
Sbjct: 122 ADARRYFQQLVSAVAFCHARGVFHRDIKPENLLVDDAGDLKVSDFGLSAVADGMRRDGLF 181
Query: 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE 244
HTFCGTPAYVAPEVLSR+GYDAA D+WSCGV+LFVLMAGYLPFQD+N+ MY+KI+KG+
Sbjct: 182 HTFCGTPAYVAPEVLSRRGYDAAGADLWSCGVVLFVLMAGYLPFQDRNLAGMYRKIHKGD 241
Query: 245 FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDV 304
FR P+WFSP+LIRLL +L TNP +R T IMEN WF+ GF+ F +EDD+ ++
Sbjct: 242 FRCPKWFSPELIRLLRGVLVTNPQRRATAEGIMENEWFKIGFRRFSFRVEDDRTFTCFEL 301
Query: 305 DH------------------TDDVGPC----SDDHSLSEPEPEPEL-ETKRKLT-SLPRP 340
D + DVG SL+ + P L E + L S R
Sbjct: 302 DDDAAVDAPTSPPDTPRTVDSGDVGAAPTRPRKAGSLTSCDSAPSLLEGRFGLGGSSRRR 361
Query: 341 ASLNAFDLISFSPGFDLSGLF--------------EEGGEGARFVSGAPVSKIITKLEEI 386
+SLNAFD+ISFSPGFDLSGLF E+ ARFVS APV I+ LE
Sbjct: 362 SSLNAFDIISFSPGFDLSGLFDQDDGGGAGAGSIPEQQKHTARFVSAAPVEVIVATLEAA 421
Query: 387 AKVVSFTVRKK-DCRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGEYEEF 445
A VR++ D +S+EG+REG G L +A EI+ELTP+LVVVEV++K G EYEEF
Sbjct: 422 AAAAGMAVREREDGSISMEGTREGEHGALAVAAEIYELTPELVVVEVRRKAGGAAEYEEF 481
Query: 446 CNKELKPGLENLMLDE 461
LKP L L+ D+
Sbjct: 482 FRARLKPSLRELVCDD 497
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 551 bits (1419), Expect = e-156, Method: Compositional matrix adjust.
Identities = 274/455 (60%), Positives = 347/455 (76%), Gaps = 16/455 (3%)
Query: 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
++ S L+ RYE+G++LG GTFAKVYHARN+ S +SVAIKVIDKEK+L+ G++ IKREI
Sbjct: 2 EKKASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKREI 61
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
SI+R VRHPNIVQL EVMA+KSKIYF MEYVRGGELF++VA+GRLKED ARKYFQQLI A
Sbjct: 62 SIMRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIGA 121
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
V FCH+RGVYHRDLKPENLL+DENG+LKVSDFGLSA + +QDGL HT CGTPAYVAPE
Sbjct: 122 VDFCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAPE 181
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
+++++GYD AK DIWSCGVILFVL+AGYLPF D N+M MY+KI KG+ + P+WF+ D+ R
Sbjct: 182 IINKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVRR 241
Query: 258 LLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDH 317
LL++LLD NP+ RIT+ +++E+ WF+KG+K + ++ N++DV HT S DH
Sbjct: 242 LLSRLLDPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPNESNNLKDV-HT----AFSADH 296
Query: 318 SLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGE---GARFVSGA 374
+ E + K +SL +P SLNAFD+IS S GFDLSGLFE E +RF++
Sbjct: 297 K------DNEGKAKEPASSL-KPVSLNAFDIISLSKGFDLSGLFENDKEQKADSRFMTQK 349
Query: 375 PVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKK 434
P S I++KLE+IA+ SF V+K+D V L+GS+EG KG L I EIFE+TP VVEVKK
Sbjct: 350 PASAIVSKLEQIAETESFKVKKQDGLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKK 409
Query: 435 KGGDKGEYEEFCNKELKPGLENLMLD-ESESAVVA 468
GD EYE+FCNK L+P L ++ D +SE +A
Sbjct: 410 SAGDTLEYEKFCNKGLRPSLRDICWDGQSEHPSLA 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 514 bits (1324), Expect = e-145, Method: Compositional matrix adjust.
Identities = 257/445 (57%), Positives = 327/445 (73%), Gaps = 24/445 (5%)
Query: 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
+Q + L+ +YE+GKLLG GTFAKVYHARN ++ ESVAIK+IDKEK+LK GL+ IKREI
Sbjct: 3 EQRGNMLMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKREI 62
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
S+++ VRHPNIVQL+EVMATK+KIYFV+E+V+GGELFNKV +GRLKED ARKYFQQLI A
Sbjct: 63 SVMKLVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLICA 122
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
V FCH+RGVYHRDLKPENLLLDEN +LKVSDFGLSA++D RQDGL HT CGTPAYVAPE
Sbjct: 123 VDFCHSRGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 182
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
V++R+GYD AK DIWSCGVILFVL+AGYLPF D+N+M MYKKI K EF+ P WF+ D+ R
Sbjct: 183 VINRRGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDVRR 242
Query: 258 LLTKLLDTNPDKRITIPEIMENRWFRKGF--KHIKFYIEDDKMCNVEDVDHTDDVGPCSD 315
LL ++LD NP RI++ +IMEN WFRKG K +++ ++ D P
Sbjct: 243 LLLRILDPNPSTRISMDKIMENPWFRKGLDAKLLRYNLQ------------PKDAIPVDM 290
Query: 316 DHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGEG-ARFVSGA 374
P LE K P++LNAFD+IS S G DLSG+FEE + ++F S +
Sbjct: 291 STDFDSFNSAPTLEKK--------PSNLNAFDIISLSTGLDLSGMFEESDKKESKFTSTS 342
Query: 375 PVSKIITKLEEIAKVVSFTVRKKD-CRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVK 433
S II+K+E+IAK + + KKD + +EGS+ G KG + I EIFE+TP +VE+K
Sbjct: 343 TASTIISKIEDIAKGLRLKLTKKDGGLLKMEGSKPGRKGVMGIDAEIFEVTPNFHLVELK 402
Query: 434 KKGGDKGEYEEFCNKELKPGLENLM 458
K GD EY + N+E++P L++++
Sbjct: 403 KTNGDTLEYRKVLNQEMRPALKDIV 427
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 512 bits (1318), Expect = e-144, Method: Compositional matrix adjust.
Identities = 260/444 (58%), Positives = 329/444 (74%), Gaps = 12/444 (2%)
Query: 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
++N + LL RYEIGKLLG GTFAKVYH RN+ + +SVAIKVIDK+KI K GL+ IKREI
Sbjct: 5 EKNGNILLRRYEIGKLLGQGTFAKVYHGRNIVTSQSVAIKVIDKDKIFKVGLMDQIKREI 64
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
S+++ VRHPNIVQL+EVMATKSKIYFV+EYV+GGELFNKVAKGRLKED ARKYFQQL+SA
Sbjct: 65 SVMKLVRHPNIVQLYEVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVSA 124
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
V FCH+RGVYHRDLKPENLL+DENG+LK++DFGLSA+++ RQDGL HT CGTPAYVAPE
Sbjct: 125 VDFCHSRGVYHRDLKPENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAPE 184
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
V+SRKGYD KVD WSCGVILFVLMAGYLPFQD N+M MY+KI K EF+ P WFS D+ +
Sbjct: 185 VISRKGYDGVKVDTWSCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVRK 244
Query: 258 LLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDH 317
L++++LD NP R+ I +IME WF+KG D K+ +++V+ + V +D +
Sbjct: 245 LVSRILDPNPRSRMPITKIMETYWFKKGL--------DSKLI-LKNVETNEPVTALADVN 295
Query: 318 SLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGEG--ARFVSGAP 375
+ + + + +LNAFD+IS S GFDLSGLFEE + ARF S
Sbjct: 296 VVFSSMGSSSSKKTEEKQDAGKLTNLNAFDIISLSEGFDLSGLFEETDKKKEARFTSSQS 355
Query: 376 VSKIITKLEEIAKVVSFTVRKKDCRV-SLEGSREGVKGPLTIATEIFELTPKLVVVEVKK 434
S II+KLE++A TV+KK+ V +EG+ EG KG L I EIFE+TP +VE+KK
Sbjct: 356 ASAIISKLEDVASCSKLTVKKKEGGVLKMEGASEGRKGVLAIDAEIFEVTPSFHLVEIKK 415
Query: 435 KGGDKGEYEEFCNKELKPGLENLM 458
GD EY+ +++KP L++++
Sbjct: 416 NNGDTLEYQHLWKEDMKPALKDIV 439
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 481 | ||||||
| 188509970 | 477 | putative serine-threonine kinase [Gossyp | 0.981 | 0.989 | 0.839 | 0.0 | |
| 49333397 | 478 | putative serine-threonine kinase [Gossyp | 0.983 | 0.989 | 0.837 | 0.0 | |
| 359483757 | 502 | PREDICTED: CBL-interacting serine/threon | 0.983 | 0.942 | 0.784 | 0.0 | |
| 147792424 | 464 | hypothetical protein VITISV_006470 [Viti | 0.933 | 0.967 | 0.844 | 0.0 | |
| 359483761 | 464 | PREDICTED: CBL-interacting serine/threon | 0.933 | 0.967 | 0.844 | 0.0 | |
| 449433744 | 467 | PREDICTED: CBL-interacting serine/threon | 0.968 | 0.997 | 0.794 | 0.0 | |
| 297800192 | 488 | CIPK12 [Arabidopsis lyrata subsp. lyrata | 0.975 | 0.961 | 0.786 | 0.0 | |
| 224114650 | 437 | predicted protein [Populus trichocarpa] | 0.908 | 1.0 | 0.873 | 0.0 | |
| 15233981 | 489 | CBL-interacting serine/threonine-protein | 0.979 | 0.963 | 0.785 | 0.0 | |
| 224089521 | 437 | predicted protein [Populus trichocarpa] | 0.908 | 1.0 | 0.871 | 0.0 |
| >gi|188509970|gb|ACD56654.1| putative serine-threonine kinase [Gossypioides kirkii] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2119), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/480 (83%), Positives = 436/480 (90%), Gaps = 8/480 (1%)
Query: 5 TAPTSTSTTSSSKDQN--QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKE 62
+ S + TSS KD N Q+ LLGRYE+GKLLGHGTFAKVYHARNVKSG+SVAIKVIDKE
Sbjct: 3 STSKSNAATSSKKDANNGQTLLLGRYEVGKLLGHGTFAKVYHARNVKSGDSVAIKVIDKE 62
Query: 63 KILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRL 122
KILKSGL+AHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRL
Sbjct: 63 KILKSGLIAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRL 122
Query: 123 KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182
KED+ARKYFQQLISAV FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG
Sbjct: 123 KEDVARKYFQQLISAVHFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182
Query: 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK 242
LFHTFCGTPAYVAPEVL+RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM MYKKIYK
Sbjct: 183 LFHTFCGTPAYVAPEVLARKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMAMYKKIYK 242
Query: 243 GEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVE 302
GEFR PRWFSP+L+RLLTKLLDTNP+ RITIPEIME RWF+KGFKHIKFYIEDDK+C+VE
Sbjct: 243 GEFRCPRWFSPELVRLLTKLLDTNPETRITIPEIMEKRWFKKGFKHIKFYIEDDKLCSVE 302
Query: 303 DVDHTDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFE 362
D +DVG CSD S+S E E ELET++++ +LPRPASLNAFDLISFSPGF+LSGLFE
Sbjct: 303 D---DNDVGSCSDQSSMS--ESETELETRKRVGTLPRPASLNAFDLISFSPGFNLSGLFE 357
Query: 363 EGGEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFE 422
EG EG+RFVSGAPVS II+KLEEIAKVVSFTVRKKDCRVSLEGSREG KGPL+IA EIFE
Sbjct: 358 EGEEGSRFVSGAPVSTIISKLEEIAKVVSFTVRKKDCRVSLEGSREGAKGPLSIAAEIFE 417
Query: 423 LTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDE-SESAVVAAVDDALHLPSDTE 481
LTP LVVVEVKKKGG++GEYE+FCN+ELKPGLE LM++E SA + +LPSDTE
Sbjct: 418 LTPSLVVVEVKKKGGERGEYEDFCNRELKPGLEKLMMEESQSSAAASPAASLSYLPSDTE 477
|
Source: Gossypioides kirkii Species: Gossypioides kirkii Genus: Gossypioides Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|49333397|gb|AAT64036.1| putative serine-threonine kinase [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2111), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/480 (83%), Positives = 438/480 (91%), Gaps = 7/480 (1%)
Query: 5 TAPTSTSTTSSSKDQN--QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKE 62
+ S + TSS KD N Q+ LLGRYE+GKLLGHGTFAKVYHARNVKSG++VAIKVIDKE
Sbjct: 3 STSKSNAATSSKKDANNGQTLLLGRYEVGKLLGHGTFAKVYHARNVKSGDNVAIKVIDKE 62
Query: 63 KILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRL 122
KILKSGL+AHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRL
Sbjct: 63 KILKSGLIAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRL 122
Query: 123 KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182
KED+ARKYFQQLISAV FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG
Sbjct: 123 KEDVARKYFQQLISAVHFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182
Query: 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK 242
LFHTFCGTPA+VAPEVL+RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM MYKKIYK
Sbjct: 183 LFHTFCGTPAFVAPEVLARKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMAMYKKIYK 242
Query: 243 GEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVE 302
GEFR PRWFSP+LIRLLTKLLDTNP+ RITIPEIME RWF+KGFKHIKFYIEDDK+C+VE
Sbjct: 243 GEFRCPRWFSPELIRLLTKLLDTNPETRITIPEIMEKRWFKKGFKHIKFYIEDDKLCSVE 302
Query: 303 DVDHTDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFE 362
D D +DVG CSD S+S E E ELET++++ +LPRPASLNAFDLISFSPGF+LSGLFE
Sbjct: 303 DDD--NDVGSCSDQSSMS--ESETELETRKRVGTLPRPASLNAFDLISFSPGFNLSGLFE 358
Query: 363 EGGEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFE 422
EG EG+RFVSGAPVS II+KLEEIAKVVSFTVRKKDCRVSLEGSREG KGPL+IA EIFE
Sbjct: 359 EGEEGSRFVSGAPVSTIISKLEEIAKVVSFTVRKKDCRVSLEGSREGAKGPLSIAAEIFE 418
Query: 423 LTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDE-SESAVVAAVDDALHLPSDTE 481
LTP LVVVEVKKKGG++GEYE+FCN+ELKPGL+ LM++E SA + + +LPSDTE
Sbjct: 419 LTPSLVVVEVKKKGGERGEYEDFCNRELKPGLKELMVEESQSSAAASLATSSSYLPSDTE 478
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483757|ref|XP_002271196.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 12 isoform 1 [Vitis vinifera] gi|359483759|ref|XP_003633012.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 12 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2023), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/506 (78%), Positives = 428/506 (84%), Gaps = 33/506 (6%)
Query: 4 ATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEK 63
A + +T+ +NQS LLGRYEIGKLLGHGTFAKVYHARNV S ESVAIKVIDKEK
Sbjct: 2 ADRQSKENTSKRKNGENQSLLLGRYEIGKLLGHGTFAKVYHARNVGSNESVAIKVIDKEK 61
Query: 64 ILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK 123
ILK GL+AHIKREISILRRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLK
Sbjct: 62 ILKGGLIAHIKREISILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLK 121
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183
E++ARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE GDLKVSDFGLSAVSDQ+RQDGL
Sbjct: 122 EEVARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEAGDLKVSDFGLSAVSDQMRQDGL 181
Query: 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG 243
FHTFCGTPAYVAPEVL+RKGYDA+KVDIWSCGVILFVLMAGYLPF DQNIM MYKKIYKG
Sbjct: 182 FHTFCGTPAYVAPEVLARKGYDASKVDIWSCGVILFVLMAGYLPFHDQNIMAMYKKIYKG 241
Query: 244 EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDD--KMCNV 301
EFR PRWFSP+L RLLT+LLDTNP+ RITIPEIMENRWF+KGFKHIKFYIEDD ++CN
Sbjct: 242 EFRCPRWFSPELARLLTRLLDTNPETRITIPEIMENRWFKKGFKHIKFYIEDDTLRLCNA 301
Query: 302 EDVDHTDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLF 361
E+ + DDV SD E ELET+R+L++LPRPASLNAFD+ISFSPGFDLSGLF
Sbjct: 302 EEAE--DDVESLSDQSMSES---ESELETRRRLSTLPRPASLNAFDIISFSPGFDLSGLF 356
Query: 362 EEGGEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIF 421
EEGG ARFVSGAPVSKII+KLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIA EIF
Sbjct: 357 EEGGGDARFVSGAPVSKIISKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIAAEIF 416
Query: 422 ELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDESESAVVA------------- 468
ELTP LVVVEVKKKGGDKGEYEEFCN+ELKP L+NL+ D + S+
Sbjct: 417 ELTPSLVVVEVKKKGGDKGEYEEFCNRELKPVLQNLVDDSAASSHFQNSLHKGECGQLSN 476
Query: 469 ----------AVDDAL---HLPSDTE 481
VDD+ HLPSDTE
Sbjct: 477 LELESGLKNLVVDDSASTPHLPSDTE 502
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147792424|emb|CAN63583.1| hypothetical protein VITISV_006470 [Vitis vinifera] gi|229609803|gb|ACQ83517.1| CBL-interacting protein kinase 01 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2016), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/456 (84%), Positives = 413/456 (90%), Gaps = 7/456 (1%)
Query: 4 ATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEK 63
A + +T+ +NQS LLGRYEIGKLLGHGTFAKVYHARNV+S ESVAIKVIDKEK
Sbjct: 2 ADRQSKENTSKRKNGENQSLLLGRYEIGKLLGHGTFAKVYHARNVRSNESVAIKVIDKEK 61
Query: 64 ILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK 123
ILK GL+AHIKREISILRRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLK
Sbjct: 62 ILKGGLIAHIKREISILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLK 121
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183
E++ARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE GDLKVSDFGLSAVSDQ+RQDGL
Sbjct: 122 EEVARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEAGDLKVSDFGLSAVSDQMRQDGL 181
Query: 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG 243
FHTFCGTPAYVAPEVL+RKGYDA+KVDIWSCGVILFVLMAGYLPF DQNIM MYKKIYKG
Sbjct: 182 FHTFCGTPAYVAPEVLARKGYDASKVDIWSCGVILFVLMAGYLPFHDQNIMAMYKKIYKG 241
Query: 244 EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDD--KMCNV 301
EFR PRWFSP+L RLLT+LLDTNP+ RITIPEIMENRWF+KGFKHIKFYIEDD ++CN
Sbjct: 242 EFRCPRWFSPELARLLTRLLDTNPETRITIPEIMENRWFKKGFKHIKFYIEDDTXRLCNA 301
Query: 302 EDVDHTDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLF 361
E+ + DDV SD E ELET+R+L++LPRPASLNAFD+ISFSPGFDLSGLF
Sbjct: 302 EEAE--DDVESLSDQSMSES---ESELETRRRLSTLPRPASLNAFDIISFSPGFDLSGLF 356
Query: 362 EEGGEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIF 421
EEGG ARFVSGAPVSKII+KLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIA EIF
Sbjct: 357 EEGGGDARFVSGAPVSKIISKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIAAEIF 416
Query: 422 ELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENL 457
ELTP LVVVEVKKKGGDKGEYEEFCN+ELKP L+NL
Sbjct: 417 ELTPSLVVVEVKKKGGDKGEYEEFCNRELKPVLQNL 452
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483761|ref|XP_003633013.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 12 isoform 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/456 (84%), Positives = 412/456 (90%), Gaps = 7/456 (1%)
Query: 4 ATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEK 63
A + +T+ +NQS LLGRYEIGKLLGHGTFAKVYHARNV S ESVAIKVIDKEK
Sbjct: 2 ADRQSKENTSKRKNGENQSLLLGRYEIGKLLGHGTFAKVYHARNVGSNESVAIKVIDKEK 61
Query: 64 ILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK 123
ILK GL+AHIKREISILRRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLK
Sbjct: 62 ILKGGLIAHIKREISILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLK 121
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183
E++ARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE GDLKVSDFGLSAVSDQ+RQDGL
Sbjct: 122 EEVARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEAGDLKVSDFGLSAVSDQMRQDGL 181
Query: 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG 243
FHTFCGTPAYVAPEVL+RKGYDA+KVDIWSCGVILFVLMAGYLPF DQNIM MYKKIYKG
Sbjct: 182 FHTFCGTPAYVAPEVLARKGYDASKVDIWSCGVILFVLMAGYLPFHDQNIMAMYKKIYKG 241
Query: 244 EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDD--KMCNV 301
EFR PRWFSP+L RLLT+LLDTNP+ RITIPEIMENRWF+KGFKHIKFYIEDD ++CN
Sbjct: 242 EFRCPRWFSPELARLLTRLLDTNPETRITIPEIMENRWFKKGFKHIKFYIEDDTLRLCNA 301
Query: 302 EDVDHTDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLF 361
E+ + DDV SD E ELET+R+L++LPRPASLNAFD+ISFSPGFDLSGLF
Sbjct: 302 EEAE--DDVESLSDQSMSES---ESELETRRRLSTLPRPASLNAFDIISFSPGFDLSGLF 356
Query: 362 EEGGEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIF 421
EEGG ARFVSGAPVSKII+KLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIA EIF
Sbjct: 357 EEGGGDARFVSGAPVSKIISKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIAAEIF 416
Query: 422 ELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENL 457
ELTP LVVVEVKKKGGDKGEYEEFCN+ELKP L+NL
Sbjct: 417 ELTPSLVVVEVKKKGGDKGEYEEFCNRELKPVLQNL 452
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433744|ref|XP_004134657.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 12-like [Cucumis sativus] gi|449508592|ref|XP_004163356.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 12-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 774 bits (1998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/478 (79%), Positives = 418/478 (87%), Gaps = 12/478 (2%)
Query: 4 ATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEK 63
A P T +++ + LLGRYEIGKLLGHGTFAKVYHARN+K+ +SVAIKVIDKEK
Sbjct: 2 ADRPDPDKKTETTRKDMPALLLGRYEIGKLLGHGTFAKVYHARNIKTNDSVAIKVIDKEK 61
Query: 64 ILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK 123
ILK GL+AHIKREISILRRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELF KV+KGRLK
Sbjct: 62 ILKGGLIAHIKREISILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFKKVSKGRLK 121
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183
E++ARKYFQQLISAV FCHARGVYHRDLKPENLLLDENG+LKVSDFGLSAVSDQIRQDGL
Sbjct: 122 EEVARKYFQQLISAVAFCHARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGL 181
Query: 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG 243
FHTFCGTPAYVAPEVL+RKGY+AAKVDIWSCGVILFVLMAGYLPF DQNIM MYKKIYKG
Sbjct: 182 FHTFCGTPAYVAPEVLARKGYEAAKVDIWSCGVILFVLMAGYLPFHDQNIMAMYKKIYKG 241
Query: 244 EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVED 303
EFR PRWFSP+LIRLLT+LLDTNP+ R TIPEIMENRWF+KG+KHIKFYIEDDK+C++E
Sbjct: 242 EFRCPRWFSPELIRLLTRLLDTNPETRFTIPEIMENRWFKKGYKHIKFYIEDDKVCSIE- 300
Query: 304 VDHTDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEE 363
D TDDV S +ET+RK+TSLPRPASLNAFD+ISFSPGFDLSGLFE+
Sbjct: 301 -DDTDDVD--SLSDQSQSESDSEIIETRRKVTSLPRPASLNAFDIISFSPGFDLSGLFED 357
Query: 364 GGEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFEL 423
GGE ARFVS APVSKII+KLEEIAK+VSFTVRKKDCRVSLEGSREGVKGPLTIA E+FEL
Sbjct: 358 GGEEARFVSSAPVSKIISKLEEIAKLVSFTVRKKDCRVSLEGSREGVKGPLTIAAEVFEL 417
Query: 424 TPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDESESAVVAAVDDALHLPSDTE 481
TPKLV+VEVK+KGGDK EYE+FCN ELKP L NL +++S D H+PSDTE
Sbjct: 418 TPKLVMVEVKRKGGDKEEYEQFCNNELKPALLNLKVEDS--------GDPSHIPSDTE 467
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297800192|ref|XP_002867980.1| CIPK12 [Arabidopsis lyrata subsp. lyrata] gi|297313816|gb|EFH44239.1| CIPK12 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1982), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/486 (78%), Positives = 423/486 (87%), Gaps = 17/486 (3%)
Query: 10 TSTTSSSKDQN--QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS 67
T TS K+++ Q+ +LGRYE+GKLLGHGTFAKVY ARNVKSGESVAIKVIDKEK+LK
Sbjct: 6 TRETSLPKERSSPQALILGRYEMGKLLGHGTFAKVYLARNVKSGESVAIKVIDKEKVLKG 65
Query: 68 GLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLA 127
GL+AHIKREISILRRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLKE++A
Sbjct: 66 GLIAHIKREISILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVA 125
Query: 128 RKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187
RKYFQQLISAV FCHARGVYHRDLKPENLLLDENG+LKVSDFGLSAVSDQIRQDGLFHTF
Sbjct: 126 RKYFQQLISAVTFCHARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTF 185
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS 247
CGTPAYVAPEVL+RKGYDAAKVDIWSCGVILFVLMAGYLPF D+N+M MYKKIY+GEFR
Sbjct: 186 CGTPAYVAPEVLARKGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRC 245
Query: 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHT 307
PRWFS +L RLL+KLL+TNP+KR T PEIMEN WF+KGFKHIKFY+EDDK+CNV VD
Sbjct: 246 PRWFSAELTRLLSKLLETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNV--VDDN 303
Query: 308 DDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGEG 367
+ D ++SE E E LE +R++ LPRPASLNAFD+ISFS GFDLSGLF++ GEG
Sbjct: 304 ELESESDRDSAVSESEIE-YLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDDDGEG 362
Query: 368 ARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPKL 427
+RFVSGAPVSKII+KLEEIAKVVSFTVRKKDCRVSLEGSR+GVKGPLTIA EIFELTP L
Sbjct: 363 SRFVSGAPVSKIISKLEEIAKVVSFTVRKKDCRVSLEGSRQGVKGPLTIAAEIFELTPSL 422
Query: 428 VVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDE--SESAVVAAVDDA----------LH 475
VVVEVKKKGGDK EYEEFCN ELKP L+NL D+ +E +V+AVD+
Sbjct: 423 VVVEVKKKGGDKTEYEEFCNNELKPKLQNLTADDVVAEPVMVSAVDETETAIANSPPVCF 482
Query: 476 LPSDTE 481
LPSDTE
Sbjct: 483 LPSDTE 488
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114650|ref|XP_002316819.1| predicted protein [Populus trichocarpa] gi|222859884|gb|EEE97431.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/443 (87%), Positives = 415/443 (93%), Gaps = 6/443 (1%)
Query: 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL 80
QSPLLGRYEIGKLLGHGTFAKVYHARNVK+ ESVAIKVIDKEKILK GL+AHIKREISIL
Sbjct: 1 QSPLLGRYEIGKLLGHGTFAKVYHARNVKTNESVAIKVIDKEKILKVGLMAHIKREISIL 60
Query: 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140
RRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLKE++AR+YFQQLISAV F
Sbjct: 61 RRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARRYFQQLISAVSF 120
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLS 200
CHARGV+HRDLKPENLLLDENG+LKVSDFGLSAV DQIRQDGLFHTFCGTPAYVAPEVL+
Sbjct: 121 CHARGVFHRDLKPENLLLDENGNLKVSDFGLSAVPDQIRQDGLFHTFCGTPAYVAPEVLA 180
Query: 201 RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260
+KGYDAAKVDIWSCG++LFVLMAGYLPFQDQNIMVMYKKIYKGEFR PRWFS +L+RLL+
Sbjct: 181 KKGYDAAKVDIWSCGIVLFVLMAGYLPFQDQNIMVMYKKIYKGEFRCPRWFSSELVRLLS 240
Query: 261 KLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHSLS 320
KLLDTNP RITIPEIMENRWF+KGFKHIKFYIEDDK+C+V+D DDVG SD
Sbjct: 241 KLLDTNPVTRITIPEIMENRWFKKGFKHIKFYIEDDKVCSVQD---EDDVGSSSDQSLSE 297
Query: 321 EPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGEGARFVSGAPVSKII 380
E E ET+R++T+LPRPASLNAFD+ISFSPGFDLSGLFEEGGEGARFVSGAPVSKII
Sbjct: 298 S---ESEFETRRRVTTLPRPASLNAFDIISFSPGFDLSGLFEEGGEGARFVSGAPVSKII 354
Query: 381 TKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKG 440
+KLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIA EIFELTPKLVVVEVKKKGGDKG
Sbjct: 355 SKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIAAEIFELTPKLVVVEVKKKGGDKG 414
Query: 441 EYEEFCNKELKPGLENLMLDESE 463
EYEEFCN+ELKPGL+ LM +ESE
Sbjct: 415 EYEEFCNRELKPGLQKLMQEESE 437
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233981|ref|NP_193605.1| CBL-interacting serine/threonine-protein kinase 12 [Arabidopsis thaliana] gi|75337443|sp|Q9SN43.1|CIPKC_ARATH RecName: Full=CBL-interacting serine/threonine-protein kinase 12; AltName: Full=SNF1-related kinase 3.9; AltName: Full=SOS2-like protein kinase PKS8 gi|13249123|gb|AAK16687.1|AF295667_1 CBL-interacting protein kinase 12 [Arabidopsis thaliana] gi|13448041|gb|AAK26847.1|AF339149_1 SOS2-like protein kinase PKS8 [Arabidopsis thaliana] gi|4539389|emb|CAB37455.1| putative protein kinase [Arabidopsis thaliana] gi|7268664|emb|CAB78872.1| putative protein kinase [Arabidopsis thaliana] gi|16648899|gb|AAL24301.1| putative protein kinase [Arabidopsis thaliana] gi|24899685|gb|AAN65057.1| putative protein kinase [Arabidopsis thaliana] gi|332658678|gb|AEE84078.1| CBL-interacting serine/threonine-protein kinase 12 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/485 (78%), Positives = 422/485 (87%), Gaps = 14/485 (2%)
Query: 10 TSTTSSSKDQN--QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS 67
T TS K+++ Q+ +LGRYE+GKLLGHGTFAKVY ARNVK+ ESVAIKVIDKEK+LK
Sbjct: 6 TRETSLPKERSSPQALILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKG 65
Query: 68 GLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLA 127
GL+AHIKREISILRRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLKE++A
Sbjct: 66 GLIAHIKREISILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVA 125
Query: 128 RKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187
RKYFQQLISAV FCHARGVYHRDLKPENLLLDENG+LKVSDFGLSAVSDQIRQDGLFHTF
Sbjct: 126 RKYFQQLISAVTFCHARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTF 185
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS 247
CGTPAYVAPEVL+RKGYDAAKVDIWSCGVILFVLMAGYLPF D+N+M MYKKIY+GEFR
Sbjct: 186 CGTPAYVAPEVLARKGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRC 245
Query: 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHT 307
PRWFS +L RLL+KLL+TNP+KR T PEIMEN WF+KGFKHIKFY+EDDK+CNV D D
Sbjct: 246 PRWFSTELTRLLSKLLETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDEL 305
Query: 308 DDVGPCSD-DHSLSEPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGE 366
+ SD D + SE E E LE +R++ LPRPASLNAFD+ISFS GFDLSGLF++ GE
Sbjct: 306 ESDSVESDRDSAASESEIE-YLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDDDGE 364
Query: 367 GARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPK 426
G+RFVSGAPVSKII+KLEEIAKVVSFTVRKKDCRVSLEGSR+GVKGPLTIA EIFELTP
Sbjct: 365 GSRFVSGAPVSKIISKLEEIAKVVSFTVRKKDCRVSLEGSRQGVKGPLTIAAEIFELTPS 424
Query: 427 LVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDE--SESAVVAAVDDAL--------HL 476
LVVVEVKKKGGDK EYE+FCN ELKP L+NL D+ +E V+AVD+ L
Sbjct: 425 LVVVEVKKKGGDKTEYEDFCNNELKPKLQNLTADDVVAEPVAVSAVDETAIPNSPTISFL 484
Query: 477 PSDTE 481
PSDTE
Sbjct: 485 PSDTE 489
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224089521|ref|XP_002335043.1| predicted protein [Populus trichocarpa] gi|222832731|gb|EEE71208.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/443 (87%), Positives = 415/443 (93%), Gaps = 6/443 (1%)
Query: 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL 80
QSPLLGRYEIGKLLGHGTFAKVYHARNVK+ ESVAIKVIDKEKILK GL+AHIKREISIL
Sbjct: 1 QSPLLGRYEIGKLLGHGTFAKVYHARNVKTNESVAIKVIDKEKILKVGLMAHIKREISIL 60
Query: 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140
RRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLKE++AR+YFQQLISAV F
Sbjct: 61 RRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARRYFQQLISAVSF 120
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLS 200
CHARGV+HRDLKPENLLLDENG+LKVSDFGLSAV DQIRQDGLFHTFCGTPAYVAPEVL+
Sbjct: 121 CHARGVFHRDLKPENLLLDENGNLKVSDFGLSAVPDQIRQDGLFHTFCGTPAYVAPEVLA 180
Query: 201 RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260
+KGYDAAKVDIWSCG++LFVLMAGYLPFQDQNIMVMYKKIYKGEFR PRWFS +L+RLL+
Sbjct: 181 KKGYDAAKVDIWSCGIVLFVLMAGYLPFQDQNIMVMYKKIYKGEFRCPRWFSSELVRLLS 240
Query: 261 KLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHSLS 320
KLLDTNP RITIPEIMENRWF+KGFKHIKFYIEDDK+C+V+D DDVG SD
Sbjct: 241 KLLDTNPVTRITIPEIMENRWFKKGFKHIKFYIEDDKVCSVQD---EDDVGSSSDQSLSE 297
Query: 321 EPEPEPELETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGEGARFVSGAPVSKII 380
E E ET+R++T+LPRPASLNAFD+ISFSPGFDLSGLFEEGGEGARFVSGAPV+KII
Sbjct: 298 S---ESEFETRRRVTTLPRPASLNAFDIISFSPGFDLSGLFEEGGEGARFVSGAPVTKII 354
Query: 381 TKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKG 440
+KLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIA EIFELTPKLVVVEVKKKGGDKG
Sbjct: 355 SKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIAAEIFELTPKLVVVEVKKKGGDKG 414
Query: 441 EYEEFCNKELKPGLENLMLDESE 463
EYEEFCN+ELKPGL+ LM +ESE
Sbjct: 415 EYEEFCNRELKPGLQKLMQEESE 437
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 481 | ||||||
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.908 | 0.893 | 0.784 | 1.1e-183 | |
| TAIR|locus:2152370 | 483 | CIPK19 "CBL-interacting protei | 0.916 | 0.913 | 0.734 | 8.6e-175 | |
| TAIR|locus:2029974 | 520 | CIPK18 "CBL-interacting protei | 0.933 | 0.863 | 0.719 | 6.9e-173 | |
| UNIPROTKB|Q84XC0 | 516 | Q84XC0 "Calcineurin B-like-int | 0.598 | 0.558 | 0.813 | 1.4e-170 | |
| TAIR|locus:2040824 | 502 | CIPK13 "CBL-interacting protei | 0.900 | 0.862 | 0.686 | 9.6e-160 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.567 | 0.621 | 0.681 | 1.2e-125 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.542 | 0.591 | 0.716 | 6.5e-123 | |
| TAIR|locus:2181057 | 442 | SR1 "serine/threonine protein | 0.584 | 0.635 | 0.674 | 2.5e-119 | |
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.908 | 0.912 | 0.514 | 6e-119 | |
| TAIR|locus:2065781 | 435 | SIP4 "SOS3-interacting protein | 0.580 | 0.641 | 0.694 | 9.7e-118 |
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1782 (632.4 bits), Expect = 1.1e-183, P = 1.1e-183
Identities = 343/437 (78%), Positives = 375/437 (85%)
Query: 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL 80
Q+ +LGRYE+GKLLGHGTFAKVY ARNVK+ ESVAIKVIDKEK+LK GL+AHIKREISIL
Sbjct: 19 QALILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISIL 78
Query: 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140
RRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLKE++ARKYFQQLISAV F
Sbjct: 79 RRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTF 138
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLS 200
CHARGVYHRDLKPENLLLDENG+LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL+
Sbjct: 139 CHARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLA 198
Query: 201 RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260
RKGYDAAKVDIWSCGVILFVLMAGYLPF D+N+M MYKKIY+GEFR PRWFS +L RLL+
Sbjct: 199 RKGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLS 258
Query: 261 KLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHXXX 320
KLL+TNP+KR T PEIMEN WF+KGFKHIKFY+EDDK+CNV D D + SD
Sbjct: 259 KLLETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESDSVESDRDSAA 318
Query: 321 XXXXXXXXXTKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGEGARFVSGAPVSKII 380
+R++ LPRPASLNAFD+ISFS GFDLSGLF++ GEG+RFVSGAPVSKII
Sbjct: 319 SESEIEYLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDDDGEGSRFVSGAPVSKII 378
Query: 381 TKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPKLXXXXXXXXXXXXX 440
+KLEEIAKVVSFTVRKKDCRVSLEGSR+GVKGPLTIA EIFELTP L
Sbjct: 379 SKLEEIAKVVSFTVRKKDCRVSLEGSRQGVKGPLTIAAEIFELTPSLVVVEVKKKGGDKT 438
Query: 441 XXXXFCNKELKPGLENL 457
FCN ELKP L+NL
Sbjct: 439 EYEDFCNNELKPKLQNL 455
|
|
| TAIR|locus:2152370 CIPK19 "CBL-interacting protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1698 (602.8 bits), Expect = 8.6e-175, P = 8.6e-175
Identities = 326/444 (73%), Positives = 374/444 (84%)
Query: 17 KDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKRE 76
+ +Q+ +LG+YE+G+LLGHGTFAKVY ARN +SGESVAIKVIDKEK+LKSGL+AHIKRE
Sbjct: 17 QSNHQALILGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKRE 76
Query: 77 ISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLIS 136
ISILRRVRHPNIVQLFEVMATKSKIYFVMEYV+GGELFNKVAKGRLKE++ARKYFQQLIS
Sbjct: 77 ISILRRVRHPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAKGRLKEEMARKYFQQLIS 136
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP 196
AV FCH RGVYHRDLKPENLLLDENG+LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP
Sbjct: 137 AVSFCHFRGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP 196
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLI 256
EVL+RKGYD AKVDIWSCGVILFVLMAG+LPF D+N+M MYKKIY+G+FR PRWF ++
Sbjct: 197 EVLARKGYDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEIN 256
Query: 257 RLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDD-KMCNVEDVDHTDDVGPCSD 315
RLL ++L+T P++R T+P+IME WF+KGFKHIKFY+EDD ++CNV D D + + S
Sbjct: 257 RLLIRMLETKPERRFTMPDIMETSWFKKGFKHIKFYVEDDHQLCNVADDDEIESIESVSG 316
Query: 316 DHXXXXXXXXXXXXT-KRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGEGARFVSGA 374
+R+ S+PRPASLNAFDLISFSPGFDLSGLFE+ GEG+RFVSGA
Sbjct: 317 RSSTVSEPEDFESFDGRRRGGSMPRPASLNAFDLISFSPGFDLSGLFEDDGEGSRFVSGA 376
Query: 375 PVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREG-VKGPLTIATEIFELTPKLXXXXXX 433
PV +II+KLEEIA++VSFTVRKKDC+VSLEGSREG +KGPL+IA EIFELTP L
Sbjct: 377 PVGQIISKLEEIARIVSFTVRKKDCKVSLEGSREGSMKGPLSIAAEIFELTPALVVVEVK 436
Query: 434 XXXXXXXXXXXFCNKELKPGLENL 457
FCNKELKP L+NL
Sbjct: 437 KKGGDKMEYDEFCNKELKPKLQNL 460
|
|
| TAIR|locus:2029974 CIPK18 "CBL-interacting protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1680 (596.4 bits), Expect = 6.9e-173, P = 6.9e-173
Identities = 331/460 (71%), Positives = 370/460 (80%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
L+G+YE+GKLLGHGTFAKVY A+N+KSG+ VAIKVIDKEKI+KSGLVAHIKREISILRRV
Sbjct: 70 LMGKYELGKLLGHGTFAKVYLAQNIKSGDKVAIKVIDKEKIMKSGLVAHIKREISILRRV 129
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
RHP IV LFEVMATKSKIYFVMEYV GGELFN VAKGRL E+ AR+YFQQLIS+V FCH
Sbjct: 130 RHPYIVHLFEVMATKSKIYFVMEYVGGGELFNTVAKGRLPEETARRYFQQLISSVSFCHG 189
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
RGVYHRDLKPENLLLD G+LKVSDFGLSAV++Q+RQDGL HTFCGTPAY+APEVL+RKG
Sbjct: 190 RGVYHRDLKPENLLLDNKGNLKVSDFGLSAVAEQLRQDGLCHTFCGTPAYIAPEVLTRKG 249
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
YDAAK D+WSCGVILFVLMAG++PF D+NIMVMYKKIYKGEFR PRWFS DL+RLLT+LL
Sbjct: 250 YDAAKADVWSCGVILFVLMAGHIPFYDKNIMVMYKKIYKGEFRCPRWFSSDLVRLLTRLL 309
Query: 264 DTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHXXXXXX 323
DTNPD RITIPEIM+NRWF+KGFKH+KFYIEDDK+C ED D ++ S
Sbjct: 310 DTNPDTRITIPEIMKNRWFKKGFKHVKFYIEDDKLCR-EDEDEEEEAS--SSGRSSTVSE 366
Query: 324 XXXXXXTKRK-LTSLPRPASLNAFDLISFSPGFDLSGLFEE-GGEGARFVSGAPVSKIIT 381
KR + S+PRP+SLNAFD+ISFS GFDLSGLFEE GGEG RFVSGAPVSKII+
Sbjct: 367 SDAEFDVKRMGIGSMPRPSSLNAFDIISFSSGFDLSGLFEEEGGEGTRFVSGAPVSKIIS 426
Query: 382 KLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPKLXXXXXXXXXXXXXX 441
KLEEIAK+VSFTVRKK+ + LEG REG KGPLTIA EIFELTP L
Sbjct: 427 KLEEIAKIVSFTVRKKEWSLRLEGCREGAKGPLTIAAEIFELTPSLVVVEVKKKGGDREE 486
Query: 442 XXXFCNKELKPGLENLMLXXXXXXXXXXXXXXLHLPSDTE 481
FCNKEL+P LE L+ L+LPSDTE
Sbjct: 487 YEEFCNKELRPELEKLI------HEEVVVEEALYLPSDTE 520
|
|
| UNIPROTKB|Q84XC0 Q84XC0 "Calcineurin B-like-interacting protein kinase" [Pisum sativum (taxid:3888)] | Back alignment and assigned GO terms |
|---|
Score = 1271 (452.5 bits), Expect = 1.4e-170, Sum P(2) = 1.4e-170
Identities = 235/289 (81%), Positives = 267/289 (92%)
Query: 17 KDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKRE 76
K N + LLGR+E+GKLLGHGTFAKV+ A+N+K+GE+VAIK+I K+KILKSGLV+HIKRE
Sbjct: 15 KKDNPNLLLGRFELGKLLGHGTFAKVHLAKNIKTGEAVAIKIISKDKILKSGLVSHIKRE 74
Query: 77 ISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLIS 136
ISILRRVRHPNIVQLFEVMATK+KIYFVMEYVRGGELFNKVAKGRLKE++ARKYFQQLI
Sbjct: 75 ISILRRVRHPNIVQLFEVMATKTKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLIC 134
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP 196
AV FCHARGV+HRD+KPENLLLDENG+LKVSDFGLSAVSD+I+QDGLFHTFCGTPAYVAP
Sbjct: 135 AVEFCHARGVFHRDIKPENLLLDENGNLKVSDFGLSAVSDEIKQDGLFHTFCGTPAYVAP 194
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRSPRWFSPDL 255
EVLSRKGYD KVDIWSCGV+LFVLMAGYLPF D N+MVMYKKIYKG+FR PRWFSP+L
Sbjct: 195 EVLSRKGYDGGKVDIWSCGVVLFVLMAGYLPFHDPNNVMVMYKKIYKGDFRCPRWFSPEL 254
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDV 304
+ LLT+LLDT P RI+IPEIMENRWF+ GFK IKFY+EDD +CN++ +
Sbjct: 255 VNLLTRLLDTKPQTRISIPEIMENRWFKIGFKRIKFYVEDDVVCNLDSL 303
|
|
| TAIR|locus:2040824 CIPK13 "CBL-interacting protein kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1556 (552.8 bits), Expect = 9.6e-160, P = 9.6e-160
Identities = 300/437 (68%), Positives = 349/437 (79%)
Query: 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILR 81
S L+ +YEIGKLLGHG+FAKVY ARN+ SGE VAIKVIDKEKI+KSGL HIKREISILR
Sbjct: 51 SILMDKYEIGKLLGHGSFAKVYLARNIHSGEDVAIKVIDKEKIVKSGLAGHIKREISILR 110
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
RVRHP IV L EVMATK+KIY VMEYVRGGEL+N VA+GRL+E AR+YFQQLIS+V FC
Sbjct: 111 RVRHPYIVHLLEVMATKTKIYIVMEYVRGGELYNTVARGRLREGTARRYFQQLISSVAFC 170
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
H+RGVYHRDLK ENLLLD+ G++KVSDFGLS VS+Q++Q+G+ TFCGTPAY+APEVL+R
Sbjct: 171 HSRGVYHRDLKLENLLLDDKGNVKVSDFGLSVVSEQLKQEGICQTFCGTPAYLAPEVLTR 230
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261
KGY+ AK DIWSCGVILFVLMAGYLPF D+NI+VMY KIYKG+F+ P+WFSP+L RL+T+
Sbjct: 231 KGYEGAKADIWSCGVILFVLMAGYLPFDDKNILVMYTKIYKGQFKCPKWFSPELARLVTR 290
Query: 262 LLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHXXXX 321
+LDTNPD RITIPEIM++RWF+KGFKH+KFYIE+DK+C +D + DD S
Sbjct: 291 MLDTNPDTRITIPEIMKHRWFKKGFKHVKFYIENDKLCREDDDNDDDDSSSLSSGRSSTA 350
Query: 322 XXXXXXXXTKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGEGARFVSGAPVSKIIT 381
KR + S+PRPASLNAFD++SFS DLSGLFEEGG+GARFVS AP++KII+
Sbjct: 351 SEGDAEFDIKR-VDSMPRPASLNAFDILSFS---DLSGLFEEGGQGARFVSAAPMTKIIS 406
Query: 382 KLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTIATEIFELTPKLXXXXXXXXXXXXXX 441
KLEEIAK V F VRKKD V LEG REG KGPLTI EIFELTP L
Sbjct: 407 KLEEIAKEVKFMVRKKDWSVRLEGCREGAKGPLTIRVEIFELTPSLVVVEVKKKGGNIEE 466
Query: 442 XXXFCNKELKPGLENLM 458
FCNKEL+P LE LM
Sbjct: 467 YEEFCNKELRPQLEKLM 483
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1049 (374.3 bits), Expect = 1.2e-125, Sum P(2) = 1.2e-125
Identities = 186/273 (68%), Positives = 237/273 (86%)
Query: 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
D+N L+ +YE+G+LLG GTFAKVYHARN+K+GESVAIKVIDK+K+ K GL+ IKREI
Sbjct: 2 DKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREI 61
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
S++R VRHP++V L EVMA+K+KIYF MEYV+GGELF+KV+KG+LKE++ARKYFQQLI A
Sbjct: 62 SVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGA 121
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
+ +CH+RGVYHRDLKPENLLLDENGDLK+SDFGLSA+ + +QDGL HT CGTPAYVAPE
Sbjct: 122 IDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPE 181
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
V+ +KGYD AK D+WSCGV+L+VL+AG+LPF +QN++ MY+KI KGEF+ P WF P++ +
Sbjct: 182 VIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKK 241
Query: 258 LLTKLLDTNPDKRITIPEIMENRWFRKGFKHIK 290
LL+++LD NP+ RI I +IMEN WF+KGFK I+
Sbjct: 242 LLSRILDPNPNSRIKIEKIMENSWFQKGFKKIE 274
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 6.5e-123, Sum P(2) = 6.5e-123
Identities = 187/261 (71%), Positives = 229/261 (87%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
L GRYE+G+LLGHGTFAKVYHARN+++G+SVA+KV+ KEK++K G+V IKREIS++R V
Sbjct: 20 LHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMV 79
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
+HPNIV+L EVMA+KSKIYF ME VRGGELF KVAKGRL+ED+AR YFQQLISAV FCH+
Sbjct: 80 KHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCHS 139
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
RGVYHRDLKPENLLLDE G+LKV+DFGLSA ++ ++QDGL HT CGTPAYVAPEV+ +KG
Sbjct: 140 RGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKG 199
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
YD AK D+WSCGVILFVL+AGYLPFQD N++ MY+KIY+G+F+ P W S D RL+TKLL
Sbjct: 200 YDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLL 259
Query: 264 DTNPDKRITIPEIMENRWFRK 284
D NP+ RITI ++M++ WF+K
Sbjct: 260 DPNPNTRITIEKVMDSPWFKK 280
|
|
| TAIR|locus:2181057 SR1 "serine/threonine protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1054 (376.1 bits), Expect = 2.5e-119, Sum P(2) = 2.5e-119
Identities = 191/283 (67%), Positives = 240/283 (84%)
Query: 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
+ + L G+YE+GKL+G G FAKVYH R+ +G+SVAIKV+ K+++ K GL +I+REI
Sbjct: 12 ENRRGQLFGKYEVGKLVGCGAFAKVYHGRSTATGQSVAIKVVSKQRLQKGGLNGNIQREI 71
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
+I+ R+RHP+IV+LFEV+ATKSKI+FVME+ +GGELF KV+KGR EDL+R+YFQQLISA
Sbjct: 72 AIMHRLRHPSIVRLFEVLATKSKIFFVMEFAKGGELFAKVSKGRFCEDLSRRYFQQLISA 131
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
VG+CH+RG++HRDLKPENLLLDE DLK+SDFGLSA++DQIR DGL HT CGTPAYVAPE
Sbjct: 132 VGYCHSRGIFHRDLKPENLLLDEKLDLKISDFGLSALTDQIRPDGLLHTLCGTPAYVAPE 191
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
VL++KGYD AK+DIWSCG+ILFVL AGYLPF D N+MVMY+KIYKGEFR P+W SPDL R
Sbjct: 192 VLAKKGYDGAKIDIWSCGIILFVLNAGYLPFNDHNLMVMYRKIYKGEFRIPKWTSPDLRR 251
Query: 258 LLTKLLDTNPDKRITIPEIMENRWFRKGF--KHIKFYIEDDKM 298
LLT+LLDTNP RITI EI+ + WF++G+ + KF++ED M
Sbjct: 252 LLTRLLDTNPQTRITIEEIIHDPWFKQGYDDRMSKFHLEDSDM 294
|
|
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1171 (417.3 bits), Expect = 6.0e-119, P = 6.0e-119
Identities = 230/447 (51%), Positives = 315/447 (70%)
Query: 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
+ S L +Y++G+LLG GTFAKVY+ R++ + +SVAIK+IDKEK++K GL+ IKREI
Sbjct: 2 ENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREI 61
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
S++R RHPN+V+L+EVMATK++IYFVMEY +GGELFNKVAKG+L++D+A KYF QLI+A
Sbjct: 62 SVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINA 121
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
V FCH+R VYHRD+KPENLLLD+N +LKVSDFGLSA++D RQDGL HT CGTPAYVAPE
Sbjct: 122 VDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 181
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
V++RKGYD K DIWSCGV+LFVL+AGYLPF D N+M MY+KI K +F++P WF+P++ R
Sbjct: 182 VINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRR 241
Query: 258 LLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDH----TDDVGPC 313
LL K+LD NP+ RITI I E+ WFRKG H+K + ++ + V+ T++ G
Sbjct: 242 LLCKMLDPNPETRITIARIRESSWFRKGL-HMKQKKMEKRVKEINSVEAGTAGTNENGAG 300
Query: 314 SDDHXXXXXXXXXXXXTKRKLTSLPRPASLNAFDLISFSPGFDLSGLF-EEGGEGARFVS 372
++ T+ T P +LNAFDLI+ S GFDL+GLF ++ +RF S
Sbjct: 301 PSENGAGPSENGDRV-TEENHTD--EPTNLNAFDLIALSAGFDLAGLFGDDNKRESRFTS 357
Query: 373 GAPVSKIITKLEEIAKVVSFTVRKKDCRV-SLEGSREGVKGPLTIATEIFELTPKLXXXX 431
P S II+KLEE+A+ + ++RK++ + LE +EG KG L++ EIF++TP
Sbjct: 358 QKPASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVE 417
Query: 432 XXXXXXXXXXXXXFCNKELKPGLENLM 458
++L+P L +++
Sbjct: 418 VKKSNGDTLEYQKLVAEDLRPALSDIV 444
|
|
| TAIR|locus:2065781 SIP4 "SOS3-interacting protein 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 9.7e-118, Sum P(2) = 9.7e-118
Identities = 198/285 (69%), Positives = 247/285 (86%)
Query: 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH-IKREIS 78
N L G+YE+GKLLG G FAKV+HAR+ ++G+SVA+K+++K+K+L + +A+ IKREIS
Sbjct: 13 NNDALFGKYELGKLLGCGAFAKVFHARDRRTGQSVAVKILNKKKLLTNPALANNIKREIS 72
Query: 79 ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISA 137
I+RR+ HPNIV+L EVMATKSKI+F ME+V+GGELFNK++K GRL EDL+R+YFQQLISA
Sbjct: 73 IMRRLSHPNIVKLHEVMATKSKIFFAMEFVKGGELFNKISKHGRLSEDLSRRYFQQLISA 132
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
VG+CHARGVYHRDLKPENLL+DENG+LKVSDFGLSA++DQIR DGL HT CGTPAYVAPE
Sbjct: 133 VGYCHARGVYHRDLKPENLLIDENGNLKVSDFGLSALTDQIRPDGLLHTLCGTPAYVAPE 192
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
+LS+KGY+ AKVD+WSCG++LFVL+AGYLPF D N+M MYKKIYKGE+R PRW SPDL R
Sbjct: 193 ILSKKGYEGAKVDVWSCGIVLFVLVAGYLPFNDPNVMNMYKKIYKGEYRFPRWMSPDLKR 252
Query: 258 LLTKLLDTNPDKRITIPEIMENRWF-RKGFKHIKFY---IEDDKM 298
+++LLD NP+ RITI EI+++ WF R GFK IKF+ IED K+
Sbjct: 253 FVSRLLDINPETRITIDEILKDPWFVRGGFKQIKFHDDEIEDQKV 297
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SN43 | CIPKC_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7855 | 0.9792 | 0.9631 | yes | no |
| Q9LP51 | CIPKI_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7389 | 0.9646 | 0.8923 | no | no |
| Q9FJ55 | CIPKJ_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7565 | 0.9501 | 0.9461 | no | no |
| Q68Y49 | CIPKJ_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6659 | 0.9334 | 0.8838 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 481 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-112 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-97 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-86 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-83 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-73 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-71 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-69 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-67 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-64 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-63 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-61 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-61 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-59 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-58 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-58 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-56 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-56 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-56 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-54 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-54 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-54 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-53 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-53 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-52 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-50 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-49 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-49 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-49 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-49 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-48 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-48 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-47 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 1e-47 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-47 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-47 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-47 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-47 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-47 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-46 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-46 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-46 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-46 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-46 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-46 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-46 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-45 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-45 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-45 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-44 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-44 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-43 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-42 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-42 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-42 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-42 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-42 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-42 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-42 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-42 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-42 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-42 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-41 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-40 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-40 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-40 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-39 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-39 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-39 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-38 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-38 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-38 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-38 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-38 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-38 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-37 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-37 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-37 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-37 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-37 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-37 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-37 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-37 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-36 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-36 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-36 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-36 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-35 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-35 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-35 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-35 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-35 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-35 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-35 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-35 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-35 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-35 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-34 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-34 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-34 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-34 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-34 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-33 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-33 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-33 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-32 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-31 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-31 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-31 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-31 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-31 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-31 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-31 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-31 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-31 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-30 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-30 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-30 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-30 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-30 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-30 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-30 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-30 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-30 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-30 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-30 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-29 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-29 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-29 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-29 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-29 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-29 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-28 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-28 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-27 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-27 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-27 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-27 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-27 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-27 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-27 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-26 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-25 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-25 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-25 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-24 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-24 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-24 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-24 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-24 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-24 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-23 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-23 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-23 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-22 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-22 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-20 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-18 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-18 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-15 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| TIGR01982 | 437 | TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 4e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 5e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.001 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 331 bits (851), Expect = e-112
Identities = 126/260 (48%), Positives = 175/260 (67%), Gaps = 11/260 (4%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
YEI + LG G+F KVY AR+ K+G+ VAIKVI K+KI K I REI IL++++HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARGV 146
IV+L++V + K+Y VMEY GG+LF+ +GRL ED AR Y +Q++SA+ + H++G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
HRDLKPEN+LLDE+G +K++DFGL+ Q+ TF GTP Y+APEVL KGY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYG- 174
Query: 207 AKVDIWSCGVILFVLMAGYLPFQ-DQNIMVMYKKIYKG--EFRSPRW-FSPDLIRLLTKL 262
VDIWS GVIL+ L+ G PF D ++ ++KKI K F P W SP+ L+ KL
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 263 LDTNPDKRITIPEIMENRWF 282
L +P+KR+T E +++ +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 292 bits (749), Expect = 8e-97
Identities = 104/263 (39%), Positives = 150/263 (57%), Gaps = 11/263 (4%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
YE+ + LG G+F VY A++ +G+ VA+K++ K REI ILRR+ HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARGV 146
IV+L + K +Y VMEY GG+LF+ G L ED A+K Q++ + + H+ G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
HRDLKPEN+LLDENG +K++DFGL+ ++ TF GTP Y+APEVL
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 207 AKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYKGEFRSPRWF----SPDLIRLL 259
KVD+WS GVIL+ L+ G PF +NI + + ++I S + L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 260 TKLLDTNPDKRITIPEIMENRWF 282
K L+ +P KR T EI+++ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (681), Expect = 1e-86
Identities = 106/253 (41%), Positives = 156/253 (61%), Gaps = 7/253 (2%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G+F KV R +G+ A+KV+ K+KI+K V H E +IL R+ HP IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLK 152
T+ K+Y V+EY GGELF+ ++K GR E+ AR Y +++ A+ + H+ G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 153 PENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW 212
PEN+LLD +G +K++DFGL+ + +TFCGTP Y+APEVL KGY A VD W
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDWW 177
Query: 213 SCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRIT 272
S GV+L+ ++ G PF ++ +Y+KI K R P + SP+ L++ LL +P KR+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 273 ---IPEIMENRWF 282
EI + +F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 2e-83
Identities = 108/262 (41%), Positives = 161/262 (61%), Gaps = 12/262 (4%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+E K LG G+F +V R+ SG+ A+K++ K KI+K V H+ E IL+ +RHP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGV 146
+V L+ S +Y VMEYV GGELF+ + K GR E +AR Y Q++ A+ + H+ +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
+RDLKPENLLLD +G +K++DFG + R G +T CGTP Y+APE++ KGY
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177
Query: 207 AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTN 266
A VD W+ G++++ ++AGY PF D N + +Y+KI +G+ R P +FSPD L+ LL +
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 267 PDKRI-----TIPEIMENRWFR 283
KR+ + +I + WF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 5e-73
Identities = 101/249 (40%), Positives = 142/249 (57%), Gaps = 38/249 (15%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G F VY AR+ K+G+ VAIK+I KE S L+ + REI IL+++ HPNIV+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDL 151
V ++ +Y VMEY GG L + + + G+L ED + Q++ + + H+ G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 152 KPENLLLDE-NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVD 210
KPEN+LLD NG +K++DFGLS + L T GTPAY+APEVL KGY + K D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270
IWS GVIL+ L P+L L+ K+L +P+KR
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 271 ITIPEIMEN 279
+ EI+E+
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 2e-71
Identities = 90/281 (32%), Positives = 155/281 (55%), Gaps = 29/281 (10%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHP 86
++ GK++G G+F+ V A+ ++ + AIK++DK +++K V ++K E +L R+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARG 145
I++L+ + +YFV+EY GEL + K G L E R Y +++ A+ + H++G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAV------SDQIRQDGLFH------------TF 187
+ HRDLKPEN+LLD++ +K++DFG + V + + D +F
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 188 CGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF 245
GT YV+PE+L+ K G D+W+ G I++ ++ G PF+ N + ++KI K E+
Sbjct: 183 VGTAEYVSPELLNEKPAGK---SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 246 RSPRWFSPDLIRLLTKLLDTNPDKRITI----PEIMENRWF 282
P F PD L+ KLL +P R+ + E+ + +F
Sbjct: 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 221 bits (567), Expect = 2e-69
Identities = 93/265 (35%), Positives = 147/265 (55%), Gaps = 22/265 (8%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID------KEKILKSGLVAHIKREISIL 80
+YEI K +G G+F KVY R G+ +K ID KE+ E+ IL
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53
Query: 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR-----LKEDLARKYFQQLI 135
+++ HPNI++ +E K K+ VMEY GG+L K+ K + E+ +F QL
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195
A+ + H+R + HRD+KP+N+ L NG +K+ DFG+S V L T GTP Y++
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLS 171
Query: 196 PEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWFSPD 254
PE+ K Y+ K DIWS G +L+ L PF+ +N++ + KI KG++ P +S +
Sbjct: 172 PELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230
Query: 255 LIRLLTKLLDTNPDKRITIPEIMEN 279
L L++ LL +P++R +I +I+++
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 8e-67
Identities = 93/258 (36%), Positives = 146/258 (56%), Gaps = 13/258 (5%)
Query: 37 GTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96
G + +V+ A+ +G+ AIKVI K +++ V + E IL + + P +V+L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 97 TKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPEN 155
K +Y VMEY+ GG+L + + G L ED+AR Y +++ A+ + H+ G+ HRDLKP+N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 156 LLLDENGDLKVSDFGLSAVSDQIRQDGLF------HTFCGTPAYVAPEVLSRKGYDAAKV 209
+L+D NG LK++DFGLS V RQ L GTP Y+APEV+ +G+ V
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT-V 182
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF--SPDLIRLLTKLLDTNP 267
D WS G IL+ + G PF + +++ I G+ P S + I L++KLL +P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 268 DKRI---TIPEIMENRWF 282
+KR+ +I EI + +F
Sbjct: 243 EKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 6e-64
Identities = 98/259 (37%), Positives = 144/259 (55%), Gaps = 14/259 (5%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G F +V + + A+K + K I+++G HI E IL HP IV+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 94 VMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLK 152
K IY +MEY GGEL+ + +G E AR Y ++ A + H RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 153 PENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW 212
PENLLLD NG +K+ DFG + +++ TFCGTP YVAPE++ KGYD + VD W
Sbjct: 121 PENLLLDSNGYVKLVDFGF---AKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 213 SCGVILFVLMAGYLPFQ--DQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPD 268
S G++L+ L+ G PF D++ M +Y I KG + P + L+ +LL NP+
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 269 KRI-----TIPEIMENRWF 282
+R+ I +I +++WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 3e-63
Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 8/262 (3%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+ G+LLG G+F VY A + +GE +A+K ++ + L A ++REI IL ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-LEREIRILSSLQHP 59
Query: 87 NIVQLF--EVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA 143
NIV+ + E K+ + +EYV GG L + + K G+L E + RKY +Q++ + + H+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
G+ HRD+K N+L+D +G +K++DFG + I + GTP ++APEV+ +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPF--QDQNIMVMYKKIYKGEFRS-PRWFSPDLIRLLT 260
Y DIWS G + + G P+ + +YK GE P S + L
Sbjct: 180 YG-RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 261 KLLDTNPDKRITIPEIMENRWF 282
K L +P KR T E++++ +
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 1e-61
Identities = 103/249 (41%), Positives = 151/249 (60%), Gaps = 9/249 (3%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
L +E+G+ LG G+F +V A++ +GE AIK + K +ILK V H+ +E SIL +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA 143
HP IV + ++++YF++E+V GGELF + K GR D+A+ Y +L+ A + H+
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
+ + +RDLKPENLLLD G +KV+DFG + V D+ T CGTP Y+APEV+ K
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT------FTLCGTPEYLAPEVIQSK 190
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262
G+ A VD W+ GV+L+ +AGY PF D +Y+KI G + P WF L+ L
Sbjct: 191 GHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249
Query: 263 LDTNPDKRI 271
L T+ KR+
Sbjct: 250 LQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 6e-61
Identities = 107/258 (41%), Positives = 152/258 (58%), Gaps = 9/258 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
KLLG GTF KV R +G+ A+K++ KE I+ VAH E +L+ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAKGRL-KEDLARKYFQQLISAVGFCHARGVYHRD 150
T ++ FVMEY GGELF +++ R+ ED AR Y +++SA+G+ H+ V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVD 210
LK ENL+LD++G +K++DFGL + I TFCGTP Y+APEVL Y A VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGL--CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VD 177
Query: 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270
W GV+++ +M G LPF +Q+ +++ I E R PR SP+ LL LL +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 271 I-----TIPEIMENRWFR 283
+ EIME+R+F
Sbjct: 238 LGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-59
Identities = 94/273 (34%), Positives = 148/273 (54%), Gaps = 31/273 (11%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVID------KEKILKSGLVAHIKREISILR 81
YE+ + +G G+F V R G+ + K ID KEK LV+ E++ILR
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ---LVS----EVNILR 54
Query: 82 RVRHPNIVQLF--EVMATKSKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQL 134
++HPNIV+ + + + +Y VMEY GG+L + K ++E+ + QL
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 135 ISAVGFCHARG-----VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF-HTFC 188
+ A+ CH R V HRDLKP N+ LD N ++K+ DFGL+ + + D F T+
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI---LGHDSSFAKTYV 171
Query: 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS- 247
GTP Y++PE L+ YD K DIWS G +++ L A PF +N + + KI +G+FR
Sbjct: 172 GTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230
Query: 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENR 280
P +S +L ++ +L+ +PDKR + E+++
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 5e-58
Identities = 101/301 (33%), Positives = 150/301 (49%), Gaps = 65/301 (21%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRRV 83
YE + LG GT+ VY AR+ K+GE VA+K I ++E I + L REIS+L+ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-----REISLLKEL 55
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYV----RGGELFNKVAKGRLKEDLARKYFQQLISAVG 139
+HPNIV+L +V+ T+ K+Y V EY + + G L +L + QL+ +
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMDLKK---YLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPA-----Y 193
+CH+ + HRDLKP+N+L++ +G LK++DFGL+ A +R T Y
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--------THEVVTLWY 164
Query: 194 VAPEVL-SRKGYDAAKVDIWSCGVILFVLMAGYLPFQ-----DQ-----NIM-------- 234
APE+L K Y A VDIWS G I ++ G F DQ I+
Sbjct: 165 RAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW 223
Query: 235 --VMYKKIYKGEFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281
V YK F P++ P+ I LL+K+L NP KRI+ E +++ +
Sbjct: 224 PGVTKLPDYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
Query: 282 F 282
F
Sbjct: 282 F 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 5e-58
Identities = 89/264 (33%), Positives = 148/264 (56%), Gaps = 14/264 (5%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
E K +G GTF +V+ R+ S A+KV+ ++++ H+ E +L+ V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARGV 146
I++LF + +Y +MEYV GGELF+ + GR Y +++ A+ + H++ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+RDLKPEN+LLD+ G +K++DFG + + D+ T CGTP Y+APEV+ KG++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT------WTLCGTPEYLAPEVIQSKGHN 176
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265
A VD W+ G++++ ++ GY PF D N +Y+KI G+ PR L+ KLL
Sbjct: 177 KA-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235
Query: 266 NPDKRI-----TIPEIMENRWFRK 284
+ +R+ ++ +RWF+
Sbjct: 236 DRTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-56
Identities = 104/257 (40%), Positives = 151/257 (58%), Gaps = 9/257 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
KLLG GTF KV R +G A+K++ KE I+ VAH E +L+ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAKGRL-KEDLARKYFQQLISAVGFCHARGVYHRD 150
T ++ FVMEY GGELF +++ R+ E+ AR Y +++SA+ + H+R V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVD 210
+K ENL+LD++G +K++DFGL + I TFCGTP Y+APEVL Y A VD
Sbjct: 121 IKLENLMLDKDGHIKITDFGL--CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VD 177
Query: 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270
W GV+++ +M G LPF +Q+ +++ I E R PR SP+ LL LL +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 271 I-----TIPEIMENRWF 282
+ E+ME+R+F
Sbjct: 238 LGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 2e-56
Identities = 92/260 (35%), Positives = 145/260 (55%), Gaps = 14/260 (5%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+EI + +G G F +VY AR+ ++G+ VAIKVI E K I EI IL++ +HPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHPN 58
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARG 145
IV+ + K +++ VME+ GG L + K L E ++L+ + + H+ G
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+ HRD+K N+LL +G++K+ DFGLSA Q+ +T GTP ++APEV++ K YD
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 206 AAKVDIWSCGVILFVLMA-GYLPFQDQNIM-VMYKKIYKG--EFRSPRWFSPDLIRLLTK 261
K DIWS G I + +A G P+ + M ++K G R+P +S + L K
Sbjct: 176 -YKADIWSLG-ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 262 LLDTNPDKRITIPEIMENRW 281
L NP+KR T +++++ +
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 191 bits (485), Expect = 3e-56
Identities = 103/343 (30%), Positives = 148/343 (43%), Gaps = 30/343 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP- 86
Y I + LG G+F +VY AR+ K VA+KV+ K+ KS V REI IL + HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELF----NKVAKGRLKEDLARKYFQQLISAVGFCH 142
NIV+L++ + +Y VMEYV GG L KG L E A Q++SA+ + H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 143 ARGVYHRDLKPENLLLDENGD-LKVSDFGLSAVSDQIRQ----DGLFHTFCGTPAYVAPE 197
++G+ HRD+KPEN+LLD +G +K+ DFGL+ + L T GTP Y+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 198 VLS--RKGYDAAKVDIWSCGVILFVLMAGYLPFQ----DQNIMVMYKKIYKGEFRS---- 247
VL Y ++ DIWS G+ L+ L+ G PF+ K I + S
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 248 -----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVE 302
P S LL KLL +P R++ + + + K +
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK--PDD 296
Query: 303 DVDHTDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPASLNA 345
+ P + S + S
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPN 339
|
Length = 384 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 3e-54
Identities = 98/245 (40%), Positives = 143/245 (58%), Gaps = 8/245 (3%)
Query: 32 KLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGL-VAHIKREISILRRVRHPN 87
K+LG G + KV+ R V +G+ A+KV+ K I+++ AH K E +IL V+HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGV 146
IV L T K+Y ++EY+ GGELF + + G ED A Y ++ A+ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
+RDLKPEN+LLD G +K++DFGL + I + + HTFCGT Y+APE+L R G+
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGL--CKESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179
Query: 207 AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTN 266
A VD WS G +++ ++ G PF +N KI KG+ P + +P+ LL KLL N
Sbjct: 180 A-VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 267 PDKRI 271
P R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 5e-54
Identities = 97/327 (29%), Positives = 161/327 (49%), Gaps = 44/327 (13%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
+E+ K++G G F +V+ R+ +G+ A+KV+ K ++K +AH++ E IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHAR 144
P IV+L+ + +Y VMEY+ GG+L N + K E+ AR Y +L+ A+ H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSA---------------------------VSDQ 177
G HRD+KP+N+L+D +G +K++DFGL D
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY 237
++ ++ GTP Y+APEVL Y + D WS GVIL+ ++ G+ PF + Y
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 238 KKI--YKGEFRSP--RWFSPDLIRLLTKLLDTNPDKRIT-IPEIMENRWFRK-GFKHIK- 290
KI +K R P SP+ I L+ +LL +P+ R+ EI + +F+ +++++
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFKGIDWENLRE 298
Query: 291 ----FYIE---DDKMCNVEDVDHTDDV 310
F E N +D + D+
Sbjct: 299 TKPPFVPELSSPLDTSNFDDFEDDKDL 325
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 95/242 (39%), Positives = 141/242 (58%), Gaps = 5/242 (2%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
K+LG G+F KV A + E A+KV+ K+ IL+ V E +L +HP + Q
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 91 LFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L TK +++FVMEYV GG+L F+ GR E AR Y +++ + F H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N+LLD G +K++DFG+ + I TFCGTP Y+APE+LS + Y A V
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W+ GV+L+ ++AG PF+ + +++ I + E R PRW S + +L L NP+K
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 270 RI 271
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 5e-53
Identities = 94/242 (38%), Positives = 136/242 (56%), Gaps = 5/242 (2%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL-RRVRHPNIVQ 90
K++G G+F KV A++ G+ A+KV+ K+ ILK HI E ++L + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHR 149
L T K+YFV++YV GGELF + + R E AR Y ++ SA+G+ H+ + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLKPEN+LLD G + ++DFGL + I TFCGTP Y+APEVL ++ YD V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL--CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W G +L+ ++ G PF ++ MY I R S LL LL + K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 270 RI 271
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 8e-53
Identities = 104/257 (40%), Positives = 151/257 (58%), Gaps = 9/257 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
KLLG GTF KV R SG+ A+K++ KE I+ VAH E +L+ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAKGRL-KEDLARKYFQQLISAVGFCHARGVYHRD 150
TK ++ FVMEYV GGELF +++ R+ ED R Y +++SA+ + H+ + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVD 210
LK ENL+LD++G +K++DFGL + I TFCGTP Y+APEVL Y A VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGL--CKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA-VD 177
Query: 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270
W GV+++ +M G LPF +Q+ +++ I + + PR S D LL+ LL +P+KR
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 271 I-----TIPEIMENRWF 282
+ EIM + +F
Sbjct: 238 LGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 1e-52
Identities = 103/258 (39%), Positives = 153/258 (59%), Gaps = 10/258 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
KLLG GTF KV + +G A+K++ KE I+ VAH E +L+ RHP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAKGRL-KEDLARKYFQQLISAVGFCHA-RGVYHR 149
T ++ FVMEY GGELF +++ R+ ED AR Y +++SA+ + H+ + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK ENL+LD++G +K++DFGL + I+ TFCGTP Y+APEVL Y A V
Sbjct: 121 DLKLENLMLDKDGHIKITDFGL--CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W GV+++ +M G LPF +Q+ +++ I E R PR SP+ LL+ LL +P +
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 270 RI-----TIPEIMENRWF 282
R+ EIM++++F
Sbjct: 238 RLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-51
Identities = 86/261 (32%), Positives = 138/261 (52%), Gaps = 16/261 (6%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH-PNIVQ 90
K + G F VY A+ +G+ AIKV+ K ++ V ++K E +I+ P + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L+ +K +Y VMEY+ GG+ + + G L ED A++Y +++ V H RG+ HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
D+KPENLL+D+ G LK++DFGLS + ++ F GTP Y+APE + G D
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDKM-S 174
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSPDLIRLLTKLLDT 265
D WS G ++F + GY PF + ++ I P + SP+ + L+ +LL
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234
Query: 266 NPDKRI---TIPEIMENRWFR 283
+P KR+ EI + +F+
Sbjct: 235 DPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-50
Identities = 82/258 (31%), Positives = 137/258 (53%), Gaps = 6/258 (2%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
Y++G L+G G F VY N+++G+ VAIK I EKI + L I +EI +L+ ++HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL-KSIMQEIDLLKNLKHP 59
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARG 145
NIV+ + T +Y ++EY G L + K G E L Y Q++ + + H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
V HRD+K N+L ++G +K++DFG++ + + GTP ++APEV+ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGA- 176
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264
+ DIWS G + L+ G P+ D N M +++ + P SP+L L +
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236
Query: 265 TNPDKRITIPEIMENRWF 282
+P+ R T +++++ W
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-49
Identities = 91/242 (37%), Positives = 137/242 (56%), Gaps = 5/242 (2%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQ 90
++LG G+F KV AR +SG A+KV+ K+ IL+ V E IL R HP + Q
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHR 149
L+ T +++FVME+V GG+L + K R E AR Y ++ SA+ F H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N+LLD G K++DFG+ + I TFCGTP Y+APE+L Y + V
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM--CKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W+ GV+L+ ++ G+ PF+ +N +++ I E P W S D + +L + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 270 RI 271
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 5e-49
Identities = 92/239 (38%), Positives = 134/239 (56%), Gaps = 4/239 (1%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G+F KV R + A+K I K I+ V H E ++L +V P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLK 152
+ K+Y V+ ++ GGELF+ + + GR AR Y +L+ A+ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 153 PENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW 212
PEN+LLD G + + DFGL ++ ++ D +TFCGTP Y+APE+L GY A VD W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYTKA-VDWW 177
Query: 213 SCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRI 271
+ GV+L+ ++ G PF D+N+ MY+KI + R P F D LL LL +P +R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 5e-49
Identities = 88/268 (32%), Positives = 141/268 (52%), Gaps = 18/268 (6%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
R++ G +G GTF KVY A N+ +GE +A+K I + + I E+ +L ++HP
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHP 59
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARG 145
N+V+ + V + K+Y MEY GG L + GR L E + R Y QL+ + + H+ G
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 146 VYHRDLKPENLLLDENGDLKVSDFG----LSAVSDQIRQDGLFHTFCGTPAYVAPEVLS- 200
+ HRD+KP N+ LD NG +K+ DFG L + + + GTPAY+APEV++
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPEVITG 177
Query: 201 --RKGYDAAKVDIWSCGVILFVLMAGYLPF--QDQNIMVMYKKIYKGE---FRSPRWFSP 253
KG+ A DIWS G ++ + G P+ D +M+ + G SP
Sbjct: 178 GKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMF-HVGAGHKPPIPDSLQLSP 235
Query: 254 DLIRLLTKLLDTNPDKRITIPEIMENRW 281
+ L + L+++P KR T E++++ +
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 6e-49
Identities = 92/288 (31%), Positives = 146/288 (50%), Gaps = 37/288 (12%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
KLLG G +V+ R +G+ A+KV+DK++++K V + E IL + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 92 FEVMATKSKIYFVMEYVRGGELF---NKVAKGRLKEDLARKYFQQLISAVGFCHARGVYH 148
+ T++ + VM+Y GGELF + L E++AR Y +++ A+ + H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSD----QIRQDGLF-------------------- 184
RDLKPEN+LL E+G + +SDF LS SD + +
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 185 ---HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY 241
++F GT Y+APEV+S G+ +A VD W+ G++L+ ++ G PF+ N + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 242 KGEFRSPR--WFSPDLIRLLTKLLDTNPDKRI----TIPEIMENRWFR 283
K E P S L+ KLL +P KR+ EI ++ +FR
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 78/258 (30%), Positives = 142/258 (55%), Gaps = 14/258 (5%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
Y+ + +G G +VY A + +G+ VAIK + K K I EI I++ +HPN
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL----IINEILIMKDCKHPN 76
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARG 145
IV ++ +++ VMEY+ GG L + + R+ E ++++ + + H++
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF-HTFCGTPAYVAPEVLSRKGY 204
V HRD+K +N+LL ++G +K++DFG +A Q+ ++ ++ GTP ++APEV+ RK Y
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAA---QLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG--EFRSPRWFSPDLIRLLTK 261
KVDIWS G++ + G P+ + + ++ KG ++P +SP+ L K
Sbjct: 194 G-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252
Query: 262 LLDTNPDKRITIPEIMEN 279
L +P+KR + E++++
Sbjct: 253 CLVKDPEKRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-48
Identities = 75/249 (30%), Positives = 139/249 (55%), Gaps = 10/249 (4%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+E+ +++G G F KV + + + A+K ++K+K ++ G V ++ E IL+ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
+V L+ + +Y V++ + GG+L ++ K + E+ + + +++ A+ + H++G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
HRD+KP+N+LLDE G + ++DF ++ ++ D L + GTP Y+APEVL R+GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGYSV 178
Query: 207 AKVDIWSCGVILFVLMAGYLPFQ----DQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262
A VD WS GV + + G P++ + K+ W S + I + KL
Sbjct: 179 A-VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW-STEAIDAINKL 236
Query: 263 LDTNPDKRI 271
L+ +P KR+
Sbjct: 237 LERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 93/244 (38%), Positives = 146/244 (59%), Gaps = 8/244 (3%)
Query: 32 KLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
K+LG G+F KV+ R + +G+ A+KV+ K+ LK K E IL V HP I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRL-KEDLARKYFQQLISAVGFCHARGVY 147
V+L T+ K+Y +++++RGG+LF +++K + E+ + Y +L A+ H+ G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAA 207
+RDLKPEN+LLDE G +K++DFGLS S I + ++FCGT Y+APEV++R+G+ +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 208 KVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNP 267
D WS GV++F ++ G LPFQ ++ I K + P++ SP+ LL L NP
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237
Query: 268 DKRI 271
R+
Sbjct: 238 ANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-47
Identities = 64/115 (55%), Positives = 74/115 (64%), Gaps = 4/115 (3%)
Query: 344 NAFDLISFSPGFDLSGLFEEGGE---GARFVSGAPVSKIITKLEEIAKVVSFTVRKK-DC 399
NAFDLIS S G DLSGLFEE E RF S P +II KLEE AK + F VRKK +
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 400 RVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGL 454
V LEG + G KG L ++ E+FE+TP LVVVEVKK GD EY +F L+P L
Sbjct: 61 GVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLL 115
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 77/263 (29%), Positives = 126/263 (47%), Gaps = 24/263 (9%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID------KEKILKSGLVAHIKREISIL 80
+++ K LG G++ VY + + + A+K +D KE+ EI IL
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER-------EDAVNEIRIL 53
Query: 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR-----LKEDLARKYFQQLI 135
V HPNI+ E +K+ VMEY G+L ++K + + E + F QL+
Sbjct: 54 ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195
+ H + + HRDLK N+LL N +K+ D G+S V + + T GTP Y+A
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMA 169
Query: 196 PEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPD 254
PEV + Y K DIWS G +L+ + PF+ +++ + K+ +G++ P +S D
Sbjct: 170 PEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQD 228
Query: 255 LIRLLTKLLDTNPDKRITIPEIM 277
L + +L P R +I+
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 2e-47
Identities = 90/242 (37%), Positives = 137/242 (56%), Gaps = 5/242 (2%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL-RRVRHPNIVQ 90
K++G G+F KV A+ G A+KV+ K+ ILK HI E ++L + ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHR 149
L T K+YFV++YV GGELF + + R E AR Y ++ SA+G+ H+ + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLKPEN+LLD G + ++DFGL + + + TFCGTP Y+APEVL ++ YD V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL--CKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W G +L+ ++ G PF +++ MY I + P + LL LL + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 270 RI 271
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 88/263 (33%), Positives = 133/263 (50%), Gaps = 21/263 (7%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL---RRVRHPNIVQ 90
LG G F KV A K+GE AIK + K I+ V + E I RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRD 150
LF T+ + FVMEY GG+L + E A Y ++ + + H + +RD
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH-----TFCGTPAYVAPEVLSRKGYD 205
LK +NLLLD G +K++DFGL ++G+ TFCGTP ++APEVL+ Y
Sbjct: 127 LKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265
A VD W GV+++ ++ G PF + ++ I E R PR+ S + I ++ +LL
Sbjct: 180 RA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR 238
Query: 266 NPDKRI-----TIPEIMENRWFR 283
NP++R+ ++ + +FR
Sbjct: 239 NPERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-47
Identities = 89/242 (36%), Positives = 133/242 (54%), Gaps = 5/242 (2%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQ 90
K+LG G+F KV A + E AIKV+ K+ IL+ V E IL HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHR 149
L TK +++FVMEYV GG+L ++ + R E +R Y ++ A+ F H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N+LLD G K++DFG+ + I TFCGTP Y+APE+L Y + V
Sbjct: 121 DLKLDNILLDAEGHCKLADFGM--CKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W+ GV+++ +MAG PF+ N +++ I + P W S + + +L + NP+K
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 270 RI 271
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 3e-47
Identities = 97/244 (39%), Positives = 135/244 (55%), Gaps = 9/244 (3%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQ 90
+G GTF +VY R + A+KV+ K++I+ VAH E +IL R P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L T S +Y V +Y+ GGELF + K GR ED A+ Y +L+ A+ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV-LSRKGYDAAK 208
DLKPEN+LLD G + + DFGLS + + + +TFCGT Y+APEV L KGY
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKAN--LTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 209 VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK-LLDTNP 267
VD WS GV++F + G+ PF ++ MY+ I G+ R P+ D R K LL+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 268 DKRI 271
R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 95/246 (38%), Positives = 139/246 (56%), Gaps = 13/246 (5%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL-RRVRHPNIVQ 90
K++G G+F KV AR+ + A+KV+ K+ ILK HI E ++L + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHR 149
L T K+YFV++Y+ GGELF + + R E AR Y ++ SA+G+ H+ + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLKPEN+LLD G + ++DFGL + I +G TFCGTP Y+APEVL ++ YD V
Sbjct: 121 DLKPENILLDSQGHIVLTDFGL--CKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLI----RLLTKLLDT 265
D W G +L+ ++ G PF +N MY I P P++ LL LL
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI----LNKPLQLKPNITNSARHLLEGLLQK 233
Query: 266 NPDKRI 271
+ KR+
Sbjct: 234 DRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 86/264 (32%), Positives = 134/264 (50%), Gaps = 23/264 (8%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G + +V+ A+ +GE VA+K + K + K V H+ E IL + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 94 VMATKSKIYFVMEYVRGGE---LFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRD 150
+Y MEYV GG+ L N G L ED AR Y ++ AV H G HRD
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 151 LKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAK 208
LKPEN L+D +G +K++DFGLS V+ ++ G+P Y+APEVL KGYD
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIVT-------YANSVVGSPDYMAPEVLRGKGYDFT- 178
Query: 209 VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY--KGEFRSPRW------FSPDLIRLLT 260
VD WS G +L+ + G+ PF ++ + K + P + S + L+T
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238
Query: 261 KLLDTNPDKRITIPEIMENRWFRK 284
KL++ + ++ +I + +F++
Sbjct: 239 KLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 90/279 (32%), Positives = 133/279 (47%), Gaps = 40/279 (14%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
Y+ +G GT+ VY AR+ +GE VAIK I K + G+ REI +L+ + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR---LKEDLARKYFQQLISAVGFCHAR 144
I++L +V K +Y V E++ K+ K R L E L + Y QL+ + FCH+
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT-FCGTPAYVAPEVLSRKG 203
G+ HRDLKPENLL++ G LK++DFGL+ +T + T Y APE+L
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARS---FGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 204 YDAAKVDIWSCGVILFVLMAG-------------YLPFQ-----DQNIM-VMYKKIYKGE 244
+ VDIWS G I L++ + F+ D + +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 245 FRSPRW-----------FSPDLIRLLTKLLDTNPDKRIT 272
F P+ SP + LL+++L +P KRIT
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 4e-46
Identities = 78/270 (28%), Positives = 133/270 (49%), Gaps = 26/270 (9%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVI---DKEKILKSGLVAHIKREISILRRVRH 85
E K+LG G+ VY R+ +G+ A+K I E+ K + RE+ LR
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ-----LLRELKTLRSCES 58
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA- 143
P +V+ + + +I V+EY+ GG L + + K G++ E + +Q++ + + H
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK- 202
R + HRD+KP NLL++ G++K++DFG+S V + +TF GT Y++PE + +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGES 176
Query: 203 -GYDAAKVDIWSCGVILFVLMAGYLPFQDQN---IMVMYKKIYKGEFRSPRW----FSPD 254
Y A DIWS G+ L G PF + + I G P FSP+
Sbjct: 177 YSYAA---DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPE 231
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
++ L +P KR + E++++ + +K
Sbjct: 232 FRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 6e-46
Identities = 92/293 (31%), Positives = 141/293 (48%), Gaps = 44/293 (15%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
YE +G GT+ +VY ARN K+GE VA+K I E K G REI +L+++RHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPN 59
Query: 88 IVQLFEVMATKSK--IYFVMEYVR---GGELFNKVAKGRLKEDLARKYFQQLISAVGFCH 142
IV+L E++ +K K IY V EY+ G L + K E + Y +QL+ + + H
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--FTESQIKCYMKQLLEGLQYLH 117
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPAYVAPEVL-S 200
+ G+ HRD+K N+L++ +G LK++DFGL+ + + D + T Y PE+L
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD--YTNRVITLWYRPPELLLG 175
Query: 201 RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK------------------ 242
Y VD+WS G IL L G FQ + +KI++
Sbjct: 176 ATRYGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234
Query: 243 -GEFRSPR------------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
+ + P + LL KLL +P KRI+ + +++ +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 6e-46
Identities = 92/256 (35%), Positives = 149/256 (58%), Gaps = 8/256 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLV--AHIKREISILRRVRHPNIV 89
K+LG G+F KV A + E AIK + K+ +L+ V ++R + L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLT 59
Query: 90 QLFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYH 148
LF TK ++FVMEY+ GG+L F+ + GR E AR Y ++I + F H +G+ +
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAK 208
RDLK +N+LLD++G +K++DFG+ + + +G TFCGTP Y+APE+L + Y+ +
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYNES- 176
Query: 209 VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPD 268
VD WS GV+L+ ++ G PF ++ ++ I PRW S + L+KL + +P
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236
Query: 269 KRITIP-EIMENRWFR 283
KR+ + +I ++ +FR
Sbjct: 237 KRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 9e-46
Identities = 97/301 (32%), Positives = 140/301 (46%), Gaps = 59/301 (19%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVR 84
RYE GK LG GT+A VY AR+ ++G VAIK I + K K G+ REI +L+ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGG-ELFNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
HPNI+ L +V KS I V E++ E K L + Y + + + H+
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA----------- 192
+ HRDLKP NLL+ +G LK++DFGL+ G+P
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVVTRW 167
Query: 193 YVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAG--YLP-----------FQ------DQ 231
Y APE+L +R Y VD+WS G I L+ +LP F+ ++
Sbjct: 168 YRAPELLFGARH-YGVG-VDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225
Query: 232 NIMVMYKKIYKGEFRS----PRW--F---SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
N + EF+ P F S D + LL +LL NP+KRIT + +E+ +F
Sbjct: 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
Query: 283 R 283
Sbjct: 286 S 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 78/257 (30%), Positives = 134/257 (52%), Gaps = 8/257 (3%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKV--IDKEKILKSGLVAHIKREISILRRVR 84
R+ G+LLG G+F VY N+ G+ A+K + + V +++EI++L +++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA 143
HPNIVQ + +Y +E V GG L + K G E + R Y +Q++ + + H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
R HRD+K N+L+D NG +K++DFG+ + Q+ + +F G+P ++APEV++++G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGM---AKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPF-QDQNIMVMYKKIYKGEFRS-PRWFSPDLIRLLTK 261
DIWS G + + G P+ Q + + ++K E P S + + K
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 262 LLDTNPDKRITIPEIME 278
L +P R T E++E
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 4e-45
Identities = 91/275 (33%), Positives = 148/275 (53%), Gaps = 23/275 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV 83
+E+ ++LG G + KV+ R V +G+ A+KV+ K I+ K+ H + E +L V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 84 RH-PNIVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFC 141
R P +V L T +K++ +++YV GGELF + + E R Y +++ A+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLS---AVSDQIRQDGLFHTFCGTPAYVAPEV 198
H G+ +RD+K EN+LLD G + ++DFGLS ++ R ++FCGT Y+APEV
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA----YSFCGTIEYMAPEV 177
Query: 199 LSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQ---DQNIMV-MYKKIYKGEFRSPRWFS 252
+ G+D A VD WS GV+ F L+ G PF +QN + ++I K + P+ S
Sbjct: 178 IRGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236
Query: 253 PDLIRLLTKLLDTNPDKRI---TIPEIMENRWFRK 284
+ + KLL+ +P KR+ EI + +F+
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-45
Identities = 94/260 (36%), Positives = 136/260 (52%), Gaps = 24/260 (9%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
YE+ + +G GT+ VY AR++ +GE VAIKVI K+ I++EIS+L+ RHP
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHP 60
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHAR 144
NIV F + K++ VMEY GG L + +V +G L E ++ + + + H
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAV---SDQIRQDGLFHTFCGTPAYVAPEVL-- 199
G HRD+K N+LL E+GD+K++DFG+SA + R+ +F GTP ++APEV
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-----SFIGTPYWMAPEVAAV 175
Query: 200 -SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP------RWFS 252
+ GYD K DIW+ G+ L P D + M I K F P +W S
Sbjct: 176 ERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW-S 233
Query: 253 PDLIRLLTKLLDTNPDKRIT 272
P + K L +P KR T
Sbjct: 234 PVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-44
Identities = 92/286 (32%), Positives = 140/286 (48%), Gaps = 46/286 (16%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
+G GT+ VY AR+ +GE VA+K I + E G+ + REIS+L+ + HPNIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRL 63
Query: 92 FEVMATKSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
+V+ +++K+Y V E++ + + L L + Y QL+ + +CH+ V HR
Sbjct: 64 LDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHR 123
Query: 150 DLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAK 208
DLKP+NLL+D G LK++DFGL+ A +R H T Y APE+L +
Sbjct: 124 DLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGSRQYSTP 180
Query: 209 VDIWSCGVILFVLMAGYLPF--QDQNIMVMYKKI-------------------YKGEFRS 247
VDIWS G I F M P D I +++ YK F
Sbjct: 181 VDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF-- 237
Query: 248 PRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
P+W D + LL+K+L +P KRI+ +++ +F
Sbjct: 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 7e-44
Identities = 86/264 (32%), Positives = 140/264 (53%), Gaps = 17/264 (6%)
Query: 31 GKLLGHGTFAKVYHARNVKSGESVAIK-------VIDKEKILKSGLVAHIKREISILRRV 83
G+L+G GT+ +VY A NV +GE +A+K + + + +V ++ EI L+ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCH 142
H NIVQ T+ + +EYV GG + + + GR +E L R + +Q++ + + H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV--LS 200
++G+ HRDLK +NLL+D +G K+SDFG+S SD I + + G+ ++APEV
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 201 RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP------RWFSPD 254
+GY +AKVDIWS G ++ + AG P+ D+ + K+ P SP
Sbjct: 186 SQGY-SAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 255 LIRLLTKLLDTNPDKRITIPEIME 278
+ L NPD R T E+++
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-44
Identities = 88/242 (36%), Positives = 137/242 (56%), Gaps = 5/242 (2%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL-RRVRHPNIVQ 90
K++G G+F KV A+ G+ A+KV+ K+ +L HI E ++L + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHR 149
L T K+YFV+++V GGELF + + R E AR Y ++ SA+G+ H+ + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLKPEN+LLD G + ++DFGL + I Q TFCGTP Y+APEV+ ++ YD V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL--CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W G +L+ ++ G PF +++ MY I S +L +LL+ + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 270 RI 271
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 88/290 (30%), Positives = 140/290 (48%), Gaps = 39/290 (13%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
RY+I +G G V+ A++ ++GE+VA+K + + L+ G+ REI L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHP 59
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR--LKEDLARKYFQQLISAVGFCHAR 144
+V+L +V S VMEY+ +L + L E + Y + L+ V + HA
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL--SRK 202
G+ HRDLKP NLL+ +G LK++DFGL+ + + + L+ T Y APE+L +RK
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSE-EEPRLYSHQVATRWYRAPELLYGARK 177
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQ-DQNIMVM-----------------------YK 238
YD VD+W+ G I L+ G F + +I + Y
Sbjct: 178 -YDPG-VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 239 KIYKGEFRSPRW------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
KI E + SP+ + LL LL +P KR++ E + + +F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 86/300 (28%), Positives = 139/300 (46%), Gaps = 46/300 (15%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+E K++G G F +V + +G A+K + K ++L+ VAH++ E IL +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARGV 146
+V+L+ ++ +Y +MEY+ GG++ + K E+ R Y + I A+ H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 147 YHRDLKPENLLLDENGDLKVSDFGL-------------------------SAVSDQIRQD 181
HRD+KP+NLLLD G +K+SDFGL +S +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 182 GLFHTF-----------CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD 230
T+ GTP Y+APEV + GY+ D WS GVI++ ++ GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYPPFCS 241
Query: 231 QNIMVMYKKIYKGE----FRSPRWFSPDLIRLLTKLLDTNPDKRITIP---EIMENRWFR 283
N Y+KI + F SP+ L+ +L ++R+ EI + +F+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 92/287 (32%), Positives = 143/287 (49%), Gaps = 48/287 (16%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
LG GT+A VY RN +GE VA+K I D E+ S + REIS+++ ++H NIV+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI----REISLMKELKHENIVRL 63
Query: 92 FEVMATKSKIYFVMEYVRGG---ELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYH 148
+V+ T++K+ V EY+ + +G L + + + QL+ + FCH V H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL-FHTFCG---TPAYVAPEVLSRKGY 204
RDLKP+NLL+++ G+LK++DFGL+ R G+ +TF T Y AP+VL
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-----------GEFRSPRW--- 250
+ +DIWS G I+ ++ G F N KI++ G + P +
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237
Query: 251 ---------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
P I LL +LL NP+ RI+ + +++ WF
Sbjct: 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 81/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
YE+ +++G G A VY A + + E VAIK ID EK S V +++E+ + + HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPN 60
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFN----KVAKGRLKEDLARKYFQQLISAVGFCHA 143
+V+ + +++ VM Y+ GG L + +G L E + ++++ + + H+
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLS- 200
G HRD+K N+LL E+G +K++DFG+SA R + TF GTP ++APEV+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 201 RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF------RSPRWFSPD 254
GYD K DIWS G+ L G P+ M + + + + +S
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWF 282
++++ L +P KR T E++++++F
Sbjct: 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-42
Identities = 94/268 (35%), Positives = 141/268 (52%), Gaps = 22/268 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVID--KEKILKSGLVAHIKREISILRRVRH 85
+EI LG G F KVY A++ ++G A K+I E+ L+ +V EI IL +H
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-----EIDILSECKH 61
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFN---KVAKGRLKEDLARKYFQQLISAVGFCH 142
PNIV L+E ++K++ ++E+ GG L + ++ +G L E R +Q++ A+ F H
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH 120
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL--- 199
+ V HRDLK N+LL +GD+K++DFG+SA + Q TF GTP ++APEV+
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACE 178
Query: 200 --SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPD 254
YD K DIWS G+ L L P + N M + KI K E P +S
Sbjct: 179 TFKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWF 282
L L +PD R T E++++ +
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 3e-42
Identities = 86/257 (33%), Positives = 143/257 (55%), Gaps = 8/257 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
K+LG G+F KV+ A + + AIK + K+ +L V E +L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYF--QQLISAVGFCHARGVYH 148
L+ TK ++FVMEY+ GG+L + K DL R F ++I + F H++G+ +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAK 208
RDLK +N+LLD +G +K++DFG+ + + D TFCGTP Y+APE+L + Y+ +
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGM--CKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS- 176
Query: 209 VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPD 268
VD WS GV+L+ ++ G PF + +++ I PRW + + +L KL P+
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPE 236
Query: 269 KRITIP-EIMENRWFRK 284
+R+ + +I ++ +FR+
Sbjct: 237 RRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 83/261 (31%), Positives = 139/261 (53%), Gaps = 9/261 (3%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+ + + +G G+F +VY A + ++ + VAIKVID E+ + I++EI L + R P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
I + + SK++ +MEY GG + + G+L E ++++ + + H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL-FHTFCGTPAYVAPEVLSRKGYD 205
HRD+K N+LL E GD+K++DFG VS Q+ +TF GTP ++APEV+ + GYD
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS--PRWFSPDLIRLLTKLL 263
K DIWS G+ L G P D + M + I K S FS ++ L
Sbjct: 177 -EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235
Query: 264 DTNPDKRITIPEIMENRWFRK 284
+ +P +R + E++++++ +K
Sbjct: 236 NKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 4e-42
Identities = 93/293 (31%), Positives = 136/293 (46%), Gaps = 48/293 (16%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----GLVAHIKREISILRR 82
Y++ K LG GTF VY ARN ++GE VAIK + K+K S L RE+ LR+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKK-FYSWEECMNL-----REVKSLRK 53
Query: 83 V-RHPNIVQLFEVMATKSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLISAVG 139
+ HPNIV+L EV ++YFV EY+ G +L E + R Q++ +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
H G +HRDLKPENLL+ +K++DFGL+ +IR + + T Y APE+L
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPEIL 170
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEFRSPRW------- 250
R ++ VDIW+ G I+ L F + + KI G W
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230
Query: 251 ------F---------------SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
F SP+ I L+ +L +P KR T + +++ +F
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 89/301 (29%), Positives = 134/301 (44%), Gaps = 51/301 (16%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
K +G G F +V R V + A+K + K +L AH+K E IL + +V+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 92 FEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRD 150
+ K +YFVM+Y+ GG++ + + G +EDLAR Y +L A+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 151 LKPENLLLDENGDLKVSDFGLSA------------VSDQIRQDG---------------- 182
+KP+N+L+D +G +K++DFGL D RQD
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 183 -------------LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ 229
L H+ GTP Y+APEVL R GY D WS GVIL+ ++ G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFL 245
Query: 230 DQNIMVMYKKI--YKGEFRSPRW--FSPDLIRLLTKLLDTNPDKRI---TIPEIMENRWF 282
K+ ++ P S + L+ +L + R+ EI + +F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF 304
Query: 283 R 283
+
Sbjct: 305 K 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 9e-42
Identities = 86/251 (34%), Positives = 141/251 (56%), Gaps = 14/251 (5%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
+++G G++AKV K+ A+KVI KE + + ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 91 LFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L T+S+++FV+E+V GG+L F+ + +L E+ AR Y ++ A+ F H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N+LLD G +K++D+G+ + IR TFCGTP Y+APE+L + Y + V
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM--CKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQ--------DQNIM-VMYKKIYKGEFRSPRWFSPDLIRLLT 260
D W+ GV++F +MAG PF DQN +++ I + + R PR S +L
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 261 KLLDTNPDKRI 271
L+ +P +R+
Sbjct: 238 GFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 9e-42
Identities = 96/345 (27%), Positives = 147/345 (42%), Gaps = 71/345 (20%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVRH 85
RYE+ K +G G + V A + ++G VAIK I + + A I REI +LR +RH
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 86 PNIVQLFEVMATKSK-----IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ----QLIS 136
NI+ L +++ S +Y V E + +KV K + L + Q Q++
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKS--PQPLTDDHIQYFLYQILR 114
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV-- 194
+ + H+ V HRDLKP N+L++ N DLK+ DFGL+ D + F T YV
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-----YVVT 169
Query: 195 ----APEV-LSRKGYDAAKVDIWSCGVILFVLMAG--YLP---FQDQNIMVM-------- 236
APE+ LS Y A +DIWS G I L+ P + DQ +++
Sbjct: 170 RWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 237 -----------YKKIYKGEFRSPRWF-------SPDLIRLLTKLLDTNPDKRITIPEIME 278
+ + + SP+ I LL K+L +P KRIT E +
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
Query: 279 NRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHSLSEPE 323
+ + + + +D+ D DD L+E E
Sbjct: 289 HPYLA------QLHDPEDEPVAKPPFDFDFF-----DDDELTEEE 322
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 88/276 (31%), Positives = 146/276 (52%), Gaps = 27/276 (9%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-R 84
G +E+ +++G GT+ KVY AR+ K+G+ VAIK++D + + IK E +ILR+
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE----EIKEEYNILRKYSN 61
Query: 85 HPNIVQLFEVMATKS------KIYFVMEYVRGG---ELFNKVAK--GRLKEDLARKYFQQ 133
HPNI + K+ +++ VME GG +L + K RLKE+ ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 134 LISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAY 193
+ + + H V HRD+K +N+LL +N ++K+ DFG+SA D G +TF GTP +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD--STLGRRNTFIGTPYW 179
Query: 194 VAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EF 245
+APEV++ YD A+ D+WS G+ L G P D + M KI +
Sbjct: 180 MAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238
Query: 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281
+SP +S +++ L N ++R + E++E+ +
Sbjct: 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 78/250 (31%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
++I + LG G++ VY A + ++G+ VAIKV+ E+ L+ I +EISIL++ P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE-----IIKEISILKQCDSPY 59
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARG 145
IV+ + + ++ VMEY G + + K+ L E+ Q + + + H+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF--HTFCGTPAYVAPEVLSRKG 203
HRD+K N+LL+E G K++DFG VS Q+ D + +T GTP ++APEV+ G
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFG---VSGQL-TDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQD---QNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260
Y+ K DIWS G+ + G P+ D + M P +SP+ +
Sbjct: 176 YN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234
Query: 261 KLLDTNPDKR 270
K L +P++R
Sbjct: 235 KCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 91/288 (31%), Positives = 141/288 (48%), Gaps = 50/288 (17%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
+G GT+ VY ARN +GE VA+K I D E G+ + REIS+L+ + HPNIV+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 64
Query: 92 FEVMATKSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
+V+ T++K+Y V E++ + + + L + Y QL+ + FCH+ V HR
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL-FHTFCG---TPAYVAPEVLSRKGYD 205
DLKP+NLL++ G +K++DFGL+ R G+ T+ T Y APE+L Y
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQ-DQNIMVMYK-------------------KIYKGEF 245
+ VDIWS G I ++ F D I +++ YK F
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238
Query: 246 RSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
P+W D LL+++L +P+KRI+ + + +F
Sbjct: 239 --PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 79/258 (30%), Positives = 131/258 (50%), Gaps = 7/258 (2%)
Query: 31 GKLLGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRHPNI 88
GKLLG G F +VY +V +G +A+K + D + V ++ EI +L+ ++H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARGVY 147
VQ + + + MEY+ GG + +++ A G L E + RKY +Q++ V + H+ +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF-HTFCGTPAYVAPEVLSRKGYDA 206
HRD+K N+L D G++K+ DFG S I G + GTP +++PEV+S +GY
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-G 185
Query: 207 AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEFRSPRWFSPDLIRLLTKLLD 264
K D+WS G + ++ P+ + M KI + P SPD L +
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245
Query: 265 TNPDKRITIPEIMENRWF 282
N KR + E++ + +
Sbjct: 246 ENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 3e-40
Identities = 89/258 (34%), Positives = 140/258 (54%), Gaps = 11/258 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
RYEI K +G G+F K+Y A+ E IK ID K+ A K+E+ +L +++HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHP 59
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR---LKEDLARKYFQQLISAVGFCHA 143
NIV F +++ VMEY GG+L ++ + R ED +F Q+ + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 144 RGVYHRDLKPENLLLDENGDL-KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
R + HRD+K +N+ L +NG + K+ DFG++ + + L +T GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNR 177
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLT 260
Y+ K DIWS G +L+ L PF+ N+ + KI +G F SP FS DL L++
Sbjct: 178 PYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN-FSRDLRSLIS 235
Query: 261 KLLDTNPDKRITIPEIME 278
+L +P R +I I++
Sbjct: 236 QLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 8e-40
Identities = 85/257 (33%), Positives = 138/257 (53%), Gaps = 12/257 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+YE +++G G F V+ R + V IK I E++ K +A + E +L+ + HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHP 59
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR---LKEDLARKYFQQLISAVGFCHA 143
NI++ +E + VMEY GG L + K L ED +F Q++ A+ H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 144 RGVYHRDLKPENLLLDENGD-LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
+ + HRDLK +N+LLD++ +K+ DFG+S + + +T GTP Y++PE+ K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCEGK 176
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLT 260
Y+ K DIW+ G +L+ L + F+ N+ + KI G F S R +SPDL +L+
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR-YSPDLRQLIL 234
Query: 261 KLLDTNPDKRITIPEIM 277
+L+ +P KR + +IM
Sbjct: 235 SMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 87/278 (31%), Positives = 147/278 (52%), Gaps = 18/278 (6%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN-IVQ 90
+LG G+F KV A + E AIK++ K+ I++ V E +L P + Q
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L T ++YFVMEYV GG+L + + G+ KE A Y ++ + F H++G+ +R
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N++LD G +K++DFG+ + I TFCGTP Y+APE+++ + Y + V
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGM--CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS-V 182
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W+ GV+L+ ++AG PF ++ +++ I + P+ S + + + LL +P K
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAK 242
Query: 270 RITI-----PEIMENRWFRKGFKHIKFYIEDDKMCNVE 302
R+ +I E+ +FR I+ +K+ E
Sbjct: 243 RLGCGPTGERDIREHAFFR--------RIDWEKLERRE 272
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 7e-39
Identities = 85/276 (30%), Positives = 144/276 (52%), Gaps = 21/276 (7%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+E KL+ +G + VY R+ ++ + A+K I+K+ ++ + + E IL +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGV 146
+V +F TK + VMEYV GG+ + G L D+AR YF + + A+ + H G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVS-------------DQIRQDGLFHTFCGTPAY 193
HRDLKP+NLL+ G +K++DFGLS + ++ ++ L CGTP Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 194 VAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW--- 250
+APEV+ R+GY VD W+ G+IL+ + G +PF ++ ++ + P
Sbjct: 183 IAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241
Query: 251 FSPDLIRLLTKLLDTNPDKRITIP---EIMENRWFR 283
D L+++LL NP +R+ E+ ++R+F
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-39
Identities = 81/256 (31%), Positives = 141/256 (55%), Gaps = 13/256 (5%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G+ V A + +G VA+K +D K + L+ + E+ I+R +HPNIV+++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQHPNIVEMYS 83
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKP 153
+++ VME++ GG L + V R+ E+ ++ A+ F HA+GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143
Query: 154 ENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW 212
+++LL +G +K+SDFG A VS ++ + + GTP ++APEV+SR Y +VDIW
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISRLPYG-TEVDIW 199
Query: 213 SCGVILFVLMAGYLP-FQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLTKLLDTNPD 268
S G+++ ++ G P F + + M K+I ++ SP L L ++L +P
Sbjct: 200 SLGIMVIEMVDGEPPYFNEPPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPA 258
Query: 269 KRITIPEIMENRWFRK 284
+R T E++ + + K
Sbjct: 259 QRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 9e-39
Identities = 87/259 (33%), Positives = 138/259 (53%), Gaps = 15/259 (5%)
Query: 32 KLLGHGTFAKVYHARNVKSGE--SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV 89
+ LG G+F +V A K+ + VAIK +K KI+K V H+ E IL + HP V
Sbjct: 36 RTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 90 QLFEVMATKSKIYFVMEYVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYH 148
L+ +S +Y V+E+V GGE F + + R D+ Y Q++ + + + +
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAK 208
RDLKPENLLLD++G +K++DFG + V D +T CGTP Y+APE+L G+ A
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKA- 208
Query: 209 VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPD 268
D W+ G+ ++ ++ G PF +++Y+KI +G P++ + L+ KLL +
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLT 268
Query: 269 KRI-----TIPEIMENRWF 282
KR + E+ WF
Sbjct: 269 KRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 90/296 (30%), Positives = 133/296 (44%), Gaps = 47/296 (15%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIK----VIDKEKILKSGLVAHIKREISILR 81
+YE+ ++G G + V RN +GE VAIK D E + K+ L RE+ +LR
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-----REVKVLR 55
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLISAVG 139
++RH NIV L E K ++Y V EYV EL G L D R Y QL+ A+
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQAIA 114
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
+CH+ + HRD+KPEN+L+ E+G LK+ DFG A + + R + T Y APE+L
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGF-ARALRARPASPLTDYVATRWYRAPELL 173
Query: 200 -SRKGYDAAKVDIWSCGVILFVLMAGYLPF--------------------QDQNIMVMYK 238
Y VD+W+ G I+ L+ G F +
Sbjct: 174 VGDTNYGKP-VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 239 KIYKG------------EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
+ G E R P S + L L +P +R+T E++++ +F
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 4e-38
Identities = 85/251 (33%), Positives = 142/251 (56%), Gaps = 14/251 (5%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
+++G G++AKV R K+ A+KV+ KE + + ++ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 91 LFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L T+S+++FV+EYV GG+L F+ + +L E+ AR Y ++ A+ + H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N+LLD G +K++D+G+ + +R TFCGTP Y+APE+L + Y V
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 210 DIWSCGVILFVLMAGYLPFQ--------DQNIM-VMYKKIYKGEFRSPRWFSPDLIRLLT 260
D W+ GV++F +MAG PF DQN +++ I + + R PR S +L
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 261 KLLDTNPDKRI 271
L+ +P +R+
Sbjct: 238 SFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 4e-38
Identities = 70/247 (28%), Positives = 119/247 (48%), Gaps = 8/247 (3%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+EI +G G+F V+ A+K ID K+ + I E +L ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR---LKEDLARKYFQQLISAVGFCHAR 144
I++ +E K K+ VMEY G+L + R L ED ++F Q++ + H++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
+ HRD+K NL LD ++K+ D G++ + +T GTP Y++PE+ K Y
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPY 178
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWFSPDLIRLLTKLL 263
+ K D+W+ GV+L+ G PF N + KI +G F + +S L +L+ + L
Sbjct: 179 N-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 264 DTNPDKR 270
+ +R
Sbjct: 238 TKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 77/263 (29%), Positives = 139/263 (52%), Gaps = 14/263 (5%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH- 85
R E L+G G + VY ++V +G VA+K+I+ + V+ I+RE+++L ++R
Sbjct: 5 RLE---LIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQS 59
Query: 86 --PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
PNI + + +++ +MEY GG + + G + E ++++ A+ + H
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR-K 202
GV HRD+K N+L+ G++K+ DFG++A+ +Q TF GTP ++APEV++ K
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGK 177
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFRSP-RWFSPDLIRLLT 260
YD K DIWS G+ ++ + G P+ D + M R +S L +
Sbjct: 178 YYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236
Query: 261 KLLDTNPDKRITIPEIMENRWFR 283
LD P +R++ E+++++W +
Sbjct: 237 ACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 6e-38
Identities = 80/263 (30%), Positives = 124/263 (47%), Gaps = 21/263 (7%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G V + +G+ +A+K I E + + I RE+ IL + P IV +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 94 VMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCH-ARGVYHRD 150
I MEY+ GG L K +GR+ E + K ++ + + H + HRD
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVD 210
+KP N+L++ G +K+ DFG VS Q+ + L TF GT +Y+APE + Y K D
Sbjct: 127 VKPSNILVNSRGQIKLCDFG---VSGQL-VNSLAKTFVGTSSYMAPERIQGNDYS-VKSD 181
Query: 211 IWSCGVILFVLMAGYLPFQDQN-----IMVMYKKIYKGEFRSPRW----FSPDLIRLLTK 261
IWS G+ L L G P+ +N I + + I PR FSPD +
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--PPRLPSGKFSPDFQDFVNL 239
Query: 262 LLDTNPDKRITIPEIMENRWFRK 284
L +P +R + E++E+ + +K
Sbjct: 240 CLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-38
Identities = 78/256 (30%), Positives = 135/256 (52%), Gaps = 8/256 (3%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+Y K +G G+F K ++ + G+ IK I+ K + ++E+++L ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR---LKEDLARKYFQQLISAVGFCHA 143
NIVQ E +Y VM+Y GG+L+ K+ R ED +F Q+ A+ H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
R + HRD+K +N+ L ++G +K+ DFG++ V + + L T GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWFSPDLIRLLTKL 262
Y+ K DIW+ G +L+ + F+ N+ + KI +G + +S DL L+++L
Sbjct: 178 YN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 263 LDTNPDKRITIPEIME 278
NP R ++ I+E
Sbjct: 237 FKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 75/265 (28%), Positives = 134/265 (50%), Gaps = 13/265 (4%)
Query: 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRVRHPN 87
G+ LG G F+ Y AR+VK+G +A+K + + S +V +++EI ++ R+ HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGV 146
I+++ S +E++ GG + + ++K G KE + Y +QL+ + + H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 147 YHRDLKPENLLLDENG-DLKVSDFGLSA-VSDQIRQDGLFH-TFCGTPAYVAPEVLSRKG 203
HRD+K NLL+D G L+++DFG +A ++ + G F GT A++APEVL +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-----GEFRSPRWFSPDLIRL 258
Y D+WS G ++ + P+ + I+K P SP L +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 259 LTKLLDTNPDKRITIPEIMENRWFR 283
+ L+ P+ R E++++ FR
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 81/244 (33%), Positives = 134/244 (54%), Gaps = 5/244 (2%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
K+LG G+F KV A GE A+K + K+ +L V E +L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 91 LFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L+ TK ++FVME++ GG+L F+ KGR A Y +++ + F H++G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N++LD +G +K++DFG+ + + D TFCGTP Y+APE+L Y + V
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGM--CKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-V 177
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D WS GV+L+ ++ G PF + +++ I PRW + + +L KL + +P +
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 270 RITI 273
R+ +
Sbjct: 238 RLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 97/305 (31%), Positives = 137/305 (44%), Gaps = 54/305 (17%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
K LG G F +V AR V + A+K + K+ +L VAH+K E IL + +V+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRD 150
+ K +YFVM+Y+ GG++ + + + G EDLAR Y +L AV H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 151 LKPENLLLDENGDLKVSDFGLSA------------VSDQIRQDG---------------- 182
+KP+N+L+D +G +K++DFGL D +RQD
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 183 -----------------LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGY 225
L H+ GTP Y+APEVL R GY D WS GVIL+ ++ G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQ 245
Query: 226 LPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
PF Q + K+ W + I KL D I + E+R + G
Sbjct: 246 PPFLAQTPLETQMKVI-------NWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNG 298
Query: 286 FKHIK 290
IK
Sbjct: 299 ADEIK 303
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 5e-37
Identities = 87/274 (31%), Positives = 150/274 (54%), Gaps = 18/274 (6%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
+LG G+F KV A + E AIK++ K+ +++ V E +L + P + Q
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L T ++YFVMEYV GG+L ++ + GR KE A Y ++ + F H++G+ +R
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N++LD G +K++DFG+ + + TFCGTP Y+APE+++ + Y V
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGM--CKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 182
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W+ GV+L+ ++AG PF+ ++ +++ I + P+ S + + + L+ +P K
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 242
Query: 270 RITI-PE----IMENRWFRKGFKHIKFYIEDDKM 298
R+ PE I E+ +FR YI+ +K+
Sbjct: 243 RLGCGPEGERDIKEHAFFR--------YIDWEKL 268
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 6e-37
Identities = 84/259 (32%), Positives = 143/259 (55%), Gaps = 10/259 (3%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL-RRVRHPNIVQL 91
+LG G+F KV A + E AIK++ K+ +++ V E +L + + P + QL
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRD 150
T ++YFVMEYV GG+L + + G+ KE A Y ++ + F H RG+ +RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVD 210
LK +N++LD G +K++DFG+ + + TFCGTP Y+APE+++ + Y VD
Sbjct: 127 LKLDNVMLDSEGHIKIADFGM--CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270
W+ GV+L+ ++AG PF ++ +++ I + P+ S + + + L+ +P KR
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
Query: 271 ITI-PE----IMENRWFRK 284
+ PE I E+ +FR+
Sbjct: 244 LGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 6e-37
Identities = 82/249 (32%), Positives = 140/249 (56%), Gaps = 12/249 (4%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQ 90
+++G G++AKV R K+ + A+KV+ KE + + ++ E + + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 91 LFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L T S+++ V+EYV GG+L F+ + +L E+ AR Y ++ A+ F H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N+LLD +G +K++D+G+ + + TFCGTP Y+APE+L + Y V
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM--CKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 210 DIWSCGVILFVLMAGYLPFQ------DQNIM-VMYKKIYKGEFRSPRWFSPDLIRLLTKL 262
D W+ GV++F +MAG PF D N +++ I + R PR+ S +L
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 263 LDTNPDKRI 271
L+ +P +R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 8e-37
Identities = 81/256 (31%), Positives = 125/256 (48%), Gaps = 15/256 (5%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+++ L+G G F +V R +G+ A+KV+ K +L V+ + E IL P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARG 145
I QL K +Y VMEY GG+L + + + + ED+A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF-CGTPAYVAPEVL----- 199
HRD+KPEN+L+D G +K++DFG +A + GTP Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--YKGEFRSPR--WFSPDL 255
KG + D WS GVI + ++ G PF + Y I ++ + P S D
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 256 IRLLTKLLDTNPDKRI 271
+ L+ LL +R+
Sbjct: 241 LDLIQSLL-CGQKERL 255
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-37
Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 43/285 (15%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G GT+ VY RN K+G+ VA+K I E + G+ + REIS+L+ ++HPNIV L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 94 VMATKSKIYFVMEYVRGG--ELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHRD 150
V+ +S++Y + E++ + + + KG+ + +L + Y Q++ + FCH+R V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 151 LKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
LKP+NLL+D G +K++DFGL+ A +R ++ T Y APEVL + V
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVR---VYTHEVVTLWYRAPEVLLGSPRYSTPV 183
Query: 210 DIWSCGVILFVLMAGYLP-FQ-DQNIMVMYK-------------------KIYKGEFRSP 248
DIWS G I F MA P F D I +++ YK F P
Sbjct: 184 DIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF--P 240
Query: 249 RWFSPDL-----------IRLLTKLLDTNPDKRITIPEIMENRWF 282
+W L + LL K+L +P KRI+ + + + +F
Sbjct: 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 87/254 (34%), Positives = 144/254 (56%), Gaps = 11/254 (4%)
Query: 28 YEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV 83
+E+ K+LG G + KV+ R V +G+ A+KV+ K ++ K+ V H + E ++L V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 84 RH-PNIVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFC 141
R P +V L T++K++ +++YV GGE+F + + ED R Y ++I A+
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
H G+ +RD+K EN+LLD G + ++DFGLS ++ + +FCGT Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY-SFCGTIEYMAPEIIRG 180
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPFQ---DQNIMV-MYKKIYKGEFRSPRWFSPDLIR 257
KG VD WS G+++F L+ G PF ++N + ++I K + P + P+
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240
Query: 258 LLTKLLDTNPDKRI 271
LL KLL +P KR+
Sbjct: 241 LLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 86/294 (29%), Positives = 139/294 (47%), Gaps = 48/294 (16%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRR 82
+YE + +G GT+ V+ A+N ++ E VA+K + D E + S L REI +L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 55
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYV-RGGELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
++H NIV+L++V+ + K+ V EY + + + G + ++ + + QL+ + FC
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPAYVAPEVL- 199
H+ V HRDLKP+NLL+++NG+LK++DFGL+ A +R + T Y P+VL
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDVLF 172
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPF------QDQ---------------------- 231
K Y + +D+WS G I L P DQ
Sbjct: 173 GAKLYSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
Query: 232 ---NIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
MY P+ S LL LL NP +RI+ E +++ +F
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGR-DLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 81/266 (30%), Positives = 141/266 (53%), Gaps = 18/266 (6%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
LG ++I K +G G F+ VY A + G VA+K + +++ + +EI +L+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGEL------FNKVAKGRL-KEDLARKYFQQLISA 137
HPN+++ +++ V+E G+L F K + RL E KYF QL SA
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSA 118
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV-SDQIRQDGLFHTFCGTPAYVAP 196
+ H++ + HRD+KP N+ + G +K+ D GL S + H+ GTP Y++P
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMSP 175
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF-QDQ-NIMVMYKKIYKGEFR--SPRWFS 252
E + GY+ K DIWS G +L+ + A PF D+ N+ + KKI K ++ +S
Sbjct: 176 ERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234
Query: 253 PDLIRLLTKLLDTNPDKRITIPEIME 278
+L L+++ ++ +P+KR I +++
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 92/316 (29%), Positives = 134/316 (42%), Gaps = 69/316 (21%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL----KSGLVAHIKREISIL 80
L YEI LG GTF +VY AR +K+G VA+K KIL K G REI IL
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKIL 61
Query: 81 RRVRHPNIVQLFEVMATKSK--------IYFVMEYVR---GGELFNKVAKGRLKEDLARK 129
++++HPN+V L ++ + +Y V Y+ G L N K L E +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKC 119
Query: 130 YFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189
Y QL+ + + H + HRD+K N+L+D G LK++DFGL+ D + G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 190 TPAYV---------APE-VLSRKGYDAAKVDIWSCGVIL--------------------- 218
T Y PE +L + Y A VDIW G +
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238
Query: 219 -FVLM----------AGYLP-FQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTN 266
F L LP + + Y + + F P+ + LL+KLL +
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGK---LGPEGLDLLSKLLSLD 295
Query: 267 PDKRITIPEIMENRWF 282
P KR+T + +E+ +F
Sbjct: 296 PYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-35
Identities = 83/267 (31%), Positives = 135/267 (50%), Gaps = 14/267 (5%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+++ K++G G F +V R+ S + A+K++ K +++K A E I+
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY 147
IVQL +Y VMEY+ GG+L N ++ + E AR Y +++ A+ H+ G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH--TFCGTPAYVAPEVLSRKGYD 205
HRD+KP+N+LLD++G LK++DFG D +G+ T GTP Y++PEVL +G D
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMD---ANGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 206 AA---KVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--YKGEFRSPR--WFSPDLIRL 258
+ D WS GV L+ ++ G PF +++ Y KI +K P S L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281
Query: 259 LTKLLDTNPDK--RITIPEIMENRWFR 283
+ L + R + EI + +F+
Sbjct: 282 ICAFLTDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 82/256 (32%), Positives = 135/256 (52%), Gaps = 11/256 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+Y + +++G G+F + ++V S + A+K I K S V ++E +L +++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVA--KGRL-KEDLARKYFQQLISAVGFCHA 143
NIV E +Y VMEY GG+L K+ +G+L ED ++F Q+ V H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH-TFCGTPAYVAPEVLSRK 202
+ V HRD+K +N+ L +NG +K+ DFG + + + G + T+ GTP YV PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL---LTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWFSPDLIRLLTK 261
Y+ K DIWS G IL+ L PFQ + + K+ +G ++ P +S +L L+ +
Sbjct: 176 PYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234
Query: 262 LLDTNPDKRITIPEIM 277
+ NP R + I+
Sbjct: 235 MFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 76/218 (34%), Positives = 122/218 (55%), Gaps = 8/218 (3%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
Y++ K++G G F +V R+ S + A+K++ K +++K A E I+ P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY 147
+VQLF +Y VMEY+ GG+L N ++ + E A+ Y +++ A+ H+ G+
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH--TFCGTPAYVAPEVLSRK--- 202
HRD+KP+N+LLD++G LK++DFG D+ G+ T GTP Y++PEVL +
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDET---GMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI 240
GY + D WS GV LF ++ G PF +++ Y KI
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 80/262 (30%), Positives = 133/262 (50%), Gaps = 18/262 (6%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID----KEKILKSGLVAHIKREISILRR 82
Y ++LG G F + R + V K ++ EK + L EI IL
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSL 55
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVA--KGRL-KEDLARKYFQQLISAVG 139
++HPNI+ + + + MEY GG L++K+ KG+L +E++ Y Q++SAV
Sbjct: 56 LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV-SDQIRQDGLFHTFCGTPAYVAPEV 198
+ H G+ HRD+K N+ L + G +K+ DFG+S + + + T GTP Y++PE+
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---SMAETVVGTPYYMSPEL 172
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWFSPDLIR 257
Y+ K DIW+ G +L+ L+ F N + + KI +G + +S +LI
Sbjct: 173 CQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELIS 231
Query: 258 LLTKLLDTNPDKRITIPEIMEN 279
L+ LL +P+KR T E+++
Sbjct: 232 LVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 86/263 (32%), Positives = 135/263 (51%), Gaps = 21/263 (7%)
Query: 31 GKLLGHGTFAKVYHARNVKSGESVAIKVID------KEKILKSGLVAHIKREISILRRVR 84
G L+G G+F VY N SGE +A+K ++ K K ++ + REI++L+ ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGE---LFNKVAKGRLKEDLARKYFQQLISAVGFC 141
H NIVQ + +EYV GG L N G +E L R + +Q++ + +
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYL 122
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLS----AVSDQIRQDGLFHTFCGTPAYVAPE 197
H RG+ HRD+K N+L+D G +K+SDFG+S A S + +G + G+ ++APE
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW---FSPD 254
V+ + Y K DIWS G ++ ++ G PF D + KI GE SP S +
Sbjct: 183 VVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--GENASPEIPSNISSE 239
Query: 255 LIRLLTKLLDTNPDKRITIPEIM 277
I L K + + +KR T E++
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 86/258 (33%), Positives = 147/258 (56%), Gaps = 18/258 (6%)
Query: 28 YEIGKLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV 83
+E+ K+LG G + KV+ R V SG+ A+KV+ K I+ K+ H + E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 84 RH-PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFC 141
R P +V L T +K++ +++Y+ GGELF ++ + R KE + Y +++ A+
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVL 199
H G+ +RD+K EN+LLD NG + ++DFGLS D++ + ++FCGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA---YSFCGTIEYMAPDIV 178
Query: 200 S--RKGYDAAKVDIWSCGVILFVLMAGYLPFQ---DQNIMV-MYKKIYKGEFRSPRWFSP 253
G+D A VD WS GV+++ L+ G PF ++N + ++I K E P+ S
Sbjct: 179 RGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237
Query: 254 DLIRLLTKLLDTNPDKRI 271
++ +LL +P KR+
Sbjct: 238 LAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 89/290 (30%), Positives = 139/290 (47%), Gaps = 48/290 (16%)
Query: 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNI 88
+GK+ G GTF++V A++ K+G+ AIK + +K KS + REI LRR+ HPNI
Sbjct: 4 LGKI-GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 89 VQLFEVM--ATKSKIYFVMEYVRGG--ELFNKVAKGR---LKEDLARKYFQQLISAVGFC 141
++L EV+ ++ V E + EL KGR L E + Y QL+ ++
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELI----KGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
H G++HRD+KPEN+L+ ++ LK++DFG S I + + T Y APE L
Sbjct: 117 HRNGIFHRDIKPENILIKDD-ILKLADFG-SCRG--IYSKPPYTEYISTRWYRAPECLLT 172
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--------------------- 240
GY K+DIW+ G + F +++ + F N + KI
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232
Query: 241 -YKGEFRSPRWF-------SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
Y + S + + LL KLL +PD+RIT + + + +F
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 5e-35
Identities = 93/296 (31%), Positives = 133/296 (44%), Gaps = 68/296 (22%)
Query: 37 GTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVM- 95
GT+ VY AR+ K+GE VA+K + EK K G REI+IL +++HPNIV + EV+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVTVKEVVV 74
Query: 96 -ATKSKIYFVMEYVRGGELFNKVAKGRLKEDLA---RKYF-QQLISAVGFCHARGVYHRD 150
+ KIY VMEYV +L K +K+ K QL+S V H + HRD
Sbjct: 75 GSNLDKIYMVMEYVEH-DL--KSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD 131
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA-----------YVAPEVL 199
LK NLLL+ G LK+ DFGL+ R+ G+P Y APE+L
Sbjct: 132 LKTSNLLLNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWYRAPELL 178
Query: 200 -SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-----GEFRSPRWFSP 253
K Y A +D+WS G I L+ F ++ + KI+K E P +
Sbjct: 179 LGAKEYSTA-IDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237
Query: 254 DLIR---------------------------LLTKLLDTNPDKRITIPEIMENRWF 282
+ LL +LL +P KRI+ + +++ +F
Sbjct: 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 6e-35
Identities = 79/258 (30%), Positives = 140/258 (54%), Gaps = 19/258 (7%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G VY A +V +G+ VAIK ++ ++ K L I EI ++R +HPNIV +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKHPNIVNYLD 83
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKP 153
+++ VMEY+ GG L + V + + E ++ + A+ F H+ V HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 143
Query: 154 ENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDI 211
+N+LL +G +K++DFG A +Q ++ T GTP ++APEV++RK Y KVDI
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAY-GPKVDI 198
Query: 212 WSCGVILFVLMAGYLPFQDQNIMVMYKKIY------KGEFRSPRWFSPDLIRLLTKLLDT 265
WS G++ ++ G P+ ++N + + +Y E ++P S L + L+
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 255
Query: 266 NPDKRITIPEIMENRWFR 283
+ +KR + E++++ + +
Sbjct: 256 DVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 82/243 (33%), Positives = 115/243 (47%), Gaps = 47/243 (19%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
K LG G F +V A V + A+K + K+ +L VAH+K E IL + +V+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRD 150
+ K +YFVM+Y+ GG++ + + + E LAR Y +L A+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 151 LKPENLLLDENGDLKVSDFGLSA------------VSDQIRQDG---------------- 182
+KP+N+L+D +G +K++DFGL IRQD
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 183 -----------------LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGY 225
L H+ GTP Y+APEVL RKGY D WS GVILF ++ G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILFEMLVGQ 245
Query: 226 LPF 228
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 9e-35
Identities = 85/293 (29%), Positives = 139/293 (47%), Gaps = 44/293 (15%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR--- 84
YE +G G + VY AR++ +G VA+K + + + + G+ REI++L+++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 85 HPNIVQLFEVMATKS-----KIYFVMEYVRG--GELFNKVAKGRLKEDLARKYFQQLISA 137
HPNIV+L +V K+ V E+V +K K L + + +QL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV-SDQIRQDGLFHTFCGTPAYVAP 196
V F H+ + HRDLKP+N+L+ +G +K++DFGL+ + S ++ + T Y AP
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA----LTSVVVTLWYRAP 175
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------------- 242
EVL + Y A VD+WS G I L F+ + KI+
Sbjct: 176 EVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234
Query: 243 ---------GEFRSPRWFSPDL----IRLLTKLLDTNPDKRITIPEIMENRWF 282
RS + F P++ + LL K+L NP KRI+ E +++ +F
Sbjct: 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-34
Identities = 83/262 (31%), Positives = 146/262 (55%), Gaps = 16/262 (6%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
RYE +G G V+ A +V +G+ VAIK I+ +K K L+ + EI +++ +++P
Sbjct: 23 RYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN---EILVMKELKNP 76
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
NIV + +++ VMEY+ GG L + V + + E ++ + A+ F HA V
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
HRD+K +N+LL +G +K++DFG A +Q ++ T GTP ++APEV++RK Y
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAY 192
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG--EFRSPRWFSPDLIRLLTK 261
KVDIWS G++ ++ G P+ ++N + +Y G E ++P SP L +
Sbjct: 193 -GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251
Query: 262 LLDTNPDKRITIPEIMENRWFR 283
L+ + +KR + E++++ + +
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 74/262 (28%), Positives = 126/262 (48%), Gaps = 20/262 (7%)
Query: 29 EIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+GK LG G F +VY + K VA+K + ++ + + RE I+R++
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKLD 59
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCH 142
HPN+V+L V + +Y VMEY+ GG+L + + + +L + Q+ + +
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLS---AVSDQIRQDGLFHTFCGTP-AYVAPEV 198
++ HRDL N L+ EN +K+SDFGLS D R+ G P ++APE
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG-----GKLPIRWMAPES 174
Query: 199 LSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR-SPRWFSPDLI 256
L + +K D+WS GV+L+ + G P+ + + + + G P P+L
Sbjct: 175 LKEGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELY 233
Query: 257 RLLTKLLDTNPDKRITIPEIME 278
L+ + +P+ R T E++E
Sbjct: 234 DLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 75/218 (34%), Positives = 123/218 (56%), Gaps = 8/218 (3%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
YE+ K++G G F +V R+ + + A+K++ K +++K A E I+ P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY 147
+VQLF +Y VMEY+ GG+L N ++ + E AR Y +++ A+ H+ G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH--TFCGTPAYVAPEVLSRK--- 202
HRD+KP+N+LLD++G LK++DFG ++ ++G+ T GTP Y++PEVL +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI 240
GY + D WS GV L+ ++ G PF +++ Y KI
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 81/263 (30%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI--LKSGLVAHIKREISILRRVR 84
RY + + LG G+F VY ++ K+ +KV+ + + L +E +L ++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV-----AKGRLKEDLARKYFQQLISAVG 139
HP IV+ + + EY G +L K+ L E+ ++F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
+ H R + HRDLK +N+ L N LK+ DFG+S + + L TF GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWFSPDLIRL 258
+GYD +K DIWS G IL+ + F+ QN + + +I +G S P +S L +
Sbjct: 178 KHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 259 LTKLLDTNPDKRITIPEIMENRW 281
+ +L+ +P R + EI+ N +
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 89/287 (31%), Positives = 133/287 (46%), Gaps = 42/287 (14%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
RY+ +G G + V A + +G VAIK I REI ILRR +H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRRFKHE 63
Query: 87 NIVQLFEVMATKS-----KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
NI+ + +++ S +Y V E + +L+ + L D + + Q++ + +
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT-FCGTPAYVAPEV-L 199
H+ V HRDLKP NLLL+ N DLK+ DFGL+ ++D F T + T Y APE+ L
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAG--------YL------------PFQD--QNIMVMY 237
+ KGY A +DIWS G IL +++ YL P Q+ I+ +
Sbjct: 183 NSKGYTKA-IDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241
Query: 238 KKIY--KGEFRSPRWF-------SPDLIRLLTKLLDTNPDKRITIPE 275
+ Y F+ + P + LL K+L NP KRIT+ E
Sbjct: 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 93/305 (30%), Positives = 138/305 (45%), Gaps = 80/305 (26%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVI--DKEK--ILKSGLVAHIKREISILRRVRHPNIV 89
+G GT+ VY AR+ SGE VA+K + D E+ I S L REI++L +RHPNIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-----REITLLLNLRHPNIV 69
Query: 90 QLFEVMATKS--KIYFVMEYVRGGELFNKVAKGRLKEDLARKY--------FQQLISAVG 139
+L EV+ K I+ VMEY +L L +++ + QL+ +
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCE-QDL------ASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG--TPA----- 192
+ H + HRDLK NLLL + G LK++DFGL+ + TP
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART---------YGLPAKPMTPKVVTLW 173
Query: 193 YVAPEVL-SRKGYDAAKVDIWSCGVILFVLMAG--YLPFQDQ----NIMV---------- 235
Y APE+L Y A +D+W+ G IL L+A LP + + ++++
Sbjct: 174 YRAPELLLGCTTYTTA-IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232
Query: 236 --------MYKKIY---------KGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ K K +F W S +RLL LL +P KR T E +E
Sbjct: 233 WPGFSDLPLVGKFTLPKQPYNNLKHKF---PWLSEAGLRLLNFLLMYDPKKRATAEEALE 289
Query: 279 NRWFR 283
+ +F+
Sbjct: 290 SSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 78/246 (31%), Positives = 123/246 (50%), Gaps = 13/246 (5%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G F +V + +G+ A K +DK+++ K E IL +V IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 94 VMATKSKIYFVMEYVRGGEL---FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRD 150
TK + VM + GG+L V + E A Y Q+I + H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 151 LKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
LKPEN+LLD++G++++SD GL+ + + GTP Y+APEVL + YD + V
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKK----IKGRAGTPGYMAPEVLQGEVYDFS-V 175
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265
D ++ G L+ ++AG PF+ + V + ++ + P FSP+ L LL
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235
Query: 266 NPDKRI 271
+P+KR+
Sbjct: 236 DPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-33
Identities = 79/251 (31%), Positives = 144/251 (57%), Gaps = 13/251 (5%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G+ V AR SG VA+K++D K + L+ + E+ I+R +H N+V++++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYK 85
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKP 153
+++ +ME+++GG L + V++ RL E+ + ++ A+ + H++GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 154 ENLLLDENGDLKVSDFGLSAVSDQIRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW 212
+++LL +G +K+SDFG A QI +D + GTP ++APEV+SR Y +VDIW
Sbjct: 146 DSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 213 SCGVILFVLMAGYLP-FQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLLTKLLDTNPD 268
S G+++ ++ G P F D + M K++ + ++ SP L L ++L P
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQ 260
Query: 269 KRITIPEIMEN 279
+R T E++++
Sbjct: 261 ERATAQELLDH 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 3e-33
Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 22/270 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVID--KEKILKSGLVAHIKREISILRRVRH 85
+EI LG G F KVY A+N ++G A KVI+ E+ L+ +V EI IL H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-----EIEILATCNH 68
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGE---LFNKVAKGRLKEDLARKYFQQLISAVGFCH 142
P IV+L K++ ++E+ GG + ++ +G L E + +Q++ A+ + H
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLH 127
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV---- 198
+ + HRDLK N+LL +GD+K++DFG+SA + + Q +F GTP ++APEV
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCE 185
Query: 199 -LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPD 254
+ YD K DIWS G+ L + P + N M + KI K E P +S +
Sbjct: 186 TMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
L LD +P+ R + +++E+ +
Sbjct: 245 FRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 3e-33
Identities = 78/262 (29%), Positives = 144/262 (54%), Gaps = 13/262 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+Y + +G G VY A ++ +G+ VAIK ++ ++ K L+ + EI ++R ++P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKNP 76
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
NIV + +++ VMEY+ GG L + V + + E ++ + A+ F H+ V
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
HRD+K +N+LL +G +K++DFG A +Q ++ T GTP ++APEV++RK Y
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAY 192
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG--EFRSPRWFSPDLIRLLTK 261
KVDIWS G++ ++ G P+ ++N + +Y G E ++P S L +
Sbjct: 193 -GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251
Query: 262 LLDTNPDKRITIPEIMENRWFR 283
L+ + D+R + E++++ + +
Sbjct: 252 CLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 3e-33
Identities = 78/262 (29%), Positives = 145/262 (55%), Gaps = 13/262 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+Y + +G G VY A +V +G+ VAI+ ++ ++ K L+ + EI ++R ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNP 77
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
NIV + +++ VMEY+ GG L + V + + E ++ + A+ F H+ V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
HRD+K +N+LL +G +K++DFG A +Q ++ + GTP ++APEV++RK Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----VGTPYWMAPEVVTRKAY 193
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG--EFRSPRWFSPDLIRLLTK 261
KVDIWS G++ ++ G P+ ++N + +Y G E ++P S L +
Sbjct: 194 -GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 262 LLDTNPDKRITIPEIMENRWFR 283
LD + +KR + E++++++ +
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 78/264 (29%), Positives = 138/264 (52%), Gaps = 10/264 (3%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G+F +VY + ++ E VAIK+ID E+ + I++EI++L + P I + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKP 153
+K++ +MEY+ GG + + G L+E ++++ + + H+ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKA 129
Query: 154 ENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDI 211
N+LL E GD+K++DFG++ QI+++ TF GTP ++APEV+ + YD K DI
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 212 WSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR-WFSPDLIRLLTKLLDTNPDKR 270
WS G+ L G P D + M + I K + +S + L+ +P R
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFR 244
Query: 271 ITIPEIMENRWFRKGFKHIKFYIE 294
T E++++++ + K F E
Sbjct: 245 PTAKELLKHKFITRYTKKTSFLTE 268
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 76/262 (29%), Positives = 123/262 (46%), Gaps = 19/262 (7%)
Query: 29 EIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
E+GK LG G F +VY + VA+K + KE + E SI++++
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREE-FLEEASIMKKLS 59
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCH 142
HPNIV+L V +Y V EY+ GG+L F + +L + Q+ + +
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP---AYVAPEVL 199
++ HRDL N L+ EN +K+SDFGL S I +D + G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGL---SRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 200 SRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFRSPR--WFSPDLI 256
+ +K D+WS GV+L+ + G P+ + + + + G R PR +L
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY-RLPRPENCPDELY 234
Query: 257 RLLTKLLDTNPDKRITIPEIME 278
L+ + +P+ R T E++E
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 94/299 (31%), Positives = 145/299 (48%), Gaps = 55/299 (18%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+YE + +G GT+ VY AR+ + E++A+K I E+ G+ + REIS+L+ ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHG 61
Query: 87 NIVQLFEVMATKSKIYFVMEYVR--------GGELFNKVAKGRLKEDLARKYFQQLISAV 138
NIV+L +V+ ++ ++Y V EY+ F K + L + Y Q++ +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR------LIKTYLYQILRGI 115
Query: 139 GFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPAYVAP 196
+CH+ V HRDLKP+NLL+D LK++DFGL+ A +R F T Y AP
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT---FTHEVVTLWYRAP 172
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF--QDQNIMVMYKKI-------------- 240
E+L + + VDIWS G I F M P D I ++K
Sbjct: 173 EILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 241 -----YKGEFRSPRWFSPDL-----------IRLLTKLLDTNPDKRITIPEIMENRWFR 283
YK F P+W DL + LL+K+L +P KRIT +E+ +F+
Sbjct: 232 TSLPDYKSAF--PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 76/270 (28%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 29 EIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+GK LG G F +VY VA+K + ++ + + RE I+R++
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLD 59
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYF--QQLISAVGFC- 141
HPNIV+L V + + VMEY+ GG+L L+ K L+S F
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDL-----LDYLR-KNRPKELSLSDLLS---FAL 110
Query: 142 ---------HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT-P 191
++ HRDL N L+ EN +K+SDFGL S + D + G P
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYKVKGGKLP 167
Query: 192 -AYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR-SP 248
++APE L + +K D+WS GV+L+ + G P+ + + + + KG P
Sbjct: 168 IRWMAPESLKEGKFT-SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP 226
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
P+L +L+ + +P+ R T E++E
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 86/298 (28%), Positives = 135/298 (45%), Gaps = 59/298 (19%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI--------DKEKILKSGLVAHIKRE 76
L +YEI + LG G + V+ A + ++ E VA+K I D ++ RE
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF---------RE 56
Query: 77 ISILRRVR-HPNIVQLFEVM-ATKSK-IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQ 133
I L+ + HPNIV+L V+ A K IY V EY+ +L + L++ R Q
Sbjct: 57 IMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQ 115
Query: 134 LISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS---AVSDQIRQDGLFHTFCGT 190
L+ A+ + H+ V HRDLKP N+LL+ + +K++DFGL+ + ++ ++ + + T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 191 PAYVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-------------- 234
Y APE+L S + Y VD+WS G IL ++ G F + +
Sbjct: 176 RWYRAPEILLGSTR-YTKG-VDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233
Query: 235 -------------VMYKKIYKGEFRSPRWF----SPDLIRLLTKLLDTNPDKRITIPE 275
M + + S D + LL KLL NP+KR+T E
Sbjct: 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 81/302 (26%), Positives = 140/302 (46%), Gaps = 52/302 (17%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRR 82
RY+ + +G G + V A + +SG+ VAIK I D + K L RE+ ILR
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-----RELKILRH 60
Query: 83 VRHPNIVQLFEVMATKSK----IYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISA 137
+H NI+ + +++ +Y VM+ + +L + + + L E+ R + QL+
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL--SAVSDQIRQDGLFHTFCGTPAYVA 195
+ + H+ V HRDLKP NLL++E+ +L++ DFG+ S + T Y A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 196 PEVL-SRKGYDAAKVDIWSCGVILFVLMAGYLPF--------QDQNIMVM---------- 236
PE+L S Y A +D+WS G I F M G Q + I+ +
Sbjct: 180 PELLLSLPEYTTA-IDMWSVGCI-FAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237
Query: 237 -------YKKIYKGEFRSPRWF-------SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
K I + P + SP+ + LL+++L +P++RIT+ + +++ +
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
Query: 283 RK 284
+
Sbjct: 298 AQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 91/289 (31%), Positives = 140/289 (48%), Gaps = 55/289 (19%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK----SGLVAHIKREISILRR 82
RY + +G G F V AR+ +G++VAIK KI+K L RE+ +L+
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKLLKH 65
Query: 83 VRHPNIVQLFEVMATKSK-IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
+RH NI+ L ++ + + IYFV E + G +L + L++ + + Q++ + +
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTE-LLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV-LS 200
H+ GV HRDLKP N+L++EN DLK+ DFGL+ + QD + T Y APE+ L+
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLT 179
Query: 201 RKGYDAAKVDIWSCGVILFVLMAG--YLPFQD-------------------------QNI 233
+ YD +VDIWS G I ++ G P +D +N
Sbjct: 180 WQKYD-VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238
Query: 234 MVMYKKIYKGEFRSPRWFS-------PDLIRLLTKLLDTNPDKRITIPE 275
+ + + K R P FS P I LL K+L +P KRI+ E
Sbjct: 239 LRFVQSLPK---REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 82/261 (31%), Positives = 135/261 (51%), Gaps = 15/261 (5%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+E+ + +G GT+ VY ARNV +GE AIKVI K+ A +++EI +++ +H N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARGV 146
IV F + K++ ME+ GG L + G L E ++ + + + H++G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEV--LSRKG 203
HRD+K N+LL +NG +K++DFG+SA ++ I + +F GTP ++APEV + RKG
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPYWMAPEVAAVERKG 184
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW-----FSPDLIRL 258
DIW+ G+ L P D + M + K F+ P+ +S
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF 244
Query: 259 LTKLLDTNPDKRITIPEIMEN 279
+ L NP KR T +++++
Sbjct: 245 VKMALTKNPKKRPTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-31
Identities = 88/266 (33%), Positives = 139/266 (52%), Gaps = 24/266 (9%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVID--KEKILKSGLVAHIKREISILRRVRH 85
+EI LG G F KVY A+N ++G A KVID E+ L+ +V EI IL H
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-----EIDILASCDH 61
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR--LKEDLARKYFQQLISAVGFCHA 143
PNIV+L + ++ ++ ++E+ GG + + + L E R +Q + A+ + H
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI--RQDGLFHTFCGTPAYVAPEVL-- 199
+ HRDLK N+L +GD+K++DFG+SA + + R+D +F GTP ++APEV+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD----SFIGTPYWMAPEVVMC 177
Query: 200 ---SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSP 253
+ YD K D+WS G+ L + P + N M + KI K E P +S
Sbjct: 178 ETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236
Query: 254 DLIRLLTKLLDTNPDKRITIPEIMEN 279
+ L K L+ N D R T +++++
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 76/268 (28%), Positives = 138/268 (51%), Gaps = 24/268 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGES-VAIKVID-------KEKILKSGLVAHIKREISI 79
Y + + LG G F VY R +G++ +A+K I+ K+K + + I E++I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 80 LR-RVRHPNIVQLFEVMATKSKIYFVMEYVRG---GELFN--KVAKGRLKEDLARKYFQQ 133
++ ++RHPNIV+ ++ ++Y VM+ + G GE FN K K R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 134 LISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
++ A+ + H + + HRDL P N++L E+ + ++DFGL+ Q + + + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTIL 178
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRW 250
Y PE++ + Y K D+W+ G IL+ + PF N++ + KI + +
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278
+S D+ ++T L + + R P+I++
Sbjct: 238 YSEDVTDVITSCLTPDAEAR---PDIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 79/290 (27%), Positives = 141/290 (48%), Gaps = 23/290 (7%)
Query: 4 ATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI---D 60
+++ +S+S+++S + + L E +G G VY + +G A+KVI
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN-KVAK 119
++ + + I REI ILR V HPN+V+ ++ +I ++E++ GG L +A
Sbjct: 112 EDTVRRQ-----ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD 166
Query: 120 GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179
+ D+AR Q++S + + H R + HRD+KP NLL++ ++K++DFG+S + Q
Sbjct: 167 EQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222
Query: 180 QDGLFHTFCGTPAYVAPEV----LSRKGYDAAKVDIWSCGVILFVLMAGYLPF----QDQ 231
++ GT AY++PE L+ YD DIWS GV + G PF Q
Sbjct: 223 DP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
Query: 232 NIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281
+M +P S + ++ L P KR + +++++ +
Sbjct: 281 WASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 84/297 (28%), Positives = 141/297 (47%), Gaps = 53/297 (17%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK----REISILRR 82
+YE L+G G++ V ++ ++G+ VAIK K L+S +K REI +L++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQ 56
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLISAVGFC 141
+RH N+V L EV K ++Y V E+V L + + L E RKY Q++ + FC
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLS---AVSDQIRQDGLFHTFCGTPAYVAPEV 198
H+ + HRD+KPEN+L+ ++G +K+ DFG + A ++ D + T Y APE+
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD-----YVATRWYRAPEL 171
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAG--YLPFQDQNIMVMY------------------- 237
L VDIW+ G ++ ++ G P D +I +Y
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYHIIKCLGNLIPRHQEIFQK 230
Query: 238 ------------KKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
K+I E R P+ S ++ L + L +PD R + +++ + +F
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 89/308 (28%), Positives = 139/308 (45%), Gaps = 61/308 (19%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
K++G G F +V + +G+ A+K + K ++ K +AH+K E +L P +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAKGRL-KEDLARKYFQQLISAVGFCHARGVYHRD 150
+ +Y +ME++ GG+L + K ED+ R Y + + A+ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 151 LKPENLLLDENGDLKVSDFGLSA------------------------------VSDQI-- 178
+KP+N+L+D G +K+SDFGLS D I
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 179 --------------RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG 224
R+ + T GTP Y+APE+ ++GY + D WS G I+F + G
Sbjct: 187 TMSSKDQIATWKKNRRLMAYST-VGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIG 244
Query: 225 YLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRL------LTKLLDTNPDKRI---TIPE 275
+ PF +N Y+KI +R +F PD I L L + L TN + R+ E
Sbjct: 245 WPPFCSENSHETYRKIIN--WRETLYF-PDDIHLSVEAEDLIRRLITNAENRLGRGGAHE 301
Query: 276 IMENRWFR 283
I + +FR
Sbjct: 302 IKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-31
Identities = 86/259 (33%), Positives = 131/259 (50%), Gaps = 18/259 (6%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+Y I ++LG G V A+ V GE A+KV+D E + + E+ L
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQAEVCCLLNCDFF 91
Query: 87 NIVQLFEVMATK--------SKIYFVMEYVRGGELFNKVAKGRLK------EDLARKYFQ 132
+IV+ E A K I V++Y G+L ++ K R K E A F
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI-KSRAKTNRTFREHEAGLLFI 150
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
Q++ AV H++ + HRD+K N+LL NG +K+ DFG S + D + TFCGTP
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWF 251
YVAPE+ RK Y + K D++S GV+L+ L+ PF +N+ + K G + P
Sbjct: 211 YVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSI 269
Query: 252 SPDLIRLLTKLLDTNPDKR 270
SP++ ++T LL ++P +R
Sbjct: 270 SPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 93/301 (30%), Positives = 144/301 (47%), Gaps = 55/301 (18%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIK----VIDKEKILKSGLVAHIKREISILRRV 83
YE + +G GT+ KVY AR+ +G+ VA+K +D+E I + L REIS+L+ +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-----REISLLQML 57
Query: 84 RH-PNIVQLFEVMATKSK-----IYFVMEYVRGG-----ELFNKVAKGRLKEDLARKYFQ 132
IV+L +V + K +Y V EY+ + + L + +
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLD-ENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGT 190
QL+ V CH GV HRDLKP+NLL+D + G LK++D GL A S ++ H T
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIV-T 174
Query: 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF-----QDQNIMVMYK------- 238
Y APEVL + + VDIWS G I F M+ P + Q ++ ++K
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCI-FAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233
Query: 239 KIYKG--EFRS----PRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281
+++ G + R P+W SP+ + LL K+L +P KRI+ + + +
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
Query: 282 F 282
F
Sbjct: 294 F 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 80/260 (30%), Positives = 135/260 (51%), Gaps = 17/260 (6%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
YE+ + +G GT+ VY ARN+ +GE A+K+I K+ + I++EI +++ +H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARGV 146
IV F ++ K++ MEY GG L + G L E ++ + + + H++G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRK--- 202
HRD+K N+LL +NGD+K++DFG++A ++ I + +F GTP ++APEV + +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTPYWMAPEVAAVEKNG 184
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW-----FSPDLIR 257
GY+ DIW+ G+ L P D + M + K F+ P+ +S
Sbjct: 185 GYNQL-CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243
Query: 258 LLTKLLDTNPDKRITIPEIM 277
+ L NP KR T ++
Sbjct: 244 FVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 85/304 (27%), Positives = 136/304 (44%), Gaps = 62/304 (20%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDK--EKILKSGLVAHIK---REISILR 81
RY+ +G G + +V A + K+G VAIK + + + + H K RE+ +L+
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI------HAKRTYRELRLLK 69
Query: 82 RVRHPNIVQLFEVMATKS------KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLI 135
+ H N++ L +V S +Y V + G +L N V +L +D + Q++
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ-DGLFHTFCGTPAYV 194
+ + H+ G+ HRDLKP N+ ++E+ +LK+ DFGL+ R D + T Y
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA------RHTDDEMTGYVATRWYR 182
Query: 195 APEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF-------QDQNIM------------- 234
APE++ + VDIWS G I+ L+ G F Q + IM
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242
Query: 235 --------------VMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENR 280
M KK +K F +P I LL K+L +PDKRIT E + +
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVF---SGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299
Query: 281 WFRK 284
+ +
Sbjct: 300 YLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 87/300 (29%), Positives = 132/300 (44%), Gaps = 53/300 (17%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRH 85
++I +G GT+ +VY AR+ +GE VA+K + D EK G REI ILR++ H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNH 65
Query: 86 PNIVQLFEVMATKSK----------IYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQ 133
NIV L E++ K Y V EY+ +L + G ED + + +Q
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 134 LISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV--SDQIRQDGLFHTFCGTP 191
L+ + +CH + HRD+K N+LL+ G +K++DFGL+ + S++ R + T
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR---PYTNKVITL 181
Query: 192 AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY-------------- 237
Y PE+L + +D+WSCG IL L FQ +
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241
Query: 238 ---------------KKIYKGEFRSPRWFSP-DLIRLLTKLLDTNPDKRITIPEIMENRW 281
KK Y+ R F P + LL +L +P KR T E + + W
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 77/255 (30%), Positives = 131/255 (51%), Gaps = 12/255 (4%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
L + I K +G G F++VY A + G VA+K + ++ + A +EI +L+++
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFN-----KVAKGRLKEDLARKYFQQLISAVG 139
HPN+++ + +++ V+E G+L K K + E KYF QL SA+
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
H+R V HRD+KP N+ + G +K+ D GL + H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPF--QDQNIMVMYKKIYKGEFR--SPRWFSPDL 255
GY+ K DIWS G +L+ + A PF N+ + KKI + ++ +S +L
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 256 IRLLTKLLDTNPDKR 270
+L+ ++ +P+KR
Sbjct: 238 RQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 2e-30
Identities = 76/266 (28%), Positives = 137/266 (51%), Gaps = 14/266 (5%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G+F +V+ + ++ + VAIK+ID E+ + I++EI++L + P + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKP 153
+K++ +MEY+ GG + + G E ++++ + + H+ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKA 129
Query: 154 ENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDI 211
N+LL E GD+K++DFG++ QI+++ TF GTP ++APEV+ + YD +K DI
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 212 WSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW---FSPDLIRLLTKLLDTNPD 268
WS G+ L G P D + M + I K P FS + L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPPTLTGEFSKPFKEFIDACLNKDPS 242
Query: 269 KRITIPEIMENRWFRKGFKHIKFYIE 294
R T E++++++ K K + E
Sbjct: 243 FRPTAKELLKHKFIVKNAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 77/248 (31%), Positives = 132/248 (53%), Gaps = 19/248 (7%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+EI K++G G F +V + + + A+K+++K ++LK A + E +L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARG 145
I L ++ +Y VM+Y GG+L ++K RL ED+AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT--FCGTPAYVAPEVLSR-- 201
HRD+KP+N+L+D NG ++++DFG ++ +DG + GTP Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 202 --KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--YKGEFRSPRWFS----- 252
KG + D WS GV ++ ++ G PF ++++ Y KI +K F+ P +
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 253 -PDLIRLL 259
DLIR L
Sbjct: 240 AKDLIRRL 247
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-30
Identities = 71/216 (32%), Positives = 119/216 (55%), Gaps = 7/216 (3%)
Query: 31 GKLLGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRHPNI 88
GKLLG G F +VY +V +G +A K + D E S V+ ++ EI +L+ ++H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 89 VQLFEVMATKSK--IYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARG 145
VQ + + +++ + MEY+ GG + +++ A G L E + RKY +Q++ + + H+
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL-FHTFCGTPAYVAPEVLSRKGY 204
+ HRD+K N+L D G++K+ DFG S I G + GTP +++PEV+S +GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI 240
K D+WS G + ++ P+ + M KI
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 76/231 (32%), Positives = 129/231 (55%), Gaps = 13/231 (5%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+EI K++G G F +V + +G+ A+K+++K ++LK A + E +L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARG 145
I L ++ +Y VM+Y GG+L ++K RL ED+AR Y +++ A+ H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF--CGTPAYVAPEVLSR-- 201
HRD+KP+N+LLD+NG ++++DFG S + ++ DG + GTP Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 202 --KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--YKGEFRSP 248
KG + D WS GV ++ ++ G PF ++++ Y KI +K F+ P
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 4e-30
Identities = 76/224 (33%), Positives = 122/224 (54%), Gaps = 22/224 (9%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-R 84
G +E+ +++G+GT+ +VY R+VK+G+ AIKV+D + IK EI++L++
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 85 HPNIVQLFEVMATKS------KIYFVMEYVRGGELFNKVAKGR---LKEDLARKYFQQLI 135
H NI + KS +++ VME+ G + + V + LKED ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195
+ HA V HRD+K +N+LL EN ++K+ DFG+SA D R G +TF GTP ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMA 189
Query: 196 PEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM 234
PEV++ YD + DIWS G+ + G P D + M
Sbjct: 190 PEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 76/263 (28%), Positives = 134/263 (50%), Gaps = 12/263 (4%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
L ++I K +G G F++VY A + + VA+K + +++ + +EI +L+++
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGEL-----FNKVAKGRLKEDLARKYFQQLISAVG 139
HPN+++ + +++ V+E G+L + K K + E KYF QL SAV
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
H+R V HRD+KP N+ + G +K+ D GL + H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPF--QDQNIMVMYKKIYKGEFR--SPRWFSPDL 255
GY+ K DIWS G +L+ + A PF N+ + +KI + ++ +S L
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 256 IRLLTKLLDTNPDKRITIPEIME 278
L++ + +PD+R I + +
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 87/295 (29%), Positives = 141/295 (47%), Gaps = 49/295 (16%)
Query: 27 RYE-IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK----REISILR 81
+YE + K+ G G++ V+ RN ++G+ VAIK K ++S IK REI +L+
Sbjct: 2 KYEKLSKI-GEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLK 55
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVG 139
+++HPN+V L EV K K++ V EY L K +G + E L +K Q + AV
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVN 114
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
FCH HRD+KPEN+L+ + G +K+ DFG + + + + T Y APE+L
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELL 172
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQ------DQ---------NIMVMYKKI---- 240
VD+W+ G + L+ G P DQ +++ +++I
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231
Query: 241 --YKG------EFRSP-----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
+KG E R P S + L L +P +R++ E++E+ +F
Sbjct: 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-29
Identities = 77/256 (30%), Positives = 140/256 (54%), Gaps = 11/256 (4%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G+ V A SG+ VA+K +D K + L+ + E+ I+R +H N+V+++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKP 153
+++ VME++ GG L + V R+ E+ ++ A+ HA+GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 154 ENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW 212
+++LL +G +K+SDFG A VS ++ + + GTP ++APE++SR Y +VDIW
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRLPY-GPEVDIW 200
Query: 213 SCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
S G+++ ++ G P+ ++ M M + + ++ SP L L +LL +P +
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 270 RITIPEIMENRWFRKG 285
R T E++++ + K
Sbjct: 261 RATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 74/247 (29%), Positives = 120/247 (48%), Gaps = 35/247 (14%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+E K++G G F +V + +G A+K++ K +L+ VAHI+ E IL
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARGV 146
+V++F K +Y +ME++ GG++ + K L E+ + Y + + A+ H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 147 YHRDLKPENLLLDENGDLKVSDFGL---------------------------------SA 173
HRD+KP+NLLLD G +K+SDFGL A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI 233
+ + + L ++ GTP Y+APEV + GY+ D WS GVI++ ++ GY PF +
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 234 MVMYKKI 240
Y+K+
Sbjct: 242 QETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 69/219 (31%), Positives = 119/219 (54%), Gaps = 7/219 (3%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRH 85
+ +GKLLG G F +VY + +G +A+K + D + S V ++ EI +L+ +RH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 86 PNIVQLFEVM--ATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCH 142
IVQ + + + K+ +EY+ GG + +++ A G L E++ R+Y +Q++ V + H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL-FHTFCGTPAYVAPEVLSR 201
+ + HRD+K N+L D G++K+ DFG S I G + GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI 240
+GY K D+WS + ++ P+ + M KI
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 76/263 (28%), Positives = 125/263 (47%), Gaps = 25/263 (9%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH-----IKREISILRRVRHPNI 88
+GHG+F VY AR+V++ E VAIK K+ SG ++ I +E+ L+++RHPN
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIK-----KMSYSGKQSNEKWQDIIKEVRFLQQLRHPNT 77
Query: 89 VQLFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY 147
++ + + VMEY G +V K L+E + + + H+
Sbjct: 78 IEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV---LSRKGY 204
HRD+K N+LL E G +K++DFG +++ ++F GTP ++APEV + Y
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQY 191
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLTK 261
D KVD+WS G+ L P + N M I + + S W S +
Sbjct: 192 D-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW-SDYFRNFVDS 249
Query: 262 LLDTNPDKRITIPEIMENRWFRK 284
L P R + E++++R+ +
Sbjct: 250 CLQKIPQDRPSSEELLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 85/254 (33%), Positives = 133/254 (52%), Gaps = 19/254 (7%)
Query: 46 RNVKSGESVAIKVID-KEKILKSGLV-------AHIKREISILRRVRHPNIVQLFEVMAT 97
RN + VA + D KEK++ ++ A+ + E+ L H IV+ F+ +
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 98 KSKIYFVMEYVRGGELFNKVAKGRLKEDLARK------YFQQLISAVGFCHARGVYHRDL 151
K+ +MEY GG+L NK K RLKE L + F Q++ A+ H+R + HRDL
Sbjct: 137 DDKLLLIMEYGSGGDL-NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDL 195
Query: 152 KPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVD 210
K N+ L G +K+ DFG S SD + D + +FCGTP Y+APE+ RK Y + K D
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWERKRY-SKKAD 253
Query: 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWFSPDLIRLLTKLLDTNPDK 269
+WS GVIL+ L+ + PF+ + + +++ G++ P S + LL LL NP
Sbjct: 254 MWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPAL 313
Query: 270 RITIPEIMENRWFR 283
R T +++ + +
Sbjct: 314 RPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 4e-29
Identities = 67/265 (25%), Positives = 117/265 (44%), Gaps = 28/265 (10%)
Query: 32 KLLGHGTFAKVYHAR---NVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRHP 86
K LG G F +VY + VA+K + D + + + +E +++++ HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL----KEARVMKKLGHP 56
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGEL----------FNKVAKGRLKEDLARKYFQQLIS 136
N+V+L V + +Y V+EY+ GG+L F K L + Q+
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV-- 194
+ + ++ HRDL N L+ E+ +K+SDFGL S + D + G +
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPIRW 173
Query: 195 -APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEF-RSPRWF 251
APE L + +K D+WS GV+L+ + G P+ + + + + KG P +
Sbjct: 174 MAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYC 232
Query: 252 SPDLIRLLTKLLDTNPDKRITIPEI 276
+L L+ +P+ R T E+
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 4e-29
Identities = 79/262 (30%), Positives = 125/262 (47%), Gaps = 37/262 (14%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+E K++G G F +V + +G A+K++ K +L+ V HI+ E IL
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARGV 146
+V++F K +Y +ME++ GG++ + K L E+ + Y + + A+ H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 147 YHRDLKPENLLLDENGDLKVSDFGL------------------SAVSDQIRQD------- 181
HRD+KP+NLLLD G +K+SDFGL S SD Q+
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 182 --------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI 233
L + GTP Y+APEV + GY+ D WS GVI++ ++ GY PF +
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 234 MVMYKKIYKGEFRSPRWFSPDL 255
YKK+ ++ F P++
Sbjct: 242 QETYKKVMN--WKETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 70/219 (31%), Positives = 118/219 (53%), Gaps = 7/219 (3%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRH 85
+ +GKLLG G F +VY + +G +A+K + D E S V ++ EI +L+ + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 86 PNIVQLFEVM--ATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCH 142
IVQ + + + + ME++ GG + +++ + G L E++ RKY +Q++ V + H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL-FHTFCGTPAYVAPEVLSR 201
+ + HRD+K N+L D G++K+ DFG S I G + GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI 240
+GY K DIWS G + ++ P+ + M KI
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 86/317 (27%), Positives = 139/317 (43%), Gaps = 59/317 (18%)
Query: 18 DQNQSPL---LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL----KSGLV 70
DQ + P + +YE +G GTF +V+ AR+ K+ + VA+K K+L K G
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFP 55
Query: 71 AHIKREISILRRVRHPNIVQLFEVMATKSK--------IYFVMEYVR---GGELFNKVAK 119
REI IL+ ++H N+V L E+ TK+ Y V E+ G L NK K
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK 115
Query: 120 GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI 178
L E +K + L++ + + H + HRD+K N+L+ ++G LK++DFGL+ A S
Sbjct: 116 FTLSE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSK 173
Query: 179 RQDG-LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVIL------FVLMAGYLPFQDQ 231
+ T Y PE+L + +D+W G I+ +M G
Sbjct: 174 NSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233
Query: 232 NI------------------MVMYKKIY--KGEFR------SPRWFSPDLIRLLTKLLDT 265
+ + ++KK+ +G+ R P P + L+ KLL
Sbjct: 234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL 293
Query: 266 NPDKRITIPEIMENRWF 282
+P KRI + + +F
Sbjct: 294 DPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 94/322 (29%), Positives = 158/322 (49%), Gaps = 36/322 (11%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESV-AIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+EI K++G G F +V + +K E + A+K+++K ++LK A + E ++L
Sbjct: 3 FEIIKVIGRGAFGEVAVVK-MKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHAR 144
I L ++ +Y VM+Y GG+L ++K RL ED+AR Y +++ A+ H
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT--FCGTPAYVAPEVLSR- 201
HRD+KP+N+LLD NG ++++DFG ++ QDG + GTP Y++PE+L
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCL---KMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 202 ---KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRL 258
G + D WS GV ++ ++ G PF ++++ Y KI E R +
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER---------FQF 229
Query: 259 LTKLLDTNPDKRITIPEIMENRWFRKG------FKHIKFY--IEDDKMCNVE-----DVD 305
+ + D + + + I ++ +R R G FK F+ I+ + + N+E DV
Sbjct: 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVS 289
Query: 306 HTDDVGPCS-DDHSLSEPEPEP 326
D DD L PE P
Sbjct: 290 SPSDTSNFDVDDDVLRNPEIAP 311
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 73/264 (27%), Positives = 139/264 (52%), Gaps = 10/264 (3%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G+F +V+ + ++ + VAIK+ID E+ + I++EI++L + P + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKP 153
+K++ +MEY+ GG + + G L E ++++ + + H+ HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 129
Query: 154 ENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDI 211
N+LL E+G++K++DFG++ QI+++ TF GTP ++APEV+ + YD +K DI
Sbjct: 130 ANVLLSEHGEVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIKQSAYD-SKADI 184
Query: 212 WSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW-FSPDLIRLLTKLLDTNPDKR 270
WS G+ L G P + + M + I K + +S L + L+ P R
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR 244
Query: 271 ITIPEIMENRWFRKGFKHIKFYIE 294
T E++++++ + K + E
Sbjct: 245 PTAKELLKHKFIVRFAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 77/247 (31%), Positives = 129/247 (52%), Gaps = 13/247 (5%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-LKSGLVAHIKREI--SILRRVRHPNIV 89
++G G F +VY R +G+ A+K +DK++I +K G + I S++ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 90 QLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYH 148
+ T K+ F+++ + GG+L +++ G E R Y ++I + H R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK-GYDAA 207
RDLKP N+LLDE+G +++SD GL+ + + H GT Y+APEVL + YD++
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSS 176
Query: 208 KVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW---FSPDLIRLLTKLLD 264
D +S G +LF L+ G+ PF+ ++ + FSP+L LL LL
Sbjct: 177 -ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 265 TNPDKRI 271
+ ++R+
Sbjct: 236 RDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 72/254 (28%), Positives = 134/254 (52%), Gaps = 11/254 (4%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G+ V A +G+ VA+K +D K + L+ + E+ I+R H N+V ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMYN 86
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKP 153
+++ VME++ GG L + V R+ E+ ++ A+ + H +GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 154 ENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW 212
+++LL +G +K+SDFG A VS ++ + + GTP ++APEV+SR Y +VDIW
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRLPY-GTEVDIW 202
Query: 213 SCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLLTKLLDTNPDK 269
S G+++ ++ G P+ ++ + ++I + S L L +L P +
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQ 262
Query: 270 RITIPEIMENRWFR 283
R T E++++ + +
Sbjct: 263 RATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 24/271 (8%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-R 84
G +E+ +L+G+GT+ +VY R+VK+G+ AIKV+D + IK+EI++L++
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 85 HPNIVQLFEVMATKS------KIYFVMEYVRGG---ELFNKVAKGRLKEDLARKYFQQLI 135
H NI + K+ +++ VME+ G +L LKE+ ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195
+ H V HRD+K +N+LL EN ++K+ DFG+SA D R G +TF GTP ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMA 179
Query: 196 PEVLS-RKGYDAA---KVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSP 248
PEV++ + DA K D+WS G+ + G P D + M I + +S
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
+W S + L N +R T ++M++
Sbjct: 240 KW-SKKFQSFIESCLVKNHSQRPTTEQLMKH 269
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 89/325 (27%), Positives = 140/325 (43%), Gaps = 69/325 (21%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKS--GESVAIK----VIDKEKILKSGLVAHIKREISIL 80
RYE+ K LG G + V ARN ++ E+VAIK V K+ + K L RE+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLL 55
Query: 81 RRVR-HPNIVQLFEV-MATKSK---IYFVMEYVRGGELFNKVAKGRLKEDLARKYF-QQL 134
R R H NI L+++ + +Y E + +L + G+ D + F Q+
Sbjct: 56 RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 135 ISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPA 192
+ + + H+ V HRDLKP NLL++ + +LK+ DFGL+ + G + T
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 193 YVAPEV-LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------- 242
Y APE+ LS + Y A +D+WS G IL L+ F+ ++ + +I +
Sbjct: 175 YRAPEIMLSFQSYTKA-IDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233
Query: 243 -GEFRSPRWF---------------------SPDLIRLLTKLLDTNPDKRITIPEIME-- 278
SP+ +P + LL KLL +P KRI++ E +E
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293
Query: 279 --NRW------------FRKGFKHI 289
W F F+
Sbjct: 294 YLAIWHDPDDEPVCQKPFDFSFESE 318
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 92/302 (30%), Positives = 143/302 (47%), Gaps = 53/302 (17%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDK--EKILKSGLVAHIKREISILRRVR 84
RY+I +++G G++ V A + +GE VAIK I+ E + + I REI +LR +R
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA---TRILREIKLLRLLR 57
Query: 85 HPNIVQLFEVMATKSK-----IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ----QLI 135
HP+IV++ +M S+ IY V E + ++V K +DL ++ Q QL+
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKA--NDDLTPEHHQFFLYQLL 113
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT-FCGTPAYV 194
A+ + H V+HRDLKP+N+L + + LK+ DFGL+ V+ +F T + T Y
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 195 APEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI------------ 240
APE+ Y A +DIWS G I ++ G F +N++ I
Sbjct: 174 APELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232
Query: 241 ----------YKGEFRS--PRWFS-------PDLIRLLTKLLDTNPDKRITIPEIMENRW 281
Y R P FS P +RLL +LL +P R T E + + +
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 282 FR 283
F+
Sbjct: 293 FK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 82/264 (31%), Positives = 135/264 (51%), Gaps = 18/264 (6%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-LKSGLVAHIKREI--SILRRVRHPNIV 89
++G G F +VY R +G+ A+K +DK++I +K G + I S++ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 90 QLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYH 148
+ T K+ F+++ + GG+L +++ G E R Y ++I + H R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR-KGYDAA 207
RDLKP N+LLDE+G +++SD GL+ + + H GT Y+APEVL + YD++
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSS 176
Query: 208 KVDIWSCGVILFVLMAGYLPFQDQNIMVMY---KKIYKGEFRSPRWFSPDLIRLLTKLLD 264
D +S G +LF L+ G+ PF+ + + P FSP+L LL LL
Sbjct: 177 -ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 265 TNPDKRITI-----PEIMENRWFR 283
+ KR+ E+ E+ +F+
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-27
Identities = 71/203 (34%), Positives = 109/203 (53%), Gaps = 17/203 (8%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-- 84
+YE +G G + VY AR+ SG VA+K + + + + GL RE+++L+R+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 85 -HPNIVQLFEVMAT-----KSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLIS 136
HPNIV+L +V AT ++K+ V E+V +KV L + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV-SDQIRQDGLFHTFCGTPAYVA 195
+ F HA + HRDLKPEN+L+ G +K++DFGL+ + S Q+ + T Y A
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YRA 175
Query: 196 PEVLSRKGYDAAKVDIWSCGVIL 218
PEVL + Y A VD+WS G I
Sbjct: 176 PEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 82/312 (26%), Positives = 133/312 (42%), Gaps = 60/312 (19%)
Query: 27 RYE-IGKLLGHGTFAKVYHARNVKSGESVAIKVI-----------DKEKILKSGLVAHIK 74
RY G LG GT+ KV A + +G+ VAIK + D++ + G+
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 75 REISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG--GELFNKVAKGRLKEDLARKYFQ 132
RE+ I+ ++H NI+ L +V I VM+ + ++ + K RL E +
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD--RKIRLTESQVKCILL 126
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-------AVSDQIRQDGLFH 185
Q+++ + H HRDL P N+ ++ G K++DFGL+ + + +
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 186 TFCGTPA-----YVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK 238
T Y APE+L + K + A VD+WS G I L+ G F +N +
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFA--VDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
Query: 239 KIYK-------------------GEF--RSPRWF-------SPDLIRLLTKLLDTNPDKR 270
+I++ EF R P+ S D I LL LL NP +R
Sbjct: 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 271 ITIPEIMENRWF 282
I+ E +++ +F
Sbjct: 305 ISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 87/289 (30%), Positives = 131/289 (45%), Gaps = 50/289 (17%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G++A VY R+ +G+ VA+K I E + G RE S+L+ ++H NIV L +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDL 151
++ TK + V EY+ +L + G L R + QL+ + +CH R V HRDL
Sbjct: 71 IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDL 129
Query: 152 KPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCG---TPAYVAPEVLSRKGYDAA 207
KP+NLL+ E G+LK++DFGL+ A S T+ T Y P+VL +
Sbjct: 130 KPQNLLISERGELKLADFGLARAKSVPS------KTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 208 KVDIWSCGVILFVLMAGYLPF------QDQNIMVMYK-------------------KIYK 242
+D+W G I + + G F +DQ + +++ K Y
Sbjct: 184 SLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-LHKIFRVLGTPTEETWPGVSSNPEFKPYS 242
Query: 243 GEFRSPRWF---------SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
F PR P L K L P KRI+ E M++ +F
Sbjct: 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 84/302 (27%), Positives = 136/302 (45%), Gaps = 59/302 (19%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIK--------VIDKEKILKSGLVAHIKREIS 78
+Y K +G G + V A+N ++ E VAIK ID ++ L REI
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL---------REIK 56
Query: 79 ILRRVRHPNIVQLFEVMATKSK-----IYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQ 132
+LR + H N++ + ++M + +Y V E + +L + + L +D + +
Sbjct: 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLY 115
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
QL+ + + H+ V HRDLKP NLLL+ N DLK+ DFGL+ + + + + T
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRW 173
Query: 193 YVAPEV-LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------- 242
Y APE+ L+ Y A +D+WS G I L+ F ++ + K I +
Sbjct: 174 YRAPELLLNCSEYTTA-IDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232
Query: 243 -GEFRSP------------------RWF---SPDLIRLLTKLLDTNPDKRITIPEIMENR 280
G R+ R F +P I LL K+L +P KRIT+ E + +
Sbjct: 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292
Query: 281 WF 282
+
Sbjct: 293 YL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 72/255 (28%), Positives = 136/255 (53%), Gaps = 9/255 (3%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
Y +++G G++ +V R+ G+ IK ++ + A ++E +L +++HPN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKA-AEQEAQLLSQLKHPN 60
Query: 88 IVQLFEVM-ATKSKIYFVMEYVRGGELFNKVA--KGRL-KEDLARKYFQQLISAVGFCHA 143
IV E +Y VM + GG+L++K+ KG+L E+ ++F Q+ A+ + H
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
+ + HRDLK +N+ L +KV D G++ V + Q + T GTP Y++PE+ S K
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKP 178
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLTKL 262
Y+ K D+W+ G ++ + F +++ + +I +G+ P+ +SP+L L+ +
Sbjct: 179 YN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237
Query: 263 LDTNPDKRITIPEIM 277
L P+KR ++ I+
Sbjct: 238 LSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 84/297 (28%), Positives = 133/297 (44%), Gaps = 58/297 (19%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI---DKEKILKSGLVAHIKREISILRR 82
RY + LG G+ V+ A + + VA+K I D + V H REI I+RR
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------VKHALREIKIIRR 58
Query: 83 VRHPNIVQLFEVMATKSK--------------IYFVMEYVRGGELFNKVAKGRLKEDLAR 128
+ H NIV+++EV+ +Y V EY+ +L N + +G L E+ AR
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHAR 117
Query: 129 KYFQQLISAVGFCHARGVYHRDLKPENLLLD-ENGDLKVSDFGLSAVSDQ-IRQDGLFHT 186
+ QL+ + + H+ V HRDLKP N+ ++ E+ LK+ DFGL+ + D G
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 187 FCGTPAYVAPE-VLSRKGYDAAKVDIWSCGVILFVLMAGYLPF----------------- 228
T Y +P +LS Y A +D+W+ G I ++ G F
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 229 ----QDQN----IMVMYKKIYKGEFRSP-RWFSPDL----IRLLTKLLDTNPDKRIT 272
+D+N ++ + + GE R P R P + + L ++L NP R+T
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 83/271 (30%), Positives = 120/271 (44%), Gaps = 48/271 (17%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR----EISILRRVRHPN 87
+ +G G F VY +K VA+K +S L +KR E IL++ HPN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTC------RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVG---FCH 142
IV+L V K IY VME V GG L + K RL +K Q + A +
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLLQMSLDAAAGMEYLE 110
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLS--------AVSDQIRQDGLFHTFCGTP-AY 193
++ HRDL N L+ EN LK+SDFG+S VSD ++Q P +
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ---------IPIKW 161
Query: 194 VAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFS 252
APE L G ++ D+WS G++L+ G P+ + ++I G +R P
Sbjct: 162 TAPEAL-NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPA--- 216
Query: 253 PDLI-----RLLTKLLDTNPDKRITIPEIME 278
P L RL+ + +P+ R + EI
Sbjct: 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-26
Identities = 75/262 (28%), Positives = 127/262 (48%), Gaps = 17/262 (6%)
Query: 31 GKLLGHGTFAKVYHARNVKSGESVAIK--VIDKEKILKS-GLVAHIKREISILRRVRHPN 87
G++LG G + VY G+ +A+K +D +L + ++ E+ +L+ ++H N
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGV 146
IVQ + I ME+V GG + + + + G L E + KY +Q++ V + H V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 147 YHRDLKPENLLLDENGDLKVSDFG----LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
HRD+K N++L NG +K+ DFG L+ V + + GTP ++APEV++
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-----PRWFSPDLIR 257
GY K DIWS G +F + G P ++ + Y G R P FS I
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPL--ASMDRLAAMFYIGAHRGLMPRLPDSFSAAAID 240
Query: 258 LLTKLLDTNPDKRITIPEIMEN 279
+T L + +R + +++ +
Sbjct: 241 FVTSCLTRDQHERPSALQLLRH 262
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 70/204 (34%), Positives = 108/204 (52%), Gaps = 14/204 (6%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRR 82
++E+ ++G G + V R+ ++ E VAIK + E++ ++ L RE+ +LR
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTL-----RELKMLRT 56
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLISAVGF 140
++ NIV+L E + K+Y V EYV EL ++ G E + R Y QLI A+ +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-RSYIYQLIKAIHW 115
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLS 200
CH + HRD+KPENLL+ N LK+ DFG + + + + + T Y +PE+L
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRSPELLL 174
Query: 201 RKGYDAAKVDIWSCGVILFVLMAG 224
Y A VD+WS G IL L G
Sbjct: 175 GAPYGKA-VDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 85/286 (29%), Positives = 136/286 (47%), Gaps = 25/286 (8%)
Query: 9 STSTTSSSKDQNQSPLLGRYEIGKL------LGHGTFAKVYHARNVKSGESVAIKVIDKE 62
STS S KD + L + + KL +GHG+F VY AR+V++ E VAIK +
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS 61
Query: 63 KILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG--ELFNKVAKG 120
+ I +E+ L+R++HPN ++ + + VMEY G +L +V K
Sbjct: 62 GKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLL-EVHKK 120
Query: 121 RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180
L+E + + + H+ + HRD+K N+LL E G +K++DFG ++++
Sbjct: 121 PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178
Query: 181 DGLFHTFCGTPAYVAPEV---LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY 237
++F GTP ++APEV + YD KVD+WS G+ L P + N M
Sbjct: 179 ----NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSAL 233
Query: 238 KKIYKGE---FRSPRWFSPDLIR-LLTKLLDTNPDKRITIPEIMEN 279
I + E +S W D R + L P R T E++++
Sbjct: 234 YHIAQNESPTLQSNEW--SDYFRNFVDSCLQKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 78/250 (31%), Positives = 125/250 (50%), Gaps = 18/250 (7%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G F +V + +G+ A K ++K+++ K E IL +V IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 94 VMATKSKIYFVMEYVRGGEL------FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY 147
TK+ + VM + GG+L ++ G E A Y Q+IS + H R +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRII 119
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+RDLKPEN+LLD +G++++SD GL+ Q + G + GTP ++APE+L + YD
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG----YAGTPGFMAPELLQGEEYD 175
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPDLIRLLTK 261
+ VD ++ GV L+ ++A PF+ + V + ++I P FSP
Sbjct: 176 FS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEA 234
Query: 262 LLDTNPDKRI 271
LL +P+KR+
Sbjct: 235 LLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-25
Identities = 51/154 (33%), Positives = 88/154 (57%), Gaps = 1/154 (0%)
Query: 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRR 82
P + + I K + G F KVY R + + A+KV+ K ++ +V ++ E L
Sbjct: 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL 60
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFC 141
+ P IV L+ + + + +Y VMEY+ GG++ + + G E++A KY ++ A+ +
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175
H G+ HRDLKP+N+L+ G +K++DFGLS V+
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 86/321 (26%), Positives = 138/321 (42%), Gaps = 70/321 (21%)
Query: 27 RYEIGKLLGHGTFAKVYHAR--NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+YEI +G GT+ +VY A+ N K G+ AIK +K +G+ REI++LR ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 85 HPNIVQLFEVMATKS--KIYFVMEYVRGGEL----FNKVAKGR-LKEDLARKYFQQLISA 137
H N+V L EV + +Y + +Y F++ AK + + + Q+++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 138 VGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLSAVSDQIRQ-----DGLFHTFC 188
V + H+ V HRDLKP N+L+ E G +K+ D GL+ + + + D + T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 189 GTPAYVAPEV-LSRKGYDAAKVDIWSCGVILFVL-------------MAGYLPFQ----D 230
Y APE+ L + Y A +DIW+ G I L + PFQ +
Sbjct: 181 ----YRAPELLLGARHYTKA-IDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235
Query: 231 QNIMVM----------------YKKIYKGEFRS-------PRWF------SPDLIRLLTK 261
+ V+ Y + K +W LL K
Sbjct: 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295
Query: 262 LLDTNPDKRITIPEIMENRWF 282
LL+ +P KRIT E +E+ +F
Sbjct: 296 LLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 77/272 (28%), Positives = 124/272 (45%), Gaps = 22/272 (8%)
Query: 29 EIGKL--LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
EI L LG G + VY + +G ++A+K I E L I E+ IL + P
Sbjct: 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSP 59
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGEL----FNKVAKGRLKEDLARKYFQQLISAVGFCH 142
IV + + +Y MEY+ G L VA + ED+ R+ ++ + F
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 143 AR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
+ HRD+KP N+L++ NG +K+ DFG VS + L T G +Y+APE +
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFG---VSGNLVAS-LAKTNIGCQSYMAPERIKS 175
Query: 202 KGYDAA-----KVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGE-FRSPRWFS 252
G + + D+WS G+ + + G P+ + NI I G+ P +S
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235
Query: 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
D + K L+ P++R T +++E+ W K
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 79/281 (28%), Positives = 133/281 (47%), Gaps = 35/281 (12%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG GT+A V+ R+ + VA+K I E + G RE+S+L+ ++H NIV L +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 94 VMATKSKIYFVMEYV-RGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLK 152
++ T + V EY+ + + + + + + Q++ + +CH R V HRDLK
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 153 PENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW 212
P+NLL++E G+LK++DFGL+ + + T Y P+VL + ++D+W
Sbjct: 132 PQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMW 189
Query: 213 SCGVILFVLMAGYLPFQDQNIMVMYKKIYK----------------GEFRS---PRW--- 250
G I F + +G F + I++ EF++ P++
Sbjct: 190 GVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQ 249
Query: 251 ----FSPDL----IRLLTKLLDTNPDKRITIPEIMENRWFR 283
+P L I LLTK L KRI+ E M++ +FR
Sbjct: 250 PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-24
Identities = 76/276 (27%), Positives = 136/276 (49%), Gaps = 32/276 (11%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HP 86
+EI + +G GT+ KV+ N K+G A+K++D + I+ E +IL+ + HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE----EIEAEYNILKALSDHP 75
Query: 87 NIVQLFEVMATKS-----KIYFVMEYVRGGELFNKVAKG------RLKEDLARKYFQQLI 135
N+V+ + + K +++ V+E GG + + KG R++E + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAY 193
+ H HRD+K N+LL G +K+ DFG+SA S ++R++ T GTP +
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPFW 190
Query: 194 VAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EF 245
+APEV++ YD A+ D+WS G+ L G P D + M KI +
Sbjct: 191 MAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249
Query: 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281
P +S + + K L + +KR T+ +++++ +
Sbjct: 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 78/283 (27%), Positives = 133/283 (46%), Gaps = 44/283 (15%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+ RY+I +L+G G +VY A + VA+K I ++ L RE I +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRG---GELFNKV-AKGRLKEDLARK--------YFQ 132
HP IV ++ + + +Y+ M Y+ G L V K L ++LA K F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD----------- 181
++ + + + H++GV HRDLKP+N+LL G++ + D+G A+ ++ ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA-AIFKKLEEEDLLDIDVDERN 179
Query: 182 GLFHTF------CGTPAYVAPEVLSRKGYDAA-KVDIWSCGVILFVLMAGYLPFQDQNIM 234
+ + GTP Y+APE L G A+ DI++ GVIL+ ++ P++ +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKK-- 235
Query: 235 VMYKKI-YKGEFRSP------RWFSPDLIRLLTKLLDTNPDKR 270
+KI Y+ SP R P L ++ K L +P +R
Sbjct: 236 --GRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 76/259 (29%), Positives = 122/259 (47%), Gaps = 17/259 (6%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+GHG+F VY AR+V++ E VAIK + + I +E+ L+++RHPN +Q
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 94 VMATKSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDL 151
+ + VMEY G +L +V K L+E + + + H+ + HRD+
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141
Query: 152 KPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV---LSRKGYDAAK 208
K N+LL E G +K+ DFG +++ + F GTP ++APEV + YD K
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYD-GK 194
Query: 209 VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLTKLLDT 265
VD+WS G+ L P + N M I + E +S W S + L
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCLQK 253
Query: 266 NPDKRITIPEIMENRWFRK 284
P R T ++++R+ +
Sbjct: 254 IPQDRPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 84/294 (28%), Positives = 139/294 (47%), Gaps = 47/294 (15%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVRH 85
RY K +G G + V A + ++GE VAIK + + +S + A RE+++L+ ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP--FQSEIFAKRAYRELTLLKHMQH 73
Query: 86 PNIVQLFEVMATKS------KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG 139
N++ L +V + Y VM Y++ K+ L ED + Q++ +
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
+ H+ G+ HRDLKP NL ++E+ +LK+ DFGL+ D + T Y APEV+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVI 186
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK------GEF-------- 245
+ VDIWS G I+ ++ G F+ ++ + +I K EF
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 246 ---------RSPR-----WF---SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
+ PR F SP + LL K+L+ + DKR+T E +E+ +F
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 29/280 (10%)
Query: 17 KDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH---- 72
KD + +G +EIG HG+F VY A N + E VA+K K+ SG +
Sbjct: 16 KDDPEEIFVGLHEIG----HGSFGAVYFATNSHTNEVVAVK-----KMSYSGKQTNEKWQ 66
Query: 73 -IKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKY 130
I +E+ L++++HPN ++ + + VMEY G +V K L+E
Sbjct: 67 DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI 126
Query: 131 FQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190
+ + + H+ + HRD+K N+LL E G +K++DFG ++ S ++F GT
Sbjct: 127 THGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------NSFVGT 180
Query: 191 PAYVAPEV---LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--- 244
P ++APEV + YD KVD+WS G+ L P + N M I + +
Sbjct: 181 PYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 239
Query: 245 FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
+S W + + L P +R E++ + + R+
Sbjct: 240 LQSNEW-TDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 47/286 (16%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG GT+A VY R+ + VA+K I E + G RE+S+L+ ++H NIV L +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKE-------DLARKYFQQLISAVGFCHARGV 146
++ T+ + V EY+ +K K L + + + QL+ + +CH R V
Sbjct: 72 IIHTEKSLTLVFEYL------DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
HRDLKP+NLL++E G+LK++DFGL+ + + T Y P++L +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYS 183
Query: 207 AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK----------------GEFRS--- 247
++D+W G I + + G F + I++ EF+S
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243
Query: 248 PRWFS-----------PDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
P++ + D LL+KLL KRI+ E M++ +F
Sbjct: 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 70/215 (32%), Positives = 112/215 (52%), Gaps = 19/215 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
YE + LG G++A VY ++ +G+ VA+KVI ++ + G RE S+L+ ++H N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHAN 64
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARG 145
IV L +++ TK + V EYV +L + K G L + + + QL+ + + H R
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG---TPAYVAPEVLSRK 202
+ HRDLKP+NLL+ + G+LK++DFGL+ HT+ T Y P+VL
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-----HTYSNEVVTLWYRPPDVLLGS 178
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPF------QDQ 231
+ +D+W G I ++ G F QDQ
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 74/269 (27%), Positives = 128/269 (47%), Gaps = 18/269 (6%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G F +V + +G+ A K +DK+++ K E IL +V P IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 94 VMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLAR--KYFQQLISAVGFCHARGVYHRD 150
+K+ + VM + GG+L ++ G ++ R Y Q+ + H+ + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVD 210
+KPEN+LLD+ G+ ++SD GL+ +++ GT Y+APE+L + Y + VD
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPY-SYPVD 176
Query: 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF--------SPDLIRLLTKL 262
++ G ++ ++AG PF+D V +++ + F S D+ RL
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL---F 233
Query: 263 LDTNPDKRITIPEIMENRWFRKGFKHIKF 291
L P+ R+ E ++ + FK I F
Sbjct: 234 LAKKPEDRLGSREKNDDPRKHEFFKTINF 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
E+ +L G G V R +G A+K I + L I RE+ I + + P I
Sbjct: 5 ELSRL-GEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYI 61
Query: 89 VQLFEVMATK--SKIYFVMEYVRGGEL---FNKVAK--GRLKEDLARKYFQQLISAVGFC 141
V+ + + S I MEY GG L + KV K GR+ E + K + ++ + +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLS--AVSDQIRQDGLFHTFCGTPAYVAPEVL 199
H+R + HRD+KP N+LL G +K+ DFG+S V+ TF GT Y+APE +
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG------TFTGTSFYMAPERI 175
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPF 228
K Y + D+WS G+ L + PF
Sbjct: 176 QGKPY-SITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 63/195 (32%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
+ LG G++A VY + +G+ VA+KVI + + G+ RE S+L+ ++H NIV L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLL 68
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHR 149
+++ TK + FV EY+ +L + + G L R + QL+ + + H + + HR
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLKP+NLL+ G+LK++DFGL+ Q + + T Y P+VL ++ +
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSAL 185
Query: 210 DIWSCGVILFVLMAG 224
DIW G I ++ G
Sbjct: 186 DIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-23
Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 15/252 (5%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
+LLG G F +V+ +K VA+K ++ L L E IL++ HPNIV+L
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKL 57
Query: 92 FEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
V + IY VME V GG+ F + K LK K+ + + + ++ HR
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT--FCGTP-AYVAPEVLSRKGYDA 206
DL N L+ EN LK+SDFG+S D DG++ + P + APE L+ Y +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQED----DGIYSSSGLKQIPIKWTAPEALNYGRY-S 172
Query: 207 AKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLD 264
++ D+WS G++L+ + G P+ +++ KG P+ D+ +++ + D
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD 232
Query: 265 TNPDKRITIPEI 276
P+ R E+
Sbjct: 233 YKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 48/295 (16%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVRH 85
RY K +G G + V A + ++G VAIK + + +S L A RE+ +L+ ++H
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMKH 73
Query: 86 PNIVQLFEVMATKSKI------YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG 139
N++ L +V + Y VM ++ G +L + +L ED + Q++ +
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ-DGLFHTFCGTPAYVAPEV 198
+ HA G+ HRDLKP NL ++E+ +LK+ DFGL+ RQ D + T Y APEV
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQTDSEMTGYVVTRWYRAPEV 186
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ-----DQ---------------------- 231
+ + VDIWS G I+ ++ G F+ DQ
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 232 ---NIMVMYKKIYKGEFRSP-RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
N + + K +FRS +P + +L K+L + + RIT E + + +F
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 76/305 (24%), Positives = 132/305 (43%), Gaps = 33/305 (10%)
Query: 50 SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF-VMEYV 108
+G VAIK++ + + A +RE ++ R+ HPNIV L + + F V EYV
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 109 RGGELFNKVA-KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---L 164
G L +A G L + Q++ A+ H +G+ HRDLKP+N+++ + G
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 165 KVSDFGLSA----VSDQIRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF 219
KV DFG+ V D GTP Y APE L R D+++ G+I
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIFL 180
Query: 220 VLMAGYLPFQDQNIM-VMYKKIYKGEFRSPRWF-SPDLIRLLTKLLDTNPDKRITIPEIM 277
+ G Q ++ ++Y+++ + P W L ++L K L+ +P +R +
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPAL 240
Query: 278 ENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHSLSEP-----EPEPELETKR 332
R F+ ++ + +G + +++ P + E +R
Sbjct: 241 AER-----FRALEL----------CALVGILRMGEGAGREAIAAPLVASGTLDGETGERR 285
Query: 333 KLTSL 337
+LT+L
Sbjct: 286 QLTAL 290
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 6e-23
Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 27/260 (10%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
++G +G G F V G+ VA+K + + +A E S++ +RHPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDSTAAQAFLA----EASVMTTLRHPNL 62
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHA---- 143
VQL V+ + +Y V EY+ G L + + ++GR LA QQL A+ C
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA----QQLGFALDVCEGMEYL 118
Query: 144 --RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA-YVAPEVLS 200
+ HRDL N+L+ E+ KVSDFGL+ + Q + G P + APE L
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEAL- 171
Query: 201 RKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258
R+ + K D+WS G++L+ + + G +P+ + + + KG +P P++ ++
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV 231
Query: 259 LTKLLDTNPDKRITIPEIME 278
+ + +P KR T ++ E
Sbjct: 232 MKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 7e-23
Identities = 63/250 (25%), Positives = 122/250 (48%), Gaps = 16/250 (6%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+ + + LG G F +V+ K+ VAIK++ + +LK +E+ L+R+RH +
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQ---KEVQALKRLRHKH 63
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQ-QLISAVGFCHAR 144
++ LF V + +Y + E + G L F + +G++ + Q+ + + +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP-AYVAPEVLSRKG 203
HRDL N+L+ E+ KV+DFGL+ + I++D + P + APE S
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 204 YDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFRSPRWFS--PDLIRLLT 260
+ + K D+WS G++L+ + G +P+ N +Y +I G +R P ++ +++
Sbjct: 181 F-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIML 238
Query: 261 KLLDTNPDKR 270
+ P+ R
Sbjct: 239 ECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 32 KLLGHGTFAKVYHAR----NVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRH 85
K LG G F KV R +GE VA+K + E+ +S +REI ILR + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF----EREIEILRTLDH 65
Query: 86 PNIVQLFEVM--ATKSKIYFVMEYVRGGELFNKVAKGRLKEDLAR--KYFQQLISAVGFC 141
NIV+ V + +MEY+ G L + + + R + +L R + Q+ + +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ------IRQDGLFHTFCGTPAYVA 195
++ HRDL N+L++ +K+SDFGL+ V + +++ G F + A
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF-----WYA 180
Query: 196 PEVLS-RKGYDAAKVDIWSCGVILFVLMAGYLPFQD--QNIMVM 236
PE L K A+ D+WS GV L+ L P Q + M
Sbjct: 181 PECLRTSKFSSAS--DVWSFGVTLYELFTYGDPSQSPPAEFLRM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 37/272 (13%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-----H-- 85
+G GT +VY R K+G +A+K ++ ++G KR IL + H
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKR---ILMDLDVVLKSHDC 73
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCH 142
P IV+ + T S ++ ME + +K+ K G + ED+ K ++ A+ +
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 143 AR-GVYHRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTPAYVAPEVL 199
+ GV HRD+KP N+LLD +G++K+ DFG+S V + + G AY+APE +
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-----AGCAAYMAPERI 186
Query: 200 SRKG----YDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFRSP---RWF 251
YD + D+WS G+ L L G P+++ + KI + E S F
Sbjct: 187 DPPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF 245
Query: 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283
SPD + L + KR E++++ + R
Sbjct: 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 76/260 (29%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLF 92
+LG GT+ VY AR++ + +AIK I + S V + EI++ ++H NIVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 93 EVMATKSKIYFVMEYVRGGELF----NKVAKGRLKEDLARKYFQQLISAVGFCHARGVYH 148
+ ME V GG L +K + E Y +Q++ + + H + H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 149 RDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQDGL---FHTFCGTPAYVAPEVLSR--K 202
RD+K +N+L++ +G +K+SDFG S R G+ TF GT Y+APEV+ + +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQD--QNIMVMYK-KIYKGEFRSPRWFSPDLIRLL 259
GY A DIWS G + + G PF + + M+K ++K P S + +
Sbjct: 187 GYGAP-ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245
Query: 260 TKLLDTNPDKRITIPEIMEN 279
+ + +PDKR + +++++
Sbjct: 246 LRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 63/192 (32%), Positives = 99/192 (51%), Gaps = 5/192 (2%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG GT+A V+ R+ + VA+K I E + G RE+S+L+ ++H NIV L +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ-QLISAVGFCHARGVYHRDLK 152
++ T+ + V EY+ G L K F QL+ + +CH R + HRDLK
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 153 PENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW 212
P+NLL++E G+LK++DFGL+ + + T Y P+VL + +D+W
Sbjct: 131 PQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMW 188
Query: 213 SCGVILFVLMAG 224
G IL+ + G
Sbjct: 189 GVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 75/249 (30%), Positives = 122/249 (48%), Gaps = 34/249 (13%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-R 84
+EI + +G GT+ KVY N K G A+K++D S + I+ E +IL+ +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP----ISDVDEEIEAEYNILQSLPN 77
Query: 85 HPNIVQLFEVMATKSK-----IYFVMEYVRGGELFNKVAKG------RLKEDLARKYFQQ 133
HPN+V+ + + K ++ V+E GG + ++ KG RL E +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAMISYILYG 136
Query: 134 LISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA--VSDQIRQDGLFHTFCGTP 191
+ + H + HRD+K N+LL G +K+ DFG+SA S ++R++ T GTP
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTP 192
Query: 192 AYVAPEVLS-RKGYDA---AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS 247
++APEV++ + YD A+ D+WS G+ L G P D + + K F+
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------KTLFKI 245
Query: 248 PRWFSPDLI 256
PR P L+
Sbjct: 246 PRNPPPTLL 254
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 11/247 (4%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
++LG G F +V + +G+ A K ++K++I K + E IL +V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 92 FEVMATKSKIYFVMEYVRGGEL---FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYH 148
TK + V+ + GG+L + + +E A Y ++ + H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAK 208
RDLKPEN+LLD++G +++SD GL+ + + GT Y+APEV+ + Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 182
Query: 209 VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK----GEFRSPRWFSPDLIRLLTKLLD 264
D W+ G +L+ ++AG PFQ + + +++ + + FSPD L LL
Sbjct: 183 -DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 265 TNPDKRI 271
+P +R+
Sbjct: 242 KDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 13/248 (5%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
++LG G F +V + +G+ A K ++K++I K A E IL +V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 92 FEVMATKSKIYFVMEYVRGGEL---FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYH 148
TK + V+ + GG+L + E+ A Y ++ + H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAK 208
RDLKPEN+LLD+ G +++SD GL+ +I + GT Y+APEV+ + Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERYTFS- 181
Query: 209 VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-----GEFRSPRWFSPDLIRLLTKLL 263
D W G +++ ++ G PF+ + V +++ + E S + FS + +LL
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK-FSEAARSICRQLL 240
Query: 264 DTNPDKRI 271
+P R+
Sbjct: 241 TKDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 67/204 (32%), Positives = 112/204 (54%), Gaps = 18/204 (8%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSG-ESVAIKVIDKEKILKSGLVAHIKREISILRRVR- 84
+YE +G G + KV+ AR++K+G VA+K + + + + G+ RE+++LR +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 85 --HPNIVQLFEVMAT-----KSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLI 135
HPN+V+LF+V ++K+ V E+V +KV + + + + QL+
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV-SDQIRQDGLFHTFCGTPAYV 194
+ F H+ V HRDLKP+N+L+ +G +K++DFGL+ + S Q+ + T Y
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWYR 176
Query: 195 APEVLSRKGYDAAKVDIWSCGVIL 218
APEVL + Y A VD+WS G I
Sbjct: 177 APEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 5e-22
Identities = 73/241 (30%), Positives = 119/241 (49%), Gaps = 38/241 (15%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
L YE+ K +G+G F +V+ ++ ++ E K I + LK + + E++++R ++
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMRELK 70
Query: 85 HPNIVQLFEVMATKS--KIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISA 137
H NIV+ + K+ K+Y +ME+ G+L + K G+++E +QL+ A
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 138 VGFCH-------ARGVYHRDLKPENLLLDE---------------NGD--LKVSDFGLSA 173
+ +CH V HRDLKP+N+ L NG K+ DFGLS
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS- 189
Query: 174 VSDQIRQDGLFHTFCGTPAYVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ 231
I + + H+ GTP Y +PE+L K YD K D+W+ G I++ L +G PF
Sbjct: 190 --KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHKA 246
Query: 232 N 232
N
Sbjct: 247 N 247
|
Length = 1021 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 9e-22
Identities = 79/295 (26%), Positives = 139/295 (47%), Gaps = 48/295 (16%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR---EISILRRV 83
RY+ +G G + V A + K+G VA+K + + +S + H KR E+ +L+ +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQS--IIHAKRTYRELRLLKHM 73
Query: 84 RHPNIVQLFEVMATKSKI-----YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAV 138
+H N++ L +V + +++ ++ G +L N V +L +D + Q++ +
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 198
+ H+ + HRDLKP NL ++E+ +LK+ DFGL+ +D G + T Y APE+
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTG----YVATRWYRAPEI 188
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAGYLPF-------QDQNIM--------VMYKKIYKG 243
+ + VDIWS G I+ L+ G F Q + I+ + KKI
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248
Query: 244 EFRS--------PRW--------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
R+ P+ +P + LL K+L + DKRIT + + + +F
Sbjct: 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-21
Identities = 35/58 (60%), Positives = 40/58 (68%), Gaps = 4/58 (6%)
Query: 343 LNAFDLISFSPGFDLSGLFEEGGEG----ARFVSGAPVSKIITKLEEIAKVVSFTVRK 396
LNAFDLIS S G DLSGLFEE + RF S P S+II+KLEEIAK + F V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 30/273 (10%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
E LG G V +++ +G +A KV+ KS + I RE+ I+ R P I
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYI 65
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCH-ARG 145
V + ++ I ME++ G L +++ K G + ++ K ++ + + +
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
+ HRD+KP N+L++ G +K+ DFG+S + + I TF GT Y++PE + Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGKY 179
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQN-----------IMVMYKKIYKGEFRSPRW--- 250
K D+WS G+ + L G PF N I+ + ++I + PR
Sbjct: 180 -TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPRLPSS 236
Query: 251 -FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
F DL + L +P +R T ++ F
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-21
Identities = 71/245 (28%), Positives = 119/245 (48%), Gaps = 15/245 (6%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G F +V+ R VA+K + L L A +E IL++ HPNIV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 94 VMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDL 151
V K IY VME V+GG+ F + RLK + + + + + ++ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 152 KPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP----AYVAPEVLSRKGYDAA 207
N L+ E LK+SDFG+S + +DG++ + G + APE L+ Y ++
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRY-SS 175
Query: 208 KVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLI-RLLTKLLDT 265
+ D+WS G++L+ G +P+ + + + I +G PD + RL+ + +
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 266 NPDKR 270
+P +R
Sbjct: 236 DPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 9e-21
Identities = 68/268 (25%), Positives = 122/268 (45%), Gaps = 35/268 (13%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LGHG VY A ++ + +A+KVI + ++ L I E+ IL + P I+ +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFYG 66
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARG-------- 145
+++I E++ GG L D+ RK + ++ + +G
Sbjct: 67 AFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+ HRD+KP N+L++ G +K+ DFG VS Q+ + + T+ GT AY+APE +S + Y
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFG---VSTQL-VNSIAKTYVGTNAYMAPERISGEQY- 170
Query: 206 AAKVDIWSCGVILFVLMAG---YLPFQDQNIMVMYKKIYKG--EFRSPRW----FSPDLI 256
D+WS G+ L G Y Q +M ++ + + P FS +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230
Query: 257 RLLTKLLDTNPDKRITIPEIMENRWFRK 284
+T+ + P +R +M++ + +
Sbjct: 231 HFITQCMRKQPKERPAPENLMDHPFIVQ 258
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 79/297 (26%), Positives = 129/297 (43%), Gaps = 59/297 (19%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G V + SG +A K+I E +K + I RE+ +L P IV +
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLIS-AV--GFCHAR---G 145
+ +I ME++ GG L ++V K GR+ E++ K IS AV G + R
Sbjct: 67 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGK-----ISIAVLRGLTYLREKHK 120
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+ HRD+KP N+L++ G++K+ DFG VS Q+ D + ++F GT +Y++PE L Y
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFG---VSGQL-IDSMANSFVGTRSYMSPERLQGTHY- 175
Query: 206 AAKVDIWSCGVILFVLMAGYLPF---QDQNIMVMY----KKIYKGEFRSP---------- 248
+ DIWS G+ L + G P + + M+ + E P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 249 ---------------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
FS + + K L NP +R + E+ ++ + ++
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 69/252 (27%), Positives = 123/252 (48%), Gaps = 13/252 (5%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
++LG G F +V + +G+ A K ++K++I K + E IL +V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 92 FEVMATKSKIYFVMEYVRGGEL----FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY 147
TK + V+ + GG+L +N G +E+ A Y +++ + H
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLHRENTV 124
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAA 207
+RDLKPEN+LLD+ G +++SD GL+ +I + GT Y+APEVL+ + Y +
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 208 KVDIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
D W G +++ ++ G PF+ + V + +++ + E FS + + LL
Sbjct: 182 P-DYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 264 DTNPDKRITIPE 275
+P +R+ E
Sbjct: 241 TKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 23/259 (8%)
Query: 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQ 90
K LG G F V H + VAIK+I +E + E ++ ++ HPN+VQ
Sbjct: 9 LKELGSGQFGVV-HLGKWRGKIDVAIKMI-REGAMSEDDFIE---EAKVMMKLSHPNLVQ 63
Query: 91 LFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARGVYH 148
L+ V + I+ V EY+ G L N + KG+L + + A+ + + G H
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123
Query: 149 RDLKPENLLLDENGDLKVSDFGLS--AVSDQIRQDGLFHTFCGTP---AYVAPEVLSRKG 203
RDL N L+ E+ +KVSDFGL+ + DQ GT + PEV
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ------GTKFPVKWAPPEVFDYSR 177
Query: 204 YDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLT 260
+ ++K D+WS GV+++ V G +P++ + + + + G +R P+ ++ ++
Sbjct: 178 F-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKLAPTEVYTIMY 235
Query: 261 KLLDTNPDKRITIPEIMEN 279
P+ R +++
Sbjct: 236 SCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 80/279 (28%), Positives = 130/279 (46%), Gaps = 44/279 (15%)
Query: 34 LGHGTFAKV----YHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV 89
LG G F KV Y +GE VA+K + E +A +K+EI ILR + H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 90 QLFEVMATK---SKIYFVMEYVRGGELFNKVAKGRLKEDLAR--KYFQQLISAVGFCHAR 144
+ ++ + T+ + I +ME++ G L + + + K +L + KY Q+ + + +R
Sbjct: 70 K-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF---CGTPAY-VAPEVLS 200
HRDL N+L++ +K+ DFGL+ I D ++T +P + APE L
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKA---IETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 201 R-KGYDAAKVDIWSCGVILFVL----------MAGYL----PFQDQNIMVMYKKIYKGEF 245
+ K Y A+ D+WS GV L+ L M +L P Q + ++ +
Sbjct: 186 QSKFYIAS--DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 246 RSPRWFSPD-----LIRLLTKLLDTNPDKRITIPEIMEN 279
R PR P + +L+ K + P KR T ++E
Sbjct: 244 RLPR---PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 69/255 (27%), Positives = 122/255 (47%), Gaps = 19/255 (7%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G + +VY K +VA+K + KE ++ V +E ++++ ++HPN+VQL
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ---QLISAVGFCHARGVYHRD 150
V + Y + E++ G L + + + +E A Q+ SA+ + + HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP---AYVAPEVLSRKGYDAA 207
L N L+ EN +KV+DFGLS ++ + G + APE L+ + +
Sbjct: 130 LAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SI 184
Query: 208 KVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLD 264
K D+W+ GV+L+ + G P+ ++ +Y+ + KG +R P P + L+
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELMRACWQ 243
Query: 265 TNPDKRITIPEIMEN 279
NP R + EI +
Sbjct: 244 WNPSDRPSFAEIHQA 258
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 80/294 (27%), Positives = 137/294 (46%), Gaps = 46/294 (15%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH-IKREISILRRVRH 85
RY+ +G G + V A + + + VA+K + + +S + A RE+ +L+ ++H
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP--FQSLIHARRTYRELRLLKHMKH 73
Query: 86 PNIVQLFEVMATKSKI-----YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140
N++ L +V + I +++ + G +L N V +L ++ + QL+ + +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ-DGLFHTFCGTPAYVAPEVL 199
H+ G+ HRDLKP N+ ++E+ +L++ DFGL+ RQ D + T Y APE++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLA------RQADDEMTGYVATRWYRAPEIM 187
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPF-------QDQNIMV--------MYKKIYKGE 244
+ VDIWS G I+ L+ G F Q + IM + KKI
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 245 FRS-----P-----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
R P R +P I LL K+L + DKRI+ E + + +F
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 70/248 (28%), Positives = 117/248 (47%), Gaps = 13/248 (5%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
++LG G F +V + +G+ A K ++K++I K A E IL +V +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 92 FEVMATKSKIYFVMEYVRGGEL----FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY 147
TK + V+ + GG+L +N G E A Y +L + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAA 207
+RDLKPEN+LLD+ G +++SD GL+ QI + GT Y+APEV++ + Y
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKY-TF 180
Query: 208 KVDIWSCGVILFVLMAGYLPFQDQNIMVMY----KKIYKGEFRSPRWFSPDLIRLLTKLL 263
D W G +++ ++ G PF+ + V +++ + + FS D + LL
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 264 DTNPDKRI 271
NP +R+
Sbjct: 241 TKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 68/257 (26%), Positives = 123/257 (47%), Gaps = 23/257 (8%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
K LG G F V H ++ VAIK I++ + + + E ++ ++ HP +VQL
Sbjct: 10 KELGSGQFG-VVHLGKWRAQIKVAIKAINEGAMSEEDFI----EEAKVMMKLSHPKLVQL 64
Query: 92 FEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
+ V + +Y V E++ G L N + +G+L +D+ Q + + + HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 150 DLKPENLLLDENGDLKVSDFGLS--AVSDQIRQDGLFHTFCGTP---AYVAPEVLSRKGY 204
DL N L+ G +KVSDFG++ + D+ + + G + PEV + Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE------YTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 205 DAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLTK 261
++K D+WS GV+++ V G +PF+ ++ + + I +G FR P+ S + ++
Sbjct: 179 -SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-FRLYRPKLASMTVYEVMYS 236
Query: 262 LLDTNPDKRITIPEIME 278
P+ R T E++
Sbjct: 237 CWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 34/269 (12%)
Query: 29 EIGKLLGHGTFAKVYHARNV-KSGE--SVAIKVI-------DKEKILKSGLVAHIKREIS 78
+G+ +G G F VY + E +VA+K +EK L+ E
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ---------EAY 59
Query: 79 ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLIS 136
I+R+ HP+IV+L V+ T++ ++ VME GEL + +V K L Y QL +
Sbjct: 60 IMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT-P-AYV 194
A+ + ++ HRD+ N+L+ +K+ DFGLS + + + G P ++
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWM 175
Query: 195 APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQ--DQNIMVMYKKIYKGE-FRSPRW 250
APE ++ + + +A D+W GV ++ +LM G PFQ N ++ +I GE P
Sbjct: 176 APESINFRRFTSAS-DVWMFGVCMWEILMLGVKPFQGVKNNDVIG--RIENGERLPMPPN 232
Query: 251 FSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
P L L+TK +P KR E+
Sbjct: 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 31/264 (11%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR---EISILRRVRH-PNIV 89
LG G + V R+V +G +A+K +I + KR ++ I R P V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 90 QLFEVMATKSKIYFVMEYVRGG--ELFNKVAKG--RLKEDLARKYFQQLISAVGFCHAR- 144
+ + + ++ ME + + + KV + ED+ K ++ A+ + H++
Sbjct: 64 TFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF-CGTPAYVAPE----VL 199
V HRD+KP N+L++ NG +K+ DFG +S + D + T G Y+APE L
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFG---ISGYL-VDSVAKTIDAGCKPYMAPERINPEL 179
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV-MYKKIYKGEFRSPRW----FSPD 254
++KGYD K D+WS G+ + L G P+ K++ + SP+ FSP+
Sbjct: 180 NQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--SPQLPAEKFSPE 236
Query: 255 LIRLLTKLLDTNPDKRITIPEIME 278
+ K L N +R PE+++
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-18
Identities = 60/237 (25%), Positives = 111/237 (46%), Gaps = 21/237 (8%)
Query: 37 GTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96
G KV + ++ ++ +K + KS + + I I V PN+V L + +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILK-----GLRKSSEYSRERLTI-IPHCV--PNMVCLHKYIV 55
Query: 97 TKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPEN 155
++ ++ V+++ GG+L++ ++K + E+ +++ +++ A+ H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 156 LLLDENGDLKVSDFG-LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSC 214
+LLD+ G ++++ F S V D + + + +C APEV A D WS
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEVGGISEETEA-CDWWSL 168
Query: 215 GVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRI 271
G ILF L+ G + + P W S + LL +LL NP +R+
Sbjct: 169 GAILFELLTGKTLVECHPSGINTHT----TLNIPEWVSEEARSLLQQLLQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 45/292 (15%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA--HIKREISILRRVRHPNIVQL 91
+G+G F V+ + + G+ VA+K K + LV+ + RE+ +L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK---KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 92 FEVMATKSKIYFVMEYVRGGELFNK------VAKGRLKEDLARKYFQQLISAVGFCHARG 145
+++ F YV EL V+ L D + + Q++ + + H+ G
Sbjct: 65 LDILQPPHIDPFEEIYVVT-ELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+ HRD+KP NLL++ N LK+ DFGL+ V + + T Y APE+L +
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEILMGSRHY 182
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQ----------------NIMVMY-------KKIYK 242
+ VDIWS G I L+ + FQ Q ++ M I +
Sbjct: 183 TSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILR 242
Query: 243 GEFRSPR-----WFSPDL----IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
G + P S + LL ++L +PDKRI+ + + + + +G
Sbjct: 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 4e-18
Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 31/262 (11%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
K LG G F V + + + VAIK+I + + + + E ++ ++ H +VQL
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI----EEAKVMMKLSHEKLVQL 64
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLIS-------AVGFCHAR 144
+ V + IY V EY+ G L N L+E R QL+ + + ++
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLN-----YLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLS--AVSDQIRQDGLFHTFCGTPAYV---APEVL 199
HRDL N L+D+ G +KVSDFGLS + D+ + + G+ V PEVL
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPEVL 173
Query: 200 SRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIR 257
+ ++K D+W+ GV+++ V G +P++ N +K+ +G P S +
Sbjct: 174 LYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYA 232
Query: 258 LLTKLLDTNPDKRITIPEIMEN 279
++ ++R T +++ +
Sbjct: 233 IMYSCWHEKAEERPTFQQLLSS 254
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 19/259 (7%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
L + +G+++G G F V G+ VA+K I + ++ L E +++ ++
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTAQAFL-----EETAVMTKLH 57
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCH- 142
H N+V+L V+ +Y VME + G L N + +GR + + L A G +
Sbjct: 58 HKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 143 -ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
++ + HRDL N+L+ E+G KVSDFGL+ V + + APE L
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKH 171
Query: 202 KGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259
K + ++K D+WS GV+L+ V G P+ ++ + + + KG P D+ L+
Sbjct: 172 KKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230
Query: 260 TKLLDTNPDKRITIPEIME 278
T +T P KR + ++ E
Sbjct: 231 TSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
Y + K L G+ +V+ A + V +K+ K L + +L+ V HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM---------LLQNVNHPS 118
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARG 145
++++ + + + + V+ + +L+ + K L D A +Q++ + + HA+
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+ HRD+K EN+ +++ + + D G + F GT APEVL+R Y+
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFP---VVAPAFLGLAGTVETNAPEVLARDKYN 234
Query: 206 AAKVDIWSCGVILFVLMA 223
+K DIWS G++LF ++A
Sbjct: 235 -SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G V ++ SG +A K+I E +K + I RE+ +L P IV +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARG-------- 145
+ +I ME++ GG L ++V LKE A++ ++++ V RG
Sbjct: 71 AFYSDGEISICMEHMDGGSL-DQV----LKE--AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 146 -VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
+ HRD+KP N+L++ G++K+ DFG VS Q+ D + ++F GT +Y++PE L Y
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFG---VSGQL-IDSMANSFVGTRSYMSPERLQGTHY 179
Query: 205 DAAKVDIWSCGVILFVLMAGYLP 227
+ + DIWS G+ L L G P
Sbjct: 180 -SVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 24/232 (10%)
Query: 30 IGKLLGHGTFAKVYHAR---NVKSGESVAIKVIDKEKILKSGLVAHIK----REISILRR 82
I K++G G F +V R K VAIK LK+G + E SI+ +
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT------LKAGSSDKQRLDFLTEASIMGQ 61
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGF 140
HPNI++L V+ + + EY+ G L F + G+ + + S + +
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG-TPA-YVAPEV 198
HRDL N+L++ N KVSDFGLS + + + T G P + APE
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEA 179
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQD-QNIMVMYKKIYKGEFRSP 248
++ + + +A D+WS G++++ +M+ G P+ D N V+ K + G +R P
Sbjct: 180 IAYRKFTSAS-DVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDG-YRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G V+ + SG +A K+I E +K + I RE+ +L P IV +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDL 151
+ +I ME++ GG L + K GR+ E + K +I + + + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 152 KPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDI 211
KP N+L++ G++K+ DFG VS Q+ D + ++F GT +Y++PE L Y + + DI
Sbjct: 131 KPSNILVNSRGEIKLCDFG---VSGQL-IDSMANSFVGTRSYMSPERLQGTHY-SVQSDI 185
Query: 212 WSCGVILFVLMAGYLP 227
WS G+ L + G P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 70/230 (30%), Positives = 119/230 (51%), Gaps = 28/230 (12%)
Query: 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
D N+SP Y++G ++G+G+F VY A + + E VAIK + ++ K+ RE+
Sbjct: 59 DINRSPNKS-YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-------REL 110
Query: 78 SILRRVRHPNIVQLFEVMATKS------KIYF--VMEYVRGGELFNKVAKGRLKED---- 125
I++ + H NI+ L + T+ I+ VME++ + +K K + +
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALP 168
Query: 126 --LARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQDG 182
L + Y QL A+ + H++ + HRDLKP+NLL+D N LK+ DFG SA + Q
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRS 227
Query: 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN 232
+ ++ + Y APE++ +D+WS G I+ ++ GY F Q+
Sbjct: 228 V--SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 81/307 (26%), Positives = 134/307 (43%), Gaps = 61/307 (19%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR---EISIL 80
+L RY+ K +G G V A + G +VA+K + + ++ H KR E+ +L
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLL 74
Query: 81 RRVRHPNIVQLFEVMATKSK------IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQL 134
+ V H NI+ L V + +Y VME + +V L + Q+
Sbjct: 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQM 132
Query: 135 ISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV 194
+ + H+ G+ HRDLKP N+++ + LK+ DFGL+ + + + + T Y
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYR 189
Query: 195 APEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK------GEFRS- 247
APEV+ GY VDIWS G I+ L+ G + FQ + + + K+ + EF +
Sbjct: 190 APEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248
Query: 248 ------------------------PRWFSP-----DLIR------LLTKLLDTNPDKRIT 272
P W P D ++ LL+K+L +PDKRI+
Sbjct: 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS 308
Query: 273 IPEIMEN 279
+ E + +
Sbjct: 309 VDEALRH 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 18/222 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
IGK V+ A++ + VA+K I+ + K L +++EI R+++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKL-LQQEIITSRQLQHPN 60
Query: 88 IVQLFEVMATKSKIYFVMEYVRGG---ELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR 144
I+ S++Y V + G +L L E + +++A+ + H++
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAY-------VAPE 197
G HR +K ++LL +G + +S GL I+ P ++PE
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 198 VLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY 237
VL + +GY+ K DI+S G+ L G++PF+D M
Sbjct: 179 VLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 29/232 (12%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR---EISIL 80
+L RY+ K +G G V A + +G++VAIK + + V H KR E+ ++
Sbjct: 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSR----PFQNVTHAKRAYRELVLM 69
Query: 81 RRVRHPNIVQLFEV------MATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQL 134
+ V H NI+ L V + +Y VME + +V + L + Q+
Sbjct: 70 KLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSYLLYQM 127
Query: 135 ISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA-- 192
+ + H+ G+ HRDLKP N+++ + LK+ DFGL+ R G +F TP
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG--TSFMMTPYVV 179
Query: 193 ---YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY 241
Y APEV+ GY VDIWS G I+ ++ G + F + + + KI
Sbjct: 180 TRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 8e-17
Identities = 74/284 (26%), Positives = 132/284 (46%), Gaps = 51/284 (17%)
Query: 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGL--VAHIKREISILRRVRHPN 87
+ + LG G F +V+ + + VA+K LK G +E I++++RH
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK-VAVKT------LKPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARK-YFQQLI-------SAVG 139
+VQL+ V + + IY V EY+ G L + LK +K QL+ +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLD-----FLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV-SDQI---RQDGLFHTFCGTP-AYV 194
+ +R HRDL N+L+ EN K++DFGL+ + D R+ F P +
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF------PIKWT 171
Query: 195 APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFRSPRWFS- 252
APE + G K D+WS G++L ++ G +P+ + +++ +G +R PR +
Sbjct: 172 APEA-ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNC 229
Query: 253 -PDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIED 295
+L L+ + D +P++R T F++++ ++ED
Sbjct: 230 PEELYDLMLQCWDKDPEERPT-------------FEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 8e-17
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 44/230 (19%)
Query: 29 EIGKLLGHGTFAKVYH--ARNVKSGES---VAIKVI-----DKEKILKSGLVAHIKREIS 78
+ + LG G+F VY A+ V GE VAIK + +E+I E S
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-------EFLNEAS 61
Query: 79 ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKY----FQQL 134
+++ ++V+L V++T VME + G+L + + R + + Q+
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 135 ISAVG-------FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA---VSDQIRQDG-- 182
I + A+ HRDL N ++ E+ +K+ DFG++ +D R+ G
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 183 -LFHTFCGTPA-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQ 229
L P ++APE L + G K D+WS GV+L+ + P+Q
Sbjct: 182 LL-------PVRWMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 69/257 (26%), Positives = 112/257 (43%), Gaps = 14/257 (5%)
Query: 32 KLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
K LG G+F V SG VA+K + +K+ S ++ +E +I+ + H N+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENL 58
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFN---KVAKGRLKEDLARKYFQQLISAVGFCHARG 145
++L+ V+ T + V E G L + K A G Y Q+ + + + ++
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP-AYVAPEVLSRKGY 204
HRDL N+LL + +K+ DFGL Q + P A+ APE L + +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 205 DAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYK-GE-FRSPRWFSPDLIRLLTK 261
A D+W GV L+ + G P+ + + KKI K GE P D+ ++ +
Sbjct: 178 SHAS-DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236
Query: 262 LLDTNPDKRITIPEIME 278
NP R T + E
Sbjct: 237 CWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 24/212 (11%)
Query: 32 KLLGHGTFAKV----YHARNVKSGESVAIKVIDKE--KILKSGLVAHIKREISILRRVRH 85
++LG G F KV Y N +GE VA+K + +E + SG K+EI+IL+ + H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGW----KKEINILKTLYH 65
Query: 86 PNIVQLFEVMATKSK--IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
NIV+ + + + +MEYV G L + + K +L + QQ+ + + H+
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSD-----QIRQDGLFHTFCGTPAYVAPE 197
+ HRDL N+LLD + +K+ DFGL+ AV + ++R+DG F + A E
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAVE 180
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ 229
L + A D+WS GV L+ L+ Q
Sbjct: 181 CLKENKFSYAS-DVWSFGVTLYELLTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 69/257 (26%), Positives = 119/257 (46%), Gaps = 34/257 (13%)
Query: 32 KLLGHGTFAKVYHAR-NVKSGESVAIKVIDKEKILKSGL--VAHIKREISILRRVRHPNI 88
+ LG G F +V+ N + VA+K LK G E I++++RHP +
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKT------LKPGTMDPKDFLAEAQIMKKLRHPKL 63
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKE-------DLARKYFQQLISAVGFC 141
+QL+ V + IY V E ++ G L + G + D+A Q+ S + +
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQVASGMAYL 119
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP---AYVAPEV 198
A+ HRDL N+L+ EN KV+DFGL+ V I++D ++ G + APE
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARV---IKED-IYEAREGAKFPIKWTAPEA 175
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFRSPRWFS--PDL 255
+ + K D+WS G++L ++ G +P+ + +++ +G +R P +L
Sbjct: 176 ALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKEL 233
Query: 256 IRLLTKLLDTNPDKRIT 272
++ +PD R T
Sbjct: 234 YDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 82/326 (25%), Positives = 138/326 (42%), Gaps = 77/326 (23%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK----SGLVAHIKREISIL 80
L YE G +G GT+ VY A+ K G+ +KE LK +G+ REI++L
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKR-KDGKD------EKEYALKQIEGTGISMSACREIALL 52
Query: 81 RRVRHPNIVQLFEVMATKS--KIYFVMEYVRGGEL----FNKVAKG-----RLKEDLARK 129
R ++HPN++ L +V + S K++ + +Y F++ +K +L + +
Sbjct: 53 RELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKS 112
Query: 130 YFQQLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLSAV-SDQIRQDGLF 184
Q++ + + HA V HRDLKP N+L+ E G +K++D G + + + ++
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF---------------- 228
T Y APE+L + +DIW+ G I L+ F
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
Query: 229 -----------------QDQNIMVMYKKIYKGEFRSPRWFSPDLIR-------------- 257
+D M Y + K +FR + + LI+
Sbjct: 233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQK-DFRRTTYANSSLIKYMEKHKVKPDSKVF 291
Query: 258 -LLTKLLDTNPDKRITIPEIMENRWF 282
LL KLL +P KRIT + +++ +F
Sbjct: 292 LLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 66/247 (26%), Positives = 118/247 (47%), Gaps = 23/247 (9%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH--IKREISILRRVRHPNIVQL 91
+G G F V+ ++ + VAIK I + G ++ E ++ ++ HP +VQL
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTI------REGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 92 FEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149
+ V +S I V E++ G L + + +G+ ++ + + + + V HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP---AYVAPEVLSRKGYDA 206
DL N L+ EN +KVSDFG++ + D + + GT + +PEV S Y +
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY-S 179
Query: 207 AKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLTKLL 263
+K D+WS GV+++ V G P+++++ + + I G FR PR S + L+
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHCW 238
Query: 264 DTNPDKR 270
P+ R
Sbjct: 239 KERPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 15/195 (7%)
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHA 143
+PN ++L+ + T +M+Y++ G+LF+ + +G+L E +K +QL+ A+ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 144 RGVYHRDLKPENLLLDENGD-LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
+ H D+K EN+L D D + + D+GL + I + GT Y +PE +
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYD---GTLDYFSPEKIKGH 181
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPF-----QDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
YD + D W+ GV+ + L+ G PF ++ ++ + K+ K + + S +
Sbjct: 182 NYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-KLPFIKNVSKNAND 239
Query: 258 LLTKLLDTNPDKRIT 272
+ +L N + R+T
Sbjct: 240 FVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 22/240 (9%)
Query: 3 HATAPTST--STTSSSKDQNQSPLLG-----------RYEIGKLLGHGTFAKVYHARNVK 49
HAT + S + + + +Y I L G+ +V+ K
Sbjct: 56 HATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVC--TK 113
Query: 50 SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109
G+ KVI K + REI IL+ + H I+ L KS + VM +
Sbjct: 114 HGDEQRKKVIVK-AVTGGK---TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169
Query: 110 GGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168
+LF V G L + A ++L+ A+ + H RG+ HRD+K EN+ LDE + + D
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGD 228
Query: 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF 228
FG + D + + GT +PE+L+ Y AK DIWS G++LF + +
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 67/251 (26%), Positives = 119/251 (47%), Gaps = 19/251 (7%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
+G G F V G VA+K I + ++ L E S++ ++RH N+VQL
Sbjct: 14 IGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQLLG 66
Query: 94 VMAT-KSKIYFVMEYVRGGELFNKV-AKGR--LKEDLARKYFQQLISAVGFCHARGVYHR 149
V+ K +Y V EY+ G L + + ++GR L D K+ + A+ + A HR
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DL N+L+ E+ KVSDFGL+ + + G + APE L K + + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKF-STKS 180
Query: 210 DIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNP 267
D+WS G++L+ + + G +P+ + + ++ KG + +P P + ++ + +
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDA 240
Query: 268 DKRITIPEIME 278
R + ++ E
Sbjct: 241 ATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 68/263 (25%), Positives = 121/263 (46%), Gaps = 16/263 (6%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGES----VAIKVIDKEKILKSGLVAHIKREISILR 81
E K+LG G F VY + GE VAIKV+ +E K+ I E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMA 64
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVG 139
V HP++V+L + + S++ + + + G L + V K + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG-TP-AYVAPE 197
+ + + HRDL N+L+ +K++DFGL+ + D + +H G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALE 181
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDL 255
+ + Y K D+WS GV ++ LM G P++ + + + KGE P + D+
Sbjct: 182 SILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240
Query: 256 IRLLTKLLDTNPDKRITIPEIME 278
+L K + + R T E++
Sbjct: 241 YMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 83/325 (25%), Positives = 141/325 (43%), Gaps = 75/325 (23%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK----SGLVAHIKREISIL 80
L YE G +G GT+ VY A+ K G+ D++ LK +G+ REI++L
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKR-KDGKD------DRDYALKQIEGTGISMSACREIALL 52
Query: 81 RRVRHPNIVQLFEVMATKS--KIYFVMEYVRGGEL----FNKVAKG-----RLKEDLARK 129
R ++HPN++ L +V + + K++ + +Y F++ +K +L + +
Sbjct: 53 RELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 112
Query: 130 YFQQLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLSAV-SDQIRQDGLF 184
Q++ + + HA V HRDLKP N+L+ E G +K++D G + + + ++
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF--------------QD 230
T Y APE+L + +DIW+ G I L+ F D
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
Query: 231 Q-----NIMVM-----YKKIYK--------GEFRSPRWFSPDLIR--------------- 257
Q N+M ++ I K +FR + + LI+
Sbjct: 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292
Query: 258 LLTKLLDTNPDKRITIPEIMENRWF 282
LL KLL +P KRIT + M++ +F
Sbjct: 293 LLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 67/275 (24%), Positives = 117/275 (42%), Gaps = 36/275 (13%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH-PNIVQL 91
+G G F V + SG +A+K I K + ++ ++ R P IV+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDVVMRSSDCPYIVKF 68
Query: 92 FEVMATKSKIYFVMEYVRGG-ELFNKVAKGRLKEDLARKYFQQLISAVGFCHARG----- 145
+ + + + ME + + F K LK + ++++ + +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP----EEILGKIAVATVKALNYLK 124
Query: 146 ----VYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQ--DGLFHTFCGTPAYVAPEV 198
+ HRD+KP N+LLD NG++K+ DFG+S + D I + D G Y+APE
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA------GCRPYMAPER 178
Query: 199 L---SRKGYDAAKVDIWSCGVILFVLMAGYLPFQ------DQNIMVMYKKIYKGEFRSPR 249
+ +R GYD + D+WS G+ L+ + G P+ DQ V+ R
Sbjct: 179 IDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237
Query: 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
FSP + + L + KR E++E+ + +
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 68/279 (24%), Positives = 123/279 (44%), Gaps = 22/279 (7%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
+L RY+ K +G G V A + +VAIK + + RE+ +++ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCV 73
Query: 84 RHPNIVQLFEVMATK------SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
H NI+ L V + +Y VME + +V + L + Q++
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCG 131
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
+ H+ G+ HRDLKP N+++ + LK+ DFGL+ + + + T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPE 188
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
V+ GY VDIWS G I+ ++ + F ++ + + K+ + + +P P+ ++
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE-QLGTP---CPEFMK 243
Query: 258 LLTKLLDTNPDKR-----ITIPEIMENRWFRKGFKHIKF 291
L + + R +T P++ + F +H K
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 282
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 29/246 (11%)
Query: 9 STSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVY------------HARNVKS---GES 53
+ +K ++ L + + L G F K++ R V S G+
Sbjct: 131 GPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKP 190
Query: 54 VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEV--------MATKSKIYFVM 105
++I K S ++ EI L R+ H NI+++ E+ M T+ + +
Sbjct: 191 KCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLY 250
Query: 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLK 165
++ K + LK+ R +QL+ AV + H + + HRD+K EN+ L+ +G +
Sbjct: 251 SFMYDEAFDWK-DRPLLKQ--TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307
Query: 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-G 224
+ DFG + ++ R+ + + GT A +PE+L+ GY DIWSCG+IL +++
Sbjct: 308 LGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHD 365
Query: 225 YLPFQD 230
+ P D
Sbjct: 366 FCPIGD 371
|
Length = 501 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 2/162 (1%)
Query: 64 ILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK 123
++K+G E ILR + HP+I+QL ++ + AK +
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIA 180
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183
+ ++ A+ + H + HRD+K EN+ ++ GD+ + DFG + I +
Sbjct: 181 ICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK- 239
Query: 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGY 225
++ + GT A APE+L+R Y A VDIWS G++LF + +
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 73/235 (31%), Positives = 117/235 (49%), Gaps = 23/235 (9%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKR----EISI 79
+I K++G G F +V R G+ VAIK LK+G +R E SI
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKT------LKAGYTEKQRRDFLSEASI 58
Query: 80 LRRVRHPNIVQLFEVMATKSK-IYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLIS 136
+ + HPNI+ L E + TKSK + V EY+ G L F + G+ + + S
Sbjct: 59 MGQFDHPNIIHL-EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS 117
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT-PA-YV 194
+ + G HRDL N+L++ N KVSDFGLS V + + + T G P +
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWT 176
Query: 195 APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFRSP 248
APE ++ + + +A D+WS G++++ +M+ G P+ + + + K I +G +R P
Sbjct: 177 APEAIAYRKFTSAS-DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-15
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 4/158 (2%)
Query: 64 ILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK 123
++K+G A E +LRR+ HP ++ L +V V+ R +L+ +
Sbjct: 198 VVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRP 256
Query: 124 EDLAR--KYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181
LA+ +QL+SA+ + H G+ HRD+K EN+L++ D+ + DFG + +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316
Query: 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF 219
+ GT APEVL+ Y + VDIWS G+++F
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGLVAHIKR----EISILR 81
+I +++G G F +V R G+ VAIK LKSG +R E SI+
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKT------LKSGYTEKQRRDFLSEASIMG 60
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVG 139
+ HPNI+ L V+ + + E++ G L F + G+ + + + +
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA---YVAP 196
+ HRDL N+L++ N KVSDFGLS + D + + G + AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQD 230
E ++ + + +A D+WS G++++ +M+ G P+ D
Sbjct: 181 EAIAYRKFTSAS-DVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 73/276 (26%), Positives = 130/276 (47%), Gaps = 40/276 (14%)
Query: 32 KLLGHGTFAKVYHARNVKSGES-VAIKVIDKEKILKSGLVA--HIKREISILRRVRHPNI 88
K LG+G F +V+ +G + VA+K LK G ++ E I++++RH +
Sbjct: 12 KKLGNGQFGEVW--MGTWNGNTKVAVKT------LKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 89 VQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGR-LKEDLARKYFQQLISAVGFCHARG 145
VQL+ V+ ++ IY V EY+ G L F K +GR LK Q+ + + +
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ----IRQDGLFHTFCGTPAYVAPEVLSR 201
HRDL+ N+L+ + K++DFGL+ + + RQ F + APE +
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI-----KWTAPEA-AL 176
Query: 202 KGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259
G K D+WS G++L L+ G +P+ N + +++ +G P+ L L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236
Query: 260 TKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIED 295
+ +P++R T F++++ ++ED
Sbjct: 237 LQCWKKDPEERPT-------------FEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 13/223 (5%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
+L RY+ K +G G V A + +VAIK + + RE+ +++ V
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCV 80
Query: 84 RHPNIVQLFEVMATKSK------IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
H NI+ L V + +Y VME + +V + L + Q++
Sbjct: 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCG 138
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
+ H+ G+ HRDLKP N+++ + LK+ DFGL+ + + + T Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPE 195
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI 240
V+ GY VDIWS G I+ ++ G + F + + + K+
Sbjct: 196 VILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 43/283 (15%)
Query: 30 IGKLLGHGTFAKV-----YHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+GK LG G F KV + + +VA+K++ KE S L + E ++L++V
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLS-EFNLLKQVN 61
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFN------KVAKGRLKEDLARK--------- 129
HP++++L+ + + ++EY + G L + KV L D R
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 130 ----------YFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179
+ Q+ + + + HRDL N+L+ E +K+SDFGLS D
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RDVYE 179
Query: 180 QDGLFHTFCG-TPA-YVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPF---QDQNI 233
+D G P ++A E L Y + D+WS GV+L+ ++ G P+ + +
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 234 MVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEI 276
+ K Y+ E P S ++ L+ PDKR T +I
Sbjct: 239 FNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 32 KLLGHGTFAKV----YHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVRH 85
+ LG G F V Y +GE VA+K + + L+ +REI IL+ ++H
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD-----FEREIEILKSLQH 64
Query: 86 PNIVQLFEVM--ATKSKIYFVMEYVRGGELFNKVAKGRLKEDLAR--KYFQQLISAVGFC 141
NIV+ V A + + VMEY+ G L + + K R + D + Y Q+ + +
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ------IRQDGLFHTFCGTPAYVA 195
++ HRDL N+L++ +K+ DFGL+ V Q +R+ G F + A
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-----WYA 179
Query: 196 PEVLSRKGYDAAKVDIWSCGVILFVL 221
PE L+ + A D+WS GV+L+ L
Sbjct: 180 PESLTESKFSVAS-DVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 39/274 (14%)
Query: 34 LGHGTFAKVYHA--RNVKSGESVAIKVIDKEKILKSGLVAHIK----REISILRRVRHPN 87
LG G F KV+ +++ + + K LK + RE +L +H N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAV---KTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGEL---------------FNKVAKGRLKEDLARKYFQ 132
IV+ + V V EY+ G+L G L +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA---VSDQIRQDGLFHTFCG 189
Q+ S + + ++ HRDL N L+ + +K+ DFG+S +D R G HT
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG--HTM-- 185
Query: 190 TPA-YVAPE-VLSRKGYDAAKVDIWSCGVILF-VLMAGYLP-FQDQNIMVMYKKIYKG-E 244
P ++ PE ++ RK + D+WS GV+L+ + G P + N V+ + I +G
Sbjct: 186 LPIRWMPPESIMYRKF--TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI-ECITQGRL 242
Query: 245 FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ PR ++ ++ +P +RI I +I E
Sbjct: 243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 72/264 (27%), Positives = 111/264 (42%), Gaps = 39/264 (14%)
Query: 34 LGHGTFAKV----YHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV 89
LGHG F V Y ++ K E VA+K + +E I RE S++ ++ HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE-VAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIV 59
Query: 90 QLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY-- 147
+L V + + VME G L K K R ++ ++L V A G+
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPL-LKYLKKR--REIPVSDLKELAHQV----AMGMAYL 111
Query: 148 ------HRDLKPENLLLDENGDLKVSDFGLS----AVSD--QIRQDGLFHTFCGTP-AYV 194
HRDL N+LL K+SDFG+S A SD + G + P +
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW------PLKWY 165
Query: 195 APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFS 252
APE ++ + +K D+WS GV L+ G P+ + + + GE P
Sbjct: 166 APECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECP 224
Query: 253 PDLIRLLTKLLDTNPDKRITIPEI 276
++ ++ P+ R T E+
Sbjct: 225 QEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 77/282 (27%), Positives = 128/282 (45%), Gaps = 38/282 (13%)
Query: 27 RYEIGKLLGHGTFAKVYHAR-----NVKSGESVAIKVIDK---EKILKSGLVAHIKREIS 78
R +GK LG G F +V A N +VA+K++ EK L S LV+ E+
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL-SDLVS----EME 67
Query: 79 ILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
+++ + +H NI+ L V + +Y V+EY G L + + R + A +
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 138 -------VGFCH--ARGV--------YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180
V F + ARG+ HRDL N+L+ E+ +K++DFGL+ D
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA--RDIHHI 185
Query: 181 DGLFHTFCG-TPA-YVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMY 237
D T G P ++APE L + Y D+WS GV+L+ + G P+ + ++
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGGSPYPGIPVEELF 244
Query: 238 KKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
K + +G P+ + +L L+ P +R T +++E
Sbjct: 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 68/256 (26%), Positives = 124/256 (48%), Gaps = 33/256 (12%)
Query: 32 KLLGHGTFAKV---YHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
K LG G F +V Y+ + K VAIK + + + +A E +++++++HP +
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTK----VAIKSLKQGSMSPEAFLA----EANLMKQLQHPRL 63
Query: 89 VQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKG-RLKEDLARKYFQQLISAVGFCHARG 145
V+L+ V+ T+ IY + EY+ G L F K +G +L + Q+ + F +
Sbjct: 64 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAV---SDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
HRDL+ N+L+ E K++DFGL+ + ++ ++G + APE ++
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI----KWTAPEAINY- 177
Query: 203 GYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPD-----LI 256
G K D+WS G++L ++ G +P+ + + + +G +R PR PD L
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPR---PDNCPEELY 233
Query: 257 RLLTKLLDTNPDKRIT 272
L+ P++R T
Sbjct: 234 ELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 18/232 (7%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
EIG+ G VY AR+ +G V +++ D E + L A ++ E+ + RHPNI
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKA-LQNEVVLSHFFRHPNI 61
Query: 89 VQLFEVMATKSKIYFV---MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARG 145
+ + V T S ++ + M Y L + E L + + + H G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAY-------VAPEV 198
HR++K ++L+ +G + +S GLS + +R P + ++PE+
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 199 LSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP 248
L + GY+ K DI+S G+ L G +PFQD M + KG SP
Sbjct: 180 LRQDLYGYNV-KSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 30/267 (11%)
Query: 32 KLLGHGTFAKVYHARNVKSGES-----VAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
LG G F +V+ A+ E V +K + K K L + +RE+ + R++ H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHK 68
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCHAR 144
N+V+L + Y ++EY G+L F + K + ++ + A+ A
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 145 GV--------YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA-YVA 195
G+ HRDL N L+ ++KVS LS D + P ++A
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRWLA 186
Query: 196 PEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPD 254
PE + + + K D+WS GV+++ V G LPF + + ++ G+ P+
Sbjct: 187 PEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL---ELPVPE 242
Query: 255 -----LIRLLTKLLDTNPDKRITIPEI 276
L +L+T+ NP R + E+
Sbjct: 243 GCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 31/270 (11%)
Query: 27 RYEIGKLLGHGTFAKVYHARN---VKSGESVAIKVIDKEKILKSGLVAH------IKREI 77
GK LG G F KV A KS + + V K+LK AH + E+
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAV----KMLKP--TAHSSEREALMSEL 89
Query: 78 SILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK----EDLARKYFQ 132
I+ + H NIV L I + EY G+L N + + R EDL +
Sbjct: 90 KIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLL-SFSY 148
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT-- 190
Q+ + F ++ HRDL N+LL +K+ DFGL+ I D +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARL 205
Query: 191 PA-YVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFR-- 246
P ++APE + Y + D+WS G++L+ + + G P+ + + K+ K +R
Sbjct: 206 PVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA 264
Query: 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEI 276
P ++ ++ D +P KR T +I
Sbjct: 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 73/278 (26%), Positives = 113/278 (40%), Gaps = 44/278 (15%)
Query: 32 KLLGHGTFAKVYHAR-----NVKSGES-VAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
LG G F +VY SG VA+K + K + +E ++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNH 58
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH--- 142
PNIV+L V Y +ME + GG+L + + R ++ L++
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDAR-----VERFGPPLLTLKELLDICL 113
Query: 143 --ARG-VY-------HRDLKPENLLLDENGD-----LKVSDFGLSA---VSD--QIRQDG 182
A+G VY HRDL N L+ E G +K+ DFGL+ SD + +G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQD-QNIMVMYKKI 240
L ++APE L G + D+WS GV+++ +L G P+ N V+
Sbjct: 174 LLPV-----RWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227
Query: 241 YKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
G + P + +L+T +P +R T I E
Sbjct: 228 AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 32 KLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGLVAHIKR----EISILRRVR 84
K++G G F +V+ G VAIK LK G ++ E SI+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKT------LKPGYTEKQRQDFLSEASIMGQFS 64
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCH 142
H NI++L V+ + EY+ G L + + G + + + + +
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA--YVAPEVLS 200
HRDL N+L++ N + KVSDFGLS V + +G + T G + APE ++
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED-DPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 201 RKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFRSP 248
+ + +A D+WS G++++ +M+ G P+ D + + K I G FR P
Sbjct: 184 YRKFTSAS-DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 64/264 (24%), Positives = 118/264 (44%), Gaps = 26/264 (9%)
Query: 28 YEIGKLLGHGTFAKVYHAR---NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+ +G++LG G F V A+ S + VA+K++ K I S + RE + ++
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 85 HPNIVQLFEV---MATKSKI---YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLI--- 135
HPN+++L V K ++ ++ +++ G+L + R+ E+ Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 136 ----SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP 191
S + + ++ HRDL N +L+EN + V+DFGLS +I + C +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK---KIYSGDYYRQGCASK 176
Query: 192 ---AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FR 246
++A E L+ Y D+W+ GV ++ +M G P+ +Y + KG +
Sbjct: 177 LPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235
Query: 247 SPRWFSPDLIRLLTKLLDTNPDKR 270
P D+ L+ + P R
Sbjct: 236 QPPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 34/271 (12%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE 93
LG G F +V+ VAIK + ++ + +E I++++RH +V L+
Sbjct: 14 LGQGCFGEVWMG-TWNGTTKVAIKTLKPGTMMPEAFL----QEAQIMKKLRHDKLVPLYA 68
Query: 94 VMATKSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRD 150
V+ ++ IY V E++ G L + + +G LK Q+ + + HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQ----IRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
L+ N+L+ +N K++DFGL+ + + RQ F + APE + G
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI-----KWTAPEA-ALYGRFT 181
Query: 207 AKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLD 264
K D+WS G++L L+ G +P+ + +++ +G P+ L L+
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWK 241
Query: 265 TNPDKRITIPEIMENRWFRKGFKHIKFYIED 295
+PD+R T F++I+ ++ED
Sbjct: 242 KDPDERPT-------------FEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 45/240 (18%)
Query: 34 LGHGTFAKVYHAR-----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
LG G F KVY S SVAIK + + K + ++E ++ ++HPNI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELF---------NKVAKGRLKEDLARKYFQ------- 132
V L V + + EY+ G+L + V E +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 133 -QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP 191
Q+ + + + + HRDL N L+ E +K+SDFGLS +D +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS-------RDIYSADYYRVQ 183
Query: 192 A-------YVAPE-VLSRKGYDAAKVDIWSCGVILFVL----MAGYLPFQDQNIMVMYKK 239
+ ++ PE +L G + DIWS GV+L+ + + Y F +Q ++ M +
Sbjct: 184 SKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 58/231 (25%), Positives = 110/231 (47%), Gaps = 30/231 (12%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGL--VAHIKREISILRRVRHPNIV 89
K LG G F +V+ S + VA+K LK G V E ++++ ++H +V
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTK-VAVKT------LKPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 90 QLFEVMATKSKIYFVMEYVRGGELFNKV---AKGRLKEDLARKYFQQLISAVGFCHARGV 146
+L+ V+ + IY + EY+ G L + + G++ + Q+ + + +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQ----IRQDGLFHTFCGTPAYVAPEVLSRK 202
HRDL+ N+L+ E+ K++DFGL+ V + R+ F + APE ++
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-----KWTAPEAINFG 179
Query: 203 GYDAAKVDIWSCGVILF-VLMAGYLPF---QDQNIMVMYKKIYKGEFRSPR 249
+ K D+WS G++L+ ++ G +P+ + ++M ++ Y R PR
Sbjct: 180 SF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY----RMPR 225
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 34 LGHGTFAKVYHARNVKSGES-VAIKVIDKEKILKSGLVA--HIKREISILRRVRHPNIVQ 90
LG G F +V+ +G + VAIK LK G ++ +E +++++RH +VQ
Sbjct: 14 LGQGCFGEVW--MGTWNGTTRVAIKT------LKPGTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKGR----LKEDLARKYFQQLISAVGFCHARGV 146
L+ V+ ++ IY V EY+ G L + + KG L+ Q+ S + +
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQ----IRQDGLFHTFCGTPAYVAPEVLSRK 202
HRDL+ N+L+ EN KV+DFGL+ + + RQ F + APE +
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-----KWTAPEA-ALY 177
Query: 203 GYDAAKVDIWSCGVILFVLMA-GYLPF 228
G K D+WS G++L L G +P+
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 73/273 (26%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 32 KLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
+++G G F VYH + S A+K +++ I V +E I++ HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 89 VQLFEVMATKSKI-YFVMEYVRGGELFN-------------------KVAKGRLKEDLAR 128
+ L + V+ Y++ G+L N +VAKG E LA
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKG--MEYLAS 116
Query: 129 KYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTF 187
K F HRDL N +LDE+ +KV+DFGL+ + D+ HT
Sbjct: 117 KKF---------------VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161
Query: 188 CGTPA-YVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-E 244
P ++A E L + + K D+WS GV+L+ LM G P+ D + + + +G
Sbjct: 162 AKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
Query: 245 FRSPRWFSPD-LIRLLTKLLDTNPDKRITIPEI 276
P + PD L ++ P+ R T E+
Sbjct: 221 LLQPE-YCPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 51/283 (18%)
Query: 29 EIGKLLGHGTFAKVY-----HARNVKSGESVAIKVI-------DKEKILKSGLVAHIKRE 76
+ + LGHG F +VY VA+K + D+ L L
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL------- 61
Query: 77 ISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKED----LARKYFQ 132
I+ + H NIV+L V + + ++E + GG+L + + + R + + L +
Sbjct: 62 --IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT---MK 116
Query: 133 QLIS-----AVGFCH---ARGVYHRDLKPENLLLDENGD---LKVSDFGLSA---VSDQI 178
L+ A G C HRD+ N LL G K++DFG++ +
Sbjct: 117 DLLFCARDVAKG-CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
Query: 179 RQDGLFHTFCGTP-AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQ-NIMV 235
R+ G P ++ PE G +K D+WS GV+L+ + + GY+P+ + N V
Sbjct: 176 RKGGR----AMLPIKWMPPEAF-LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
Query: 236 MYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
M G P+ + R++T P+ R I+E
Sbjct: 231 MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 38/271 (14%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR----EISILRRV-RHPN 87
++G G F +V AR K G +++ K +K R E+ +L ++ HPN
Sbjct: 2 VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKED---LARKY-------FQQLI-- 135
I+ L + +Y +EY G L + + K R+ E A QQL+
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 136 -----SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF--HTFC 188
+ + + HRDL N+L+ EN K++DFGLS R ++ T
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTMG 171
Query: 189 GTPA-YVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EF 245
P ++A E L+ Y D+WS GV+L+ +++ G P+ +Y+K+ +G
Sbjct: 172 RLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 230
Query: 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEI 276
P ++ L+ + P +R + +I
Sbjct: 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 71/280 (25%), Positives = 128/280 (45%), Gaps = 36/280 (12%)
Query: 30 IGKLLGHGTFAKVYHARNV-------KSGESVAIKVIDKEKILKSGLVAHIKREISILRR 82
+GK LG G F +V A + K +VA+K++ + K ++ + E+ +++
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKM 76
Query: 83 V-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKE-----DLAR-----KYF 131
+ +H NI+ L +Y ++EY G L + R D+AR F
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 132 QQLISAVGFCHARGV--------YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183
+ L+S + ARG+ HRDL N+L+ EN +K++DFGL+ + I D
Sbjct: 137 KDLVSCT-YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI--DYY 193
Query: 184 FHTFCGT-PA-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKI 240
T G P ++APE L + Y + D+WS GV+++ + G P+ + ++K +
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252
Query: 241 YKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
+G P + +L ++ P R T +++E+
Sbjct: 253 KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 69/271 (25%), Positives = 122/271 (45%), Gaps = 38/271 (14%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR----EISILRRV-RHPN 87
++G G F +V A K G + + K+LK + R E+ +L ++ HPN
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKED---LARKY-------FQQLI-- 135
I+ L + +Y +EY G L + + K R+ E A+++ QQL+
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 136 -----SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF--HTFC 188
+ + + + HRDL N+L+ EN K++DFGLS R + ++ T
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS------RGEEVYVKKTMG 178
Query: 189 GTPA-YVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EF 245
P ++A E L+ Y K D+WS GV+L+ +++ G P+ +Y+K+ +G
Sbjct: 179 RLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM 237
Query: 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEI 276
PR ++ L+ + P +R +I
Sbjct: 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 67/251 (26%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 27 RYEIGKLLGHGTFAKVYHA--RNVKSGES--VAIK-VIDKEKILKSGLVAHIKREISILR 81
R + LL GTF ++++ + K G+ V +K V D ++ V + +E +L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ---VTLLLQESCLLY 63
Query: 82 RVRHPNIVQLFEVMATKSKIYFVME-YVRGGELFNKVAKGRLKE-DLARKYFQ------- 132
+ H NI+ + V + FV+ Y+ G L + + RL E + +
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 133 -QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC--- 188
Q+ + + H RGV H+D+ N ++DE +K++D LS D D +H C
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS--RDLFPMD--YH--CLGD 177
Query: 189 --GTP-AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE 244
P ++A E L K Y +A D+WS GV+L+ LM G P+ + + M + G
Sbjct: 178 NENRPVKWMALESLVNKEYSSAS-DVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG- 235
Query: 245 FRSPRWFS-PD 254
+R + + PD
Sbjct: 236 YRLAQPINCPD 246
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 83/335 (24%), Positives = 129/335 (38%), Gaps = 97/335 (28%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR----EISILRR 82
R ++GK LG G F KV A +S + + + K+LK G A + E+ IL
Sbjct: 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTV-AVKMLKEGATASEYKALMTELKILIH 66
Query: 83 V-RHPNIVQLFEVMATKS-KIYFVMEYVRGGELFN------------------------- 115
+ H N+V L + ++EY + G L N
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQK 126
Query: 116 KVAKGRL-----KEDLARKYFQQ-------------------------LIS-----AVG- 139
+ K RL + A F + LIS A G
Sbjct: 127 EGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGM 186
Query: 140 -FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV---- 194
F +R HRDL N+LL EN +K+ DFGL+ I +D P YV
Sbjct: 187 EFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKD---------PDYVRKGD 234
Query: 195 --------APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMY-KKIYKG- 243
APE + K Y + D+WS GV+L+ + G P+ I + +++ +G
Sbjct: 235 ARLPLKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT 293
Query: 244 EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
R+P + +P++ ++ NP+ R T E++E
Sbjct: 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 80/335 (23%), Positives = 127/335 (37%), Gaps = 96/335 (28%)
Query: 27 RYEIGKLLGHGTFAKVYHA-----RNVKSGESVAIKVI------DKEKILKSGL--VAHI 73
R +GK+LGHG F KV A S +VA+K++ + K L S L + HI
Sbjct: 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHI 67
Query: 74 --------------------------------------KREISILRRVRHPNIVQLFEVM 95
KRE R + P F M
Sbjct: 68 GNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAM 127
Query: 96 ATKSKIYFVMEYVRGGELFNKVAKG--------RLKEDLARK---------YFQQLISAV 138
+S++ +E + LF++ + +DL + Y Q+ +
Sbjct: 128 VEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGM 187
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV---- 194
F +R HRDL N+LL EN +K+ DFGL+ I +D P YV
Sbjct: 188 EFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKD---------PDYVRKGS 235
Query: 195 --------APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-- 243
APE + K Y + D+WS GV+L+ + + G P+ I + + K
Sbjct: 236 ARLPLKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294
Query: 244 EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
R+P +P++ R++ +P +R T ++E
Sbjct: 295 RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 63/254 (24%), Positives = 125/254 (49%), Gaps = 23/254 (9%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
++ K LG G F +V+ A K + VA+K + + + E ++++ ++H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL----AEANVMKTLQHDKL 63
Query: 89 VQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLAR--KYFQQLISAVGFCHAR 144
V+L V+ TK IY + E++ G L F K +G K+ L + + Q+ + F R
Sbjct: 64 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP---AYVAPEVLSR 201
HRDL+ N+L+ + K++DFGL+ ++ +D + G + APE ++
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINF 177
Query: 202 KGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFS--PDLIRL 258
+ K D+WS G++L ++ G +P+ + + + + +G +R PR + +L +
Sbjct: 178 GSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNI 235
Query: 259 LTKLLDTNPDKRIT 272
+ + P++R T
Sbjct: 236 MMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 74/272 (27%), Positives = 118/272 (43%), Gaps = 38/272 (13%)
Query: 34 LGHGTFAKV-----YHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
LG G F KV Y+ K VA+K + K+ L + +RE +L ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKV------------------AKGRLKEDLARKY 130
V+ + V + V EY++ G+L NK AKG L
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 131 FQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA---VSDQIRQDGLFHTF 187
Q+ S + + ++ HRDL N L+ N +K+ DFG+S +D R G HT
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--HTM 186
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLP-FQDQNIMVMYKKIYKGE- 244
++ PE + + + + D+WS GVIL+ + G P FQ N V+ + I +G
Sbjct: 187 LPI-RWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-ECITQGRV 243
Query: 245 FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEI 276
PR ++ ++ P +R+ I EI
Sbjct: 244 LERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 45 ARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104
AR +GE V ++ I+ E + +V ++ E+ + + HPNIV ++++ V
Sbjct: 19 ARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77
Query: 105 ---MEYVRGGELFNKVAKGRLKEDLARKY-FQQLISAVGFCHARGVYHRDLKPENLLLDE 160
M Y +L + E LA Y Q ++ A+ + H G HR +K ++L+
Sbjct: 78 TSFMAYGSAKDLICTHFMDGMSE-LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV 136
Query: 161 NGDLKVSDFGLSAVSDQIRQDG---LFHTFCGTPAY-------VAPEVLSR--KGYDAAK 208
+G + +S GL + I + H F P Y ++PEVL + +GYDA K
Sbjct: 137 DGKVYLS--GLRSNLSMINHGQRLRVVHDF---PKYSVKVLPWLSPEVLQQNLQGYDA-K 190
Query: 209 VDIWSCGVILFVLMAGYLPFQD 230
DI+S G+ L G++PF+D
Sbjct: 191 SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 66/265 (24%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 34 LGHGTFAKVYHAR--NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
LG G F KV+ A N+ + + + K RE +L ++H +IV+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 92 FEVMATKSKIYFVMEYVRGGELFNK-----------VAKGRLKEDLARKYF----QQLIS 136
+ V + V EY++ G+L NK +A+G +L + QQ+ +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA---VSDQIRQDGLFHTFCGTPAY 193
+ + ++ HRDL N L+ EN +K+ DFG+S +D R G HT +
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI-RW 188
Query: 194 VAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWF 251
+ PE + + + + D+WS GV+L+ + G P+ + + + I +G + PR
Sbjct: 189 MPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 247
Query: 252 SPDLIRLLTKLLDTNPDKRITIPEI 276
++ L+ P R+ I EI
Sbjct: 248 PKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 53/225 (23%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 63 KILKSGLVAHIKR----EISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNK 116
L++G +R E L + H NIV+L V+ + + V EY+ G L F +
Sbjct: 39 HTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR 98
Query: 117 VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176
+G+L L S + + G H+ L +L++ + K+S F
Sbjct: 99 KHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQ 155
Query: 177 QIRQDGLFHTFCG-TPA-YVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNI 233
+ + + ++ T G +P + APE + + +A D+WS G++++ +M+ G P+ D +
Sbjct: 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS-DVWSFGIVMWEVMSYGERPYWDMSG 214
Query: 234 MVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEI 276
+ K + G FR +PR L +L+ +R +I
Sbjct: 215 QDVIKAVEDG-FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 62/272 (22%), Positives = 113/272 (41%), Gaps = 37/272 (13%)
Query: 34 LGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV 89
LG F K+Y + + VAIK + + I ++E S++ + HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 90 QLFEVMATKSKIYFVMEYVRGGELFNKV--------------AKGRLKEDLARKYFQ--- 132
L V+ + + + EY+ G+L + G +K L F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 133 -QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT- 190
Q+ + + + + H+DL N+L+ E +K+SD GLS +I + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR---EIYSADYYRVQPKSL 187
Query: 191 -PA-YVAPEVLSRKGYDAAKVDIWSCGVILFVL----MAGYLPFQDQNIMVMYKKIYKGE 244
P ++ PE + + ++ DIWS GV+L+ + + Y F +Q ++ M +K +
Sbjct: 188 LPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQL 244
Query: 245 FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEI 276
P + L+T+ P +R +I
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 46/277 (16%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL------RRVRHPN 87
+G+G F KV G S A +V+ KE L++ A ++ L R + HPN
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKA-RVVVKE--LRAS--ATPDEQLLFLQEVQPYRELNHPN 56
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKE------DLARKYFQQLISAVGFC 141
++Q V+E+ G+L N + R D+ ++ ++ S + +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC-GTP-AYVAPEVL 199
H H DL N L + +K+ D+GL+ +Q +D C P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 200 SRKGYDAAKVD------IWSCGVILFVLM-AGYLPFQD--------QNIMVMYKKIYKGE 244
+G D D IWS GV ++ L A P+ D Q + K+ K +
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234
Query: 245 FRSP---RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
RW+ + + +P+ R T E+ E
Sbjct: 235 LDLKYSDRWYE------VMQFCWLDPETRPTAEEVHE 265
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 72/292 (24%), Positives = 131/292 (44%), Gaps = 54/292 (18%)
Query: 27 RYEIGKLLGHGTFAKVYHARNV-------KSGESVAIKVIDKEKILKSGLVAHIKREISI 79
R +GK LG G F +V A + +VA+K++ + K ++ + E+ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD--LSDLVSEMEM 70
Query: 80 LRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDL-ARK-------- 129
++ + +H NI+ L +Y ++EY +KG L+E L AR+
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYA---------SKGNLREYLRARRPPGMDYSF 121
Query: 130 ----------YFQQLISAVGFCHARGV--------YHRDLKPENLLLDENGDLKVSDFGL 171
F+ L+S + ARG+ HRDL N+L+ E+ +K++DFGL
Sbjct: 122 DTCKLPEEQLTFKDLVSC-AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 172 SAVSDQIRQDGLFHTFCGT-PA-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPF 228
+ D D T G P ++APE L + Y + D+WS GV+L+ + G P+
Sbjct: 181 A--RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPY 237
Query: 229 QDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
+ ++K + +G P + +L ++ + P +R T +++E+
Sbjct: 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 61/249 (24%), Positives = 114/249 (45%), Gaps = 21/249 (8%)
Query: 34 LGHGTFAKVYHA--RNVKSGESVAIKVI---DKEKILKSGLVAHIKREISILRRVRHPNI 88
LG G F V + KS ++VA+K++ + + LK L+ RE ++++++ +P I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELL----REANVMQQLDNPYI 58
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVY 147
V++ + +S + VME G L + K + + E + Q+ + +
Sbjct: 59 VRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP----AYVAPEVLSRKG 203
HRDL N+LL K+SDFGLS + D ++ + APE ++
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKA---LGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 204 YDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261
+ ++K D+WS GV+++ + G P++ + + I GE P+ P++ L+
Sbjct: 175 F-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKL 233
Query: 262 LLDTNPDKR 270
D+R
Sbjct: 234 CWTYGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 65/271 (23%), Positives = 116/271 (42%), Gaps = 27/271 (9%)
Query: 30 IGKLLGHGTFAKVYHAR--NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+GK LG G F V + S VA+K + K I + E ++ HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 88 IVQLFEV--MATKSKIY----FVMEYVRGGELFNKVAKGRLKE-------DLARKYFQQL 134
+++L V +S+ Y ++ +++ G+L + + RL + + K+ +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 135 ISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV---SDQIRQDGLFHTFCGTP 191
S + + ++ HRDL N +L+EN ++ V+DFGLS D RQ + P
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI----AKMP 177
Query: 192 A-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKG-EFRSP 248
++A E L+ + Y K D+WS GV ++ + G P+ +Y + +G + P
Sbjct: 178 VKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
L L++ NP R + +
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQL 91
++G G F +V AR K G + + ++ E+ +L ++ HPNI+ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAKGRLKE---------DLARKYFQQLISAVGFCH 142
+ +Y +EY G L + + K R+ E A Q +
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 143 ARGV--------YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA-Y 193
ARG+ HRDL N+L+ EN K++DFGLS + + T P +
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK----TMGRLPVRW 189
Query: 194 VAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKG-EFRSPRWF 251
+A E L+ Y D+WS GV+L+ ++ G P+ +Y+K+ +G P
Sbjct: 190 MAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 248
Query: 252 SPDLIRLLTKLLDTNPDKRITIPEIM 277
++ L+ + P +R + +I+
Sbjct: 249 DDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 30 IGKLLGHGTFAKVYHAR---NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+GK+LG G F V + + S VA+K + K I + E + ++ HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 87 NIVQLFEV---MATKSKI---YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLIS---- 136
N+++L V ++ KI ++ +++ G+L + + RL + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 137 -AVG--FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV---SDQIRQDGLFHTFCGT 190
A+G + R HRDL N +L E+ + V+DFGLS D RQ
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG---RIAKMP 178
Query: 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSP 248
++A E L+ + Y +K D+W+ GV ++ + G P+ +Y + G + P
Sbjct: 179 VKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+L L+ +P R T ++ E
Sbjct: 238 EDCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 32/176 (18%)
Query: 26 GRYEIGKLLGHGTFAKVY--------------HARNVKSGES--VAIKVIDKEKILKSGL 69
+ LG G F +V+ A N + VA+KV+ +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNA 62
Query: 70 VAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARK 129
+E+ IL R+ PNI +L V + +MEY+ G+L N+ + + E
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLA 121
Query: 130 YFQQLISAVGFCH-----ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS 172
+ +S + A G Y HRDL N L+ +N +K++DFG+S
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 30/167 (17%)
Query: 34 LGHGTFAKVYHAR--NVKSGES---VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
+G G F +V+ AR + E VA+K++ +E + A +RE +++ HPNI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDHPNI 70
Query: 89 VQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYF--------------- 131
V+L V A + + EY+ G+L F + R + L+
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 132 ------QQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172
+Q+ + + + R HRDL N L+ EN +K++DFGLS
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 74/291 (25%), Positives = 130/291 (44%), Gaps = 54/291 (18%)
Query: 27 RYEIGKLLGHGTFAKVYHAR-------NVKSGESVAIKVIDKEKILKSGLVAHIKREISI 79
R +GK LG G F +V A +VA+K++ K +A + E+ +
Sbjct: 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD--LADLISEMEL 70
Query: 80 LRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDL-ARK-------- 129
++ + +H NI+ L V + +Y ++EY AKG L+E L AR+
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYA---------AKGNLREFLRARRPPGPDYTF 121
Query: 130 ----------YFQQLISAVGFCHARGV--------YHRDLKPENLLLDENGDLKVSDFGL 171
F+ L+S + ARG+ HRDL N+L+ E+ +K++DFGL
Sbjct: 122 DITKVPEEQLSFKDLVSCA-YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 172 SAVSDQIRQDGLFHTFCG-TPA-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPF 228
+ I D T G P ++APE L + Y + D+WS G++++ + G P+
Sbjct: 181 ARGVHDI--DYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPY 237
Query: 229 QDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ ++K + +G P + +L L+ + P +R T +++E
Sbjct: 238 PGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 63/251 (25%), Positives = 113/251 (45%), Gaps = 8/251 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK--REISILRRVRHPNIV 89
K+LG G F VY V GE+V I V K +G A+++ E I+ + HP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 90 QLFEVMATKSKIYFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVY 147
+L V + + I V + + G L + V K + L + Q+ + + R +
Sbjct: 73 RLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAA 207
HRDL N+L+ +K++DFGL+ + + ++ ++A E + + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF-TH 190
Query: 208 KVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDT 265
+ D+WS GV ++ LM G P+ + + KGE P + D+ ++ K
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250
Query: 266 NPDKRITIPEI 276
+ D R E+
Sbjct: 251 DADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 69/284 (24%), Positives = 127/284 (44%), Gaps = 38/284 (13%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGES-------VAIKVIDKEKILKSGLVAHIKREISI 79
R +GK LG G F +V A + + VA+K++ + K ++ + E+ +
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD--LSDLISEMEM 76
Query: 80 LRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKY-------- 130
++ + +H NI+ L +Y ++EY G L + + R + Y
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL-REYLRARRPPGMEYCYNPTQVPEE 135
Query: 131 ---FQQLISAVGFCHARGV--------YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179
F+ L+S + ARG+ HRDL N+L+ E+ +K++DFGL+ I
Sbjct: 136 QLSFKDLVSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI- 193
Query: 180 QDGLFHTFCGT-PA-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVM 236
D T G P ++APE L + Y + D+WS GV+L+ + G P+ + +
Sbjct: 194 -DYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
Query: 237 YKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
+K + +G P + +L ++ P +R T +++E+
Sbjct: 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI----SILRRVRHPN 87
K+LG G F VY + GE V I V KE L+ +EI ++ V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPH 70
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ----QLISAVGFCHA 143
+ +L + T S + + + + G L + V + K+++ +Y Q+ + +
Sbjct: 71 VCRLLGICLT-STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG-TP-AYVAPEVLSR 201
R + HRDL N+L+ +K++DFGL+ + ++ +H G P ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE--YHAEGGKVPIKWMALESILH 185
Query: 202 KGYDAAKVDIWSCGVILFVLMA-GYLPF 228
+ Y + D+WS GV ++ LM G P+
Sbjct: 186 RIY-THQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 28/166 (16%)
Query: 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK---------------REIS 78
LG G F +V H + E K + ++ +K +EI
Sbjct: 13 LGEGQFGEV-HLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 79 ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLA----------- 127
I+ R++ PNI++L V T + + EY+ G+L +++ +E
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 128 -RKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172
Q+ S + + + HRDL N L+ +N +K++DFG+S
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 66/269 (24%), Positives = 118/269 (43%), Gaps = 33/269 (12%)
Query: 34 LGHGTFAKVYH--ARNVKSGES---VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
LG G+F VY AR++ GE+ VA+K +++ L+ + E S+++ ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 71
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKV---------AKGRLKEDLARKYFQ---QLIS 136
V+L V++ VME + G+L + + GR L ++ Q ++
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL-QEMIQMAAEIAD 130
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA---VSDQIRQ--DGLFHTFCGTP 191
+ + +A+ HRDL N ++ + +K+ DFG++ +D R+ GL
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV----- 185
Query: 192 AYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQD-QNIMVMYKKIYKGEFRSPR 249
++APE L + G D+WS GV+L+ + P+Q N V+ + G P
Sbjct: 186 RWMAPESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 244
Query: 250 WFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ L+ NP R T EI+
Sbjct: 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 27/111 (24%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 75 REISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARK----- 129
+EI I+ R+++PNI++L V + + + EY+ G+L +++ ++
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 130 -------YFQ-QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172
Y Q+ S + + + HRDL N L+ + +K++DFG+S
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 31/268 (11%)
Query: 34 LGHGTFAKVYHAR--NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
LG G F KV+ A N+ + + + K +RE +L ++H +IV+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 92 FEVMATKSKIYFVMEYVRGGELFNK-----------------VAKGRLKEDLARKYFQQL 134
+ V + V EY+R G+L N+ VA G+L Q+
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 135 ISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA---VSDQIRQDGLFHTFCGTP 191
S + + + HRDL N L+ + +K+ DFG+S +D R G T
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG--RTMLPI- 188
Query: 192 AYVAPE-VLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKG-EFRSP 248
++ PE +L RK + DIWS GV+L+ + G P+ + + I +G E P
Sbjct: 189 RWMPPESILYRKF--TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP 246
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEI 276
R P++ ++ P +R+ I +I
Sbjct: 247 RTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 63/269 (23%), Positives = 118/269 (43%), Gaps = 31/269 (11%)
Query: 34 LGHGTFAKVYH--ARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
LG G+F VY A+ V E VAIK +++ ++ + E S+++ ++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFNCHHV 71
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKED----LARKYFQQLISAVG----- 139
V+L V++ +ME + G+L + + R + + A +++I G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 140 --FCHARGVYHRDLKPENLLLDENGDLKVSDFGLS---AVSDQIRQ--DGLFHTFCGTPA 192
+ +A HRDL N ++ E+ +K+ DFG++ +D R+ GL
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-----R 186
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF 251
+++PE L + G D+WS GV+L+ + P+Q + + + + +G
Sbjct: 187 WMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDN 245
Query: 252 SPD-LIRLLTKLLDTNPDKRITIPEIMEN 279
PD L L+ NP R + EI+ +
Sbjct: 246 CPDMLFELMRMCWQYNPKMRPSFLEIISS 274
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 14 SSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHI 73
SS K++N ++ G Y +++K+G +K I+ + S
Sbjct: 690 SSLKEEN------------VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS------ 731
Query: 74 KREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQ 133
EI+ + +++HPNIV+L + ++ Y + EY+ G L ++V + L + RK
Sbjct: 732 -SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-SEVLRN-LSWERRRKIAIG 788
Query: 134 LISAVGFCHAR---GVYHRDLKPENLLLD--ENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188
+ A+ F H R V +L PE +++D + L++S GL
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDT---------KCF 839
Query: 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLP 227
+ AYVAPE K K DI+ G+IL L+ G P
Sbjct: 840 ISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 39/236 (16%)
Query: 34 LGHGTFAKVY--HARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
LG F KVY H GE +VAIK + K+K + L K E + R++HPNI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELF-----------------NKVAKGRLKEDLARKYF 131
V L V+ + + + Y +L +K K L+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 132 QQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL-----SAVSDQIRQDGLFHT 186
Q+ + + F + V H+DL N+L+ + ++K+SD GL +A ++ + L
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVL----MAGYLPFQDQNIMVMYK 238
+++PE + G + DIWS GV+L+ + + Y + +Q+++ M +
Sbjct: 191 -----RWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 34 LGHGTFAKVYHA--RNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
LG G F V + K VAIKV+ E + + + RE I+ ++ +P IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG----FCHARGVY 147
V ++ + VME GG L NK G+ K+++ +L+ V + +
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPL-NKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH---TFCGTP-AYVAPEVLSRKG 203
HRDL N+LL K+SDFGLS + D ++ + P + APE ++ +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKA---LGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 204 YDAAKVDIWSCGVILF 219
+ +++ D+WS G+ ++
Sbjct: 175 F-SSRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 63/257 (24%), Positives = 114/257 (44%), Gaps = 16/257 (6%)
Query: 32 KLLGHGTFAKVYHARNVKSGES----VAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
K+LG G F VY + GE+ VAIKV+ + K+ I E ++ V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPY 70
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARG 145
+ +L + T S + V + + G L + V K R+ + Q+ + +
Sbjct: 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG-TP-AYVAPEVLSRKG 203
+ HRDL N+L+ +K++DFGL+ + D + +H G P ++A E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRR 187
Query: 204 YDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261
+ + D+WS GV ++ LM G P+ + + KGE P + D+ ++ K
Sbjct: 188 F-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVK 246
Query: 262 LLDTNPDKRITIPEIME 278
+ + R E+++
Sbjct: 247 CWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 62/257 (24%), Positives = 112/257 (43%), Gaps = 18/257 (7%)
Query: 31 GKLLGHGTFAKVYHARNVKSGES----VAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
KLLG G F V+ + G+S VAIK I ++ I + + + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQT--FQEITDHMLAMGSLDHA 69
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR--LKEDLARKYFQQLISAVGFCHAR 144
IV+L + S + V + G L + V + R L + Q+ + +
Sbjct: 70 YIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG--LFHTFCGTP-AYVAPEVLSR 201
+ HR+L N+LL + ++++DFG V+D + D F++ TP ++A E +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFG---VADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 202 KGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259
Y + D+WS GV ++ +M+ G P+ + + KGE P+ + D+ ++
Sbjct: 186 GRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVM 244
Query: 260 TKLLDTNPDKRITIPEI 276
K + + R T E+
Sbjct: 245 VKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 46/173 (26%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 123 KEDLARK---------YFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS- 172
+EDL +K Y Q+ + F +R HRDL N+LL EN +K+ DFGL+
Sbjct: 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
Query: 173 ---AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPF 228
D +R+ ++APE + + Y + D+WS GV+L+ + + G P+
Sbjct: 228 DIYKDPDYVRKGDARLPL----KWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPY 282
Query: 229 QDQNIMVMY-KKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
I + +++ +G R+P + +P++ + + P +R T E++E+
Sbjct: 283 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 64/233 (27%), Positives = 95/233 (40%), Gaps = 50/233 (21%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
R++I LLG GTF KV A + K E A+K++ + K A I EI + +VR
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--RNVPKYTRDAKI--EIQFMEKVRQ 184
Query: 86 PNIVQLFEVMATKSKIYF---------VM-EYVRGGELFNKVAKGRLKEDLARKYFQQLI 135
+ F +M K + YF VM +Y G L + + K + ++ Q+I
Sbjct: 185 ADPADRFPLM--KIQRYFQNETGHMCIVMPKY--GPCLLDWIMK---HGPFSHRHLAQII 237
Query: 136 SAVG-----FCHARGVYHRDLKPENLLLDENGD-----------------LKVSDFGLSA 173
G F + H DLKPEN+L+ E D +++ D G
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLGGCC 296
Query: 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYL 226
R T Y +PEV+ G+ D+WS G I++ L G L
Sbjct: 297 DERHSRT-----AIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 62/266 (23%), Positives = 112/266 (42%), Gaps = 50/266 (18%)
Query: 34 LGHGTFAKVYHA--RNVKSGES-----VAIKVIDK------EKILKSGLVAHIKREISIL 80
LG GTF K++ R V V +KV+DK E ++ S++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAA---------SMM 53
Query: 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKY--FQQLISAV 138
++ H ++V + V + V EYV+ G L + K + +++ K +QL A+
Sbjct: 54 SQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWAL 113
Query: 139 GFCHARGVYHRDLKPENLLLDENGD--------LKVSDFGLS--AVSDQIRQDGLFHTFC 188
F +G+ H ++ +N+LL D +K+SD G+S + +I + +
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI----- 168
Query: 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLP---FQDQNIMVMYKKIYKGE 244
+V PE + + D WS G L+ + G P Q + Y+ + +
Sbjct: 169 ---PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQ 223
Query: 245 FRSPRWFSPDLIRLLTKLLDTNPDKR 270
+P+W +L L+ + +D PD R
Sbjct: 224 LPAPKW--TELANLINQCMDYEPDFR 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 44/178 (24%)
Query: 34 LGHGTFAKVYHAR--------------NVKSGES--VAIKVI--DKEKILKSGLVAHIKR 75
LG G F +V+ NV+ G VA+K++ D K ++ + +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL----K 68
Query: 76 EISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKED---------- 125
E+ IL R++ PNI++L V + + + EY+ G+L N+ +D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVP 127
Query: 126 -----LARKY------FQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172
A Y Q+ S + + + HRDL N L+ EN +K++DFG+S
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 66/274 (24%), Positives = 116/274 (42%), Gaps = 44/274 (16%)
Query: 34 LGHGTFAKVYHAR-NVKS-------GESVAIKVIDKEKILKSGLVAHIKREISI------ 79
LG GT ++Y N K IKVI K+L R+IS+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVI--LKVLDPS-----HRDISLAFFETA 55
Query: 80 --LRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLI 135
+R+V H +IV L+ V + V E+V G +LF L K +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLA 115
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGD-------LKVSDFG--LSAVSDQIRQDGLFHT 186
SA+ + + + H ++ +N+LL G +K+SD G ++ +S Q + +
Sbjct: 116 SALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--- 172
Query: 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEF 245
++APE + + D WS G L+ + G +P +D+ + ++ Y+G+
Sbjct: 173 -----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEKERFYEGQC 226
Query: 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
+L L+T ++ +P++R IM +
Sbjct: 227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 14/102 (13%)
Query: 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP 248
GTP Y+APE+L K + A VD W+ GV LF + G PF D+ +++ I R
Sbjct: 542 GTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN---RDI 597
Query: 249 RWFSPDLIRLLTK--------LLDTNPDKRITIPEIMENRWF 282
W P+ L+ LL +P KR + E+ ++ F
Sbjct: 598 PW--PEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 35/157 (22%), Positives = 59/157 (37%), Gaps = 28/157 (17%)
Query: 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH---- 85
KLL G +VY E +K+ A +RE++IL+ +
Sbjct: 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSR-----EKGADREREVAILQLLARKGLP 54
Query: 86 -PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQL-----ISAVG 139
P ++ E Y +ME++ G L KED+A + + L + +
Sbjct: 55 VPKVLASGES---DGWSYLLMEWIEGETLDE--VSEEEKEDIAEQLAELLAKLHQLPLLV 109
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176
CH DL P N+L+D+ L + D+ +
Sbjct: 110 LCHG------DLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 10/88 (11%)
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKV---AKG-RLKEDLARKYFQQLISAVGFCHARGV 146
L ++M +K Y V Y L KV KG + + + +Q++ A+ H+ G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 147 YHRDLKPENLLLDE-NGDLKVSDFGLSA 173
HRD+KP+N++ E +G K+ D G +A
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 23/160 (14%)
Query: 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQ 90
KL+ G A++Y + IK + K +I K + I R R I+
Sbjct: 1 MKLIKRGAEAEIYLGDFLG------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMS 54
Query: 91 -----------LFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG 139
++ V I VMEY+ G L + + + +++ VG
Sbjct: 55 RARKAGVNVPAVYFVDPENFII--VMEYIEGEPLKDLINSN---GMEELELSREIGRLVG 109
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179
H+ G+ H DL N++L G + + DFGL+ S +
Sbjct: 110 KLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAEFSKDLE 148
|
Length = 211 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK--REISILRRVRHPNIV 89
K +G+G F KV V SG + A +V+ KE + + + +K E R ++H N++
Sbjct: 1 KEIGNGWFGKVILGE-VNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 90 QLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLA------RKYFQQLISAVGFCHA 143
Q + VME+ G+L + R E + ++ ++ + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ----IRQDGLFHTFCGTP-AYVAPEV 198
H DL N LL + +K+ D+GLS + + D L+ P ++APE+
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW-----VPLRWIAPEL 173
Query: 199 LSRKGYDAAKVD------IWSCGVILFVL 221
+ + VD +WS GV ++ L
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183
EDL + Q+ + F ++ HRDL N+LL K+ DFGL+ IR D
Sbjct: 214 EDLL-SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIRNDSN 269
Query: 184 FHTFCGTP----AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYK 238
+ G ++APE + Y + D+WS G++L+ + + G P+ + +
Sbjct: 270 Y-VVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327
Query: 239 KIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
K+ K +R SP ++ ++ D +P KR T +I++
Sbjct: 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLI 135
S++ +V H ++ + V S+ V E+V G L + KGR+ QQL
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENG-------DLKVSDFGLS--AVSDQIRQDGLFHT 186
SA+ + + + H ++ +N+LL G +K+SD G+S A+S + R + +
Sbjct: 128 SALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--- 184
Query: 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEF 245
++APE + + D WS G L + G +P +++ ++ Y+ +
Sbjct: 185 -----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEKERFYEKKH 238
Query: 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
R P +L L+++ L P +R + I+ +
Sbjct: 239 RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 44/197 (22%), Positives = 77/197 (39%), Gaps = 70/197 (35%)
Query: 40 AKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL--------------RRVRH 85
A+V+ AR + G+ VA+KV L+ G+ I +I++L RR+R
Sbjct: 131 AQVHRAR-LVDGKEVAVKV------LRPGIEKTIAADIALLYRLARIVERLSPDSRRLRP 183
Query: 86 PNIVQLFEV---------------------MATKSKIY-------------FVMEYVRGG 111
+V+ FE +Y ME++ G
Sbjct: 184 TEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGI 243
Query: 112 ELFNKVA-------KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDL 164
L + A + L E+LAR + Q++ G +H DL P N+ + ++G +
Sbjct: 244 PLSDIAALDEAGLDRKALAENLARSFLNQVL-------RDGFFHADLHPGNIFVLKDGKI 296
Query: 165 KVSDFGL-SAVSDQIRQ 180
DFG+ +S++ R+
Sbjct: 297 IALDFGIVGRLSEEDRR 313
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 38/144 (26%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT-- 190
Q+ + F ++ HRDL N+LL + +K+ DFGL+ I D + + T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR---DIMHDSNYVSKGSTFL 301
Query: 191 PA-YVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNI-MVMYKKIYKG-EFR 246
P ++APE + Y D+WS G++L+ + + G P+ + Y KI G
Sbjct: 302 PVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
Query: 247 SPRWFSPDLIRLLTKLLDTNPDKR 270
P + ++ ++ K ++ P+KR
Sbjct: 361 KPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 17/46 (36%), Positives = 31/46 (67%)
Query: 125 DLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170
++ + +Q+++ + H G+ HRD+KPENLL+ +G +K+ DFG
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 11/107 (10%)
Query: 74 KREISILRRVRHP--NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYF 131
+RE IL + R + +++V I VMEY+ G L + + + R DL R+
Sbjct: 47 RREARILAKAREAGVPVPIVYDVDPDNGLI--VMEYIEGELLKDALEEARP--DLLRE-- 100
Query: 132 QQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178
+ VG H G+ H DL N++L G + DFGL SD++
Sbjct: 101 --VGRLVGKLHKAGIVHGDLTTSNIIL-SGGRIYFIDFGLGEFSDEV 144
|
Length = 204 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 36/164 (21%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 27 RYEIGKLLGHGTFAKVYH---ARNVKSGESVAIKV--IDKEKILKSGLV---AHIKREIS 78
++I KL+G G F VY A + K+ ++ E I+ LV + +I+
Sbjct: 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIA 72
Query: 79 ILRRVR---HPNIVQLFEVMATK-SKIYF---VME--YVRGGELFNKVAKGRLKEDLARK 129
+ + + H I + + + K ++Y+ ++E E+F ++ K L +
Sbjct: 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKK--LIKN 130
Query: 130 YFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173
+ +++ + + H G+ H D+KPEN+++D N + D+G+++
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 48/183 (26%), Positives = 74/183 (40%), Gaps = 35/183 (19%)
Query: 47 NVKSGESVAIKVIDKEKILKS----GLVAHIKRE--------ISILRR--VRHPNIVQLF 92
++K GE + + KE++ K L ++ E +S RR V P I +
Sbjct: 348 DIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI---Y 404
Query: 93 EVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLK 152
+V + I VMEY+ GG+ V +G +L RK + V H G+ H DL
Sbjct: 405 DVDPEEKTI--VMEYI-GGKDLKDVLEGN--PELVRK----VGEIVAKLHKAGIVHGDLT 455
Query: 153 PENLLLDENGDLKVSDFGLSAVSDQIRQDG-----LFHTFCGTPAYVAPEVLSR--KGYD 205
N ++ + L + DFGL SD I L + T Y E+ +GY
Sbjct: 456 TSNFIVR-DDRLYLIDFGLGKYSDLIEDKAVDLHVLKQSLEST-HYDFEELWEAFLEGYR 513
Query: 206 AAK 208
+
Sbjct: 514 ETE 516
|
Length = 535 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 18/66 (27%), Positives = 35/66 (53%), Gaps = 5/66 (7%)
Query: 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD 163
VMEY+ G EL + R+ ED + +++ + + G+ H DL N+L+D++
Sbjct: 109 VMEYIDGVEL----YRVRVLED-PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163
Query: 164 LKVSDF 169
+ + D+
Sbjct: 164 IYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 30/246 (12%)
Query: 51 GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLF----EVMATKSKIYFVME 106
+ V I+ K L+ + EI LRR+ NI++++ +++ ++ ++E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY---------HRDLKPENLL 157
Y G L + K + DL+ + +L A+ C +G+Y +++L + L
Sbjct: 103 YCTRGYLREVLDKEK---DLS--FKTKLDMAIDCC--KGLYNLYKYTNKPYKNLTSVSFL 155
Query: 158 LDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCG 215
+ EN LK+ GL ++I F Y + ++L+ Y K DI+S G
Sbjct: 156 VTENYKLKIICHGL----EKILSSPPFKNV-NFMVYFSYKMLNDIFSEY-TIKDDIYSLG 209
Query: 216 VILFVLMAGYLPFQDQNIMVMYKKIYK--GEFRSPRWFSPDLIRLLTKLLDTNPDKRITI 273
V+L+ + G +PF++ +Y I + P ++ ++ + KR I
Sbjct: 210 VVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
Query: 274 PEIMEN 279
EI+ N
Sbjct: 270 KEILYN 275
|
Length = 283 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 22/66 (33%), Positives = 36/66 (54%), Gaps = 4/66 (6%)
Query: 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD 163
VMEY+ G EL + RL + + +++ V + RG+ H DL N+L+ E+GD
Sbjct: 185 VMEYIEGVEL----YRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240
Query: 164 LKVSDF 169
+ V D+
Sbjct: 241 IVVIDW 246
|
Length = 304 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 30/148 (20%)
Query: 47 NVKSGESVAIKVIDKEKILKS----GLVAHIKRE--------ISILRR--VRHPNIVQLF 92
+ G+ + +K + KE++ KS L I+RE +S R+ V P + +
Sbjct: 9 IIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVV---Y 65
Query: 93 EVMATKSKIYFVMEYVRGGELFNKVAKGRLK--EDLARKYFQQLISAVGFCHARGVYHRD 150
+V I VMEY+ G L + + +G + ++ R VG H G+ H D
Sbjct: 66 DVDPDNKTI--VMEYIEGKPLKDVIEEGNDELLREIGR--------LVGKLHKAGIVHGD 115
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQI 178
L N+++ + L + DFGL SD+I
Sbjct: 116 LTTSNIIVR-DDKLYLIDFGLGKYSDEI 142
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 43/191 (22%), Positives = 72/191 (37%), Gaps = 58/191 (30%)
Query: 40 AKVYHARNVKSGESVAIKVI--DKEKILKS------GLVAHIKREISILRRVRHPNIV-- 89
A+V+ A +KSGE VA+KV + +++ L IKR RR+ +V
Sbjct: 139 AQVHRAV-LKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDE 197
Query: 90 -------------------QLFEVMATKSKIYF-------------VMEYVRGGELFNKV 117
+ E +Y ME++ G ++ +
Sbjct: 198 FEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIA 257
Query: 118 AKG-------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170
A L E L R + +QL+ GF HA D P N+L+ +G + + DFG
Sbjct: 258 ALKSAGIDRKELAELLVRAFLRQLLRD-GFFHA------DPHPGNILVRSDGRIVLLDFG 310
Query: 171 LSA-VSDQIRQ 180
+ + + R+
Sbjct: 311 IVGRLDPKFRR 321
|
Length = 517 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 13/155 (8%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHAR-NVKSGESVAIKVIDKEKILKSGLVAHI--KREISIL 80
L R+ +L F+ V G + A++ E S +A REI L
Sbjct: 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRAL 75
Query: 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140
+ VR +V +++AT K V + G L +A+ D A +F+ A+
Sbjct: 76 KTVRGIGVVP--QLLAT-GKDGLVRGWTEGVPL--HLARPH--GDPA--WFRSAHRALRD 126
Query: 141 CHARGVYHRDL-KPENLLLDENGDLKVSDFGLSAV 174
H G+ H DL KP+N L+ +G+ V DF L++V
Sbjct: 127 LHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161
|
Length = 365 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 41/162 (25%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183
+DL R + Q+ + F ++ HRD+ N+LL + K+ DFGL+ I D
Sbjct: 212 DDLLR-FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---DIMNDSN 267
Query: 184 FHTFCGTP----AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMV--- 235
+ G ++APE + Y + D+WS G++L+ + + G P+ I+V
Sbjct: 268 Y-VVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPY--PGILVNSK 323
Query: 236 MYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEI 276
YK + +G + P + P++ ++ + P +R T +I
Sbjct: 324 FYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 481 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.49 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.16 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.53 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.45 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.2 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.91 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.84 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.7 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.65 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.6 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.52 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.43 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.4 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.15 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.98 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.91 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.6 | |
| PLN02236 | 344 | choline kinase | 96.57 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.36 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.2 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.13 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.02 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.94 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.61 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.56 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.47 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.19 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.06 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.54 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-61 Score=489.10 Aligned_cols=261 Identities=59% Similarity=1.031 Sum_probs=245.5
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS--GLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
....++|++++.||+|+||+|++|.+..+++.||+|+++++..... ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 4578999999999999999999999999999999998887633311 35677889999999999 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~ 176 (481)
..+|+|||||.||+|++++.. +++.|.+++.+|+||++||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999987 899999999999999999999999999999999999999999 999999999998764
Q ss_pred ccccCCcccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCC-CHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF-SPD 254 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~ 254 (481)
.....+++.|||+.|+|||++.+.+ |.+.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.++ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 4567789999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+++|+.+||.+||.+|+|+.+|+.||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-62 Score=475.70 Aligned_cols=261 Identities=41% Similarity=0.740 Sum_probs=232.4
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS----GLVAHIKREISILRRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (481)
..+.+.|.+.+.||+|+||.|.+|..+.||+.||||++++...... .-...+.+|++||++|+|||||++++++..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 3477889999999999999999999999999999999988765431 123447799999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEecCCcc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVSDFGLSA 173 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~DFGla~ 173 (481)
.+..||||||++||+|++++.. +.+.|+..+.+++||+.|+.|||++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999999999865 789999999999999999999999999999999999999877 579999999999
Q ss_pred cccccccCCcccccCCCCccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCCCC--C
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY--DAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFRS--P 248 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~--~ 248 (481)
..+ ......+.||||.|+|||++.+.++ ++.++||||+||+||.+|+|++||.+.... .+..+|.+|.+.+ +
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 754 4556789999999999999987664 345789999999999999999999887654 4899999998655 2
Q ss_pred C--CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 249 R--WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 249 ~--~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .+|.++++||.+||..||++|||++|+|+||||+..
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 3 389999999999999999999999999999999743
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-61 Score=490.75 Aligned_cols=260 Identities=42% Similarity=0.795 Sum_probs=246.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.-.|-|+++++||.|+-|.|.+|++..||+.+|||++.+...........+.+||.||+.+.||||+++|+++++...+|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 34788999999999999999999999999999999998875445555677999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~-~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|.||++||+||+++. +|+++|.++.++|+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+. ..+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cCC
Confidence 9999999999999986 589999999999999999999999999999999999999999999999999999864 346
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
.++.+.||+|+|.|||++.+.+|++.++||||||||||.||+|.+||++.|...++.++..|.+..|..+|+++++||++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||..||.+|+|.+||++|||+...
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HhccCccccccHHHHhhCchhhcC
Confidence 999999999999999999999753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-60 Score=482.62 Aligned_cols=260 Identities=37% Similarity=0.711 Sum_probs=246.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|+.++.||+|||+.||.+++..+|+.||+|++.+..+.+....+.+.+||+|++.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|+|+.++|..+++. +.++|.+++.|++||+.||.|||+++|+|||||..|+|++++.+|||+|||||+.... .....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 99999999999986 5899999999999999999999999999999999999999999999999999997653 22344
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
.+.||||.|+||||+...++ +..+||||+||+||.||.|++||...+..+.|.+|...++..|..+|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 68899999999999998888 67899999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCHhHHHhCcccccCccc
Q 011628 265 TNPDKRITIPEIMENRWFRKGFKH 288 (481)
Q Consensus 265 ~dP~~Rps~~eil~h~~f~~~~~~ 288 (481)
+||.+|||+++||.|+||..++..
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcC
Confidence 999999999999999999777644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=438.99 Aligned_cols=259 Identities=41% Similarity=0.773 Sum_probs=240.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.-.++|+++++||+|+||+||.++.+.|++.+|+|++++..+......+..+.|..||..++||.||+++..|++..++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44789999999999999999999999999999999999998887777889999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|+||+.||+|+..+++ +.++|+.++.|+.+|+.||.|||++||+||||||||||+|.+|+++|+|||+++..-. ..
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 99999999999999985 8999999999999999999999999999999999999999999999999999985322 23
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLT 260 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 260 (481)
....+.|||+.|||||++.+.+|+ ..+|.|||||++|+|++|.+||.+.+...++.+|..+. ...|..++.+++++++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 345678999999999999999995 57999999999999999999999999999999999999 4556669999999999
Q ss_pred HhcccCcCCCC----CHhHHHhCccccc
Q 011628 261 KLLDTNPDKRI----TIPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rp----s~~eil~h~~f~~ 284 (481)
++|..||++|. ++++|.+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999995 6999999999964
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-57 Score=423.68 Aligned_cols=255 Identities=42% Similarity=0.779 Sum_probs=241.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
-.++|++.++||.|+||.|.+++.+.+|..+|+|++++..+.+...++...+|..+|+.+.||+++++++.+.+.+.+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 46889999999999999999999999999999999999988877788889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||++||+|+.++++ +++++..++.|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+... +
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-----~ 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-----G 196 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----C
Confidence 9999999999999987 799999999999999999999999999999999999999999999999999998543 3
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
...+.||||.|+|||++..++|. ..+|.|||||++|||++|.+||.+.+++.+|.+|..++...|+.+++++++||.++
T Consensus 197 rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~L 275 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKL 275 (355)
T ss_pred cEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHH
Confidence 35788999999999999999995 57999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCC-----CHhHHHhCccccc
Q 011628 263 LDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 263 L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
|+.|-.+|. ..++|.+||||+.
T Consensus 276 L~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 276 LQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HhhhhHhhhcCcCCCccccccCccccc
Confidence 999999995 5789999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-57 Score=434.78 Aligned_cols=255 Identities=32% Similarity=0.578 Sum_probs=233.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK-IY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~ 102 (481)
..++.+.++.||+|+.|+||+++++.|++.+|+|++... .+....+++.+|+++++.++|||||.+|++|..... ++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 345788899999999999999999999999999999544 355678999999999999999999999999999994 99
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+||+|.+.+.. ++++|....+++.++++||.|||. ++|+||||||+|||++..|.+||||||.|+....
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 99999999999999986 899999999999999999999995 9999999999999999999999999999986543
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHhhCC-CCCCCC-CCH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-----NIMVMYKKIYKGE-FRSPRW-FSP 253 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~ 253 (481)
....+.+||..|||||.+.+..| +.++||||||+.++|+.+|+.||... +..+++..|..+. +..|.. +|+
T Consensus 232 -S~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 -SIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred -hhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 25678999999999999999888 67899999999999999999999875 6678888998875 456776 999
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++++||..||++||.+|||+.|+++|||+++.
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 99999999999999999999999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-56 Score=445.16 Aligned_cols=260 Identities=35% Similarity=0.662 Sum_probs=241.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (481)
-..+|..++.||+|+|++|++|+++.+++.||||++.++.+.++..++-+.+|-.+|.+| .||.|+++|..|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 467999999999999999999999999999999999999888777778889999999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|+||+++|+|.++|.+ |.|++..++.|+.||+.||+|||++|||||||||||||+|.+|++||+|||.|+........
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999987 89999999999999999999999999999999999999999999999999999875432211
Q ss_pred ---------Cc--ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 011628 182 ---------GL--FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW 250 (481)
Q Consensus 182 ---------~~--~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 250 (481)
.. ..+.+||..|++||++..... +..+|||+||||||.|++|.+||.+.+.-.++++|..-.+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 11 145899999999999987655 678999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+++.+++||+++|..||.+|+|++||.+||||..
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999999999999999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-55 Score=426.33 Aligned_cols=260 Identities=40% Similarity=0.711 Sum_probs=237.0
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.....++|++.+.||+|+||+||+|++++++..||||.+.+... .....+.+..|+.||+.++|||||++++++..++.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 34568899999999999999999999999999999999988764 34567788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC------CCEEEEecCCcc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN------GDLKVSDFGLSA 173 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~------g~lkl~DFGla~ 173 (481)
+|+|||||.||+|.++++. +.++|..++.++.||+.|+++||+++|+||||||+||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999999986 699999999999999999999999999999999999999875 358999999999
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCC
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRW 250 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~ 250 (481)
... ......+.||+|.|||||++....|+ +|+|+||+|+|||+|++|+.||+..+..+++..+.++.. ..+.+
T Consensus 164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhh
Confidence 765 35567889999999999999888885 689999999999999999999999999999998887753 34667
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++...+|+...|..+|..|.+..+-+.|+++...
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 88889999999999999999999999999998654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=424.96 Aligned_cols=262 Identities=42% Similarity=0.782 Sum_probs=247.0
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+-.||++.++||.|+||+|.+|.....|+.||||.|+++.+.+......++|||+||..|+||||+.+|++|++.+.+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 45678999999999999999999999999999999999999998888888999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
.|||||+.||+|++++.. +.++|.+++++|+||++|+.|||.++++|||||.+|||+|.|+++||+|||++..+. .
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---D 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---c
Confidence 999999999999999976 789999999999999999999999999999999999999999999999999998754 4
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
...+.++||+|.|.+||++++.+|.++.+|-|||||+||.|+.|..||++.+...+.++|..|.+..|.. +.++.-||+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIR 284 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIR 284 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHH
Confidence 5678999999999999999999999999999999999999999999999999999999999999887764 667899999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
.||..||++|.|+++|-.|=|+.=++.
T Consensus 285 wmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred HHHhcCcccchhHHHHhhhheeecccc
Confidence 999999999999999999988765543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-53 Score=425.59 Aligned_cols=261 Identities=37% Similarity=0.651 Sum_probs=234.6
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..-.++|++++.||+||||.||+|+.+.||+.+|+|++++......+.++.++.|-.+|....+|+||++|..|.+..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34578999999999999999999999999999999999998888888889999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc--
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI-- 178 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~-- 178 (481)
||||||++||++..+|.+ +.++|++++.|+.+++.|++-+|+.|++||||||+|+|||..|++||+||||++.....
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999999999875 88999999999999999999999999999999999999999999999999998532110
Q ss_pred -----------------c-cCC-------------------------cccccCCCCccccccccccCCCCCCcchHHHHH
Q 011628 179 -----------------R-QDG-------------------------LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCG 215 (481)
Q Consensus 179 -----------------~-~~~-------------------------~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlG 215 (481)
. .+. ...+.+|||-|+||||+.+++| +..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHH
Confidence 0 000 0124689999999999999998 5679999999
Q ss_pred HHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC--CCCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 216 VILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP--RWFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 216 vil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
||+||||.|.+||.+.++.+.+.+|..-. +..| ..+++++++||.+||. ||++|.. ++||.+||||+.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999999999999999998764 4444 3478999999999999 9999984 999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=403.14 Aligned_cols=249 Identities=34% Similarity=0.608 Sum_probs=223.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-EEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE-VMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~ 99 (481)
+..-...|+|++.||+|+||.||++++..+|..||.|.+.-... +......+..|+.+|++|+|||||++++ .+....
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 34456789999999999999999999999999999999986553 3445677889999999999999999998 444444
Q ss_pred -EEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--cC--ceecCCCCCcEEEccCCCEEEEec
Q 011628 100 -KIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHA--RG--VYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~--~g--i~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.++||||||.+|+|.++|+. ..++|..+|+++.||+.||.+||+ .. |+||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 49999999999999999863 469999999999999999999999 44 999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CC
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SP 248 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~ 248 (481)
|+++.+.. .....++.+|||+||+||++...+| ..|+||||+||++|||++-+.||.+.+..++..+|.+|+++ +|
T Consensus 173 GL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 173 GLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99998754 3345678999999999999999999 57999999999999999999999999999999999999876 66
Q ss_pred -CCCCHHHHHHHHHhcccCcCCCCCH
Q 011628 249 -RWFSPDLIRLLTKLLDTNPDKRITI 273 (481)
Q Consensus 249 -~~~s~~~~~li~~~L~~dP~~Rps~ 273 (481)
..+|.++..||..|+..||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 6799999999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=417.62 Aligned_cols=265 Identities=36% Similarity=0.653 Sum_probs=233.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch-----------hHHHHHHHHHHHHHhCCCCCcceE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----------GLVAHIKREISILRRVRHPNIVQL 91 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l 91 (481)
...+.|++++.||+|.||+|.+|++..+++.||||++.+...... .-.+++++||.||++|+|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 347899999999999999999999999999999999987543221 123578999999999999999999
Q ss_pred EEEEEeC--CEEEEEEeccCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 92 FEVMATK--SKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 92 ~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
+++..+. +.+|||+|||..|.+...=.... +++.++++|+++++.||+|||.+||+||||||.|+||+++|++||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 9999764 68999999999998876655555 99999999999999999999999999999999999999999999999
Q ss_pred cCCccccccc---ccCCcccccCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh
Q 011628 169 FGLSAVSDQI---RQDGLFHTFCGTPAYVAPEVLSR---KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK 242 (481)
Q Consensus 169 FGla~~~~~~---~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~ 242 (481)
||.+..+... ..+..+....|||.|+|||.+.+ ..+.+.+.||||+||+||+|+.|++||-+....+++.+|.+
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9998765322 22233456899999999999876 55778899999999999999999999999999999999999
Q ss_pred CCCCCCCC--CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 243 GEFRSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 243 ~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
..+.+|.. +.+.+++||.+||++||++|+++.+|..|||......
T Consensus 334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 98777765 7899999999999999999999999999999987644
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=428.47 Aligned_cols=258 Identities=37% Similarity=0.666 Sum_probs=243.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 103 (481)
.++|+++++||+|+||+|++|..+.+++.+|||+++++.+...+.++..+.|-+|+...+ ||.+++++.+|.+.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 679999999999999999999999999999999999999988888999999999999886 9999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||+.||++...++.+.+++..++.|+..++.||.|||++||+|||||.+|||||.+|++||+|||+++.. ...+..
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~~g~~ 524 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MGQGDR 524 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CCCCCc
Confidence 999999999777777789999999999999999999999999999999999999999999999999999742 234556
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 263 (481)
..|.||||.|||||++.+..| +..+|.|||||+|||||.|+.||.+.+..+++..|...+..+|.|+|.++.++++++|
T Consensus 525 TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll 603 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLL 603 (694)
T ss_pred cccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHh
Confidence 789999999999999999988 6789999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCC-----HhHHHhCcccccC
Q 011628 264 DTNPDKRIT-----IPEIMENRWFRKG 285 (481)
Q Consensus 264 ~~dP~~Rps-----~~eil~h~~f~~~ 285 (481)
.+||++|.. +++|.+||||+..
T Consensus 604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 604 RKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ccCcccccCCCCCCchhhhhCCccccC
Confidence 999999985 5899999999753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=397.14 Aligned_cols=256 Identities=30% Similarity=0.512 Sum_probs=220.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|+.+.++|+|+||+||++++++||+.||||.+-... .+....+-..|||++|++|+|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 578999999999999999999999999999999986543 3334455678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|||+-.-|.++-.. .+++++.+++|++|++.|+.|||+++++||||||||||++.+|.+||||||+|+.... ....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 999987544444433 5799999999999999999999999999999999999999999999999999997653 4556
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--------------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-------------------- 243 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------------- 243 (481)
++.++.|.+|+|||.+.+...++.++|||++||++.||++|.+-|++.+..+....|.+.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 788999999999999998655578899999999999999999999998876655544321
Q ss_pred -CCCCC----------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 244 -EFRSP----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 244 -~~~~~----------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.++.| +.++.-+.+|+++||..||++|++.+|++.|+||.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 01111 12456789999999999999999999999999993
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=393.60 Aligned_cols=258 Identities=37% Similarity=0.725 Sum_probs=233.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.+.+.|++-+.||+|.|+.||++.+..+|+.+|+|+++....... ..+.+.+|+.|-+.|+||||+++++.+.+....|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 356789999999999999999999999999999999987765544 4577999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEecCCccccccc
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~DFGla~~~~~~ 178 (481)
+|+|++.|++|+.-|.. .-.+|..+-.+++||+.||.|||.+||+|||+||+|+|+... .-+||+|||+|...+
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999999999877654 468999999999999999999999999999999999999654 359999999997654
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC----CCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~ 254 (481)
.........|||.|||||++...+| +.++|||+||||||-||.|++||.+++...+|.+|..+.+..|+ .++++
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 3445677899999999999999998 56799999999999999999999999999999999999765543 48999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++||++||..||.+|+|+.|.|+|||+.+.
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 9999999999999999999999999999764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=408.54 Aligned_cols=258 Identities=33% Similarity=0.606 Sum_probs=221.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--KIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 102 (481)
..+|..++.||+|+||.||++.+.++|...|||.+...... ..+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 56799999999999999999999999999999999876322 2677899999999999999999999854444 699
Q ss_pred EEEeccCCCchHHHHHc-C-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCccccccc-
Q 011628 103 FVMEYVRGGELFNKVAK-G-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQI- 178 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~- 178 (481)
++|||++||+|.+++.+ + +++|+.++.|.+|++.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999986 4 6999999999999999999999999999999999999999 799999999999865531
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCC--CCCCCCCCHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGE--FRSPRWFSPDL 255 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~s~~~ 255 (481)
..........||+.|||||++........++|||||||++.||+||..||.+ .........+.... +..|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122234578999999999998632333489999999999999999999998 44444444444333 56789999999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++||.+|+..||++|||++++|+|||.+..
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-53 Score=420.45 Aligned_cols=257 Identities=33% Similarity=0.653 Sum_probs=239.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+++....+ ...+.+.+|++|++.++|||||.++++|++...+|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 468999999999999999999999999999999998876433 4567899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|||.| +|+.+++. +.++|+.++.++.|+++||.|||+++|+|||+||.|||++.+|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 99999986 7899999999999999999999999999999999999999999999999999987554 3446
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 263 (481)
+....|||.|||||++.+.+|+ ..+|+||||||+|||++|++||-......+.+.|.+...+.|...|..+.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6778999999999999998885 569999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCCHhHHHhCcccccCc
Q 011628 264 DTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 264 ~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.+||.+|.|..+++.|||.+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999987654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=381.22 Aligned_cols=255 Identities=39% Similarity=0.716 Sum_probs=241.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|.||.||+|+.++++-.||+|++.++.+...+...++.||++|...|+||||+++|++|-+...+|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 68899999999999999999999999999999999998888777888999999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||+.+|+|+..+.. .++++..+..|++|++.|+.|||.++|+||||||+|+|++..|.+||+|||.+-... .
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----C
Confidence 999999999999984 469999999999999999999999999999999999999999999999999986532 3
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
+...+.|||.-|.+||...+.+++ ..+|+|++|++.||++.|.+||...+..+.|++|.+.++..|+.++.++.+||.+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISR 255 (281)
T ss_pred CCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHH
Confidence 445788999999999999999996 4699999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCCHhHHHhCccccc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||.++|.+|.+..|++.|||+..
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=408.37 Aligned_cols=256 Identities=35% Similarity=0.590 Sum_probs=227.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (481)
.+.|+.+++||+|+||.||+|++..||+.||+|.+..+.. +.++.....|||.||++|+||||+++.++..+. ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 5689999999999999999999999999999999988763 456777788999999999999999999999877 6899
Q ss_pred EEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|+|||+. +|.-++... .|++.++..|++||+.||+|||++||+|||||.+|||||.+|.+||+|||||+++....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~- 272 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG- 272 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC-
Confidence 99999976 888888764 79999999999999999999999999999999999999999999999999999876533
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CC--------CCC--
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EF--------RSP-- 248 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~--------~~~-- 248 (481)
...++..+-|.+|+|||.+.+...++..+|+||+||||.||++|++.|.+.+..+...+|++- .+ ..|
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 334677788999999999998877788999999999999999999999999988888888652 10 111
Q ss_pred -----------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 249 -----------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 249 -----------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
..+++.+.+|+..||..||.+|.|+.++|+++||.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 12677899999999999999999999999999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=411.45 Aligned_cols=260 Identities=33% Similarity=0.549 Sum_probs=227.5
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 99 (481)
...++.||.+.++||.|+||.||+|+.+.+|+.||||.+++....-++. . -.||+..|++|+ |||||++++++.+.+
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~-nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-M-NLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-H-HHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3457899999999999999999999999999999999997765432222 2 358999999999 999999999998888
Q ss_pred -EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 100 -KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
.+|+||||++. .|+++++. ..+++..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||+|+...
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999975 99999976 469999999999999999999999999999999999999999999999999998543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------- 243 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 243 (481)
....++.++.|.+|+|||++...++++.+.|||++|||++|+.+-++-|++.+..+...+|..-
T Consensus 162 ---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 ---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 3345678899999999999999999999999999999999999999999999887777777531
Q ss_pred ------CCCCC-----------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 244 ------EFRSP-----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 244 ------~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.+..| +..++++.+||.+||.+||++|||+.|+++||||+...
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 11111 12678899999999999999999999999999998754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=408.00 Aligned_cols=255 Identities=40% Similarity=0.752 Sum_probs=232.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 36889999999999999999999999999999999987654444455778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~----- 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----- 170 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-----
Confidence 9999999999999876 6799999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+....|.++++.+++||.+|
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 171 RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249 (329)
T ss_pred CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHH
Confidence 1234689999999999988777 578999999999999999999999998888899999998889999999999999999
Q ss_pred cccCcCCCCC-----HhHHHhCccccc
Q 011628 263 LDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 263 L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
|+.||.+||+ +++++.||||..
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999997 799999999975
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=393.72 Aligned_cols=260 Identities=31% Similarity=0.545 Sum_probs=229.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.-.+.|++...||.|.-++||+|++..+++.||||+++.++.... .+.+.+|+..|+.++||||++++..|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 347899999999999999999999999999999999999886543 788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 103 FVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+||.|+.+|++.+++.. .+++|..+..++++++.||.|||++|.+|||||+.||||+.+|.|||+|||.+......+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999999975 469999999999999999999999999999999999999999999999999876433222
Q ss_pred cCC--cccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC------
Q 011628 180 QDG--LFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR------ 249 (481)
Q Consensus 180 ~~~--~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~------ 249 (481)
... .+++..|||+|||||++.. .+| ..|+||||||++..||.+|..||....++.+...-.++.++.+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GY-dfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGY-DFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCc-cchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 111 1267799999999999533 456 57999999999999999999999999998877776776655322
Q ss_pred ----CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 250 ----WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 250 ----~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.++..++.+|..||++||.+|||++++++|+||++.
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 256779999999999999999999999999999875
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=407.53 Aligned_cols=262 Identities=42% Similarity=0.719 Sum_probs=243.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
...+.|=|.+.++||+|-|++|.+|++.-||+.||||++++.+... -...++.+|+..|+.++|||||++|++..++.+
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 3456788999999999999999999999999999999999887543 344678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCcccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~ 177 (481)
+|+|+|+-+||+|+++|.+ .++.|+.+++||.||+.|+.|||+..++||||||||+.+.+ -|-+||+|||++..+.
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 9999999999999999976 47999999999999999999999999999999999998765 5889999999997654
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 257 (481)
+...+.+.||+..|-|||++.+..|+.+++||||||||||.|++|++||...+..+..-.|....+..|..+|.++++
T Consensus 171 --PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrd 248 (864)
T KOG4717|consen 171 --PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRD 248 (864)
T ss_pred --CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHH
Confidence 345678999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
||..||..||.+|.|.++|..++|++..-
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCCC
Confidence 99999999999999999999999998653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=398.08 Aligned_cols=253 Identities=34% Similarity=0.654 Sum_probs=229.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654333344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999999875 6799999999999999999999999999999999999999999999999999875422 12
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+....|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 34579999999999988776 57899999999999999999999999988889999998888898999999999999999
Q ss_pred cCcCCCCC-----HhHHHhCccccc
Q 011628 265 TNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps-----~~eil~h~~f~~ 284 (481)
.||.+||+ ++++++||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=404.45 Aligned_cols=260 Identities=39% Similarity=0.724 Sum_probs=236.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSK 100 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 100 (481)
..+...|++++.||+|.||.||.++++.||+.+|+|++.+...........+.+|+.||+++. |||||.+++++++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 445678999999999999999999999999999999999887665545678999999999998 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC----CCEEEEecCCccccc
Q 011628 101 IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN----GDLKVSDFGLSAVSD 176 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~----g~lkl~DFGla~~~~ 176 (481)
+|+|||+|.||+|++.+....++|..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999976569999999999999999999999999999999999999654 479999999998754
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC--CCC--CC
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS--PRW--FS 252 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~--~s 252 (481)
. .......||||.|+|||++...+| +..+||||+||++|.|++|..||.+.+....+.++..+++.+ +.| +|
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 3 456788999999999999988888 568999999999999999999999999988888999987644 333 78
Q ss_pred HHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..++++|++||..||.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999998653
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=401.25 Aligned_cols=258 Identities=33% Similarity=0.611 Sum_probs=232.0
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSG-ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
...-.++|++.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3345788999999999999999999976654 689999997765444445667889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||+.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 99999999999999999976 5799999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRL 258 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 258 (481)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+....|..+++.+.++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 1235689999999999987766 57899999999999999999999999988889999998888899999999999
Q ss_pred HHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
|++||+.||.+|+ |++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999996 8999999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=399.88 Aligned_cols=251 Identities=41% Similarity=0.709 Sum_probs=225.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567789999999999999999999999999999999999999
Q ss_pred chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 112 ELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 112 ~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99999875 6799999999999999999999999999999999999999999999999999874221 12223456899
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+....|..+++++.+||.+||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999988777 57899999999999999999999998888888888888888889999999999999999999999
Q ss_pred C-----CHhHHHhCcccccC
Q 011628 271 I-----TIPEIMENRWFRKG 285 (481)
Q Consensus 271 p-----s~~eil~h~~f~~~ 285 (481)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=370.53 Aligned_cols=255 Identities=33% Similarity=0.548 Sum_probs=223.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|...+.||+|+||.||+|++.+||+.||||.+..... +.+......|||+.|+.++||||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 589999999999999999999999999999999987753 3445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++. +|...++.. .++...+..|+.|++.||+|||++.|+||||||+|+|++.+|.+||+|||+|+.+..... .
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--I 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--c
Confidence 99975 999999863 689999999999999999999999999999999999999999999999999998765333 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCC---------C----
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRS---------P---- 248 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~---------~---- 248 (481)
....+-|.+|+|||.+.+...++..+||||.|||+.||+-|.+-|.+.+..+....|+..- +.. |
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 2333789999999999887766888999999999999999999999998888777776521 100 1
Q ss_pred -------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 -------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 -------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+..++++.+|+.+||..||.+|+|+.|+++|+||..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 114667899999999999999999999999999974
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=407.91 Aligned_cols=254 Identities=33% Similarity=0.603 Sum_probs=230.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|...+.||+|+-|.||.|+...+++.||||.++....... +-+.+|+.+|+..+|+|||++++.|...+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 4689999999999999999999999999999999998765544 4478999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++||+|.+.+....++|.++..+.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++........ .-
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR 426 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence 9999999999999998899999999999999999999999999999999999999999999999999987654332 34
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh-C--CCCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-G--EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~li~~ 261 (481)
.+.+|||+|||||++..+.| +.|.||||||++++||+-|++||-.+++......|.. | +++.|..+|+.+++|+.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 67899999999999999888 6799999999999999999999998887665555544 4 355688899999999999
Q ss_pred hcccCcCCCCCHhHHHhCccccc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||+.||++|+++.|||+||||..
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999954
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-51 Score=375.95 Aligned_cols=258 Identities=36% Similarity=0.712 Sum_probs=231.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC-CCCcceEEEEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-----KSGLVAHIKREISILRRVR-HPNIVQLFEVMA 96 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 96 (481)
.+-.+|+--+.||+|..++|..+.++.+|+.+|+|++...... ..++.+.-.+|+.||+++. ||||+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4567899999999999999999999999999999999753221 2245566778999999995 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
++..+++|+|.|+.|+|+|++.. -.++|.+.+++++||+.|++|||.++|+||||||+|||++++.++||+|||+|+..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999987 47999999999999999999999999999999999999999999999999999864
Q ss_pred cccccCCcccccCCCCcccccccccc------CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--C
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSR------KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--S 247 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~------~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~ 247 (481)
. .+..+...||||+|+|||.+.. .+| +..+|+|+||||+|.|+.|.+||-....+-+.+.|..|++. .
T Consensus 174 ~---~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 174 E---PGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred C---CchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 3 3445678899999999999854 345 56799999999999999999999999999999999999754 4
Q ss_pred CCC--CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 248 PRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 248 ~~~--~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
|.| +|...++||.+||+.||.+|+|++|+|.||||.+
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 666 7889999999999999999999999999999965
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=387.27 Aligned_cols=259 Identities=32% Similarity=0.512 Sum_probs=232.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++++.||.|.-|+||+++...++..+|+|+++++......-..++.-|-.||+.++||.++.+|..+++....|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 57899999999999999999999999999999999998877666778888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc---
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI--- 178 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~--- 178 (481)
||||+||+|..+.++ +.+++..++.|+.+++.||+|||-.||++||||||||||-++|++.|+||.|+......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999999999876 36999999999999999999999999999999999999999999999999987432100
Q ss_pred -----------------------------c-c---------------------CCcccccCCCCccccccccccCCCCCC
Q 011628 179 -----------------------------R-Q---------------------DGLFHTFCGTPAYVAPEVLSRKGYDAA 207 (481)
Q Consensus 179 -----------------------------~-~---------------------~~~~~~~~gt~~y~APEvl~~~~~~~~ 207 (481)
. . +....+.+||-.|+|||++.+.++ +.
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH-gs 314 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH-GS 314 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC-Cc
Confidence 0 0 001134689999999999999999 46
Q ss_pred cchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC--CCCHHHHHHHHHhcccCcCCCCC----HhHHHhCcc
Q 011628 208 KVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR--WFSPDLIRLLTKLLDTNPDKRIT----IPEIMENRW 281 (481)
Q Consensus 208 ~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps----~~eil~h~~ 281 (481)
++|.|+|||.+|||+.|..||.+.+..+.+.+|......+|. .++..+++||+++|.+||.+|.. +.||.+|||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 799999999999999999999999999999999988776654 46789999999999999999998 999999999
Q ss_pred ccc
Q 011628 282 FRK 284 (481)
Q Consensus 282 f~~ 284 (481)
|+.
T Consensus 395 F~g 397 (459)
T KOG0610|consen 395 FEG 397 (459)
T ss_pred ccC
Confidence 964
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=406.12 Aligned_cols=263 Identities=46% Similarity=0.812 Sum_probs=246.4
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
....+.|.+.++||+|.|++|.+|++..++..||||++++....... ...+.+|+++|+.++|||||+++.+..++..+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34578899999999999999999999999999999999987755443 34488999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+.||++++++.+ +++.+..++.+|.|+++|++|||+++|+|||||++||||+.+.++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 999999999999999986 789999999999999999999999999999999999999999999999999998765 3
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
...+.+.||++.|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+...+..+...+.+..|-.++.++.++|+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 55678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKGFKH 288 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~~~~ 288 (481)
++|.++|.+|+++++|+.|+|...++..
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999998766544
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=391.58 Aligned_cols=254 Identities=34% Similarity=0.612 Sum_probs=226.2
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL---RRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.++ +.++||||+++++++.....+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999866443334456677777665 456799999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++||+|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999864322 12223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....|..+++.+.++|.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 45789999999999987776 57899999999999999999999999888888888888888888999999999999999
Q ss_pred cCcCCCC-----CHhHHHhCccccc
Q 011628 265 TNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.||.+|| ++.++++||||..
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999 6999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=392.77 Aligned_cols=249 Identities=38% Similarity=0.664 Sum_probs=223.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865444444556788999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCc
Q 011628 114 FNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192 (481)
Q Consensus 114 ~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 192 (481)
.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 999865 6799999999999999999999999999999999999999999999999999875322 1223345689999
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCC-
Q 011628 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRI- 271 (481)
Q Consensus 193 y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 271 (481)
|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..+....|..+++++.+||.+||+.||.+||
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999988777 568999999999999999999999988888889998888888999999999999999999999997
Q ss_pred --CHhHHHhCcccccC
Q 011628 272 --TIPEIMENRWFRKG 285 (481)
Q Consensus 272 --s~~eil~h~~f~~~ 285 (481)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=397.73 Aligned_cols=257 Identities=31% Similarity=0.547 Sum_probs=221.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ---- 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 180 (481)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999875 6899999999999999999999999999999999999999999999999999875321100
Q ss_pred -----------------------------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc
Q 011628 181 -----------------------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ 231 (481)
Q Consensus 181 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 231 (481)
.......+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 001234689999999999988777 56899999999999999999999998
Q ss_pred hHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhcccCcC---CCCCHhHHHhCccccc
Q 011628 232 NIMVMYKKIYKG--EFRSPR--WFSPDLIRLLTKLLDTNPD---KRITIPEIMENRWFRK 284 (481)
Q Consensus 232 ~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~---~Rps~~eil~h~~f~~ 284 (481)
+....+.++... ....|. .+++++++||.+|+. +|. .||+++||++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888888888763 333443 378999999999775 444 4689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=392.69 Aligned_cols=250 Identities=40% Similarity=0.693 Sum_probs=224.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445667889999999999999999999999999999999999999
Q ss_pred chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 112 ELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 112 ~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99998875 5799999999999999999999999999999999999999999999999999874221 12223456899
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+....|..+++++.+||.+||++||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987776 57899999999999999999999988888888888888888889999999999999999999999
Q ss_pred C-----CHhHHHhCccccc
Q 011628 271 I-----TIPEIMENRWFRK 284 (481)
Q Consensus 271 p-----s~~eil~h~~f~~ 284 (481)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=392.03 Aligned_cols=253 Identities=32% Similarity=0.581 Sum_probs=224.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999975 6799999999999999999999999999999999999999999999999999875432 23
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCC------CCCHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR------WFSPDLI 256 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~s~~~~ 256 (481)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 45689999999999988766 578999999999999999999999988777766665432 22222 3589999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+||.+||..+|.+||+++++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=390.87 Aligned_cols=250 Identities=40% Similarity=0.709 Sum_probs=224.1
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567788999999999999999999999999999999999999
Q ss_pred chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 112 ELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 112 ~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 99998875 5799999999999999999999999999999999999999999999999999864211 12223456899
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 99999999987777 57899999999999999999999998888888888888888888999999999999999999999
Q ss_pred C-----CHhHHHhCccccc
Q 011628 271 I-----TIPEIMENRWFRK 284 (481)
Q Consensus 271 p-----s~~eil~h~~f~~ 284 (481)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=379.80 Aligned_cols=260 Identities=30% Similarity=0.490 Sum_probs=222.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----C
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-----K 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~ 98 (481)
+..+|...+.||+|+||.|..|.++.+|+.||||.+.... ...-..++..||+.+++.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 4567777899999999999999999999999999997433 334456888899999999999999999999865 3
Q ss_pred CEEEEEEeccCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+|+|+|++ +.+|.+.++.++ ++++.++.+++||+.||+|+|+.+|+||||||.|+|++.+..+||+|||+|+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 5799999999 569999999876 99999999999999999999999999999999999999999999999999997654
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------- 242 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------- 242 (481)
....+..+.++.|.+|+|||++.....++...||||+|||+.||++|++-|.+.+.......|..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 44455667889999999999986655557889999999999999999999988765544444332
Q ss_pred --------CCCCC--------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 --------GEFRS--------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 --------~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..... -+..++.+.+|+.+||..||.+|+|++|+|+|||+..-
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11111 12468899999999999999999999999999999653
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=394.36 Aligned_cols=257 Identities=33% Similarity=0.619 Sum_probs=223.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998764444455667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC---
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD--- 181 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 181 (481)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999875 67999999999999999999999999999999999999999999999999998643211000
Q ss_pred ---------------------------------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q 011628 182 ---------------------------------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF 228 (481)
Q Consensus 182 ---------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf 228 (481)
....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 01123579999999999988777 57899999999999999999999
Q ss_pred CCchHHHHHHHHhhCC--CCCCC--CCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 229 QDQNIMVMYKKIYKGE--FRSPR--WFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 229 ~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
.+.+....+..+.... +..|. .+++++++||.+||. +|.+|++ ++++++||||..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9988877777776543 23333 468999999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=388.59 Aligned_cols=255 Identities=33% Similarity=0.608 Sum_probs=227.2
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP-NIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~ 105 (481)
+|++.+.||+|+||.||+|++..+++.||||++.+...........+..|..+++.+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444556778899999999765 5888999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999864221 12233
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......|..+++++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 45689999999999988777 56899999999999999999999999888888899888888888999999999999999
Q ss_pred cCcCCCCCH-----hHHHhCccccc
Q 011628 265 TNPDKRITI-----PEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps~-----~eil~h~~f~~ 284 (481)
+||.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=389.60 Aligned_cols=250 Identities=36% Similarity=0.662 Sum_probs=223.1
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876443334456677888888877 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999998875 6799999999999999999999999999999999999999999999999999864321 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+..+....|.++++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999987776 5689999999999999999999999998888999998888889999999999999999999999
Q ss_pred CCCH------hHHHhCccccc
Q 011628 270 RITI------PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~------~eil~h~~f~~ 284 (481)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 99999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=397.60 Aligned_cols=258 Identities=34% Similarity=0.568 Sum_probs=220.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
..|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998765555556678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ---- 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 180 (481)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999876 6799999999999999999999999999999999999999999999999999753211000
Q ss_pred -----------------------------------------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHH
Q 011628 181 -----------------------------------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF 219 (481)
Q Consensus 181 -----------------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ 219 (481)
.....+.+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHH
Confidence 001134689999999999988777 57899999999999
Q ss_pred HHhcCCCCCCCchHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhc--ccCcCCCCCHhHHHhCccccc
Q 011628 220 VLMAGYLPFQDQNIMVMYKKIYKG--EFRSPR--WFSPDLIRLLTKLL--DTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 220 elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L--~~dP~~Rps~~eil~h~~f~~ 284 (481)
+|++|..||...+......++... ....|. .+++++.+||.+|| ..+|..|++++++++||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 999999999988776666666532 333343 47999999999965 455666999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=395.55 Aligned_cols=256 Identities=31% Similarity=0.548 Sum_probs=230.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
...|+..+.||+|+||.||+|.+..+++.||+|+++.+... ..+..+.+|+.++.+++++||.++|+.+..+..+|++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 45688889999999999999999999999999999987643 4578899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAKGRL-KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l-~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||.||++.++++.+.+ +|..+.-++++++.|+.|||.++.+|||||+.|||+..+|.+||+|||++........ .
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--R 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--c
Confidence 999999999999998765 9999999999999999999999999999999999999999999999999976544322 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 262 (481)
..+.+|||.||||||+.+.+|+ .|+||||||++.+||++|.+||.+..++.....|-+..++ ....+|+.+++||..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 2788999999999999988885 6899999999999999999999999987766666555433 3446899999999999
Q ss_pred cccCcCCCCCHhHHHhCcccccC
Q 011628 263 LDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|++||+.|||+.++|+|+|+++.
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhc
Confidence 99999999999999999999874
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=395.74 Aligned_cols=259 Identities=31% Similarity=0.524 Sum_probs=226.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 57899999999999999999999999999999999765433333445678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~~~ 200 (370)
T cd05596 122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRC 200 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-cccC
Confidence 999999999999988889999999999999999999999999999999999999999999999999987543211 1122
Q ss_pred cccCCCCccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCC--CCCHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKG---YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR--WFSPDLIR 257 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~ 257 (481)
...+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+.++.... ...|. .+|.++.+
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHH
Confidence 3568999999999986542 34678999999999999999999999998888888887643 34444 47999999
Q ss_pred HHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 258 LLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
||.+||+.+|.+ |+|++++++||||+.
T Consensus 281 li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 281 LICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 999999999998 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=385.80 Aligned_cols=250 Identities=32% Similarity=0.628 Sum_probs=220.0
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||.||+|++..+|+.||+|++.+...........+..|..++... +||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999875433223345567788888765 899999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999998875 5799999999999999999999999999999999999999999999999999864211 1223345789
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....|.+++.++++||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999988777 5789999999999999999999999888888888887778888999999999999999999999
Q ss_pred CCCH-hHHHhCccccc
Q 011628 270 RITI-PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~-~eil~h~~f~~ 284 (481)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 238 RLGVVGNIRGHPFFKT 253 (316)
T ss_pred cCCChHHHHcCCCcCC
Confidence 9998 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=380.31 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=218.7
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 88999999999999999999999999999999866544333345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 108 VRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 108 ~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
++||+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCee
Confidence 999999888753 3689999999999999999999999999999999999999999999999999875322 1223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+. ......+.......+..+++++.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred cCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 45679999999999988777 5689999999999999999999987543 233334444455667779999999999
Q ss_pred HhcccCcCCCCC-----HhHHHhCccccc
Q 011628 261 KLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
+||+.||.+||+ ++++++||||..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 999999999997 899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=388.20 Aligned_cols=250 Identities=36% Similarity=0.637 Sum_probs=223.8
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||.||+|++..+++.||+|++.+...........+..|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444556677899998876 799999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999998865 6799999999999999999999999999999999999999999999999999874322 2223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+..+....|.++++++.++|.+||++||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 999999999987777 5689999999999999999999999999899999999888889999999999999999999999
Q ss_pred CC-------CHhHHHhCccccc
Q 011628 270 RI-------TIPEIMENRWFRK 284 (481)
Q Consensus 270 Rp-------s~~eil~h~~f~~ 284 (481)
|| +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=396.78 Aligned_cols=257 Identities=37% Similarity=0.632 Sum_probs=221.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765444455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR----- 179 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~----- 179 (481)
||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999875 679999999999999999999999999999999999999999999999999975321000
Q ss_pred ----------------------------------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHH
Q 011628 180 ----------------------------------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF 219 (481)
Q Consensus 180 ----------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ 219 (481)
......+.+||+.|+|||++.+.++ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHH
Confidence 0001124579999999999988887 46899999999999
Q ss_pred HHhcCCCCCCCchHHHHHHHHhhCC--CCCC--CCCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 220 VLMAGYLPFQDQNIMVMYKKIYKGE--FRSP--RWFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 220 elltg~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
+|++|..||.+.+......++.... ...| ..+++++.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 9999999999888777666665432 2333 457999999999986 59999997 999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=385.04 Aligned_cols=257 Identities=35% Similarity=0.615 Sum_probs=220.3
Q ss_pred CeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999999864 47899999999765432 223456678999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 999999999999999865 579999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc----hHHHHHHHHhhCCCCCCCCCCHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ----NIMVMYKKIYKGEFRSPRWFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~ 256 (481)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+.......|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 122335689999999999977654467899999999999999999999643 3345555666666777888999999
Q ss_pred HHHHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
++|.+||+.||++|| +++++++||||+.
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 7889999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=396.11 Aligned_cols=257 Identities=31% Similarity=0.582 Sum_probs=220.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC---
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD--- 181 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 181 (481)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999875 67999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHH
Q 011628 182 ------------------------------------------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF 219 (481)
Q Consensus 182 ------------------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ 219 (481)
......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 00013579999999999988777 57899999999999
Q ss_pred HHhcCCCCCCCchHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhcccCcCCC---CCHhHHHhCccccc
Q 011628 220 VLMAGYLPFQDQNIMVMYKKIYKG--EFRSPR--WFSPDLIRLLTKLLDTNPDKR---ITIPEIMENRWFRK 284 (481)
Q Consensus 220 elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R---ps~~eil~h~~f~~ 284 (481)
+|++|..||.+.+....+..+... ....|. .+++++.+||.+||. +|.+| +|+.+++.||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777777653 233343 478999999999997 77765 59999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=379.36 Aligned_cols=253 Identities=29% Similarity=0.492 Sum_probs=212.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++.+.||.|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 57899999999999999999999999999999999754322 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.| +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CCc
Confidence 999986 89888864 3589999999999999999999999999999999999999999999999999875332 122
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------------ 244 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------------ 244 (481)
......|++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 23445789999999998764444678999999999999999999998876654444332210
Q ss_pred -CCC-----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 -FRS-----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 -~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
... ...+++++++||.+||++||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 001 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=389.07 Aligned_cols=250 Identities=40% Similarity=0.704 Sum_probs=223.6
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444566788999999999999999999999999999999999999
Q ss_pred chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 112 ELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 112 ~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
+|...+.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99998875 579999999999999999999997 7999999999999999999999999999864221 1222345679
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..+++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999987777 5789999999999999999999999888888888888888888899999999999999999999
Q ss_pred CC-----CHhHHHhCccccc
Q 011628 270 RI-----TIPEIMENRWFRK 284 (481)
Q Consensus 270 Rp-----s~~eil~h~~f~~ 284 (481)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=378.23 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=212.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2234567789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++++.+..+... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 99999877666543 579999999999999999999999999999999999999999999999999997643211 1223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------------C
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------F 245 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------~ 245 (481)
....|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 34679999999999987776 568999999999999999999998765433322221100 0
Q ss_pred CC-------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 RS-------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 ~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.. ...+|+++.+||.+||++||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 11267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=392.27 Aligned_cols=257 Identities=35% Similarity=0.671 Sum_probs=226.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR----- 179 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~----- 179 (481)
||++|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999876 589999999999999999999999999999999999999999999999999987543322
Q ss_pred ----------------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHH
Q 011628 180 ----------------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY 237 (481)
Q Consensus 180 ----------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~ 237 (481)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0112345679999999999988776 57899999999999999999999998887777
Q ss_pred HHHhh--CCCCCCCC--CCHHHHHHHHHhcccCcCCCCC-HhHHHhCccccc
Q 011628 238 KKIYK--GEFRSPRW--FSPDLIRLLTKLLDTNPDKRIT-IPEIMENRWFRK 284 (481)
Q Consensus 238 ~~i~~--~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps-~~eil~h~~f~~ 284 (481)
.++.. .....|.. +++++.+||.+||. ||.+||+ ++++++||||..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77776 34444433 59999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=370.04 Aligned_cols=257 Identities=34% Similarity=0.476 Sum_probs=223.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA--TKSKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~ 102 (481)
.+.|+.+..|++|+||.||+|+++.|++.||+|.++.+. .+.++--.-.|||.++.+++|||||.+.++.. +-+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 568999999999999999999999999999999998776 34455556679999999999999999998875 446799
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||||+. +|..++.. .++...+++.++.|+++|++|||.+.|+||||||+|+|+++.|.+||+|||+|+.++..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-- 230 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-- 230 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC--
Confidence 99999976 88888876 47999999999999999999999999999999999999999999999999999976643
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-----------CCCCC
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-----------FRSPR 249 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------~~~~~ 249 (481)
...++..+-|.+|+|||.+.+...++.++|+||+|||+.||+++.+-|.+........+|+.-- ...|.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 2335566789999999999988777888999999999999999999999998887777776410 00110
Q ss_pred -------------------C--CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 250 -------------------W--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 250 -------------------~--~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+ ++....+|+..+|..||.+|.|++|.|+|.||...
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 0 45778999999999999999999999999999763
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=384.93 Aligned_cols=255 Identities=32% Similarity=0.609 Sum_probs=227.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+ +||+|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876543344455667788888877 5899999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999874321 12233
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 45689999999999988777 57899999999999999999999999888889999888888888999999999999999
Q ss_pred cCcCCCCCH-----hHHHhCccccc
Q 011628 265 TNPDKRITI-----PEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps~-----~eil~h~~f~~ 284 (481)
.||.+|++. .++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=395.37 Aligned_cols=257 Identities=33% Similarity=0.587 Sum_probs=220.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR----- 179 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~----- 179 (481)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999876 578999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc
Q 011628 180 ------------------------------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA 223 (481)
Q Consensus 180 ------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt 223 (481)
........+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 0001123579999999999988777 578999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhhCC--CCC--CCCCCHHHHHHHHHhcccCcCCCC---CHhHHHhCccccc
Q 011628 224 GYLPFQDQNIMVMYKKIYKGE--FRS--PRWFSPDLIRLLTKLLDTNPDKRI---TIPEIMENRWFRK 284 (481)
Q Consensus 224 g~~Pf~~~~~~~~~~~i~~~~--~~~--~~~~s~~~~~li~~~L~~dP~~Rp---s~~eil~h~~f~~ 284 (481)
|..||.+.+.......+.... ... ...+++++.++|.+|+ .+|.+|+ |++++++||||..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 999999888776666665432 222 3357899999999976 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=392.93 Aligned_cols=260 Identities=32% Similarity=0.547 Sum_probs=224.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999999976543333344567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 121 v~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-cee
Confidence 9999999999999988889999999999999999999999999999999999999999999999999997643211 112
Q ss_pred ccccCCCCccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCC--CCCHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKG---YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR--WFSPDLI 256 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~ 256 (481)
..+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+.++.... +..|. .+++.++
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 24668999999999987543 34678999999999999999999999988887888887643 34444 4689999
Q ss_pred HHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
++|.+||..+|.+ |+|++|+++||||+.
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 9999999866654 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=383.95 Aligned_cols=250 Identities=38% Similarity=0.649 Sum_probs=219.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS-ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998654433333444555554 56889999999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 999998875 5799999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+..+....+..+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 999999999988777 5689999999999999999999999988888888988887788888999999999999999999
Q ss_pred CCCH----hHHHhCccccc
Q 011628 270 RITI----PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~----~eil~h~~f~~ 284 (481)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9997 69999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=383.51 Aligned_cols=250 Identities=36% Similarity=0.686 Sum_probs=219.6
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876543333445556677777654 799999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 999999865 6899999999999999999999999999999999999999999999999999874322 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987776 5789999999999999999999999888888888888777888899999999999999999999
Q ss_pred CCCHh-HHHhCccccc
Q 011628 270 RITIP-EIMENRWFRK 284 (481)
Q Consensus 270 Rps~~-eil~h~~f~~ 284 (481)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99864 8889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=385.02 Aligned_cols=250 Identities=34% Similarity=0.630 Sum_probs=218.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445566788999999998 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence 999998865 689999999999999999999999999999999999999999999999999986421 11223345789
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---------hHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---------NIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
|+.|+|||++.+..+ +.++|+|||||++|+|++|..||... .....+..+.......|..+++.+.++|.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999988777 56899999999999999999999631 12335566677777889999999999999
Q ss_pred HhcccCcCCCCC------HhHHHhCccccc
Q 011628 261 KLLDTNPDKRIT------IPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps------~~eil~h~~f~~ 284 (481)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=383.36 Aligned_cols=250 Identities=36% Similarity=0.632 Sum_probs=218.5
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS-ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333333445556654 56789999999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999988875 6799999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...++..+.......++..+..+.++|.+||+.+|.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 999999999988777 5689999999999999999999999888888888888877777778999999999999999999
Q ss_pred CCCH----hHHHhCccccc
Q 011628 270 RITI----PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~----~eil~h~~f~~ 284 (481)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9986 58999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=383.42 Aligned_cols=252 Identities=40% Similarity=0.704 Sum_probs=222.3
Q ss_pred EeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 31 GKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
++.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47899999999765432 12234567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 107 YVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 107 y~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
|++|++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 9999999999875 6789999999999999999999999999999999999999999999999999864321 122334
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhccc
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 265 (481)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+....|..+++++.+||.+||++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 5689999999999987766 578999999999999999999999988888888888888888999999999999999999
Q ss_pred CcCCCC-----CHhHHHhCcccccC
Q 011628 266 NPDKRI-----TIPEIMENRWFRKG 285 (481)
Q Consensus 266 dP~~Rp-----s~~eil~h~~f~~~ 285 (481)
||++|| +++++++||||...
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=378.86 Aligned_cols=255 Identities=30% Similarity=0.510 Sum_probs=209.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999999754322 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+. ++|.+.+.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99996 577777754 5699999999999999999999999999999999999999999999999999864322 112
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhh--CCC--------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYK--GEF-------------- 245 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~--~~~-------------- 245 (481)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+.. +..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 234567899999999987655446789999999999999999999987532 222222211 000
Q ss_pred -----C--CC---------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 246 -----R--SP---------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 246 -----~--~~---------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
. .+ ..+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 0 00 013567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=383.63 Aligned_cols=257 Identities=32% Similarity=0.542 Sum_probs=222.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765434445667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 99999999999975 5799999999999999999999999999999999999999999999999999975432111 12
Q ss_pred ccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--C--CCCCCCCHH
Q 011628 184 FHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--F--RSPRWFSPD 254 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~--~~~~~~s~~ 254 (481)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... . +....++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2233578999999999999999999999888777777776542 2 223357999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+.+||.+||. +|.+|||++++++||||.+
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=381.58 Aligned_cols=250 Identities=38% Similarity=0.697 Sum_probs=223.5
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||||++.+...........+.+|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444456677899999888 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999998876 5899999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......|..+++.+.+||.+||..||++
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 999999999988777 5689999999999999999999999888888888888888888889999999999999999999
Q ss_pred CCCH-----hHHHhCccccc
Q 011628 270 RITI-----PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~-----~eil~h~~f~~ 284 (481)
|||+ .++++||||..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 9999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=370.27 Aligned_cols=260 Identities=39% Similarity=0.705 Sum_probs=241.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.+-+++|..+++||+|+||+|.+++.+.+++.+|+|+++++-+...+.+..-.-|-++|+.++||.+..+...|...+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34589999999999999999999999999999999999998877766777777899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+.||+|+-.+.+ ..++|+.++.|-..|++||.|||+++|++||||.+|+|+|.+|++||+|||+++. ....
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~ 321 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKY 321 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cccc
Confidence 999999999999988876 5799999999999999999999999999999999999999999999999999874 2234
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
.....+.||||.|+|||++....| +..+|.|.+||++|||++|++||...+...++..|..++.++|..++++++.|+.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred cceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 455678999999999999999888 5679999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCcCCCC-----CHhHHHhCccccc
Q 011628 261 KLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.+|.+||.+|. .+.||.+|+||..
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999998 4899999999964
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=380.64 Aligned_cols=255 Identities=32% Similarity=0.605 Sum_probs=226.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+|++.+.||+|+||+||+|++..+|+.||+|++.+...........+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765433444566778999998886 577888999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 99999999999876 6899999999999999999999999999999999999999999999999999874321 11223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+.......|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 45679999999999987776 56899999999999999999999999888888889888888888999999999999999
Q ss_pred cCcCCCCC-----HhHHHhCccccc
Q 011628 265 TNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps-----~~eil~h~~f~~ 284 (481)
+||.+|++ .+++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 478999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=389.34 Aligned_cols=257 Identities=32% Similarity=0.586 Sum_probs=222.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.++..++||||+++++.+.....+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655444455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ---- 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 180 (481)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999875 6799999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc
Q 011628 181 -----------------------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ 231 (481)
Q Consensus 181 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 231 (481)
.....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence 011224589999999999988887 56899999999999999999999998
Q ss_pred hHHHHHHHHhhCC--CCCCC--CCCHHHHHHHHHhcccCcCCCC---CHhHHHhCccccc
Q 011628 232 NIMVMYKKIYKGE--FRSPR--WFSPDLIRLLTKLLDTNPDKRI---TIPEIMENRWFRK 284 (481)
Q Consensus 232 ~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~Rp---s~~eil~h~~f~~ 284 (481)
+....+.++.... ...|. .+++++++||.+|+ .||.+|+ +++++++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 8888887776532 33333 37899999999987 4999998 4899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=380.17 Aligned_cols=250 Identities=33% Similarity=0.643 Sum_probs=219.6
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||||++................|..+++.. +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876433233345566788888764 899999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999976 5799999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+.......|.+++.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 999999999987777 5789999999999999999999999888888888877777788899999999999999999999
Q ss_pred CCCHh-HHHhCccccc
Q 011628 270 RITIP-EIMENRWFRK 284 (481)
Q Consensus 270 Rps~~-eil~h~~f~~ 284 (481)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 238 RLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99996 8999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=388.19 Aligned_cols=259 Identities=32% Similarity=0.542 Sum_probs=223.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 58999999999999999999999999999999999765433333445678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++||+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ....
T Consensus 122 ~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~~~ 200 (371)
T cd05622 122 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRC 200 (371)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999987543211 1122
Q ss_pred cccCCCCccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC--CCCCHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKG---YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP--RWFSPDLIR 257 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~ 257 (481)
.+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||...+....+.++.... ...| ..+++.+++
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHH
Confidence 4568999999999986543 24678999999999999999999999998888888887643 3333 458999999
Q ss_pred HHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 258 LLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
||.+||..++.+ |+++++|++||||..
T Consensus 281 li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 281 LICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 999999854443 789999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=383.03 Aligned_cols=248 Identities=31% Similarity=0.556 Sum_probs=215.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcE-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES-VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-KIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~ 102 (481)
.....+.+.||+|+||+||+|.+ .|+. ||||++......... .+.+.+|+.+|++++|||||+++|++.+.. ..+
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 45567778899999999999998 4556 999999876544433 778999999999999999999999999988 799
Q ss_pred EEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCcEEEccCC-CEEEEecCCcccccc
Q 011628 103 FVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARG-VYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQ 177 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~g-i~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~ 177 (481)
|||||+++|+|.+++.. +.++...+..++.||+.|++|||+++ |+||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999965 68999999999999999999999999 99999999999999998 999999999986543
Q ss_pred cccCCcccccCCCCccccccccc--cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh-C-CCCCCCCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLS--RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-G-EFRSPRWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~--~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~-~~~~~~~~s~ 253 (481)
.. .......||+.|||||++. ...| +.|+||||+|+++|||+||..||.+.........+.. + ....|..+++
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 21 2223368999999999998 4566 6799999999999999999999999887666655543 3 3455777999
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..|+.+||..||.+||++.+|+.
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999976
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=381.69 Aligned_cols=250 Identities=33% Similarity=0.641 Sum_probs=217.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445566788899988877 799999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 999988865 6799999999999999999999999999999999999999999999999999864221 1222345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC---------chHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD---------QNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.. .........+.......|..++..+.+||.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999988777 5689999999999999999999952 122345566667777888899999999999
Q ss_pred HhcccCcCCCCC------HhHHHhCccccc
Q 011628 261 KLLDTNPDKRIT------IPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps------~~eil~h~~f~~ 284 (481)
+||+.||.+||| ++++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 589999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=381.89 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=214.2
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34678999999999999999999999999999999986543 2345567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
+||||+.+|+|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D 223 (353)
T ss_pred EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence 99999999998653 345778889999999999999999999999999999999999999999999987643211 1
Q ss_pred cccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---HHHHHHHhh-CCCCCCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYK-GEFRSPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~-~~~~~~~~~s~~ 254 (481)
......||..|+|||++.. ..+.+.++|||||||++|+|++|..||..... ......+.. .....+..++++
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2245679999999999743 23445689999999999999999999974322 222222222 234456678999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+||.+||+.||++|||+.|+++||||.+.
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999999999999999999999764
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=377.39 Aligned_cols=250 Identities=37% Similarity=0.647 Sum_probs=217.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHH-HHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI-SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999865433322333444444 456889999999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 999999876 5799999999999999999999999999999999999999999999999999874321 2223445689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......++.+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999988776 5689999999999999999999999888888888888777777789999999999999999999
Q ss_pred CCCHh----HHHhCccccc
Q 011628 270 RITIP----EIMENRWFRK 284 (481)
Q Consensus 270 Rps~~----eil~h~~f~~ 284 (481)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999954
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=386.28 Aligned_cols=257 Identities=30% Similarity=0.518 Sum_probs=237.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK-IYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~l 103 (481)
+++|+.++++|+|+||.+++++++..++.+++|.+........ ......+|+.+++++.|||||.+++.|..++. .+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 6789999999999999999999999999999999988775544 34478899999999999999999999998888 999
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||+||+||+|.+.|.+ ..++|+.+..||.|++.|+.|||+++|+|||||+.||+++.++.+||+|||+|+..+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 9999999999999975 25999999999999999999999999999999999999999999999999999976542
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
.....+..|||.||+||++.+.+| +.|+|||||||++|||++-+.+|...+...+..+|..+. .+.|..++.+++.+|
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 246678999999999999999999 579999999999999999999999999999999999987 677999999999999
Q ss_pred HHhcccCcCCCCCHhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.||.++|..||++.++|.+|.....
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999999887643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=378.24 Aligned_cols=255 Identities=31% Similarity=0.523 Sum_probs=207.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK-----SKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 101 (481)
+|++.+.||+|+||.||+|++..+++.||||.+...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999998753222 22345678999999999999999999988543 358
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+. ++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 689888865 5799999999999999999999999999999999999999999999999999975332111
Q ss_pred -CCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------- 242 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------- 242 (481)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 122345689999999999865 344 6789999999999999999999987654322211110
Q ss_pred -----------CCCCC-----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 243 -----------GEFRS-----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 243 -----------~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
...+. .+.+++.+.++|.+||+.||++|||++|+++||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00000 1236788999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=369.34 Aligned_cols=248 Identities=30% Similarity=0.475 Sum_probs=213.2
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||+||++.+..+++.||+|.+.+...........+..|+.+++.++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999765544333446678899999999999999999999999999999999999999
Q ss_pred HHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccC
Q 011628 114 FNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188 (481)
Q Consensus 114 ~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 188 (481)
...+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 887732 46899999999999999999999999999999999999999999999999998754321 12234467
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ......+.......|..+++.+.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 9999999999988777 5689999999999999999999976432 3344445555556677899999999999999
Q ss_pred cCcCCCC-----CHhHHHhCccccc
Q 011628 265 TNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.||++|| +++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=365.71 Aligned_cols=257 Identities=35% Similarity=0.560 Sum_probs=220.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN-IVQLFEVMATKS---- 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~---- 99 (481)
+..|+.++.||+|+||+||+|+.+.+|+.||+|.+..+... ++.-....||+.+++.|+|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 66788889999999999999999999999999999876532 334456789999999999999 999999998877
Q ss_pred --EEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 --KIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 --~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
.+++|+||++. +|.+++.. ..++...++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 89888865 24788899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---------
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--------- 243 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------- 243 (481)
+.... ....+...++|.+|+|||++.+...++...||||+|||++||++++.-|.+.+.......|..-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 86542 2233567789999999999999866678899999999999999999999999887777777541
Q ss_pred ---------CCCCCCC------------CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 ---------EFRSPRW------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ---------~~~~~~~------------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
....+.| .+++..+++.+||+.+|.+|.|+..++.||||...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111222 23478999999999999999999999999999764
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=377.13 Aligned_cols=250 Identities=36% Similarity=0.644 Sum_probs=218.7
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS-ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998665433333445555554 67889999999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 999988865 5799999999999999999999999999999999999999999999999999874221 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......|...+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 999999999987777 5689999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCH----hHHHhCccccc
Q 011628 270 RITI----PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~----~eil~h~~f~~ 284 (481)
||++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 49999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=381.74 Aligned_cols=249 Identities=38% Similarity=0.645 Sum_probs=216.2
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
||+|+||+||+|++..+++.||+|++.+.............+|..++..+ .||||+++++++.....+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333344455677777665 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999998865 6799999999999999999999999999999999999999999999999999864321 2223346789
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC-CCCHHHHHHHHHhcccCcC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR-WFSPDLIRLLTKLLDTNPD 268 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~s~~~~~li~~~L~~dP~ 268 (481)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+..+....|. .+++++.+||.+||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999876544467899999999999999999999999888888888888776664 4799999999999999999
Q ss_pred CCC----CHhHHHhCccccc
Q 011628 269 KRI----TIPEIMENRWFRK 284 (481)
Q Consensus 269 ~Rp----s~~eil~h~~f~~ 284 (481)
+|| +++++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=374.64 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=216.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..++..||+|++.... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999997653 234557789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||++||+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----c
Confidence 999999999999976 5799999999999999999999986 699999999999999999999999999875422 2
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHH----------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI---------------------- 240 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i---------------------- 240 (481)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..++...+
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2345679999999999987766 57899999999999999999999765543332211
Q ss_pred ------------------------hhCCC-C-CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 241 ------------------------YKGEF-R-SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 241 ------------------------~~~~~-~-~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..... . ....+++++++||.+||+.||++|||+.+|++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 11110 0 112368899999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=379.20 Aligned_cols=249 Identities=37% Similarity=0.687 Sum_probs=220.8
Q ss_pred eEecccCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||++++. .+|+.||+|++.+..... .....+.+|+.++++++||||+++++++.....+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999863 578999999998654322 23345678999999999999999999999999999999999
Q ss_pred CCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccccc
Q 011628 109 RGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187 (481)
Q Consensus 109 ~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 187 (481)
.||+|.+.+.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecc
Confidence 99999999875 5799999999999999999999999999999999999999999999999999875432 11223456
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP 267 (481)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++.+.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 89999999999987776 57899999999999999999999998888888888888888888999999999999999999
Q ss_pred CCCCC-----HhHHHhCccccc
Q 011628 268 DKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 268 ~~Rps-----~~eil~h~~f~~ 284 (481)
.+||| +++++.||||..
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCC
Confidence 99999 778999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=376.57 Aligned_cols=250 Identities=33% Similarity=0.633 Sum_probs=218.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++.++ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999999888 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999998865 6899999999999999999999999999999999999999999999999999864221 1223345789
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-------hHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-------NIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||... .....+..+.......|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999987777 57899999999999999999999531 2234556666666778888999999999999
Q ss_pred cccCcCCCCC------HhHHHhCccccc
Q 011628 263 LDTNPDKRIT------IPEIMENRWFRK 284 (481)
Q Consensus 263 L~~dP~~Rps------~~eil~h~~f~~ 284 (481)
|+.||.+|++ ++++++||||..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=367.76 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=218.5
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999988999999999976544333334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+.||+|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 9999999988753 3689999999999999999999999999999999999999999999999999875322 122
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH----HHHHHhhCCCCCCCCCCHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPDLIRLL 259 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~~~~li 259 (481)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+... ....+.......+..+++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 234579999999999987666 568999999999999999999998765432 233334444556667899999999
Q ss_pred HHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 260 TKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 260 ~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.+||..||.+|| +++++++||||.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=374.87 Aligned_cols=258 Identities=30% Similarity=0.540 Sum_probs=218.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444445566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999999975 4799999999999999999999999999999999999999999999999999865332111 11
Q ss_pred ccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC---CCCCHH
Q 011628 184 FHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP---RWFSPD 254 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 254 (481)
....+||+.|+|||++.. ....+.++||||+||++|+|++|..||.+.+....+..+.... +..| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999863 2334678999999999999999999999888777777776532 2222 347999
Q ss_pred HHHHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
++++|++||..++++ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999998764444 889999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=391.72 Aligned_cols=261 Identities=32% Similarity=0.522 Sum_probs=227.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
...++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3468999999999999999999999999999999999876533 334566889999999999999999988775432
Q ss_pred -----EEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 100 -----KIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 100 -----~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.+++||||+++|+|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 37899999999999998853 35899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCC
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSP 248 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~ 248 (481)
|+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++..+.. +.|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 99976543333333456789999999999988777 5789999999999999999999999888888777777654 457
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+++++.+++.+||+.||.+||++.++++|||++..
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 7899999999999999999999999999999998653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=388.44 Aligned_cols=258 Identities=29% Similarity=0.479 Sum_probs=225.2
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKS-GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
+....|.+.+.||+|+||.||.|.+..+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 4456799999999999999999998877 7889999875432 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
|+||||++||+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999999887742 368999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDL 255 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~ 255 (481)
.........+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+.. +.|..+++++
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 3222233456789999999999987776 6789999999999999999999999888777777777654 3566789999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.++|.+||.+||++|||+++++.|+|++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.15 Aligned_cols=251 Identities=31% Similarity=0.472 Sum_probs=207.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMA----- 96 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~----- 96 (481)
.+|++.+.||+|+||+||+|++.. +++.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 57889999987654222 2334456788777766 6999999999985
Q ss_pred eCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
....+++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999997 588888864 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-C------
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-R------ 246 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~------ 246 (481)
..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+......++..... +
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 54321 23345679999999999987766 5689999999999999999999998876666555543210 0
Q ss_pred --------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 --------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 --------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..+.+++.+.+||.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012467788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=385.75 Aligned_cols=249 Identities=28% Similarity=0.453 Sum_probs=204.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK------ 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 98 (481)
..+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 468999999999999999999999999999999886432 1234799999999999999999886432
Q ss_pred --CEEEEEEeccCCCchHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecC
Q 011628 99 --SKIYFVMEYVRGGELFNKVA-----KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFG 170 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~-----~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFG 170 (481)
..+++||||+++ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 247799999986 6666553 24699999999999999999999999999999999999999765 69999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------- 243 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------- 243 (481)
+|+.... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++...
T Consensus 217 la~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9975432 122335678999999999876544467899999999999999999999987655444443321
Q ss_pred ----------CC------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 244 ----------EF------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 244 ----------~~------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.. ..|...++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 00 123446789999999999999999999999999999965
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=371.90 Aligned_cols=258 Identities=29% Similarity=0.518 Sum_probs=219.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654333444556788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+.||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-cce
Confidence 99999999999975 579999999999999999999999999999999999999999999999999986432211 112
Q ss_pred ccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC---CCCCHH
Q 011628 184 FHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP---RWFSPD 254 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 254 (481)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ...| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234679999999999862 2333678999999999999999999999988888888886653 2223 357899
Q ss_pred HHHHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
+++||++||..+|.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=363.05 Aligned_cols=251 Identities=32% Similarity=0.535 Sum_probs=213.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS---- 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 99 (481)
..=.|+-.+++|.|+||.||.|...++++.||||.+-.++... .+|+++|+.++|||||++..+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 4457999999999999999999999999999999986665332 27999999999999999998885432
Q ss_pred -EEEEEEeccCCCchHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCc
Q 011628 100 -KIYFVMEYVRGGELFNKVA-----KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLS 172 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~-----~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla 172 (481)
...+||||++. +|.+.++ +.+++.-.++-|++||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 34589999976 8988887 3579999999999999999999999999999999999999987 89999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---------
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--------- 243 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------- 243 (481)
+..... ....++..|..|+|||.+.+...++.+.||||+||++.||+.|++-|.+.+.......|.+-
T Consensus 174 K~L~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 174 KVLVKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeeccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 875432 22357788999999999988877788999999999999999999999998876666555431
Q ss_pred --------CCC------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 --------EFR------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 --------~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.. .....++++.+|+.++|..+|.+|.++.|++.||||..-
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 111 122368899999999999999999999999999999754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=373.99 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=210.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 468999999999999999999999999999999999976532 2334566789999999999999999999986543
Q ss_pred ---EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 100 ---KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 100 ---~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
.+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 5666554 358999999999999999999999999999999999999999999999999987432
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------------- 242 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------------- 242 (481)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 175 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 T---NFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred c---CccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 2 222345678999999999988777 5689999999999999999999987654332222111
Q ss_pred --------CCCC--------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 243 --------GEFR--------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 243 --------~~~~--------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.... .+...++.+++||.+||..||++|||+.|+++||||...+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 1000 0112357789999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=366.39 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=212.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 57899999999999999999999999999999999765422 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--TK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--cc
Confidence 999986 78777754 35899999999999999999999999999999999999999999999999998753321 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------- 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------- 243 (481)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2234568999999999876554467899999999999999999999876654433333210
Q ss_pred CCC-----------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 EFR-----------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ~~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
... ....+++++++||.+||+.||.+|||++|+++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 000 112368899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=378.62 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=205.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||.||+|++..+++.||+|.... ..+.+|+.+++.++||||+++++++......++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 34689999999999999999999999999999997532 235689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|+|++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 999995 688888765 679999999999999999999999999999999999999999999999999997533211 12
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch-------HHHHHHHH---------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-------IMVMYKKI--------------- 240 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i--------------- 240 (481)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .......+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2345689999999999988777 678999999999999999998764321 00111111
Q ss_pred -----------hhCCCC----CCC-----CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 241 -----------YKGEFR----SPR-----WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 241 -----------~~~~~~----~~~-----~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...... .|. .++.++.+||.+||+.||.+|||++|+++||||+..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 111110 111 245679999999999999999999999999999753
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=360.98 Aligned_cols=253 Identities=42% Similarity=0.773 Sum_probs=228.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997665444455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999876 67999999999999999999999999999999999999999999999999998754321 2
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..+....|..+++.++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 34578999999999877655 56899999999999999999999988877788888888888888899999999999999
Q ss_pred cCcCCCC-----CHhHHHhCccccc
Q 011628 265 TNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.||.+|+ +++++++||||..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 8999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=370.75 Aligned_cols=258 Identities=29% Similarity=0.508 Sum_probs=219.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654333344566788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+.||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999975 579999999999999999999999999999999999999999999999999987543211 111
Q ss_pred ccccCCCCccccccccccC----CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCC---CCCHH
Q 011628 184 FHTFCGTPAYVAPEVLSRK----GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR---WFSPD 254 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 254 (481)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|..||...+....+.++.... ++.|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998652 223578999999999999999999999888877777776543 33333 36899
Q ss_pred HHHHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
++++|.+||..++.+ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 568999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.75 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=213.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 467899999999999999999999999999999999876432 222345677899999999999999999987543
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|+++|++ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3578999988 7799998888889999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------ 244 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------ 244 (481)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 23456799999999998775445778999999999999999999998766544433332110
Q ss_pred ----------C-CC--------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 ----------F-RS--------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 ----------~-~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
. .. ....++.+.+||.+||..||.+|||+.|+++||||.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0 00 1235677899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=356.26 Aligned_cols=252 Identities=42% Similarity=0.737 Sum_probs=213.7
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++++.||+|+||+||+|++..+++.||+|++........ ......+|+.+++.++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987754332 233445699999999999999999999999999999999
Q ss_pred cCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccc
Q 011628 108 VRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT 186 (481)
Q Consensus 108 ~~gg~L~~~i~-~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 186 (481)
+.+++|.+++. .+.+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.... ........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc
Confidence 99999999998 5789999999999999999999999999999999999999999999999999987431 12233456
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhCCCCC----CCCCCHHHHHHH
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGEFRS----PRWFSPDLIRLL 259 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~~----~~~~s~~~~~li 259 (481)
..+++.|+|||++......+.++|+||||+++|+|++|..||... +......+........ ....++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 788999999999873334477999999999999999999999987 3334443333322111 111248899999
Q ss_pred HHhcccCcCCCCCHhHHHhCccc
Q 011628 260 TKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=377.05 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=213.2
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-----KI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 101 (481)
+|++++.||+|+||.||+|.+..+|+.||||.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4889999999999999999998999999999986532 22234567889999999999999999999998776 79
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999997 578777765 67999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh------------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK------------------ 242 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~------------------ 242 (481)
........+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12233457899999999998765456789999999999999999999988765544443321
Q ss_pred -----CCC---------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 -----GEF---------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 -----~~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
... ......++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1223357889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=352.37 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=220.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK--SGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+.|++.+.||+|+||.||.|.+..+++.||+|.+....... ......+.+|+.++++++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 1234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD- 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~- 181 (481)
++||++|++|.+.+.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999875 57899999999999999999999999999999999999999999999999998754322111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li 259 (481)
.......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+......++... ....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11134568899999999987765 67899999999999999999999887665555554433 3445677899999999
Q ss_pred HHhcccCcCCCCCHhHHHhCccc
Q 011628 260 TKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=366.64 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=215.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3578999999999999999999999999999999987643 23345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||+.||+|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 9999999999999876 5789999999999999999999985 799999999999999999999999999875422
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHH-----------------------
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK----------------------- 238 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~----------------------- 238 (481)
.......|++.|+|||++.+..+ +.++|+|||||++|+|++|..||..........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 12234579999999999987666 578999999999999999999997654332211
Q ss_pred ---------------------HHhhCC-CCC-CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 239 ---------------------KIYKGE-FRS-PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 239 ---------------------~i~~~~-~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+.... ... ...++.++++||.+||+.||++|||+.|++.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 111111 011 12367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=384.34 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=201.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH------PNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~ 98 (481)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.+.| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996432 223445678888877755 4588888888764
Q ss_pred -CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCC-------------
Q 011628 99 -SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENG------------- 162 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g------------- 162 (481)
..+|+|||++ |++|.+++.+ +.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999988 6788888765 689999999999999999999998 5999999999999998766
Q ss_pred ---CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHH
Q 011628 163 ---DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKK 239 (481)
Q Consensus 163 ---~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 239 (481)
.+||+|||++.... ......+||+.|+|||++.+..| +.++|||||||++|+|++|++||.+.+.......
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875422 12245689999999999988877 5689999999999999999999987665433322
Q ss_pred HhhCCCCC----------------------------CC--------------CCCHHHHHHHHHhcccCcCCCCCHhHHH
Q 011628 240 IYKGEFRS----------------------------PR--------------WFSPDLIRLLTKLLDTNPDKRITIPEIM 277 (481)
Q Consensus 240 i~~~~~~~----------------------------~~--------------~~s~~~~~li~~~L~~dP~~Rps~~eil 277 (481)
+....... +. ..++.+.+||.+||++||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 21110000 00 0134578999999999999999999999
Q ss_pred hCcccccCc
Q 011628 278 ENRWFRKGF 286 (481)
Q Consensus 278 ~h~~f~~~~ 286 (481)
+||||.+.+
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=369.24 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=204.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999852 345789999987542 223446788999999999 899999999988764
Q ss_pred -CEEEEEEeccCCCchHHHHHcC---------------------------------------------------------
Q 011628 99 -SKIYFVMEYVRGGELFNKVAKG--------------------------------------------------------- 120 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~~--------------------------------------------------------- 120 (481)
..+|++|||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999988641
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccc
Q 011628 121 ------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV 194 (481)
Q Consensus 121 ------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 194 (481)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 36778889999999999999999999999999999999999999999999997542211111122345678899
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHH-HHHHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCC
Q 011628 195 APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIM-VMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRI 271 (481)
Q Consensus 195 APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~-~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rp 271 (481)
|||++.+..+ +.++|||||||++|+|++ |..||.+.... .....+..+. ...|..+++++.+++.+||+.||.+||
T Consensus 244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999987776 578999999999999997 99999876543 3333344333 445677899999999999999999999
Q ss_pred CHhHHHh
Q 011628 272 TIPEIME 278 (481)
Q Consensus 272 s~~eil~ 278 (481)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=371.60 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=211.5
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 467899999999999999999999999999999999976432 223446678999999999999999999987543
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999976 66666643 48899999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-----------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF----------- 245 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------- 245 (481)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++.....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 222345679999999999988777 5689999999999999999999988766555444432100
Q ss_pred -----------C--------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 -----------R--------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 -----------~--------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .....+..+++||.+||+.||.+|||++|+++||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0 001134578999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=357.35 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=215.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+++++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999976654444445567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+.|++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 9999999988853 3589999999999999999999999999999999999999999999999999865321 112
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---HHHHHHh-hCCCCCCCCCCHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---VMYKKIY-KGEFRSPRWFSPDLIRLL 259 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~-~~~~~~~~~~s~~~~~li 259 (481)
.....|++.|+|||++.+..+ +.++||||+||++|+|++|..||...... .....+. ......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 234579999999999987776 57899999999999999999999864321 1122221 122334566899999999
Q ss_pred HHhcccCcCCCCC-----HhHHHhCccccc
Q 011628 260 TKLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 260 ~~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
.+||+.||.+||| ++|+++||||..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=369.95 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=210.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 467899999999999999999999999999999999876432 233456678999999999999999999988643
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 56666543 58999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------- 243 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 243 (481)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 222345679999999999988777 56899999999999999999999876654333322110
Q ss_pred ---------CC--------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 244 ---------EF--------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 244 ---------~~--------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.. ..+...+.++++||.+||+.||.+|||+.|+++||||...+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 00 00112356789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.77 Aligned_cols=253 Identities=36% Similarity=0.662 Sum_probs=220.0
Q ss_pred CCCCccCCeeE-EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 011628 20 NQSPLLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMAT 97 (481)
Q Consensus 20 ~~~~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 97 (481)
+...+.++|.+ -++||-|-.|+|-.+.++.||+.+|+|++... ...+||+++.-+.+ |||||.++++|++
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 44567899988 57899999999999999999999999998532 34678999888775 9999999999865
Q ss_pred ----CCEEEEEEeccCCCchHHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEE
Q 011628 98 ----KSKIYFVMEYVRGGELFNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVS 167 (481)
Q Consensus 98 ----~~~~~lv~Ey~~gg~L~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~ 167 (481)
...+.+|||.++||+|+..++. | .++|.++..+++||..|+.|||+.+|.||||||||+|.... ..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4578899999999999999986 3 49999999999999999999999999999999999999764 469999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch----HHHHHHHHhhC
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKG 243 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~ 243 (481)
|||+|+... ....+.+.|-||+|+|||++....|+ ...|+||+||++|.|++|++||.... ...+..+|..|
T Consensus 207 DfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 207 DFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred ccccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 999998643 24567889999999999999888886 46999999999999999999997543 24567888888
Q ss_pred CCCC--CCC--CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 244 EFRS--PRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 244 ~~~~--~~~--~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+.+ |.| +|.+++++|+++|..+|.+|.|++++++|||+..
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 7554 455 7999999999999999999999999999999865
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=357.42 Aligned_cols=250 Identities=33% Similarity=0.505 Sum_probs=205.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMAT-----K 98 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~ 98 (481)
+|++.+.||+|+||+||+|++..+++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 699999999999999999999999999999998764322 22233455777777666 69999999998864 3
Q ss_pred CEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
..++++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999985 88888765 35899999999999999999999999999999999999999999999999998764
Q ss_pred cccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-----------
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE----------- 244 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 244 (481)
... .......||+.|+|||++.+..+ +.++||||+||++|+|++|..||..........++....
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 321 22234578999999999987766 578999999999999999999998776655444443210
Q ss_pred -------C---------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 -------F---------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 -------~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+ ...+.++..+.+||.+||++||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112367788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=380.37 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=228.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
-+.|+|+..||.|+||+||+|.+++++-..|.|+|... ..+...++.-||.||..|.||+||++++.|...+++||+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 35689999999999999999999999999999999643 345677888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
.|||.||-....+.. ..+.+++++.+.+|++.||.|||+++|+|||||..|||++-+|.++|+|||.+...... ..
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ 185 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence 999999999888764 57999999999999999999999999999999999999999999999999998753221 22
Q ss_pred cccccCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC---CCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR---SPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~ 254 (481)
...++.|||+|||||++. ..+|+ .++||||||++|.+|..+.+|....+++.+..+|.+.+++ .|..++..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 235789999999999974 45664 6899999999999999999999999999999999887654 37888999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+|+.+||.+||..||++.+|++||||+..
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999999999999999999854
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=357.92 Aligned_cols=256 Identities=30% Similarity=0.510 Sum_probs=213.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 67899999999999999999999999999999998755322 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+. ++|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--CC
Confidence 99997 488888764 46899999999999999999999999999999999999999999999999998753321 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------- 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------- 243 (481)
......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+.......+...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 2234467899999999876554567899999999999999999999887654443332210
Q ss_pred CCCCC-----------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 EFRSP-----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
....| ..+++.+.+||.+||+.||.+|||++|+++||||+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00111 2468889999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=354.65 Aligned_cols=247 Identities=26% Similarity=0.456 Sum_probs=208.1
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||.||++++..+|+.||+|.+.............+..|+.+++.++||||+++++++.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333344566799999999999999999999999999999999999999
Q ss_pred HHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 114 FNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 114 ~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
.+.+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... ........|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 988754 2588999999999999999999999999999999999999999999999999875432 1122345789
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch----HHHHHHHHhhCCCCC-CCCCCHHHHHHHHHhccc
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKGEFRS-PRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~-~~~~s~~~~~li~~~L~~ 265 (481)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.... ............... ...+++++++||.+||++
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999987775 678999999999999999999997642 234444444444333 245899999999999999
Q ss_pred CcCCCCCH----hHHHhCccccc
Q 011628 266 NPDKRITI----PEIMENRWFRK 284 (481)
Q Consensus 266 dP~~Rps~----~eil~h~~f~~ 284 (481)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=354.23 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=219.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+++++.+..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999977654444445567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 9999999888753 3699999999999999999999999999999999999999999999999999865322 122
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH----HHHHHhhCCCCCCCCCCHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPDLIRLL 259 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~~~~li 259 (481)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||....... ....+.......+..+++++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 234579999999999987766 568999999999999999999998765432 333334444555667899999999
Q ss_pred HHhcccCcCCCCC-----HhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRIT-----IPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps-----~~eil~h~~f~~~ 285 (481)
.+||+.||.+||+ +.++++|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=375.98 Aligned_cols=252 Identities=33% Similarity=0.522 Sum_probs=215.8
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-----CCcceEEEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-H-----PNIVQLFEVM 95 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~ 95 (481)
..+..||++.+.||+|+||+|.+|.+.+|++.||||+++... .+..+...|+.+|..|+ | -|+|+++++|
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 455679999999999999999999999999999999997654 56777888999999997 4 3799999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC--CEEEEecC
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG--DLKVSDFG 170 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g--~lkl~DFG 170 (481)
...++.|||.|.++ -+|+++++. .+++...++.+++||+.||.+||+.||||+|||||||||.+-+ .+||+|||
T Consensus 258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999999995 599999986 4699999999999999999999999999999999999997654 69999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------- 243 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------- 243 (481)
.|+.... .. .+++-+..|+|||++.+.+|+ .+.||||||||+.||++|.+-|.+.+..+.+..|..-
T Consensus 337 SSc~~~q----~v-ytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 337 SSCFESQ----RV-YTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cccccCC----cc-eeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9986443 22 388999999999999999996 5799999999999999999999988776665555320
Q ss_pred ---------------------------------------------CCCCCCC-----------CCHHHHHHHHHhcccCc
Q 011628 244 ---------------------------------------------EFRSPRW-----------FSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 244 ---------------------------------------------~~~~~~~-----------~s~~~~~li~~~L~~dP 267 (481)
....|.. -...+.+||++||+.||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 0001100 01237899999999999
Q ss_pred CCCCCHhHHHhCccccc
Q 011628 268 DKRITIPEIMENRWFRK 284 (481)
Q Consensus 268 ~~Rps~~eil~h~~f~~ 284 (481)
.+|+|..|+++||||..
T Consensus 491 ~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTG 507 (586)
T ss_pred hhcCCHHHHhcCccccc
Confidence 99999999999999974
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=344.36 Aligned_cols=252 Identities=27% Similarity=0.542 Sum_probs=218.6
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-KSKIYFVM 105 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~ 105 (481)
+|++.+.||.|+||.||.|.+..+++.||+|.+...... ....+.+.+|+.++++++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999989999999999765432 2345668899999999999999999998764 44689999
Q ss_pred eccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 106 EYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 106 Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||+++++|.+.+.. ..+++.+++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999999864 3589999999999999999999999999999999999999999999999999875432 122
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLTK 261 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 261 (481)
......|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. ..+..+++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3345678999999999987766 5689999999999999999999988777666666666654 4566789999999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||++||++|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=347.30 Aligned_cols=255 Identities=30% Similarity=0.579 Sum_probs=218.8
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK------SGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
+|.++..||+|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 6899999999999999999998899999999987543221 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
.+++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 678999999999999999999999999999999999999999999999999987654211
Q ss_pred c----CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-CCCCCCCCCHH
Q 011628 180 Q----DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPD 254 (481)
Q Consensus 180 ~----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 254 (481)
. ........|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+......++... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 111123468899999999987666 56899999999999999999999887665555554443 23456678999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+.++|.+||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=350.92 Aligned_cols=252 Identities=33% Similarity=0.540 Sum_probs=208.7
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999998999999999875432 22334667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 107 YVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 107 y~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.+|.++|+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 997 588887753 46899999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------- 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------- 243 (481)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234467899999999876554467899999999999999999999876543222221110
Q ss_pred -C---------CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 244 -E---------FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 244 -~---------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ......+++++.++|.+||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 00123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=355.78 Aligned_cols=258 Identities=35% Similarity=0.589 Sum_probs=224.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999899999999998765544445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-
Q 011628 106 EYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD- 181 (481)
Q Consensus 106 Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~- 181 (481)
||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999875 36899999999999999999999999999999999999999999999999998643221100
Q ss_pred --------------------------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH
Q 011628 182 --------------------------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV 235 (481)
Q Consensus 182 --------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~ 235 (481)
.......|+..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468899999999987766 678999999999999999999999888777
Q ss_pred HHHHHhhCCCCCCCC--CCHHHHHHHHHhcccCcCCCCC----HhHHHhCccccc
Q 011628 236 MYKKIYKGEFRSPRW--FSPDLIRLLTKLLDTNPDKRIT----IPEIMENRWFRK 284 (481)
Q Consensus 236 ~~~~i~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps----~~eil~h~~f~~ 284 (481)
.+..+.......+.. +++.+.++|.+||..||++||| ++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777776655544443 6899999999999999999999 999999999965
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=354.50 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=213.8
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..++..+|+|.+..+. ......++.+|+++++.++||||+++++++..++.+|++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987542 2345567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++|++|.+++.. +.+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 99999999999975 679999999999999999999997 5999999999999999999999999999864322 22
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------------- 242 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------------- 242 (481)
....+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345678999999999877665 5789999999999999999999976553332222211
Q ss_pred ---------------CC-CCCC-CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 ---------------GE-FRSP-RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 ---------------~~-~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.. ...| ..+++++.+||.+||..||++|||+.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00 0111 1267889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=367.13 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=206.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNV--KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.+..+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+.+++.++||||+++++++.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 44678999999999999999999764 356789999886432 24579999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+|++||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999996 588888864 679999999999999999999999999999999999999999999999999997544322
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---HHHHHHHhhC-------------
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYKG------------- 243 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~------------- 243 (481)
.........||+.|+|||++.+..| +.++|||||||++|+|++|..||.+... ...+..+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 2222335679999999999987777 5689999999999999999999965421 1111111110
Q ss_pred ----------------CCCCC-----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 ----------------EFRSP-----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ----------------~~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+..| ..++.++.++|.+||..||++|||+.|++.||||.+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 01111 1246678999999999999999999999999999763
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=352.26 Aligned_cols=255 Identities=29% Similarity=0.522 Sum_probs=219.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
...+|++.+.||+|+||.||+|++..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+..+...|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 357999999999999999999999899999999999765432 23567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172 (296)
T ss_pred eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--ccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999998753321 112
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLT 260 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~ 260 (481)
.....|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.... ...+..+++.+.++|.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred cCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 234578999999999877665 578999999999999999999998876643333332221 2335568899999999
Q ss_pred HhcccCcCCCCCHhHHHhCccccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+||..+|++|||+.++++||||..
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhc
Confidence 999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=347.54 Aligned_cols=262 Identities=29% Similarity=0.590 Sum_probs=224.0
Q ss_pred CCCccCCeeE-EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 21 QSPLLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 21 ~~~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
.+.+.+-|++ .+.||+|+||.|-.+.+..+|..+|||++++.. .....++.||++++.+++ |+||+.++++|+++
T Consensus 72 ~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 72 SGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred cchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3445667777 578999999999999999999999999998763 355688999999999995 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEecCCccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFGLSAV 174 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~---lkl~DFGla~~ 174 (481)
+.+|+|||-+.||.|...|.+ ..++|.++.++.++|+.||.|||.+||.||||||+|||...... +|||||.+..-
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 999999999999999999876 57999999999999999999999999999999999999976654 79999998754
Q ss_pred cccc-----ccCCcccccCCCCccccccccc----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCc--------------
Q 011628 175 SDQI-----RQDGLFHTFCGTPAYVAPEVLS----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-------------- 231 (481)
Q Consensus 175 ~~~~-----~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-------------- 231 (481)
.... .....+.+.||+..|||||+.. ...++..+.|.||||+|||-||+|++||.+.
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 2211 1122345789999999999862 2233456899999999999999999999652
Q ss_pred -hHHHHHHHHhhCCCCCCCC----CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 232 -NIMVMYKKIYKGEFRSPRW----FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 232 -~~~~~~~~i~~~~~~~~~~----~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
-...++..|..|.+.+|.. +|.++++||+.+|..|+.+|.++.++++|||++.-
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 1356788899998877653 89999999999999999999999999999999753
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=340.57 Aligned_cols=252 Identities=27% Similarity=0.492 Sum_probs=221.7
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 489999999999999999999999999999999765433 3345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|++|++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 9999999999865 36899999999999999999999999999999999999999999999999998754332 122
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 262 (481)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+..+ .+..+++++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 244578999999999987766 56899999999999999999999988877777777766543 3446889999999999
Q ss_pred cccCcCCCCCHhHHHhCccc
Q 011628 263 LDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f 282 (481)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=354.44 Aligned_cols=261 Identities=33% Similarity=0.604 Sum_probs=235.3
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
......+|..+.+||.|+||+|-+|..+.+.+.+|||+++++-+.+.+.++--..|-++|... +-|.++.++.++.+.+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 344577899999999999999999999999999999999988766554444445677777766 4788999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||+.||+|.-.|+. |++.|..+..|+..|+.||-+||++||++||||..|||++.+|++||+|||+++. ..
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--cc
Confidence 99999999999999988887 8999999999999999999999999999999999999999999999999999873 22
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRL 258 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 258 (481)
.......+.||||.|+|||++...+| +..+|.||+||+||||++|++||++++..++++.|......+|..+|.++.++
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred cCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence 33445678999999999999999998 56799999999999999999999999999999999999999999999999999
Q ss_pred HHHhcccCcCCCCC-----HhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
.+.+|.+.|.+|.. -.+|..||||+.
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999974 468999999975
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=356.54 Aligned_cols=246 Identities=28% Similarity=0.481 Sum_probs=193.5
Q ss_pred EeEecccCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 011628 31 GKLLGHGTFAKVYHARNV--KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKIYFVME 106 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~E 106 (481)
+++||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999975 3678999999865432 2346789999999999999999999854 457899999
Q ss_pred ccCCCchHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEecCCc
Q 011628 107 YVRGGELFNKVAK----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLS 172 (481)
Q Consensus 107 y~~gg~L~~~i~~----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl----~~~g~lkl~DFGla 172 (481)
|+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 78777642 148999999999999999999999999999999999999 45678999999999
Q ss_pred ccccccc-cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---------HHHHHHHhh
Q 011628 173 AVSDQIR-QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---------MVMYKKIYK 242 (481)
Q Consensus 173 ~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---------~~~~~~i~~ 242 (481)
+...... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||..... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7653321 112234568899999999997765557789999999999999999999964321 011111111
Q ss_pred C----------------------------CCCC----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 243 G----------------------------EFRS----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 243 ~----------------------------~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. .... ....++.+.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000 01135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.35 Aligned_cols=258 Identities=33% Similarity=0.620 Sum_probs=221.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999987664333344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ---- 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 180 (481)
||++|++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999975 6789999999999999999999999999999999999999999999999999864211000
Q ss_pred ---------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC---
Q 011628 181 ---------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP--- 248 (481)
Q Consensus 181 ---------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--- 248 (481)
........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+.......+..+....|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001123467889999999877666 6789999999999999999999998887777777776654332
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
..+++++.++|.+||++||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 257899999999999999999998 799999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.59 Aligned_cols=254 Identities=30% Similarity=0.542 Sum_probs=220.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 4679999999999999999999999999999999875432 2345678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
+||+.|++|..++....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccC
Confidence 999999999999988889999999999999999999999999999999999999999999999999987543211 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~ 261 (481)
....|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+.... ...+..+++.+.++|.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 34578999999999977666 568999999999999999999998877654444443332 33456688999999999
Q ss_pred hcccCcCCCCCHhHHHhCccccc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||..||.+|||+.+++.||||+.
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhh
Confidence 99999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=343.48 Aligned_cols=255 Identities=30% Similarity=0.552 Sum_probs=219.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997654322 4577899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 106 EYVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 106 Ey~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||++|++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999865 35899999999999999999999999999999999999999999999999998765432221
Q ss_pred --CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CC-----CCCCH
Q 011628 182 --GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SP-----RWFSP 253 (481)
Q Consensus 182 --~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~-----~~~s~ 253 (481)
.......|+..|+|||++......+.++|+|||||++|+|++|..||...+....+.++...... .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12244578999999999876644477899999999999999999999888776666666554322 11 24678
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+.+++.+||..||++|||+++|+.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=347.24 Aligned_cols=254 Identities=31% Similarity=0.543 Sum_probs=215.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999989999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 107 YVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 107 y~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|+ |++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999999864 5699999999999999999999999999999999999999999999999999876543211 223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--------------------
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------- 244 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------- 244 (481)
....|+..|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 456789999999998765555778999999999999999999998776554444433210
Q ss_pred -CC---------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 245 -FR---------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 245 -~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
+. .....+..+.++|.+||..+|++|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 0123568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.83 Aligned_cols=256 Identities=31% Similarity=0.556 Sum_probs=223.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||.|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.....+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999976532 233466789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
||+++++|.+++..+++++..+..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||+++...... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999997654321 1223
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCC-CCHHHHHHHHHhc
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRW-FSPDLIRLLTKLL 263 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~~~L 263 (481)
...|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. ..+.. +++++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 4578899999999987765 6789999999999999999999988776666555555433 33344 7899999999999
Q ss_pred ccCcCCCCCHhHHHhCcccccCc
Q 011628 264 DTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 264 ~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
..+|++|||++++++||||++..
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCCC
Confidence 99999999999999999997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=346.01 Aligned_cols=252 Identities=29% Similarity=0.592 Sum_probs=222.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+......|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999988999999999987655444566789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 107 YVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 107 y~~gg~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
|+.|++|.+.+... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC---cccc
Confidence 99999999999764 8999999999999999999999999999999999999999999999999998754321 1234
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---HHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
...|+..|+|||++.+..+ +.++|+||||+++|+|++|..||...+. ..............|..+++.+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678899999999977665 6789999999999999999999987663 33333333355666778899999999999
Q ss_pred cccCcCCCCCH--hHHHhCccc
Q 011628 263 LDTNPDKRITI--PEIMENRWF 282 (481)
Q Consensus 263 L~~dP~~Rps~--~eil~h~~f 282 (481)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=351.89 Aligned_cols=252 Identities=30% Similarity=0.543 Sum_probs=208.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999976432 22234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 107 YVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 107 y~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 77777653 57999999999999999999999999999999999999999999999999998754321 1223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCC-CCchHHHHHHHHhhCC-------------------
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF-QDQNIMVMYKKIYKGE------------------- 244 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf-~~~~~~~~~~~i~~~~------------------- 244 (481)
....+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+....+..+....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877554467899999999999999988885 4444433333332110
Q ss_pred C----------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 F----------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ...+.+++++.+||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=363.43 Aligned_cols=245 Identities=25% Similarity=0.459 Sum_probs=212.8
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.+++++.||+|-||.||.|.+. ....||+|.+....... ..+.+|+++|++|+|+|||++++++..+..+|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 4456889999999999999983 33589999997754332 446699999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|++.|+|.++++. +.+.......++.||++|++||+++++|||||...||||+++..+||+|||||+.... .....
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~ 360 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTA 360 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC-Cceee
Confidence 9999999999986 4699999999999999999999999999999999999999999999999999994321 11111
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 261 (481)
.....-...|.|||.+....+ +.|||||||||+||||+| |+.||.+.+..+....+.+| +++.|..+|+++.+++..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred cCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence 122223567999999988777 679999999999999999 99999999999999999888 478899999999999999
Q ss_pred hcccCcCCCCCHhHHHh
Q 011628 262 LLDTNPDKRITIPEIME 278 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~ 278 (481)
||..+|++|||++.+..
T Consensus 440 CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 440 CWHEDPEDRPTFETLRE 456 (468)
T ss_pred HhhCCcccCCCHHHHHH
Confidence 99999999999986643
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=349.23 Aligned_cols=256 Identities=34% Similarity=0.516 Sum_probs=220.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||.|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998654 223456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 999999999999875 469999999999999999999999999999999999999999999999999886543211 1
Q ss_pred cccccCCCCccccccccccC----CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRK----GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPDL 255 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~ 255 (481)
......|++.|+|||++... ...+.++|+|||||++|+|++|..||...+......++..+.. ..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 22345789999999997532 1224679999999999999999999998877766667766542 3356688999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.++|.+||+.+|.+|||++++++||||.+.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=353.52 Aligned_cols=253 Identities=27% Similarity=0.465 Sum_probs=224.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..-|.++.+||+|+||.||+|.++++|+.+|||.+..+. ....+.+|+.||++|..|++|++|+.+.....+|||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 456889999999999999999999999999999987654 346688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||..|+..+.++. ..++|+++..+++.-+.||+|||...-+|||||..|||++.+|..||+|||.|....... .
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A 184 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence 999999999999864 579999999999999999999999999999999999999999999999999987543322 2
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLL 259 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li 259 (481)
..++..|||.|||||++..-+|++ ++||||||++..||..|++||.+-.++....-|-... ++-|...|.++.+||
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~-~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDT-KADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred hhCccccCcccccHHHHHHhccch-hhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 236789999999999999999964 7999999999999999999999988876554443332 334666789999999
Q ss_pred HHhcccCcCCCCCHhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++||-++|++|.|+-++++|||++..
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 99999999999999999999999765
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=345.38 Aligned_cols=250 Identities=24% Similarity=0.466 Sum_probs=211.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.++++++||||+++++.+......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36899999999999999999999999999999987653 2234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
||+++++|... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..... ....
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----cccc
Confidence 99999998654 4578999999999999999999999999999999999999999999999999875432 2234
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch-------HHHHHHHHhhCCCC--CCCCCCHHHH
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-------IMVMYKKIYKGEFR--SPRWFSPDLI 256 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~~--~~~~~s~~~~ 256 (481)
..+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||.... .......+...... ....+++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 5689999999999987766 578999999999999999999996532 12222333322221 1334788999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++|.+||+.||++||+++++++||||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=388.40 Aligned_cols=265 Identities=27% Similarity=0.492 Sum_probs=218.5
Q ss_pred CCCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 17 KDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 17 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
....+..+.++|++++.||+|+||+||+|++..++..||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 3445667789999999999999999999999999999999999765433 334567889999999999999999999885
Q ss_pred e--CCEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc-------CceecCCCCCcEEEcc--
Q 011628 97 T--KSKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHAR-------GVYHRDLKPENLLLDE-- 160 (481)
Q Consensus 97 ~--~~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~-------gi~HrDLKp~NILl~~-- 160 (481)
. ...+||||||+.+|+|.+++.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 4 4579999999999999998864 5699999999999999999999985 4999999999999964
Q ss_pred ---------------CCCEEEEecCCcccccccccCCcccccCCCCccccccccccC-CCCCCcchHHHHHHHHHHHhcC
Q 011628 161 ---------------NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSCGVILFVLMAG 224 (481)
Q Consensus 161 ---------------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~elltg 224 (481)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 23489999999975432 2223456799999999998643 2236789999999999999999
Q ss_pred CCCCCCchHH-HHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 225 YLPFQDQNIM-VMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 225 ~~Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..||...+.. .+...+..+........++++.+||.+||..+|.+||++.|+|.|||+...
T Consensus 240 k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 9999866543 333333333322234578999999999999999999999999999999754
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=369.41 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=203.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.++++++||||+++++++......++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 5689999999999999999999999999999996422 2345899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99995 688888764 469999999999999999999999999999999999999999999999999997653322222
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC--------chHHHHHHHHhhCCC---------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD--------QNIMVMYKKIYKGEF--------- 245 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~--------~~~~~~~~~i~~~~~--------- 245 (481)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|..|+-. .....+.+.+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2234679999999999988777 5789999999999999998765421 111222222222111
Q ss_pred --------------------CCCC-----CCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 246 --------------------RSPR-----WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 246 --------------------~~~~-----~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+. .+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111 24568999999999999999999999999999964
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=352.12 Aligned_cols=256 Identities=29% Similarity=0.521 Sum_probs=219.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
...+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++......|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 458999999999999999999999999999999999754322 23567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||++|++|.+++.+..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK 171 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cC
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987543211 12
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-C--CCCCCCCCHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-E--FRSPRWFSPDLIRLLT 260 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~--~~~~~~~s~~~~~li~ 260 (481)
.....|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... . ...|..+++.+.+|+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 234578999999999987666 57899999999999999999999876654332222222 1 2245667889999999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccC
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+||..||++||+++++++||||+..
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=343.08 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=215.6
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL---KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+|++++.||+|+||.||+|.+ .+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 58899999998754321 12334678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc---
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR--- 179 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~--- 179 (481)
++||++|++|.+++.+ +.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999976 678999999999999999999999999999999999999999999999999987542211
Q ss_pred -cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHH
Q 011628 180 -QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDL 255 (481)
Q Consensus 180 -~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~ 255 (481)
.........|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1122334578999999999987766 56899999999999999999999876654443333332 124566689999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.++|++||.++|.+||++.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.06 Aligned_cols=254 Identities=29% Similarity=0.486 Sum_probs=211.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999998999999999865432 2223355778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++++.|..++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 99999988888765 579999999999999999999999999999999999999999999999999987643321 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------------C-
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-------------------E- 244 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------------~- 244 (481)
....++..|+|||++.+....+.++|+||+||++|+|++|..||.+.+..+....+... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567899999999876554467899999999999999999999876543332222110 0
Q ss_pred -CCC----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 -FRS----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 -~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+. ...++..+.+||.+||+++|++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 12357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.62 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=206.5
Q ss_pred eEEeEeccc--CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 29 EIGKLLGHG--TFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 29 ~i~~~LG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+++++||+| +|++||++++..+|+.||+|.++.+.. .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 357889999 789999999999999999999976543 23455678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc---
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--- 180 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~--- 180 (481)
|+++|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999999864 3589999999999999999999999999999999999999999999999986532211110
Q ss_pred --CCcccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC----------
Q 011628 181 --DGLFHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR---------- 246 (481)
Q Consensus 181 --~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---------- 246 (481)
........++..|+|||++.+. ++ +.++||||+||++|+|++|..||..............+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0111223577889999998753 34 57899999999999999999999875543333222222110
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 247 ------------------------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 247 ------------------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
....+++.+.+||.+||+.||++|||++|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01124678999999999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=390.83 Aligned_cols=258 Identities=32% Similarity=0.532 Sum_probs=228.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|+|+++||+|+||.|.+++++.|++.||+|++++....+......|..|-.+|...+.+.|+.++..|.+..++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 47899999999999999999999999999999999886555444456688899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||++||+|..++.+ +++||++++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-..+..+ ...
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V~ 232 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVR 232 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-cEE
Confidence 999999999999987 579999999999999999999999999999999999999999999999999876544321 223
Q ss_pred ccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCC--CCCCHHH
Q 011628 184 FHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSP--RWFSPDL 255 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~ 255 (481)
....+|||-|++||++.. .+.++..+|.||+||++|||+.|..||...+....|.+|.+- .+.+| ..+|.++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 456799999999999853 245577899999999999999999999999999999999875 46666 5689999
Q ss_pred HHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 256 IRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
++||.+++ .+|+.|.. ++++..||||..
T Consensus 313 kdLI~~ll-~~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 313 KDLIEALL-CDREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence 99999987 47788887 999999999964
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=344.83 Aligned_cols=252 Identities=31% Similarity=0.525 Sum_probs=211.8
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK---- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~---- 98 (481)
..++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 46789999999999999999999999999999999875431 235678899999998 699999999998653
Q ss_pred --CEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
..+|++|||+.+++|.+++.. ..+++..+..++.|++.|+.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 468999999999999999875 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC--C
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--R 246 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~ 246 (481)
..... ........|++.|+|||++.+ ..+ +.++|+||+||++|+|++|..||...........+..... .
T Consensus 160 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 160 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred ecccc--cccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 54321 122345679999999999853 234 5689999999999999999999987665544444433321 2
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+..++.++.+|+.+||..||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.27 Aligned_cols=251 Identities=31% Similarity=0.516 Sum_probs=211.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.....+|++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999876532 2235577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||+++++|.+++.. +.+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence 999999999999865 68999999999999999999999999999999999999999999999999998654321 112
Q ss_pred ccccCCCCccccccccc---cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-----CCCCCHHH
Q 011628 184 FHTFCGTPAYVAPEVLS---RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-----PRWFSPDL 255 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~s~~~ 255 (481)
.....|++.|+|||++. ...+ +.++|+|||||++|+|++|..||................... ...++..+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred cccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 23457899999999974 2334 568999999999999999999997665443333333333222 12367889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
.++|.+||..+|++|||+++|++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=346.75 Aligned_cols=254 Identities=32% Similarity=0.497 Sum_probs=217.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||.||+|++..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 477999999999999999999999999999999986542 33456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||++|++|...+.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 999999999888753 56899999999999999999999999999999999999999999999999988643221 11
Q ss_pred cccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~ 254 (481)
......+++.|+|||++.+ ..+ +.++|+|||||++|+|++|..||...+......++..... ..+..++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred ccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 2234568899999999853 223 4679999999999999999999988776666666654432 235567889
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+.++|.+||..||++||+++++++||||..
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=343.90 Aligned_cols=252 Identities=31% Similarity=0.493 Sum_probs=211.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 5689999999999999999999999999999999975432 2235678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||+++++|.+++.. +.+++..+..++.|++.|+.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cc
Confidence 999999999998864 679999999999999999999999999999999999999999999999999987543211 11
Q ss_pred ccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-----CCCCCHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-----PRWFSPDLI 256 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~s~~~~ 256 (481)
.....|++.|+|||++... ...+.++|+||+||++|+|++|..||...........+....+.. +..++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 2345789999999998432 222568999999999999999999997665444333333332222 234678999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
+||++||..+|++|||+++|++|+|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=338.83 Aligned_cols=252 Identities=31% Similarity=0.588 Sum_probs=221.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||.+++..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999999765432 2344678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+.+++|.+.+.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--L 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--h
Confidence 9999999998864 2589999999999999999999999999999999999999999999999999875433211 1
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~ 262 (481)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+.. ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223468899999999877665 5789999999999999999999998887777777766654 35667899999999999
Q ss_pred cccCcCCCCCHhHHHhCccc
Q 011628 263 LDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f 282 (481)
|+.+|++||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=337.46 Aligned_cols=252 Identities=29% Similarity=0.542 Sum_probs=222.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|++|++|.+.+.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 9999999999865 358999999999999999999999999999999999999999999999999987543322 12
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 262 (481)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.+. .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 345678999999999877665 56899999999999999999999998887777777776543 3456789999999999
Q ss_pred cccCcCCCCCHhHHHhCccc
Q 011628 263 LDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f 282 (481)
|.++|.+|||+.++++|+|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=347.71 Aligned_cols=254 Identities=28% Similarity=0.511 Sum_probs=216.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||.||+|++..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999899999999986542 2233467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 106 EYVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999999988764 79999999999999999999997 5999999999999999999999999999865322
Q ss_pred CCcccccCCCCccccccccccCCC-----CCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHH---HHhhCC-CCCCCCC
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGY-----DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK---KIYKGE-FRSPRWF 251 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~---~i~~~~-~~~~~~~ 251 (481)
.......|++.|+|||++.+... .+.++|+|||||++|+|++|..||........+. .+..+. ...|..+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 22345578899999999854332 2568999999999999999999997655443333 333333 3456668
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++++.++|.+||..+|++||+++++++||||.+.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=344.84 Aligned_cols=254 Identities=32% Similarity=0.504 Sum_probs=216.5
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
-|++.+.||+|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3789999999999999999999999999999986542 2345667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 107 YVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 107 y~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|+++++|...+.. +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence 9999999988754 57999999999999999999999999999999999999999999999999998653221 1122
Q ss_pred cccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIR 257 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~ 257 (481)
....|++.|+|||++.. ....+.++|+||+||++|+|++|..||...+.......+.... ...|..++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 34578999999999842 1222468999999999999999999998877666655555443 2345668899999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+|.+||+.||.+|||++++++||||...
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=342.27 Aligned_cols=256 Identities=33% Similarity=0.583 Sum_probs=214.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-------KSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 699999999999999999999889999999998643211 1123456889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+++||||+.|++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999876 68999999999999999999999999999999999999999999999999998754332
Q ss_pred ccCCcccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC----CCC
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP----RWF 251 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~----~~~ 251 (481)
..........|+..|+|||++.... ..+.++|+||||+++|+|++|..||...........+.... ...+ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233457899999999987654 23678999999999999999999998765544444333221 2222 235
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+.++.++|.+||.++|.+|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=346.50 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=215.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSG-----ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 457999999999999999999976554 689999986543 2344567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 100 KIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
..|++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999999864 3478889999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999875322211122334567889999999877666 578999999999999998 999999888877777776
Q ss_pred hCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+. ...|..+++++.+|+.+||+.||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 665 34567789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.41 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=207.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||.||+|++..+ +..||+|++..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 46799999999999999999986543 35799999976532 23456788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-----------------------------------------------------------
Q 011628 99 SKIYFVMEYVRGGELFNKVAK----------------------------------------------------------- 119 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~----------------------------------------------------------- 119 (481)
..+|+||||+++|+|.+++..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998753
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccccc
Q 011628 120 ------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187 (481)
Q Consensus 120 ------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 187 (481)
.++++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 13678889999999999999999999999999999999999999999999998754321111111223
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHHHHHHhcc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~ 264 (481)
.+++.|+|||++.+..+ +.++|||||||++|+|++ |..||........+...... ....|..+++++.++|.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 45678999999977666 678999999999999997 99999876554444344333 344567789999999999999
Q ss_pred cCcCCCCCHhHHHh
Q 011628 265 TNPDKRITIPEIME 278 (481)
Q Consensus 265 ~dP~~Rps~~eil~ 278 (481)
.||.+|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=346.38 Aligned_cols=239 Identities=20% Similarity=0.270 Sum_probs=208.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEec
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----KSKIYFVMEY 107 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey 107 (481)
..||+|++|.||+|.. +|+.||||++...........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999987 789999999987654444556788899999999999999999999876 4578999999
Q ss_pred cCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 108 VRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 108 ~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
++||+|.+++.. +.+++.....++.|++.|+.|||+. +++||||||+|||++.++.+||+|||+++..... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cc
Confidence 999999999976 5789999999999999999999984 9999999999999999999999999998754321 12
Q ss_pred ccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHHHHHH
Q 011628 186 TFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 261 (481)
...|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+....+..+..+ .++.|..+++.+.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999975 345 67899999999999999999999998887777777544 345565789999999999
Q ss_pred hcccCcCCCCCHhHHHh
Q 011628 262 LLDTNPDKRITIPEIME 278 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~ 278 (481)
||+.||++|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999986
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=348.84 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=204.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK----------------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (481)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 5789999999999999999998532 34479999987643 23345678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 011628 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKG--------------------RLKEDLARKYFQQLISAVGFCHARGVYH 148 (481)
Q Consensus 89 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--------------------~l~e~~~~~~~~ql~~al~yLH~~gi~H 148 (481)
+++++++...+..++||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999999999999999999999999988542 2567788999999999999999999999
Q ss_pred cCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCC
Q 011628 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYL 226 (481)
Q Consensus 149 rDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~ 226 (481)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999875432211112233456788999999877666 578999999999999986 678
Q ss_pred CCCCchHHHHHHHHhh---C-----CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 227 PFQDQNIMVMYKKIYK---G-----EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 227 Pf~~~~~~~~~~~i~~---~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
||...+.......+.. . ....|+.+++.+.+|+.+||+.||.+|||+.+|.+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8887655444333211 1 12235567899999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=340.54 Aligned_cols=247 Identities=39% Similarity=0.712 Sum_probs=218.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+..+..+|+++||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999889999999999876554445567899999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCc
Q 011628 114 FNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192 (481)
Q Consensus 114 ~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 192 (481)
.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999976 468999999999999999999999999999999999999999999999999987543321 2234578999
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch--HHHHHHHHhh--CCCCCCCCCCHHHHHHHHHhcccCcC
Q 011628 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN--IMVMYKKIYK--GEFRSPRWFSPDLIRLLTKLLDTNPD 268 (481)
Q Consensus 193 y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~--~~~~~~~~~s~~~~~li~~~L~~dP~ 268 (481)
|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... ....+.++.. .....|...++++.++|.+||..||+
T Consensus 158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 999999877666 568999999999999999999998776 6667777763 34566777789999999999999999
Q ss_pred CCCC-----HhHHHhCccccc
Q 011628 269 KRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 269 ~Rps-----~~eil~h~~f~~ 284 (481)
+||+ ++|+++||||..
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999964
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=340.25 Aligned_cols=256 Identities=28% Similarity=0.510 Sum_probs=213.8
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKI 101 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 101 (481)
-.|++++.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3699999999999999999999999999999998754321 22345678899999999999999999998865 4678
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR- 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~- 179 (481)
++++||+++++|.+.+.. +.+++...+.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999876 578999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 257 (481)
.........|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...........+... ....|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 1112234568899999999987665 56899999999999999999999877655444443322 23446678889999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
++ +||..+|++||+++||++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 67778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=338.48 Aligned_cols=256 Identities=28% Similarity=0.509 Sum_probs=214.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKI 101 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 101 (481)
.+|++++.||+|+||.||.|++..+++.||||.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999999999999999998654321 22345678899999999999999999998866 3578
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|++|||++|++|.+++.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999876 5789999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHHHH
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDLIR 257 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~ 257 (481)
........|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...........+.... ...|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 112234568999999999977665 578999999999999999999998776554444443322 3345667888999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
+|.+||. +|++||+++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=349.12 Aligned_cols=257 Identities=33% Similarity=0.483 Sum_probs=213.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (481)
.++|++.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.++++++|+||+++++++... +.+|
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 678999999999999999999999999999999987554222 2233456899999999999999999998754 5789
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+||||+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~- 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence 99999975 78888764 569999999999999999999999999999999999999999999999999987644321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-----------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG----------------- 243 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~----------------- 243 (481)
.......+++.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+...
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 163 -KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred -CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 12233356788999999876554467899999999999999999999988776665555431
Q ss_pred --CCCC-----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 --EFRS-----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 --~~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+.. ..++++++.+||.+||+.||++|||+++++.||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0111 12358889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=342.17 Aligned_cols=256 Identities=28% Similarity=0.542 Sum_probs=214.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL---KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+|+.++.||+|+||.||.|.+..+++.||+|++...... .......+.+|+.++++++||||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999999754321 12345778999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCccccccccc-
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQ- 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~~~- 180 (481)
|+||+.|++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999999875 6799999999999999999999999999999999999998876 599999999875433211
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---HHHHHHh--hCCCCCCCCCCHH
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---VMYKKIY--KGEFRSPRWFSPD 254 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~--~~~~~~~~~~s~~ 254 (481)
........|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...... .....+. ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111223468899999999977666 57899999999999999999999754432 2222221 1223456678899
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=345.94 Aligned_cols=254 Identities=29% Similarity=0.494 Sum_probs=213.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999998899999999986544322 34566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++++.|..+... +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999999888765 46999999999999999999999999999999999999999999999999998754321 1223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------------C
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------F 245 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------~ 245 (481)
....++..|+|||++.+....+.++|||||||++|+|++|..||...........+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 445688999999998765555678999999999999999999998765443333322100 0
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 ------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 ------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..++.++..+.+|+.+||+.+|++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=344.03 Aligned_cols=256 Identities=35% Similarity=0.692 Sum_probs=226.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv 104 (481)
.+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++. ||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765444444577889999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC--
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD-- 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~-- 181 (481)
|||+.+++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.+++++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999976 48999999999999999999999999999999999999999999999999998764432211
Q ss_pred ----------------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC
Q 011628 182 ----------------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF 245 (481)
Q Consensus 182 ----------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 245 (481)
.......|+..|+|||++....+ +.++|+||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12234567899999999876654 6789999999999999999999998887777777777777
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCH----hHHHhCccc
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITI----PEIMENRWF 282 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~----~eil~h~~f 282 (481)
..|..+++.+.++|.+||+.+|.+|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=340.21 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=211.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 357999999999999999999865 356789999987653 223446688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999999865 478999999999999999999999999999999999999999999999999876432111
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
. .......++..|+|||++.+..+ +.++||||+||++|++++ |..||.+.+.......+..+. .+.|..++..+.+
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 I-YTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred h-hcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 0 11112345678999999987766 578999999999999775 999999887777777666553 4557778999999
Q ss_pred HHHHhcccCcCCCCCHhHHHh
Q 011628 258 LLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~ 278 (481)
++.+||+.+|.+|||+++|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.72 Aligned_cols=251 Identities=32% Similarity=0.537 Sum_probs=219.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++.+......++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999865433 2345778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCcccccccccCC
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~~~~~ 182 (481)
|++|++|.+++.. ..+++..+..++.|++.|++|||++|++|+||||+||+++.++ .+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 9999999999975 2489999999999999999999999999999999999998655 5799999998754322 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 261 (481)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+. ...+..+++++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2234568999999999987665 568999999999999999999999888777776666554 34566789999999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||..||++|||+.|+++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=343.14 Aligned_cols=248 Identities=31% Similarity=0.502 Sum_probs=203.0
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILR---RVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654432222233344544443 4479999999999999999999999999
Q ss_pred CCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccC
Q 011628 110 GGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188 (481)
Q Consensus 110 gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 188 (481)
||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999998865 67999999999999999999999999999999999999999999999999998654321 123457
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch---HHHHHHHHhhCCCCCCCCCCHHHHHHHHHhccc
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN---IMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 265 (481)
|++.|+|||.+.+....+.++||||+||++|+|++|..||.... ...............|..+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643333578999999999999999999997532 222222223334456777899999999999999
Q ss_pred CcCCCC-----CHhHHHhCccccc
Q 011628 266 NPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 266 dP~~Rp-----s~~eil~h~~f~~ 284 (481)
||.+|| |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=346.30 Aligned_cols=257 Identities=33% Similarity=0.485 Sum_probs=215.2
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+|++.+.||+|+||.||+|.+..+++.||||.+...... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 699999999999999999999889999999999765433 123445677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+ +++|.+++... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 89999999764 59999999999999999999999999999999999999999999999999987644321 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-----------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF----------------- 245 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------------- 245 (481)
......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+....+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345688999999986655557789999999999999999988987766554444432100
Q ss_pred ------C-----CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 246 ------R-----SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 246 ------~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
. .....+..+.++|.+||.+||++|||+.|++.|+||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0 0123467899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=360.64 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=206.5
Q ss_pred cCCeeEEeEecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARN-----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||+||+|.+ ..++..||||++..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 34677899999865432 23346788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcC----------------------------------------------------------
Q 011628 99 SKIYFVMEYVRGGELFNKVAKG---------------------------------------------------------- 120 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~---------------------------------------------------------- 120 (481)
+..|+|||||+||+|.+++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 9999999999999999888531
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 121 ------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 121 ------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 36778899999999999999999999999999999999999999999999987543222111
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHH-HHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVM-YKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~-~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
......++..|+|||++.+..+ +.++|||||||++|+|++ |..||........ ...+..+. ...|...+.++.+||
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 1122345678999999987776 578999999999999998 9999987654433 33333332 334566788999999
Q ss_pred HHhcccCcCCCCCHhHHHhC
Q 011628 260 TKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h 279 (481)
.+||+.||++|||+.+|++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.56 Aligned_cols=253 Identities=30% Similarity=0.544 Sum_probs=217.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI--LKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+|+..+.||+|+||+||+|.+..+++.|++|.+..... ......+.+.+|+.+++.++||||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 68899999999999999999988999999999875432 1223457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+||++|++|.+++.+ +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999976 458999999999999999999999999999999999999999999999999987543322 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh-C-CCCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-G-EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~-~~~~~~~~s~~~~~li~~ 261 (481)
.....|++.|+|||.+......+.++|+|||||++|+|++|..||...........+.. . ....+..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987655236789999999999999999999987665444444433 2 234566789999999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||+.+|++||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=352.90 Aligned_cols=259 Identities=30% Similarity=0.519 Sum_probs=211.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
+.++|++.+.||+|+||.||+|++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4579999999999999999999999999999999986432 223456678899999999999999999887654
Q ss_pred CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
..+|+++||+.+ +|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999975 8888888888999999999999999999999999999999999999999999999999998754322
Q ss_pred cc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------
Q 011628 179 RQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------- 242 (481)
Q Consensus 179 ~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------- 242 (481)
.. .......+|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223467899999999876544446789999999999999999999977654322221110
Q ss_pred CC-------C----C-----CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 GE-------F----R-----SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 ~~-------~----~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.. . . ..+.+++++.++|.+||+.+|++|||+.++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 0 0 012357889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.51 Aligned_cols=248 Identities=32% Similarity=0.579 Sum_probs=217.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||++.+..+++.+|+|.++.... ....+.+.+|+.+++.++||||+++++.+...+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 59999999999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--cc
Confidence 9999999998864 358999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~ 262 (481)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234578999999999977665 5689999999999999999999998887777777766654 35667889999999999
Q ss_pred cccCcCCCCCHhHHHhC
Q 011628 263 LDTNPDKRITIPEIMEN 279 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h 279 (481)
|+.||++|||+.+|+..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=364.28 Aligned_cols=252 Identities=29% Similarity=0.466 Sum_probs=222.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
..|.=++.||.|+||.||.|++..+.+.||||.+........+-..+|.+|+..|++++|||+|.+.++|......|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 45777899999999999999999999999999998876666666788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||-| +-.|++. +.++.|.++..+..+.+.||.|||+++.||||||..|||+++.|.|||+|||.|.+...
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------ 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ 178 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------
Confidence 99965 6667664 46799999999999999999999999999999999999999999999999999986543
Q ss_pred ccccCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-C-CCCCCHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSR---KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-S-PRWFSPDLIRL 258 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~~~~l 258 (481)
.++++|||+||||||+.. ..|++ ++|||||||+..||...++|+-..|.+.....|...+.+ . ...+|..+++|
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdg-kvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred hhcccCCccccchhHheeccccccCC-ccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 357899999999999743 34654 799999999999999999999999988777777665433 2 23368899999
Q ss_pred HHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|..||++-|.+|||.+++++|+|+...
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhccC
Confidence 999999999999999999999998764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=341.88 Aligned_cols=255 Identities=29% Similarity=0.594 Sum_probs=217.9
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR---HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 103 (481)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987543 2234567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|||++|++|.+++..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCC-CCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPR-WFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~-~~s~~~~~li~~ 261 (481)
.....|+..|+|||.+.+....+.++|+|||||++|+|++|..||...........+..... ..+. .++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 23457899999999986544446789999999999999999999988766554444333322 2222 278899999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||+.||++||++.+++.|+||++.
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhcc
Confidence 999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=335.90 Aligned_cols=251 Identities=35% Similarity=0.566 Sum_probs=215.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.....+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 3689999999999999999999988999999999976532 2457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence 999999999998865 579999999999999999999999999999999999999999999999999987543321 1
Q ss_pred cccccCCCCccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-----CCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRK---GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-----SPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~ 254 (481)
......++..|+|||.+.+. .+ +.++|+||||+++|+|++|..||.+.+.......+....+. .+..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 22345788999999998765 55 56899999999999999999999887655544444444222 23345788
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
+.+++.+||..+|..|||+.+++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=342.47 Aligned_cols=256 Identities=27% Similarity=0.499 Sum_probs=221.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
...|+..+.||.|+||.||.|.+..+++.||+|++..... ......+.+|+.+++.+.||||+++++++.+....|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3568899999999999999999988999999999875432 23457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++|++|.+++..+++++..+..++.|++.|++|||+++++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999987543211 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L 263 (481)
....++..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+. ...+..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33568889999999877665 678999999999999999999998877665555443332 2334457888999999999
Q ss_pred ccCcCCCCCHhHHHhCcccccC
Q 011628 264 DTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 264 ~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+|++||++++++.|+||.+.
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=356.15 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=198.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++++.||+|+||.||+|++..+++.||+|+..... ...|+.++++++||||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 357999999999999999999999999999999854332 24699999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99996 578887754 5799999999999999999999999999999999999999999999999999874322 12
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC-CCCchH---------HHHHHHHhhC-C---CCCC
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLP-FQDQNI---------MVMYKKIYKG-E---FRSP 248 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~P-f~~~~~---------~~~~~~i~~~-~---~~~~ 248 (481)
......||+.|+|||++.+..+ +.++|||||||++|+|+++..| |..... ......+... . ...+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 2234679999999999988777 5789999999999999985444 433110 0011111110 0 0000
Q ss_pred ------------------------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 ------------------------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 ------------------------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667788999999999999999999999999974
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=354.04 Aligned_cols=258 Identities=27% Similarity=0.483 Sum_probs=212.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 357899999999999999999999999999999999865432 223445677899999999999999999988644
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 888877654 8999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------- 243 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 243 (481)
. ........|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+.++...
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 122344578999999999988777 57899999999999999999999876654443333210
Q ss_pred ---------CCC--------------C-------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 244 ---------EFR--------------S-------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 244 ---------~~~--------------~-------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
... . +...++.++++|.+||+.||.+|||+.|++.||||+.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 000 0 1123556899999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.98 Aligned_cols=255 Identities=33% Similarity=0.562 Sum_probs=214.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++...+..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 579999999999999999999999999999999875432 2344577889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++++.+..+..+ ..+++..+..++.|++.|+.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99999877776655 5699999999999999999999999999999999999999999999999999876543221 133
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--------------------C-
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------------G- 243 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------------~- 243 (481)
....++..|+|||++.+....+.++|+||+|+++|+|++|..||.+.+.......+.. +
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 4567889999999998773446789999999999999999999987654433322211 0
Q ss_pred CC-----------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 244 EF-----------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 244 ~~-----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+ ..+..+++++.+||++||..+|++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1233458889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.73 Aligned_cols=252 Identities=34% Similarity=0.557 Sum_probs=212.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC----
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS---- 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~---- 99 (481)
.++|++.+.||+|+||.||+|.+..+++.+++|++..... ....+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5899999999999999999999988999999999876532 235688999999999 6999999999996644
Q ss_pred --EEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 --KIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 --~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
.+|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999988753 46899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCC----CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG----YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--- 245 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--- 245 (481)
...... ........|++.|+|||++.... ..+.++|||||||++|+|++|..||..........++..+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 754321 12223457899999999975422 225689999999999999999999987766555555555432
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..+..++..+.+||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233467899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=341.93 Aligned_cols=252 Identities=31% Similarity=0.521 Sum_probs=210.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT----- 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----- 97 (481)
..++|++.+.||.|+||.||+|++..+++.+|+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3589999999999999999999999999999999986543 2335678899999998 69999999999853
Q ss_pred -CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 98 -KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 98 -~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
...+|++|||+.+|+|.+++.. ..+++..+..++.||+.|+.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 4678999999999999999864 358899999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-- 246 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-- 246 (481)
..... ........|++.|+|||++.. ..+ +.++|+|||||++|+|++|..||...........+......
T Consensus 170 ~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 54321 122345678999999999853 234 56899999999999999999999876654444333333211
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+..++.++.+||.+||..||.+|||+.||++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 233578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=340.03 Aligned_cols=254 Identities=27% Similarity=0.466 Sum_probs=212.7
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK---- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~---- 98 (481)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4688999999999999999999999999999999986532 2235577899999999 799999999998653
Q ss_pred -CEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 99 -SKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..+|+||||++|++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 368999999999999988752 46899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCC----CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG----YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--- 245 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--- 245 (481)
........ ......|+..|+|||++.... ..+.++|||||||++|+|++|..||...+.......+..+..
T Consensus 176 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 176 AQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred hhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 75432111 123456899999999985432 125789999999999999999999988766555555544422
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
..+..++..+.+||.+||+.+|++||++.+|++||||+
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23455778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=312.07 Aligned_cols=255 Identities=31% Similarity=0.563 Sum_probs=219.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|.-.++||+|+||+||+|++.++++.||+|.++.+. .+++......|||.+++.++|.|||+++++..+..++-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46777889999999999999999999999999998765 33445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||.. +|..+... |.++.+.++.++.|++.||.|||++++.||||||.|+|++.+|.+|++|||+++.++... ..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence 99965 78777764 789999999999999999999999999999999999999999999999999998765422 23
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC--C-----CC----CCC--
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG--E-----FR----SPR-- 249 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--~-----~~----~~~-- 249 (481)
+...+-|.+|.+|.++.+...++...|+||.|||+.|+.. |.+.|++.+.....++|+.. . ++ .|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 4445679999999999888777788999999999999986 88889999888888777642 1 11 111
Q ss_pred ----------------CCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 250 ----------------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 250 ----------------~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.++..-++|+.++|..+|.+|+++++.++||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 12344689999999999999999999999999964
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=342.32 Aligned_cols=252 Identities=33% Similarity=0.558 Sum_probs=209.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.|++.+.||.|+||.||+|++..+++.||||.+..... .......+.+|+.++++++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999875532 22234568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+. ++|..++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 588888754 46899999999999999999999999999999999999999999999999998754321 112
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------------- 244 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------------- 244 (481)
.....+++.|+|||++.+....+.++|||||||++|+|++|..||...+......++....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 2344678899999998776655678999999999999999999998765443332222100
Q ss_pred -C---------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 -F---------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 -~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+ .....++++++++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 0122367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.38 Aligned_cols=253 Identities=32% Similarity=0.544 Sum_probs=206.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 57899999999999999999999889999999998764322 1223466899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--K 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--c
Confidence 999985 89988865 468999999999999999999999999999999999999999999999999986432211 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhC------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG------------------ 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~------------------ 243 (481)
......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.. .......+...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12233578899999998764434678999999999999999999997654 22222222110
Q ss_pred ---CCC---------CCCCCC--HHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 244 ---EFR---------SPRWFS--PDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 244 ---~~~---------~~~~~s--~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
... ....++ .++.+++.+||+++|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 001234 778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=344.72 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=207.5
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
...++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 4577899999999999999999999999999999998754322 223345678999999999999999999986543
Q ss_pred -----EEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 -----KIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 -----~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..|+||||+.+ +|.+.+... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 46999999975 788777653 6899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC--CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--CCC---
Q 011628 173 AVSDQIRQD--GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEF--- 245 (481)
Q Consensus 173 ~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~--- 245 (481)
......... .......++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+.. +..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 754332211 1223456788999999987654446789999999999999999999987665433222211 100
Q ss_pred --------------CC-------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 --------------RS-------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 --------------~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.. +...++.+.+||.+||..||.+|||++++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00 11135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=333.88 Aligned_cols=252 Identities=34% Similarity=0.634 Sum_probs=219.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 104 (481)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 599999999999999999999999999999998765432 3345678899999999999999999998754 4578999
Q ss_pred EeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-----HcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 105 MEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCH-----ARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH-----~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
|||+++++|.+++.. +.+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998863 46899999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCH
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSP 253 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 253 (481)
..... .......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. ..+..++.
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 54322 11334578999999999977665 5789999999999999999999998877777777776654 34667889
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+.+++.+||+.+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=366.16 Aligned_cols=250 Identities=30% Similarity=0.520 Sum_probs=217.8
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
-+||+|+||+||.|++..|....|||.+.... ....+-+..||.+.++|+|.|||+++|.+..++.+-|+||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 37999999999999999999999999996543 345567889999999999999999999999999999999999999
Q ss_pred chHHHHHc--CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCcccccccccCCcccc
Q 011628 112 ELFNKVAK--GRL--KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQDGLFHT 186 (481)
Q Consensus 112 ~L~~~i~~--~~l--~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~ 186 (481)
+|.++++. |++ +|..+..|.+||++||.|||++.|+|||||-+|+|++. .|.+||+|||.++.... -+....+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence 99999985 777 88899999999999999999999999999999999975 68999999999986543 3445678
Q ss_pred cCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCch-H-HHHH-HHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 187 FCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQN-I-MVMY-KKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~-~~~~-~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
.-||..|||||++... +| +.++|||||||++.||.||++||.... + ..++ ..+++-.++.|..+|.++++||.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred cccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 8899999999999543 45 678999999999999999999997643 2 2222 233555677888999999999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccCcc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
|+.++|.+||++.++|.+||++.+.+
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccCCC
Confidence 99999999999999999999987643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=359.57 Aligned_cols=258 Identities=34% Similarity=0.601 Sum_probs=238.4
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..-..+.+++-+||-|+||.|-+++.......+|+|++++..+.+....+.+..|-.||..++.|.||++|..|.+...+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34467788999999999999999987665556999999998888777788899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|++||-|-||+|+..+.. |.+.+..++.|...+++|++|||++||++|||||||++++.+|-+||.|||+|+... .
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---S 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---c
Confidence 999999999999999986 789999999999999999999999999999999999999999999999999998654 3
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~l 258 (481)
.....+.||||.|+|||++.+++++ ..+|.||||+++|||++|.+||.+.+++..|+.|.+|- +..|..++..+.+|
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 4556789999999999999999996 46999999999999999999999999999999999984 67799999999999
Q ss_pred HHHhcccCcCCCCC-----HhHHHhCcccc
Q 011628 259 LTKLLDTNPDKRIT-----IPEIMENRWFR 283 (481)
Q Consensus 259 i~~~L~~dP~~Rps-----~~eil~h~~f~ 283 (481)
|+++...+|.+|.. +.+|.+|.||.
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 99999999999985 89999999994
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=340.29 Aligned_cols=249 Identities=31% Similarity=0.504 Sum_probs=206.7
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKRE---ISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E---i~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
.||+|+||.||+|++..+++.||+|.+.+..............| +.+++...||||+++++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987543322211222233 345555689999999999999999999999999
Q ss_pred CCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccC
Q 011628 110 GGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188 (481)
Q Consensus 110 gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 188 (481)
||+|.+++.. +.+++..++.++.|++.|+.|||+++|+||||||+||+++.++.++|+|||++...... .....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999998865 57999999999999999999999999999999999999999999999999998754321 223457
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhccc
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 265 (481)
|+..|+|||++.+....+.++||||+||++|+|++|..||.+. ........+.......|..+|+++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875433357899999999999999999999876 3344444444445666777899999999999999
Q ss_pred CcCCCC-----CHhHHHhCcccccC
Q 011628 266 NPDKRI-----TIPEIMENRWFRKG 285 (481)
Q Consensus 266 dP~~Rp-----s~~eil~h~~f~~~ 285 (481)
+|.+|| ++.++++||||...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=341.28 Aligned_cols=247 Identities=32% Similarity=0.508 Sum_probs=210.7
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765433333445567899999999999999999999999999999999999999
Q ss_pred HHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 114 FNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 114 ~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 999865 3 699999999999999999999999999999999999999999999999999875432 2222345678
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTN 266 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d 266 (481)
..|+|||++.+..+ +.++|+||+||++|+|++|..||..... ..+...+.......+..+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999877665 5789999999999999999999976543 233333344445566678999999999999999
Q ss_pred cCCCC-----CHhHHHhCccccc
Q 011628 267 PDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 267 P~~Rp-----s~~eil~h~~f~~ 284 (481)
|.+|| ++.+++.||||.+
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.54 Aligned_cols=249 Identities=30% Similarity=0.524 Sum_probs=215.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.+|+|.+..... ...+.+|+.+++.++||||+++++++.....+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 679999999999999999999988899999999865431 567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+.+++|.+++.. ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 99999999999864 4689999999999999999999999999999999999999999999999999876433221 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~ 260 (481)
.....|+..|+|||++.+..+ +.++||||+|+++|+|++|..||...........+... ....+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 233458899999999987766 57899999999999999999999877655443333322 22334557889999999
Q ss_pred HhcccCcCCCCCHhHHHhCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f 282 (481)
+||+.||++|||+.|++.||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=333.09 Aligned_cols=255 Identities=32% Similarity=0.594 Sum_probs=215.6
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
||++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|+||++++++....+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999889999999999766533 3456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC-c-
Q 011628 107 YVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG-L- 183 (481)
Q Consensus 107 y~~gg~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~- 183 (481)
|+++++|.+++..+ .+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999774 68999999999999999999999999999999999999999999999999987643322111 1
Q ss_pred ccccCCCCccccccccccCC--CCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhC-CCCCCCCC--CHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKG--YDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG-EFRSPRWF--SPDLIR 257 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~-~~~~~~~~--s~~~~~ 257 (481)
.....+++.|+|||++.+.. ..+.++||||||+++|++++|..||.... .......+..+ ....|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999987654 13578999999999999999999997653 22222223222 23445544 899999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+|.+||+.+|.+|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=336.93 Aligned_cols=250 Identities=36% Similarity=0.688 Sum_probs=219.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||.|+||.||+|++..+|+.+|+|++.............+.+|+.++++++||||+++++.+......|+++||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999889999999999766544445567789999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc------CCcccc
Q 011628 114 FNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ------DGLFHT 186 (481)
Q Consensus 114 ~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~------~~~~~~ 186 (481)
.+++.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999976 6799999999999999999999999999999999999999999999999999875332211 112234
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCC--CHHHHHHHHHhcc
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF--SPDLIRLLTKLLD 264 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~li~~~L~ 264 (481)
..++..|+|||.+....+ +.++|+||||+++|+|++|..||........+..+..+....|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999877664 6789999999999999999999998888888888877666666555 8999999999999
Q ss_pred cCcCCCCCH---hHHHhCccccc
Q 011628 265 TNPDKRITI---PEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps~---~eil~h~~f~~ 284 (481)
.+|.+|||+ .++++||||.+
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=345.58 Aligned_cols=257 Identities=27% Similarity=0.487 Sum_probs=219.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 34566777889999999999999998899999999986543 233466889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
+||||++|++|.+++..+.+++..+..++.||+.|+.|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus 96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~ 173 (292)
T cd06658 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VP 173 (292)
T ss_pred EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999998653321 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li 259 (481)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+... .......++..+.+++
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 2234578999999999977666 56899999999999999999999887765555544432 2223335788999999
Q ss_pred HHhcccCcCCCCCHhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+||..||.+|||++++++||||...
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhcc
Confidence 99999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=338.04 Aligned_cols=254 Identities=27% Similarity=0.505 Sum_probs=220.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
-|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37788999999999999999988999999999865432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccc
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT 186 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 186 (481)
|+++++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNT 160 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhcc
Confidence 9999999999988889999999999999999999999999999999999999999999999999986543211 11234
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhccc
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 265 (481)
..|+..|+|||.+.+... +.++|+||+||++|+|++|..||...+.......+..+. ...+..++.++.++|.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 568899999999876655 568999999999999999999998877665555554443 234566889999999999999
Q ss_pred CcCCCCCHhHHHhCcccccC
Q 011628 266 NPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 266 dP~~Rps~~eil~h~~f~~~ 285 (481)
+|.+||++.++++||||.+.
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=355.70 Aligned_cols=253 Identities=34% Similarity=0.662 Sum_probs=220.0
Q ss_pred CCeeE--EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 26 GRYEI--GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 26 ~~y~i--~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
.-|+| .++||+|-||+||-|+++++|+.||||+|++.+....+ ..+++.|+.||+.++||.||.+-..+++.+.+++
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 44666 58999999999999999999999999999988765543 3778999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEecCCccccccc
Q 011628 104 VMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---DLKVSDFGLSAVSDQI 178 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---~lkl~DFGla~~~~~~ 178 (481)
|||-+.|.-|.-.+. +|++++.....++.||+.||.|||-++|+|+||||||||+.... .+||||||+|++.+.
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE- 719 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE- 719 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch-
Confidence 999997744444443 48999999999999999999999999999999999999997654 589999999998654
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC----CCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~ 254 (481)
.....+.+|||.|+|||++..++|. ..-|+||.|||+|.-|+|..||.... ++..+|.+..+.+|+ .++++
T Consensus 720 --ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 720 --KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred --hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHH
Confidence 3344678999999999999999996 45999999999999999999998764 345566666655543 38999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+||..+|+..-.+|+|+++.+.|||++.-
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999753
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=344.11 Aligned_cols=255 Identities=28% Similarity=0.508 Sum_probs=218.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
..|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 467888999999999999999988999999999875432 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
||+++++|.+++..+.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhh
Confidence 99999999999988889999999999999999999999999999999999999999999999999987543211 1122
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcc
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 264 (481)
...|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...........+..+. ...+..++.++.++|.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 3468899999999987766 568999999999999999999998766555444443332 22344578889999999999
Q ss_pred cCcCCCCCHhHHHhCcccccC
Q 011628 265 TNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 265 ~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+|++|||+.++++||||.+.
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=340.53 Aligned_cols=254 Identities=33% Similarity=0.478 Sum_probs=208.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE----
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSK---- 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~---- 100 (481)
++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999876532 2233456788999999995 6999999999877665
Q ss_pred -EEEEEeccCCCchHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCc
Q 011628 101 -IYFVMEYVRGGELFNKVAK------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLS 172 (481)
Q Consensus 101 -~~lv~Ey~~gg~L~~~i~~------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla 172 (481)
.|++|||+++ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78887753 24799999999999999999999999999999999999998 889999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-------
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF------- 245 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------- 245 (481)
...... ........+++.|+|||++.+....+.++|+||||+++|+|++|..||.+.+......++.....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 754321 11223346788999999986644446789999999999999999999988766554444432100
Q ss_pred ----------CC-----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 246 ----------RS-----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 246 ----------~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.. .+.+++++.+||.+||..||.+|||+.|++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 123688899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=348.28 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=214.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 46789999999999999999999999999999999986543 22334466889999999999999999999987653
Q ss_pred ---EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 100 ---KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 100 ---~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
.+++||||+ |++|.+++..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999999 7799999888889999999999999999999999999999999999999999999999999987533
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-----------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF----------- 245 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------- 245 (481)
. ......+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+....+.++.....
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 2 123456789999999987644446789999999999999999999987765444443322110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 --------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 --------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.....+++.+.++|.+||+.||.+|||+.+++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0123567889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.58 Aligned_cols=246 Identities=27% Similarity=0.485 Sum_probs=192.1
Q ss_pred EeEecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 011628 31 GKLLGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKIYFVME 106 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~E 106 (481)
+..||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 5789999999999999754 668899999865432 2346789999999999999999998854 567899999
Q ss_pred ccCCCchHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEecCCc
Q 011628 107 YVRGGELFNKVAK----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLS 172 (481)
Q Consensus 107 y~~gg~L~~~i~~----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl----~~~g~lkl~DFGla 172 (481)
|+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9875 77776641 248899999999999999999999999999999999999 45678999999999
Q ss_pred cccccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---------HHHHHHhh
Q 011628 173 AVSDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---------VMYKKIYK 242 (481)
Q Consensus 173 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---------~~~~~i~~ 242 (481)
+....... ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... ....++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 76533211 112345678999999999977555577899999999999999999999643210 00000000
Q ss_pred ----------------------------CCC----------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 243 ----------------------------GEF----------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 243 ----------------------------~~~----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
... ......+..+.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=349.14 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=226.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.+.|+.-++||+|+||.||-++-+.||+-+|.|.+.+..+....--.....|-.|+.+++.+.||.+-..|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 56788999999999999999999999999999999887766554445577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|..|.||+|.-.|-+ | .++|..++.|+.+|+.||++||+++|++|||||+|||+|+.|+++|+|+|+|..... .
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~---g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE---G 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC---C
Confidence 999999999777754 4 799999999999999999999999999999999999999999999999999985432 3
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCCCCCCCCHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFRSPRWFSPDLIR 257 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~ 257 (481)
......+||.+|||||++.+..| +...|.|||||+||+|+.|+.||..... .++-+.+......+|..+|+++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks 419 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS 419 (591)
T ss_pred CccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence 33455699999999999998887 5679999999999999999999976532 355566677777888999999999
Q ss_pred HHHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 258 LLTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
|.+.+|.+||.+|. +++++.+||||+.
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 99999999999998 4789999999975
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.79 Aligned_cols=254 Identities=34% Similarity=0.497 Sum_probs=212.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (481)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999989999999999765432 23445677899999999999999999998877 8999
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+||||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99999975 89888865 358999999999999999999999999999999999999999999999999987654321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC----------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---------------- 244 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------------- 244 (481)
.......+++.|+|||++.+....+.++|+||+|+++|+|++|..||..........++....
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 222345678999999998765545678999999999999999999998876655444432210
Q ss_pred ---------------CCCCCC-CCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 ---------------FRSPRW-FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ---------------~~~~~~-~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
...+.. +++.+.++|.+||+.||++|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=337.31 Aligned_cols=248 Identities=32% Similarity=0.534 Sum_probs=205.0
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK--SKIYFV 104 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lv 104 (481)
|++.+.||+|+||.||+|.+..+++.||+|.+....... . .....+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 789999999999999999999999999999987543221 1 223457899999885 99999999999887 889999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.| +|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++. +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999975 77777764 46899999999999999999999999999999999999999 99999999998754321 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC------------------C
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------E 244 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------~ 244 (481)
......+++.|+|||++...++.+.++||||+||++|+|++|..||.+.+.......+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2234568899999998766555577899999999999999999999887655444433221 0
Q ss_pred CCC-----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 FRS-----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+.. ...++..+.++|.+||+++|++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 111 12467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.35 Aligned_cols=257 Identities=30% Similarity=0.472 Sum_probs=211.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
+.++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 56899999999999999999999999999999999876542 3346688999999999999999999776543
Q ss_pred ---------CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEe
Q 011628 99 ---------SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSD 168 (481)
Q Consensus 99 ---------~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~D 168 (481)
...|++|||+. ++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 58999888888999999999999999999999999999999999999985 55789999
Q ss_pred cCCccccccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---
Q 011628 169 FGLSAVSDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--- 244 (481)
Q Consensus 169 FGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--- 244 (481)
||+++....... .+......|+..|+|||++.+....+.++|||||||++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432211 1122334678999999987654444678999999999999999999998766544444332210
Q ss_pred ----------------------CC-----CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 ----------------------FR-----SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 ----------------------~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.. ....++.++.+||.+||+.||.+|||+++++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 11246788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.43 Aligned_cols=252 Identities=30% Similarity=0.520 Sum_probs=216.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+.....+|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999976542 244567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||+.|++|.+++.. ..+++..+..++.|++.|++|||+ .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 99999999999975 578999999999999999999999 999999999999999999999999999986543211
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHhhCC-CCCCCC-CCHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-----NIMVMYKKIYKGE-FRSPRW-FSPDL 255 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~~~ 255 (481)
.....|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||... ........+.... ...+.. +++++
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred -hhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 122678999999999987766 57899999999999999999999764 2334444444433 233443 78999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.++|.+||..||++|||+.+++.||||++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=338.81 Aligned_cols=252 Identities=28% Similarity=0.508 Sum_probs=209.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----e
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMA-----T 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~-----~ 97 (481)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 4689999999999999999999999999999999886432 1235577899999999 6999999999874 3
Q ss_pred CCEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
+..+|+||||++|++|.+++.. ..+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 4679999999999999988742 46899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--- 244 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--- 244 (481)
...... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...........+....
T Consensus 172 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 172 AQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred eecccC--CCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 754321 112234578999999999853 223 568999999999999999999998876554444433322
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
...|..++..+.++|.+||+.||++|||+.|+++|+||
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22355578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=333.88 Aligned_cols=252 Identities=29% Similarity=0.536 Sum_probs=212.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++...+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998764444445556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 105 MEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988752 348999999999999999999999999999999999999999999999999987643211
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch--HHHHHHHHhhCCCC-C-CCCCCHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN--IMVMYKKIYKGEFR-S-PRWFSPDL 255 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~~-~-~~~~s~~~ 255 (481)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+.....+ . +..++..+
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred --HHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 12234578999999999987766 568999999999999999999996543 23444444443322 2 23577889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.++|.+||..+|++|||+.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=345.30 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=209.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES----VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..+|++.+.||+|+||.||+|++..+++. ||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45799999999999999999998766654 8999986432 234456788999999999999999999998764 5
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.++++||+.+|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 7899999999999999875 36899999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 256 (481)
..........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ..+.+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 22111222345678999999987776 578999999999999997 99999887765554444333 2455677899999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h 279 (481)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=338.19 Aligned_cols=251 Identities=35% Similarity=0.569 Sum_probs=210.2
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||.|++|.||+|++..+|+.||||++...... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 599999999999999999999999999999999765322 223556789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 107 YVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 107 y~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--N 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--c
Confidence 9986 88887764 358999999999999999999999999999999999999999999999999987543211 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------------ 244 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------------ 244 (481)
......+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+......++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998765555678999999999999999999998876555444433210
Q ss_pred --CC---------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 --FR---------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 --~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+ ..+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 012357789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.99 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=216.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+++++.++||||+++++.+.....+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 367999999999999999999999999999999987543 234567788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+++++|.+++.. +.+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----S 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----h
Confidence 999999999999876 679999999999999999999997 6999999999999999999999999999864322 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-----------HHHHHHHhhCC-CCCCCC
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-----------MVMYKKIYKGE-FRSPRW 250 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----------~~~~~~i~~~~-~~~~~~ 250 (481)
.....+|+..|+|||++.+..+ +.++|+||+||++|+|++|..||..... ......+.... ...+..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 1234578999999999876655 5689999999999999999999986443 12333333332 222222
Q ss_pred -CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 251 -FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 251 -~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
++.++.+|+.+||++||++|||++|+++|+||.+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 778899999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=337.95 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=211.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEc----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..+|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 367999999999999999999853 356789999987533 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 101 IYFVMEYVRGGELFNKVAK------------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~------------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
.|++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 9999999999999999852 2378888999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.+||+|||+++...............++..|+|||++.+..+ +.++|+|||||++|+|++ |..||.+.+.......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999975432221122234456778999999977666 578999999999999998 999998877666655555
Q ss_pred hCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
... ...+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 45577789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=337.82 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=204.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++|+||+++++++..+...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998755322 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+. ++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++...... .
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--Q 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--C
Confidence 99996 566666543 468899999999999999999999999999999999999999999999999987533211 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhC------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKG------------------ 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~------------------ 243 (481)
......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.. +...++...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2234467899999999876443356899999999999999999999765432 222221110
Q ss_pred --C-CC--CC---------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 244 --E-FR--SP---------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 244 --~-~~--~~---------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. .. .+ ...++++.+++.+||..||.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00 00 0125678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=338.30 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=213.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998743 46789999987543 2234577899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCE
Q 011628 100 KIYFVMEYVRGGELFNKVAK---------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~---------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~l 164 (481)
..|++|||++|++|.+++.. ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999999864 237888999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC
Q 011628 165 KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG 243 (481)
Q Consensus 165 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~ 243 (481)
||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999874322111111223456788999999987776 568999999999999998 99999888777777777766
Q ss_pred CCC-CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 244 EFR-SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 244 ~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
... .+..++..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 543 35678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=333.46 Aligned_cols=246 Identities=34% Similarity=0.648 Sum_probs=208.5
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL-RRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+||||+++++++...+.+|+++||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998765432222333444555544 455899999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999976 6799999999999999999999999999999999999999999999999999875322 234568
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC----CCCCCHHHHHHHHHhccc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS----PRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~li~~~L~~ 265 (481)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+..+.... +..+++.+.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987664 678999999999999999999999888777777766554322 335789999999999999
Q ss_pred CcCCCC---CHhHHHhCccccc
Q 011628 266 NPDKRI---TIPEIMENRWFRK 284 (481)
Q Consensus 266 dP~~Rp---s~~eil~h~~f~~ 284 (481)
||++|| +++|++.||||.+
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 4579999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=333.02 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=213.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++.+.||+|+||+||+|++..+ ...||+|.+.... .......+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998644 4579999986543 233456688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|++|||+++++|.+++.. +.+++..+..++.|++.|+.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999865 578999999999999999999999999999999999999999999999999998654211
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 257 (481)
.........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+ ..+.+..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1111112344678999999987666 578999999999999998 99999887776666666655 34556678999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhC
Q 011628 258 LLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h 279 (481)
++.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=392.47 Aligned_cols=259 Identities=32% Similarity=0.578 Sum_probs=223.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.+.-||.-+..||.|.||.||.|.+..||+..|+|.+...... ....+.+.+|..++..++|||+|++|++-...+..|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3466899999999999999999999999999999998765543 345577899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc--
Q 011628 103 FVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR-- 179 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~-- 179 (481)
|.||||+||+|.++++.|+ .+|...+.|..|++.|+.|||++||+||||||+||+++.+|.+|++|||.|.......
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999999999999875 6777788899999999999999999999999999999999999999999987543321
Q ss_pred cCCcccccCCCCccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhC-CCCCCCCCCHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRK---GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKG-EFRSPRWFSPD 254 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~ 254 (481)
-.+.+....|||.|||||++.+. +. +-++|||||||++.||+||+.||...+.. .+..++-.| .++.|..+|++
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~-~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGH-GGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCC-CcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 23456678999999999999654 34 34699999999999999999999875432 333333344 57789999999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.++||.+||..||++|.++.||++|.|-.
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 99999999999999999999999999853
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=337.72 Aligned_cols=256 Identities=20% Similarity=0.296 Sum_probs=212.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 5789999999999999999997642 355899999865432 223345778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 100 KIYFVMEYVRGGELFNKVAKG-----------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~-----------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
..|+||||+++|+|.+++... .++...+..++.|++.||.|||++||+||||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999999998641 245678899999999999999999999999999999999999999999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CC
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FR 246 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~ 246 (481)
||+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.........+..+. ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999875322111111122345778999999877666 578999999999999998 899998887777776666554 34
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh------Ccccc
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME------NRWFR 283 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~------h~~f~ 283 (481)
.+..+++.+.+++.+||+.||++|||+.++++ ||||+
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 56677899999999999999999999999987 78875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=337.98 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=211.7
Q ss_pred CCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 57999999999999999999852 345679999886532 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 011628 101 IYFVMEYVRGGELFNKVAKG--------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~--------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
+|++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 99999999999999998642 3899999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCCC
Q 011628 167 SDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEF 245 (481)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 245 (481)
+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999875422111111223446788999999987666 568999999999999998 9999998887777777777653
Q ss_pred -CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 246 -RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 246 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+..+++++.+|+.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 446678999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=331.21 Aligned_cols=252 Identities=34% Similarity=0.607 Sum_probs=216.8
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+.....+|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 6999999999999999999999999999999997654322 234567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-EEEEecCCcccccccccCC
Q 011628 107 YVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD-LKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 107 y~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~-lkl~DFGla~~~~~~~~~~ 182 (481)
|+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||.+...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 99999999998652 4799999999999999999999999999999999999998864 699999998764321 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLTK 261 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 261 (481)
......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. ..+..++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 2234568999999999876665 5789999999999999999999998777666666655543 3355678899999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=336.21 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=210.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
..++|++.+.||+|+||.||.|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35789999999999999999998642 45689999986432 122345678999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEE
Q 011628 99 SKIYFVMEYVRGGELFNKVAKG-----------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVS 167 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~-----------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~ 167 (481)
...++||||+++++|.+++... .++...+..++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999998642 24677889999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-C
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-F 245 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~ 245 (481)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999864322111111122356788999999977666 678999999999999999 799999888777666666554 3
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+..+++.+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=330.95 Aligned_cols=244 Identities=27% Similarity=0.454 Sum_probs=204.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+++.||+|.+.... ..+....+.+|+.+++.++||||+++++++.....+|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999899999999886432 3345567889999999999999999999999999999999999999
Q ss_pred chHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 112 ELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 112 ~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999865 3589999999999999999999999999999999999999999999999999875332111111111123
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcccCc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP 267 (481)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+... ....+..++..+.+++.+||+.+|
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999977666 568999999999999997 99999877665555555443 345566788999999999999999
Q ss_pred CCCCCHhHHHh
Q 011628 268 DKRITIPEIME 278 (481)
Q Consensus 268 ~~Rps~~eil~ 278 (481)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=341.70 Aligned_cols=255 Identities=30% Similarity=0.527 Sum_probs=218.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 5899999999999999999999988999999999865432 2245678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
+||+++++|.+++.+..+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999886543221 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-C--CCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-E--FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~--~~~~~~~s~~~~~li~~ 261 (481)
....|++.|+|||.+....+ +.++|+|||||++|++++|..||...+.......+..+ . +..+..++..+.++|.+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 34568999999999877666 56899999999999999999999877654433333222 1 22344567889999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||..+|.+||++++++.|+||+..
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcC
Confidence 999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.61 Aligned_cols=252 Identities=36% Similarity=0.657 Sum_probs=222.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 699999999999999999999889999999999765432 2445678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 107 YVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 107 y~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|++|++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999998864 569999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLT 260 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 260 (481)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+............. ..|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 23345678999999999877765 5689999999999999999999998877777776666543 446678899999999
Q ss_pred HhcccCcCCCCCHhHHHhCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f 282 (481)
+||..+|.+|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=343.05 Aligned_cols=255 Identities=29% Similarity=0.500 Sum_probs=205.6
Q ss_pred CeeEEeEecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIY 102 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (481)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999875422334456678899999999999999999999888 8899
Q ss_pred EEEeccCCCchHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc----CCCEEEEecCCc
Q 011628 103 FVMEYVRGGELFNKVAK------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE----NGDLKVSDFGLS 172 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~----~g~lkl~DFGla 172 (481)
+||||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 66665532 26899999999999999999999999999999999999999 899999999998
Q ss_pred cccccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH---------HHHHHhh
Q 011628 173 AVSDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV---------MYKKIYK 242 (481)
Q Consensus 173 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------~~~~i~~ 242 (481)
........ .......++++.|+|||++.+....+.++|||||||++|+|++|..||.+..... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76433222 1122345789999999998765444678999999999999999999997543211 0000000
Q ss_pred ------------------------C--CCCCC-----------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 243 ------------------------G--EFRSP-----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 243 ------------------------~--~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ....+ ...+..+.+++.+||+.||++|||+.|++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 00111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=339.19 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=216.2
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.....+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34457799999999999999999999889999999998755444444556788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+||||+.| +|.+.+. .+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 999999975 6666654 35799999999999999999999999999999999999999999999999999865332
Q ss_pred cCCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CC-CCCCCHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RS-PRWFSPDL 255 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~s~~~ 255 (481)
.....|++.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+..... .. +..++..+
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 124568899999999742 22335689999999999999999999988776655444443322 22 33467889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.++|.+||..||++||++.+|+.||||.+.
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=333.68 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=209.0
Q ss_pred eeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK---- 100 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 100 (481)
|++++.||+|+||.||.|....+ +..||+|.+..+... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67899999999999999987653 478999998765332 2345678899999999999999999998866554
Q ss_pred --EEEEEeccCCCchHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 101 --IYFVMEYVRGGELFNKVAK-------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 101 --~~lv~Ey~~gg~L~~~i~~-------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
.+++|||+++|+|...+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 7999999999999988743 2589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCC
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPR 249 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~ 249 (481)
++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+....+..+..+. ...|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875432221111222345678999999876666 678999999999999999 999998887777777766653 45677
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=342.11 Aligned_cols=255 Identities=29% Similarity=0.527 Sum_probs=218.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..-|+....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..+...|++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 3446667789999999999999988999999999865432 2345678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||+++++|..++....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 97 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~ 174 (297)
T cd06659 97 MEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR 174 (297)
T ss_pred EecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence 999999999998887889999999999999999999999999999999999999999999999999986433211 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~ 261 (481)
...+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...........+.... ...+..+++.+.++|.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 34678999999999987666 678999999999999999999998777665555554332 22344578899999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||+.+|.+||+++++++||||.+.
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccC
Confidence 999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=369.76 Aligned_cols=247 Identities=32% Similarity=0.520 Sum_probs=207.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEE-EEe-----
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEV-MAT----- 97 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~----- 97 (481)
..+++|.+.|.+|||+.||+|++...|..||+|++-.. ++...+.+++||++|++|+ |+|||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34678899999999999999999888899999998654 4566788999999999997 9999999993 321
Q ss_pred -CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEecCC
Q 011628 98 -KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 98 -~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
.-.++|.||||.||.|-|+++. .+|+|.++.+||.|+++||.+||... |||||||-|||||+.+|+.||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 1257899999999999999974 46999999999999999999999997 99999999999999999999999999
Q ss_pred ccccccccc--CCc--c---cccCCCCcccccccc---ccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh
Q 011628 172 SAVSDQIRQ--DGL--F---HTFCGTPAYVAPEVL---SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 172 a~~~~~~~~--~~~--~---~~~~gt~~y~APEvl---~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 241 (481)
++-.-.... .+. + -...-|+.|+|||++ .+.+. +.|+|||+|||+||-||...+||++... ..|.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIl 267 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAIL 267 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEE
Confidence 874222110 000 0 023569999999997 34454 6799999999999999999999998743 3567
Q ss_pred hCCCCCCC--CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGEFRSPR--WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++.+.+|+ .++..+.+||+.||+.||++||++.|++.+
T Consensus 268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 78877765 689999999999999999999999998874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=348.70 Aligned_cols=257 Identities=30% Similarity=0.460 Sum_probs=216.4
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK- 100 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 100 (481)
..+.++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3568899999999999999999999999999999999865432 22344667789999999999999999988766554
Q ss_pred -----EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 101 -----IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 101 -----~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
.|+|+||+ |++|.+++..+++++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 669999998888999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC---------
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--------- 246 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--------- 246 (481)
.. ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 32 1234578899999999866444467899999999999999999999877665555444331100
Q ss_pred ----------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 247 ----------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 247 ----------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
....+++.+.++|.+||+.||.+|||+.+|+.||||.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 012358899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=331.36 Aligned_cols=248 Identities=25% Similarity=0.441 Sum_probs=213.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
...|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.....++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 356999999999999999999999999999999986542 2245678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999999999864 35899999999999999999999999999999999999999999999999998754331111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 259 (481)
......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+....+..+..+ ....|..+++++.++|
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 1112234667999999877766 568999999999999998 99999988877777776654 3455677899999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.||++|||+.++++
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=335.74 Aligned_cols=254 Identities=30% Similarity=0.524 Sum_probs=218.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|.-.+.||+|++|.||+|.+..+++.+|+|+++... ....+.+.+|+.+++.++||||+++++++...+..|+++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 34566789999999999999998899999999986433 223456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
||+.|++|.+.+..+++++..+..++.|++.|++|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK 173 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999876433211 1223
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC---CCCCCHHHHHHHHHh
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS---PRWFSPDLIRLLTKL 262 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s~~~~~li~~~ 262 (481)
...|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..+..+. +..+++.+.++|.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 4568999999999977666 568999999999999999999998887776666666553222 333788999999999
Q ss_pred cccCcCCCCCHhHHHhCcccccC
Q 011628 263 LDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|+.+|++|||+.++++||||.+.
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred cccChhhCcCHHHHccCcccccC
Confidence 99999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=338.66 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=214.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
..+|++.+.||+|+||.||+|.+..+ ++.||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45689999999999999999987543 5789999997543 2334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 100 KIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999999852 2478888999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999875432222222234456789999999876666 568999999999999998 999999888877777777
Q ss_pred hCCC-CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+.. ..+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7653 4577789999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=335.85 Aligned_cols=251 Identities=33% Similarity=0.544 Sum_probs=209.1
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++......|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 78899999999999999999999999999999765422 23345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 108 VRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 108 ~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
+. ++|.+++... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 6899988653 5899999999999999999999999999999999999999999999999998754321 1122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--------------------
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------- 244 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------- 244 (481)
....+++.|+|||++.+....+.++|+||||+++|+|++|..||...+......++....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578899999998765444678999999999999999999998776544333332210
Q ss_pred ---------CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 ---------FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ---------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
......+++.+.++|.+||++||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.49 Aligned_cols=254 Identities=30% Similarity=0.565 Sum_probs=220.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|++|.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765422 34577889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+++++|.+++.. +.+++..+..++.|++.|+.|||+ +|++||||+|+||+++.++.++|+|||++........ .
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--Q 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--c
Confidence 99999999999976 789999999999999999999999 9999999999999999999999999999876533221 1
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhCC-CCCCCC-CCHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGE-FRSPRW-FSPDLIRL 258 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~-~~~~~~-~s~~~~~l 258 (481)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ........+.... ...+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999877655 67899999999999999999999776 4445555555443 334455 78999999
Q ss_pred HHHhcccCcCCCCCHhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
|.+||.++|++|||+.++++||||+.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.65 Aligned_cols=246 Identities=25% Similarity=0.435 Sum_probs=209.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||.||+|++. .+..+|+|.+...... ...+.+|+.+++.++||||+++++++......|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56999999999999999999874 4568999988654322 346788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++||+|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 99999999999864 4689999999999999999999999999999999999999999999999999875322111 01
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 261 (481)
.....++..|+|||++.+..+ +.++|+||||+++|+|++ |..||...+.......+..+. ...|...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 112235668999999987766 568999999999999999 999999888777777777664 33466678899999999
Q ss_pred hcccCcCCCCCHhHHHh
Q 011628 262 LLDTNPDKRITIPEIME 278 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~ 278 (481)
||+.+|.+|||++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=325.85 Aligned_cols=254 Identities=31% Similarity=0.545 Sum_probs=218.9
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv 104 (481)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... ......+.+|+.++++++||||+++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999889999999999765432 34467788999999999999999999999988 899999
Q ss_pred EeccCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999999999999764 899999999999999999999999999999999999999999999999999876544322112
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhh--CCCCCCCCCCHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYK--GEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~--~~~~~~~~~s~~~~~li~ 260 (481)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||.... .......+.. .....|..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 344678999999999876654 678999999999999999999998765 3333333332 234556778999999999
Q ss_pred HhcccCcCCCCCHhHHHhCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f 282 (481)
+||+.||++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.76 Aligned_cols=253 Identities=27% Similarity=0.472 Sum_probs=205.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISI-LRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
++|++.+.||+|+||.||+|++..+|+.||+|.+....... ....+..|+.+ ++.++||||+++++++.....+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653222 22345556664 6777899999999999999999999
Q ss_pred EeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 105 MEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
|||++ |+|.+++.. ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 577666643 3689999999999999999999998 9999999999999999999999999998754321
Q ss_pred ccCCcccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhC-CCCCC-CCC
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG-EFRSP-RWF 251 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~-~~~~~-~~~ 251 (481)
.......|+..|+|||++.+ .++ +.++|+|||||++|+|++|..||.... .......+..+ ....| ..+
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred ---cccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 11223568899999998854 233 568999999999999999999997532 22333333333 22333 357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|.++.++|.+||..+|.+|||+.++++||||++.
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 8999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.98 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=212.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 56899999999999999999998643 4789999986543 2233456789999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 100 KIYFVMEYVRGGELFNKVAK-----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
..|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 99999999999999999853 1367889999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CC
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FR 246 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~ 246 (481)
||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 999875433221122234457889999999876665 678999999999999998 999998887777666666543 45
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.|..++..+.++|.+||+.+|++|||+.+++.
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 57778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=332.75 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=207.1
Q ss_pred eeEEeEecccCceEEEEEEEcCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGE--SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK------S 99 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 99 (481)
|.+++.||+|+||.||+|++..++. .||+|.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999877765 699999876432 334457788999999999999999999987432 2
Q ss_pred EEEEEEeccCCCchHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..+++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 24789999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRW 250 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 250 (481)
+...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||........+..+..+. ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 76432211111123356778999999987666 678999999999999999 899998877777777777654 345667
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++..+.++|.+||+.||++|||+++|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=333.96 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=210.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4679999999999999999999977 77889999886443 2233456888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEe
Q 011628 100 KIYFVMEYVRGGELFNKVAKG--------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---DLKVSD 168 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~--------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---~lkl~D 168 (481)
..|++|||+.|++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 999999999999999998642 488999999999999999999999999999999999998765 599999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCC
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFR 246 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~ 246 (481)
||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999875422111111112234568999999977666 678999999999999997 99999987766666555443 345
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.|..++..+.+++.+||+.+|++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 567789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.07 Aligned_cols=256 Identities=32% Similarity=0.528 Sum_probs=210.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 36899999999999999999999889999999998665322 23345678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCccccccccc
Q 011628 105 MEYVRGGELFNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~~~ 180 (481)
|||+++ +|.+.+.. . .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999964 78777754 2 3688899999999999999999999999999999999985 457999999998754321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC----------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---------------- 244 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------------- 244 (481)
........|++.|+|||++.+....+.++||||+||++|+|++|..||...+......++....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1122345678999999998765444678999999999999999999998776554444432210
Q ss_pred -------CC------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 -------FR------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 -------~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+. ....+++.+.++|.+||+.+|++||++.+++.||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00 11346788999999999999999999999999999975
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=348.56 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=208.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 103 (481)
...|+++++||+||.++||++..- +.+.+|+|.+.... .+...+..+.+|+..|.+|+ |.+||++|++-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 678999999999999999999974 44556666554332 34567788999999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||-+ .+|..+++++ .++.-.++.|.+||+.|+.++|++||+|.||||.|+|+ -.|.+||+|||+|.........
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccc
Confidence 999753 5999999874 34445899999999999999999999999999999998 4579999999999865543333
Q ss_pred CcccccCCCCccccccccccCCCC----------CCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhCC--CCCC
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYD----------AAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKGE--FRSP 248 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~----------~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~--~~~~ 248 (481)
-...+-+||+.||+||.+....+. +.++||||||||||+|+.|++||.... ...-+..|.... ..+|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 344577999999999998654432 568999999999999999999998754 444455555542 3444
Q ss_pred CCCCHH-HHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 RWFSPD-LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 ~~~s~~-~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..-+.. +.++++.||..||++|||+.++|+|||++-
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 433333 999999999999999999999999999863
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=328.25 Aligned_cols=255 Identities=28% Similarity=0.505 Sum_probs=215.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI--LKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKI 101 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 101 (481)
.+|++++.||+|+||.||+|++..+++.||+|.+..... ........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999864321 1233456788999999999999999999998664 568
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
++++||++|++|.+.+.. +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999999875 5789999999999999999999999999999999999999999999999999975432111
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHHHH
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDLIR 257 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~ 257 (481)
........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+........++.... ...|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 112234568999999999987665 578999999999999999999998876655555554332 3457778999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+|.+||. +|.+||++.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=346.42 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=211.8
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA----TKS 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~ 99 (481)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 35789999999999999999999999999999999876432 2234567788999999999999999998875 345
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7899999996 589888865 56999999999999999999999999999999999999999999999999998754322
Q ss_pred cc--CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--------------
Q 011628 179 RQ--DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------------- 242 (481)
Q Consensus 179 ~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------------- 242 (481)
.. ........|+..|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 11223457899999999986644446789999999999999999999987654332221111
Q ss_pred ---------C---CCCC-----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 ---------G---EFRS-----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 ---------~---~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .... .+..++++.++|.+||+.+|.+|||+++++.||||.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0 0000 13368889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=352.34 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=206.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||.||+|.+... +..||||++.... .......+.+|+.+++.+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 56788999999999999999987533 3479999996543 2234567889999999996 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-----------------------------------------------------------
Q 011628 99 SKIYFVMEYVRGGELFNKVAK----------------------------------------------------------- 119 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~----------------------------------------------------------- 119 (481)
..+|+|||||++|+|.+++..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999988753
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC
Q 011628 120 --------------------------------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 120 --------------------------------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~ 161 (481)
..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHH-HHHHH
Q 011628 162 GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIM-VMYKK 239 (481)
Q Consensus 162 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~-~~~~~ 239 (481)
+.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... ..+..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999875433222112233457788999999987666 578999999999999997 99999876443 33344
Q ss_pred HhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 240 IYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 240 i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+..+ ....+..+++++.+++.+||+.||++|||+.++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4433 24456678899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=324.64 Aligned_cols=252 Identities=33% Similarity=0.624 Sum_probs=220.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.++++++|||++++++++.+...+|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 699999999999999999999889999999999776532 2455778999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 107 YVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 107 y~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
|+++++|.+++.. +.+++..++.++.|++.|+.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 9999999999876 6899999999999999999999999999999999999999999999999999976543221 123
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh-hCCCCCCCCCCHHHHHHHHHhcc
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY-KGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+......++. ......+..+++.+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4578999999999877664 678999999999999999999998766544444443 33345567789999999999999
Q ss_pred cCcCCCCCHhHHHhCccc
Q 011628 265 TNPDKRITIPEIMENRWF 282 (481)
Q Consensus 265 ~dP~~Rps~~eil~h~~f 282 (481)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=339.38 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=207.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES--VAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...+.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 56899999999999999999999877765 466665432 2334456788999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCE
Q 011628 102 YFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~l 164 (481)
|+||||+++++|.+++... .+++..++.++.|++.|++|||++|++||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 9999999999999998642 47899999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC
Q 011628 165 KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG 243 (481)
Q Consensus 165 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~ 243 (481)
||+|||++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+
T Consensus 164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 164 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999863221111 111234667999999877665 578999999999999998 99999887777666666544
Q ss_pred C-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 244 E-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 244 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
. ...+..+++++.+||.+||+.+|++||++++++.+
T Consensus 240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 33455678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.29 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=207.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++++.||+|+||.||+|++..+|+.||+|++...........+++.+|+.+++.++||||+++++++...+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999999765444444567788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 105 MEYVRGGELFNKVAK------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
|||++||+|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999998853 12455678899999999999999999999999999999999999999999999
Q ss_pred cccccccc----------------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH
Q 011628 173 AVSDQIRQ----------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM 236 (481)
Q Consensus 173 ~~~~~~~~----------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 236 (481)
........ .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76421100 001123579999999999988776 6789999999999999999999987654332
Q ss_pred HHHH-hhCC--CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 237 YKKI-YKGE--FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 237 ~~~i-~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.... .... ......+++.+.+++.+||+.||++||+..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2221 1111 1112357889999999999999999987655544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=346.55 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=204.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT- 97 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~- 97 (481)
.++|++++.||+|+||.||+|++.. +++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3589999999999999999997543 45789999986543 223346678899999999 79999999998865
Q ss_pred CCEEEEEEeccCCCchHHHHHc----------------------------------------------------------
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK---------------------------------------------------------- 119 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~---------------------------------------------------------- 119 (481)
...++++|||+++++|.+++..
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4578999999999999988753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCcccc
Q 011628 120 ----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195 (481)
Q Consensus 120 ----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 195 (481)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++................++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578899999999999999999999999999999999999999999999999975432111111223456778999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHH-HHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCC
Q 011628 196 PEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMY-KKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRIT 272 (481)
Q Consensus 196 PEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~-~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps 272 (481)
||++.+..+ +.++|||||||++|+|++ |..||.+....+.. ..+..+. ...|...++++.+++.+||+.+|++||+
T Consensus 244 PE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999988777 568999999999999998 99999875443333 3333332 3446667899999999999999999999
Q ss_pred HhHHHhC
Q 011628 273 IPEIMEN 279 (481)
Q Consensus 273 ~~eil~h 279 (481)
++|+++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=332.24 Aligned_cols=250 Identities=30% Similarity=0.564 Sum_probs=212.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.+|||.+.............+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 67999999999999999999998999999999887654444445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 106 EYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999998862 45899999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH--HHHHHHHhhCCCC--CCCCCCHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI--MVMYKKIYKGEFR--SPRWFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~~~~--~~~~~s~~~~ 256 (481)
........|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+... ......+.....+ .+..+++.+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 122345678999999999977766 5689999999999999999999976533 3444444433322 2345788999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||..||++|||+.+|++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.00 Aligned_cols=252 Identities=25% Similarity=0.450 Sum_probs=212.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++.+.||+|+||.||+|.+... ...+|+|.+..... ......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 47899999999999999999997643 37899999875432 23346688999999999 799999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~ 161 (481)
..+|++|||+.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 999999999999999999853 358899999999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHH
Q 011628 162 GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKI 240 (481)
Q Consensus 162 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i 240 (481)
+.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||........+..+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999976433221111122335678999999877666 578999999999999997 99999988877777776
Q ss_pred hhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 241 YKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 241 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+. ...+..++..+.+|+.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6654 34566788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.43 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=211.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 356899999999999999999999989999999999875432 222345677899999999999999999988643
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|++++++ |++|.+++..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 7899998888889999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------ 244 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------ 244 (481)
. ......|++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+....
T Consensus 172 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred c-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 2 22345789999999998664444678999999999999999999998765444333322110
Q ss_pred -----------CCC--------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 245 -----------FRS--------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 245 -----------~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
... ....++++.++|.+||+.||.+|||+.+++.||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000 11257789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.59 Aligned_cols=245 Identities=26% Similarity=0.446 Sum_probs=213.4
Q ss_pred eEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.+++.++|+||+++++++.....++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999766 8999999997654322 4577889999999999999999999999999999999999
Q ss_pred CCCchHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 109 RGGELFNKVAK----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 109 ~gg~L~~~i~~----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
++++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999975 56899999999999999999999999999999999999999999999999999765432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........+++.|+|||.+....+ +.++|||||||++|+|++ |..||...........+..+. ...|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122334567889999999877655 678999999999999999 699999988877777777553 456778899999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h 279 (481)
+++.+||+.||.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=344.62 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=210.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
+..+|++.+.||+|+||+||.|++..+++.||||.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 567899999999999999999999999999999998754322 22345677899999999999999999987654
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+|+++||+. ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 688888865 6799999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------- 242 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------- 242 (481)
. ........++..|+|||++......+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 161 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 K--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred C--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 1 12234557899999999986544446789999999999999999999987654322221110
Q ss_pred --------CC-----C---CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 243 --------GE-----F---RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 243 --------~~-----~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.. . ...+.+++++.++|.+||+.+|++|||++++++||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00 0 012347889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=326.54 Aligned_cols=250 Identities=30% Similarity=0.571 Sum_probs=212.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.++++++|+||+++++++......+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999998899999999987654444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 106 EYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999998853 35899999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch--HHHHHHHHhhCCC-CCCC-CCCHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN--IMVMYKKIYKGEF-RSPR-WFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~~~ 256 (481)
........|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.... .......+..+.. +.|. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 122234578999999999987776 568999999999999999999996543 3344445444433 2333 6788999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
++|.+||..+|++|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=328.58 Aligned_cols=247 Identities=30% Similarity=0.503 Sum_probs=205.8
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
-..||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++..++.+++++||++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 458999999999999998899999999986543 22346788999999999999999999999999999999999999
Q ss_pred CchHHHHHc--CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCcccccccccCCccc
Q 011628 111 GELFNKVAK--GRL--KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 111 g~L~~~i~~--~~l--~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
++|.+.+.. +.+ ++..+..++.|++.|+.|||++||+||||||+||+++. ++.++|+|||++...... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 167 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTE 167 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccc
Confidence 999999875 345 88899999999999999999999999999999999986 679999999998754321 12223
Q ss_pred ccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchH--HHHHHH-HhhCCCCCCCCCCHHHHHHHHH
Q 011628 186 TFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNI--MVMYKK-IYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~-i~~~~~~~~~~~s~~~~~li~~ 261 (481)
...|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||..... ...+.. ........|..+++++.+++.+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 446899999999986533 235789999999999999999999976432 222221 1222344577789999999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||+.+|.+|||+.+++.||||
T Consensus 248 ~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.83 Aligned_cols=245 Identities=25% Similarity=0.438 Sum_probs=203.9
Q ss_pred ccCCeeEEeEe--cccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 011628 24 LLGRYEIGKLL--GHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSK 100 (481)
Q Consensus 24 ~~~~y~i~~~L--G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 100 (481)
+.++|++.+.+ |+|+||.||++.+..++..+|+|++....... .|+.....+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 35678887776 99999999999999999999999987653221 122222222 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~ 178 (481)
.|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 9999999999999999976 4899999999999999999999999999999999999999998 999999999875432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH----HHHHHhhCCCCCCCCCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~ 254 (481)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||....... ............+..+++.
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 123468999999999988776 568999999999999999999997553221 1222223344556678999
Q ss_pred HHHHHHHhcccCcCCCCC-HhHHHhCcccc
Q 011628 255 LIRLLTKLLDTNPDKRIT-IPEIMENRWFR 283 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps-~~eil~h~~f~ 283 (481)
+.+||.+||+++|.+||+ ++++++||||.
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999996 69999999995
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=361.95 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=196.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcC-CCcEEEEEEe--------------ecccccchhHHHHHHHHHHHHHhCCCCC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVI--------------DKEKILKSGLVAHIKREISILRRVRHPN 87 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i--------------~~~~~~~~~~~~~~~~Ei~il~~l~Hpn 87 (481)
.+.++|++++.||+|+||+||++..+. ++...+.|.+ .+...........+.+|+.+++.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 456899999999999999999987654 2233333311 1111112234456789999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC
Q 011628 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 88 Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~ 161 (481)
|+++++++...+..|+++|++. ++|.+++..+ ......++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999999999999999995 4777766432 23467788999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCC-CCCCc--hHHHHHH
Q 011628 162 GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYL-PFQDQ--NIMVMYK 238 (481)
Q Consensus 162 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~-Pf~~~--~~~~~~~ 238 (481)
+.+||+|||++....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|.. ||... +......
T Consensus 304 ~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999997653321 112234689999999999988777 568999999999999999875 44322 1212222
Q ss_pred HHhhC------CCC---------------------C-----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 239 KIYKG------EFR---------------------S-----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 239 ~i~~~------~~~---------------------~-----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++... .++ . ...++.++.++|.+||+.||.+|||+.|++.||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11110 000 0 01245678889999999999999999999999999764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=352.62 Aligned_cols=233 Identities=27% Similarity=0.498 Sum_probs=207.4
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
++-||.|+.|.||+|+. .++.||||.++.-+ .-+|+-|++|+||||+.|.++|.....++||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 56799999999999987 67899999875322 2478889999999999999999999999999999999
Q ss_pred CchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|.|...++.+ .+.......|..+|+.|+.|||.+.|||||||.-||||..+..+||+|||.++..... ...-.++|
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 9999999875 6899999999999999999999999999999999999999999999999999865433 23346899
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHHHHHHHHhcccCc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~li~~~L~~dP 267 (481)
|..|||||++.+.+. +.|+|||||||+|||||||..||.+-+...+...+-... ++.|..++..++=||++||+-.|
T Consensus 274 TVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred hHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence 999999999998877 679999999999999999999999888776665554443 56788899999999999999999
Q ss_pred CCCCCHhHHHhC
Q 011628 268 DKRITIPEIMEN 279 (481)
Q Consensus 268 ~~Rps~~eil~h 279 (481)
..||++.+|+.|
T Consensus 353 RNRPSFrqil~H 364 (904)
T KOG4721|consen 353 RNRPSFRQILLH 364 (904)
T ss_pred CCCccHHHHHHH
Confidence 999999999998
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=344.17 Aligned_cols=261 Identities=32% Similarity=0.483 Sum_probs=213.8
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK-- 98 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-- 98 (481)
..+.++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 34678999999999999999999999889999999998654222 22335567899999999 999999999988653
Q ss_pred CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
...|+||||+.+ +|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 468999999974 9999998778899999999999999999999999999999999999999999999999998754332
Q ss_pred ccC---CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-----------
Q 011628 179 RQD---GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE----------- 244 (481)
Q Consensus 179 ~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 244 (481)
... .......|++.|+|||++.+....+.++|+||||+++|+|++|+.||.+........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 233446789999999998665555678999999999999999999998765443333221110
Q ss_pred ----------------C----CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 ----------------F----RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 ----------------~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
. .....++.++.++|.+||+.||.+|||+.++++||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 0 011226888999999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=331.13 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=210.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKIYF 103 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 103 (481)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|++++++++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999999876432 2345678899999999999999999998865 347899
Q ss_pred EEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 104 VMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
||||++|++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887642 45899999999999999999999999999999999999999999999999998653321
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHhhCCC-CCC----
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-----NIMVMYKKIYKGEF-RSP---- 248 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-----~~~~~~~~i~~~~~-~~~---- 248 (481)
......++..|+|||.+.+..+ +.++|+|||||++|+|++|..||... ...+....+..... ..+
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 1123467889999999877666 56899999999999999999999865 22333333333211 111
Q ss_pred --CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 249 --RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 249 --~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+++.+.++|.+||..||.+|||+.|++.||||.+.
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1246789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=325.91 Aligned_cols=246 Identities=43% Similarity=0.758 Sum_probs=220.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+..+..+|++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999877655445567789999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCc
Q 011628 114 FNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192 (481)
Q Consensus 114 ~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 192 (481)
.+++.. +.+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999976 478999999999999999999999999999999999999999999999999987643321 12345678899
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCC
Q 011628 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRIT 272 (481)
Q Consensus 193 y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 272 (481)
|+|||...+... +.++|+||||+++|+|++|..||...+.......+....+..|..++..+.++|.+||..||++||+
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999877655 5689999999999999999999988877777778877778888888999999999999999999999
Q ss_pred H---hHHHhCccc
Q 011628 273 I---PEIMENRWF 282 (481)
Q Consensus 273 ~---~eil~h~~f 282 (481)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=336.14 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=212.1
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVK-------SGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFE 93 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 93 (481)
....++|.+++.||+|+||.||+|++.. ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3346899999999999999999998643 23579999997643 223346688899999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 94 VMATKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 94 ~~~~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
++......|+||||+.+|+|.+++... .++...+..++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999999999999642 378889999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMV 235 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~ 235 (481)
+++.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999875432111111122234578999999977666 578999999999999998 999998887777
Q ss_pred HHHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 236 MYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 236 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
....+..+. ...|..++.++.+||.+||..+|.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 666665554 34566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=330.60 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=208.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..+|++.+.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 4689999999999999999999877776 48999986543 23345678899999999999999999999875 45
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.++++||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 7899999999999999865 46899999999999999999999999999999999999999999999999998765422
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+. .+.+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 11111122345678999999977766 568999999999999998 999998876666555555543 345667899999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||+.||++||++.++++
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=332.06 Aligned_cols=258 Identities=33% Similarity=0.583 Sum_probs=216.4
Q ss_pred CeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
.|++.+.||.|+||.||.|++. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999975 47899999999764322 223346678899999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 999999999999999875 578999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCch----HHHHHHHHhhCCCCCCCCCCHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKGEFRSPRWFSPDL 255 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 255 (481)
........|+..|+|||.+... ...+.++||||||+++|+|++|..||...+ .......+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1222346789999999998643 233568999999999999999999997432 33444555555566677789999
Q ss_pred HHHHHHhcccCcCCCC-----CHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRI-----TIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rp-----s~~eil~h~~f~~~ 285 (481)
.+++.+||+.||++|| ++++++.||||.+.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.02 Aligned_cols=258 Identities=29% Similarity=0.538 Sum_probs=211.1
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-- 99 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 99 (481)
....++|++.+.||+|+||.||+|.+..+|+.||+|+++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45678999999999999999999999999999999999765322 223356778999999999999999999987654
Q ss_pred --------EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 100 --------KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 100 --------~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.+|+++||+++ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999987 67676664 46899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CC-
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EF- 245 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~- 245 (481)
|++........ .......+++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+... ..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99876433221 11222356788999998865544467899999999999999999999877655444333321 10
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 --------------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 --------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.....+++.+.++|.+||..||.+|||+++++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=331.06 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=207.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES----VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.++|++++.||+|+||+||+|.+..+++. +++|.+.... .......+..|+.+++.++||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 46899999999999999999999877764 6777764322 2233466788999999999999999999875 456
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.++++||+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999964 46899999999999999999999999999999999999999999999999999754322
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 22222334567788999999977666 578999999999999998 999998877666555555554 344556788899
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||..||++|||+.|+++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.42 Aligned_cols=247 Identities=21% Similarity=0.396 Sum_probs=209.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|.+ .++..||+|.+..... ..+.+.+|+.+++.++||||+++++++......|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 56899999999999999999986 4567899999865432 246688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 999999999999864 4688999999999999999999999999999999999999999999999999976432111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
.......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+. .+.+..++.++.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11122345678999999877665 568999999999999998 999998877766666665542 334456789999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||..+|++|||++++++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=330.92 Aligned_cols=252 Identities=35% Similarity=0.568 Sum_probs=211.3
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIYFVM 105 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~ 105 (481)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... ...|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999899999999998764 2334456678999999999999999999999888 8999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+++ +|.+.+.. ..+++..++.++.|++.||+|||++|++|+||||+||++++++.++|+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 88888865 3799999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--C----------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--F---------------- 245 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~---------------- 245 (481)
.....++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.... .
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 2344678899999987665444678999999999999999999998877655544443210 0
Q ss_pred -----C--------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 -----R--------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 -----~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ....+++.+.++|.+||..+|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 001137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=333.87 Aligned_cols=248 Identities=24% Similarity=0.416 Sum_probs=208.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGE--SVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (481)
++|++.+.||+|+||.||+|+...++. .+++|.+.... .....+.+.+|+.+++++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877765 46888876322 223456788999999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 011628 103 FVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lk 165 (481)
++|||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999998642 378899999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC
Q 011628 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 166 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 244 (481)
|+|||++........ ......+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+........++..+.
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999864221111 111223557999999877666 578999999999999997 999999888777777776653
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 245 -FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 245 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
...|..+++++.+|+.+||+.+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=333.80 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=209.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCC----------------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSG----------------ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (481)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... ......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876543 5689999876532 2456778899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKG------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 89 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
+++++++......+++|||+.+++|.+++... .+++..++.++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99999999999999999999999999998652 489999999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCCCchHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYLPFQDQNIM 234 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~~~ 234 (481)
+++.++.++|+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999875432221222234566788999999877655 678999999999999998 78899876655
Q ss_pred HHHHHHhhC--------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 235 VMYKKIYKG--------EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 235 ~~~~~i~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+..+... ....+..++.++.+++.+||+.||.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 555444322 12335567889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=333.84 Aligned_cols=254 Identities=22% Similarity=0.415 Sum_probs=213.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEc-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNV-------KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEV 94 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 94 (481)
...++|++++.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 44789999999999999999999753 234579999986542 223456788999999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 011628 95 MATKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLL 157 (481)
Q Consensus 95 ~~~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NIL 157 (481)
+......|++|||+.+|+|.+++... .++...+..++.|++.||.|||++|++||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999999999998642 3677889999999999999999999999999999999
Q ss_pred EccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHH
Q 011628 158 LDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVM 236 (481)
Q Consensus 158 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 236 (481)
++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999876543222222233456778999999977666 568999999999999998 8999998887777
Q ss_pred HHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 237 YKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 237 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
...+..+. ...+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 77776553 34466788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=340.61 Aligned_cols=261 Identities=30% Similarity=0.415 Sum_probs=213.4
Q ss_pred ccCCeeE-EeEecccCceEEEEEEEcCCCcEEEEEEeecccccch-----------hHHHHHHHHHHHHHhCCCCCcceE
Q 011628 24 LLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----------GLVAHIKREISILRRVRHPNIVQL 91 (481)
Q Consensus 24 ~~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l 91 (481)
+.+||.. .+.||+|+||+||+|++..+++.||||++........ .....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4678864 6789999999999999999999999999865432210 011246789999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecC
Q 011628 92 FEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 92 ~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFG 170 (481)
++++......|++|||+. |+|.+.+.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999997 589888865 579999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHH
Q 011628 171 LSAVSDQIR------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK 238 (481)
Q Consensus 171 la~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 238 (481)
++....... .........+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987544110 01122334578899999998765555778999999999999999999998877655544
Q ss_pred HHhhCC--CC--------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 239 KIYKGE--FR--------------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 239 ~i~~~~--~~--------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+.... .. .....+.++.++|.+||+.+|.+|||+++++.||||+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 443210 00 012357789999999999999999999999999999754
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=332.43 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=211.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|.+.+.||+|+||.||+|.+. .++..+++|.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 467999999999999999999854 245679999886443 223456889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 100 KIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
..++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999864 2378999999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.++|+|||++................|++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999875432211112233457889999999987666 568999999999999998 999998887777777676
Q ss_pred hCCC-CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 242 KGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 242 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+.. ..+..++..+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6654 345567899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=332.52 Aligned_cols=249 Identities=24% Similarity=0.403 Sum_probs=208.4
Q ss_pred CeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235789998865432 23346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 102 YFVMEYVRGGELFNKVAK-------------------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
|+++||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999998753 2377889999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMV 235 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~ 235 (481)
|+++++.+||+|||+++...............++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999875432211111223456778999999876665 578999999999999998 999999888777
Q ss_pred HHHHHhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 236 MYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 236 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
....+..+ ....|..++.++.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66665544 24456778999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=325.32 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=209.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++......|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999974 567899999875432 235578899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+.|++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999999752 5899999999999999999999999999999999999999999999999999765421111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
......++..|+|||++.+..+ +.++|+||||+++|+|++ |+.||.+.+.......+.... ...+..++..+.+++
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1111223457999999877665 578999999999999999 999999887777776665542 345666889999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.+|.+||++.+++.
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=335.20 Aligned_cols=251 Identities=24% Similarity=0.425 Sum_probs=210.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-------SGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMA 96 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 96 (481)
.++|.+++.||+|+||.||+|++.. ....+|+|.+.... .......+.+|+.+++.+ .||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 5799999999999999999998642 34579999987543 223456788999999999 6999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD 159 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~ 159 (481)
....+|++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 99999999999999999999864 2378889999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHH
Q 011628 160 ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYK 238 (481)
Q Consensus 160 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 238 (481)
.++.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+....+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999975432211111222334568999999977666 578999999999999999 899999888777777
Q ss_pred HHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 239 KIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 239 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..+. ...+..++.++.+++.+||..||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 766654 3456678889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.61 Aligned_cols=257 Identities=32% Similarity=0.526 Sum_probs=207.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
..++|++.+.||+|+||.||+|.+..+++.+|+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 368999999999999999999999999999999998765422 22234567899999999999999999887443
Q ss_pred ---CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 99 ---SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 99 ---~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
..+|+||||+.+ +|...+.. ..+++..+..++.|+++||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 357999999975 67666653 479999999999999999999999999999999999999999999999999987
Q ss_pred cccccccC---------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC
Q 011628 174 VSDQIRQD---------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 174 ~~~~~~~~---------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 244 (481)
........ .......|++.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54322111 112234678899999998665444678999999999999999999998877665555443210
Q ss_pred C-----------------------CCC-------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 F-----------------------RSP-------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~-----------------------~~~-------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ..+ ..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000 1244678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=352.83 Aligned_cols=245 Identities=34% Similarity=0.545 Sum_probs=216.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
++.+.|++...+|.|+|+.|..+.+..+++..++|++.+.... ..+|+.++... +||||+++++++.++...
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCcee
Confidence 5678999999999999999999999999999999999876322 23577666666 699999999999999999
Q ss_pred EEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE-ccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL-DENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl-~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+|||++.|+.|.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999999999999999987665558888999999999999999999999999999999 58899999999998754332
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCCCCCCCCHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFRSPRWFSPDLIRLL 259 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~s~~~~~li 259 (481)
..+.|-|..|+|||++...+| +..+||||||++||+||+|+.||..... .++..++..+.+. .++|..+++||
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred ---hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 456678899999999998888 5679999999999999999999976544 4777777766655 78999999999
Q ss_pred HHhcccCcCCCCCHhHHHhCccc
Q 011628 260 TKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+||+.||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=326.25 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=208.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||+||.|.+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++......|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 357999999999999999999874 3456999998754321 34578899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+|+|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 999999999999875 3689999999999999999999999999999999999999999999999999875322111 0
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLT 260 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 260 (481)
......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.. ..+...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1112235577999999977666 568999999999999998 9999988877767777766543 345567899999999
Q ss_pred HhcccCcCCCCCHhHHHhC
Q 011628 261 KLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h 279 (481)
+||+.||.+|||+.+|+.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=342.77 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=204.0
Q ss_pred cCCeeEEeEecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARN-----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT- 97 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~- 97 (481)
.++|++++.||+|+||+||+|++ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46899999999999999999985 34678999999975432 23356688999999999 68999999998765
Q ss_pred CCEEEEEEeccCCCchHHHHHcC---------------------------------------------------------
Q 011628 98 KSKIYFVMEYVRGGELFNKVAKG--------------------------------------------------------- 120 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~~--------------------------------------------------------- 120 (481)
...++++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45689999999999999988531
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 121 -----------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 121 -----------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
.++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 256778889999999999999999999999999999999999999999999875422111111123345
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHH-HHHHHHhhC-CCCCCCCCCHHHHHHHHHhcccC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIM-VMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTN 266 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~d 266 (481)
++.|+|||++.+..+ +.++||||||+++|+|++ |..||...... .....+..+ ....|.+.++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 678999999877666 578999999999999997 99999875433 223333333 34557778999999999999999
Q ss_pred cCCCCCHhHHHhC
Q 011628 267 PDKRITIPEIMEN 279 (481)
Q Consensus 267 P~~Rps~~eil~h 279 (481)
|.+|||+.+|++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.86 Aligned_cols=247 Identities=23% Similarity=0.427 Sum_probs=212.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++++.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++......|++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999976 89999999876532 2345688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 999999999999975 3589999999999999999999999999999999999999999999999999875432111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 259 (481)
......++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+....+..+..+ ..+.+..+++.+.++|
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred -cccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 1123345678999999877666 568999999999999998 89999888777777766654 3455677899999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.||.+|||+.+|++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=325.50 Aligned_cols=243 Identities=23% Similarity=0.358 Sum_probs=204.0
Q ss_pred EecccCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 33 LLGHGTFAKVYHARN--VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
.||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.+.||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999964 4578899999987543 23345677889999999999999999999875 4567899999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-CcccccC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD-GLFHTFC 188 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~~~~~ 188 (481)
|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999865 57999999999999999999999999999999999999999999999999998754322110 0112234
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcccC
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTN 266 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 266 (481)
+++.|+|||.+....+ +.++|+|||||++|+|++ |..||...+.......+.++. ...|..+++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876555 568999999999999998 999999887777777776654 4567779999999999999999
Q ss_pred cCCCCCHhHHHh
Q 011628 267 PDKRITIPEIME 278 (481)
Q Consensus 267 P~~Rps~~eil~ 278 (481)
|++||++++|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=333.46 Aligned_cols=253 Identities=29% Similarity=0.506 Sum_probs=215.0
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|+-...||+|+||.||+|.+..+++.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 333478999999999999999999999999985432 23356688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccccc
Q 011628 108 VRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187 (481)
Q Consensus 108 ~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 187 (481)
+++++|.+++..+++++..++.++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 999999999888889999999999999999999999999999999999999999999999999876432211 112345
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHHHHHHHHhcc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~~L~ 264 (481)
.|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+... .......+++.+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 78999999999876665 57899999999999999999999887665544444332 222344578999999999999
Q ss_pred cCcCCCCCHhHHHhCcccccCc
Q 011628 265 TNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 265 ~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.+|.+||++.+++.||||.+..
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CCcccCcCHHHHhcChHHhccC
Confidence 9999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.40 Aligned_cols=249 Identities=22% Similarity=0.436 Sum_probs=216.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..+...++..||+|.||+||+|++.. .||||+++.+.... +..+.+++|+.++++-+|.||+-+.|++..+.. .|
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 35667789999999999999999854 49999998877554 477899999999999999999999999998887 99
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|+.+|+|.+|+.++.- -+|.....+.|++|++.|+.|||.++|+|||||..||++.+++.|||+|||++.........
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 9999999999999864 57999999999999999999999999999999999999999999999999999876655555
Q ss_pred CcccccCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-----CCCCCCH
Q 011628 182 GLFHTFCGTPAYVAPEVLSR---KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-----SPRWFSP 253 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~ 253 (481)
..+....|...|||||+++. .+| +..+||||+||++|||++|.+||...+...+...+-.|... .-..++.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 55667788999999999863 344 67899999999999999999999987777776666666322 2334667
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++++|+..||.+++++||.+.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 8999999999999999999999986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.29 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=214.8
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..+.|...+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++|||++++++++.+....|+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34568888999999999999999989999999999976654444455678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||+.| +|.+.+.. +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----- 172 (313)
T cd06633 99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----- 172 (313)
T ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence 9999964 77777653 568999999999999999999999999999999999999999999999999886422
Q ss_pred CcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--CCCCCCHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIR 257 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~ 257 (481)
......|+..|+|||++.. .+..+.++|||||||++|+|++|..||...+.......+.....+ ....++..+.+
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 1234578999999999842 233356899999999999999999999887765555555444322 12346788999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|+.+||+.+|.+||++.+++.||||+..
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=326.19 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=207.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|++..+ ..||+|++...... ...+.+|+.+++.++||||+++++.+. ....|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 357899999999999999999988655 46999998764421 246788999999999999999999874 456899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~- 156 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 156 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence 9999999999999975 358999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. .+.+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 111223446778999999877666 578999999999999999 899998877766666665542 44456688999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||++||++|||+.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=326.12 Aligned_cols=247 Identities=24% Similarity=0.428 Sum_probs=208.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||.||+|++. ++..+|+|++...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999875 5678999998654322 245678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++|++|.+++.. +.+++..++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||+++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 99999999999864 4689999999999999999999999999999999999999999999999999875432111 01
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 261 (481)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.......+..+ ....|..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 111223457999999987766 568999999999999999 89999887777666666655 345566789999999999
Q ss_pred hcccCcCCCCCHhHHHhC
Q 011628 262 LLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h 279 (481)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=333.47 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=209.9
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVM 95 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 95 (481)
....++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 344678999999999999999999853 345689999987543 223456788999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
...+..|++|||+.+|+|.+++... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999999998652 3899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC--CCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE--FRSPR 249 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~--~~~~~ 249 (481)
................+++.|+|||++.+..+ +.++||||+||++|+|++ |..||........+.+..... ...+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 75432211111123346788999999877666 568999999999999998 999998776554444443332 23456
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..++.+.+++.+||.++|++|||+.++++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 68899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=365.92 Aligned_cols=150 Identities=33% Similarity=0.644 Sum_probs=139.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
.+++|++++.||+|+||+||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 36899999999999999999999999999999999987655555566788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999975 678999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=340.16 Aligned_cols=257 Identities=32% Similarity=0.479 Sum_probs=216.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-----KI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 101 (481)
||++.+.||+|+||.||+|++..+++.||||.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999998899999999987643 22344567889999999999999999999987765 78
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|++|||+.+ +|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999984 88888876 4799999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC--C-----------
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--R----------- 246 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~----------- 246 (481)
........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+....+..+..... .
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 12234456899999999998773446789999999999999999999998876665555443110 0
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 247 ------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 247 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+.+++.+.++|.+||+++|.+|||+++++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 012367889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.62 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=217.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
..-..|+..+.||+|+||.||+|++..++..||+|++.............+.+|+.+++.++|||++++++++......|
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 34455899999999999999999998899999999997654444455677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+||||+.| +|.+.+. ...+++..+..++.|++.|+.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 99999975 7777664 35789999999999999999999999999999999999999999999999998864322
Q ss_pred CCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--CCCCCCHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~ 256 (481)
.....|++.|+|||++.. .+..+.++|+||+||++|+|++|..||...+.......+..+... .+..+++.+.
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 254 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHH
Confidence 234578999999999742 223366899999999999999999999887766666666554432 2345788899
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++|.+||+.+|.+||++.++++|+|+...
T Consensus 255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 99999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.76 Aligned_cols=248 Identities=35% Similarity=0.603 Sum_probs=213.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58999999999999999999988999999999976542 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 107 YVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 107 y~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|++|++|.+++... .+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998764 799999999999999999999999999999999999999999999999999876543221 3
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-C--CCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-F--RSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~--~~~~~~s~~~~~li~~ 261 (481)
....|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.... . ..+..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45578999999999876654 678999999999999999999998875443333333222 2 2233348899999999
Q ss_pred hcccCcCCCCCHhHHHhCcc
Q 011628 262 LLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~ 281 (481)
||+.||.+|||+.+++.|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=329.18 Aligned_cols=247 Identities=31% Similarity=0.537 Sum_probs=204.5
Q ss_pred eEEeEecccCceEEEEEEEc----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 29 EIGKLLGHGTFAKVYHARNV----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
++.+.||.|+||.||+|... ..+..|+||++... ......+.+.+|+.++++++||||+++++++......++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999987 35678999999543 2333467889999999999999999999999988889999
Q ss_pred EeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||+++|+|.+++... .+++.....++.|++.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999764 7999999999999999999999999999999999999999999999999998765221111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
.......+...|+|||.+.+..+ +.++||||||+++||+++ |..||.+.+......++..+. ...+..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 12233456788999999977765 679999999999999999 789999988877777776654 445677899999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=322.93 Aligned_cols=250 Identities=30% Similarity=0.504 Sum_probs=219.5
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5999999999999999999999999999999997654322 334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 107 YVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 107 y~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998865 46899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLT 260 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 260 (481)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.+ ..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 2334568999999999987666 5689999999999999999999998887776666666554 345568899999999
Q ss_pred HhcccCcCCCCCHhHHHhCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f 282 (481)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=335.96 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=211.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-KSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~ 102 (481)
..++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46789999999999999999999999999999999865432 22344667899999999999999999999865 56789
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
+++||+ +++|.+++..+.+++..+..++.|++.||.|||++||+||||+|.||+++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 999998 56899988888899999999999999999999999999999999999999999999999999874322
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------------------- 242 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------------------- 242 (481)
......+++.|+|||++.+....+.++|+||+||++|+|++|..||........+..+.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 223456788999999986644446789999999999999999999987654322211110
Q ss_pred ------CCCCC-----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 ------GEFRS-----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 ------~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..... .+.+++.+.++|.+||+.+|++|||+++++.||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00011 12467889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=339.56 Aligned_cols=254 Identities=31% Similarity=0.503 Sum_probs=209.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|.+.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 456899999999999999999999988999999999876432 223445678999999999999999999998654
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..+|+|+||+.+ +|.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 356999999964 666654 3468999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------ 244 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------ 244 (481)
. ......|++.|+|||++.+....+.++|+|||||++|+|++|+.||.+.+....+..+....
T Consensus 169 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 169 A-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred C-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 2 12345678999999998764444678999999999999999999999876554444333210
Q ss_pred -----------CCC--------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 -----------FRS--------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 -----------~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
... .+..++.+.+||.+||+.||.+||++++++.||||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 000 1235778999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=329.07 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=209.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
..+|.+.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 357889999999999999999743 356789999876432 234567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC
Q 011628 100 KIYFVMEYVRGGELFNKVAKG----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD 163 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~ 163 (481)
..|++|||+++++|.+++... .+++..+..++.|++.|+.|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 999999999999999998642 3788999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhh
Q 011628 164 LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYK 242 (481)
Q Consensus 164 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~ 242 (481)
+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |.+||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999864322111111223345788999999987776 568999999999999998 9999988776666666655
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 243 GE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 243 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+. ...+..+++.+.++|.+||+.||.+||++++|++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 53 4556778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=329.27 Aligned_cols=254 Identities=30% Similarity=0.558 Sum_probs=219.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
....|++.+.||+|+||.||.|.+..+++.||+|++..... ....+.+|+.+++.++|+||+++++++......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 56679999999999999999999988899999999976532 34667899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
++||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999999874 79999999999999999999999999999999999999999999999999886543211
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPDLIRL 258 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~l 258 (481)
.......+++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..... ..+..++..+.++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 12234467899999999877666 5789999999999999999999998776555555443322 2233378899999
Q ss_pred HHHhcccCcCCCCCHhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
|.+||+.+|.+|||+.+++.|+||.+
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=330.27 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=211.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4679999999999999999998743 67899999987543 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 100 KIYFVMEYVRGGELFNKVAKG-----------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~-----------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
..|++|||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999999999998632 367888999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMV 235 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~ 235 (481)
+++.++.++|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999874322111111122345677999999877766 578999999999999997 889998877777
Q ss_pred HHHHHhhCCC-CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 236 MYKKIYKGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 236 ~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
....+..+.. ..|..++.++.+||.+||+.+|.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777766653 446678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=325.36 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=210.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++++.||+|+||.||+|++..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865443 79999986543 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|++|||++|++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999875 468999999999999999999999999999999999999999999999999987643321
Q ss_pred cCC-cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 180 QDG-LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 180 ~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
... ......++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+.........+..+. .+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 111 1111223568999999987666 678999999999999886 999998877666666666542 344556789999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||+++|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.41 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=206.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKS--GESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT----KS 99 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~ 99 (481)
+|++.+.||+|+||.||+|++..+ +..||+|.+.... ........+.+|+.+++++ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 599999999999999999999887 8999999986532 2223346678899999999 59999999987543 24
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+++||+. ++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 588888865 57999999999999999999999999999999999999999999999999999754322
Q ss_pred cc--CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------
Q 011628 179 RQ--DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------- 243 (481)
Q Consensus 179 ~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 243 (481)
.. ........|++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234578999999998765433367899999999999999999999876543333222110
Q ss_pred ------------C---CC---CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 ------------E---FR---SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ------------~---~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .. .....+..+.+++.+||+.||.+|||+.+++.||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 00 112257889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=318.41 Aligned_cols=250 Identities=27% Similarity=0.471 Sum_probs=210.7
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.+.+..||.|+.|+|++++.+.+|...|||.+.+.. ..+..+++.+.+.++...+ +|+||+.+|+|..+..++|.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345678999999999999999999999999997754 3455788999999888876 9999999999999999999999
Q ss_pred ccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
.+.. .+..++. +++++|..+-++...++.||.||.+ +||+|||+||+|||+|+.|++|+||||++...-... .
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A 247 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A 247 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence 9853 4444444 3689999999999999999999985 599999999999999999999999999997643322 2
Q ss_pred ccccCCCCccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCCC-C--CCCCHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRK---GYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFRS-P--RWFSPDLI 256 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~-~--~~~s~~~~ 256 (481)
.....|.+.|||||.+... .| ..++||||||++|+||.||+.||.+.+. -+...++.+.+++. | ..+|+.++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kY-DiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKY-DIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred cccccCCccccCccccCCCCCCcc-chhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 2345799999999998533 45 3579999999999999999999998543 46677777765543 2 23899999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+|+..||.+|+.+||...++|+|||+..
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceee
Confidence 9999999999999999999999999864
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=325.28 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=210.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.+.|++.+.||+|+||.||+|.+..+++ .||||.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999877664 69999986542 234457789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
++||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999874 468999999999999999999999999999999999999999999999999987543222
Q ss_pred cCCcccccC---CCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHH
Q 011628 180 QDGLFHTFC---GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPD 254 (481)
Q Consensus 180 ~~~~~~~~~---gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 254 (481)
......... .+..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 2457999999987776 568999999999999886 99999887776666666543 23445667899
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHh
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+.+++.+||..+|.+||++++|+.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=338.33 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=202.9
Q ss_pred eEeccc--CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHG--TFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
..||+| +||+||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..+...|+|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999998765432 2445788999999999999999999999999999999999999
Q ss_pred CCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC----
Q 011628 110 GGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG---- 182 (481)
Q Consensus 110 gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~---- 182 (481)
+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999999875 358999999999999999999999999999999999999999999999998653221111000
Q ss_pred -cccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---------------
Q 011628 183 -LFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--------------- 245 (481)
Q Consensus 183 -~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------------- 245 (481)
......++..|+|||++.+.. ..+.++||||+||++|+|++|..||.+............+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 001123566799999986632 125789999999999999999999987654433333222111
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 246 --------------------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 246 --------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
+.+..+++.+.+||++||+.||++|||++|+++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 01122567799999999999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=331.66 Aligned_cols=250 Identities=19% Similarity=0.292 Sum_probs=203.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCC--------------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSG--------------ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 91 (481)
++|++.+.||+|+||.||++++..++ ..||+|.+.... .......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 58999999999999999999875432 358999987543 23345678899999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE
Q 011628 92 FEVMATKSKIYFVMEYVRGGELFNKVAKG-------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL 158 (481)
Q Consensus 92 ~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl 158 (481)
++++......|+||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 99999999999999999999999988542 26788899999999999999999999999999999999
Q ss_pred ccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCCCchHHHH
Q 011628 159 DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYLPFQDQNIMVM 236 (481)
Q Consensus 159 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~~~~~ 236 (481)
+.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+....
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999999999875322111112223445778999999877666 678999999999999988 7789987665444
Q ss_pred HHHHhh-----CC---CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 237 YKKIYK-----GE---FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 237 ~~~i~~-----~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
...+.. +. ...+..+++.+.+|+.+||+.||++|||+++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 333321 11 2235557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=336.40 Aligned_cols=253 Identities=23% Similarity=0.413 Sum_probs=211.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKS-------GESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVM 95 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 95 (481)
...+|++++.||+|+||.||.|++... +..||+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 346899999999999999999986432 2368999886542 223456788999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL 158 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl 158 (481)
.....+|++|||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 9999999999999999999998641 36778889999999999999999999999999999999
Q ss_pred ccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHH
Q 011628 159 DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMY 237 (481)
Q Consensus 159 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~ 237 (481)
+.++.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999875433221111222344567999999987766 568999999999999998 89999988877777
Q ss_pred HHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 238 KKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 238 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+..+. ...+..++.++.+++.+||+.+|++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7776553 34566788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.59 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=212.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.++|++++.||+|+||+||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 5789999999999999999999877665 589998865532 3345678899999999999999999999887 78
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+++|||+.+|+|.+.+.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999999875 46899999999999999999999999999999999999999999999999999765422
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........++..|+|||.+....+ +.++|+|||||++|++++ |..||.+.........+..+. .+.|...+..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 11111112234568999999876666 568999999999999998 999999988777777776654 455667889999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||..||+.|||+.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=327.26 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=202.3
Q ss_pred cCCe-eEEeEecccCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-
Q 011628 25 LGRY-EIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK- 98 (481)
Q Consensus 25 ~~~y-~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~- 98 (481)
.+|| ++.+.||+|+||+||++. ...++..||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4677 999999999999998865 335788999999876432 22346678899999999999999999987653
Q ss_pred -CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 -SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+|++|||+.+++|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 4689999999999999999888899999999999999999999999999999999999999999999999999875432
Q ss_pred cccC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH--H-------------HHHHHh
Q 011628 178 IRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM--V-------------MYKKIY 241 (481)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~-------------~~~~i~ 241 (481)
.... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... . ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 1111 11122345677999999877665 57899999999999999999998653211 0 011111
Q ss_pred hC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 242 KG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 242 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+ ..+.+..++..+.+++.+||+.+|++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 12345667899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=323.89 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=207.4
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 4578999999999999999999864 5677999998765432 245789999999999999999999875 456899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999999999864 3589999999999999999999999999999999999999999999999999975432111
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
.......++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ..+.+...+..+.+|
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 11122335667999999876665 568999999999999999 99999888777766666554 345566788999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||.++|++|||++++.+
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=330.35 Aligned_cols=251 Identities=20% Similarity=0.309 Sum_probs=204.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK----------------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (481)
.++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986532 34579999987542 23345678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKG------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 89 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
+++++++......|++|||+.+++|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999998652 256778999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCCCchHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYLPFQDQNIM 234 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~~~ 234 (481)
|++.++.++|+|||+++...............+++.|+|||+..+..+ +.++|+|||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999875422111111223345678999998876666 678999999999999998 78999876654
Q ss_pred HHHHHHhh--------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 235 VMYKKIYK--------GEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 235 ~~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
........ ...+.+..+++.+.+|+.+||+.||++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 44332211 123445668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=344.46 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=207.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
.++|.+++.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.++.++. ||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 467889999999999999999964 345689999997543 2233456889999999997 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcC----------------------------------------------------------
Q 011628 99 SKIYFVMEYVRGGELFNKVAKG---------------------------------------------------------- 120 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~---------------------------------------------------------- 120 (481)
+.+|+||||+++|+|.+++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999999988532
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc
Q 011628 121 -----------------------------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD 159 (481)
Q Consensus 121 -----------------------------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~ 159 (481)
.++...++.++.||+.||.|||++|++||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 245667888999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHH
Q 011628 160 ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYK 238 (481)
Q Consensus 160 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 238 (481)
.++.+||+|||+++...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||..........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999975432111111223467889999999987666 678999999999999998 899998765444333
Q ss_pred H-HhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 239 K-IYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 239 ~-i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
. +..+ ....|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 3333 244567789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=346.74 Aligned_cols=257 Identities=34% Similarity=0.599 Sum_probs=221.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.-|..++.||-|+||+|.+++..+|...+|+|.+++..+...+.+..++.|-.||..-..+.||++|..|.+.+++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45888999999999999999999999999999999988877778888999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR----- 179 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~----- 179 (481)
+|++||++..++-+ |-|+|+.++.|+.+|..|+++.|..|+|||||||+|||||.+|++||+||||++-+...-
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999988754 889999999999999999999999999999999999999999999999999986432100
Q ss_pred -------cCC----------------------------cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC
Q 011628 180 -------QDG----------------------------LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG 224 (481)
Q Consensus 180 -------~~~----------------------------~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg 224 (481)
.+. ..+..+||+.|+|||++...+| +..+|.||.|||||||+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHhhC
Confidence 000 1145689999999999999998 5679999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhC----CCCCCCCCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 225 YLPFQDQNIMVMYKKIYKG----EFRSPRWFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 225 ~~Pf~~~~~~~~~~~i~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
+.||.+.++.+...++.+= .+.....+|+++.++|.++. .+++.|.. .+|+..||||+-
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 9999888766554444321 34556679999999999854 57778874 778999999964
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=329.99 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=205.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv 104 (481)
++|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4577788999999999999999999999999998765322 34566889999999996 99999999999999999999
Q ss_pred EeccCCCchHH---HHH---cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 105 MEYVRGGELFN---KVA---KGRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 105 ~Ey~~gg~L~~---~i~---~~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
|||+.+ +|.+ .+. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999875 4433 322 25799999999999999999999975 999999999999999999999999999865322
Q ss_pred cccCCcccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCC-CC----CC
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEF-RS----PR 249 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~-~~----~~ 249 (481)
........|++.|+|||++.+. ...+.++||||+||++|+|++|..||..... .....++..+.. .. +.
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 ---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred ---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1112334689999999998765 2336789999999999999999999976542 222333333322 11 22
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+++++.+||.+||++||++|||+++|++||||++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 37889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=321.87 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=205.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ....+.+|+.+++.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 357899999999999999999987544 5699998865432 2355788999999999999999999875 456899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence 9999999999999965 247899999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
........++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.........+..+ ....+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 111122345678999999876665 678999999999999999 99999988776666666554 234466688999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||.+||++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.00 Aligned_cols=247 Identities=22% Similarity=0.402 Sum_probs=207.7
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.+++.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 457899999999999999999986 46788999998754422 356788999999999999999999864 457899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999999999864 3689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
.......++..|+|||++....+ +.++||||||+++|+|++ |.+||.+.+.......+..+. ...+...+.++.++
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred -ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11123345678999999877665 578999999999999998 999999887766666665542 34566688999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
|.+||+.+|++|||+++++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.51 Aligned_cols=243 Identities=25% Similarity=0.376 Sum_probs=203.4
Q ss_pred eEecccCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNVKSG---ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. ...++++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876654 78999999766532 34567889999999999999999999876 45689999999
Q ss_pred CCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC-cccc
Q 011628 109 RGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG-LFHT 186 (481)
Q Consensus 109 ~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~~~~ 186 (481)
.+|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999976 459999999999999999999999999999999999999999999999999987543221110 0111
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcc
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 264 (481)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..+++.++++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123467999999977666 568999999999999998 999998887766666665553 35577789999999999999
Q ss_pred cCcCCCCCHhHHHh
Q 011628 265 TNPDKRITIPEIME 278 (481)
Q Consensus 265 ~dP~~Rps~~eil~ 278 (481)
.+|++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=327.84 Aligned_cols=251 Identities=35% Similarity=0.589 Sum_probs=211.0
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++.+.||+|++|.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++..+..+|+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999889999999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 108 VRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 108 ~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
+.+ +|.+.+.. +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 88887765 479999999999999999999999999999999999999999999999999987554322 1223
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------------CC
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------FR 246 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------~~ 246 (481)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+......++.... ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 35678899999998776344778999999999999999999998877655544432210 00
Q ss_pred -----------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 -----------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 -----------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..+.++.++.++|.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 012357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=319.93 Aligned_cols=242 Identities=26% Similarity=0.477 Sum_probs=209.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++......|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 46899999999999999999987 589999999976532 356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 9999999999998753 58999999999999999999999999999999999999999999999999987642211
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 259 (481)
....++..|+|||++....+ +.++|+||||+++|+|++ |..||...+.......+..+ ....+..+++.+.++|
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 12344667999999876655 568999999999999997 99999888777666665544 3345667899999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||..+|++|||+.++++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 233 KDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.10 Aligned_cols=242 Identities=23% Similarity=0.361 Sum_probs=201.9
Q ss_pred EecccCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 33 LLGHGTFAKVYHARNV--KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999875 345679999987543 2344567889999999999999999999875 4578999999999
Q ss_pred CchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-Cccccc
Q 011628 111 GELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD-GLFHTF 187 (481)
Q Consensus 111 g~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~~~~ 187 (481)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......... ......
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999864 57999999999999999999999999999999999999999999999999998754321111 011112
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhccc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 265 (481)
.+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...|...++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 33578999999877666 568999999999999996 999999887777766666654 456777899999999999999
Q ss_pred CcCCCCCHhHHHh
Q 011628 266 NPDKRITIPEIME 278 (481)
Q Consensus 266 dP~~Rps~~eil~ 278 (481)
||++||++.+|.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=324.24 Aligned_cols=252 Identities=31% Similarity=0.553 Sum_probs=212.9
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
||.+.+.||+|+||.||++.+..++..+++|++...... .......+.+|+.+++.++||||+++++.+......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 799999999999999999999888777877776543221 112334567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 105 MEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+||+++++|.+.+.. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999988753 46899999999999999999999999999999999999975 5799999999875432
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRL 258 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~l 258 (481)
.........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+..+.. ..+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 1222334568899999999877666 4679999999999999999999988777666666666543 3456688999999
Q ss_pred HHHhcccCcCCCCCHhHHHhCccc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f 282 (481)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=323.00 Aligned_cols=260 Identities=29% Similarity=0.500 Sum_probs=211.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-K 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~ 98 (481)
....|++...||+|+||.||+|..+.++. .+|||.+.-++. ..+.....-||+.+++.++||||+.+..++.+ +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 46789999999999999999997655433 689999976643 22445667899999999999999999999977 8
Q ss_pred CEEEEEEeccCCCchHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC----CCEEEEe
Q 011628 99 SKIYFVMEYVRGGELFNKVAK------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN----GDLKVSD 168 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~----g~lkl~D 168 (481)
..+|+++||++. +|.+.|.- ..++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999986 88888853 358999999999999999999999999999999999999988 8999999
Q ss_pred cCCcccccccccC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---------HHHHH
Q 011628 169 FGLSAVSDQIRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---------MVMYK 238 (481)
Q Consensus 169 FGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---------~~~~~ 238 (481)
||+++++...-.. ......+-|.+|+|||.+.+...++.+.|+|+.|||+.||++-++-|.+... .....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999987643221 1334567799999999999988889999999999999999998888754321 12233
Q ss_pred HHhh--CCC---------CCCCC--------------------------CCHHHHHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 239 KIYK--GEF---------RSPRW--------------------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 239 ~i~~--~~~---------~~~~~--------------------------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
+|++ |-+ ..|.+ -++...+|+.+||..||.+|+|+++.++|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 3322 100 11211 2455899999999999999999999999999
Q ss_pred cccC
Q 011628 282 FRKG 285 (481)
Q Consensus 282 f~~~ 285 (481)
|++.
T Consensus 340 F~~d 343 (438)
T KOG0666|consen 340 FTED 343 (438)
T ss_pred cccC
Confidence 9865
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.41 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=209.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-KS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~ 99 (481)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.+++.++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4689999999999999999999876 35889999886432 33445778899999999999999999998765 56
Q ss_pred EEEEEEeccCCCchHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecC
Q 011628 100 KIYFVMEYVRGGELFNKVAK---------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~---------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFG 170 (481)
..++++||+.+++|.+++.. ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 78999999999999999864 348899999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCC
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSP 248 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~ 248 (481)
+++...............++..|+|||++.+..+ +.++|||||||++|++++ |..||...+.......+..+. +..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 9975422111111122345678999999977666 578999999999999999 999999887777666665543 3445
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=325.93 Aligned_cols=258 Identities=33% Similarity=0.575 Sum_probs=215.0
Q ss_pred CeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
+|++.+.||+|+||.||+|++. .+++.||||++.+.... .......+.+|+.+++++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998754322 223446678999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+.||+|.+.+.. +.+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 999999999999999875 578999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCch----HHHHHHHHhhCCCCCCCCCCHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKGEFRSPRWFSPDL 255 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 255 (481)
.......+|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... .......+.......|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11123456899999999986543 23568999999999999999999996432 23444555566667777889999
Q ss_pred HHHHHHhcccCcCCCCC---HhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRIT---IPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps---~~eil~h~~f~~~ 285 (481)
.++|.+||+.||++||| +.++++||||+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5678999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=319.82 Aligned_cols=241 Identities=27% Similarity=0.460 Sum_probs=205.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA-TKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~l 103 (481)
..+|++.+.||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.++++++|||++++++++. .....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 45899999999999999999976 58889999986432 2456789999999999999999999764 5567999
Q ss_pred EEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-- 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--
Confidence 99999999999998752 3789999999999999999999999999999999999999999999999998743221
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
.....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...+..+++.+.++
T Consensus 156 ---~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 ---QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred ---CCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 123345678999999877666 568999999999999997 999999887777766665553 34466789999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||+.+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=322.16 Aligned_cols=258 Identities=33% Similarity=0.630 Sum_probs=231.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (481)
-..+|.++++||+|+|++|.+++.++|.+.+|+|+++++-..+.+.+..+..|-.+..+- +||.+|-++.+|.++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 367999999999999999999999999999999999998877777777777788777766 6999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|.||++||+|.-.+++ ++++|+.++.|...|+.||.|||++||++||||..|+|+|..|++||+|+|+++. .....
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l~~g 405 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GLGPG 405 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CCCCC
Confidence 99999999999666654 7899999999999999999999999999999999999999999999999999874 23455
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-------ch-HHHHHHHHhhCCCCCCCCCCH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-------QN-IMVMYKKIYKGEFRSPRWFSP 253 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-------~~-~~~~~~~i~~~~~~~~~~~s~ 253 (481)
....+.||||.|+|||++.+..| +..+|.|+|||+++||++|+.||+- .+ ...+++-|.....+.|..+|-
T Consensus 406 d~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv 484 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV 484 (593)
T ss_pred cccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence 56788999999999999999988 6789999999999999999999952 22 345677778888999999999
Q ss_pred HHHHHHHHhcccCcCCCC------CHhHHHhCccccc
Q 011628 254 DLIRLLTKLLDTNPDKRI------TIPEIMENRWFRK 284 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rp------s~~eil~h~~f~~ 284 (481)
.+..+++..|++||.+|. ...++..|+||+.
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 999999999999999996 4789999999973
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=329.74 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=213.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
...+|...+.||+|+||.||+|++..+++.+|+|.+............++.+|+.+++.++|||++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34568889999999999999999999999999999876443333445678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||+. |+|.+.+. ...+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 999997 57777664 34689999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--CCCCCCHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIR 257 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~ 257 (481)
.....|++.|+|||++.+ ....+.++|||||||++|+|++|..||...+.......+..+..+ .+..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 123568899999999742 222356899999999999999999999877655444444444322 23457888999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||.+||..+|++||+++++++|||+.+
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCccccc
Confidence 999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=319.98 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=209.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4578999999999999999999876654 79999986543 223356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+||||+++++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999864 578999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCcc-cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 180 QDGLF-HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 180 ~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..... .....++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. .+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11223457999999977666 578999999999999997 999998877766666665542 334455789999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||..+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=318.83 Aligned_cols=248 Identities=23% Similarity=0.410 Sum_probs=210.8
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|.+. .++.||||.+..... ....+.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3578999999999999999999974 567899999875442 23567899999999999999999999999899999
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999999965 3689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
.......++..|+|||.+.+..+ +.++|+||+|+++|+|++ |+.||.+.+.......+..+ ....+...+.++.++
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11112234578999999987665 678999999999999998 99999888777777777655 344566678999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||+.+|.+||+++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=312.08 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=205.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK-----S 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 99 (481)
..||++.+.||+|||+.||++++..+++.+|+|.+.... .+..+.+.+|+...++++|||+++++++...+ .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 579999999999999999999999999999999997664 23467788999999999999999998776433 3
Q ss_pred EEEEEEeccCCCchHHHHHc----C-CCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 KIYFVMEYVRGGELFNKVAK----G-RLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~----~-~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..||+++|...|+|.+.++. | -++|.++..|+.++++||++||+.. .+||||||.|||+.+.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 59999999999999998864 3 5999999999999999999999998 999999999999999999999999998
Q ss_pred ccccccccCC-------cccccCCCCccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCchH--HHHHHHHh
Q 011628 173 AVSDQIRQDG-------LFHTFCGTPAYVAPEVLSRKGY--DAAKVDIWSCGVILFVLMAGYLPFQDQNI--MVMYKKIY 241 (481)
Q Consensus 173 ~~~~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~ 241 (481)
+...-.-... ....-..|..|+|||.+.-+.+ .+.++|||||||+||+|+.|.-||+..-. ..+.-.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 7532211110 0112346889999999854433 25789999999999999999999964321 12222334
Q ss_pred hCCCCCC--CCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGEFRSP--RWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++.+..| ..+|..+.++|+.||+.||.+||++.+++.+
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 4444433 3489999999999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=342.77 Aligned_cols=251 Identities=25% Similarity=0.445 Sum_probs=214.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc---E-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE---S-VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.++-.+.+.||+|+||.||+|+.+..+. . ||+|....+..........+.+|.++|++++|||||++||+.....-
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455667999999999999999765422 3 89999876444455677889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
+|+|||+|.||+|.+++++. .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.....
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 99999999999999999873 4999999999999999999999999999999999999999999999999998754321
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDL 255 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~ 255 (481)
..... ...-...|+|||.+...-| +.++||||+||++||+++ |..||.+........+|.... .+.|...+.++
T Consensus 316 ~~~~~--~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 316 VMKKF--LKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred eeccc--cccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 11110 1124578999999987755 789999999999999999 889999999999999996554 34566678889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHh
Q 011628 256 IRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..++.+|+..||++|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999875
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.35 Aligned_cols=251 Identities=36% Similarity=0.596 Sum_probs=210.8
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++.+.||+|+||.||.|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+...+++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 778899999999999999999999999999998654 2233456677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 108 VRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 108 ~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
+.+ +|.+++... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cccC
Confidence 984 899999764 79999999999999999999999999999999999999999999999999987543321 1223
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--------------------CC
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--------------------EF 245 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------------------~~ 245 (481)
...++..|+|||.+.+....+.++|+|||||++|+|++|..||...+......++... .+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 3456788999999876644477899999999999999999999887655544443221 00
Q ss_pred C---------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 R---------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 ~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+ ..+.++..+.++|.+||+.||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 011247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.30 Aligned_cols=256 Identities=32% Similarity=0.565 Sum_probs=211.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----- 97 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----- 97 (481)
....+|+.++.||+||||.||+++++-+|+.||||.|.... .......+.+|+..+.+|+|||||++|..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 35677888999999999999999999999999999998764 33456779999999999999999999832210
Q ss_pred --------------------------------------------------------------------------------
Q 011628 98 -------------------------------------------------------------------------------- 97 (481)
Q Consensus 98 -------------------------------------------------------------------------------- 97 (481)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------CEEEEEEeccCCCchHHHHHcCCCC--HHHHHHHHHHHHHHHHHH
Q 011628 98 --------------------------K--------SKIYFVMEYVRGGELFNKVAKGRLK--EDLARKYFQQLISAVGFC 141 (481)
Q Consensus 98 --------------------------~--------~~~~lv~Ey~~gg~L~~~i~~~~l~--e~~~~~~~~ql~~al~yL 141 (481)
+ ..+||-||||+...|.+++..+.+. .+.+|++|+||++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 1268999999999999999887664 889999999999999999
Q ss_pred HHcCceecCCCCCcEEEccCCCEEEEecCCccccc----c------------cccCCcccccCCCCccccccccccCC--
Q 011628 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD----Q------------IRQDGLFHTFCGTPAYVAPEVLSRKG-- 203 (481)
Q Consensus 142 H~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~APEvl~~~~-- 203 (481)
|++||+||||||.||++++++.|||+|||+|+... . ....+..+..+||..|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998611 0 01122345679999999999997765
Q ss_pred CCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCCCCCCCCC----CHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 204 YDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRSPRWF----SPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 204 ~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~----s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..|+|+|||||||+||+. ||.. .........+.++.++.|..+ -+.-..+|+.||+.||.+|||+.|+|+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 23679999999999999984 5654 344566777777777766322 234678999999999999999999999
Q ss_pred Ccccc
Q 011628 279 NRWFR 283 (481)
Q Consensus 279 h~~f~ 283 (481)
+.||.
T Consensus 871 s~llp 875 (1351)
T KOG1035|consen 871 SELLP 875 (1351)
T ss_pred ccCCC
Confidence 99987
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=318.25 Aligned_cols=243 Identities=25% Similarity=0.438 Sum_probs=205.1
Q ss_pred eEecccCceEEEEEEEcC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNVK-SGE--SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||+|.+.. +++ .||||.+...... ...+.+.+|+.++++++||||+++++++.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876543 556788999999999999999999999988 8899999999
Q ss_pred CCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-Ccc
Q 011628 109 RGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD-GLF 184 (481)
Q Consensus 109 ~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~ 184 (481)
++++|.+.+... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999998753 5899999999999999999999999999999999999999999999999998765332111 111
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 261 (481)
....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+... ....+..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 23457788999999877666 568999999999999998 99999887776666665532 233455678999999999
Q ss_pred hcccCcCCCCCHhHHHh
Q 011628 262 LLDTNPDKRITIPEIME 278 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~ 278 (481)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=316.85 Aligned_cols=243 Identities=28% Similarity=0.432 Sum_probs=205.3
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999877 999999998765432 34567889999999999999999999999999999999999999
Q ss_pred chHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 112 ELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 112 ~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999865 4689999999999999999999999999999999999999999999999999875432111111112234
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcccCc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP 267 (481)
+..|+|||++.+..+ +.++|+|||||++|+|++ |..||...........+..+ ....|..++..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999877665 678999999999999998 89999887766666666544 344566788999999999999999
Q ss_pred CCCCCHhHHHh
Q 011628 268 DKRITIPEIME 278 (481)
Q Consensus 268 ~~Rps~~eil~ 278 (481)
.+|||+.|+++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=322.70 Aligned_cols=249 Identities=32% Similarity=0.504 Sum_probs=206.5
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE----
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMATKSK---- 100 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~---- 100 (481)
|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988899999999975543 223334566788877766 59999999999988776
Q ss_pred -EEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 101 -IYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 101 -~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
++++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78888765 258999999999999999999999999999999999999999999999999987653
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-------C---
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-------R--- 246 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------~--- 246 (481)
.. .......++..|+|||++.+..+ +.++|+||+||++|+|++|..||.+.+..+...++..... .
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 32 12234457889999999987665 5789999999999999999999998876666555543100 0
Q ss_pred -----------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 -----------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 -----------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
....+++.+.++|.+||+.||.+||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001245778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=316.71 Aligned_cols=248 Identities=24% Similarity=0.410 Sum_probs=209.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 357999999999999999999874 4778999998654322 24577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+++|.+++.. +.++++.++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence 999999999999864 468999999999999999999999999999999999999999999999999987542211 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLT 260 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 260 (481)
......++..|+|||++.+..+ +.++|+||||+++|+|++ |..||...........+..+. ...|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 1122335678999999977666 568999999999999998 999999887777777766553 3345667899999999
Q ss_pred HhcccCcCCCCCHhHHHhC
Q 011628 261 KLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h 279 (481)
+||+.+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=321.01 Aligned_cols=241 Identities=24% Similarity=0.429 Sum_probs=200.9
Q ss_pred eEecccCceEEEEEEEcCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNVKSGE--SVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||+|++..++. .+|+|.+.... .......+.+|+.+++++ +||||+++++++.....+|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988776 46888876432 223456788999999999 7999999999999999999999999
Q ss_pred CCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 109 RGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 109 ~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
++|+|.+++... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998642 378899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCC
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPR 249 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~ 249 (481)
+........ ......++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+....+..+..+. ...+.
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhhh---ccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 863221111 112234567999999877666 578999999999999997 999998877776666665542 34455
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.++.++.+++.+||..||.+|||++++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 67899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=315.24 Aligned_cols=242 Identities=29% Similarity=0.481 Sum_probs=203.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|.. .++..+|+|++.... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4689999999999985 478899999987543 2233456889999999999999999999999999999999999999
Q ss_pred chHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 112 ELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 112 ~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .......+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 99999864 4689999999999999999999999999999999999999999999999999864322111 11112244
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcccCc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP 267 (481)
++.|+|||++.+..+ +.++||||||+++|++++ |..||...+.......+..+. ...+..++..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999876655 678999999999999998 999998877766666665543 34566789999999999999999
Q ss_pred CCCCCHhHHHh
Q 011628 268 DKRITIPEIME 278 (481)
Q Consensus 268 ~~Rps~~eil~ 278 (481)
++|||+.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=316.28 Aligned_cols=247 Identities=28% Similarity=0.475 Sum_probs=210.9
Q ss_pred eeEEeEecccCceEEEEEEEcCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSG----ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+++.+.||+|+||.||+|.+..++ ..||+|++..... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467899999999999999998766 8999999965532 2245778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcC--C-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAKG--R-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~--~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||++|++|.+.+... . +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998753 2 99999999999999999999999999999999999999999999999999876543211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
... ....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.......+..+. ...+..++.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 11236789999999866555 678999999999999998 899999887777777776654 34466789999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||..||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=345.19 Aligned_cols=254 Identities=25% Similarity=0.546 Sum_probs=220.9
Q ss_pred cCCe-eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 011628 25 LGRY-EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-LKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK-- 100 (481)
Q Consensus 25 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 100 (481)
.+|| +....||+|+|-+||+|.|..+|-.||--.+..... .......++..|+.+|+.|+|||||++|++|.+..+
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 5778 668899999999999999999999998554443333 344567889999999999999999999999988665
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCcEEEccC-CCEEEEecCCccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR--GVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSD 176 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~--gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~ 176 (481)
+.+|+|.+.+|+|+.++++ ++++...++.|.+||+.||.|||++ .|+|||||-+||+|+.+ |.|||+|+|||++..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8899999999999999987 7899999999999999999999998 49999999999999875 899999999998754
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCCCCC--CCCCCH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRS--PRWFSP 253 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~--~~~~s~ 253 (481)
. ......+|||.|||||+.. ..|+ ..+||||||..+.||+|+..||.. .++..+|+++..|..+. ..--.|
T Consensus 198 ~----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 198 K----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred c----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 3 2344579999999999986 5675 579999999999999999999987 57889999999986432 222478
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++++||.+||.. ...|+|+.|+|+||||...
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999999 8999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=318.75 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=208.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 35699999999999999999987544 3468999886543 22345678899999999999999999998875 457
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|++|||+++|+|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 899999999999999975 358999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
.. ......+++.|+|||.+....+ +.++|||||||++|+|++ |..||...........+..+. ...|..+++.+.+
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 162 YY-KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred ce-ecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 11 1112334568999999877666 578999999999999986 999998887766666666553 4557778999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhC
Q 011628 258 LLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h 279 (481)
+|.+||..+|.+|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.32 Aligned_cols=248 Identities=22% Similarity=0.385 Sum_probs=207.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 35789999999999999999999864 56679999886532 234568889999999999999999999887 7789
Q ss_pred EEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 103 FVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999975 357888999999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
........++..|+|||++....+ +.++|+|||||++|++++ |..||.+.+.......+..+. ...+...+.++.+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred -cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 111122345677999999976655 668999999999999998 999999877666666655543 3445678899999
Q ss_pred HHHHhcccCcCCCCCHhHHHh
Q 011628 258 LLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~ 278 (481)
++.+||+++|++||++.+++.
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=329.14 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=199.7
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
.+++.+|.| |.||.+++..+++.||||++..... .......+.+|+.+++.++||||+++++++......|++|||+
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 344444444 5556666666999999999986532 2345678999999999999999999999999999999999999
Q ss_pred CCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc-----
Q 011628 109 RGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ----- 180 (481)
Q Consensus 109 ~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~----- 180 (481)
.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999999875 3689999999999999999999999999999999999999999999999998864321111
Q ss_pred CCcccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF------------- 245 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------- 245 (481)
........++..|+|||++.+. ++ +.++|+||+||++|+|++|..||..............+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1112344678889999998653 34 5689999999999999999999987654332222111110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 ---------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 ---------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+..++.++.+|+.+||..||++|||++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0011234678899999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=325.93 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=206.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..+|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4678999999999999999999887776 47888876543 223344678999999999999999999998754 4
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.++++||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6799999999999999875 36899999999999999999999999999999999999999999999999999764332
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ++.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22112223456778999999877666 578999999999999997 999998876555444444433 444566788999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h 279 (481)
+++.+||..+|++||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=320.37 Aligned_cols=250 Identities=23% Similarity=0.396 Sum_probs=210.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.+|++.+.||+|+||.||+|+.+. +.+.||+|.+.... .......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999754 34679999886543 22356778899999999999999999999999899
Q ss_pred EEEEEeccCCCchHHHHHc-C---------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecC
Q 011628 101 IYFVMEYVRGGELFNKVAK-G---------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~---------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFG 170 (481)
.|+||||+++|+|.+++.. . .+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999999875 3 48999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCCC--CC
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEF--RS 247 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~--~~ 247 (481)
++...... .........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+..+.. ..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 98643211 1112233456788999999876665 568999999999999998 8999987766666666665543 34
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+..++..+.+++.+||+.+|.+|||+.+++..
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=321.61 Aligned_cols=238 Identities=24% Similarity=0.373 Sum_probs=197.6
Q ss_pred eEecccCceEEEEEEEcCCCcE-------EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 32 KLLGHGTFAKVYHARNVKSGES-------VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~-------vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+.||+|+||.||+|.+..++.. +|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4689999999999998665443 8888875432 23456678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--------EEEEecCCccc
Q 011628 105 MEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD--------LKVSDFGLSAV 174 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~--------lkl~DFGla~~ 174 (481)
|||+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999999753 5899999999999999999999999999999999999988765 69999998864
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCchHHHHHHHHhhCCCCCCCCCCH
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIMVMYKKIYKGEFRSPRWFSP 253 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 253 (481)
... .....+++.|+|||++.+....+.++|||||||++|+|++| ..||...+..... .........|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 321 12356889999999997655446789999999999999998 5777665544332 234445566666788
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++.+||.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=322.24 Aligned_cols=249 Identities=35% Similarity=0.544 Sum_probs=206.3
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 106 (481)
|++.+.||+|+||+||+|.+..+++.||||.+....... ......+|+..+++++ ||||+++++++..+...|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 789999999999999999998899999999986543221 1223457999999999 9999999999999999999999
Q ss_pred ccCCCchHHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+ +|+|.+.+.. . .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 99 7799888865 2 6899999999999999999999999999999999999999999999999998754321 22
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--C-----------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--E----------------- 244 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~----------------- 244 (481)
.....|+..|+|||++.+....+.++|+||||+++++|++|..||...+....+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999999865544467899999999999999999999877654444333210 0
Q ss_pred CC-----------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 FR-----------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.. .....++.+.++|++||+.+|++|||++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=319.29 Aligned_cols=244 Identities=20% Similarity=0.303 Sum_probs=192.8
Q ss_pred eEecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 468999999999997533 44578888875432 22344567889999999999999999999999999999999999
Q ss_pred CCchHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 110 GGELFNKVAKG------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 110 gg~L~~~i~~~------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|+|.+++... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998652 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred ccccCCCCccccccccccC------CCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCC-----CCCC
Q 011628 184 FHTFCGTPAYVAPEVLSRK------GYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFR-----SPRW 250 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~------~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~-----~~~~ 250 (481)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||...........+... ... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233467789999997532 223568999999999999999 89999887655554444332 222 2335
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+.+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=320.67 Aligned_cols=237 Identities=24% Similarity=0.350 Sum_probs=193.4
Q ss_pred EecccCceEEEEEEEcCC------------------------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011628 33 LLGHGTFAKVYHARNVKS------------------------GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~------------------------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (481)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2358899886542 2334567889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----
Q 011628 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---- 162 (481)
Q Consensus 89 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---- 162 (481)
+++++++......|+||||+++|+|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998864 5789999999999999999999999999999999999998654
Q ss_pred ---CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHh-cCCCCCCCchHHHHHH
Q 011628 163 ---DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLM-AGYLPFQDQNIMVMYK 238 (481)
Q Consensus 163 ---~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ell-tg~~Pf~~~~~~~~~~ 238 (481)
.+|++|||++..... .....++..|+|||.+.+....+.++|||||||++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753211 122357888999999876444467899999999999985 7999998766544322
Q ss_pred HHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 239 KIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 239 ~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
........|...++.+.++|.+||+.+|++|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2333344555567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=351.02 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=216.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
...-+..+.||+|+||+||+|+... ....||||.++... ......+|+||++++..++|||||+++|+|..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 4566778999999999999998642 34679999997654 3346789999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-C----------C----CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCE
Q 011628 100 KIYFVMEYVRGGELFNKVAK-G----------R----LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~----------~----l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~l 164 (481)
-+|+|+||+..|+|.+++.. + . ++..+...++.||+.|++||-++.++||||-..|+||.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 99999999999999999853 1 1 7788999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC
Q 011628 165 KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG 243 (481)
Q Consensus 165 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~ 243 (481)
||+|||+++..=............-..+|||||.+....| +.+|||||+||+|||+++ |..||.+....+....|..|
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 9999999984211111111112233578999999988888 668999999999999998 99999999999999999988
Q ss_pred C-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 244 E-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 244 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
. ++.|..+|.++.+|+..||+.+|.+||++.||-.
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 7 6789999999999999999999999999999854
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=320.99 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=201.0
Q ss_pred eeEEeEecccCceEEEEEEE----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 011628 28 YEIGKLLGHGTFAKVYHARN----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKI 101 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 101 (481)
|++.+.||+|+||.||.|+. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 68999999999999999984 3578899999986543 233456789999999999999999999998775 578
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
++||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999999999999865 358999999999999999999999999999999999999999999999999987543221
Q ss_pred cC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch---------------HHHHHHHHhhC
Q 011628 180 QD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN---------------IMVMYKKIYKG 243 (481)
Q Consensus 180 ~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---------------~~~~~~~i~~~ 243 (481)
.. .......|+..|+|||++.+..+ +.++|||||||++|+|+++..|+.... .......+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 11 11234567778999999877665 568999999999999999876653211 11111112222
Q ss_pred -CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 244 -EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 244 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+.+..+++.+.+|+.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 233456688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.17 Aligned_cols=245 Identities=23% Similarity=0.389 Sum_probs=199.8
Q ss_pred eEecccCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEec
Q 011628 32 KLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA-TKSKIYFVMEY 107 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lv~Ey 107 (481)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++. .+...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 34579999885432 2334567889999999999999999999765 45668999999
Q ss_pred cCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc--CCc
Q 011628 108 VRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGL 183 (481)
Q Consensus 108 ~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~ 183 (481)
+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999875 3567788899999999999999999999999999999999999999999999874322110 011
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 261 (481)
.....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..+. ...+..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 123346778999999877666 578999999999999999 577888777766666666654 34466678999999999
Q ss_pred hcccCcCCCCCHhHHHhC
Q 011628 262 LLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h 279 (481)
||..+|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.95 Aligned_cols=238 Identities=24% Similarity=0.354 Sum_probs=194.7
Q ss_pred eEecccCceEEEEEEEcC------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 32 KLLGHGTFAKVYHARNVK------------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
+.||+|+||+||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 23358999876542 234456788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-------EEEEecC
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD-------LKVSDFG 170 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~-------lkl~DFG 170 (481)
..+++|||+++|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888864 46899999999999999999999999999999999999987764 8999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHh-cCCCCCCCchHHHHHHHHhhCCCCCCC
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLM-AGYLPFQDQNIMVMYKKIYKGEFRSPR 249 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~ 249 (481)
++..... .....|+..|+|||.+......+.++|||||||++|+|+ .|..||......+.. ....+......
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 8864321 123467889999999875444467899999999999997 599999876654432 33344444444
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=318.90 Aligned_cols=244 Identities=24% Similarity=0.393 Sum_probs=202.5
Q ss_pred eEecccCceEEEEEEEcCCC------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 32 KLLGHGTFAKVYHARNVKSG------ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+.||+|+||.||+|++.... +.+|+|.+.... .......+.+|+.+++.++||||+++++++......|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999986543 689999886542 1233456888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-----CEEEEecCCc
Q 011628 106 EYVRGGELFNKVAK--------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-----DLKVSDFGLS 172 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-----~lkl~DFGla 172 (481)
||++|++|.+++.. ..+++..+..++.|++.|+.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999999863 2378899999999999999999999999999999999999887 8999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRW 250 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 250 (481)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75322111111123345788999999977666 678999999999999998 99999887766666665543 3455677
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++..+.++|.+||..+|.+||+++++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.68 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=207.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 103 (481)
.+.|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.++..+. ||||+++++++.+....|+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 57899999999999999999999888999999999754321 23345666777676664 9999999999999999999
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+.+ +|.+++.. +.+++..+..++.|++.|+.|||+ .||+||||+|+||+++.++.+||+|||++.......
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 9999854 67776654 578999999999999999999997 599999999999999999999999999987543211
Q ss_pred CCcccccCCCCccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCC-C--CCCCCH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKG---YDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFR-S--PRWFSP 253 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~-~--~~~~s~ 253 (481)
......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||..... .+.+..+...... . ...++.
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 112345788999999986543 235689999999999999999999976433 3444444444322 2 223688
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++.+|+.+||..||.+||++++++.||||+..
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 99999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.69 Aligned_cols=244 Identities=18% Similarity=0.238 Sum_probs=193.1
Q ss_pred eEecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
+.||+|+||.||+|.... ++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 468999999999998643 557899998865532 2233568889999999999999999999999999999999999
Q ss_pred CCchHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 110 GGELFNKVAKG------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 110 gg~L~~~i~~~------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|+|.+++... ..++..+..++.|++.|++|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999998641 356778889999999999999999999999999999999999999999999864322111111
Q ss_pred ccccCCCCccccccccccCC------CCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCC-----CCC
Q 011628 184 FHTFCGTPAYVAPEVLSRKG------YDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRS-----PRW 250 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~------~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~-----~~~ 250 (481)
.....|++.|+|||++.+.. ..+.++||||+|+++|+|++ |..||..............+ .... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22356788899999985432 12568999999999999996 99999876655443333222 2211 223
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.++.+.+++.+|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=314.72 Aligned_cols=228 Identities=25% Similarity=0.437 Sum_probs=192.2
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHH
Q 011628 37 GTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK 116 (481)
Q Consensus 37 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~ 116 (481)
|+||+||+|++..+++.||+|.+..... ..+|...+....||||+++++++......|++|||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976431 22344555556799999999999999999999999999999999
Q ss_pred HHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCcccc
Q 011628 117 VAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195 (481)
Q Consensus 117 i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 195 (481)
+.+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 865 57999999999999999999999999999999999999999999999999987643321 223456788999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCH--
Q 011628 196 PEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITI-- 273 (481)
Q Consensus 196 PEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-- 273 (481)
||.+.+..+ +.++|+||+|+++|+|++|..||........ .......|.++++.+.++|.+||+.||++||++
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876666 5689999999999999999998765332100 112245678899999999999999999999985
Q ss_pred ---hHHHhCccc
Q 011628 274 ---PEIMENRWF 282 (481)
Q Consensus 274 ---~eil~h~~f 282 (481)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=313.20 Aligned_cols=240 Identities=27% Similarity=0.491 Sum_probs=204.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 36799999999999999999864 78899999986532 235678899999999999999999998654 47999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999999875 25899999999999999999999999999999999999999999999999998753221
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
......+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+..+. ...+..+++.+.+++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred --CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 122334678999999876665 578999999999999997 999999887776666665553 334556889999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.+|++||++++++.
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 231 TSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=316.71 Aligned_cols=250 Identities=22% Similarity=0.388 Sum_probs=206.1
Q ss_pred eeEEeEecccCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 011628 28 YEIGKLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS----- 99 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 99 (481)
|++.+.||+|+||.||+|.... +++.||||++..+.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6789999999999999998653 578999999976542 3334567889999999999999999999886532
Q ss_pred -EEEEEEeccCCCchHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 100 -KIYFVMEYVRGGELFNKVAK-------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~~-------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 35789999999999887642 1478899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCC
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPR 249 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~ 249 (481)
++...............+++.|++||.+.+..+ +.++|||||||++|+|++ |..||.+.+....+..+..+. ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 875432111111123345678999999877666 568999999999999999 999998887777777666553 44566
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+++.+.+++.+||+.+|++|||+.+++..
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=316.32 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=199.3
Q ss_pred CCeeEEeEecccCceEEEEEEE----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 011628 26 GRYEIGKLLGHGTFAKVYHARN----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KS 99 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 99 (481)
.+|++.+.||+|+||.||.|.. ..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4799999999999999999974 4578899999986543 2345678899999999999999999998754 35
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
.+++||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 68999999999999999865 4689999999999999999999999999999999999999999999999999976432
Q ss_pred cccCC-cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH---------------HHHHHh
Q 011628 178 IRQDG-LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV---------------MYKKIY 241 (481)
Q Consensus 178 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------------~~~~i~ 241 (481)
..... ......++..|+|||++.+..+ +.++|||||||++|+|++|..|+....... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 11110 1112234456999999977666 578999999999999999877764332110 011112
Q ss_pred hC--CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 242 KG--EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 242 ~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.. .++.+..++.++.+||.+||..+|++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 21 23445668899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=311.55 Aligned_cols=235 Identities=22% Similarity=0.300 Sum_probs=192.5
Q ss_pred eEecccCceEEEEEEEcCCC----------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 32 KLLGHGTFAKVYHARNVKSG----------ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998766 3578887754431 14667899999999999999999999888 778
Q ss_pred EEEEeccCCCchHHHHHc-C-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-------CEEEEecCCc
Q 011628 102 YFVMEYVRGGELFNKVAK-G-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-------DLKVSDFGLS 172 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-------~lkl~DFGla 172 (481)
++||||+++|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999975 3 589999999999999999999999999999999999999888 7999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccC-CCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCCCCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFRSPRW 250 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 250 (481)
..... .....++..|+|||++.+. ...+.++|||||||++|+|++ |..||...+......... .....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75332 1234567889999998766 234678999999999999999 688887765333222222 22222322
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=311.81 Aligned_cols=249 Identities=27% Similarity=0.548 Sum_probs=210.0
Q ss_pred CeeEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccc-------cchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKI-------LKSGLVAHIKREISILRR-VRHPNIVQLFEVMAT 97 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 97 (481)
.|++.+.||+|+||.||+|++.. +++.+|+|.+..... ........+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 688999999864321 122344567788888865 799999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
.+..+++|||++|++|.+++.. ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999888732 468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-C-C
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-P-R 249 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~-~ 249 (481)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..+.... + .
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 87643321 3345678999999999987665 678999999999999999999998887776666666654332 2 2
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+++.+.++|.+||+.||++||++.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.00 Aligned_cols=250 Identities=24% Similarity=0.431 Sum_probs=212.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCC-Cc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKS-GE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~-~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..-++++.||+|+||.||.|..... |. .||||.+.+. .+.+....+.+|..+|+.++|||||+++|++.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 4668899999999999999997653 33 3888887654 355667889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 101 IYFVMEYVRGGELFNKVAKG--------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~--------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
.+|++|||+||+|..+|++. .++......++.|++.|..||++++++||||...|+||+....+||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999863 3888999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHH-hhCCCCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKI-YKGEFRSPRW 250 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i-~~~~~~~~~~ 250 (481)
+..-.......-....-...|||||.+....+ +.|+|||||||+|||+++ |..||.+.+..++.... ..|++..|..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 82111110000011123467999999987655 779999999999999999 99999998887777644 4557888999
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++..+.+++..||+.+|++||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999987
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.73 Aligned_cols=244 Identities=20% Similarity=0.280 Sum_probs=192.7
Q ss_pred eEecccCceEEEEEEEcCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHGTFAKVYHARNVKS--GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
+.||+|+||.||+|+.... ...+++|.+..... ......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 23566777654432 2345678899999999999999999999999999999999999
Q ss_pred CCchHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 110 GGELFNKVAKG-----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 110 gg~L~~~i~~~-----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
+|+|.+++.+. ..++..+..++.|++.||+|||+++++||||||+|||++.++.++|+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999998642 3567788899999999999999999999999999999999999999999997532111111122
Q ss_pred cccCCCCccccccccccCC------CCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-C-----CCCCCC
Q 011628 185 HTFCGTPAYVAPEVLSRKG------YDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-F-----RSPRWF 251 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~------~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~-----~~~~~~ 251 (481)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+....+..+..+. . ..+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999975321 12468999999999999996 688998777666655554432 1 223347
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++.+.+++.+|| .+|++||++++|++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=313.01 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=203.6
Q ss_pred CCeeEEeEecccCceEEEEEEEc----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNV----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KS 99 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 99 (481)
.+|++.+.||+|+||.||+|+.. .++..||+|++...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56889999999999999999864 34889999999765432 345778999999999999999999999877 56
Q ss_pred EEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+++|||+++++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 799999999999999999764 499999999999999999999999999999999999999999999999999976542
Q ss_pred cccC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH---------------HHHHHh
Q 011628 178 IRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV---------------MYKKIY 241 (481)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------------~~~~i~ 241 (481)
.... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||....... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 11112345567999999877665 568999999999999999999986542211 112222
Q ss_pred hC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 242 KG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 242 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+ ..+.+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 23445667889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=314.75 Aligned_cols=253 Identities=15% Similarity=0.219 Sum_probs=193.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccc--hhH------HHHHHHHHHHHHhCCCCCcceE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILK--SGL------VAHIKREISILRRVRHPNIVQL 91 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~--~~~------~~~~~~Ei~il~~l~HpnIv~l 91 (481)
...++|++.+.||+|+||+||+|++..+ +..+|+|+........ ... ......++..++.+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4467999999999999999999998777 6778888754332110 000 0112234455667789999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 011628 92 FEVMATKS----KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 92 ~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
++++.... ..++++|++.. ++.+.+.. ...++..+..++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 99876543 45788888754 56666655 34788999999999999999999999999999999999999999999
Q ss_pred EecCCccccccccc-----CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-H------
Q 011628 167 SDFGLSAVSDQIRQ-----DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-M------ 234 (481)
Q Consensus 167 ~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~------ 234 (481)
+|||+|+....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+. .
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999976432111 111233579999999999988777 6789999999999999999999986632 1
Q ss_pred --HHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 235 --VMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 235 --~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
....++..+.... ...++.+.+++..|+..+|++||++++|++
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1223334443333 346888999999999999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=336.48 Aligned_cols=254 Identities=30% Similarity=0.543 Sum_probs=222.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----C
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT-----K 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-----~ 98 (481)
.+.|+|..+||.|.+|+||+++++.+++.+|+|+.+.... ..+.++.|..|++.+ .|||++.+|+++.- +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 5789999999999999999999999999999999877642 335577899999988 59999999999854 5
Q ss_pred CEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
+.+|||||||.||+.-|++++ +++.|+.+..+++.++.|+.+||.+.++|||||-.|||++.+|.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 789999999999999999875 57999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCCcccccCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CC
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRK-----GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RS 247 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~ 247 (481)
+. .-+...+..|||.|||||++... .| ...+|+||||++..||..|.+|+-+..++....+|-.... .-
T Consensus 174 ds--T~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 174 DS--TVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred ec--ccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 53 23345678999999999998543 34 3579999999999999999999999999877777765542 23
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|...+.++.++|..||.+|-.+||+..++++|||+...
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 55678899999999999999999999999999999743
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=307.44 Aligned_cols=264 Identities=27% Similarity=0.449 Sum_probs=216.4
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-- 97 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 97 (481)
+.-...+.|+-..+||+|.||.||+|+...+|+.||+|++-.+. .+.++-....+|+.++..|+|+|++.++++|.+
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 34445789999999999999999999999999999999875543 234556667899999999999999999988743
Q ss_pred ------CCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 98 ------KSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 98 ------~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
...+|+|+.+|+. +|+-++.. -+++..++.++++++.+||.|+|++.|+|||+||+|+||+.+|.+||+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 2358999999976 88888865 47999999999999999999999999999999999999999999999999
Q ss_pred CCccccccccc--CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--CCC
Q 011628 170 GLSAVSDQIRQ--DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEF 245 (481)
Q Consensus 170 Gla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~ 245 (481)
|+++.+..... ...++..+-|.+|++||.+.+...++.+.|||+.|||+.+|.+|.+-+.+.+.......|.. |..
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99976543222 22244556799999999999887778999999999999999999999988765444333321 111
Q ss_pred C--------------------CC-------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 R--------------------SP-------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 ~--------------------~~-------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .| -.-++++.+|+.++|..||.+|++++++++|.||.+.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 00 0124578899999999999999999999999999864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.43 Aligned_cols=241 Identities=38% Similarity=0.602 Sum_probs=196.8
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS------ 99 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 99 (481)
+-|..-+.||+||||.||+++++++|+.||||.++..... .-.+..-+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 6688899999999999999999999999999999875422 23566779999999999999999998865543
Q ss_pred EEEEEEeccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC--C--CEEEEecCC
Q 011628 100 KIYFVMEYVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN--G--DLKVSDFGL 171 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~--g--~lkl~DFGl 171 (481)
...+|||||.||+|+..+++ .+++|.+.+.++..+..|+.|||++||+||||||.||++-.. | ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 56899999999999999975 479999999999999999999999999999999999998543 3 369999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHhh----
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-----NIMVMYKKIYK---- 242 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-----~~~~~~~~i~~---- 242 (481)
|+-.+. +....+.+||+.|.+||++...++++..+|.||+||++|++.||.+||... +...++..+.+
T Consensus 171 Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 986543 447788999999999999986455577899999999999999999999432 11223332221
Q ss_pred ----------C------CCCCCCCCCHH----HHHHHHHhcccCcCCCC
Q 011628 243 ----------G------EFRSPRWFSPD----LIRLLTKLLDTNPDKRI 271 (481)
Q Consensus 243 ----------~------~~~~~~~~s~~----~~~li~~~L~~dP~~Rp 271 (481)
| .++.|..+++. +..++..+|..+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 22334445554 45678889999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=318.61 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=196.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-KIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~l 103 (481)
.+.|.-.+.||+|+||.||+|.- .+|..||||.+....... ...+.+|+.++.+++|||+|+++|+|.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 46777789999999999999986 455899999876654321 345899999999999999999999999998 5999
Q ss_pred EEeccCCCchHHHHHc--C-CCCHHHHHHHHHHHHHHHHHHHHcC---ceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 104 VMEYVRGGELFNKVAK--G-RLKEDLARKYFQQLISAVGFCHARG---VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~-~l~e~~~~~~~~ql~~al~yLH~~g---i~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
|+||++.|+|.+.+.. + .+++....+|+.+++.||+|||... |+||||||+|||||++.+.||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999975 3 7899999999999999999999853 99999999999999999999999999965332
Q ss_pred cccCCccccc-CCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch------HHH-HHHHHhhCC-----
Q 011628 178 IRQDGLFHTF-CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN------IMV-MYKKIYKGE----- 244 (481)
Q Consensus 178 ~~~~~~~~~~-~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~------~~~-~~~~i~~~~----- 244 (481)
. .....+. .||.+|+|||++..... +.|+||||+||+|.||++|+.|.+... ... ....+..+.
T Consensus 230 ~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 230 G--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred c--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 1 2222222 89999999999976444 779999999999999999998887432 111 112222221
Q ss_pred -CCCC-CCCC--HH---HHHHHHHhcccCcCCCCCHhHHHh
Q 011628 245 -FRSP-RWFS--PD---LIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 245 -~~~~-~~~s--~~---~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.... ..++ .. +..+..+|++.+|..||++.|+++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 2233 22 556888999999999999999754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=315.36 Aligned_cols=252 Identities=32% Similarity=0.510 Sum_probs=205.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCC----cceEEEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR--HPN----IVQLFEVM 95 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--Hpn----Iv~l~~~~ 95 (481)
..+.+||++..++|+|+||+|-.+.+.+++..||||+++.-. .+.+..+-|+.+++++. -|+ +|.+.++|
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 356789999999999999999999999999999999996433 23455667999999994 333 77888889
Q ss_pred EeCCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc------------
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE------------ 160 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~------------ 160 (481)
.-.++++||+|.+ |.++++++.++ +++.+.++.+.+||+.+++|||+.+++|-||||||||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999988 67999999863 6999999999999999999999999999999999999832
Q ss_pred --------CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch
Q 011628 161 --------NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN 232 (481)
Q Consensus 161 --------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 232 (481)
+..++|+|||.|+...+. -.+.+.|..|+|||++.+.++ +.++||||+||||+||.+|..-|...+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCC
Confidence 235899999999864331 256678999999999999999 678999999999999999999997543
Q ss_pred H---HHHHHHHhhC------------------CCCCCCC----------------------CC---HHHHHHHHHhcccC
Q 011628 233 I---MVMYKKIYKG------------------EFRSPRW----------------------FS---PDLIRLLTKLLDTN 266 (481)
Q Consensus 233 ~---~~~~~~i~~~------------------~~~~~~~----------------------~s---~~~~~li~~~L~~d 266 (481)
. ..+...|... .+..|.. -+ .++.+||++||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 2 1233333221 1110100 01 23789999999999
Q ss_pred cCCCCCHhHHHhCccccc
Q 011628 267 PDKRITIPEIMENRWFRK 284 (481)
Q Consensus 267 P~~Rps~~eil~h~~f~~ 284 (481)
|.+|+|+.|+|.||||..
T Consensus 394 P~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 394 PARRITLREALSHPFFAR 411 (415)
T ss_pred ccccccHHHHhcCHHhhc
Confidence 999999999999999965
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=334.01 Aligned_cols=253 Identities=20% Similarity=0.322 Sum_probs=178.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKS----GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEV----- 94 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~----- 94 (481)
-.++|++++.||+|+||.||+|++..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 467999999999999999999999888 999999987643211 111111 1122222223222211
Q ss_pred -EEeCCEEEEEEeccCCCchHHHHHcCCC---------------------CHHHHHHHHHHHHHHHHHHHHcCceecCCC
Q 011628 95 -MATKSKIYFVMEYVRGGELFNKVAKGRL---------------------KEDLARKYFQQLISAVGFCHARGVYHRDLK 152 (481)
Q Consensus 95 -~~~~~~~~lv~Ey~~gg~L~~~i~~~~l---------------------~e~~~~~~~~ql~~al~yLH~~gi~HrDLK 152 (481)
......+++|+||+.+++|.+++....+ .+..+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456679999999999999998865321 134467899999999999999999999999
Q ss_pred CCcEEEcc-CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCC---------------------CCcch
Q 011628 153 PENLLLDE-NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD---------------------AAKVD 210 (481)
Q Consensus 153 p~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~---------------------~~~~D 210 (481)
|+|||++. ++.+||+|||+|+..... ........+|++.|+|||++....+. +.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 579999999999754321 12233457899999999976432211 23569
Q ss_pred HHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---------------------CCCCCCCHHHHHHHHHhcccCcCC
Q 011628 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---------------------RSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 211 iwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---------------------~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|||+||+||+|+++..|++.... .....+..... ......+....+||.+||++||.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 99999999999998877654321 11111111110 001112234568999999999999
Q ss_pred CCCHhHHHhCcccccC
Q 011628 270 RITIPEIMENRWFRKG 285 (481)
Q Consensus 270 Rps~~eil~h~~f~~~ 285 (481)
|||+.++|+||||+..
T Consensus 441 R~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 441 RISAKAALAHPYFDRE 456 (566)
T ss_pred CCCHHHHhCCcCcCCC
Confidence 9999999999999753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=313.18 Aligned_cols=263 Identities=28% Similarity=0.462 Sum_probs=220.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEE-e
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK----SGLVAHIKREISILRRVRHPNIVQLFEVMA-T 97 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~ 97 (481)
.+.+||-++++||+|||+.||+|.+....+.||+|+-...+.+. .++.+..-||..|.+.|.||.||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 46789999999999999999999999999999999976554332 346677889999999999999999999995 5
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCcEEEcc---CCCEEEEecCC
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR--GVYHRDLKPENLLLDE---NGDLKVSDFGL 171 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~--gi~HrDLKp~NILl~~---~g~lkl~DFGl 171 (481)
.+.+|-|+|||+|.+|.-+++. ..++|.+++.|+.||+.||.||.+. .|+|-||||.|||+-. -|.+||+|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 5678999999999999888876 4689999999999999999999976 6999999999999954 36799999999
Q ss_pred cccccccccCC-----cccccCCCCccccccccc-c--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---HHHHHH
Q 011628 172 SAVSDQIRQDG-----LFHTFCGTPAYVAPEVLS-R--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---VMYKKI 240 (481)
Q Consensus 172 a~~~~~~~~~~-----~~~~~~gt~~y~APEvl~-~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i 240 (481)
+++.+....+. +..-..||.+|++||.+. + .+-.+.|+||||+|||+|.++.|+.||...... ..+.-|
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 99876543321 234468999999999863 2 344477999999999999999999999875432 223344
Q ss_pred hhC---CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 241 YKG---EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 241 ~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+. .++..+.+++++++||++||+.--++|+.+.++-.||||...
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 443 355566799999999999999999999999999999999653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=296.72 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=205.6
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILR-RVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.+-+..||.|+||+|++..++.+|+..|||.|+.... ....+++..|..... .-++||||++||....++..||.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3345689999999999999999999999999987654 234567778887554 4479999999999999999999999
Q ss_pred ccCCCchHHHH------HcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 107 YVRGGELFNKV------AKGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 107 y~~gg~L~~~i------~~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+++- +|..+. ++.+++|+..-.+....+.||.||-. ..|+|||+||+|||++..|.+||||||++......
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 9964 443322 34679999999999999999999985 48999999999999999999999999998643221
Q ss_pred cCCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCCC---C---CC
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFRS---P---RW 250 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~---~---~~ 250 (481)
-..+.-.|...|||||.+.. .+|+ .++|+||||++|||+.||..||..-+. .+....+..|.++. + -.
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 11233578899999999854 3564 689999999999999999999988654 46666677776553 2 23
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
++..+..+|..||.+|-..||...+++++||++.
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 7889999999999999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=288.60 Aligned_cols=239 Identities=50% Similarity=0.839 Sum_probs=206.6
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHH
Q 011628 38 TFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV 117 (481)
Q Consensus 38 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i 117 (481)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999988999999999976543321 577889999999999999999999999999999999999999999999
Q ss_pred HcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccc
Q 011628 118 AKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP 196 (481)
Q Consensus 118 ~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 196 (481)
... .++...+..++.|++.++.|||+.|++|+||+|.||+++.++.++|+|||.+....... ......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 764 48999999999999999999999999999999999999999999999999987654321 33456788999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCCCCCCCC---CCHHHHHHHHHhcccCcCCCCC
Q 011628 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRSPRW---FSPDLIRLLTKLLDTNPDKRIT 272 (481)
Q Consensus 197 Evl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~li~~~L~~dP~~Rps 272 (481)
|.+.+..+ +.++||||||+++|+|++|..||.. .+.......+..+....... ++.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99976666 4589999999999999999999988 55555555555554433222 7889999999999999999999
Q ss_pred HhHHHhCccc
Q 011628 273 IPEIMENRWF 282 (481)
Q Consensus 273 ~~eil~h~~f 282 (481)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.39 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=219.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-SGE--SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++..+.++||+|+||+|+.|.+.. +|+ .||||.+....... ...+|.+|+.+|.+|+|||++++||+..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 4677888999999999999999875 333 58999998765432 56889999999999999999999999987 678
Q ss_pred EEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+|++++|+|.+.+.+ +.|.......|+.||+.|+.||.+++.|||||...|+|+.....+||+||||.+-.+..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 899999999999999976 46888999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCcc-cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHH
Q 011628 179 RQDGLF-HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDL 255 (481)
Q Consensus 179 ~~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 255 (481)
...... ....-...|+|||.++...+ +.++|+|++||++|||++ |+.||.+.+...+.++|-.++ ++-|..+|.++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDI 344 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHH
Confidence 221111 11223457999999988877 678999999999999998 899999999999999987664 67789999999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.++++.||..+|.+|||+..|.+.-+.+
T Consensus 345 Y~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhHHHH
Confidence 9999999999999999999997654433
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=310.82 Aligned_cols=242 Identities=27% Similarity=0.471 Sum_probs=206.5
Q ss_pred EEeEecccCceEEEEEEEcCC--C--cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKS--G--ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~--~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+.+.||.|-||.||.|..... | -.||||..+.+.. .+..+.+..|..+|+.++|||||+++|++.+. ..||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 357899999999999997532 3 3589998876543 33467899999999999999999999999875 489999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+++-|+|..+++. ..++......|..||+.||.|||+..++||||...|||+.....+||+|||+++..... ..
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~---~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD---AY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc---ch
Confidence 99999999999975 46899999999999999999999999999999999999999999999999999865432 22
Q ss_pred ccccCC--CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 184 FHTFCG--TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 184 ~~~~~g--t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
++...| ...|||||.++-..+ +.++|||-|||.+||++. |..||.+-...+..-.+-+|+ +++|+.+++.+..|+
T Consensus 547 YkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred hhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHH
Confidence 232233 456999999987776 567999999999999987 999999877666666777774 789999999999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.+|.+||++.+|..
T Consensus 626 skcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHhccCcccCCcHHHHHH
Confidence 9999999999999877754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=281.80 Aligned_cols=249 Identities=29% Similarity=0.541 Sum_probs=203.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--EE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKS--KI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~ 101 (481)
.++|++.+++|+|.|+.||.|++..+++.++||++++-+ .+.++||+.||+.|. ||||++++++..++. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 679999999999999999999999999999999986543 367899999999997 999999999987653 57
Q ss_pred EEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~~~~~ 180 (481)
.+++||+...+...+... ++.-.++.|+.||+.||.|||++||+|||+||.|+++|.. ..++|+|+|+|.+....
T Consensus 111 aLiFE~v~n~Dfk~ly~t--l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-- 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT--LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-- 186 (338)
T ss_pred hhHhhhhccccHHHHhhh--hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC--
Confidence 799999998776666543 7888999999999999999999999999999999999976 46999999999876432
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHh-------------h----
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIY-------------K---- 242 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~-------------~---- 242 (481)
...+..+.+..|--||.+.........-|+|||||+|..|+..+-||-. .+......+|. +
T Consensus 187 -~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 187 -KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred -ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 2345567889999999997766666779999999999999999999832 21111111111 1
Q ss_pred ---------CCCCCCCC-----------CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 243 ---------GEFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 243 ---------~~~~~~~~-----------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+...-.+| .++++.+|+.++|..|-.+|+|+.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 01111111 5789999999999999999999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=292.72 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=213.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS---- 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 99 (481)
...||.-++.+|.|+- .|..|-+.-+++.||+|....... .....++..+|..++..++|+||++++.++....
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 4678999999999998 888899988999999999877643 3345577889999999999999999999996544
Q ss_pred --EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 --KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 --~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..|+||||+.. +|.+.+. -.++-..+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+..+.
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 57999999965 8888776 4478889999999999999999999999999999999999999999999999985433
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------- 244 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------- 244 (481)
. -..+.++.|..|.|||++.+.+| ...+||||+||++.||++|..-|.+.+....+.++....
T Consensus 171 ~---~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 171 D---FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred c---cccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 2 24567889999999999999997 578999999999999999999999887766666654310
Q ss_pred --------------CCC----CCC-----------CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 245 --------------FRS----PRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 245 --------------~~~----~~~-----------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
+.. |.. -+..+++|+.+||..||++|+|++++|+|||++-++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY 317 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec
Confidence 000 110 123489999999999999999999999999997553
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=312.11 Aligned_cols=260 Identities=18% Similarity=0.301 Sum_probs=188.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEc----------------CCCcEEEEEEeecccccc-hhH----------HHHHHHHH
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV----------------KSGESVAIKVIDKEKILK-SGL----------VAHIKREI 77 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~~~~vAvK~i~~~~~~~-~~~----------~~~~~~Ei 77 (481)
.++|++.++||+|+||+||+|... ..++.||||.+....... .++ .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 245679999986542110 001 11223477
Q ss_pred HHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCchHHHHHc--C----------------------
Q 011628 78 SILRRVRHPNI-----VQLFEVMAT--------KSKIYFVMEYVRGGELFNKVAK--G---------------------- 120 (481)
Q Consensus 78 ~il~~l~HpnI-----v~l~~~~~~--------~~~~~lv~Ey~~gg~L~~~i~~--~---------------------- 120 (481)
.++.+++|.++ +++++++.. ....|+||||+++++|.+++.. +
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 566666643 3568999999999999888753 1
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCcccccccc
Q 011628 121 -RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199 (481)
Q Consensus 121 -~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl 199 (481)
.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhh
Confidence 134567889999999999999999999999999999999999999999999865322111 111123458999999997
Q ss_pred ccCC--------------------CC-CCcchHHHHHHHHHHHhcCCC-CCCCchH-----------HHHHHHHhhCC--
Q 011628 200 SRKG--------------------YD-AAKVDIWSCGVILFVLMAGYL-PFQDQNI-----------MVMYKKIYKGE-- 244 (481)
Q Consensus 200 ~~~~--------------------~~-~~~~DiwSlGvil~elltg~~-Pf~~~~~-----------~~~~~~i~~~~-- 244 (481)
.... |. ..+.|+||+||++|+|++|.+ ||.+... ...+..+....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 5322 11 124799999999999999876 7754221 11122222223
Q ss_pred CCCCCCCCHHHHHHHHHhcccCc---CCCCCHhHHHhCcccccC
Q 011628 245 FRSPRWFSPDLIRLLTKLLDTNP---DKRITIPEIMENRWFRKG 285 (481)
Q Consensus 245 ~~~~~~~s~~~~~li~~~L~~dP---~~Rps~~eil~h~~f~~~ 285 (481)
+......++..++|+.+||..+| .+|+|++|+|+||||...
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 23334578999999999999866 689999999999999653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.24 Aligned_cols=241 Identities=26% Similarity=0.502 Sum_probs=212.2
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
..-++||.|-||.||.|.+++-.-.||||.++.+.. .+..+..|..+|+.++|||+|+++++|..+.-+|||+|||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345789999999999999999889999999876542 3567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 109 RGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 109 ~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
..|+|.++++. ..++.-....++.||.+|++||..+++|||||...|+|+.++..+||+|||++++... ..++
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DTYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Ccee
Confidence 99999999986 2467777888999999999999999999999999999999999999999999997543 2233
Q ss_pred ccCC---CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 011628 186 TFCG---TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 186 ~~~g---t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 260 (481)
...| ...|.|||-+....+ +.|+|||+|||+|||+.| |--||.+-+...+|..+-++ .+.-|..+++.+.+|++
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 3333 456999999977666 679999999999999998 99999999999998888776 36678999999999999
Q ss_pred HhcccCcCCCCCHhHHHh
Q 011628 261 KLLDTNPDKRITIPEIME 278 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~ 278 (481)
.||+++|.+||++.||-+
T Consensus 501 aCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHhcCCcccCccHHHHHH
Confidence 999999999999998844
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=307.99 Aligned_cols=254 Identities=30% Similarity=0.518 Sum_probs=211.6
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCcceEEEE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH------PNIVQLFEV 94 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~ 94 (481)
+..+.+||++....|+|-|++|..|.+...|+.||||+|....+ +.+.=.+|++||++|+. -|+++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 46678999999999999999999999999999999999986543 44555689999999963 479999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHc-C---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEec
Q 011628 95 MATKSKIYFVMEYVRGGELFNKVAK-G---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDF 169 (481)
Q Consensus 95 ~~~~~~~~lv~Ey~~gg~L~~~i~~-~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DF 169 (481)
|...+++|||+|-+. ..|.+.+.+ | ++....++.|++||..||..|-..||+|.||||.|||+++.. .+|||||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 999999999999885 489999876 3 588899999999999999999999999999999999999875 5899999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--CCCCC
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEFRS 247 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~ 247 (481)
|.|..... ...+.+.-+..|.|||++.+.+|+ ...|+||+||+||||.||+..|++.+...++..... |.++.
T Consensus 582 GSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 582 GSASFASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccc----ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 99876432 334556678889999999999995 679999999999999999999998765555443322 21110
Q ss_pred ----------------------------------------C-----------CCCC-------HHHHHHHHHhcccCcCC
Q 011628 248 ----------------------------------------P-----------RWFS-------PDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 248 ----------------------------------------~-----------~~~s-------~~~~~li~~~L~~dP~~ 269 (481)
| +.++ ..+++|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0 0011 13789999999999999
Q ss_pred CCCHhHHHhCccccc
Q 011628 270 RITIPEIMENRWFRK 284 (481)
Q Consensus 270 Rps~~eil~h~~f~~ 284 (481)
|.|+.|+|+||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=315.68 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=220.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
..-.|.++||.|-||.|+.|+.+..|+ .||||.++... .+.....|..|..||-+++||||+++-|+.....-++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 445889999999999999999887664 69999997654 3445678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||+|||+.|+|..+++. |+++.-+..-+++.|+.|++||-+.|.+||||...|||++.+-..|++|||+++......
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 99999999999999975 789999999999999999999999999999999999999999999999999999764422
Q ss_pred CCcccccCC--CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHH
Q 011628 181 DGLFHTFCG--TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~g--t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 256 (481)
+..+.+..| ..+|.|||.+....+ +.++||||+||+|||.++ |..||-+.+..+..+.|..| .++.|-.++..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 333344333 467999999988877 567999999999999877 99999999988999888877 4777888999999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h 279 (481)
+|+..||++|-.+||.+.||+.+
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999873
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.76 Aligned_cols=255 Identities=32% Similarity=0.514 Sum_probs=224.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.+|.|+||.||+|+++.+++..|+|+++.+... ...-+.+|+-+++.++||||+.+++.+......|++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 57899999999999999999999999999999999876532 345677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~-~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||.||+|++.-. .|.++|.++....+..+.|++|||++|-+|||||-.|||+++.|.+|++|||.+......- ..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--hh
Confidence 99999999999876 4899999999999999999999999999999999999999999999999999987544321 22
Q ss_pred ccccCCCCcccccccc---ccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-----CCCCCHHH
Q 011628 184 FHTFCGTPAYVAPEVL---SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-----PRWFSPDL 255 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl---~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~s~~~ 255 (481)
.....|||+|||||+. +..+| ..++|||++|+...|+-.-++|--+..++.......+..+.. +...++.+
T Consensus 169 rksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 3567999999999985 33455 578999999999999999999988888877776666655544 33468889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+|++.+|.++|++|||++.+|.|||....
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 999999999999999999999999998765
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=300.75 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=206.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
-.+..+.++||+|-||.|.++.- ..+.+||||.++.+. ..+..+.+.+|+++|.+|+||||++++++|..++.++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 35678899999999999999985 446999999998764 334568899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAKGR---LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~---l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||++.|+|.+++.... .......+++.||++|++||.+.+++||||.+.|+|++.++++||+|||+++-.-.....
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999999998752 244566779999999999999999999999999999999999999999999832111111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCCCchHHHHHHHH---hhC-----CCCCCCCC
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYLPFQDQNIMVMYKKI---YKG-----EFRSPRWF 251 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~~~~~~~~i---~~~-----~~~~~~~~ 251 (481)
..-...+-...|||||.+....+ +.++|+|++|+++||+++ ...||.+.+........ ... -+..|.-+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 11122344678999999877776 678999999999999764 89999887765554433 222 13457789
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+..+.+++.+||..+-++|||++++-.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 999999999999999999999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=301.39 Aligned_cols=202 Identities=34% Similarity=0.578 Sum_probs=183.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHH-----HHHHHHHHHhCC---CCCcceEEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH-----IKREISILRRVR---HPNIVQLFEVMA 96 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~-----~~~Ei~il~~l~---HpnIv~l~~~~~ 96 (481)
...|..++.||+|+||+|++|.++++...|+||.|.++++....+++. +-.||+||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 567999999999999999999999999999999999988765544432 457999999997 999999999999
Q ss_pred eCCEEEEEEeccC-CCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 97 TKSKIYFVMEYVR-GGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 97 ~~~~~~lv~Ey~~-gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
+++.+||+||-.. |.+||++|+. .+++|.++..+|+|++.|+++||++||+|||||-||+.++.+|-+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 9999999999764 4599999986 5799999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD 230 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 230 (481)
. ..+.+....||..|.|||++.+..|-+.+-|||+||++||.++....||..
T Consensus 720 ~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 T----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred h----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 3 456678889999999999999999999999999999999999999999853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=284.85 Aligned_cols=257 Identities=28% Similarity=0.489 Sum_probs=209.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----E
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-----K 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~ 100 (481)
.+.+-.+-||-|+||+||.+.+..+|+.||+|.+..-. ..-...+++.+|+.++..++|.|++..+++..... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 45566789999999999999999999999999985432 22234477889999999999999999998876654 3
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+|+++|.+.. +|...|.. ..++.+.+.-+.+||++||+|||+.||.||||||.|+|++.|..+||||||+++......
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 6788888854 78887765 679999999999999999999999999999999999999999999999999999765432
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh------------------
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY------------------ 241 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~------------------ 241 (481)
.. ..+..+-|.+|+|||++.+...++...||||.|||+.||+..+..|...++.+....|.
T Consensus 211 ~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 211 RL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 22 22334568899999999998877889999999999999999999998777655544432
Q ss_pred -----hCCCCCCC-----------CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 242 -----KGEFRSPR-----------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 242 -----~~~~~~~~-----------~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+..+.|+ .-..+...++.++|.+||++|++.++.+.|++..++
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 12222222 123357889999999999999999999999998654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.90 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=201.8
Q ss_pred EeEecccCceE-EEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 011628 31 GKLLGHGTFAK-VYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 31 ~~~LG~G~fg~-Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
-+.+|.|+-|+ ||+|.. .|+.||||.+-.+ ....+.||+..++..+ |||||++|+.-.+....||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 36789999985 899987 7889999987543 3456789999999994 999999999999999999999999
Q ss_pred CCCchHHHHHcC-C----CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CC--CEEEEecCCccccccc
Q 011628 109 RGGELFNKVAKG-R----LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---NG--DLKVSDFGLSAVSDQI 178 (481)
Q Consensus 109 ~gg~L~~~i~~~-~----l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---~g--~lkl~DFGla~~~~~~ 178 (481)
.. +|.++++.. . ...-..+..+.|+++||++||+.+|+||||||.||||+. ++ +++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 75 999999863 1 111445889999999999999999999999999999986 34 5899999999865432
Q ss_pred c-cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCchHHHHHHHHhhCCCCCC---CCCCH
Q 011628 179 R-QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIMVMYKKIYKGEFRSP---RWFSP 253 (481)
Q Consensus 179 ~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~---~~~s~ 253 (481)
. .-....+..||-+|+|||++..... +.++||||+||++|+.++| .+||.+.-.. ..+|..+....- +.-..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCchH
Confidence 1 2223556789999999999987665 4579999999999998885 9999876432 235555554321 11112
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccCccccceeec
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIE 294 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~~~~~~~~ 294 (481)
++.+||.+|+.++|..||++.++|.||+|....++..|..+
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~d 782 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRD 782 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHh
Confidence 89999999999999999999999999999987776666543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=332.82 Aligned_cols=237 Identities=23% Similarity=0.388 Sum_probs=187.8
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
..|...+.||+|+||.||+|++..++..||||.+...... ..+|+.++++++|||||++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 4566678999999999999999889999999998643311 124688999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH---ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH---~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||++||+|.+++.. +++..+.+++.|++.|++||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred eCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 99999999999964 889999999999999999999 6699999999999999999888876 665543211
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHH-hh---------CCCCC-
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKI-YK---------GEFRS- 247 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i-~~---------~~~~~- 247 (481)
.....||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.... ...+.+. .. .....
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 123468899999999987777 5789999999999999999999854211 1111111 10 00000
Q ss_pred ---CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 248 ---PRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 248 ---~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+.....++.+++.+||+.||++|||+.|+++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112246789999999999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=283.11 Aligned_cols=131 Identities=30% Similarity=0.549 Sum_probs=115.0
Q ss_pred Ccc-CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CC---CcceEEE
Q 011628 23 PLL-GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-----HP---NIVQLFE 93 (481)
Q Consensus 23 ~~~-~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----Hp---nIv~l~~ 93 (481)
++. +||.+.++||.|-|++||+|.+..+.+.||+|+.+... .+.+....||.+|++++ |+ +||++++
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 454 89999999999999999999999999999999987654 45566778999999984 33 5999999
Q ss_pred EEEe----CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEE
Q 011628 94 VMAT----KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLL 158 (481)
Q Consensus 94 ~~~~----~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl 158 (481)
.|.. +.++++|+|++ |-.|..+|.. .+++...+++|++|++.||.|||.. ||||-||||+|||+
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 9854 56899999999 6688888875 5799999999999999999999965 99999999999999
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=279.40 Aligned_cols=250 Identities=26% Similarity=0.469 Sum_probs=195.6
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEEEEEEeC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV--RHPNIVQLFEVMATK 98 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~ 98 (481)
+..+.....+.+.||+|.||.||+|++ .|+.||||++.... -....||.+|.+.. +|+||+.+++.-...
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 455678899999999999999999998 68999999996542 13456788877654 899999998775332
Q ss_pred ----CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCcEEEccCCCEEE
Q 011628 99 ----SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR--------GVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 99 ----~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~--------gi~HrDLKp~NILl~~~g~lkl 166 (481)
.++|||++|.+.|+|+|++....++.+...+++..+++||+|||.. .|+|||||..|||+..+|..-|
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 4799999999999999999999999999999999999999999953 4999999999999999999999
Q ss_pred EecCCccccccccc--CCcccccCCCCccccccccccC----CCCC-CcchHHHHHHHHHHHhcC----------CCCCC
Q 011628 167 SDFGLSAVSDQIRQ--DGLFHTFCGTPAYVAPEVLSRK----GYDA-AKVDIWSCGVILFVLMAG----------YLPFQ 229 (481)
Q Consensus 167 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~----~~~~-~~~DiwSlGvil~elltg----------~~Pf~ 229 (481)
+|+|||-....... +-..+..+||.+|||||++... .+.+ ..+||||||.++||++.. ++||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 99999976443221 2233567999999999998542 1222 259999999999999742 68885
Q ss_pred C-----chHHHHHHHHhhCC--CCC-CCCCCHH----HHHHHHHhcccCcCCCCCHhHHHh
Q 011628 230 D-----QNIMVMYKKIYKGE--FRS-PRWFSPD----LIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 230 ~-----~~~~~~~~~i~~~~--~~~-~~~~s~~----~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+ ++.+++.+-+.-.+ +.. +.|-|.+ +-.+++.||..||.-|.|+--|.+
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 4 34445544443333 333 3454443 456889999999999999866643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.98 Aligned_cols=248 Identities=25% Similarity=0.465 Sum_probs=208.1
Q ss_pred CeeEEeEecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVK-------SGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
+..+.+.||+|+||+|++|.-.. ....||||........ ...+.+..|+.+|+.+ .||||+.+.+++...
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 33567799999999999997431 1457999998765432 4567899999999999 599999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcCC-----------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGR-----------------LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~-----------------l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~ 161 (481)
..+++|+|||..|+|.++++..+ ++......++.||+.|++||++..++||||-..|||+..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence 99999999999999999998766 8899999999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCcccccCC--CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCch-HHHHH
Q 011628 162 GDLKVSDFGLSAVSDQIRQDGLFHTFCG--TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQN-IMVMY 237 (481)
Q Consensus 162 g~lkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~-~~~~~ 237 (481)
..+||+|||+|+......... .....| ...|||||.+....| +.++||||+||+|||+++ |..||.+-. ...++
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 999999999998432211110 011222 345999999988655 779999999999999998 999999854 45556
Q ss_pred HHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 238 KKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 238 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+..|. ...|..+++++.++++.||+.+|++||++.++.+
T Consensus 533 ~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 6777775 5779999999999999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=253.47 Aligned_cols=212 Identities=26% Similarity=0.471 Sum_probs=175.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 103 (481)
.+...-+..||+|+||.|-+.++..+|...|+|.+...- .....++..+|+.+..+. .+|.+|.+|+.+.....+||
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 345566789999999999999999999999999997643 234567788899877666 69999999999999999999
Q ss_pred EEeccCCCchHHHH----Hc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 104 VMEYVRGGELFNKV----AK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 104 v~Ey~~gg~L~~~i----~~-~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
.||.+.. +|..+- .+ +.++|..+-+++..++.||.|||++ .|+|||+||+|||++.+|++|+||||++.....
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9999964 664443 33 4799999999999999999999987 899999999999999999999999999975432
Q ss_pred cccCCcccc-cCCCCccccccccc----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-hHHHHHHHHhhCC
Q 011628 178 IRQDGLFHT-FCGTPAYVAPEVLS----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NIMVMYKKIYKGE 244 (481)
Q Consensus 178 ~~~~~~~~~-~~gt~~y~APEvl~----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~~~~~i~~~~ 244 (481)
....+ ..|...|||||.+. ..+| +-++||||||++++||.+++.||+.- ++-++.+++....
T Consensus 202 ----SiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 202 ----SIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred ----hhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 22233 56888999999974 3456 57899999999999999999999764 5566777776654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=278.60 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=195.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEEEEEEeCC---
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV--RHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~~--- 99 (481)
....++.++||+|.||.||+|+. +++.||||++.... ...+..|-.|.+.. .|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 45577889999999999999986 67999999996543 34455666666554 7999999998866555
Q ss_pred -EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---------CceecCCCCCcEEEccCCCEEEEec
Q 011628 100 -KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR---------GVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~---------gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.++||+||.+.|+|.+++....+++....+++..+++||+|||+- .|+|||||..||||..|+..-|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 899999999999999999999999999999999999999999962 5999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCC-----CcchHHHHHHHHHHHhcCC------------CCCC---
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA-----AKVDIWSCGVILFVLMAGY------------LPFQ--- 229 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~-----~~~DiwSlGvil~elltg~------------~Pf~--- 229 (481)
|+|..+......+-...-+||.+|||||++.+.--.. .+.||||+|.+||||++.. +||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998877655566666789999999999986532211 3589999999999999752 3443
Q ss_pred --CchHHHHHHHHhhC--CCCCCCC-----CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 230 --DQNIMVMYKKIYKG--EFRSPRW-----FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 230 --~~~~~~~~~~i~~~--~~~~~~~-----~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+...++...+... ++.+|.. --..+++.+.-||+.||+.|.|+.=+.+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 22344444444433 3333332 1234789999999999999999765544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.73 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=213.8
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
..+..++||+|+||+||+|.+...|+ +||||++...... .....+.+|+-+|..+.|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34557899999999999999876655 5899988765433 33567889999999999999999999998766 88
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||++|+++|.|.++++. +.+.......|..||++|+.|||.++++||||-..|+|+..-..+||.|||+++.......
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999999875 6789999999999999999999999999999999999999999999999999987655333
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
.-......-.+.|||-|.+....| +.++||||+||++||++| |..|+.+....++-..+..|+ ++.|+.++.++..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHH
Confidence 322233333567999999988777 678999999999999998 999999998888877777764 78899999999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||..|++.||+++++..
T Consensus 933 mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHhccCcccCccHHHHHH
Confidence 99999999999999988765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=246.98 Aligned_cols=212 Identities=47% Similarity=0.825 Sum_probs=186.3
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++|+++++++......++++||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654321 346788999999999999999999999999999999999999999
Q ss_pred HHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCcccccccccCCcccccCCC
Q 011628 114 FNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 114 ~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
.+++... .++...++.++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999864 7999999999999999999999999999999999999999 89999999999875433211 12345678
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
..|++||.+......+.++|+|++|+++++| ..+.+++.+|++.||.+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987652446789999999999999 678899999999999999
Q ss_pred CCHhHHHhCc
Q 011628 271 ITIPEIMENR 280 (481)
Q Consensus 271 ps~~eil~h~ 280 (481)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=275.82 Aligned_cols=255 Identities=30% Similarity=0.522 Sum_probs=203.5
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
.+...|.+.++||+|+|++||+|.+.. ..+.||+|.+..... ..++..|+++|..+. +.||+++.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 346789999999999999999999887 788999999876432 355889999999995 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~~ 177 (481)
+...+|+||.+..+..++... ++..+++.|++.++.||.++|.+||+||||||.|+|.+.. +.-.|+|||+|...+.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999999888888765 6788999999999999999999999999999999999864 6789999999972111
Q ss_pred cc-------------------------------cCCcc-----------cccCCCCccccccccccCCCCCCcchHHHHH
Q 011628 178 IR-------------------------------QDGLF-----------HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCG 215 (481)
Q Consensus 178 ~~-------------------------------~~~~~-----------~~~~gt~~y~APEvl~~~~~~~~~~DiwSlG 215 (481)
.. ..+.. -...||++|+|||++...+-.++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 00000 1246999999999998888778899999999
Q ss_pred HHHHHHhcCCCCCCCch-----HHHHH---------------------H--------------------HHhhCCC---C
Q 011628 216 VILFVLMAGYLPFQDQN-----IMVMY---------------------K--------------------KIYKGEF---R 246 (481)
Q Consensus 216 vil~elltg~~Pf~~~~-----~~~~~---------------------~--------------------~i~~~~~---~ 246 (481)
||+..++++..||-... ..++. . .+.+.+. .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999983210 00000 0 0000000 0
Q ss_pred ---CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 247 ---SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 247 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
....++..+.+|+.+||+.||.+|+|+++.|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 01124557899999999999999999999999999973
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-31 Score=248.30 Aligned_cols=218 Identities=44% Similarity=0.719 Sum_probs=186.3
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67899999999999999999888999999999765432 2467888999999999999999999999999999999999
Q ss_pred cCCCchHHHHHcC-C-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 108 VRGGELFNKVAKG-R-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 108 ~~gg~L~~~i~~~-~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
+.+++|.+++... . +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 9999999999764 4 8999999999999999999999999999999999999999999999999987654322 11234
Q ss_pred ccCCCCcccccccc-ccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-c-hHHHHHHHHhhCCCCCCC
Q 011628 186 TFCGTPAYVAPEVL-SRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-Q-NIMVMYKKIYKGEFRSPR 249 (481)
Q Consensus 186 ~~~gt~~y~APEvl-~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~-~~~~~~~~i~~~~~~~~~ 249 (481)
...++..|++||.+ ....+ +.++|+|+||+++++|++|+.||.. . +...+.+.+..+.....+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 45788899999998 44445 4589999999999999999999988 4 445777777777654443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-33 Score=255.68 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=204.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE-EEeC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEV-MATK 98 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~-~~~~ 98 (481)
.-.+.+.|.|.+.||+|-||++.+++++.+++.+++|.+..... ..+.+.+|..---.| .|.||+.-|++ |++.
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 34567899999999999999999999999999999999987653 346677888766666 48999998876 5677
Q ss_pred CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc--CCCEEEEecCCccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE--NGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~--~g~lkl~DFGla~~~~ 176 (481)
+.+.+++||++.|+|..-+...++.|....+++.|+++|++|+|+++++|||||.+||||.. ..++||||||+++..+
T Consensus 95 d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 78889999999999999999888999999999999999999999999999999999999954 3479999999987533
Q ss_pred ccccCCcccccCCCCccccccccccCCC----CCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCC-CCC
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGY----DAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGE-FRS 247 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~----~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~-~~~ 247 (481)
. ..+..--+..|.+||++..... ..+.+|+|.||+++|.+++|.+||..... -..+.++.++. ...
T Consensus 175 ~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 175 T-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred c-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 2 2222334567999998643221 12458999999999999999999985432 23445555543 233
Q ss_pred C---CCCCHHHHHHHHHhcccCcCCC---CCHhHHHhCcccccC
Q 011628 248 P---RWFSPDLIRLLTKLLDTNPDKR---ITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ~---~~~s~~~~~li~~~L~~dP~~R---ps~~eil~h~~f~~~ 285 (481)
| ..+|+.+..+.++-|.++|++| .++.......|....
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 3 3478999999999999999999 566666777887554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=293.01 Aligned_cols=261 Identities=31% Similarity=0.521 Sum_probs=212.9
Q ss_pred ccCCe-eEEeEecccCceEEEEEEEcCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 24 LLGRY-EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKE---KILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 24 ~~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
+..+| .....+|.|++|.|+.+......+.++.|..... ..........+..|+.+-..++|||++.....+....
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 45667 6689999999999998888777777777765421 1122233344788999999999999988777666666
Q ss_pred EEEEEEeccCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
..+-.||||++ +|+.++... .+...++..+++||+.||.|+|+.||.|||+||+|+++..+|.+||+|||.+..+...
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 66666999999 999999875 8999999999999999999999999999999999999999999999999999876654
Q ss_pred ccC--CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHH---------HHHhhCCCCC
Q 011628 179 RQD--GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY---------KKIYKGEFRS 247 (481)
Q Consensus 179 ~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---------~~i~~~~~~~ 247 (481)
... ......+|+..|+|||++.+..|+....||||+|++++.|.+|+.||......... .++..+..+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 444 45567899999999999999999999999999999999999999999765433211 1111122222
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...++...+.+|.+||++||.+|+|+++|++++||+..
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 33467788999999999999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=248.52 Aligned_cols=251 Identities=21% Similarity=0.299 Sum_probs=209.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA-TK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~ 98 (481)
..|+++..++-+|+||.||.|++.+. .+.|-+|.++... .+-.+..+..|...+..++|||+..+.++.. +.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 46788889999999999999987643 2346667664332 2234566788999999999999999999875 45
Q ss_pred CEEEEEEeccCCCchHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 99 SKIYFVMEYVRGGELFNKVAK---------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~---------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
...++++.+..-|+|..++.. ..++..+...++.|++.|++|||++||+|.||...|++||+.-.+||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 678899999999999999872 13677788899999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCC
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRS 247 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~ 247 (481)
.+++-........+-..-.....||+||.+.+..| +..+|+|||||+||||+| |..||.+-++.+++..+.+|. +..
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 99986444333222233345678999999998888 567999999999999998 999999999999999998884 667
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
|-.+|+++..++..||...|++||+.+|+..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 8889999999999999999999999999865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=292.94 Aligned_cols=198 Identities=15% Similarity=0.204 Sum_probs=146.3
Q ss_pred CCC-CCcceEEEEE-------EeCCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCC
Q 011628 83 VRH-PNIVQLFEVM-------ATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLK 152 (481)
Q Consensus 83 l~H-pnIv~l~~~~-------~~~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLK 152 (481)
++| +||+++++.+ .....++.++||+ +++|++++.. +.+++.++..+++||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 445 5777777776 2234577888887 5699999975 459999999999999999999999999999999
Q ss_pred CCcEEEccC-------------------CCEEEEecCCccccccccc--------------CCcccccCCCCcccccccc
Q 011628 153 PENLLLDEN-------------------GDLKVSDFGLSAVSDQIRQ--------------DGLFHTFCGTPAYVAPEVL 199 (481)
Q Consensus 153 p~NILl~~~-------------------g~lkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APEvl 199 (481)
|+||||+.. +.+|++|||+++....... .......+||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 4456666666653211000 0001124689999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 200 ~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..| +.++|||||||+||||++|..|+..... ....+.....+ .+....+...+++.+||+++|.+|||+.|+++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88887 6789999999999999999998765332 11112111111 11112456789999999999999999999999
Q ss_pred Cccccc
Q 011628 279 NRWFRK 284 (481)
Q Consensus 279 h~~f~~ 284 (481)
||||.+
T Consensus 265 h~~~~~ 270 (793)
T PLN00181 265 SEFINE 270 (793)
T ss_pred chhhhh
Confidence 999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-27 Score=230.57 Aligned_cols=254 Identities=37% Similarity=0.593 Sum_probs=211.7
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP-NIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~E 106 (481)
|++.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 88999999877654444567889999999999988 79999999988888999999
Q ss_pred ccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCcccccccccC
Q 011628 107 YVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 107 y~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~~~~ 181 (481)
|+.++++.+.+... .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999877764 699999999999999999999999999999999999999998 6999999998754332221
Q ss_pred C----cccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCC-CCCC
Q 011628 182 G----LFHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFR-SPRW 250 (481)
Q Consensus 182 ~----~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 250 (481)
. .....+||..|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34678999999999999874 4556789999999999999999999887763 4555555444433 2222
Q ss_pred CC--------HHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 251 FS--------PDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 251 ~s--------~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.. ..+.+++.+++..+|..|.+..+...++|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 22 46899999999999999999999988866544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=244.81 Aligned_cols=171 Identities=24% Similarity=0.261 Sum_probs=136.1
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcce-EEEEEE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKI--LKSGLVAHIKREISILRRVRHPNIVQ-LFEVMA 96 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~ 96 (481)
-.++.++|++.+.||+|+||+||+|++.. +++.||||++..... ........+.+|+.+|+.++|+||+. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34678999999999999999999999876 678889998753311 12234567899999999999999985 4432
Q ss_pred eCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCcEEEccCCCEEEEecCCcccc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDL-KPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDL-Kp~NILl~~~g~lkl~DFGla~~~ 175 (481)
...|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 458999999999999732 21 11 1578999999999999999999999 999999999999999999999865
Q ss_pred cccccCCc------ccccCCCCcccccccccc
Q 011628 176 DQIRQDGL------FHTFCGTPAYVAPEVLSR 201 (481)
Q Consensus 176 ~~~~~~~~------~~~~~gt~~y~APEvl~~ 201 (481)
........ ....++++.|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 44332221 246688999999999854
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=223.13 Aligned_cols=158 Identities=21% Similarity=0.262 Sum_probs=128.6
Q ss_pred CchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccC
Q 011628 111 GELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188 (481)
Q Consensus 111 g~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 188 (481)
|+|.+++.. +.+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 689999974 46999999999999999999999999 999999999999999 9998764331 236
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCCC-------CCCCCCH--HHHHH
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFR-------SPRWFSP--DLIRL 258 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~-------~~~~~s~--~~~~l 258 (481)
||+.|+|||++.+..| +.++||||+||++|+|++|..||...... .....+..+... .+..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 8999999999988877 57899999999999999999999765432 333333322111 1222333 69999
Q ss_pred HHHhcccCcCCCCCHhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
|.+||..||.+|||+.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=252.56 Aligned_cols=239 Identities=35% Similarity=0.606 Sum_probs=207.3
Q ss_pred EecccCceEEEEEEE---cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 011628 33 LLGHGTFAKVYHARN---VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
++|+|+||.|++++. .+.|..+|+|+..+......... .-+.|-.++..++ ||.+++++..+.++.+.|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998763 24678899999877654433222 4556888888887 999999999999999999999999
Q ss_pred CCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccccc
Q 011628 109 RGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187 (481)
Q Consensus 109 ~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 187 (481)
.||+|+..+.+ ..+.+.....+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..-... ..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence 99999999876 468888899999999999999999999999999999999999999999999998643211 22
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP 267 (481)
|||..|||||+++ ++ ...+|.||+|+++|+|++|..||.. +....|.+.++..|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999997 45 3469999999999999999999998 677788888999999999999999999999999
Q ss_pred CCCCC-----HhHHHhCcccccC
Q 011628 268 DKRIT-----IPEIMENRWFRKG 285 (481)
Q Consensus 268 ~~Rps-----~~eil~h~~f~~~ 285 (481)
.+|.- +.|+++|+||+..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhccCcchhHHHhccchheee
Confidence 99975 6899999999764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-25 Score=224.01 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=193.7
Q ss_pred CeeEEeEecccCceEEEEEEEcCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSG-ESVAIKVIDKEKILKSGLVAHIKREISILRRVRH----PNIVQLFEVM-ATKSK 100 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~ 100 (481)
+|++.+.||+|+||.||++.+..++ ..+|+|+......... ..++.|+.++..+.. +++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 6789998766532221 157789999998873 6899999999 57888
Q ss_pred EEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-----CCEEEEecCCc
Q 011628 101 IYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-----GDLKVSDFGLS 172 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-----g~lkl~DFGla 172 (481)
-|+||+.+ |.+|.++... +.++...+..++.|++.+|+++|+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 7799998753 579999999999999999999999999999999999999865 35999999999
Q ss_pred ccccccccCC-------c-ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---HHHHHHh
Q 011628 173 AVSDQIRQDG-------L-FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---VMYKKIY 241 (481)
Q Consensus 173 ~~~~~~~~~~-------~-~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~ 241 (481)
+........+ . .....||..|+++....+... +.+.|+||++.++.+|+.|.+||...... ..+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8322111111 1 123459999999999888776 67899999999999999999999775532 2222222
Q ss_pred hCCCC--CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..... .....+..+..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22211 223345677777777777899999998887664
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-25 Score=211.46 Aligned_cols=247 Identities=19% Similarity=0.307 Sum_probs=198.0
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 99 (481)
...+.-.|+++++||+|+||+.+.|.+.-+++.||||.-.... ...+++.|....+.|. .++|...|.+..++.
T Consensus 23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ceEecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 3456779999999999999999999999999999999754332 2456888999999995 799999999988888
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-----CEEEEecCCc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-----DLKVSDFGLS 172 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-----~lkl~DFGla 172 (481)
.-.||||++ |-+|.|+..- ++|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .+.|+|||+|
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 888999998 7799998874 5799999999999999999999999999999999999997644 4899999999
Q ss_pred ccccccccC-----CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhCC
Q 011628 173 AVSDQIRQD-----GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGE 244 (481)
Q Consensus 173 ~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~ 244 (481)
+.+...... +...+..||..||+--...+... +.+.|+-|||-+++.+|-|.+||.+. +..+-|.+|-...
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 865432221 12345689999999887777665 67899999999999999999999874 4456677775433
Q ss_pred CCC-----CCCCCHHHHHHHHHhcccCcCCCCCHh
Q 011628 245 FRS-----PRWFSPDLIRLLTKLLDTNPDKRITIP 274 (481)
Q Consensus 245 ~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ 274 (481)
..- ...+|.++...++-.-..+-.+-|..+
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 221 344677776666666555556666644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=201.72 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=199.0
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMAT 97 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 97 (481)
...-...++|++++.||+|+||.+|+|....+|+.||||+-.... . ..++..|..+.+.|+ ...|..+..+..+
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhccc
Confidence 344456899999999999999999999999999999999865432 2 234668999999997 4778888888888
Q ss_pred CCEEEEEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEecCCc
Q 011628 98 KSKIYFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVSDFGLS 172 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~DFGla 172 (481)
...-.+||+.. |-+|.++.. ...++...+.-++-|++.-++|+|.++++||||||+|.|+.-+ ..+.++|||+|
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 88899999998 779999886 3679999999999999999999999999999999999999754 45899999999
Q ss_pred ccccccccCC-----cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---HHHHHHHhhCC
Q 011628 173 AVSDQIRQDG-----LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYKGE 244 (481)
Q Consensus 173 ~~~~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~ 244 (481)
+.+....... .-....||..|.+--...+... +.+.|+-|+|.+|..+.-|.+||.+... ..-+.+|..-.
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 8754433221 1234579999998776655444 5679999999999999999999998644 35566665554
Q ss_pred CCC-----CCCCCHHHHHHHHHhcccCcCCCCCHh
Q 011628 245 FRS-----PRWFSPDLIRLLTKLLDTNPDKRITIP 274 (481)
Q Consensus 245 ~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ 274 (481)
... ...+|.++...+.-|-..--++-|...
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 433 455788999999988776666667643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=242.46 Aligned_cols=225 Identities=32% Similarity=0.620 Sum_probs=179.1
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
....+...+|+.+++|..|+||.||+++++.+.+.+|+| +++++.. .|- |+.....|.+|
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--------lRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------LRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--------hhc--cccccCCccee---------
Confidence 366677889999999999999999999999999999995 4443321 111 33333344444
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
|+-..+++. +.++.+. +.+++|||+.||+|||+||+|++|+.=|++|++|||+++....
T Consensus 136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 455556654 5566544 8899999999999999999999999999999999999875321
Q ss_pred cccC----C---------cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC
Q 011628 178 IRQD----G---------LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 178 ~~~~----~---------~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 244 (481)
.... + .-...||||.|+||||+...+| +.++|.|++|+|+|+++-|..||.++++++++.......
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 1111 0 0134699999999999999999 678999999999999999999999999999999988876
Q ss_pred CCCCC---CCCHHHHHHHHHhcccCcCCCC---CHhHHHhCccccc
Q 011628 245 FRSPR---WFSPDLIRLLTKLLDTNPDKRI---TIPEIMENRWFRK 284 (481)
Q Consensus 245 ~~~~~---~~s~~~~~li~~~L~~dP~~Rp---s~~eil~h~~f~~ 284 (481)
...|. -++++++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 54443 3788999999999999999996 5778999999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-26 Score=242.43 Aligned_cols=259 Identities=31% Similarity=0.536 Sum_probs=220.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 102 (481)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... .......++..|..+.+.++ |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5568999999999999999988744 45567888776554 33456677888999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHH-HcC--CCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCcEEEccCC-CEEEEecCCcccccc
Q 011628 103 FVMEYVRGGELFNKV-AKG--RLKEDLARKYFQQLISAVGFCH-ARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQ 177 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i-~~~--~l~e~~~~~~~~ql~~al~yLH-~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~ 177 (481)
++++|..|+++++.+ ... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ +++++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 553 6888999999999999999999 99999999999999999999 999999999998766
Q ss_pred -cccCCcccccCC-CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH-HHHHhhC--C--CCCCCC
Q 011628 178 -IRQDGLFHTFCG-TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM-YKKIYKG--E--FRSPRW 250 (481)
Q Consensus 178 -~~~~~~~~~~~g-t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i~~~--~--~~~~~~ 250 (481)
.+........+| ++.|+|||...+..|.+...|+||+|+++..+++|..||........ +...... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 555666778899 99999999998888888899999999999999999999987654321 1222221 1 233455
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
++....+++.++|..+|..|.+++++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7888999999999999999999999999999976
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=205.06 Aligned_cols=175 Identities=18% Similarity=0.209 Sum_probs=137.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhCCCCCcceEEEEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH------IKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
.+.++|++.+.||.|+||.||++.. ++..+|||++.......+..... +.+|+..+.++.||+|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4578999999999999999999755 57789999998765544444444 579999999999999999998865
Q ss_pred eC--------CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 97 TK--------SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 97 ~~--------~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
.. ...+++|||++|.+|.+... +++ ....+++.++..||++|++|||+||+||+++.+| ++|+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 43 35789999999999988732 333 3466999999999999999999999999999988 99999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHh
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLM 222 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ell 222 (481)
||.+......... ..++....|+ .++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a~--------------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK--------------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH--------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 9987643211110 1133445565 6899999999877553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=198.62 Aligned_cols=141 Identities=24% Similarity=0.336 Sum_probs=113.2
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----------------------HHHHHHHHHHHHHhCCCCC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG-----------------------LVAHIKREISILRRVRHPN 87 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~Hpn 87 (481)
...||+|+||.||+|.+. +|+.||||+++........ ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321111 0123456999999998888
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHH-HHcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCcEEEccCCCEE
Q 011628 88 IVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFC-HARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 88 Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~-i~~~~l~e~~~~~~~~ql~~al~yL-H~~gi~HrDLKp~NILl~~~g~lk 165 (481)
+.....+... ..+|||||++|+++... +..+.+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7554433322 23899999999887655 4557899999999999999999999 799999999999999998 57899
Q ss_pred EEecCCcccc
Q 011628 166 VSDFGLSAVS 175 (481)
Q Consensus 166 l~DFGla~~~ 175 (481)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=203.97 Aligned_cols=234 Identities=24% Similarity=0.348 Sum_probs=154.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC----------CCcceEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH----------PNIVQLFEVMA 96 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H----------pnIv~l~~~~~ 96 (481)
.+..++.||.|+++.||.+.+.+||+.+|+|++...........+++++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45778999999999999999999999999999876653334456777777766555432 23333333322
Q ss_pred e---------C---C-----EEEEEEeccCCCchHHHHHc----CCC----CHHHHHHHHHHHHHHHHHHHHcCceecCC
Q 011628 97 T---------K---S-----KIYFVMEYVRGGELFNKVAK----GRL----KEDLARKYFQQLISAVGFCHARGVYHRDL 151 (481)
Q Consensus 97 ~---------~---~-----~~~lv~Ey~~gg~L~~~i~~----~~l----~e~~~~~~~~ql~~al~yLH~~gi~HrDL 151 (481)
- . + +.+++|+-+. ++|.+++.- ... .......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 2367788774 588777542 222 22233456689999999999999999999
Q ss_pred CCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCC-------CCCCcchHHHHHHHHHHHhcC
Q 011628 152 KPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG-------YDAAKVDIWSCGVILFVLMAG 224 (481)
Q Consensus 152 Kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-------~~~~~~DiwSlGvil~elltg 224 (481)
+|+|++++.+|.++|+||+.....+... .....+..|.+||...... ..+.+.|.|+||+++|.|.+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999998765433321 1133457799999864421 125679999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 225 YLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 225 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
.+||........... .+.....+|..++.||..+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999986643211110 333344789999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=192.34 Aligned_cols=142 Identities=23% Similarity=0.325 Sum_probs=115.6
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhCCCC
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----------------------GLVAHIKREISILRRVRHP 86 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~Hp 86 (481)
+...||+|+||+||+|.+. +|+.||||+++....... .......+|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 899999999986531100 0122346899999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHH-HHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCE
Q 011628 87 NIVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 87 nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~-~i~~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~l 164 (481)
+|.....+.... .|+||||++|+++.. .+..+++++..+..++.|++.++.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 986555544333 489999999986544 3556778999999999999999999999 9999999999999999 8899
Q ss_pred EEEecCCcccc
Q 011628 165 KVSDFGLSAVS 175 (481)
Q Consensus 165 kl~DFGla~~~ 175 (481)
+|+|||++...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=185.60 Aligned_cols=191 Identities=19% Similarity=0.257 Sum_probs=142.6
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh-HHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG-LVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 106 (481)
-+...|++|+||+||.+.. .+.+++.+.+......... ....+.+|+++|++|. |++|++++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4578899999999998765 7788888877654432111 1225789999999995 5889999886 44699999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCcEEEccCCCEEEEecCCcccccccccC-Cc-
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDL-KPENLLLDENGDLKVSDFGLSAVSDQIRQD-GL- 183 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDL-Kp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~- 183 (481)
|+.|.+|.+....+ ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|......... ..
T Consensus 79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99999997654322 1357899999999999999999999 799999999999999999999854432210 00
Q ss_pred ---------ccccCCCCccccccccccCCCCC-CcchHHHHHHHHHHHhcCCCCCCCc
Q 011628 184 ---------FHTFCGTPAYVAPEVLSRKGYDA-AKVDIWSCGVILFVLMAGYLPFQDQ 231 (481)
Q Consensus 184 ---------~~~~~gt~~y~APEvl~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~ 231 (481)
......++.|++|+...-..-.+ ...+.++.|+-+|.++|+.+|+-+.
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 01223678888988643322112 3578888999999999999887543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-23 Score=224.00 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=182.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEK-ILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
...|...+.||++.|=+|.+|++. .|. |+||++-+.. ...-.-..+..+|++ ...++|||.+++.-+.......|+
T Consensus 22 ~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 22 SVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHH
Confidence 347899999999999999999873 344 9999986654 111122334445666 666789999999888888888899
Q ss_pred EEeccCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc--cccc
Q 011628 104 VMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD--QIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~--~~~~ 180 (481)
|-+|... +|+|.+..++ +..-+.+.|+.||+.||.-||..||+|+|||.|||||+.-+.+.|+||...+..- ...+
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9999965 9999998765 5667788889999999999999999999999999999999999999998654210 1011
Q ss_pred CC---cccccCCCCccccccccccCC----------CCCCcchHHHHHHHHHHHhc-CCCCCCCch-----------HHH
Q 011628 181 DG---LFHTFCGTPAYVAPEVLSRKG----------YDAAKVDIWSCGVILFVLMA-GYLPFQDQN-----------IMV 235 (481)
Q Consensus 181 ~~---~~~~~~gt~~y~APEvl~~~~----------~~~~~~DiwSlGvil~ellt-g~~Pf~~~~-----------~~~ 235 (481)
.. .+.+...-..|+|||.+.... .-+++-||||+||++.||++ |++||.-.. +..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 11 123344456799999875422 12457899999999999988 799985322 122
Q ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 236 MYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 236 ~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
...+| -+..+++||..|++.||.+|.++++.|+.
T Consensus 258 ~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 22222 14468999999999999999999999984
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=197.70 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=176.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCC-----------------------------------cEEEEEEeecccccc-
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSG-----------------------------------ESVAIKVIDKEKILK- 66 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----------------------------------~~vAvK~i~~~~~~~- 66 (481)
.-.++|+|++.||+|.-+.||.|+...+| -+.|||.+-.-....
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 34788999999999999999999854311 124566553221111
Q ss_pred -hhHHHHHHHHHH------H--------HHh--------CCCCCcceEEEEEEe--------------------------
Q 011628 67 -SGLVAHIKREIS------I--------LRR--------VRHPNIVQLFEVMAT-------------------------- 97 (481)
Q Consensus 67 -~~~~~~~~~Ei~------i--------l~~--------l~HpnIv~l~~~~~~-------------------------- 97 (481)
....+..-+|.. . .+. -+|||||++...|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 112222223321 0 111 259999999876533
Q ss_pred -CCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc--cCC--CEEEEecCCc
Q 011628 98 -KSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD--ENG--DLKVSDFGLS 172 (481)
Q Consensus 98 -~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~--~~g--~lkl~DFGla 172 (481)
+..+|+||...+. +|..++-....+-...+-++.|+++|+.|||++||.|||+|.+|||+. +++ .+.|+|||.+
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 3457999987754 899999877788888999999999999999999999999999999984 333 4899999965
Q ss_pred cccccc----ccCCcccccCCCCccccccccccCCC-----CCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh-h
Q 011628 173 AVSDQI----RQDGLFHTFCGTPAYVAPEVLSRKGY-----DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY-K 242 (481)
Q Consensus 173 ~~~~~~----~~~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-~ 242 (481)
--.+.. ..........|.-.-||||+....+- +-.|+|.|++|.+.||++....||.....+.+-..-+ .
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe 472 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE 472 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence 321110 01111223467788999999754321 1247999999999999999999998855443222222 2
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 011628 243 GE-FRSPRWFSPDLIRLLTKLLDTNPDKRITI 273 (481)
Q Consensus 243 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 273 (481)
.+ +..|+.+++.+++++..+|+.||++|++.
T Consensus 473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred hhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 22 45688899999999999999999999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-22 Score=184.25 Aligned_cols=134 Identities=20% Similarity=0.279 Sum_probs=109.5
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-----RHPNIVQLFEVMATKS---KIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~ 102 (481)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||+++|+++.+.. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 57899999999995 6667666 6999876432 2346789999999999 5799999999998874 434
Q ss_pred -EEEec--cCCCchHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHcCceecCCCCCcEEEccC----CCEEEEecCCc
Q 011628 103 -FVMEY--VRGGELFNKVAKGRLKEDLARKYFQQLISAV-GFCHARGVYHRDLKPENLLLDEN----GDLKVSDFGLS 172 (481)
Q Consensus 103 -lv~Ey--~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al-~yLH~~gi~HrDLKp~NILl~~~----g~lkl~DFGla 172 (481)
+|+|| +.+|+|.+++.++.++++ ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 558999999988777776 36688888887 99999999999999999999743 37999995533
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=187.74 Aligned_cols=241 Identities=21% Similarity=0.372 Sum_probs=196.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
++...+..+|.+.-.|..|+|++ .|..+++|++...... ......+..|.-.++.+.||||+.+++.|.++.++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 55667788899999999999998 4566788888765432 23446688899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEE--ecCCcccccc
Q 011628 105 MEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDLKVS--DFGLSAVSDQ 177 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~lkl~--DFGla~~~~~ 177 (481)
..|++.|+|+..+..+ -.+..++.+++.++++|++|||+.. |----|....+++|++-..+|+ |--++- +
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---q 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---Q 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---e
Confidence 9999999999999874 3788899999999999999999874 3344588899999998776654 322211 1
Q ss_pred cccCCcccccCCCCccccccccccCCCCC--CcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCCCCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDA--AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~--~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~ 253 (481)
.. ...-+|.||+||.+..++.+. ..+|+|||.+++|||.|...||.+-.+++.-.+|.-. ...+|+.+++
T Consensus 343 -e~-----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 343 -EV-----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred -cc-----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 11 123478999999998776543 3699999999999999999999999988877776543 3567999999
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHH
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIM 277 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil 277 (481)
....|+.-|++.||.+||.++.|+
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999988764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=208.04 Aligned_cols=235 Identities=23% Similarity=0.370 Sum_probs=181.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR---HPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~ 101 (481)
..+|.|-+.||+|+||+||.|.... |+.||+|+-.....++-... .+++.+|+ -+.|+.++..+.-.+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 5789999999999999999999865 99999999877665432222 23334443 34566666666667778
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------CCCEEEEecCCcc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-------NGDLKVSDFGLSA 173 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-------~g~lkl~DFGla~ 173 (481)
++|+||.+.|+|.++++. +.+++..+..+..|++.-|++||..+|||+||||+|.||.. +--++|+|||-|-
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 999999999999999986 57999999999999999999999999999999999999953 2348999999987
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-----CC
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-----SP 248 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~~ 248 (481)
-.........+...++|-.+-.+|+..+.++ +..+|.|.+..+++.||.|+.- +..+|... .+
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y~-----------q~~~g~~~~~~~~~~ 917 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKYM-----------EVKNGSSWMVKTNFP 917 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHHH-----------HhcCCcceeccccch
Confidence 6555455556778899999999999999998 6889999999999999998532 13333211 23
Q ss_pred CCCCHH-HHHHHHHhcccCcCCCCCHhHHHh
Q 011628 249 RWFSPD-LIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 249 ~~~s~~-~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+.+..+ ..+++..+|+.|-..=|...+|..
T Consensus 918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~ 948 (974)
T KOG1166|consen 918 RYWKRDMWNKFFDLLLNPDCDTLPNLQELRT 948 (974)
T ss_pred hhhhHHHHHHHHHHHhCcCcccchhHHHHHH
Confidence 333333 456888999855555555555543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=182.16 Aligned_cols=143 Identities=21% Similarity=0.277 Sum_probs=115.0
Q ss_pred CeeEEeEecccCceEEEEEE-EcCCCcEEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 011628 27 RYEIGKLLGHGTFAKVYHAR-NVKSGESVAIKVIDKEKILK---------------------SGLVAHIKREISILRRVR 84 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~-~~~~~~~vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 84 (481)
-|++.+.||+|+||.||+|. +..+|+.||+|+++...... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 66799999999997543110 001234678999999997
Q ss_pred CCC--cceEEEEEEeCCEEEEEEeccCCCchHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCcEEEcc
Q 011628 85 HPN--IVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARG-VYHRDLKPENLLLDE 160 (481)
Q Consensus 85 Hpn--Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i-~~~~l~e~~~~~~~~ql~~al~yLH~~g-i~HrDLKp~NILl~~ 160 (481)
+.+ +.++++. ...++||||+.|++|.... ....+.+..+..++.|++.++.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3344432 2358999999998887765 3455677778899999999999999999 99999999999999
Q ss_pred CCCEEEEecCCccc
Q 011628 161 NGDLKVSDFGLSAV 174 (481)
Q Consensus 161 ~g~lkl~DFGla~~ 174 (481)
++.++|+|||.+..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-19 Score=169.03 Aligned_cols=137 Identities=24% Similarity=0.366 Sum_probs=116.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG-----LVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+.||+|++|.||+|++ +|..|++|+.......... ....+.+|+.++..+.|++|.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 7788999987543322111 22457789999999999999887777777788899999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999876422 7889999999999999999999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.8e-19 Score=164.43 Aligned_cols=133 Identities=23% Similarity=0.333 Sum_probs=109.4
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----GLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
.||+|+||.||+|.. +|..|++|+......... ....++.+|+.+++.+.|+++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 678899998654322111 1235678999999999988766655556666778999999
Q ss_pred cCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 108 VRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 108 ~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
++|++|.+.+..... .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 8899999999999999999999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=165.66 Aligned_cols=139 Identities=20% Similarity=0.321 Sum_probs=110.4
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch-------------------hHHHHHHHHHHHHHhCCCCC-
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-------------------GLVAHIKREISILRRVRHPN- 87 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~Hpn- 87 (481)
|.+.+.||+|+||.||+|.+ .+|+.||||++........ .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88899999999999999987 4899999999865431000 01123678999999998874
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 011628 88 -IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 88 -Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
+...++ ....+++|||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2345899999999998765431 346678899999999999999999999999999999999999
Q ss_pred EecCCccccc
Q 011628 167 SDFGLSAVSD 176 (481)
Q Consensus 167 ~DFGla~~~~ 176 (481)
+|||++....
T Consensus 167 iDfg~~~~~~ 176 (198)
T cd05144 167 IDWPQMVSTD 176 (198)
T ss_pred EECCccccCC
Confidence 9999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7e-19 Score=180.87 Aligned_cols=199 Identities=24% Similarity=0.420 Sum_probs=156.4
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCc-eecCCCCCcE
Q 011628 80 LRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGV-YHRDLKPENL 156 (481)
Q Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi-~HrDLKp~NI 156 (481)
|+.+.|.|+.++++.+..+...++|.+||.-|+|++.+... .++.--...++++|+.|+.|+|.-.| +|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45788999999999999999999999999999999999875 45666667788999999999998766 9999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCC------CCCcchHHHHHHHHHHHhcCCCCCCC
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY------DAAKVDIWSCGVILFVLMAGYLPFQD 230 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~------~~~~~DiwSlGvil~elltg~~Pf~~ 230 (481)
+++....+||+|||+..+..........+...-...|.|||.+..... .+.+.||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876532111111122223456999999876421 35679999999999999999999976
Q ss_pred ch----HHHHHHHHhh-CCCCC-CC-----CCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 231 QN----IMVMYKKIYK-GEFRS-PR-----WFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 231 ~~----~~~~~~~i~~-~~~~~-~~-----~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.. +.++..++.+ +.... |. .+++++..++..||..+|..||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 3445555555 32211 21 24557899999999999999999998865
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=185.22 Aligned_cols=140 Identities=21% Similarity=0.274 Sum_probs=113.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK-----SGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
...|...+.||+|+||+||+|.+. +..+++|+........ ......+.+|+.+++.++|++|+..+.+.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 345567899999999999999874 3445555433221111 112356789999999999999998887777777
Q ss_pred EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
..++||||++|++|.+.+. ....++.|++.+|.|||++|++||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8899999999999999875 457799999999999999999999999999999 678999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.5e-20 Score=184.88 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=172.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-------E
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE-------V 94 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-------~ 94 (481)
.+.+.+-+..+..+++.+...+-..+ .+.++-+..+.+.. .......+++-.+....|.+..-+.+ .
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 45667777778888887776654333 33444444433321 22333455666665555444333222 1
Q ss_pred EE-----eCCEEEEEEeccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 011628 95 MA-----TKSKIYFVMEYVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 95 ~~-----~~~~~~lv~Ey~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lk 165 (481)
.. ....+||.|++|.-.+|.+++... ..+......++.|+..|++| +|.+|||+||.||+...+..+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 11 123589999999999999999742 46777889999999999999 9999999999999999999999
Q ss_pred EEecCCcccccccc----cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHH
Q 011628 166 VSDFGLSAVSDQIR----QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKI 240 (481)
Q Consensus 166 l~DFGla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i 240 (481)
|.|||+........ .........||..||+||.+.+..| +.++||||||+||+||+. -..+|.. ......+
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~ 472 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFER---IATLTDI 472 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhh
Confidence 99999987543322 1112345689999999999999888 689999999999999997 2333322 2233344
Q ss_pred hhCCCCCCCCC-CHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 241 YKGEFRSPRWF-SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 241 ~~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..+.++.-.+. .|.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 44544421111 2445689999999999999977776666664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=156.97 Aligned_cols=139 Identities=22% Similarity=0.365 Sum_probs=101.9
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHH---------------------HHHHHHHHHHhCCCCC-
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA---------------------HIKREISILRRVRHPN- 87 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~Hpn- 87 (481)
+++.||+|+||+||+|.+. +++.||||++............ ....|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999975 8999999998764322111111 1145677777765443
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCchHH-HHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCE
Q 011628 88 -IVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 88 -Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~-~i~~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~l 164 (481)
+.++++. ...+++|||++|+.+.. .+...... ..++.++.|++.++.++|+ +||+||||||+||+++ ++.+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4555543 23589999999964432 12221111 6788999999999999999 9999999999999999 8999
Q ss_pred EEEecCCcccc
Q 011628 165 KVSDFGLSAVS 175 (481)
Q Consensus 165 kl~DFGla~~~ 175 (481)
+|+|||.+...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.9e-17 Score=158.86 Aligned_cols=138 Identities=17% Similarity=0.330 Sum_probs=107.0
Q ss_pred EeEec-ccCceEEEEEEEcCCCcEEEEEEeecccc----c------chhHHHHHHHHHHHHHhCCCCCc--ceEEEEEEe
Q 011628 31 GKLLG-HGTFAKVYHARNVKSGESVAIKVIDKEKI----L------KSGLVAHIKREISILRRVRHPNI--VQLFEVMAT 97 (481)
Q Consensus 31 ~~~LG-~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~ 97 (481)
+..|| .||.|+||.+.. .+..++||.+..... . .......+.+|+.++..|.|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35576 777788888765 478899998864321 0 11223567899999999998885 667666433
Q ss_pred C-C---EEEEEEeccCC-CchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 98 K-S---KIYFVMEYVRG-GELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 98 ~-~---~~~lv~Ey~~g-g~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
. . ..++||||++| .+|.+++..+.+++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 23599999998 6899998877777653 578999999999999999999999999999999999999987
Q ss_pred cc
Q 011628 173 AV 174 (481)
Q Consensus 173 ~~ 174 (481)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=137.96 Aligned_cols=132 Identities=23% Similarity=0.317 Sum_probs=112.9
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH--PNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~Ey 107 (481)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.+.| +++.+++......+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999973 47899999865432 3567889999999976 5899999988888899999999
Q ss_pred cCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 108 VRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR---GVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 108 ~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~---gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
+.|+.+... +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||.++.
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 5566778899999999999984 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-17 Score=179.16 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=209.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.+.+.+.+-+-+|+++.++.+.-..+|...++|+............+.+.++-.++-...+|-+++..--+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 56788888999999999999998888888888876544332222233344444444444567777665555667789999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc-----
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI----- 178 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~----- 178 (481)
++|+.|++|...+.. +..+++.++.++..+..+++|||+..+.|||++|.|+|...+|..+++|||........
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999999999987 56889999999999999999999999999999999999999999999999843221111
Q ss_pred -----c-----------------cC--CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH
Q 011628 179 -----R-----------------QD--GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM 234 (481)
Q Consensus 179 -----~-----------------~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 234 (481)
. .. ..-....||+.|.+||.+.+... +..+|+|+.|+++++.++|..||....+.
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 00 11234578999999999988877 45799999999999999999999999999
Q ss_pred HHHHHHhhCCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHh---HHHhCcccccC
Q 011628 235 VMYKKIYKGEFRS---PRWFSPDLIRLLTKLLDTNPDKRITIP---EIMENRWFRKG 285 (481)
Q Consensus 235 ~~~~~i~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~---eil~h~~f~~~ 285 (481)
..+..|.++..+. |...++.+++++.++|..+|.+|..+. ++..|+||+..
T Consensus 1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 9999999887655 445789999999999999999999877 88999999753
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-16 Score=116.36 Aligned_cols=57 Identities=65% Similarity=0.969 Sum_probs=47.5
Q ss_pred CCCccchhhhccCCCCCCCCCcccCc-----cccceecCCCHHHHHHHHHHHHHHcCcEEEE
Q 011628 340 PASLNAFDLISFSPGFDLSGLFEEGG-----EGARFVSGAPVSKIITKLEEIAKVVSFTVRK 396 (481)
Q Consensus 340 ~~~~~~~~~~~~~~~~~l~~~~~~~~-----~~~~f~~~~~~~~~~~~l~~~~~~~~~~~~~ 396 (481)
|..+|||||||+|+|||||+||+... +.+||+|+.|+++|+++||++|+.+||+|+|
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 66899999999999999999998643 4799999999999999999999999999976
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.1e-16 Score=159.41 Aligned_cols=256 Identities=20% Similarity=0.226 Sum_probs=194.8
Q ss_pred ccCCeeEEeEecc--cCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 24 LLGRYEIGKLLGH--GTFAKVYHARN--VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~--G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... ......+=.+|+...+.++ |+|.++.+..++..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccC
Confidence 4567788899999 99999999998 88999999998543221 1111222346888878785 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-C-CCCHHHHHHHHHHHHH----HHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCC
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-G-RLKEDLARKYFQQLIS----AVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGL 171 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~-~l~e~~~~~~~~ql~~----al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGl 171 (481)
+..|+-+|+|. .+|..+... . -+++..++..+.+... ||.++|+.+++|-|+||.||++..+ ...+++|||+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999999996 678777765 4 4899999999999999 9999999999999999999999999 8899999998
Q ss_pred cccccccccCCcc---cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-hH-HHHHHHHhhCCCC
Q 011628 172 SAVSDQIRQDGLF---HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NI-MVMYKKIYKGEFR 246 (481)
Q Consensus 172 a~~~~~~~~~~~~---~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~-~~~~~~i~~~~~~ 246 (481)
........-.... ...-|...|++||..++.. +...|||++|.++.+-.++..+.... +. -....+++ -...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e 346 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLE 346 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchh
Confidence 8755432211111 2235778899999986543 56799999999999988876554332 11 11111111 1112
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+....+.++...+..|++.+|-.|++...+++|+++..
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 23334667778999999999999999999999999864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.5e-15 Score=152.74 Aligned_cols=142 Identities=23% Similarity=0.314 Sum_probs=98.1
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccc-------------------------------hhHHH------HHH
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK-------------------------------SGLVA------HIK 74 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------------------------------~~~~~------~~~ 74 (481)
+.||.|++|+||+|+. .+|+.||||+.++.-... .++.. ++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999986 589999999986532100 00111 234
Q ss_pred HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHH-HHHHHHHcCc
Q 011628 75 REISILRRVR-----HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLIS-AVGFCHARGV 146 (481)
Q Consensus 75 ~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~-al~yLH~~gi 146 (481)
+|...+.++. ++++.-..-+....+..++||||++|++|.+..... ... ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4555555552 343322211222234569999999999998876432 222 3445566665 4678999999
Q ss_pred eecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 147 ~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
+|+|+||.||+++.+|.++++|||++...+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-15 Score=160.54 Aligned_cols=146 Identities=23% Similarity=0.379 Sum_probs=101.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--------------------------c-----hhHHHH
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--------------------------K-----SGLVAH 72 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--------------------------~-----~~~~~~ 72 (481)
+...|+. +.||+|++|+||.|+.+.+|+.||||++++.... + .++.+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3556777 8999999999999999878999999999754210 0 022233
Q ss_pred HHH------HHHHHHhCC----CCCcceEEEEEEe-CCEEEEEEeccCCCchHHH--HHc-C----CCCHHHHHHHHHHH
Q 011628 73 IKR------EISILRRVR----HPNIVQLFEVMAT-KSKIYFVMEYVRGGELFNK--VAK-G----RLKEDLARKYFQQL 134 (481)
Q Consensus 73 ~~~------Ei~il~~l~----HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~--i~~-~----~l~e~~~~~~~~ql 134 (481)
+.+ |...+.++. +.+.+.+-.++.+ .+..++||||+.|+.+.+. +.. + .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 333 443343332 3333443334322 4557899999999999774 333 3 24455556666666
Q ss_pred HHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEecCCcccccc
Q 011628 135 ISAVGFCHARGVYHRDLKPENLLLDENG----DLKVSDFGLSAVSDQ 177 (481)
Q Consensus 135 ~~al~yLH~~gi~HrDLKp~NILl~~~g----~lkl~DFGla~~~~~ 177 (481)
+ ..|++|+|+||.||+++.+| .++++|||++...+.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5 58999999999999999988 999999999876543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.4e-13 Score=123.70 Aligned_cols=139 Identities=19% Similarity=0.246 Sum_probs=103.5
Q ss_pred EeEecccCceEEEEEEEcC------CCcEEEEEEeecccc-------------------cchhHHHH----HHHHHHHHH
Q 011628 31 GKLLGHGTFAKVYHARNVK------SGESVAIKVIDKEKI-------------------LKSGLVAH----IKREISILR 81 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~-------------------~~~~~~~~----~~~Ei~il~ 81 (481)
...||.|.-+.||.|.... .+..+|||+.+.... .+.+.... .++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 357999998853211 00111222 348999999
Q ss_pred hCCC--CCcceEEEEEEeCCEEEEEEeccCCCchHH-HHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCcEE
Q 011628 82 RVRH--PNIVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLISAVGFC-HARGVYHRDLKPENLL 157 (481)
Q Consensus 82 ~l~H--pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~-~i~~~~l~e~~~~~~~~ql~~al~yL-H~~gi~HrDLKp~NIL 157 (481)
++.. -++..++.+ ..-+|||||+.+..+.. .+....++++.+..++.|++.++..| |+.|++|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9963 456666654 45689999998765532 34444566777888899999999998 8999999999999999
Q ss_pred EccCCCEEEEecCCccc
Q 011628 158 LDENGDLKVSDFGLSAV 174 (481)
Q Consensus 158 l~~~g~lkl~DFGla~~ 174 (481)
++ ++.+.|+|||.+-.
T Consensus 158 ~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 158 WH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EE-CCcEEEEECCCcee
Confidence 97 57899999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.9e-13 Score=139.36 Aligned_cols=171 Identities=20% Similarity=0.380 Sum_probs=131.9
Q ss_pred EEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCC
Q 011628 44 HARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK 123 (481)
Q Consensus 44 ~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~ 123 (481)
.|..+.++.+|.|.+.+.... .....+++-++-|+.++||||+++++.+++.+.+|||+|.+. -|...+.. +.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--hH
Confidence 455667899999999877653 345667888999999999999999999999999999999986 45555554 23
Q ss_pred HHHHHHHHHHHHHHHHHHH-HcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccC
Q 011628 124 EDLARKYFQQLISAVGFCH-ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202 (481)
Q Consensus 124 e~~~~~~~~ql~~al~yLH-~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~ 202 (481)
......-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++........ ......---.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 6667777899999999998 56899999999999999999999999998765443221 11111222336667665333
Q ss_pred CCCCCcchHHHHHHHHHHHhcCCC
Q 011628 203 GYDAAKVDIWSCGVILFVLMAGYL 226 (481)
Q Consensus 203 ~~~~~~~DiwSlGvil~elltg~~ 226 (481)
.+ ..|.|.|||++++++.|..
T Consensus 181 ~~---s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 EW---SIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cc---chhhhhHHHHHHHHhCccc
Confidence 32 3799999999999999933
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.3e-13 Score=121.95 Aligned_cols=127 Identities=19% Similarity=0.294 Sum_probs=97.2
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeccC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV-QLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lv~Ey~~ 109 (481)
.+.|+.|.++.||+++. .++.|++|+...... ....+.+|+.+++.+.+.+++ +++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999986 478899999765431 112356899999998765544 4554433 33589999999
Q ss_pred CCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 110 GGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGV-----YHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 110 gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi-----~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
|.++.+. ......++.+++.++..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887653 11123467899999999999985 9999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-13 Score=142.32 Aligned_cols=252 Identities=19% Similarity=0.185 Sum_probs=190.1
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEc-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNV-KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
....++|.++..||.|.|+.|+..... .++..|++|.....-....+.+. -..|+.+...+ .|.++++++..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccc
Confidence 345778999999999999999987755 57889999988665433322222 23577777777 4999999999999888
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~~ 177 (481)
..|+-.|||+++++...+.- ..+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||..+...-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 99999999999987766642 468899999999999999999999999999999999999886 7889999998764211
Q ss_pred cccCCcccccCCCCccc-cccccccCCCCCCcchHHHHHHHHHHHhcCCC-CCCCchHHHHHHHHhhCCCCCCCCCCHHH
Q 011628 178 IRQDGLFHTFCGTPAYV-APEVLSRKGYDAAKVDIWSCGVILFVLMAGYL-PFQDQNIMVMYKKIYKGEFRSPRWFSPDL 255 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~-APEvl~~~~~~~~~~DiwSlGvil~elltg~~-Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 255 (481)
.. ....+..++. .+|++........++|++|||..+++.+++.. ++.+. ....+..+..+.....+..+
T Consensus 420 --~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 420 --SS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred --ec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhh
Confidence 00 1112233344 24554443333678999999999999998753 33332 23345556666655566889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
..+.+.++.+++..|+.+.++..|.=|.
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 9999999999999999999988876553
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-12 Score=125.90 Aligned_cols=202 Identities=17% Similarity=0.260 Sum_probs=140.6
Q ss_pred HHHHhCCCCCcceEEEEEEeC-----CEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc--C
Q 011628 78 SILRRVRHPNIVQLFEVMATK-----SKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHAR--G 145 (481)
Q Consensus 78 ~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~--g 145 (481)
..+-++-|.|||+++.++.+. ....+++||++.|+|.+++++ ..+......+|.-||++||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 334445699999999988654 457899999999999999875 2588889999999999999999987 5
Q ss_pred ceecCCCCCcEEEccCCCEEEEecCCccccccccc--CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc
Q 011628 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA 223 (481)
Q Consensus 146 i~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt 223 (481)
|+|+++...-|++..+|-+|+.--.....-..... ........+-++|.|||.=..... ..++|||++|....+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHH
Confidence 99999999999999999888753221111000000 001112346788999997544444 346999999999999988
Q ss_pred CCCC-CCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 224 GYLP-FQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 224 g~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
+..- -...........+.+.-+.. -.+--+.++.+||+..|..||++.+++.||.+-
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred heeccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 7544 22222111111111111110 122245789999999999999999999999763
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.7e-11 Score=108.60 Aligned_cols=134 Identities=23% Similarity=0.337 Sum_probs=103.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhH-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGL-----VAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
..+++|+-+.+|.+.. -|..+++|.-.+.....++. ..+-.+|..++.++.--.|.-.+=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999966 34557777644333322222 2445689999999976666655556667777889999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
|++|-.|.+.+... ...+++.+-.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999898775 245677777888899999999999999999997765 99999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.7e-10 Score=103.13 Aligned_cols=144 Identities=24% Similarity=0.293 Sum_probs=109.9
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG-----LVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
....|-+|+-+.|+.+.+ .|+.+.||.-.......+. ...+.++|+.++.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567888999999999987 7888888865433322221 235678899999999766666555566666667889
Q ss_pred EeccCC-CchHHHHHc--CCCCHHH-HHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEecCCcccc
Q 011628 105 MEYVRG-GELFNKVAK--GRLKEDL-ARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFGLSAVS 175 (481)
Q Consensus 105 ~Ey~~g-g~L~~~i~~--~~l~e~~-~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~---lkl~DFGla~~~ 175 (481)
|||++| .++.+++.. ..-.++. ...+++++-+.+.-||.++|+|+||..+||++..+|. +.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999988 467777764 2223333 3789999999999999999999999999999987764 589999998653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.3e-11 Score=112.12 Aligned_cols=140 Identities=19% Similarity=0.312 Sum_probs=107.0
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEe
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH--PNIVQLFEVMATK---SKIYFVME 106 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lv~E 106 (481)
+.||.|..+.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999873 3688999997654321 123457899999999975 3457777776654 26789999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA------------------------------------------- 143 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~------------------------------------------- 143 (481)
|++|.++.+.+..+.++++....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988776543456777777777777777777773
Q ss_pred -------------cCceecCCCCCcEEEcc--CCCEEEEecCCccc
Q 011628 144 -------------RGVYHRDLKPENLLLDE--NGDLKVSDFGLSAV 174 (481)
Q Consensus 144 -------------~gi~HrDLKp~NILl~~--~g~lkl~DFGla~~ 174 (481)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.3e-09 Score=110.94 Aligned_cols=211 Identities=18% Similarity=0.276 Sum_probs=157.9
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeccCCC-c
Q 011628 38 TFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----KSKIYFVMEYVRGG-E 112 (481)
Q Consensus 38 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg-~ 112 (481)
--.+.|++....+|..|++|.++-.+.... .....-+++++++.|+|+|++.+++.+ ...+++|++|.++. +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 345789999989999999999955443322 223345788999999999999999874 34689999999874 7
Q ss_pred hHHHHH----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 113 LFNKVA----------------KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 113 L~~~i~----------------~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
|.++-- ..+.+|+.+|.|+.||..||.++|+.|..-+-|.|.+||++.+.+++|+..|+..+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 766541 1237889999999999999999999999999999999999999999998877665432
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC-CCCchHHHH-HHHHhhCCCCCCCCCCHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLP-FQDQNIMVM-YKKIYKGEFRSPRWFSPD 254 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~ 254 (481)
... . |-+.+ -.+-|.=-||.+++.|.+|..- |........ ...|. ..+|.+
T Consensus 445 ~d~--------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D 497 (655)
T KOG3741|consen 445 EDP--------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTD 497 (655)
T ss_pred CCC--------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHH
Confidence 211 1 11221 1358999999999999998543 333333322 22222 346889
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++++|.-+...+++. -++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999999987 688888875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.1e-10 Score=101.56 Aligned_cols=127 Identities=24% Similarity=0.409 Sum_probs=85.2
Q ss_pred EEEEEEEcCCCcEEEEEEeecccc-----------------------cchhHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 011628 41 KVYHARNVKSGESVAIKVIDKEKI-----------------------LKSGLVAHIKREISILRRVRHP--NIVQLFEVM 95 (481)
Q Consensus 41 ~Vy~a~~~~~~~~vAvK~i~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~ 95 (481)
.||.|.. .+|..+|||+...... ...-.....++|...|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 5788999998853211 0111235578999999999865 456666442
Q ss_pred EeCCEEEEEEeccC--CCchHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 96 ATKSKIYFVMEYVR--GGELFNKVAKGRLKEDLARKYFQQLISAVGF-CHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~--gg~L~~~i~~~~l~e~~~~~~~~ql~~al~y-LH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
. -.|||||+. |..+..+. ...++.+....++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||.+
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~-~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLK-DVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHH-HCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred --C--CEEEEEecCCCccchhhHH-hccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2 379999999 65565443 3333355677788888886555 579999999999999999887 9999999987
Q ss_pred cc
Q 011628 173 AV 174 (481)
Q Consensus 173 ~~ 174 (481)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 53
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.1e-09 Score=101.87 Aligned_cols=129 Identities=18% Similarity=0.171 Sum_probs=94.4
Q ss_pred EEEEEEEcCCCcEEEEEEeecccccchhHHH----------HHHHHHHHHHhCCCCCc--ceEEEEEEe-----CCEEEE
Q 011628 41 KVYHARNVKSGESVAIKVIDKEKILKSGLVA----------HIKREISILRRVRHPNI--VQLFEVMAT-----KSKIYF 103 (481)
Q Consensus 41 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~----------~~~~Ei~il~~l~HpnI--v~l~~~~~~-----~~~~~l 103 (481)
.|+.... .|+.|.||........ ...+ .+.+|+..+.+|..-+| ..+..+... ...-++
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~--~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWG--EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHH--HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 4555543 6788999976432210 1111 36789999988854333 333444432 235789
Q ss_pred EEeccCCC-chHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------CCCEEEEecCCc
Q 011628 104 VMEYVRGG-ELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-------NGDLKVSDFGLS 172 (481)
Q Consensus 104 v~Ey~~gg-~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-------~g~lkl~DFGla 172 (481)
|||+++|. +|.+++.. ...++.....++.+++..+.-||.+||+|+|+++.|||++. ++.+.++||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999986 78888753 45677788899999999999999999999999999999985 467999999977
Q ss_pred c
Q 011628 173 A 173 (481)
Q Consensus 173 ~ 173 (481)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 5
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-10 Score=119.88 Aligned_cols=152 Identities=20% Similarity=0.374 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCccccccccc--CCccc-----ccCCCCccccccccccCCC
Q 011628 133 QLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGLFH-----TFCGTPAYVAPEVLSRKGY 204 (481)
Q Consensus 133 ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~~~-----~~~gt~~y~APEvl~~~~~ 204 (481)
+.+.|+.|+|.. +++|+.|.|++|.++.+|..||+.|+++........ -..+. ...-...|.|||++.+. .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 444899999965 899999999999999999999999998754322111 00011 11234569999999874 4
Q ss_pred CCCcchHHHHHHHHHHHh-cCCCCCCCchHHHHHHHHh-h---CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 205 DAAKVDIWSCGVILFVLM-AGYLPFQDQNIMVMYKKIY-K---GEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 205 ~~~~~DiwSlGvil~ell-tg~~Pf~~~~~~~~~~~i~-~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+.++|+||+||++|.+. .|..-+...+....+..-. . +.+.....+++++++=+.++|..++..||++.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 477899999999999999 4555555443222222111 1 1234456789999999999999999999999999999
Q ss_pred cccccC
Q 011628 280 RWFRKG 285 (481)
Q Consensus 280 ~~f~~~ 285 (481)
|||...
T Consensus 266 ~ff~D~ 271 (700)
T KOG2137|consen 266 PFFSDP 271 (700)
T ss_pred cccCCc
Confidence 999865
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.2e-09 Score=100.82 Aligned_cols=136 Identities=26% Similarity=0.360 Sum_probs=100.8
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc-----------------cc--hhHHHHHHHHHHHHHhCCCC--
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-----------------LK--SGLVAHIKREISILRRVRHP-- 86 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----------------~~--~~~~~~~~~Ei~il~~l~Hp-- 86 (481)
+.++..||-|.-+.||.|.+ ..|.++|||.-+.... .. .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 46789999999999999997 4799999997532110 00 11234567999999999754
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 011628 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 87 nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
.+.+.+++ +.-.+||||++|-.|...-. +.+.+..++..|+.-+.-+-..||+|+|+.+-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~----~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL----DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC----cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 66666654 45689999999977765431 34444555566666555555899999999999999999999999
Q ss_pred EecCCc
Q 011628 167 SDFGLS 172 (481)
Q Consensus 167 ~DFGla 172 (481)
+||--+
T Consensus 244 IDwPQ~ 249 (304)
T COG0478 244 IDWPQA 249 (304)
T ss_pred EeCccc
Confidence 999644
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.5e-08 Score=100.97 Aligned_cols=231 Identities=19% Similarity=0.247 Sum_probs=152.2
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE------EEeC-CE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEV------MATK-SK 100 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~------~~~~-~~ 100 (481)
.+++.||+|+-+.+|-.-. -...+.|+........ .. +.+..|... .||-+-.=+.+ .... ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~---~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAA---QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch---hhchhheeecCCCchH---HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4578899999999996532 2334678887654321 11 122333333 46644331111 1122 23
Q ss_pred EEEEEeccCCCchHH-HHHc----C---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 101 IYFVMEYVRGGELFN-KVAK----G---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~-~i~~----~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
+-+.|..++|..--. +... . ...++-+.+..+.|+.+..-||..|..-+|+.++|+|+.+++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778999998864322 2221 1 2667888999999999999999999999999999999999999999986543
Q ss_pred ccccccccCCcccccCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHhcC-CCCCCCc-------hHHHHHHH
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQ-------NIMVMYKK 239 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~-------~~~~~~~~ 239 (481)
.+. ..+......+|.+.|.+||.-. +.+. +...|.|.||+++|+++.| ++||.+- ++.+ ..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 332 2334455678999999999754 2222 3469999999999999886 9999753 1211 11
Q ss_pred HhhC-----------CCCCC---C--CCCHHHHHHHHHhccc--CcCCCCCHh
Q 011628 240 IYKG-----------EFRSP---R--WFSPDLIRLLTKLLDT--NPDKRITIP 274 (481)
Q Consensus 240 i~~~-----------~~~~~---~--~~s~~~~~li~~~L~~--dP~~Rps~~ 274 (481)
|..+ ..+.| + -++++++.|..+|+.. ++.-|||++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 2111 11111 1 2678899999999865 467899854
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.8e-08 Score=89.82 Aligned_cols=104 Identities=23% Similarity=0.407 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhCCCCC--cceEEEEEEeC----CEEEEEEeccCCC-chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Q 011628 71 AHIKREISILRRVRHPN--IVQLFEVMATK----SKIYFVMEYVRGG-ELFNKVAK-GRLKEDLARKYFQQLISAVGFCH 142 (481)
Q Consensus 71 ~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~----~~~~lv~Ey~~gg-~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH 142 (481)
....+|+..+..|..-+ +.+++.+.... ...++|+|+++|. +|.+++.. ...+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 45778998888885433 34555555442 2458999999985 79998876 34777788999999999999999
Q ss_pred HcCceecCCCCCcEEEccCC---CEEEEecCCccc
Q 011628 143 ARGVYHRDLKPENLLLDENG---DLKVSDFGLSAV 174 (481)
Q Consensus 143 ~~gi~HrDLKp~NILl~~~g---~lkl~DFGla~~ 174 (481)
++||+|+|++|.|||++.++ .+.++||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999987 899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.7e-07 Score=85.74 Aligned_cols=137 Identities=12% Similarity=0.145 Sum_probs=99.3
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhCCCCC--cceEEEE--EEeC--CEEEEEE
Q 011628 35 GHGTFAKVYHARNVKSGESVAIKVIDKEKILK---SGLVAHIKREISILRRVRHPN--IVQLFEV--MATK--SKIYFVM 105 (481)
Q Consensus 35 G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~--~~~~--~~~~lv~ 105 (481)
|+||-+.|+.... .|+.+-+|.-...-... +.-...+.+|+..++.|..-+ +.++... ...+ -.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688889998765 45578888764211000 112356889999999986332 3343311 1112 2467999
Q ss_pred eccCCC-chHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--EEEEecCCcc
Q 011628 106 EYVRGG-ELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD--LKVSDFGLSA 173 (481)
Q Consensus 106 Ey~~gg-~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~--lkl~DFGla~ 173 (481)
|-+.|- +|.+++... +.++.....++.+++..+.-||+.|+.|+|+-+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 988764 898888764 4577788899999999999999999999999999999987777 9999997654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.1e-07 Score=86.76 Aligned_cols=140 Identities=21% Similarity=0.286 Sum_probs=95.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhCC---CCCcceEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH------IKREISILRRVR---HPNIVQLFEV 94 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~---HpnIv~l~~~ 94 (481)
+.++|.+.+.+-......|.+..- +|+.+++|....+....+..... ..+++..+..+. --....++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 467899999999888888887754 77899999987654332222222 233444444442 2233333333
Q ss_pred EE-----eCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 95 MA-----TKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 95 ~~-----~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.. -....+++|||++|..|.+... +++ .+...+.+++.-+|+.|++|+|.+|.|++++.+ .++++||
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 22 2234568999999988776542 233 244567788999999999999999999999865 4999999
Q ss_pred CCcc
Q 011628 170 GLSA 173 (481)
Q Consensus 170 Gla~ 173 (481)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.4e-07 Score=85.53 Aligned_cols=138 Identities=19% Similarity=0.254 Sum_probs=98.6
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh---------------------HHHHHHHHHHHHHhCC--CCC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG---------------------LVAHIKREISILRRVR--HPN 87 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---------------------~~~~~~~Ei~il~~l~--Hpn 87 (481)
.-.|+.|.-+.||+|.. .++..+|+|++......... ......+|+..|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34667788889999985 67899999998644321111 1123467888888884 444
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCc-hHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEE
Q 011628 88 IVQLFEVMATKSKIYFVMEYVRGGE-LFNKVAKGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 88 Iv~l~~~~~~~~~~~lv~Ey~~gg~-L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lk 165 (481)
+.+.+.+.. -.|||||+.... -.-.+..-++..+++..+..+++..+.-|-. .|++|+||+.-|||+. ++.+.
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 555555543 378999996642 1222333334455889999999999988766 8999999999999999 88999
Q ss_pred EEecCCccc
Q 011628 166 VSDFGLSAV 174 (481)
Q Consensus 166 l~DFGla~~ 174 (481)
|+|||-|..
T Consensus 207 iID~~QaV~ 215 (268)
T COG1718 207 IIDVSQAVT 215 (268)
T ss_pred EEECccccc
Confidence 999997754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.2e-07 Score=97.93 Aligned_cols=138 Identities=25% Similarity=0.378 Sum_probs=92.9
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccc---------------------------cc----hhHHHH------HH
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI---------------------------LK----SGLVAH------IK 74 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------------------------~~----~~~~~~------~~ 74 (481)
+-|+.++-|+||.|+. .+|+.||||+.++.-. .- .++.+. +.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6789999999999997 4699999999864210 00 011112 33
Q ss_pred HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCchHHHH--HcCCCCH-----HHHHHHHHHHHHHHHHHH
Q 011628 75 REISILRRVR-----HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV--AKGRLKE-----DLARKYFQQLISAVGFCH 142 (481)
Q Consensus 75 ~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i--~~~~l~e-----~~~~~~~~ql~~al~yLH 142 (481)
+|...+.++. .|++.-..-+++-.+.-.++|||++|..+.+.. ...+++. ..+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4555555552 344433333334455668999999999887774 4444553 23333333333
Q ss_pred HcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 143 ~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..|++|.|.+|.||+++.+|.+.+.|||+....+.
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 48999999999999999999999999999875443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.5e-09 Score=111.28 Aligned_cols=239 Identities=18% Similarity=0.160 Sum_probs=165.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN-IVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~l 103 (481)
...|...+-+++|+++++++.+...+...+ .+.+... ..+.-++++|.+++||| .++.++-+..++..++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 455677888999999999999876655444 6666433 23456899999999999 7888888888889999
Q ss_pred EEeccCCC-chHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGG-ELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg-~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
.|+++.++ +....... -.+.+-+.....+.-+.+++++|+---+||| ||+..+ +..+..||+.........
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 99999988 22222111 1233334445556667889999998778999 777665 678999999876543322
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCC---CCCCCHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRS---PRWFSPDL 255 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~---~~~~s~~~ 255 (481)
...+..+++.++|||+.....++ ...|.|++|+--.++.-|.+|-..+. .....+-.+. +.. -.|-+..-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~ 460 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFH 460 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccc
Confidence 34567899999999999888885 46999999987777877777754311 0000111110 000 01111112
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.++...|+..-|..|+.....+.|.+|.
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfn 488 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFN 488 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhc
Confidence 2477889999999999988888877764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.2e-06 Score=83.36 Aligned_cols=133 Identities=17% Similarity=0.174 Sum_probs=85.3
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+.+.+....+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25567899876432 1244688999999996443 4677888888888899999999
Q ss_pred CCc-hH--------------HHH-------HcC---CCCHHH-HHHHHHHH----------HHH-HHHHHH----cCcee
Q 011628 110 GGE-LF--------------NKV-------AKG---RLKEDL-ARKYFQQL----------ISA-VGFCHA----RGVYH 148 (481)
Q Consensus 110 gg~-L~--------------~~i-------~~~---~l~e~~-~~~~~~ql----------~~a-l~yLH~----~gi~H 148 (481)
|.+ +. ..+ ..- ..+... ...+..++ ... ..+|.+ ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 111 110 011111 11111111 111 122221 24789
Q ss_pred cCCCCCcEEEccCCCEEEEecCCccc
Q 011628 149 RDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 149 rDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999988 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-06 Score=82.09 Aligned_cols=136 Identities=21% Similarity=0.334 Sum_probs=82.1
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEE---EeCCEEEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEVM---ATKSKIYFVM 105 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~---~~~~~~~lv~ 105 (481)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..+++.+.... +.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4689999999999998743 58999997544 23466778999998885333 45666543 2334689999
Q ss_pred eccCCCchHH----------------HHH---cC--C---CCHHH------HHHH---------------HHHHHH-HHH
Q 011628 106 EYVRGGELFN----------------KVA---KG--R---LKEDL------ARKY---------------FQQLIS-AVG 139 (481)
Q Consensus 106 Ey~~gg~L~~----------------~i~---~~--~---l~e~~------~~~~---------------~~ql~~-al~ 139 (481)
++++|..+.. .+. .- . +.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 111 10 0 01000 0000 011222 233
Q ss_pred HHH-------HcCceecCCCCCcEEEc-cCCCEEEEecCCcc
Q 011628 140 FCH-------ARGVYHRDLKPENLLLD-ENGDLKVSDFGLSA 173 (481)
Q Consensus 140 yLH-------~~gi~HrDLKp~NILl~-~~g~lkl~DFGla~ 173 (481)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24599999999999999 56667899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.1e-06 Score=95.35 Aligned_cols=202 Identities=19% Similarity=0.241 Sum_probs=142.2
Q ss_pred HHHHHHHHHHhCCCCCcceEEEEEEeCCE----EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 011628 72 HIKREISILRRVRHPNIVQLFEVMATKSK----IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGV 146 (481)
Q Consensus 72 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi 146 (481)
...-|+..+....|+|++.++.+...... ..+..++|.+-++...+.. +.++.+..+.+..+++.|+.|+|+...
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 34457778888899999999988755432 3455789999999999987 789999999999999999999999965
Q ss_pred eecCCCCC---cEEEccCCCEEEE--ecCCcccccccccCCcccccCCCCccccccccccCCCCC-CcchHHHHHHHHHH
Q 011628 147 YHRDLKPE---NLLLDENGDLKVS--DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA-AKVDIWSCGVILFV 220 (481)
Q Consensus 147 ~HrDLKp~---NILl~~~g~lkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~-~~~DiwSlGvil~e 220 (481)
.|.-+... +--.+..+.+.++ ||+.+........ .....-+..+.|||......+.. ...|+|.+|..+..
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 55544444 3344555666666 8887765433222 12234456688888876655432 23699999999999
Q ss_pred HhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 221 LMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 221 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+..|..+-...... ..+. +........+.+.+|+.-++++|+++.+++.|+|.+-.
T Consensus 385 ~~~~~~i~~~~~~~---~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVP---VSLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccccccch---hhhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 98875442211110 0000 11112267889999999999999999999999997643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.4e-05 Score=73.75 Aligned_cols=129 Identities=21% Similarity=0.293 Sum_probs=92.9
Q ss_pred cCCeeEEeEecccCc-eEEEEEEEcCCCcEEEEEEeeccc----------ccc--------hhHHHHHHHHHHHHHhCC-
Q 011628 25 LGRYEIGKLLGHGTF-AKVYHARNVKSGESVAIKVIDKEK----------ILK--------SGLVAHIKREISILRRVR- 84 (481)
Q Consensus 25 ~~~y~i~~~LG~G~f-g~Vy~a~~~~~~~~vAvK~i~~~~----------~~~--------~~~~~~~~~Ei~il~~l~- 84 (481)
..+++.++.||.|+- |.||+++- .|+.+|+|++..-. ... .....-+..|.+...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 99999986 78899999932100 000 022345667777777664
Q ss_pred --CCCc--ceEEEEEEeC------------------CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 011628 85 --HPNI--VQLFEVMATK------------------SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH 142 (481)
Q Consensus 85 --HpnI--v~l~~~~~~~------------------~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH 142 (481)
+.++ |++||+..-. ...-||-||++... .....-+.+|.+-+..+|
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRDIPQMLRDLKILH 181 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhHHHHHHHHHHHHH
Confidence 5566 8999987322 12357788776543 223344667888888999
Q ss_pred HcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 143 ~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999987 4589999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.4e-06 Score=79.62 Aligned_cols=133 Identities=16% Similarity=0.154 Sum_probs=82.7
Q ss_pred ecccCc-eEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 34 LGHGTF-AKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 34 LG~G~f-g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
|-.|.. +.||+... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 334444 78999865 34678899875432 234668999998884 444667787777767789999999997
Q ss_pred chHHHH----------------Hc-CCCCH-----H-HHHHHHHH-----------------------HHHHHHHHH---
Q 011628 112 ELFNKV----------------AK-GRLKE-----D-LARKYFQQ-----------------------LISAVGFCH--- 142 (481)
Q Consensus 112 ~L~~~i----------------~~-~~l~e-----~-~~~~~~~q-----------------------l~~al~yLH--- 142 (481)
+|.... .. ..++. . .......+ +...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 664321 10 01110 0 00000000 111112221
Q ss_pred ----HcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 143 ----ARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 143 ----~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=5.2e-06 Score=74.35 Aligned_cols=133 Identities=25% Similarity=0.362 Sum_probs=97.4
Q ss_pred cCCee--EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEE
Q 011628 25 LGRYE--IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV-QLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~--i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~ 101 (481)
.+.|. ..+.||+|.+|.||++.+ .|..+|+|+-..+. ....+..|.+++..+.-.++- ++|.+.. .
T Consensus 19 ~~~~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~ 87 (201)
T COG2112 19 EGKYELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----D 87 (201)
T ss_pred ccchhhhhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----h
Confidence 34454 468899999999999987 67799999876543 346688999999999877765 3444433 3
Q ss_pred EEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCC-CCcEEEccCCCEEEEecCCccc
Q 011628 102 YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLK-PENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLK-p~NILl~~~g~lkl~DFGla~~ 174 (481)
++.|||+.|-.|.+....+ -++-...+++..--|-..||-|..|. |...++..++.+.|+||.-|++
T Consensus 88 ~i~me~i~G~~L~~~~~~~------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhcc------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 4559999998887765433 13344455666555677899999986 6666666666999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.3e-05 Score=72.69 Aligned_cols=130 Identities=20% Similarity=0.336 Sum_probs=96.9
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccc-------------cchhHHHHHHHHHHHHHhCC------CCCcceEE
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-------------LKSGLVAHIKREISILRRVR------HPNIVQLF 92 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------HpnIv~l~ 92 (481)
..||+|+.=.||.- .......||+...... ......++..+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999999952 3456678999977650 01112455677887777766 78899999
Q ss_pred EEEEeCCEEEEEEeccCCC------chHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----
Q 011628 93 EVMATKSKIYFVMEYVRGG------ELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---- 162 (481)
Q Consensus 93 ~~~~~~~~~~lv~Ey~~gg------~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---- 162 (481)
|+.++....-+|+|.+.+. +|.+++..+.+++ ...+ .+-.-..||-+++|+.+|++|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 9999999999999987642 6889998887777 3333 334445688899999999999999997543
Q ss_pred CEEEEe
Q 011628 163 DLKVSD 168 (481)
Q Consensus 163 ~lkl~D 168 (481)
.+.|+|
T Consensus 160 ~lvlID 165 (199)
T PF10707_consen 160 RLVLID 165 (199)
T ss_pred EEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.2e-06 Score=85.96 Aligned_cols=140 Identities=21% Similarity=0.295 Sum_probs=88.9
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccc----------------------------hhHHHHH------HHHH
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK----------------------------SGLVAHI------KREI 77 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----------------------------~~~~~~~------~~Ei 77 (481)
+.||.-+.|+||+|+-+ +|+.||||+-++.-... .++.+.+ .+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 68999999999999975 59999999976431100 1111222 2333
Q ss_pred HHHH----hCCCCC------cceEEEEEEeCCEEEEEEeccCCCchHHH--HHcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 011628 78 SILR----RVRHPN------IVQLFEVMATKSKIYFVMEYVRGGELFNK--VAKGRLKEDLARKYFQQLISAVGFCHARG 145 (481)
Q Consensus 78 ~il~----~l~Hpn------Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~--i~~~~l~e~~~~~~~~ql~~al~yLH~~g 145 (481)
+... .+.|-+ |.++|..+ .+...|+|||++|..+.|. +.+.+++...+...+.+.. ++.+=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 3333 333545 33433322 3456899999999876544 5555566554333222221 12333579
Q ss_pred ceecCCCCCcEEEcc----CCCEEEEecCCccccc
Q 011628 146 VYHRDLKPENLLLDE----NGDLKVSDFGLSAVSD 176 (481)
Q Consensus 146 i~HrDLKp~NILl~~----~g~lkl~DFGla~~~~ 176 (481)
++|+|=+|.||++.. ++.+.+-|||+.....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999994 5679999999986543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.7e-05 Score=89.44 Aligned_cols=146 Identities=18% Similarity=0.409 Sum_probs=92.8
Q ss_pred EEeEecccCceEEEEEEEcCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKSG--ESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNI--VQLFEVMATK---SKI 101 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~ 101 (481)
-.+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+.+++.+. |+++ .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998764332 467788765432221 1245789999999995 6765 7777777654 467
Q ss_pred EEEEeccCCCchHH--------------------HHHc-CCCC----------------HHHHHHHHHH-----------
Q 011628 102 YFVMEYVRGGELFN--------------------KVAK-GRLK----------------EDLARKYFQQ----------- 133 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~--------------------~i~~-~~l~----------------e~~~~~~~~q----------- 133 (481)
|+||||++|..+.+ .+.. ..++ ...+..|..|
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999999864321 1110 0000 1122222222
Q ss_pred ----HHHHHHHHHH-----------cCceecCCCCCcEEEccC-CC-EEEEecCCcccccc
Q 011628 134 ----LISAVGFCHA-----------RGVYHRDLKPENLLLDEN-GD-LKVSDFGLSAVSDQ 177 (481)
Q Consensus 134 ----l~~al~yLH~-----------~gi~HrDLKp~NILl~~~-g~-lkl~DFGla~~~~~ 177 (481)
+...+.+|.. ..++|+|++|.|||++.+ +. .-|.||++++..+.
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 2223456632 249999999999999853 34 57999999876443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.6e-07 Score=105.84 Aligned_cols=208 Identities=16% Similarity=0.079 Sum_probs=148.6
Q ss_pred HHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCCCchHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHc--
Q 011628 74 KREISILRRVRHPNIVQLFEVMAT--KSKIYFVMEYVRGGELFNKVAKG-----RLKEDLARKYFQQLISAVGFCHAR-- 144 (481)
Q Consensus 74 ~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~-----~l~e~~~~~~~~ql~~al~yLH~~-- 144 (481)
..|..-++...|+++...+.-... ....|..++|+.+|.+++.|-+| .+.+..+....++.+.+..-+|++
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344455566789998876655433 34578999999999999999764 245555566666668888887765
Q ss_pred ---CceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHH
Q 011628 145 ---GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVL 221 (481)
Q Consensus 145 ---gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~el 221 (481)
-.+|++||+-|.+|..+.++|+.++|+.++... .........+++.|++|++.+.-.+ +.++|+|..|+-+|+.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHH
Confidence 278999999999999999999999999984322 1223445678999999999887777 4569999999999999
Q ss_pred hcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 222 MAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 222 ltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..|..+|-.-....+...+.++. ...+...|.++-.....+|-..-..||.-..++..+.|.-
T Consensus 1434 s~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred hcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 99988875444333333333333 2334444555555666666666678898888877766643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.4e-05 Score=71.85 Aligned_cols=72 Identities=10% Similarity=0.214 Sum_probs=45.1
Q ss_pred eEecccCce-EEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEE
Q 011628 32 KLLGHGTFA-KVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP---NIVQLFEVMATK---SKIYFV 104 (481)
Q Consensus 32 ~~LG~G~fg-~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~---~~~~lv 104 (481)
+.|+.|+.. .||.. +..+++|+..... ....+.+|..+++.+... -+.++++..... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457767766 58875 2346788754321 234688999999888532 244444443332 245889
Q ss_pred EeccCCCch
Q 011628 105 MEYVRGGEL 113 (481)
Q Consensus 105 ~Ey~~gg~L 113 (481)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.84 E-value=6.9e-05 Score=69.13 Aligned_cols=96 Identities=22% Similarity=0.289 Sum_probs=79.9
Q ss_pred HHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCCchHH----HHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCc
Q 011628 75 REISILRRVRH-PNIVQLFEVMATKSKIYFVMEYVRGGELFN----KVAKGRLKEDLARKYFQQLISAVGFCHA---RGV 146 (481)
Q Consensus 75 ~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~----~i~~~~l~e~~~~~~~~ql~~al~yLH~---~gi 146 (481)
.|.-+++.+.+ +++.+++|.|.. +++.||...+++.. +.+-...++....+++.|++..+++++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58889999976 699999999854 77999998877652 2222346899999999999999999987 358
Q ss_pred eecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 147 YHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 147 ~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
.-.|++|+|+-++++|++|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 8899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00046 Score=70.89 Aligned_cols=80 Identities=15% Similarity=0.202 Sum_probs=54.5
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--c--hhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--K--SGLVAHIKREISILRRVR---HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~--~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 103 (481)
.+.||.|.+..||++.....++.|+||.-...-.. . .-...+...|...|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999998543368999985421100 1 113456677888888863 3456777766 4455789
Q ss_pred EEeccCCCc
Q 011628 104 VMEYVRGGE 112 (481)
Q Consensus 104 v~Ey~~gg~ 112 (481)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00034 Score=66.60 Aligned_cols=75 Identities=19% Similarity=0.340 Sum_probs=48.9
Q ss_pred EeEecccCceEEEEEEEcC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecc
Q 011628 31 GKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~ 108 (481)
.+.|..|-...+|+..... .++.|++|+...... ......+|+.+++.+...++ .+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567788888999987532 357899997754321 11234579999999864444 44444332 2 3799999
Q ss_pred CCCch
Q 011628 109 RGGEL 113 (481)
Q Consensus 109 ~gg~L 113 (481)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 99654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00031 Score=69.94 Aligned_cols=141 Identities=26% Similarity=0.356 Sum_probs=100.4
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc----------------------cchhHH-HHHHHHHHHHHhCCC
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI----------------------LKSGLV-AHIKREISILRRVRH 85 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----------------------~~~~~~-~~~~~Ei~il~~l~H 85 (481)
+|-..|.-|.-+.||+|.. .+|..+|||+++-.-. ....++ -...+|+.-|++++.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4456777899999999985 6788899998752210 011122 235678999999876
Q ss_pred CCcceEEEEEEeCCEEEEEEeccCCCc-hHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCcEEEccCCC
Q 011628 86 PNIVQLFEVMATKSKIYFVMEYVRGGE-LFNKVAKGRLKEDLARKYFQQLISAVGFC-HARGVYHRDLKPENLLLDENGD 163 (481)
Q Consensus 86 pnIv~l~~~~~~~~~~~lv~Ey~~gg~-L~~~i~~~~l~e~~~~~~~~ql~~al~yL-H~~gi~HrDLKp~NILl~~~g~ 163 (481)
..|...--+... .-.|||+|+.+.. -.-.+..-.++...+..+.+|++.-+.-| |..+++|.||.--|+|+ .+|.
T Consensus 226 aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 665433222222 3478999996422 23345555788889999999999988776 56799999999999998 5578
Q ss_pred EEEEecCCcc
Q 011628 164 LKVSDFGLSA 173 (481)
Q Consensus 164 lkl~DFGla~ 173 (481)
+.|+|.+-|-
T Consensus 303 lyiIDVSQSV 312 (520)
T KOG2270|consen 303 LYIIDVSQSV 312 (520)
T ss_pred EEEEEccccc
Confidence 9999998664
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00015 Score=70.12 Aligned_cols=132 Identities=17% Similarity=0.221 Sum_probs=78.6
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
.+..|-...+|+.. .+++.+++|+...... ...-...+|..+++.+...++ .+++... . -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 35667788999886 3567888997644321 111134679999999864433 3444433 2 26899999986
Q ss_pred chHH--------------HHH---cCC-----CC-HHHHHHHHHHHH---------HHHHHHHH--------cCceecCC
Q 011628 112 ELFN--------------KVA---KGR-----LK-EDLARKYFQQLI---------SAVGFCHA--------RGVYHRDL 151 (481)
Q Consensus 112 ~L~~--------------~i~---~~~-----l~-e~~~~~~~~ql~---------~al~yLH~--------~gi~HrDL 151 (481)
.+.. .+. .-+ ++ ...+..+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5421 111 111 11 122233332221 11222211 24899999
Q ss_pred CCCcEEEccCCCEEEEecCCccc
Q 011628 152 KPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 152 Kp~NILl~~~g~lkl~DFGla~~ 174 (481)
.|.||+++.++ +.|+||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00023 Score=70.34 Aligned_cols=135 Identities=17% Similarity=0.191 Sum_probs=82.3
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEV------MATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 102 (481)
.+.|..|....+|+... ++..+++|+.... . ...+..|+.+++.+.+.+ +.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56777888889999864 4457889987541 1 244667888888885332 4444331 23345678
Q ss_pred EEEeccCCCchHH-----------HH---Hc--CCCC--------HHHHHH------------HHHHHHHHHHHHHH---
Q 011628 103 FVMEYVRGGELFN-----------KV---AK--GRLK--------EDLARK------------YFQQLISAVGFCHA--- 143 (481)
Q Consensus 103 lv~Ey~~gg~L~~-----------~i---~~--~~l~--------e~~~~~------------~~~ql~~al~yLH~--- 143 (481)
++++|++|..+.. .+ .. ..+. ...... ....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999965421 11 10 0010 000000 11112233444443
Q ss_pred ----cCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 144 ----RGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 144 ----~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0008 Score=66.78 Aligned_cols=78 Identities=12% Similarity=0.119 Sum_probs=55.1
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH---PNIVQLFEVMAT---KSKIY 102 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~~ 102 (481)
.-.+.||.|..+.||.... .+..+.+|..+... . ...+.+|...++.+.- -.+.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~--~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMARSFS--T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEecccc--c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3457899999999999864 23356778743211 1 1357789999998853 357788887754 36689
Q ss_pred EEEeccCCCch
Q 011628 103 FVMEYVRGGEL 113 (481)
Q Consensus 103 lv~Ey~~gg~L 113 (481)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0001 Score=51.39 Aligned_cols=42 Identities=26% Similarity=0.468 Sum_probs=35.6
Q ss_pred ccEEEEEEEEEEc-CceEEEEeEecCCCchhHHHHhhhcccccc
Q 011628 412 GPLTIATEIFELT-PKLVVVEVKKKGGDKGEYEEFCNKELKPGL 454 (481)
Q Consensus 412 ~~l~~~~~v~~~~-~~~~lVe~~~~~Gd~le~~~~~~~~l~~~l 454 (481)
..+.+.+||+++. ++++.|+|+|.+||...|+++|.+ |-..|
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~-il~~l 45 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSK-ILNEL 45 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHH-HHHHT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHH-HHHHc
Confidence 3588999999997 899999999999999999999998 65444
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=5.5e-05 Score=74.00 Aligned_cols=134 Identities=16% Similarity=0.269 Sum_probs=95.5
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----------------chhHH--HHHHHHHHHHHhCC-CC
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-----------------KSGLV--AHIKREISILRRVR-HP 86 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----------------~~~~~--~~~~~Ei~il~~l~-Hp 86 (481)
=|.++++||-|.-+.||.+-+ ..|++.++|.-+..... ..-.. -...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367889999999999999987 57889999964322110 01111 23467999999885 33
Q ss_pred C-cceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 011628 87 N-IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 87 n-Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lk 165 (481)
. +.+.+++ +..++|||++.|..|.+.-.- ..+..+...++.-+--|-.+|+||+|..--||++++++.++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 2 3444433 456899999999777654321 12334555666666778899999999999999999999999
Q ss_pred EEecC
Q 011628 166 VSDFG 170 (481)
Q Consensus 166 l~DFG 170 (481)
++||-
T Consensus 243 vIDFP 247 (465)
T KOG2268|consen 243 VIDFP 247 (465)
T ss_pred Eeech
Confidence 99995
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00098 Score=66.38 Aligned_cols=136 Identities=18% Similarity=0.203 Sum_probs=79.9
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEV------MATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 102 (481)
.+.++.|....+|++.. . +..+++|+..... . ...+..|+.+++.|...+ +.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-C-CCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677787789998864 3 3467789875432 1 123456777777774222 3444331 12245678
Q ss_pred EEEeccCCCchH-----------HHH---Hc--CCCCH-------HHHH----------------HHHHHHHHHHHHHHH
Q 011628 103 FVMEYVRGGELF-----------NKV---AK--GRLKE-------DLAR----------------KYFQQLISAVGFCHA 143 (481)
Q Consensus 103 lv~Ey~~gg~L~-----------~~i---~~--~~l~e-------~~~~----------------~~~~ql~~al~yLH~ 143 (481)
+++||++|.++. ..+ .. ..++. ...+ .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999985431 111 11 01100 0000 001112334555532
Q ss_pred -------cCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 144 -------RGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 144 -------~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0012 Score=65.63 Aligned_cols=146 Identities=16% Similarity=0.273 Sum_probs=86.0
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH--PNIVQLFEVMATKS--KIYF 103 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~--~~~l 103 (481)
..+.+.+..|.--.+|.... +++.+++. ... ............+|..+++.+.- .-+.+.+++|.++. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 34455554444444555544 37888888 332 12222345667889999988853 22344556665555 6799
Q ss_pred EEeccCCCchHHHHHcCCC---------------------------------CHHHHHHHHHHH--------------HH
Q 011628 104 VMEYVRGGELFNKVAKGRL---------------------------------KEDLARKYFQQL--------------IS 136 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l---------------------------------~e~~~~~~~~ql--------------~~ 136 (481)
||+|++|..+.+....... ...+...+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999999432211111000 011111111111 12
Q ss_pred HHHHHHHc--------CceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 137 AVGFCHAR--------GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 137 al~yLH~~--------gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
-..|++.+ .++|+|+++.|++++.++-+-|.||+++.+.+.
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 23444432 489999999999999999999999999986544
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0021 Score=64.33 Aligned_cols=135 Identities=13% Similarity=0.192 Sum_probs=74.3
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFE------VMATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~------~~~~~~~~~ 102 (481)
.+.|+.|....+|.... . +..+++|++. .. . ...+..|+.+++.|...+ +.+++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~-~~--~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFE-RL--T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe-C-CCcEEEEEec-cC--C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 35567787789999875 2 3468899875 21 1 122334566665553212 333332 122356689
Q ss_pred EEEeccCCCchH-----------HHHH---c--CCC--------CH----HHHHH-----------HHHHHH-HHHHHHH
Q 011628 103 FVMEYVRGGELF-----------NKVA---K--GRL--------KE----DLARK-----------YFQQLI-SAVGFCH 142 (481)
Q Consensus 103 lv~Ey~~gg~L~-----------~~i~---~--~~l--------~e----~~~~~-----------~~~ql~-~al~yLH 142 (481)
+++||++|..+. ..+. . ..+ .. ..... .+.+.+ ..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999996431 1111 0 011 00 00000 111111 1122222
Q ss_pred -------HcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 143 -------ARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 143 -------~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
..|++|+|++|.|||++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999866556899999775
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0013 Score=65.18 Aligned_cols=75 Identities=17% Similarity=0.303 Sum_probs=48.4
Q ss_pred EeEecccCceEEEEEEEcC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVK------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYF 103 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l 103 (481)
++.|..|--..||+..... +++.+++|+..... .......+|..+++.+...++ .+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456667777899887532 25789999975532 112345689999988864333 345555432 35
Q ss_pred EEeccCCCch
Q 011628 104 VMEYVRGGEL 113 (481)
Q Consensus 104 v~Ey~~gg~L 113 (481)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999998655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0055 Score=62.92 Aligned_cols=85 Identities=19% Similarity=0.090 Sum_probs=55.6
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch----hHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS----GLVAHIKREISILRRVR---HPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~ 102 (481)
-.+.||.|.-..||+..+ .++.++||.-........ ....+...|...|+.+. ..++.+++.++.+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 367889999999999886 345689997652221111 12344556777777664 2477888887774 457
Q ss_pred EEEeccCCC--chHHHHH
Q 011628 103 FVMEYVRGG--ELFNKVA 118 (481)
Q Consensus 103 lv~Ey~~gg--~L~~~i~ 118 (481)
++|||++++ .+.+.+.
T Consensus 112 lvME~L~~~~~ilr~~Ll 129 (418)
T PLN02756 112 IGMRYLEPPHIILRKGLI 129 (418)
T ss_pred EEEeecCCcceehhhhhc
Confidence 889999872 3444333
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0026 Score=65.97 Aligned_cols=163 Identities=24% Similarity=0.296 Sum_probs=104.8
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceec
Q 011628 71 AHIKREISILRRVRHPNIVQLFEVMATK-SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149 (481)
Q Consensus 71 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~Hr 149 (481)
.++.-..++++.+.|+|...++++.... ....+|||++ +.+|.+.+..+.+...... .+|+.|-
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc--------------cccccee
Confidence 4456678899999999999998887543 3578899999 5589998876542211111 2222221
Q ss_pred CCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCC
Q 011628 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ 229 (481)
Q Consensus 150 DLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~ 229 (481)
| .++.+| -+.. .| |-.+ ++|+||||+|.++.++.-|..-|.
T Consensus 92 -----~-------~~~~td-~~~t------------------~~--~~~~------~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 92 -----N-------IIYITD-HFLT------------------KY--PSPI------GPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----h-------hhhccc-cccc------------------cC--CCCC------CcchhhhhHHHHHHHHHHhhHHHH
Confidence 1 223333 0100 00 1111 248999999999999999987776
Q ss_pred CchHHHHHHHHhhCCCCCC------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 230 DQNIMVMYKKIYKGEFRSP------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 230 ~~~~~~~~~~i~~~~~~~~------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
.....+....+.+-..... -.++.....+..+|+-..|..||...++.+++-|...+.
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 6554444444433211111 113555788999999999999999999999999887643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0079 Score=60.74 Aligned_cols=86 Identities=17% Similarity=0.165 Sum_probs=52.8
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeeccccc----chhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEE
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL----KSGLVAHIKREISILRRVR--HP-NIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lv~ 105 (481)
.||.|.-..||++.+...++.|+||.-...-.. -.-...+..-|...|+... .| .+.++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997543468999965321110 0112355667888887764 35 34555443 445567999
Q ss_pred eccCCC-chHHHHHcC
Q 011628 106 EYVRGG-ELFNKVAKG 120 (481)
Q Consensus 106 Ey~~gg-~L~~~i~~~ 120 (481)
|+++.. .|...+.+|
T Consensus 80 EdL~~~~ilR~~Li~g 95 (370)
T TIGR01767 80 EDLSHHKIARKGLIEG 95 (370)
T ss_pred hhCccchHHHHHHHcC
Confidence 999654 343444333
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0083 Score=58.84 Aligned_cols=31 Identities=29% Similarity=0.501 Sum_probs=26.0
Q ss_pred CceecCCCCCcEEEccCCC-EEEEecCCcccc
Q 011628 145 GVYHRDLKPENLLLDENGD-LKVSDFGLSAVS 175 (481)
Q Consensus 145 gi~HrDLKp~NILl~~~g~-lkl~DFGla~~~ 175 (481)
.++|+|++|.|||++.+++ .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 469999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.022 Score=56.56 Aligned_cols=29 Identities=34% Similarity=0.629 Sum_probs=25.4
Q ss_pred cCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 144 ~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.021 Score=57.92 Aligned_cols=136 Identities=15% Similarity=0.227 Sum_probs=81.2
Q ss_pred EeEecccCceEEEEEEEcC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVK----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV-QLFEVMATKSKIYFVM 105 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lv~ 105 (481)
.+.|-.|-.-.+|++.... +++.|++|+..... ...+. ..+|..+++.+..-++- ++++.+..+ .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 4455557788999986432 34689999876542 12222 36799999999654443 555655332 579
Q ss_pred eccCCCchHH--------------HHH---cCCC-------CHHHHHHHHHHHH-----------------HHHHHH---
Q 011628 106 EYVRGGELFN--------------KVA---KGRL-------KEDLARKYFQQLI-----------------SAVGFC--- 141 (481)
Q Consensus 106 Ey~~gg~L~~--------------~i~---~~~l-------~e~~~~~~~~ql~-----------------~al~yL--- 141 (481)
||++|.+|.. .+. ...+ ..+.+..+..++. ..+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 9998766521 111 1111 1223333332221 111122
Q ss_pred -H----HcCceecCCCCCcEEEcc-CCCEEEEecCCccc
Q 011628 142 -H----ARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAV 174 (481)
Q Consensus 142 -H----~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~ 174 (481)
. ...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 46799999988764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.032 Score=56.20 Aligned_cols=135 Identities=16% Similarity=0.254 Sum_probs=78.4
Q ss_pred eEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEec
Q 011628 32 KLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey 107 (481)
+.|..|=--.+|+...... +..|.+|+...... ..-...+|..+++.+..-++ .++++++. .+ +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence 4444466677888865332 34789998754321 12224579999999975555 35555553 22 48999
Q ss_pred cCCCchHH--------------HHH---cCCC-------CHHHHHHHHHHHH----------------------HHHHHH
Q 011628 108 VRGGELFN--------------KVA---KGRL-------KEDLARKYFQQLI----------------------SAVGFC 141 (481)
Q Consensus 108 ~~gg~L~~--------------~i~---~~~l-------~e~~~~~~~~ql~----------------------~al~yL 141 (481)
++|..|.. .+. ...+ ....+.+|+.++- .-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 98765411 111 1111 1223333333321 112111
Q ss_pred H----Hc----CceecCCCCCcEEEcc-CCCEEEEecCCccc
Q 011628 142 H----AR----GVYHRDLKPENLLLDE-NGDLKVSDFGLSAV 174 (481)
Q Consensus 142 H----~~----gi~HrDLKp~NILl~~-~g~lkl~DFGla~~ 174 (481)
. +. -.+|.|+.+.|||+++ ++.++++||..|..
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11 2799999999999975 57899999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.03 Score=57.29 Aligned_cols=88 Identities=17% Similarity=0.186 Sum_probs=55.9
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK---SGLVAHIKREISILRRVR--HP-NIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lv 104 (481)
.+.||.|.-.-||++.+...++.|+||--...-... .-...+..-|..+|+... .| .+.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678899999999999984345789999643211110 123466677888888774 45 45555543 44556789
Q ss_pred EeccCCC-chHHHHHcC
Q 011628 105 MEYVRGG-ELFNKVAKG 120 (481)
Q Consensus 105 ~Ey~~gg-~L~~~i~~~ 120 (481)
||+++.. .|.+.+..|
T Consensus 112 MEdL~~~~ilR~~Li~G 128 (409)
T PRK12396 112 MEDLSDHTILRTALINH 128 (409)
T ss_pred HHhCcccHHHHHHHHcC
Confidence 9999653 244444333
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.022 Score=53.36 Aligned_cols=30 Identities=33% Similarity=0.707 Sum_probs=21.6
Q ss_pred CceecCCCCCcEEE-ccCCCEEEEecCCccc
Q 011628 145 GVYHRDLKPENLLL-DENGDLKVSDFGLSAV 174 (481)
Q Consensus 145 gi~HrDLKp~NILl-~~~g~lkl~DFGla~~ 174 (481)
.++|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.02 Score=58.09 Aligned_cols=61 Identities=26% Similarity=0.273 Sum_probs=48.1
Q ss_pred EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHcCceecCCCCCcEEEccC
Q 011628 101 IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF-CHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~y-LH~~gi~HrDLKp~NILl~~~ 161 (481)
..++-+|..|.++..++.....+|....+++.-.+.|+-- +--.+.+|.|++|.||++--+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4567778999999999987777887777777777777643 345689999999999999544
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.15 Score=50.78 Aligned_cols=29 Identities=21% Similarity=0.235 Sum_probs=27.0
Q ss_pred CceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 145 GVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 145 gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
+++|+|+.+.|+|++.++.+.++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.034 Score=55.75 Aligned_cols=87 Identities=21% Similarity=0.308 Sum_probs=60.9
Q ss_pred CCCCCcceEEEEE-EeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEcc
Q 011628 83 VRHPNIVQLFEVM-ATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDE 160 (481)
Q Consensus 83 l~HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~ 160 (481)
..-++..+.+-+- .+....|++|++- |+.+. .+.. ...+++..++++.+.-++-+..+ ..-|||+...||||+
T Consensus 282 ~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId- 356 (488)
T COG5072 282 CGSVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIKA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID- 356 (488)
T ss_pred ccchhhhcceEEecCCceEEEEEEecC-Cceee-eeec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-
Confidence 3344555544443 3334567777775 33332 2211 35677888898888877777765 689999999999999
Q ss_pred CCCEEEEecCCccc
Q 011628 161 NGDLKVSDFGLSAV 174 (481)
Q Consensus 161 ~g~lkl~DFGla~~ 174 (481)
+|++.|+||-+++.
T Consensus 357 ~GnvtLIDfklsRl 370 (488)
T COG5072 357 EGNVTLIDFKLSRL 370 (488)
T ss_pred cCceEEEEeeeeec
Confidence 99999999999984
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.11 Score=53.49 Aligned_cols=76 Identities=21% Similarity=0.308 Sum_probs=46.2
Q ss_pred EEeEecccCceEEEEEEEcCC-CcE-----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKS-GES-----VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIY 102 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~-~~~-----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~ 102 (481)
..+.|..|--..+|++..... +.. |.+++... ..+..-.-.+|+.+++.+...++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345565688889999875332 122 44443211 11222234579999999976555 455555542 6
Q ss_pred EEEeccCCCch
Q 011628 103 FVMEYVRGGEL 113 (481)
Q Consensus 103 lv~Ey~~gg~L 113 (481)
++.||++|.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 89999999765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.25 Score=48.68 Aligned_cols=75 Identities=13% Similarity=0.205 Sum_probs=47.4
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR---HPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+-.+.+|.|....+|... .+++.+-||+-.... ...+..|..-|+.|. --.+.+++.+....+..|++|
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 346788999999999887 678899999876321 133567888777773 345778888888777789999
Q ss_pred eccCCC
Q 011628 106 EYVRGG 111 (481)
Q Consensus 106 Ey~~gg 111 (481)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.072 Score=49.93 Aligned_cols=83 Identities=19% Similarity=0.201 Sum_probs=57.8
Q ss_pred HHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--cCceec
Q 011628 72 HIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA--RGVYHR 149 (481)
Q Consensus 72 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~--~gi~Hr 149 (481)
.++.+.+++.+++ .|+++..- ..-.+-+++|+|-... . .-..++.-=+.+|.-.|+ .+.+|+
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i-~~~N~i~agi~~L~~fH~~~~~~lHG 167 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------I-NFSNFITAGIKDLMDFHSENQHCLHG 167 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------c-chhHHHHHhHHHHHHhhccCCCeecC
Confidence 3567888888775 68887732 4456779999995311 1 011111122456777784 379999
Q ss_pred CCCCCcEEEccCCCEEEEecC
Q 011628 150 DLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 150 DLKp~NILl~~~g~lkl~DFG 170 (481)
|..|+||+-|..|.+||.|=+
T Consensus 168 D~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 168 DCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred CCChhheeecCCCCEEecChh
Confidence 999999999999999999976
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.57 Score=47.02 Aligned_cols=71 Identities=15% Similarity=0.180 Sum_probs=42.8
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEE---E--EEEeCCEEEEEEeccC
Q 011628 37 GTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLF---E--VMATKSKIYFVMEYVR 109 (481)
Q Consensus 37 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~---~--~~~~~~~~~lv~Ey~~ 109 (481)
+.-..||.... .++..+++|+.+.... ....+..|+..+..|.... ++... + +..-++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34457898864 4577899998864331 1344667888777773211 22211 1 1223567888999998
Q ss_pred CCc
Q 011628 110 GGE 112 (481)
Q Consensus 110 gg~ 112 (481)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 853
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.53 Score=54.64 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=26.3
Q ss_pred cCceecCCCCCcEEEccCC--CEE-EEecCCccc
Q 011628 144 RGVYHRDLKPENLLLDENG--DLK-VSDFGLSAV 174 (481)
Q Consensus 144 ~gi~HrDLKp~NILl~~~g--~lk-l~DFGla~~ 174 (481)
++++|+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 481 | ||||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-65 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-65 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-65 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-65 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-65 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-65 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-65 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-64 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-64 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-64 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-64 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-64 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-63 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-63 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-62 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-62 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-61 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-61 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-59 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-52 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-51 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-50 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-50 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-50 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-47 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-47 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-47 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-47 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-47 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-47 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-47 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-47 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-47 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-47 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-47 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-46 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-46 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-46 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-46 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-46 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-46 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-46 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-46 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-46 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-46 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-46 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-46 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-46 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-46 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-46 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-46 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-46 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-46 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-46 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-46 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-46 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-46 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-46 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-45 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-45 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-45 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-45 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-45 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-45 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-45 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-45 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-45 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-45 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-45 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-45 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-45 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-45 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-45 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-45 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-45 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-45 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-45 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-45 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-45 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-45 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-45 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-45 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-45 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-45 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-45 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-45 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-45 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-45 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-45 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-45 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-45 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-45 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-45 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-45 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-44 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-44 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-44 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-44 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-44 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-44 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-44 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-44 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-44 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-44 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-44 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-44 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-44 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-44 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-44 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-44 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-44 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-44 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-44 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-44 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-44 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-44 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-44 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-44 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-44 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-44 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-44 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-44 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-44 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-44 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-44 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-44 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-44 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-44 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-44 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-44 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-44 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-44 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-44 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-44 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-44 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-44 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-44 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-44 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-44 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-44 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-44 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-44 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-44 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-44 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-44 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-44 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-44 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-44 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-44 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-44 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-44 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-44 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-43 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-43 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-43 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-43 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-43 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-43 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-43 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-43 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-43 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-43 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-42 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-42 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-42 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-42 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-42 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-42 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-42 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-42 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-42 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-42 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-42 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-42 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-42 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-42 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-42 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-42 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-42 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-42 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-42 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-42 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-42 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-42 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-42 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-42 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-41 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-41 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-41 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-41 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-41 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-41 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-41 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-40 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-40 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-40 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-40 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-40 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-39 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-39 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-39 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-39 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-39 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-39 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-39 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-39 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-39 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-39 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-39 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-38 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-38 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-38 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-38 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-38 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-38 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-38 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-37 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-37 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-37 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-37 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-37 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-37 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-37 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-37 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-37 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-37 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-37 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-37 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-37 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-37 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-36 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-36 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-36 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-36 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-36 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-36 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-36 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-35 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-35 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-35 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-34 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-34 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-34 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-34 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-34 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-34 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-34 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-34 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-34 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-34 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-33 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-33 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-33 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-33 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-33 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-33 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-33 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-33 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-33 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-33 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-33 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-33 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-33 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-33 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-32 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-32 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-32 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-32 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-32 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-32 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-32 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-32 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-32 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-32 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-32 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-32 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-32 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-32 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-32 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-31 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-31 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-31 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-31 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-30 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-30 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-30 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-30 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-30 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-30 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-30 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-30 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-30 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-29 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-29 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-29 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-29 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-29 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-29 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-29 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-29 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-29 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-29 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-29 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-29 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-29 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-29 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-29 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-29 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-29 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-29 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-29 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-29 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-29 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-29 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-29 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-29 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-29 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-29 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-29 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-29 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-29 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-29 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-29 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-29 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-29 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-29 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-29 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-29 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-29 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-29 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-29 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-29 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-29 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-29 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-29 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-29 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-29 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-29 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-29 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-29 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-29 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-29 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-29 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-29 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-29 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-29 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-29 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-29 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-29 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-29 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-29 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-29 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-29 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-29 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-29 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-29 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-29 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-29 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-29 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-29 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-29 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-29 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-29 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-28 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-28 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-28 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-28 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-28 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-28 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-28 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-28 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-27 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-27 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-27 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-27 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-27 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-27 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-27 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-27 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-27 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-27 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-27 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-27 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-27 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-26 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-26 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-26 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-26 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-26 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-26 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-26 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-26 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-25 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-25 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-25 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-25 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-25 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-25 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-25 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-25 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-25 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-25 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-25 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-25 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-25 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-25 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-25 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-25 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-24 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-24 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-24 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-23 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-23 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-23 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-23 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-22 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-22 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-22 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-21 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-21 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-21 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-21 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-21 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-21 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-21 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-21 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-21 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-21 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-21 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-21 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-21 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-21 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-21 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-21 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-21 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-21 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-21 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-21 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-21 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-21 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-21 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-21 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-21 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-21 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-21 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-20 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-20 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-20 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-20 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-20 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-20 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-20 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-20 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-20 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-20 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-20 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-20 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-20 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-20 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-20 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-20 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-20 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-20 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-20 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-20 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-20 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-20 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-20 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-20 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-20 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-20 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-20 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-20 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-20 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-20 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-20 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-20 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-20 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-20 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-19 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-19 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-19 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-19 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-19 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-19 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-19 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-19 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-19 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-19 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-19 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-19 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-19 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-18 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-18 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-18 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-18 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-18 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-18 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-16 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-15 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-13 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-13 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-13 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-13 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-12 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 |
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 503 bits (1297), Expect = e-177
Identities = 127/475 (26%), Positives = 219/475 (46%), Gaps = 49/475 (10%)
Query: 14 SSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHI 73
+ + + +G Y +G LG GTF KV ++ +G VA+K+++++KI +V I
Sbjct: 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI 63
Query: 74 KREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQ 132
+REI L+ RHP+I++L++V++T S I+ VMEYV GGELF+ GRL E +R+ FQ
Sbjct: 64 RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
Q++S V +CH V HRDLKPEN+LLD + + K++DFGLS + + T CG+P
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPN 180
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFS 252
Y APEV+S + Y +VDIWS GVIL+ L+ G LPF D ++ ++KKI G F +P++ +
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240
Query: 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVD------- 305
P +I LL +L +P KR TI +I E+ WF++ F + + D +
Sbjct: 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCE 300
Query: 306 -------------------------------------HTDDVGPCSDDHSLSEPEPEPEL 328
D + +
Sbjct: 301 KFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTR 360
Query: 329 ETKRKLTSLPRPASLNAFDLISFSPGFDLSGLFEEGGEGARFVSGAPVSKIITKLEEIAK 388
++ L L +P + S + + I+ ++ K
Sbjct: 361 PHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIK 420
Query: 389 VVSFTVRKKDC-RVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGEY 442
+ + + + + + ++ +++++ + +++ + + E
Sbjct: 421 QLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 491 bits (1267), Expect = e-175
Identities = 102/302 (33%), Positives = 164/302 (54%), Gaps = 6/302 (1%)
Query: 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLV-AHIKREISIL 80
+ L+G+Y +G LLG G++ KV + ++ A+K++ K+K+ + A++K+EI +L
Sbjct: 1 AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 81 RRVRHPNIVQLFEVM--ATKSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLIS 136
RR+RH N++QL +V+ K K+Y VMEY G E+ + V + R A YF QLI
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP 196
+ + H++G+ H+D+KP NLLL G LK+S G++ D T G+PA+ P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 197 EVLS-RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDL 255
E+ + + KVDIWS GV L+ + G PF+ NI +++ I KG + P P L
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSD 315
LL +L+ P KR +I +I ++ WFRK + + + +D + V P +
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLE 300
Query: 316 DH 317
D
Sbjct: 301 DL 302
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-173
Identities = 97/269 (36%), Positives = 156/269 (57%), Gaps = 6/269 (2%)
Query: 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRR 82
P + +++ + LG G + +V A N + E+VA+K++D ++ + +IK+EI I +
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKM 61
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFC 141
+ H N+V+ + + Y +EY GGELF++ + E A+++F QL++ V +
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
H G+ HRD+KPENLLLDE +LK+SDFGL+ V ++ L + CGT YVAPE+L R
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NIMVMYKKIYKGEFRSPRW--FSPDLIRL 258
+ + A VD+WSCG++L ++AG LP+ + Y + + W + L
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 259 LTKLLDTNPDKRITIPEIMENRWFRKGFK 287
L K+L NP RITIP+I ++RW+ K K
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLK 270
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 485 bits (1252), Expect = e-173
Identities = 117/274 (42%), Positives = 173/274 (63%), Gaps = 4/274 (1%)
Query: 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS 78
+ +G Y +G LG GTF KV + +G VA+K+++++KI +V IKREI
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 79 ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISA 137
L+ RHP+I++L++V++T + + VMEYV GGELF+ GR++E AR+ FQQ++SA
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
V +CH V HRDLKPEN+LLD + + K++DFGLS + + T CG+P Y APE
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPE 180
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
V+S + Y +VDIWSCGVIL+ L+ G LPF D+++ ++KKI G F P + + +
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240
Query: 258 LLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKF 291
LL +L +P KR TI +I E+ WF++ F
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 485 bits (1250), Expect = e-172
Identities = 97/269 (36%), Positives = 156/269 (57%), Gaps = 6/269 (2%)
Query: 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRR 82
P + +++ + LG G + +V A N + E+VA+K++D ++ + +IK+EI I +
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKM 61
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFC 141
+ H N+V+ + + Y +EY GGELF++ + E A+++F QL++ V +
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
H G+ HRD+KPENLLLDE +LK+SDFGL+ V ++ L + CGT YVAPE+L R
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NIMVMYKKIYKGEFRSPRW--FSPDLIRL 258
+ + A VD+WSCG++L ++AG LP+ + Y + + W + L
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 259 LTKLLDTNPDKRITIPEIMENRWFRKGFK 287
L K+L NP RITIP+I ++RW+ K K
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLK 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 472 bits (1218), Expect = e-167
Identities = 111/280 (39%), Positives = 176/280 (62%), Gaps = 5/280 (1%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+G Y I + LG G+F KV A + K+ + VA+K I ++ + KS + ++REIS L+ +R
Sbjct: 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHA 143
HP+I++L++V+ T + I V+EY GGELF+ V K R+ ED R++FQQ+I A+ +CH
Sbjct: 68 HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
+ HRDLKPENLLLD+N ++K++DFGLS + + T CG+P Y APEV++ K
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
Y +VD+WSCG++L+V++ G LPF D+ I ++KK+ + P + SP L+ +++
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243
Query: 264 DTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVED 303
+P +RITI EI + WF +E+ + +
Sbjct: 244 VADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADS 283
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 470 bits (1211), Expect = e-165
Identities = 117/363 (32%), Positives = 174/363 (47%), Gaps = 35/363 (9%)
Query: 11 STTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLV 70
T+ D RY+ K +G G F R+ + E VA+K I++ +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE--- 61
Query: 71 AHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARK 129
+++REI R +RHPNIV+ EV+ T + + +MEY GGEL+ + GR ED AR
Sbjct: 62 -NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARF 120
Query: 130 YFQQLISAVGFCHARGVYHRDLKPENLLLDEN--GDLKVSDFGLSAVSDQIRQDGLFHTF 187
+FQQL+S V +CH+ + HRDLK EN LLD + LK+ DFG S S +
Sbjct: 121 FFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKST 177
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKK----IYKG 243
GTPAY+APEVL R+ YD D+WSCGV L+V++ G PF+D Y+K I
Sbjct: 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV 237
Query: 244 EFRSPR--WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNV 301
++ P SP+ L++++ +P RI+IPEI + WF K E +
Sbjct: 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP-ADLMNESNTGSQF 296
Query: 302 EDVDHTDDVGPCSDDHSLSEPEPEPELETKRKLTS-LPRPASLNAFDLISFSPGFDLSGL 360
++ + +P L+T ++ S PA N + DL
Sbjct: 297 QEPE-----------------QPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDD 339
Query: 361 FEE 363
++
Sbjct: 340 MDD 342
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 462 bits (1191), Expect = e-163
Identities = 89/279 (31%), Positives = 160/279 (57%), Gaps = 6/279 (2%)
Query: 13 TSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH 72
T+ ++ + + ++IG+ LG G F VY AR ++ +A+KV+ K ++ K G+
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 73 IKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYF 131
++REI I +RHPNI++++ + +IY ++E+ GEL+ ++ K GR E + +
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 132 QQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP 191
++L A+ +CH R V HRD+KPENLL+ G+LK++DFG S + +R+ T CGT
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RTMCGTL 176
Query: 192 AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF 251
Y+ PE++ K +D KVD+W GV+ + + G PF + +++I + + P +
Sbjct: 177 DYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235
Query: 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIK 290
S L++KLL +P +R+ + +ME+ W + + +
Sbjct: 236 SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-161
Identities = 98/299 (32%), Positives = 152/299 (50%), Gaps = 31/299 (10%)
Query: 15 SSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS------- 67
SS L +Y + +G G++ V A N A+KV+ K+K+++
Sbjct: 2 SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 68 ----------------GLVAHIKREISILRRVRHPNIVQLFEVM--ATKSKIYFVMEYVR 109
G + + +EI+IL+++ HPN+V+L EV+ + +Y V E V
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121
Query: 110 GGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169
G + L ED AR YFQ LI + + H + + HRD+KP NLL+ E+G +K++DF
Sbjct: 122 QGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLS--RKGYDAAKVDIWSCGVILFVLMAGYLP 227
G+S D L GTPA++APE LS RK + +D+W+ GV L+ + G P
Sbjct: 182 GVSNE--FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 228 FQDQNIMVMYKKIYKGEFRSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
F D+ IM ++ KI P + DL L+T++LD NP+ RI +PEI + W +
Sbjct: 240 FMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 457 bits (1179), Expect = e-161
Identities = 95/288 (32%), Positives = 145/288 (50%), Gaps = 9/288 (3%)
Query: 2 AHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDK 61
A A AP + D RY G+ LG G FAK + + + E A K++ K
Sbjct: 20 APAAAPPAKEIPEVLVDPRS---RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPK 76
Query: 62 EKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKG 120
+LK + EISI R + H ++V ++ V+E R L +
Sbjct: 77 SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK 136
Query: 121 RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180
L E AR Y +Q++ + H V HRDLK NL L+E+ ++K+ DFGL+ ++
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT---KVEY 193
Query: 181 DGLF-HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKK 239
DG CGTP Y+APEVLS+KG+ +VD+WS G I++ L+ G PF+ + Y +
Sbjct: 194 DGERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 252
Query: 240 IYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287
I K E+ P+ +P L+ K+L T+P R TI E++ + +F G+
Sbjct: 253 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 455 bits (1174), Expect = e-160
Identities = 90/265 (33%), Positives = 139/265 (52%), Gaps = 6/265 (2%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
RY G+ LG G FAK + + + E A K++ K +LK + EISI R +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHA 143
H ++V ++ V+E R L + L E AR Y +Q++ + H
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF-HTFCGTPAYVAPEVLSRK 202
V HRDLK NL L+E+ ++K+ DFGL+ ++ DG CGTP Y+APEVLS+K
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262
G+ +VD+WS G I++ L+ G PF+ + Y +I K E+ P+ +P L+ K+
Sbjct: 191 GHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249
Query: 263 LDTNPDKRITIPEIMENRWFRKGFK 287
L T+P R TI E++ + +F G+
Sbjct: 250 LQTDPTARPTINELLNDEFFTSGYI 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 452 bits (1165), Expect = e-159
Identities = 80/265 (30%), Positives = 148/265 (55%), Gaps = 5/265 (1%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+ +++G LLG G+FA VY A ++ +G VAIK+IDK+ + K+G+V ++ E+ I +++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCH 142
HP+I++L+ + +Y V+E GE+ K E+ AR + Q+I+ + + H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
+ G+ HRDL NLLL N ++K++DFGL+ +T CGTP Y++PE+ +R
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIATRS 187
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262
+ + D+WS G + + L+ G PF + K+ ++ P + S + L+ +L
Sbjct: 188 AHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246
Query: 263 LDTNPDKRITIPEIMENRWFRKGFK 287
L NP R+++ ++++ + +
Sbjct: 247 LRRNPADRLSLSSVLDHPFMSRNSS 271
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 446 bits (1150), Expect = e-157
Identities = 90/275 (32%), Positives = 152/275 (55%), Gaps = 6/275 (2%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
L +EIG+ LG G F VY AR +S +A+KV+ K ++ K+G+ ++RE+ I +R
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA 143
HPNI++L+ +++Y ++EY G ++ ++ K + E Y +L +A+ +CH+
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
+ V HRD+KPENLLL G+LK++DFG S + R+ CGT Y+ PE++ +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----DLCGTLDYLPPEMIEGRM 183
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
+D KVD+WS GV+ + + G PF+ YK+I + EF P + + L+++LL
Sbjct: 184 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242
Query: 264 DTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKM 298
NP +R + E++E+ W +
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 448 bits (1153), Expect = e-157
Identities = 95/335 (28%), Positives = 161/335 (48%), Gaps = 18/335 (5%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
MA P + + + + +Y LG G F V+ A + + + V +K I
Sbjct: 1 MALEEPPKAVELEGLAACEGE--YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK 58
Query: 61 KEKILKSGLV-----AHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME-YVRGGELF 114
KEK+L+ + + EI+IL RV H NI+++ ++ + VME + G +LF
Sbjct: 59 KEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLF 118
Query: 115 NK-VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173
RL E LA F+QL+SAVG+ + + HRD+K EN+++ E+ +K+ DFG +A
Sbjct: 119 AFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178
Query: 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI 233
+ + LF+TFCGT Y APEVL Y ++++WS GV L+ L+ PF +
Sbjct: 179 Y---LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--- 232
Query: 234 MVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYI 293
++ + P S +L+ L++ LL P++R T+ +++ + W + +
Sbjct: 233 ---LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTW 289
Query: 294 EDDKMCNVEDVDHTDDVGPCSDDHSLSEPEPEPEL 328
E+ N + + SLS+ EL
Sbjct: 290 EEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQEL 324
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 447 bits (1152), Expect = e-157
Identities = 121/294 (41%), Positives = 186/294 (63%), Gaps = 7/294 (2%)
Query: 14 SSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHI 73
S + ++ P +G Y + K +G G FAKV AR++ +G VAIK+IDK ++ + L +
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKL 61
Query: 74 KREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQ 132
RE+ I++ + HPNIV+LFEV+ T+ +Y +MEY GGE+F+ VA GR+KE AR F+
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
Q++SAV +CH + + HRDLK ENLLLD + ++K++DFG S + G FCG P
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGAPP 178
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFS 252
Y APE+ K YD +VD+WS GVIL+ L++G LPF QN+ + +++ +G++R P + S
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238
Query: 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK--HIKFYIEDDKMCNVEDV 304
D LL + L NP KR T+ +IM++RW G + +K ++E + + +
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKR 292
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 437 bits (1125), Expect = e-153
Identities = 88/305 (28%), Positives = 146/305 (47%), Gaps = 21/305 (6%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
+ AP T T +++ Y +G LLG G F V+ + VAIKVI
Sbjct: 7 LQGPPAPPGTPTPPPGG-KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP 65
Query: 61 KEKILKSGLV---AHIKREISILRRVR----HPNIVQLFEVMATKSKIYFVMEY-VRGGE 112
+ ++L + E+++L +V HP +++L + T+ V+E + +
Sbjct: 66 RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD 125
Query: 113 LFNK-VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD-ENGDLKVSDFG 170
LF+ KG L E +R +F Q+++A+ CH+RGV HRD+K EN+L+D G K+ DFG
Sbjct: 126 LFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185
Query: 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD 230
A + D + F GT Y PE +SR Y A +WS G++L+ ++ G +PF+
Sbjct: 186 SGA----LLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
Query: 231 QNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIK 290
++I + E P SPD L+ + L P R ++ EI+ + W + + +
Sbjct: 242 ------DQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP 295
Query: 291 FYIED 295
Sbjct: 296 LNPSK 300
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 429 bits (1104), Expect = e-150
Identities = 84/294 (28%), Positives = 143/294 (48%), Gaps = 18/294 (6%)
Query: 2 AHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDK 61
+H T + + + PL +Y++G LLG G F VY V VAIK ++K
Sbjct: 19 SHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 78
Query: 62 EKILKSGLVAH---IKREISILRRVRH--PNIVQLFEVMATKSKIYFVMEYVRG-GELFN 115
++I G + + + E+ +L++V +++L + ++E +LF+
Sbjct: 79 DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 138
Query: 116 K-VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSA 173
+G L+E+LAR +F Q++ AV CH GV HRD+K EN+L+D N G+LK+ DFG A
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198
Query: 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI 233
+ +D ++ F GT Y PE + Y +WS G++L+ ++ G +PF+
Sbjct: 199 ----LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-- 252
Query: 234 MVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287
++I +G+ + S + L+ L P R T EI + W +
Sbjct: 253 ----EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 397 bits (1021), Expect = e-137
Identities = 68/329 (20%), Positives = 130/329 (39%), Gaps = 51/329 (15%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
M + S + + + + Y I + L G F K+ K + A+K +
Sbjct: 6 MKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYE 63
Query: 61 KEKILK--------------SGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106
K + K K E+ I+ +++ + ++ ++Y + E
Sbjct: 64 KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123
Query: 107 YVRGGELFN---------KVAKGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENL 156
Y+ + K + + + + ++++ + H + + HRD+KP N+
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183
Query: 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCG 215
L+D+NG +K+SDFG S D GT ++ PE S + Y+ AKVDIWS G
Sbjct: 184 LMDKNGRVKLSDFGESE----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239
Query: 216 VILFVLMAGYLPFQDQ-NIMVMYKKIYKGEFRSP-------------------RWFSPDL 255
+ L+V+ +PF + +++ ++ I P + S +
Sbjct: 240 ICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED 299
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRK 284
I L L NP +RIT + +++ W
Sbjct: 300 IDFLKLFLRKNPAERITSEDALKHEWLAD 328
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 342 bits (878), Expect = e-116
Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 37/291 (12%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+E +LG G F +V ARN AIK I + S I E+ +L + H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLLASLNHQY 63
Query: 88 IVQLFEV-------------MATKSKIYFVMEYVRGGELFNKVAKGRLK--EDLARKYFQ 132
+V+ + + KS ++ MEY G L++ + L D + F+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ------------IRQ 180
Q++ A+ + H++G+ HRDLKP N+ +DE+ ++K+ DFGL+ +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI 240
+ GT YVA EVL G+ K+D++S G+I F ++ Y + + KK+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241
Query: 241 YKGEFRSPRWF----SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287
P F +++ L+D +P+KR ++ + W +
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-108
Identities = 101/278 (36%), Positives = 147/278 (52%), Gaps = 28/278 (10%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH-----IKREISILR 81
Y + K LG G +V A K+ + VAIK+I K K ++ EI IL+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGF 140
++ HP I+++ + Y V+E + GGELF+K V RLKE + YF Q++ AV +
Sbjct: 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 141 CHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
H G+ HRDLKPEN+LL +E+ +K++DFG S + + + L T CGTP Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186
Query: 198 VLS---RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKG--EFRSPRWF 251
VL GY+ VD WS GVILF+ ++GY PF + + + +I G F W
Sbjct: 187 VLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 252 --SP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
S DL++ KLL +P R T E + + W +
Sbjct: 246 EVSEKALDLVK---KLLVVDPKARFTTEEALRHPWLQD 280
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-108
Identities = 81/332 (24%), Positives = 128/332 (38%), Gaps = 49/332 (14%)
Query: 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS 78
+ G +E+ + LG G F V + +GE VAIK +E K+ EI
Sbjct: 7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQ 64
Query: 79 ILRRVRHPNIVQLFEVMATKSKI------YFVMEYVRGGELFNKVAK----GRLKEDLAR 128
I++++ HPN+V EV K+ MEY GG+L + + LKE R
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 129 KYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFGLSAVSDQIRQDGLFH 185
+ SA+ + H + HRDLKPEN++L K+ D G + ++ Q L
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCT 181
Query: 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF 245
F GT Y+APE+L +K Y VD WS G + F + G+ PF V + + +
Sbjct: 182 EFVGTLQYLAPELLEQKKYTV-TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 246 RSPRWFSPD------------------------LIRLLTKLLDTNPDKRITIPEIMENRW 281
D L R L +L + +R T P+
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 282 FRKGFKHIK------FYIEDDKMCNVEDVDHT 307
F+ + + ++ ++
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENE 332
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-108
Identities = 98/270 (36%), Positives = 153/270 (56%), Gaps = 19/270 (7%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
Y++ + LG G F+ V + +G A K+I+ +K L + ++RE I R+++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARG 145
NIV+L + + +S Y V + V GGELF VA+ E A QQ++ ++ +CH+ G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 146 VYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
+ HR+LKPENLLL + +K++DFGL + ++ +H F GTP Y++PEVL +
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGL---AIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW--FSP---DL 255
Y VDIW+CGVIL++L+ GY PF D++ +Y +I G ++ SP W +P L
Sbjct: 183 PYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
I +L NP KRIT + ++ W
Sbjct: 242 ID---SMLTVNPKKRITADQALKVPWICNR 268
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-107
Identities = 71/321 (22%), Positives = 124/321 (38%), Gaps = 53/321 (16%)
Query: 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS 78
+QS + + +LG G A V+ R+ K+G+ AIKV + L+ V RE
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFE 59
Query: 79 ILRRVRHPNIVQLFEVM--ATKSKIYFVMEYVRGGELFNKVAK----GRLKEDLARKYFQ 132
+L+++ H NIV+LF + T +ME+ G L+ + + L E +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 133 QLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188
++ + G+ HR++KP N++ D K++DFG + ++ D F +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY 176
Query: 189 GTPAYVAPEVLSR--------KGYDAAKVDIWSCGVILFVLMAGYLPFQD----QNIMVM 236
GT Y+ P++ R K Y A VD+WS GV + G LPF+ + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 237 YKKIYKGEFRS-------------------------PRWFSPDLIRLLTKLLDTNPDKRI 271
KI G+ R L +L +L+ + +K
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
Query: 272 TIPEIMENRWFRKGFKHIKFY 292
+ + +
Sbjct: 296 GFDQFFAETSDILHRGNSHHH 316
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = e-107
Identities = 79/302 (26%), Positives = 132/302 (43%), Gaps = 22/302 (7%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLG--RYEIGKLLGHGTFAKVYHARNVKSGESVAIKV 58
M H +S + QS + Y I K +G G +KV+ N + + AIK
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKY 59
Query: 59 IDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEVMATKSKIYFVMEYVRGGELFNK 116
++ E+ L + EI+ L +++ + I++L++ T IY VME +L +
Sbjct: 60 VNLEEADNQTL-DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSW 117
Query: 117 -VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175
K + + Y++ ++ AV H G+ H DLKP N L+ +G LK+ DFG++
Sbjct: 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176
Query: 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA----------AKVDIWSCGVILFVLMAGY 225
+ + GT Y+ PE + K D+WS G IL+ + G
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 226 LPFQDQ--NIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
PFQ I ++ I E P DL +L L +P +RI+IPE++ + +
Sbjct: 237 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
Query: 283 RK 284
+
Sbjct: 297 QI 298
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 322 bits (826), Expect = e-106
Identities = 83/391 (21%), Positives = 138/391 (35%), Gaps = 66/391 (16%)
Query: 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS 78
+QS + + +LG G A V+ R+ K+G+ AIKV + L+ V RE
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFE 59
Query: 79 ILRRVRHPNIVQLFEVM--ATKSKIYFVMEYVRGGELFNK-VAKGR---LKEDLARKYFQ 132
+L+++ H NIV+LF + T +ME+ G L+ L E +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 133 QLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188
++ + G+ HR++KP N++ D K++DFG + ++ D F +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY 176
Query: 189 GTPAYVAPEVLSR--------KGYDAAKVDIWSCGVILFVLMAGYLPFQD----QNIMVM 236
GT Y+ P++ R K Y A VD+WS GV + G LPF+ + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 237 YKKIYKGEFRS-------------------------PRWFSPDLIRLLTKLLDTNPDKRI 271
KI G+ R L +L +L+ + +K
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
Query: 272 TIPEIMENRWFRKGFKHI-----------KFYIEDDKMCNVEDVDHTDDVG-PCSDDHSL 319
+ I K YI + S+ +
Sbjct: 296 GFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELI 355
Query: 320 SEPEPEPELETKRKLTSLPRPASLNAFDLIS 350
E LE R P+ N ++S
Sbjct: 356 YEGRRLV-LEPGRLAQHFPKTTEENPIFVVS 385
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = e-106
Identities = 102/296 (34%), Positives = 158/296 (53%), Gaps = 19/296 (6%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
MA T S + Y++ + LG G F+ V + +G A K+I+
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAK 119
+K L + ++RE I R+++HPNIV+L + + +S Y V + V GGELF VA+
Sbjct: 64 TKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 120 GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSD 176
E A QQ++ ++ +CH+ G+ HR+LKPENLLL + +K++DFGL+
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--- 179
Query: 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM 236
++ +H F GTP Y++PEVL + Y VDIW+CGVIL++L+ GY PF D++ +
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRL 238
Query: 237 YKKIYKG--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
Y +I G ++ SP W +P LI +L NP KRIT + ++ W
Sbjct: 239 YAQIKAGAYDYPSPEWDTVTPEAKSLID---SMLTVNPKKRITADQALKVPWICNR 291
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 321 bits (825), Expect = e-106
Identities = 101/294 (34%), Positives = 149/294 (50%), Gaps = 28/294 (9%)
Query: 11 STTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLV 70
T + L Y + K LG G +V A K+ + VAI++I K K
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR 179
Query: 71 AH-----IKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKE 124
++ EI IL+++ HP I+++ + Y V+E + GGELF+K V RLKE
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKE 238
Query: 125 DLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQD 181
+ YF Q++ AV + H G+ HRDLKPEN+LL +E+ +K++DFG S + + +
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGET 295
Query: 182 GLFHTFCGTPAYVAPEVLS---RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMY 237
L T CGTP Y+APEVL GY+ VD WS GVILF+ ++GY PF + + +
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354
Query: 238 KKIYKG--EFRSPRWFSP-----DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
+I G F W DL++ KLL +P R T E + + W +
Sbjct: 355 DQITSGKYNFIPEVWAEVSEKALDLVK---KLLVVDPKARFTTEEALRHPWLQD 405
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-105
Identities = 94/278 (33%), Positives = 146/278 (52%), Gaps = 27/278 (9%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH-----IKREISILR 81
+Y+ ++G G + V + +G A+K+++ S +RE ILR
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 82 RVR-HPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVG 139
+V HP+I+ L + + S ++ V + +R GELF+ K L E R + L+ AV
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
F HA + HRDLKPEN+LLD+N +++SDFG S + CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGF---SCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 200 SR------KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW- 250
GY VD+W+CGVILF L+AG PF + ++M + I +G +F SP W
Sbjct: 272 KCSMDETHPGYGKE-VDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 251 -FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
S DLI +LL +P+ R+T + +++ +F +
Sbjct: 331 DRSSTVKDLIS---RLLQVDPEARLTAEQALQHPFFER 365
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 314 bits (808), Expect = e-105
Identities = 100/270 (37%), Positives = 159/270 (58%), Gaps = 22/270 (8%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+ ++LG G F++V+ + +G+ A+K I K + + ++ EI++L++++H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHE 66
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARG 145
NIV L ++ + + Y VM+ V GGELF++ + +G E A QQ++SAV + H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 146 VYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
+ HRDLKPENLL +EN + ++DFGLS ++ Q+G+ T CGTP YVAPEVL++K
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW--FSP---DL 255
Y A VD WS GVI ++L+ GY PF ++ +++KI +G EF SP W S D
Sbjct: 183 PYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
I LL+ +P++R T + + + W
Sbjct: 242 IC---HLLEKDPNERYTCEKALSHPWIDGN 268
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-105
Identities = 93/296 (31%), Positives = 147/296 (49%), Gaps = 28/296 (9%)
Query: 10 TSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-- 67
T + + YE ++LG G + V + + + A+K+ID
Sbjct: 1 TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60
Query: 68 ----GLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGR 121
L +E+ ILR+V HPNI+QL + T + + V + ++ GELF+ K
Sbjct: 61 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120
Query: 122 LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181
L E RK + L+ + H + HRDLKPEN+LLD++ ++K++DFG S Q+
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF---SCQLDPG 177
Query: 182 GLFHTFCGTPAYVAPEVL------SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV 235
CGTP+Y+APE++ + GY VD+WS GVI++ L+AG PF + M+
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKE-VDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 236 MYKKIYKG--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
M + I G +F SP W +S DL+ + L P KR T E + + +F++
Sbjct: 237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-105
Identities = 97/270 (35%), Positives = 139/270 (51%), Gaps = 22/270 (8%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
Y + +G G++ +V A + A K I K + V K+EI I++ + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHP 66
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARG 145
NI++L+E + IY VME GGELF + V K +E A + + ++SAV +CH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 146 VYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
V HRDLKPEN L + LK+ DFGL+A + + T GTP YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVL-EG 182
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW--FSP---DL 255
Y + D WS GV+++VL+ GY PF + KI +G F W SP L
Sbjct: 183 LYG-PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
IR +LL +P +RIT + +E+ WF K
Sbjct: 242 IR---RLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-104
Identities = 104/295 (35%), Positives = 161/295 (54%), Gaps = 24/295 (8%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
M H +S + RY I +LG G+F +V ++ + + A+KVI+
Sbjct: 1 MHHHHHHSSGRENLYFQ----GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN 56
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAK 119
K K+ + I RE+ +L+++ HPNI++LFE++ S Y V E GGELF++ + +
Sbjct: 57 KAS-AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 120 GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSD 176
R E A + +Q+ S + + H + HRDLKPEN+LL +++ D+K+ DFGLS
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-- 173
Query: 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM 236
+Q+ GT Y+APEVL R YD K D+WS GVIL++L++G PF +N +
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVL-RGTYD-EKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
Query: 237 YKKIYKG--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
K++ G F P+W S DLIR K+L +P RIT + +E+ W +K
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIR---KMLTFHPSLRITATQCLEHPWIQK 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-104
Identities = 82/299 (27%), Positives = 144/299 (48%), Gaps = 28/299 (9%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
M H +S + + + + LG G F V+ SG IK I+
Sbjct: 1 MHHHHHHSSGRENLYFQGT----IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN 56
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV--- 117
K++ + I+ EI +L+ + HPNI+++FEV +Y VME GGEL ++
Sbjct: 57 KDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA 114
Query: 118 --AKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLS 172
L E + +Q+++A+ + H++ V H+DLKPEN+L + +K+ DFGL
Sbjct: 115 QARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL- 173
Query: 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN 232
++ + D GT Y+APEV ++ K DIWS GV+++ L+ G LPF +
Sbjct: 174 --AELFKSDEHSTNAAGTALYMAPEVF-KRDVT-FKCDIWSAGVVMYFLLTGCLPFTGTS 229
Query: 233 IMVMYKKIYKGEFRSPRWFSP------DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
+ + +K E P DL++ ++L +P++R + +++ + WF++
Sbjct: 230 LEEVQQKATYKEPNYAVECRPLTPQAVDLLK---QMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-103
Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 20/296 (6%)
Query: 5 TAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI 64
SSS ++ S Y I K +G G +KV+ N + + AIK ++ E+
Sbjct: 35 LGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA 93
Query: 65 LKSGLVAHIKREISILRRVRHPN--IVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGR 121
L + EI+ L +++ + I++L++ T IY VME +L + K
Sbjct: 94 DNQTL-DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS 151
Query: 122 LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181
+ + Y++ ++ AV H G+ H DLKP N L+ +G LK+ DFG++
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210
Query: 182 GLFHTFCGTPAYVAPEVLSRKGYDA----------AKVDIWSCGVILFVLMAGYLPFQD- 230
+ + G Y+ PE + K D+WS G IL+ + G PFQ
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 231 -QNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
I ++ I E P DL +L L +P +RI+IPE++ + + +
Sbjct: 271 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = e-103
Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 20/274 (7%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
Y I K +G G +KV+ N + + AIK ++ E+ L + EI+ L +++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEIAYLNKLQQH 67
Query: 87 N--IVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHA 143
+ I++L++ T IY VME +L + K + + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
G+ H DLKP N L+ +G LK+ DFG++ + + GT Y+ PE +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 204 YDA----------AKVDIWSCGVILFVLMAGYLPFQDQ--NIMVMYKKIYKG-EFRSPRW 250
K D+WS G IL+ + G PFQ I ++ I E P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
DL +L L +P +RI+IPE++ + + +
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-101
Identities = 101/271 (37%), Positives = 154/271 (56%), Gaps = 20/271 (7%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
Y++ + LG G F+ V V +G+ A +I+ +K L + ++RE I R ++HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREARICRLLKHP 70
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARG 145
NIV+L + ++ + Y + + V GGELF VA+ E A QQ++ AV CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 146 VYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDG-LFHTFCGTPAYVAPEVLSR 201
V HR+LKPENLLL + +K++DFGL + ++ + + F GTP Y++PEVL +
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGL---AIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW--FSP---D 254
Y VD+W+CGVIL++L+ GY PF D++ +Y++I G +F SP W +P D
Sbjct: 188 DPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
LI K+L NP KRIT E +++ W
Sbjct: 247 LIN---KMLTINPSKRITAAEALKHPWISHR 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 1e-99
Identities = 91/293 (31%), Positives = 153/293 (52%), Gaps = 13/293 (4%)
Query: 4 ATAPTSTSTTSSSKDQNQSPLLGRY-----EIGKLLGHGTFAKVYHARNVKSGESVAIKV 58
TA S + P + + GK+LG G+F+ V AR + + AIK+
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI 62
Query: 59 IDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVA 118
++K I+K V ++ RE ++ R+ HP V+L+ K+YF + Y + GEL +
Sbjct: 63 LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 122
Query: 119 K-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177
K G E R Y +++SA+ + H +G+ HRDLKPEN+LL+E+ ++++DFG + V
Sbjct: 123 KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 182
Query: 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY 237
+ ++F GT YV+PE+L+ K + D+W+ G I++ L+AG PF+ N +++
Sbjct: 183 ESKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIF 241
Query: 238 KKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIP------EIMENRWFRK 284
+KI K E+ P F P L+ KLL + KR+ + + +F
Sbjct: 242 QKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = 1e-98
Identities = 101/296 (34%), Positives = 160/296 (54%), Gaps = 18/296 (6%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
M H +S + RY I +LG G+F +V ++ + + A+KVI+
Sbjct: 1 MHHHHHHSSGRENLYFQ----GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN 56
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAK 119
K K+ + I RE+ +L+++ HPNI++LFE++ S Y V E GGELF++ + +
Sbjct: 57 KAS-AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 120 GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSD 176
R E A + +Q+ S + + H + HRDLKPEN+LL +++ D+K+ DFGL S
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL---ST 172
Query: 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM 236
+Q+ GT Y+APEVL YD K D+WS GVIL++L++G PF +N +
Sbjct: 173 CFQQNTKMKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
Query: 237 YKKIYKGE--FRSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKH 288
K++ G+ F P+W S D L+ K+L +P RIT + +E+ W +K
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 3e-98
Identities = 87/277 (31%), Positives = 154/277 (55%), Gaps = 26/277 (9%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH--IKREISILRRVR 84
YE+ +++G G F+ V N ++G+ A+K++D K S ++ +KRE SI ++
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLK----EDLARKYFQQLISAVG 139
HP+IV+L E ++ +Y V E++ G +L + V + E +A Y +Q++ A+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 140 FCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDG-LFHTFCGTPAYVA 195
+CH + HRD+KP +LL + + +K+ FG++ Q+ + G + GTP ++A
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMA 201
Query: 196 PEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW--F 251
PEV+ R+ Y VD+W CGVILF+L++G LPF +++ I KG + +W
Sbjct: 202 PEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 252 SP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
S DL+R ++L +P +RIT+ E + + W ++
Sbjct: 260 SESAKDLVR---RMLMLDPAERITVYEALNHPWLKER 293
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 5e-98
Identities = 99/300 (33%), Positives = 157/300 (52%), Gaps = 32/300 (10%)
Query: 5 TAPTSTSTTSSSKDQNQSPLLGR--------YEIGKLLGHGTFAKVYHARNVKSGESVAI 56
++ T+++ ++ + G +E+ LG G + VY + + + A+
Sbjct: 24 SSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYAL 83
Query: 57 KVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK 116
KV+ K ++ EI +L R+ HPNI++L E+ T ++I V+E V GGELF++
Sbjct: 84 KVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR 138
Query: 117 -VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLS 172
V KG E A +Q++ AV + H G+ HRDLKPENLL + LK++DFGLS
Sbjct: 139 IVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198
Query: 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ- 231
+ + L T CGTP Y APE+L Y +VD+WS G+I ++L+ G+ PF D+
Sbjct: 199 KI---VEHQVLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDER 254
Query: 232 NIMVMYKKIYKG--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
M+++I F SP W S DL+R KL+ +P KR+T + +++ W
Sbjct: 255 GDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR---KLIVLDPKKRLTTFQALQHPWVTG 311
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 6e-98
Identities = 91/342 (26%), Positives = 150/342 (43%), Gaps = 54/342 (15%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
M H +S + + L +Y + +G G++ V A ++ AIK+++
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 61 KEKI--LKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVA 118
K KI + V IK E+ +++++ HPNI +L+EV + I VME GG L +K+
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 119 K-----------------------------------------GRLKEDLARKYFQQLISA 137
+E L +Q+ SA
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 138 VGFCHARGVYHRDLKPENLLL--DENGDLKVSDFGLSAV--SDQIRQDGLFHTFCGTPAY 193
+ + H +G+ HRD+KPEN L +++ ++K+ DFGLS + T GTP +
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 194 VAPEVLS--RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR 249
VAPEVL+ + Y K D WS GV+L +L+ G +PF N ++ + F +P
Sbjct: 241 VAPEVLNTTNESYG-PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN 299
Query: 250 W--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHI 289
+ SP LL+ LL+ N D+R +++ W + I
Sbjct: 300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 300 bits (769), Expect = 5e-97
Identities = 92/270 (34%), Positives = 150/270 (55%), Gaps = 13/270 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
RY+ ++LG G+F +V ++ +G+ A+KVI K ++ + + RE+ +L+++ HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARG 145
NI++L+E K Y V E GGELF++ +++ R E A + +Q++S + + H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 146 VYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
+ HRDLKPENLLL ++ ++++ DFGL S GT Y+APEVL
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGL---STHFEASKKMKDKIGTAYYIAPEVLHGT 203
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRW--FSPDLIRL 258
YD K D+WS GVIL++L++G PF N + KK+ KG+ F P+W S L
Sbjct: 204 -YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 259 LTKLLDTNPDKRITIPEIMENRWFRKGFKH 288
+ K+L P RI+ + +++ W + K
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKE 291
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 292 bits (751), Expect = 5e-97
Identities = 90/273 (32%), Positives = 144/273 (52%), Gaps = 22/273 (8%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRV 83
YE+G+ LG G FA V R +G+ A K I K ++ S I+RE++ILR +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCH 142
RHPNI+ L ++ K+ + ++E V GGELF+ K L ED A ++ +Q++ V + H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 143 ARGVYHRDLKPENLLL----DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 198
++ + H DLKPEN++L N +K+ DFG++ I F GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEI 182
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW--FSP- 253
++ + D+WS GVI ++L++G PF + I +F + S
Sbjct: 183 VNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 254 --DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
D IR +LL +P +R+TI + +E+ W +
Sbjct: 242 AKDFIR---RLLVKDPKRRMTIAQSLEHSWIKA 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 2e-96
Identities = 100/287 (34%), Positives = 150/287 (52%), Gaps = 34/287 (11%)
Query: 21 QSPLLGRYEIG---KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
SP Y++ K LG G+F+ + KS ++ A+K+I K A+ ++EI
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEI 56
Query: 78 SILRRVR-HPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLI 135
+ L+ HPNIV+L EV + + VME + GGELF + K E A ++L+
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV 116
Query: 136 SAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
SAV H GV HRDLKPENLL ++N ++K+ DFG + + + T C T
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLH 174
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-------IMVMYKKIYKG-- 243
Y APE+L++ GYD + D+WS GVIL+ +++G +PFQ + + + KKI KG
Sbjct: 175 YAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233
Query: 244 EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
F W S DLI+ LL +P+KR+ + + N W + G
Sbjct: 234 SFEGEAWKNVSQEAKDLIQ---GLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 5e-96
Identities = 89/283 (31%), Positives = 136/283 (48%), Gaps = 29/283 (10%)
Query: 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS 78
+N YE+ + +G G+++ + + A+K+IDK K EI
Sbjct: 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIE 67
Query: 79 ILRR-VRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLIS 136
IL R +HPNI+ L +V +Y V E ++GGEL +K + + E A +
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITK 127
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGD----LKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
V + HA+GV HRDLKP N+L + +++ DFG + ++GL T C T
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTAN 185
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF---QDQNIMVMYKKIYKG--EFRS 247
+VAPEVL R+GYDAA DIWS GV+L+ ++ GY PF D + +I G
Sbjct: 186 FVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
Query: 248 PRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
W S DL+ K+L +P +R+T ++ + W
Sbjct: 245 GYWNSVSDTAKDLVS---KMLHVDPHQRLTAALVLRHPWIVHW 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 1e-95
Identities = 95/287 (33%), Positives = 146/287 (50%), Gaps = 23/287 (8%)
Query: 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH------ 72
+ + + Y + LG G + +V + AIKVI K + K
Sbjct: 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 73 ----IKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLA 127
I EIS+L+ + HPNI++LF+V K Y V E+ GGELF + + + + E A
Sbjct: 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA 148
Query: 128 RKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDGLF 184
+Q++S + + H + HRD+KPEN+LL + ++K+ DFGL S +D
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL---SSFFSKDYKL 205
Query: 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE 244
GT Y+APEVL +K Y+ K D+WSCGVI+++L+ GY PF QN + KK+ KG+
Sbjct: 206 RDRLGTAYYIAPEVL-KKKYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263
Query: 245 --FRSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287
F W S + L+ +L + +KR T E + +RW +K
Sbjct: 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 2e-95
Identities = 88/274 (32%), Positives = 140/274 (51%), Gaps = 22/274 (8%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRV 83
Y+ G+ LG G FA V R +G A K I K + S I+RE+SIL+ +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFCH 142
+HPN++ L EV K+ + ++E V GGELF+ K L E+ A ++ +Q+++ V + H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 143 ARGVYHRDLKPENLLL----DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 198
+ + H DLKPEN++L +K+ DFGL+ I F GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEI 188
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW--FSP- 253
++ + + D+WS GVI ++L++G PF + EF + S
Sbjct: 189 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 254 --DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
D IR +LL +P KR+TI + +++ W +
Sbjct: 248 AKDFIR---RLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 2e-95
Identities = 100/307 (32%), Positives = 157/307 (51%), Gaps = 25/307 (8%)
Query: 1 MAHATAPTSTSTTSSSKDQ-----------NQSPLLGRYEIGKLLGHGTFAKVYHARNVK 49
M H +S + + L Y+ K LG G + +V R+
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 50 SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109
+ AIK+I K + + + + E+++L+ + HPNI++L++ K Y VME +
Sbjct: 61 THVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 110 GGELFNK-VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLK 165
GGELF++ + + + E A +Q++S V + H + HRDLKPENLLL +++ +K
Sbjct: 120 GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179
Query: 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGY 225
+ DFGLSAV GT Y+APEVL RK YD K D+WS GVILF+L+AGY
Sbjct: 180 IVDFGLSAV---FENQKKMKERLGTAYYIAPEVL-RKKYD-EKCDVWSIGVILFILLAGY 234
Query: 226 LPFQDQNIMVMYKKIYKGE--FRSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281
PF Q + +K+ KG+ F SP W S L+ ++L + +RI+ + +E+ W
Sbjct: 235 PPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 282 FRKGFKH 288
++
Sbjct: 295 IKEMCSK 301
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 2e-95
Identities = 90/280 (32%), Positives = 136/280 (48%), Gaps = 22/280 (7%)
Query: 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGL---VAHIKREI 77
Q + Y+IG+ LG G FA V R +G A K I K + S I+RE+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLIS 136
SILR+V H N++ L +V ++ + ++E V GGELF+ K L E+ A + +Q++
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 137 AVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
V + H + + H DLKPEN++L +K+ DFGL+ +I F GTP
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPE 183
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW 250
+VAPE+++ + D+WS GVI ++L++G PF I +F +
Sbjct: 184 FVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242
Query: 251 --FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
S D IR KLL KR+TI E + + W
Sbjct: 243 SHTSELAKDFIR---KLLVKETRKRLTIQEALRHPWITPV 279
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 9e-95
Identities = 92/280 (32%), Positives = 136/280 (48%), Gaps = 22/280 (7%)
Query: 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREI 77
Q + Y+IG+ LG G FA V R +G A K I K + S I+RE+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLIS 136
SILR+V HPNI+ L +V ++ + ++E V GGELF+ K L E+ A + +Q++
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 137 AVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
V + H + + H DLKPEN++L +K+ DFGL+ I F GTP
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPE 183
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW 250
+VAPE+++ + D+WS GVI ++L++G PF I +F +
Sbjct: 184 FVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242
Query: 251 --FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
S D IR KLL KR+TI E + + W
Sbjct: 243 SQTSELAKDFIR---KLLVKETRKRLTIQEALRHPWITPV 279
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 5e-93
Identities = 80/295 (27%), Positives = 134/295 (45%), Gaps = 23/295 (7%)
Query: 6 APTSTSTTSSSKDQNQSPLLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI 64
+ T + Q+ Y + K LG G FA V + +G+ A K + K +
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR- 66
Query: 65 LKSGLVAHIKREISILRRVRH-PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK---G 120
A I EI++L + P ++ L EV S+I ++EY GGE+F+
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 121 RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQ 177
+ E+ + +Q++ V + H + H DLKP+N+LL GD+K+ DFG+S +
Sbjct: 127 MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---K 183
Query: 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY 237
I GTP Y+APE+L+ A D+W+ G+I ++L+ PF ++ Y
Sbjct: 184 IGHACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETY 242
Query: 238 KKIYKG--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
I + ++ + S D I+ LL NP+KR T + + W ++
Sbjct: 243 LNISQVNVDYSEETFSSVSQLATDFIQ---SLLVKNPEKRPTAEICLSHSWLQQW 294
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-92
Identities = 90/310 (29%), Positives = 148/310 (47%), Gaps = 41/310 (13%)
Query: 1 MAHATAPTSTSTTS--SSKDQNQSPLLGRYEIGK-LLGHGTFAKVYHARNVKSGESVAIK 57
MAH S+ + + + Y++ K +LG G KV + ++G+ A+K
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 58 VIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEV----MATKSKIYFVMEYVRGGE 112
++ ++E+ + P+IV + +V K + +ME + GGE
Sbjct: 61 LLYDSPK--------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE 112
Query: 113 LFNK-VAKGRLK--EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKV 166
LF++ +G E A + + + +A+ F H+ + HRD+KPENLL +++ LK+
Sbjct: 113 LFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 167 SDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYL 226
+DFG + + Q T C TP YVAPEVL + YD D+WS GVI+++L+ G+
Sbjct: 173 TDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFP 227
Query: 227 PFQDQN----IMVMYKKIYKG--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPE 275
PF M ++I G F +P W S LIR LL T+P +R+TI +
Sbjct: 228 PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIR---LLLKTDPTERLTITQ 284
Query: 276 IMENRWFRKG 285
M + W +
Sbjct: 285 FMNHPWINQS 294
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-91
Identities = 92/305 (30%), Positives = 145/305 (47%), Gaps = 38/305 (12%)
Query: 4 ATAPTSTSTTSSSKDQNQSPLLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKE 62
S ++ ++ Y++ ++LG G KV N ++ E A+K++
Sbjct: 39 PPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC 98
Query: 63 KILKSGLVAHIKREISILRRV-RHPNIVQLFEV----MATKSKIYFVMEYVRGGELFNK- 116
+ RE+ + R + P+IV++ +V A + + VME + GGELF++
Sbjct: 99 PKAR--------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 150
Query: 117 VAKGRLK--EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGL 171
+G E A + + + A+ + H+ + HRD+KPENLL N LK++DFG
Sbjct: 151 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ 231
+ + T C TP YVAPEVL + YD D+WS GVI+++L+ GY PF
Sbjct: 211 ---AKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSN 266
Query: 232 NIMV----MYKKIYKG--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENR 280
+ + M +I G EF +P W S LIR LL T P +R+TI E M +
Sbjct: 267 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHP 323
Query: 281 WFRKG 285
W +
Sbjct: 324 WIMQS 328
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 5e-91
Identities = 67/274 (24%), Positives = 122/274 (44%), Gaps = 22/274 (8%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+Y I + LG G F V+ S ++ K + + + +K+EISIL RH
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKG-RLKEDLARKYFQQLISAVGFCHAR 144
NI+ L E + ++ + E++ G ++F + L E Y Q+ A+ F H+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 145 GVYHRDLKPENLLL--DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
+ H D++PEN++ + +K+ +FG + Q++ F P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQ---ARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW--FSP---DL 255
A D+WS G +++VL++G PF + + + I F + S D
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHI 289
+ +LL R+T E +++ W ++ + +
Sbjct: 238 VD---RLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 277 bits (712), Expect = 1e-90
Identities = 90/262 (34%), Positives = 158/262 (60%), Gaps = 12/262 (4%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
++I + LG G+F +V+ R+ +G A+KV+ KE +++ V H E +L V HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGV 146
I++++ +I+ +M+Y+ GGELF+ + K R +A+ Y ++ A+ + H++ +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
+RDLKPEN+LLD+NG +K++DFG + + +T CGTP Y+APEV+S K Y+
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 182
Query: 207 AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTN 266
+ +D WS G++++ ++AGY PF D N M Y+KI E R P +F+ D+ LL++L+ +
Sbjct: 183 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 267 PDKRI-----TIPEIMENRWFR 283
+R+ ++ + WF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-90
Identities = 83/308 (26%), Positives = 145/308 (47%), Gaps = 45/308 (14%)
Query: 16 SKDQNQSPLLGRYEIGK-LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK 74
S D Y++ + +LG G A+V N+ + + A+K+I+K+ + +
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVF 58
Query: 75 REISILRRVR-HPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQ 132
RE+ +L + + H N+++L E + + Y V E +RGG + + + E A Q
Sbjct: 59 REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ 118
Query: 133 QLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAV-----SDQIRQDGLF 184
+ SA+ F H +G+ HRDLKPEN+L ++ +K+ DF L +
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 185 HTFCGTPAYVAPEVL-----SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI------ 233
T CG+ Y+APEV+ YD + D+WS GVIL++L++GY PF +
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 234 ---------MVMYKKIYKG--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIM 277
++++ I +G EF W S DLI KLL + +R++ +++
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS---KLLVRDAKQRLSAAQVL 294
Query: 278 ENRWFRKG 285
++ W +
Sbjct: 295 QHPWVQGC 302
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 279 bits (714), Expect = 3e-90
Identities = 52/322 (16%), Positives = 105/322 (32%), Gaps = 57/322 (17%)
Query: 7 PTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK 66
T S+ + G +LG A + ++GES + V +
Sbjct: 57 NTGQPFRVESELGERP---RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113
Query: 67 SGLVAHIKREISILRRVR-------------------------HPNIVQLFEVMATKS-- 99
S + +K E+ LR +R ++++
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 100 KIYFVME------YVRGGELFNKVAKGRLKEDLARKY-FQQLISAVGFCHARGVYHRDLK 152
+F+ G L + + + AR Q+I + H G+ H L+
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 233
Query: 153 PENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLS----------RK 202
P +++LD+ G + ++ F +DG + + PE+ + R+
Sbjct: 234 PVDIVLDQRGGVFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262
D W+ G++++ + LP + + I FRS + + LL
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGF 343
Query: 263 LDTNPDKRITIPEIMENRWFRK 284
L + R+ + ME + +
Sbjct: 344 LRYPKEDRLLPLQAMETPEYEQ 365
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 6e-90
Identities = 99/262 (37%), Positives = 151/262 (57%), Gaps = 12/262 (4%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
++ K LG G+F +V ++ +SG A+K++DK+K++K + H E IL+ V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGV 146
+V+L S +Y VMEYV GGE+F+ + + GR E AR Y Q++ + H+ +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
+RDLKPENLL+D+ G ++V+DFG + R G T CGTP +APE++ KGY+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 207 AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTN 266
A VD W+ GV+++ + AGY PF + +Y+KI G+ R P FS DL LL LL +
Sbjct: 218 A-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 267 PDKRI-----TIPEIMENRWFR 283
KR + +I ++WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 3e-89
Identities = 85/338 (25%), Positives = 153/338 (45%), Gaps = 13/338 (3%)
Query: 9 STSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG 68
+S + + +Y + +G G+F K ++ + G IK I+ + + S
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSK 65
Query: 69 LVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK---GRLKED 125
+RE+++L ++HPNIVQ E +Y VM+Y GG+LF ++ +ED
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED 125
Query: 126 LARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185
+F Q+ A+ H R + HRD+K +N+ L ++G +++ DFG++ V + L
Sbjct: 126 QILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELAR 183
Query: 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF 245
GTP Y++PE+ K Y+ K DIW+ G +L+ L F+ ++ + KI G F
Sbjct: 184 ACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF 242
Query: 246 RS-PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDV 304
+S DL L+++L NP R ++ I+E + K I+ ++ + E+
Sbjct: 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA---KRIEKFLSPQLI--AEEF 297
Query: 305 DHTDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRPAS 342
S P + + +PA+
Sbjct: 298 CLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAA 335
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 8e-89
Identities = 73/306 (23%), Positives = 139/306 (45%), Gaps = 21/306 (6%)
Query: 7 PTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK 66
+ Q + Y+I + LG G F V+ +G K I+ L
Sbjct: 32 DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD 91
Query: 67 SGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKG-RLKE 124
+K EISI+ ++ HP ++ L + K ++ ++E++ GGELF++ A+ ++ E
Sbjct: 92 ---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE 148
Query: 125 DLARKYFQQLISAVGFCHARGVYHRDLKPENLLL--DENGDLKVSDFGLSAVSDQIRQDG 182
Y +Q + H + H D+KPEN++ + +K+ DFGL+ ++ D
Sbjct: 149 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDE 205
Query: 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK 242
+ T + APE++ R+ D+W+ GV+ +VL++G PF ++ + + + +
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264
Query: 243 G--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIED 295
EF + SP D I+ LL P KR+T+ + +E+ W + ++ I
Sbjct: 265 CDWEFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 321
Query: 296 DKMCNV 301
+ +
Sbjct: 322 SRYNKI 327
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 2e-88
Identities = 87/319 (27%), Positives = 137/319 (42%), Gaps = 37/319 (11%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLG--RYEIGKLLGHGTFAKVYHARNVKSGESVAIKV 58
MA + S S Q+ LG R + ++L G FA VY A++V SG A+K
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR 60
Query: 59 IDKEKILKSGLVAHIKREISILRRVR-HPNIVQLF-------EVMATKSKIYFVMEYVRG 110
+ + K I +E+ ++++ HPNIVQ E T + ++ +
Sbjct: 61 LLSNEEEK---NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117
Query: 111 GELF----NKVAKGRLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDL 164
G+L ++G L D K F Q AV H + + HRDLK ENLLL G +
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177
Query: 165 KVSDFGLSAV-------SDQIRQDGLFH---TFCGTPAYVAPEV--LSRKGYDAAKVDIW 212
K+ DFG + S ++ L T TP Y PE+ L K DIW
Sbjct: 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237
Query: 213 SCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW--FSPDLIRLLTKLLDTNPDKR 270
+ G IL++L PF+D + +I G++ P L+ +L NP++R
Sbjct: 238 ALGCILYLLCFRQHPFEDGAKL----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEER 293
Query: 271 ITIPEIMENRWFRKGFKHI 289
++I E++ +++
Sbjct: 294 LSIAEVVHQLQEIAAARNV 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 2e-87
Identities = 86/273 (31%), Positives = 142/273 (52%), Gaps = 17/273 (6%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
YE+ +G G++ + R G+ + K +D + + E+++LR ++
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELK 63
Query: 85 HPNIVQLFE--VMATKSKIYFVMEYVRGGELFNKVAKGR-----LKEDLARKYFQQLISA 137
HPNIV+ ++ + T + +Y VMEY GG+L + + KG L E+ + QL A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 138 VGFCHARG-----VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
+ CH R V HRDLKP N+ LD ++K+ DFGL+ + + TF GTP
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPY 181
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWF 251
Y++PE ++R Y+ K DIWS G +L+ L A PF + + KI +G+FR P +
Sbjct: 182 YMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
S +L ++T++L+ R ++ EI+EN +
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 2e-87
Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 23/284 (8%)
Query: 20 NQSPLLGRYEIGKL--LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
Q + Y + K LG G F +V+ +G +A K+I + +K EI
Sbjct: 81 KQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEI 137
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKG-RLKEDLARKYFQQLI 135
S++ ++ H N++QL++ +K+ I VMEYV GGELF++ + + L E + +Q+
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197
Query: 136 SAVGFCHARGVYHRDLKPENLLL--DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAY 193
+ H + H DLKPEN+L + +K+ DFGL+ + + GTP +
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNFGTPEF 254
Query: 194 VAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW- 250
+APEV++ D+WS GVI ++L++G PF N I + +
Sbjct: 255 LAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ 313
Query: 251 -FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIK 290
S + I KLL RI+ E +++ W H +
Sbjct: 314 DISEEAKEFIS---KLLIKEKSWRISASEALKHPWLSDHKLHSR 354
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 3e-86
Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 21/270 (7%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
Y+I + LG G F V+ +G + A K + +++EI + +RHP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHP 214
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHAR 144
+V L + +++ + E++ GGELF KVA ++ ED A +Y +Q+ + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 145 GVYHRDLKPENLLL--DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
H DLKPEN++ + +LK+ DFGL + + GT + APEV K
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGL---TAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW--FSP---DL 255
D+WS GV+ ++L++G PF +N + + + S D
Sbjct: 332 PVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
IR KLL +P+ R+TI + +E+ W G
Sbjct: 391 IR---KLLLADPNTRMTIHQALEHPWLTPG 417
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 1e-85
Identities = 68/305 (22%), Positives = 117/305 (38%), Gaps = 26/305 (8%)
Query: 4 ATAPTSTSTTSSSKDQNQSPLLG--RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDK 61
+S + Q ++ Y + LG G F+ V + G A+K I
Sbjct: 5 HHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC 64
Query: 62 EKILKSGLVAHIKREISILRRVRHPNIVQLFEV----MATKSKIYFVMEYVRGGELFN-- 115
+ + +RE + R HPNI++L K + + ++ + + G L+N
Sbjct: 65 HE--QQDR-EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121
Query: 116 ---KVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172
K L ED + + HA+G HRDLKP N+LL + G + D G
Sbjct: 122 ERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181
Query: 173 AV-------SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAA--KVDIWSCGVILFVLMA 223
S Q + T +Y APE+ S + + + D+WS G +L+ +M
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241
Query: 224 GYLPFQDQNI-MVMYKKIYKGEFRSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENR 280
G P+ + + P+ S L +LL ++ +P +R IP ++
Sbjct: 242 GEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
Query: 281 WFRKG 285
+
Sbjct: 302 EALQP 306
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 4e-85
Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 13/286 (4%)
Query: 3 HATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKE 62
A + + + +S ++ LGHG++ +V+ R+ + G A+K
Sbjct: 34 RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP 93
Query: 63 KILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-- 119
A E+ +V +HP V+L + +Y E G L
Sbjct: 94 FRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG 151
Query: 120 GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179
L E Y + + A+ H++G+ H D+KP N+ L G K+ DFGL ++
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELG 208
Query: 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGY-LPFQDQNIMVMYK 238
G G P Y+APE+L + Y D++S G+ + + LP + + +
Sbjct: 209 TAGAGEVQEGDPRYMAPELL-QGSYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266
Query: 239 KIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
EF S +L +L +L+ +P R T ++ R+
Sbjct: 267 GYLPPEF--TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 2e-84
Identities = 97/286 (33%), Positives = 145/286 (50%), Gaps = 9/286 (3%)
Query: 4 ATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEK 63
A P + + N + K++G G+F KV AR+ A+KV+ K+
Sbjct: 16 APPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA 75
Query: 64 ILKSGLVAHIKREISIL-RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GR 121
ILK HI E ++L + V+HP +V L T K+YFV++Y+ GGELF + +
Sbjct: 76 ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC 135
Query: 122 LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181
E AR Y ++ SA+G+ H+ + +RDLKPEN+LLD G + ++DFGL + I +
Sbjct: 136 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHN 193
Query: 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY 241
TFCGTP Y+APEVL ++ YD VD W G +L+ ++ G PF +N MY I
Sbjct: 194 STTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
Query: 242 KGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIP----EIMENRWFR 283
+ + LL LL + KR+ EI + +F
Sbjct: 253 NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 5e-84
Identities = 103/258 (39%), Positives = 149/258 (57%), Gaps = 9/258 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
KLLG GTF KV R +G A+K++ KE I+ VAH E +L+ RHP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRD 150
T ++ FVMEY GGELF +++ E+ AR Y +++SA+ + H+R V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVD 210
+K ENL+LD++G +K++DFGL + I TFCGTP Y+APEVL Y A VD
Sbjct: 131 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VD 187
Query: 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270
W GV+++ +M G LPF +Q+ +++ I E R PR SP+ LL LL +P +R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 271 I-----TIPEIMENRWFR 283
+ E+ME+R+F
Sbjct: 248 LGGGPSDAKEVMEHRFFL 265
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 5e-84
Identities = 100/284 (35%), Positives = 155/284 (54%), Gaps = 13/284 (4%)
Query: 11 STTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-K 66
S+ +S + +E+ ++LG G + KV+ R V +G+ A+KV+ K I+
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 67 SGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKED 125
+ AH K E +IL V+HP IV L T K+Y ++EY+ GGELF ++ + G ED
Sbjct: 62 AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 126 LARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185
A Y ++ A+G H +G+ +RDLKPEN++L+ G +K++DFGL S I + H
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTH 179
Query: 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF 245
TFCGT Y+APE+L R G++ A VD WS G +++ ++ G PF +N KI K +
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238
Query: 246 RSPRWFSPDLIRLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284
P + + + LL KLL N R+ E+ + +FR
Sbjct: 239 NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 9e-83
Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 34/277 (12%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
++ +L+G G F +V+ A++ G++ IK + +RE+ L ++ H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64
Query: 87 NIVQLFE----------------VMATKSKIYFVMEYVRGGELFNKVAK---GRLKEDLA 127
NIV + ++ ME+ G L + K +L + LA
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 128 RKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187
+ F+Q+ V + H++ + +RDLKP N+ L + +K+ DFGL ++ DG
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRS 181
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS 247
GT Y++PE +S + Y +VD+++ G+IL L+ + + + + G
Sbjct: 182 KGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGII-- 236
Query: 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
F LL KLL P+ R EI+ K
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 1e-82
Identities = 71/263 (26%), Positives = 140/263 (53%), Gaps = 12/263 (4%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
EI + +G G+F KV + + + A+K ++K+K ++ V ++ +E+ I++ + HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVY 147
V L+ + ++ V++ + GG+L + + KE+ + + +L+ A+ + + +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK---GY 204
HRD+KP+N+LLDE+G + ++DF ++A + ++ T GT Y+APE+ S + GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 205 DAAKVDIWSCGVILFVLMAGYLPF---QDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261
A VD WS GV + L+ G P+ + + P +S +++ LL K
Sbjct: 195 SFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 262 LLDTNPDKRI-TIPEIMENRWFR 283
LL+ NPD+R + ++ +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMN 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 3e-82
Identities = 79/296 (26%), Positives = 139/296 (46%), Gaps = 13/296 (4%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
M P + D + L + I K +G G F++VY A + G VA+K +
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTL-ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ 66
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV--- 117
++ + A +EI +L+++ HPN+++ + +++ V+E G+L +
Sbjct: 67 IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHF 126
Query: 118 --AKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175
K + E KYF QL SA+ H+R V HRD+KP N+ + G +K+ D GL
Sbjct: 127 KKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186
Query: 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF--QDQNI 233
+ H+ GTP Y++PE + GY+ K DIWS G +L+ + A PF N+
Sbjct: 187 SS--KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNL 243
Query: 234 MVMYKKIYKGEFRS--PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287
+ KKI + ++ +S +L +L+ ++ +P+KR + + +
Sbjct: 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 3e-82
Identities = 87/255 (34%), Positives = 140/255 (54%), Gaps = 6/255 (2%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
K+LG G+F KV+ A K+ + AIK + K+ +L V E +L HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHR 149
+F TK ++FVMEY+ GG+L + + A Y ++I + F H++G+ +R
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N+LLD++G +K++DFG+ + + D +TFCGTP Y+APE+L + Y+ + V
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-V 199
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D WS GV+L+ ++ G PF Q+ ++ I PRW + LL KL P+K
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 270 RI-TIPEIMENRWFR 283
R+ +I ++ FR
Sbjct: 260 RLGVRGDIRQHPLFR 274
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 4e-82
Identities = 93/262 (35%), Positives = 148/262 (56%), Gaps = 13/262 (4%)
Query: 32 KLLGHGTFAKVYHAR---NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
K+LG G+F KV+ + + + A+KV+ K + V K E IL V HP I
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVEVNHPFI 88
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVY 147
V+L T+ K+Y +++++RGG+LF +++K E+ + Y +L A+ H+ G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAA 207
+RDLKPEN+LLDE G +K++DFGLS S I + ++FCGT Y+APEV++R+G+ +
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 208 KVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNP 267
D WS GV++F ++ G LPFQ ++ I K + P++ SP+ LL L NP
Sbjct: 207 -ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
Query: 268 DKRI-----TIPEIMENRWFRK 284
R+ + EI + +F
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFST 287
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 7e-82
Identities = 83/284 (29%), Positives = 152/284 (53%), Gaps = 11/284 (3%)
Query: 8 TSTSTTSSSKDQNQSPL-LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK 66
T+ + + + N+ + L + +LG G+F KV + + E A+K++ K+ +++
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 67 SGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKE 124
V E +L + P + QL T ++YFVMEYV GG+L + + GR KE
Sbjct: 61 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE 120
Query: 125 DLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184
A Y ++ + F ++G+ +RDLK +N++LD G +K++DFG+ + I
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTT 178
Query: 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE 244
TFCGTP Y+APE+++ + Y + VD W+ GV+L+ ++AG PF+ ++ +++ I +
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237
Query: 245 FRSPRWFSPDLIRLLTKLLDTNPDKRI-----TIPEIMENRWFR 283
P+ S + + + L+ +P KR+ +I E+ +FR
Sbjct: 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 4e-81
Identities = 102/259 (39%), Positives = 150/259 (57%), Gaps = 10/259 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
KLLG GTF KV + +G A+K++ KE I+ VAH E +L+ RHP + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 92 FEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHR 149
T ++ FVMEY GGELF +++ ED AR Y +++SA+ + H+ + V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK ENL+LD++G +K++DFGL + I+ TFCGTP Y+APEVL Y A V
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-V 330
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W GV+++ +M G LPF +Q+ +++ I E R PR P+ LL+ LL +P +
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 390
Query: 270 RI-----TIPEIMENRWFR 283
R+ EIM++R+F
Sbjct: 391 RLGGGSEDAKEIMQHRFFA 409
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 3e-80
Identities = 100/287 (34%), Positives = 152/287 (52%), Gaps = 13/287 (4%)
Query: 7 PTSTSTTSSSKDQNQSPLLGR--YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI 64
P +S + N S LG +E ++LG G+F KV AR ++G+ A+KV+ K+ I
Sbjct: 2 PKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI 61
Query: 65 LKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRL 122
L+ V E IL HP + QLF T +++FVME+V GG+L + K R
Sbjct: 62 LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF 121
Query: 123 KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182
E AR Y ++ISA+ F H +G+ +RDLK +N+LLD G K++DFG+ + I
Sbjct: 122 DEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGV 179
Query: 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK 242
TFCGTP Y+APE+L Y A VD W+ GV+L+ ++ G+ PF+ +N +++ I
Sbjct: 180 TTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
Query: 243 GEFRSPRWFSPDLIRLLTKLLDTNPDKRI------TIPEIMENRWFR 283
E P W D +L + NP R+ I+ + +F+
Sbjct: 239 DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 6e-80
Identities = 69/307 (22%), Positives = 123/307 (40%), Gaps = 50/307 (16%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RH 85
K+LG+G+ V + G VA+K + + EI +L H
Sbjct: 16 LVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDH 68
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--------GRLKEDLARKYFQQLISA 137
PN+++ + T +Y +E L + V KE +Q+ S
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 138 VGFCHARGVYHRDLKPENLLLD-------------ENGDLKVSDFGLSA--VSDQIRQDG 182
V H+ + HRDLKP+N+L+ EN + +SDFGL S Q
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 183 LFHTFCGTPAYVAPEVLS-------RKGYDAAKVDIWSCGVILFVLM-AGYLPFQDQNIM 234
+ GT + APE+L ++ + +DI+S G + + ++ G PF D+
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 235 VMYKKIYKGEF-----RSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287
I +G F + + L+++++D +P KR T +++ + F K
Sbjct: 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304
Query: 288 HIKFYIE 294
++F ++
Sbjct: 305 KLEFLLK 311
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 6e-80
Identities = 85/269 (31%), Positives = 142/269 (52%), Gaps = 18/269 (6%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
YE+ K++G G F +V R+ + + A+K++ K +++K A E I+ P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY 147
+VQLF +Y VMEY+ GG+L N ++ + E AR Y +++ A+ H+ G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF--HTFCGTPAYVAPEVLSRKG-- 203
HRD+KP+N+LLD++G LK++DFG ++ ++G+ T GTP Y++PEVL +G
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 204 --YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--YKGEFRSPR--WFSPDLIR 257
Y D WS GV L+ ++ G PF +++ Y KI +K P S +
Sbjct: 248 GYYGRE-CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
Query: 258 LLTKLLDTNPDKRIT---IPEIMENRWFR 283
L+ L T+ + R+ + EI + +F+
Sbjct: 307 LICAFL-TDREVRLGRNGVEEIKRHLFFK 334
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 2e-79
Identities = 44/288 (15%), Positives = 105/288 (36%), Gaps = 35/288 (12%)
Query: 27 RYEIGKLLGHGTFAKVYHAR-----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILR 81
+ LLG G FA+VY A + K+ + +KV + + + L+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMERLK 122
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK------GRLKEDLARKYFQQLI 135
++ + ++ V E G L N + + + L + +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 136 SAVGFCHARGVYHRDLKPENLLL-----------DENGDLKVSDFGLSAVSDQIRQDGLF 184
+ H + H D+KP+N +L D + L + D G S + +F
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIMVMYKKIYKG 243
C T + E+LS K ++ ++D + ++ ++ G Y+ +++ + +++
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 244 EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME---NRWFRKGFKH 288
W +L+ + +++ + F++ + +
Sbjct: 302 LPHLDMWN-----EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 6e-79
Identities = 67/306 (21%), Positives = 116/306 (37%), Gaps = 28/306 (9%)
Query: 8 TSTSTTSSSKDQNQSPLLG---RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI 64
+S S D+ S ++ + +LGHG + R + VA+K I E
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECF 61
Query: 65 LKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GR 121
+ RE+ +LR HPN+++ F + Y +E L V +
Sbjct: 62 ------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114
Query: 122 LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD-----LKVSDFGLSAVSD 176
QQ S + H+ + HRDLKP N+L+ +SDFGL
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 177 QIRQ-DGLFHTFCGTPAYVAPEVLSR---KGYDAAKVDIWSCGVILFVLMA-GYLPFQDQ 231
R GT ++APE+LS + VDI+S G + + +++ G PF
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKS 233
Query: 232 NIMVMYKKIYKGEFRSPRWF---SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKH 288
+ L+ K++ +P KR + ++++ +F K
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293
Query: 289 IKFYIE 294
++F+ +
Sbjct: 294 LQFFQD 299
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 1e-78
Identities = 83/294 (28%), Positives = 134/294 (45%), Gaps = 59/294 (20%)
Query: 15 SSKDQNQSPLLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHI 73
S ++ ++ Y++ ++LG G KV N ++ E A+K++ +
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------- 58
Query: 74 KREISILRRV-RHPNIVQLFEV----MATKSKIYFVMEYVRGGELFNK-VAKGRLK--ED 125
RE+ + R + P+IV++ +V A + + VME + GGELF++ +G E
Sbjct: 59 -REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 126 LARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDG 182
A + + + A+ + H+ + HRD+KPENLL N LK++DFG
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------- 166
Query: 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV----MYK 238
A E + YD D+WS GVI+++L+ GY PF + + M
Sbjct: 167 ------------AKETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
Query: 239 KIYKG--EFRSPRW--FSP---DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
+I G EF +P W S LIR LL T P +R+TI E M + W +
Sbjct: 213 RIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 1e-78
Identities = 84/269 (31%), Positives = 145/269 (53%), Gaps = 20/269 (7%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
+++G G++AKV R K+ A+KV+ KE + + ++ E + + HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L T+S+++FV+EYV GG+L + + +L E+ AR Y ++ A+ + H RG+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N+LLD G +K++D+G+ + +R TFCGTP Y+APE+L + Y + V
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 191
Query: 210 DIWSCGVILFVLMAGYLPF---------QDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260
D W+ GV++F +MAG PF +++ I + + R PR S +L
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 261 KLLDTNPDKRI------TIPEIMENRWFR 283
L+ +P +R+ +I + +FR
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-77
Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 20/269 (7%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
+++G G++AKV R K+ A++V+ KE + + ++ E + + HP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L T+S+++FV+EYV GG+L + + +L E+ AR Y ++ A+ + H RG+ +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N+LLD G +K++D+G+ + +R TFCGTP Y+APE+L + Y + V
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 234
Query: 210 DIWSCGVILFVLMAGYLPF---------QDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260
D W+ GV++F +MAG PF +++ I + + R PR S +L
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294
Query: 261 KLLDTNPDKRI------TIPEIMENRWFR 283
L+ +P +R+ +I + +FR
Sbjct: 295 SFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 3e-77
Identities = 89/275 (32%), Positives = 152/275 (55%), Gaps = 23/275 (8%)
Query: 29 EIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRVR 84
E+ K+LG G + KV+ R + +G+ A+KV+ K I+ K+ H + E +L +R
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 85 H-PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCH 142
P +V L T++K++ +++Y+ GGELF +++ R E + Y +++ A+ H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLS--AVSDQIRQDGLFHTFCGTPAYVAPEVL- 199
G+ +RD+K EN+LLD NG + ++DFGLS V+D + + FCGT Y+AP+++
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD---ETERAYDFCGTIEYMAPDIVR 233
Query: 200 -SRKGYDAAKVDIWSCGVILFVLMAGYLPF----QDQNIMVMYKKIYKGEFRSPRWFSPD 254
G+D A VD WS GV+++ L+ G PF + + + ++I K E P+ S
Sbjct: 234 GGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 292
Query: 255 LIRLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284
L+ +LL +P KR+ EI E+ +F+K
Sbjct: 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 244 bits (623), Expect = 7e-77
Identities = 44/330 (13%), Positives = 92/330 (27%), Gaps = 52/330 (15%)
Query: 2 AHATAPTSTSTTSSSKDQNQSPLLGR----YEIGKLLGHGTFAKVYHARNVKSGESVAIK 57
A + + + + LL + ++ + L G + V+ R+V+ E A+K
Sbjct: 34 AAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALK 93
Query: 58 VIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVM---------------------- 95
V + + R+ + + +
Sbjct: 94 VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSP 153
Query: 96 ----ATKSKIYFVMEYVRG-----GELFNKV--AKGRLKEDLARKYFQQLISAVGFCHAR 144
+ +M + V +G QLI ++
Sbjct: 154 GQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK 213
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
G+ H P+NL + +G L + D + Y E L+
Sbjct: 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTA 268
Query: 205 DA-AKVDIWSCGVILFVLMAGYLPFQDQN---------IMVMYKKIYKGEFRSPRWFSPD 254
++ W G+ ++ + +LPF + F S
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF 328
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
+ L+ + L+ + +R+ E ME F +
Sbjct: 329 VKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 1e-76
Identities = 75/290 (25%), Positives = 114/290 (39%), Gaps = 34/290 (11%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
L +E + LG G F V+ A+N + AIK I + + RE+ L ++
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLE 61
Query: 85 HPNIVQLFEV------------MATKSKIYFVMEYVRGGELFNKVAKGRLK----EDLAR 128
HP IV+ F + K +Y M+ R L + + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 129 KYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV----------SDQI 178
F Q+ AV F H++G+ HRDLKP N+ + +KV DFGL +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM-Y 237
GT Y++PE + Y KVDI+S G+ILF L+ PF Q V
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237
Query: 238 KKIYKGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286
+ +F P ++ +L +P +R I+EN F
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 2e-76
Identities = 80/259 (30%), Positives = 142/259 (54%), Gaps = 10/259 (3%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQ 90
+LG G+F KV + + E A+K++ K+ +++ V E +L + P + Q
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 91 LFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHR 149
L T ++YFVMEYV GG+L + + GR KE A Y ++ + F ++G+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKV 209
DLK +N++LD G +K++DFG+ + I TFCGTP Y+APE+++ + Y + V
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-V 523
Query: 210 DIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269
D W+ GV+L+ ++AG PF+ ++ +++ I + P+ S + + + L+ +P K
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 583
Query: 270 RI-----TIPEIMENRWFR 283
R+ +I E+ +FR
Sbjct: 584 RLGCGPEGERDIKEHAFFR 602
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-76
Identities = 78/274 (28%), Positives = 132/274 (48%), Gaps = 22/274 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+EI K++G G F++V + ++G+ A+K+++K +LK G V+ + E +L
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARG 145
I QL ++ +Y VMEY GG+L ++K R+ ++AR Y +++ A+ H G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF--HTFCGTPAYVAPEVLSRKG 203
HRD+KP+N+LLD G ++++DFG ++R DG GTP Y++PE+L G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 204 YDAAK------VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--YKGEFRSP---RWFS 252
D W+ GV + + G PF + Y KI YK P
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299
Query: 253 PDLIRLLTKLLDTNPDKRIT---IPEIMENRWFR 283
+ + +LL P+ R+ + + +F
Sbjct: 300 EEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFF 332
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 3e-76
Identities = 76/273 (27%), Positives = 139/273 (50%), Gaps = 22/273 (8%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+EI K++G G F +V + + + A+K+++K ++LK A + E +L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARG 145
I L + +Y VM+Y GG+L ++K RL E++AR Y +++ A+ H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF--HTFCGTPAYVAPEVL---- 199
HRD+KP+N+L+D NG ++++DFG ++ +DG GTP Y++PE+L
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 200 -SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--YKGEFRSPRW---FSP 253
+ Y D WS GV ++ ++ G PF ++++ Y KI +K F+ P S
Sbjct: 253 GGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 254 DLIRLLTKLLDTNPDKRIT---IPEIMENRWFR 283
+ L+ +L+ + + R+ I + ++ +F
Sbjct: 312 NAKDLIRRLI-CSREHRLGQNGIEDFKKHPFFS 343
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 4e-76
Identities = 74/266 (27%), Positives = 131/266 (49%), Gaps = 17/266 (6%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
++LG G F +V+ + +G+ A K ++K+++ K E IL +V IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 92 FEVMATKSKIYFVMEYVRGGELF-----NKVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
TK+ + VM + GG++ +E A Y Q++S + H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
+RDLKPEN+LLD++G++++SD GL+ + + GTP ++APE+L + YD
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 207 AKVDIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPDLIRLLTKL 262
+ VD ++ GV L+ ++A PF+ + V + +++ + P FSP L
Sbjct: 369 S-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 263 LDTNPDKRI-----TIPEIMENRWFR 283
L +P+KR+ + + + FR
Sbjct: 428 LQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 2e-74
Identities = 71/264 (26%), Positives = 127/264 (48%), Gaps = 16/264 (6%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91
++LG G F +V + +G+ A K ++K++I K A E IL +V +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 92 FEVMATKSKIYFVMEYVRGGELF---NKVAKGRLKEDLARKYFQQLISAVGFCHARGVYH 148
TK + V+ + GG+L + + E A Y ++ + H + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAK 208
RDLKPEN+LLD++G +++SD GL+ + + GT Y+APEV+ + Y +
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 365
Query: 209 VDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY----KGEFRSPRWFSPDLIRLLTKLLD 264
D W+ G +L+ ++AG PFQ + + +++ + FSP L ++LL
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 265 TNPDKRI-----TIPEIMENRWFR 283
+P +R+ + E+ E+ F+
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFK 449
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 238 bits (607), Expect = 8e-74
Identities = 54/304 (17%), Positives = 101/304 (33%), Gaps = 46/304 (15%)
Query: 22 SPLLGRY---EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS 78
S L R G +LG A + ++GES + V + S + +K E+
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 79 ILRR----------------------VRHPNIVQLFEVMATKSKIYFVMEYV-------- 108
LR V+ P ++ V + ++ + +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 109 ---RGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDL 164
G L + + L + Q+I + H G+ H L+P +++LD+ G +
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 250
Query: 165 KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAK----VDIWSCGVILFV 220
++ F V D P A +L + D W+ G+ ++
Sbjct: 251 FLTGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 221 LMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENR 280
+ LP D + + I FRS + + LL L + R+ + ME
Sbjct: 310 IWCADLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 365
Query: 281 WFRK 284
+ +
Sbjct: 366 EYEQ 369
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 6e-71
Identities = 81/266 (30%), Positives = 133/266 (50%), Gaps = 18/266 (6%)
Query: 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNI 88
+++G G F +VY R +G+ A+K +DK++I E +L V P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVY 147
V + T K+ F+++ + GG+L +++ G E R Y ++I + H R V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK-GYDA 206
+RDLKP N+LLDE+G +++SD GL+ H GT Y+APEVL + YD+
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 207 AKVDIWSCGVILFVLMAGYLPFQD---QNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
+ D +S G +LF L+ G+ PF+ ++ + + P FSP+L LL LL
Sbjct: 371 S-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 264 DTNPDKRI-----TIPEIMENRWFRK 284
+ ++R+ E+ E+ +FR
Sbjct: 430 QRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 5e-63
Identities = 52/291 (17%), Positives = 101/291 (34%), Gaps = 38/291 (13%)
Query: 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL 80
+S + + +G G F V+ G AIK K S + RE+
Sbjct: 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL-AGSVDEQNALREVYAH 64
Query: 81 RRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELF-----NKVAKGRLKEDLARKYFQQL 134
+ +H ++V+ F A + EY GG L N KE + Q+
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 135 ISAVGFCHARGVYHRDLKPENLLLDENGDL-------------------KVSDFGLSAVS 175
+ + H+ + H D+KP N+ + K+ D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-- 182
Query: 176 DQIRQDGLFHTFCGTPAYVAPEVLS-RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM 234
+ G ++A EVL + K DI++ + + ++ +
Sbjct: 183 ----RISSPQVEEGDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAEPLPRNGD-- 235
Query: 235 VMYKKIYKGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
+ +I +G R P+ S + LL ++ +P++R + ++++
Sbjct: 236 -QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-61
Identities = 63/286 (22%), Positives = 108/286 (37%), Gaps = 19/286 (6%)
Query: 5 TAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI 64
+ D + +G G+F +V+ ++ ++G A+K + E
Sbjct: 37 NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF 96
Query: 65 LKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLK 123
E+ + P IV L+ + + ME + GG L + + G L
Sbjct: 97 RV--------EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP 148
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQDG 182
ED A Y Q + + + H R + H D+K +N+LL +G + DFG +
Sbjct: 149 EDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208
Query: 183 LF---HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYK 238
GT ++APEV+ K D AKVDIWS ++ ++ G P+ +
Sbjct: 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL- 266
Query: 239 KIYKGE---FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281
KI P +P + + + L P R + E+
Sbjct: 267 KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 9e-61
Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 18/292 (6%)
Query: 8 TSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS 67
++ S +LG GT+ VY R++ + +AIK I + S
Sbjct: 4 STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DS 60
Query: 68 GLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLK-- 123
+ EI++ + ++H NIVQ + I ME V GG L + G LK
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD-ENGDLKVSDFGLSAVSDQIRQDG 182
E Y +Q++ + + H + HRD+K +N+L++ +G LK+SDFG S I
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180
Query: 183 LFHTFCGTPAYVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQD--QNIMVMYK 238
TF GT Y+APE++ +GY DIWS G + + G PF + + M+
Sbjct: 181 --ETFTGTLQYMAPEIIDKGPRGYG-KAADIWSLGCTIIEMATGKPPFYELGEPQAAMF- 236
Query: 239 KIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKH 288
K+ + P S + + K + +PDKR +++ + + + K
Sbjct: 237 KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 3e-60
Identities = 71/328 (21%), Positives = 116/328 (35%), Gaps = 75/328 (22%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVID-------KEKILK-------------- 66
+E + +G G F V+ A+N + AIK I +EK+++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 67 ----------------------------------SGLVAHIKREISILRRVRHPNIVQLF 92
+ +I + N V
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 93 EVMATKSKIYFVMEYVRGGELFNKVAKGR----LKEDLARKYFQQLISAVGFCHARGVYH 148
+ + K +Y M+ R L + + + + + F Q+ AV F H++G+ H
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQ----------IRQDGLFHTFCGTPAYVAPEV 198
RDLKP N+ + +KV DFGL DQ + GT Y++PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV-MYKKIYKGEF-RSPRWFSPDLI 256
+ Y KVDI+S G+ILF L F Q V + + +F P
Sbjct: 248 IHGNNYS-HKVDIFSLGLILFEL---LYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH 303
Query: 257 RLLTKLLDTNPDKRITIPEIMENRWFRK 284
++ +L +P +R +I+EN F
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 8e-59
Identities = 86/298 (28%), Positives = 138/298 (46%), Gaps = 53/298 (17%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRR 82
+YE L+G G++ V RN +G VAIK D + + K + REI +L++
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-----REIKLLKQ 80
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRG---GELFNKVAKGRLKEDLARKYFQQLISAVG 139
+RH N+V L EV K + Y V E+V +L ++ L + +KY Q+I+ +G
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDYQVVQKYLFQIINGIG 138
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPAYVAPEV 198
FCH+ + HRD+KPEN+L+ ++G +K+ DFG + ++ + T Y APE+
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV---YDDEVATRWYRAPEL 195
Query: 199 LSR-KGYDAAKVDIWSCGVILFVLMAGYLPFQ-----DQ--NIM-------------VMY 237
L Y A VD+W+ G ++ + G F DQ +IM
Sbjct: 196 LVGDVKYGKA-VDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 238 KKIYKGEFRSPRW------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283
++ G R P S +I L K L +PDKR E++ + +F+
Sbjct: 255 NPVFAG-VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-58
Identities = 84/303 (27%), Positives = 147/303 (48%), Gaps = 64/303 (21%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRR 82
+YE + +G GT+ V+ A+N ++ E VA+K + D E + S L REI +L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 57
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGEL----FNKVAKGRLKEDLARKYFQQLISAV 138
++H NIV+L +V+ + K+ V E+ + + G L ++ + + QL+ +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPA----- 192
GFCH+R V HRDLKP+NLL++ NG+LK+++FGL+ A +R + +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR------CY--SAEVVTLW 166
Query: 193 YVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLP-FQDQNIMVMYKKIYK--G---- 243
Y P+VL ++ Y + +D+WS G I L P F ++ K+I++ G
Sbjct: 167 YRPPDVLFGAKL-YSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 244 ----------EFRS-PRW------------FSPDLIRLLTKLLDTNPDKRITIPEIMENR 280
+++ P + + LL LL NP +RI+ E +++
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 281 WFR 283
+F
Sbjct: 285 YFS 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-58
Identities = 85/308 (27%), Positives = 139/308 (45%), Gaps = 66/308 (21%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI---DKEKILKSGLVAHIKREISILRRV 83
+++ + LG+GT+A VY N +G VA+K + +E + + REIS+++ +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-----REISLMKEL 60
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRG------GELFNKVAKGRLKEDLARKYFQQLISA 137
+H NIV+L++V+ T++K+ V E++ L+ +L + + QL+
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPA---- 192
+ FCH + HRDLKP+NLL+++ G LK+ DFGL+ A + TF +
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN------TF--SSEVVTL 172
Query: 193 -YVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--------- 240
Y AP+VL SR Y + +DIWSCG IL ++ G F N K I
Sbjct: 173 WYRAPDVLMGSRT-YSTS-IDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 241 -----------YKGEF--------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPE 275
Y + +L+ L LL NPD R++ +
Sbjct: 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290
Query: 276 IMENRWFR 283
+ + WF
Sbjct: 291 ALHHPWFA 298
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 191 bits (489), Expect = 7e-58
Identities = 90/304 (29%), Positives = 146/304 (48%), Gaps = 68/304 (22%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRR 82
+Y + +G GT+ VY A+N GE+ A+K I + E I + + REISIL+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-----REISILKE 56
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYV----RGGELFNKVAKGRLKEDLARKYFQQLISAV 138
++H NIV+L++V+ TK ++ V E++ + V +G L+ A+ + QL++ +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPA----- 192
+CH R V HRDLKP+NLL++ G+LK++DFGL+ A +R T
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHEIVTLW 165
Query: 193 YVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI---------- 240
Y AP+VL S+K Y +DIWS G I ++ G F + +I
Sbjct: 166 YRAPDVLMGSKK-YSTT-IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 241 ----------YKGEFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
Y F + I LL+K+L +P++RIT + +E+
Sbjct: 224 NWPNVTELPKYDPNF--TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
Query: 280 RWFR 283
+F+
Sbjct: 282 AYFK 285
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 9e-58
Identities = 76/305 (24%), Positives = 129/305 (42%), Gaps = 67/305 (21%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRR 82
+YE +G G++ V+ RN +G+ VAIK D I K L REI +L++
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-----REIRMLKQ 58
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRG---GELFNKVAKGRLKEDLARKYFQQLISAVG 139
++HPN+V L EV K +++ V EY EL + + E L + Q + AV
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPAYV---- 194
FCH HRD+KPEN+L+ ++ +K+ DFG + ++ + V
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD------YY--DD-EVATRW 167
Query: 195 --APEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQ-----DQ-----NIM------ 234
+PE+L + Y VD+W+ G + L++G + DQ +
Sbjct: 168 YRSPELLVGDTQ-YGPP-VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225
Query: 235 ----VMYKKIYKGEFRSPRW------------FSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ + G + P S + LL L +P +R+T +++
Sbjct: 226 HQQVFSTNQYFSG-VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284
Query: 279 NRWFR 283
+ +F
Sbjct: 285 HPYFE 289
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-57
Identities = 88/299 (29%), Positives = 126/299 (42%), Gaps = 55/299 (18%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVR 84
RYE LG G FA VY AR+ + + VAIK I K G+ REI +L+ +
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGEL----FNKVAKGRLKEDLARKYFQQLISAVGF 140
HPNI+ L + KS I V +++ E K L + Y + + +
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPA-----YV 194
H + HRDLKP NLLLDENG LK++DFGL+ + R + T Y
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR------AY--THQVVTRWYR 179
Query: 195 APEVL--SRKGYDAAKVDIWSCGVILFVLMAG--YLP-----------FQ-----DQNIM 234
APE+L +R Y VD+W+ G IL L+ +LP F+ +
Sbjct: 180 APELLFGARM-YGVG-VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237
Query: 235 ---------VMYKKIYKGEFRSP-RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283
V +K DL+ L+ L NP RIT + ++ ++F
Sbjct: 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 4e-57
Identities = 86/303 (28%), Positives = 140/303 (46%), Gaps = 65/303 (21%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRR 82
+Y+ + +G GT+ VY A++ G VA+K I + E I + + REIS+L+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI-----REISLLKE 75
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGEL----FNKVAKGRLKEDLARKYFQQLISAV 138
+ HPNIV L +V+ ++ + V E++ E K L++ + Y QL+ V
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFM---EKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPA----- 192
CH + HRDLKP+NLL++ +G LK++DFGL+ A +R ++ T
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR------SY--THEVVTLW 184
Query: 193 YVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------- 242
Y AP+VL S+K Y + VDIWS G I ++ G F KI+
Sbjct: 185 YRAPDVLMGSKK-YSTS-VDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 243 -----------GEFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENR 280
+ + F + I LL+ +L +P+KRI+ + M +
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
Query: 281 WFR 283
+F+
Sbjct: 303 YFK 305
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-57
Identities = 80/296 (27%), Positives = 134/296 (45%), Gaps = 29/296 (9%)
Query: 3 HATAPTSTSTTSSSKDQNQSPLL--GRYEI-------GKLLGHGTFAKVYHARNVKSGES 53
H P S ++++ + +I + +G G+F V+ A G
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSD 62
Query: 54 VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113
VA+K++ ++ V RE++I++R+RHPNIV + + V EY+ G L
Sbjct: 63 VAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 114 FNKVAKGRLKEDLARKYFQQLISAVGFC------HARG--VYHRDLKPENLLLDENGDLK 165
+ + K +E L + ++L A H R + HR+LK NLL+D+ +K
Sbjct: 122 YRLLHKSGAREQLDER--RRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGY 225
V DFGLS + + GTP ++APEVL + + K D++S GVIL+ L
Sbjct: 180 VCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQ 236
Query: 226 LPFQDQNIM-VMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
P+ + N V+ +K + R PR +P + ++ P KR + IM+
Sbjct: 237 QPWGNLNPAQVVAAVGFKCK-RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-57
Identities = 65/271 (23%), Positives = 131/271 (48%), Gaps = 19/271 (7%)
Query: 26 GRYE-IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
GR+ +G G+F VY + ++ VA + K+ KS K E +L+ ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQ 83
Query: 85 HPNIVQLF----EVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVG 139
HPNIV+ + + K I V E + G L + + +K + R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 140 FCHARG--VYHRDLKPENLLLD-ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP 196
F H R + HRDLK +N+ + G +K+ D GL+ +++ GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAP 199
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRS--PRWFSP 253
E+ YD VD+++ G+ + + P+ + QN +Y+++ G + + P
Sbjct: 200 EMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
++ ++ + N D+R +I +++ + +F++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-57
Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 20/265 (7%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
EIG+L+G G F +VYH R GE VAI++ID E+ + L A KRE+ R+ RH N+
Sbjct: 36 EIGELIGKGRFGQVYHGRW--HGE-VAIRLIDIERDNEDQLKA-FKREVMAYRQTRHENV 91
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
V + + + +G L++ + AK L + R+ Q+++ +G+ HA+G+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLS---AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
H+DLK +N+ D NG + ++DFGL V R++ G ++APE++ +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 204 YDAA--------KVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSP 253
D D+++ G I + L A PF+ Q + ++ G S
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 254 DLIRLLTKLLDTNPDKRITIPEIME 278
++ +L ++R T ++M+
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMD 295
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-56
Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 17/261 (6%)
Query: 29 EIGKLLGHGTFAKVYHAR-NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
+G+ +G G+F VY + + G+ VA+K+++ L A K E+ +LR+ RH N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWH---GD-VAVKMLNVTAPTPQQLQAF-KNEVGVLRKTRHVN 81
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARG 145
I+ T ++ V ++ G L++ ++ + + +Q + + HA+
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+ HRDLK N+ L E+ +K+ DFGL+ + F G+ ++APEV+ + +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 206 AA--KVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFR-----SPRWFSPDLIR 257
+ D+++ G++L+ LM G LP+ + N + + + +G + R
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260
Query: 258 LLTKLLDTNPDKRITIPEIME 278
L+ + L D+R + P I+
Sbjct: 261 LMAECLKKKRDERPSFPRILA 281
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-56
Identities = 89/340 (26%), Positives = 144/340 (42%), Gaps = 74/340 (21%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPL--------LGRYEIGKLLGHGTFAKVYHARNVKSGE 52
MAH + + ++ + + RY LG GT+ +VY A + + E
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 53 SVAIKVI----DKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108
+VAIK I ++E + + + RE+S+L+ ++H NI++L V+ +++ + EY
Sbjct: 61 TVAIKRIRLEHEEEGVPGTAI-----REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115
Query: 109 RG--GELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD-----EN 161
+ +K + + + + QLI+ V FCH+R HRDLKP+NLLL E
Sbjct: 116 ENDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASET 173
Query: 162 GDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPA-----YVAPEVL--SRKGYDAAKVDIWS 213
LK+ DFGL+ A IR F T Y PE+L SR Y + VDIWS
Sbjct: 174 PVLKIGDFGLARAFGIPIR------QF--THEIITLWYRPPEILLGSRH-YSTS-VDIWS 223
Query: 214 CGVILFVLMAGYLPFQDQNIMVMYKKI--------------------YKGEF-------- 245
I ++ F + + KI +K F
Sbjct: 224 IACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTL 283
Query: 246 --RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283
+ + LLT +L+ +P KRI+ +E+ +F
Sbjct: 284 KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 6e-56
Identities = 75/302 (24%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI---DKEKILKSGLVAHIKREISILRRV 83
Y LG GT+A VY ++ + VA+K I +E + + RE+S+L+ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-----REVSLLKDL 57
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGEL----FNKVAKGRLKEDLARKYFQQLISAVG 139
+H NIV L +++ T+ + V EY+ + + + + + QL+ +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPA-----Y 193
+CH + V HRDLKP+NLL++E G+LK++DFGL+ A S + T+ Y
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK------TY--DNEVVTLWY 166
Query: 194 VAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------- 242
P++L S Y +D+W G I + + G F + I++
Sbjct: 167 RPPDILLGSTD-YSTQ-IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224
Query: 243 ----------GEFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281
+ P++ D LLTKLL RI+ + M++ +
Sbjct: 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 282 FR 283
F
Sbjct: 285 FL 286
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 4e-55
Identities = 75/263 (28%), Positives = 145/263 (55%), Gaps = 11/263 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+ +G G+ V AR SG VA+K++D K + L + E+ I+R +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHF 102
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
N+V++++ +++ +ME+++GG L + V++ RL E+ + ++ A+ + HA+GV
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
HRD+K +++LL +G +K+SDFG A +S + + + GTP ++APEV+SR Y
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISRSLYA 219
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKG--EFRSPRWFSPDLIRLLTKL 262
+VDIWS G+++ ++ G P+ + + M + + ++ SP L L ++
Sbjct: 220 -TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 263 LDTNPDKRITIPEIMENRWFRKG 285
L +P +R T E++++ + +
Sbjct: 279 LVRDPQERATAQELLDHPFLLQT 301
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 8e-55
Identities = 78/263 (29%), Positives = 144/263 (54%), Gaps = 11/263 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+Y + +G G VY A +V +G+ VAI+ ++ ++ K L I EI ++R ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
NIV + +++ VMEY+ GG L + V + + E ++ + A+ F H+ V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
HRD+K +N+LL +G +K++DFG A ++ + + T GTP ++APEV++RK Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYG 194
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKG--EFRSPRWFSPDLIRLLTKL 262
KVDIWS G++ ++ G P+ ++N + +Y G E ++P S L +
Sbjct: 195 -PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 263 LDTNPDKRITIPEIMENRWFRKG 285
L+ + +KR + E++++++ +
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKIA 276
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-54
Identities = 71/264 (26%), Positives = 114/264 (43%), Gaps = 32/264 (12%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
E+ +++G G F V A+ + VAIK I+ E K+ E+ L RV HPNI
Sbjct: 11 EVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKA-----FIVELRQLSRVNHPNI 63
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA----- 143
V+L A + + VMEY GG L+N + + +
Sbjct: 64 VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAA--HAMSWCLQCSQGVAYLH 119
Query: 144 ----RGVYHRDLKPENLLLDENGD-LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 198
+ + HRDLKP NLLL G LK+ DFG + G+ A++APEV
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEV 174
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD--QNIMVMYKKIYKGEFR--SPRWFSPD 254
Y K D++S G+IL+ ++ PF + + ++ G R +
Sbjct: 175 FEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPLIKNLPKP 232
Query: 255 LIRLLTKLLDTNPDKRITIPEIME 278
+ L+T+ +P +R ++ EI++
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVK 256
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 84/302 (27%), Positives = 124/302 (41%), Gaps = 53/302 (17%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVR 84
RYE +G G + VY AR+ SG VA+K + GL RE+++LRR+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 85 ---HPNIVQLFEVMATKS-----KIYFVMEYVRG--GELFNKVAKGRLKEDLARKYFQQL 134
HPN+V+L +V AT K+ V E+V +K L + + +Q
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 135 ISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA-- 192
+ + F HA + HRDLKPEN+L+ G +K++DFGL+ R TP
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------RIYSYQMAL--TPVVV 181
Query: 193 ---YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--G---- 243
Y APEVL + Y VD+WS G I + F + KI+ G
Sbjct: 182 TLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 244 ----------EFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
P +LL ++L NP KRI+ +++ +
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300
Query: 283 RK 284
K
Sbjct: 301 HK 302
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-54
Identities = 78/299 (26%), Positives = 151/299 (50%), Gaps = 18/299 (6%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
MAH+ + + K + + + +G G+F +V+ + ++ + VAIK+ID
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEE----LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID 56
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG 120
E+ + I++EI++L + P + + + +K++ +MEY+ GG + + G
Sbjct: 57 LEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG 114
Query: 121 RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIR 179
L E ++++ + + H+ HRD+K N+LL E+G++K++DFG++ ++D
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174
Query: 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYK 238
+ +TF GTP ++APEV+ + YD +K DIWS G+ L G P + + M V++
Sbjct: 175 KR---NTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLF- 229
Query: 239 KIYKGEFRSPRW---FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIE 294
I K P +S L + L+ P R T E++++++ + K + E
Sbjct: 230 LIPKNN--PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-54
Identities = 67/265 (25%), Positives = 122/265 (46%), Gaps = 23/265 (8%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-LKSGLVAHIKREISILRRVRHPN 87
+ +++G G F KVY A G+ VA+K + S + ++++E + ++HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVY 147
I+ L V + + VME+ RGG L ++ R+ D+ + Q+ + + H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 148 ---HRDLKPENLLLDE--------NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP 196
HRDLK N+L+ + N LK++DFGL+ + + G A++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAP 183
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFR--SPRWFSP 253
EV+ + D+WS GV+L+ L+ G +PF+ + + V Y P
Sbjct: 184 EVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL-ALPIPSTCPE 241
Query: 254 DLIRLLTKLLDTNPDKRITIPEIME 278
+L+ + +P R + I++
Sbjct: 242 PFAKLMEDCWNPDPHSRPSFTNILD 266
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-53
Identities = 80/304 (26%), Positives = 130/304 (42%), Gaps = 61/304 (20%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKS-GESVAIKVI----DKEKILKSGLVAHIKREISILR 81
+YE +G G + KV+ AR++K+ G VA+K + +E + S + RE+++LR
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-----REVAVLR 66
Query: 82 RVR---HPNIVQLFEVMAT-----KSKIYFVMEYVRG--GELFNKVAKGRLKEDLARKYF 131
+ HPN+V+LF+V ++K+ V E+V +KV + + + +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 132 QQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP 191
QL+ + F H+ V HRDLKP+N+L+ +G +K++DFGL+ R T
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------RIYSFQMAL--TS 178
Query: 192 A-----YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--G- 243
Y APEVL + Y VD+WS G I + F+ + + KI G
Sbjct: 179 VVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 244 -------------EFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
LL K L NP KRI+ + +
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 280 RWFR 283
+F+
Sbjct: 298 PYFQ 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-52
Identities = 83/269 (30%), Positives = 134/269 (49%), Gaps = 18/269 (6%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+EI LG G F KVY A+N ++G A KVI+ + + + EI IL HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHAR 144
IV+L K++ ++E+ GG + L E + +Q++ A+ F H++
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV-----L 199
+ HRDLK N+L+ GD++++DFG+SA + + Q +F GTP ++APEV +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVMCETM 194
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGE---FRSPRWFSPDL 255
YD K DIWS G+ L + P + N M V+ KI K + +P +S +
Sbjct: 195 KDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEF 252
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRK 284
L LD NP+ R + +++E+ +
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFVSS 281
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-52
Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 29/270 (10%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVI----DKEKILKSGLVAHIKREISILRRVR 84
E K +G G F V+ R VK VAIK + + + +RE+ I+ +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCH 142
HPNIV+L + VME+V G+L++ +K + + + + +
Sbjct: 82 HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 143 ARGVY--HRDLKPENLLLDENGD-----LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195
+ HRDL+ N+ L + KV+DFGLS S G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194
Query: 196 PEVLSRKG--YDAAKVDIWSCGVILFVLMAGYLPFQDQN---IMVMYKKIYKGEFR--SP 248
PE + + Y K D +S +IL+ ++ G PF + + I + +G R P
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL-RPTIP 252
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
P L ++ +P KR I++
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-52
Identities = 52/262 (19%), Positives = 99/262 (37%), Gaps = 23/262 (8%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
L +++ R G + +KV+ + E LR HPN+
Sbjct: 13 NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNV 69
Query: 89 VQLFEVMAT--KSKIYFVMEYVRGGELFN---KVAKGRLKEDLARKYFQQLISAVGFCHA 143
+ + + + ++ G L+N + + + A K+ + + F H
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 144 RG--VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
+ L ++++DE+ ++S + PA+VAPE L +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQK 182
Query: 202 KGYDAA--KVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFR--SPRWFSPDLI 256
K D D+WS V+L+ L+ +PF D + M + K +G R P SP +
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-RPTIPPGISPHVS 241
Query: 257 RLLTKLLDTNPDKRITIPEIME 278
+L+ ++ +P KR I+
Sbjct: 242 KLMKICMNEDPAKRPKFDMIVP 263
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-52
Identities = 71/264 (26%), Positives = 132/264 (50%), Gaps = 15/264 (5%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+++ + LG G++ VY A + ++G+ VAIK + E L+ I +EISI+++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-----IIKEISIMQQCDSP 84
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHAR 144
++V+ + + ++ VMEY G + + ++ L ED Q + + + H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
HRD+K N+LL+ G K++DFG++ +T GTP ++APEV+ GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGY 202
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKG---EFRSPRWFSPDLIRLLT 260
+ DIWS G+ + G P+ D + M ++ I FR P +S + +
Sbjct: 203 N-CVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVK 260
Query: 261 KLLDTNPDKRITIPEIMENRWFRK 284
+ L +P++R T +++++ + R
Sbjct: 261 QCLVKSPEQRATATQLLQHPFVRS 284
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-50
Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 12/255 (4%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
+ RY+I LG G + VY A + VAIK I K + +RE+ ++
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFCH 142
H NIV + +V Y VMEY+ G L + G L D A + Q++ + H
Sbjct: 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQ-IRQDGLFHTFCGTPAYVAPEVLS 200
+ HRD+KP+N+L+D N LK+ DFG++ A+S+ + Q GT Y +PE
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN---HVLGTVQYFSPEQAK 185
Query: 201 RKGYDAAKVDIWSCGVILFVLMAGYLPFQ-DQNIMVMYKKIYKGEFRSPRWFSPD----L 255
+ D DI+S G++L+ ++ G PF + + + K I D L
Sbjct: 186 GEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244
Query: 256 IRLLTKLLDTNPDKR 270
++ + + + R
Sbjct: 245 SNVILRATEKDKANR 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-50
Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 16/280 (5%)
Query: 2 AHATAPTSTSTTSSSKDQNQSPL----LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIK 57
H + S D G Y + +L+G G VY A + VA+K
Sbjct: 6 HHHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALK 65
Query: 58 VIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV 117
++ + ++RE R++ P++V + + ++Y M + G +L +
Sbjct: 66 LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML 125
Query: 118 AK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL-SAVS 175
+ G L A +Q+ SA+ HA G HRD+KPEN+L+ + + DFG+ SA +
Sbjct: 126 RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185
Query: 176 DQ-IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM 234
D+ + Q G GT Y+APE S + DI++ +L+ + G P+Q +
Sbjct: 186 DEKLTQLG---NTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLS 241
Query: 235 VMYKKIYKGEFRSPRWFSPDLI----RLLTKLLDTNPDKR 270
VM I + P P + ++ + + NP+ R
Sbjct: 242 VMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-50
Identities = 76/306 (24%), Positives = 126/306 (41%), Gaps = 56/306 (18%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI--DKEKILKSGLVAHIKREISILRRVR 84
+YE +G GTF +V+ AR+ K+G+ VA+K + + EK G REI IL+ ++
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLK 74
Query: 85 HPNIVQLFEVMATKS--------KIYFVMEYVR---GGELFNKVAKGRLKEDLARKYFQQ 133
H N+V L E+ TK+ IY V ++ G L N + ++ Q
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQM 132
Query: 134 LISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFC-GTP 191
L++ + + H + HRD+K N+L+ +G LK++DFGL+ A S +T T
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192
Query: 192 AYVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK------- 242
Y PE+L R Y +D+W G I+ + Q I +
Sbjct: 193 WYRPPELLLGERD-YGPP-IDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250
Query: 243 ------------GEFRSPRW-------------FSPDLIRLLTKLLDTNPDKRITIPEIM 277
+ + P + L+ KLL +P +RI + +
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310
Query: 278 ENRWFR 283
+ +F
Sbjct: 311 NHDFFW 316
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-50
Identities = 93/382 (24%), Positives = 156/382 (40%), Gaps = 84/382 (21%)
Query: 1 MAHATAPTSTSTTSSSKDQNQS-PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI 59
++ + +T ++ Q P Y K++G+G+F VY A+ SGE VAIK +
Sbjct: 28 VSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV 87
Query: 60 --DKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS------KIYFVMEYV--- 108
DK RE+ I+R++ H NIV+L + + V++YV
Sbjct: 88 LQDKRFKN---------RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 138
Query: 109 --RGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLK 165
R +++ AK L + Y QL ++ + H+ G+ HRD+KP+NLLLD + LK
Sbjct: 139 VYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 197
Query: 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYV------APEV-LSRKGYDAAKVDIWSCGVIL 218
+ DFG + + G + +Y+ APE+ Y ++ +D+WS G +L
Sbjct: 198 LCDFGSAKQLVR----GEPNV-----SYICSRYYRAPELIFGATDYTSS-IDVWSAGCVL 247
Query: 219 FVLMAGYLPFQDQNIMVMYKKIYK-----------------GEFRSPRW----------- 250
L+ G F + + +I K EF+ P+
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 251 -FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDD 309
P+ I L ++LL+ P R+T E + +F + + K+ N D
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD------ELRDPNVKLPNGRDT----- 356
Query: 310 VGPCSDDHSLSEPEPEPELETK 331
P + + E P L T
Sbjct: 357 --PALFNFTTQELSSNPPLATI 376
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 81/307 (26%), Positives = 144/307 (46%), Gaps = 37/307 (12%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
M+ ++ S YE+ +++G G A V A E VAIK I+
Sbjct: 1 MSEDSSALPWSINRD-----------DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN 49
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN----- 115
EK S + + +EI + + HPNIV + K +++ VM+ + GG + +
Sbjct: 50 LEKCQTS--MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHI 107
Query: 116 ----KVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171
+ G L E ++++ + + H G HRD+K N+LL E+G ++++DFG+
Sbjct: 108 VAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167
Query: 172 SA---VSDQIRQDGLFHTFCGTPAYVAPEVLSR-KGYDAAKVDIWSCGVILFVLMAGYLP 227
SA I ++ + TF GTP ++APEV+ + +GYD K DIWS G+ L G P
Sbjct: 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAP 226
Query: 228 FQDQNIM-VMYK---------KIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIM 277
+ M V+ + + + + ++++ L +P+KR T E++
Sbjct: 227 YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 278 ENRWFRK 284
+++F+K
Sbjct: 287 RHKFFQK 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 58/267 (21%), Positives = 119/267 (44%), Gaps = 21/267 (7%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
G++LG G F + + ++GE + +K + + +E+ ++R + HPN+
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
++ V+ ++ F+ EY++GG L K + + + + S + + H+ +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQ------------IRQDGLFHTFCGTPAYV 194
HRDL N L+ EN ++ V+DFGL+ + +T G P ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 195 APEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFR--SPRWF 251
APE+++ + YD KVD++S G++L ++ D + + +G P
Sbjct: 190 APEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248
Query: 252 SPDLIRLLTKLLDTNPDKRITIPEIME 278
P + + D +P+KR + ++
Sbjct: 249 PPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-50
Identities = 75/267 (28%), Positives = 124/267 (46%), Gaps = 17/267 (6%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+ + +GHG+F VY AR+V++ E VAIK + + I +E+ L+++RHP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHARG 145
N +Q + + VMEY G +V K L+E + + + H+
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLS---RK 202
+ HRD+K N+LL E G +K+ DFG ++ + ++F GTP ++APEV+
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPA---NSFVGTPYWMAPEVILAMDEG 228
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKG---EFRSPRWFSPDLIRL 258
YD KVD+WS G+ L P + N M +Y I + +S W S
Sbjct: 229 QYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRNF 285
Query: 259 LTKLLDTNPDKRITIPEIMENRWFRKG 285
+ L P R T ++++R+ +
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLRE 312
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 86/304 (28%), Positives = 148/304 (48%), Gaps = 33/304 (10%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
MA + S S ++ + G +E+ +L+G+GT+ +VY R+VK+G+ AIKV+D
Sbjct: 2 MASDSPARSLDEIDLSALRDPA---GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD 58
Query: 61 KEKILKSGLVAHIKREISILRRV-RHPNIVQLFE------VMATKSKIYFVMEYVRGG-- 111
+ IK+EI++L++ H NI + +++ VME+ G
Sbjct: 59 ----VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV 114
Query: 112 -ELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170
+L LKE+ ++++ + H V HRD+K +N+LL EN ++K+ DFG
Sbjct: 115 TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 171 LSAVSDQI-RQDGLFHTFCGTPAYVAPEVLSRK-----GYDAAKVDIWSCGVILFVLMAG 224
+SA Q+ R G +TF GTP ++APEV++ YD K D+WS G+ + G
Sbjct: 175 VSA---QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEG 230
Query: 225 YLPFQDQNIM-VMYKKIYKGE---FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENR 280
P D + M ++ I + +S +W S + L N +R ++M++
Sbjct: 231 APPLCDMHPMRALF-LIPRNPAPRLKSKKW-SKKFQSFIESCLVKNHSQRPATEQLMKHP 288
Query: 281 WFRK 284
+ R
Sbjct: 289 FIRD 292
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 88/326 (26%), Positives = 140/326 (42%), Gaps = 71/326 (21%)
Query: 7 PTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK 66
P +S + Y K++G+G+F V+ A+ V+S E VAIK + ++K K
Sbjct: 21 PNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK 79
Query: 67 SGLVAHIKREISILRRVRHPNIVQLFEVMATKS------KIYFVMEYV-----RGGELFN 115
+ RE+ I+R V+HPN+V L + + V+EYV R +
Sbjct: 80 N-------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYA 132
Query: 116 KVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAV 174
K K + L + Y QL+ ++ + H+ G+ HRD+KP+NLLLD G LK+ DFG + +
Sbjct: 133 K-LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191
Query: 175 SDQIRQDGLFHTFCGTPAYV------APEV-LSRKGYDAAKVDIWSCGVILFVLMAGYLP 227
+ +Y+ APE+ Y +DIWS G ++ LM G
Sbjct: 192 LIAGE----PNV-----SYICSRYYRAPELIFGATNYTTN-IDIWSTGCVMAELMQGQPL 241
Query: 228 FQ-----DQ--------------NIMVMYKKIYKGEFRSPRW------------FSPDLI 256
F DQ I M + +F P+ PD I
Sbjct: 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKF--PQIRPHPFSKVFRPRTPPDAI 299
Query: 257 RLLTKLLDTNPDKRITIPEIMENRWF 282
L+++LL+ P R+T E + + +F
Sbjct: 300 DLISRLLEYTPSARLTAIEALCHPFF 325
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 1e-48
Identities = 78/299 (26%), Positives = 136/299 (45%), Gaps = 55/299 (18%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-H 85
Y++ + LG G +++V+ A N+ + E V +K++ K K IKREI IL +R
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRGG 90
Query: 86 PNIVQLFEVM--ATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
PNI+ L +++ V E+V + K L + R Y +++ A+ +CH+
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKALDYCHS 148
Query: 144 RGVYHRDLKPENLLLD-ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL-SR 201
G+ HRD+KP N+++D E+ L++ D+GL+ ++ ++ + + PE+L
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDY 205
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPF------QDQNIMVM----------YKKIYK--- 242
+ YD + +D+WS G +L ++ PF DQ + + Y Y
Sbjct: 206 QMYDYS-LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 243 --------GEFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
G RW SP+ + L KLL + R+T E ME+ +F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-48
Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 20/270 (7%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRR-VRHP 86
E +G GT +V+ R K+G +A+K + + I ++ ++ + P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGG-ELFNKVAKGRLKEDLARKYFQQLISAVGFCHA-R 144
IVQ F T + ++ ME + E K +G + E + K ++ A+ +
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVL---- 199
GV HRD+KP N+LLDE G +K+ DFG+S + D +D G AY+APE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD----RSAGCAAYMAPERIDPPD 200
Query: 200 -SRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGE---FRSPRWFSPD 254
++ YD + D+WS G+ L L G P+++ + + K+ + E FS D
Sbjct: 201 PTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
+ L + KR +++E+ + ++
Sbjct: 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-47
Identities = 69/353 (19%), Positives = 127/353 (35%), Gaps = 61/353 (17%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHG--TFAKVYHARNVKSGESVAIKV 58
MAH + G YE+ ++G G V AR +GE V ++
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEG-GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR 59
Query: 59 IDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG---ELFN 115
I+ E + ++ E+ + + HPNIV ++++ V ++ G +L
Sbjct: 60 INLEACSNEMV-TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 116 KVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA-- 173
+ E Q ++ A+ + H G HR +K ++L+ +G + +S +
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178
Query: 174 VSDQIRQ---DGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPF 228
+S RQ +++PEVL + +GYD AK DI+S G+ L G++PF
Sbjct: 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPF 237
Query: 229 QDQNIMVMYKKIYKG--------------------------------------------- 243
+D M + G
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 244 -EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIED 295
R FSP + + L NPD R + ++ + +F++ + + +
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPE 350
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-47
Identities = 74/261 (28%), Positives = 123/261 (47%), Gaps = 19/261 (7%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
L RYE+G++LG G ++V+ AR+++ VA+KV+ + +RE +
Sbjct: 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 84 RHPNIVQLFEV----MATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAV 138
HP IV +++ Y VMEYV G L + V G + A + A+
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQ---IRQDGLFHTFCGTPAYV 194
F H G+ HRD+KP N+++ +KV DFG++ A++D + Q GT Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA---AVIGTAQYL 186
Query: 195 APEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ-DQNIMVMYKKIYKGEFRSPRWFSP 253
+PE D A+ D++S G +L+ ++ G PF D + V Y+ + + + P
Sbjct: 187 SPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHE 244
Query: 254 D----LIRLLTKLLDTNPDKR 270
L ++ K L NP+ R
Sbjct: 245 GLSADLDAVVLKALAKNPENR 265
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-46
Identities = 77/327 (23%), Positives = 126/327 (38%), Gaps = 79/327 (24%)
Query: 27 RYEI-GKLLGHGTFAKVYHARN--VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
+E G +G GT+ VY A+ K + A+K I+ I S REI++LR +
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLREL 75
Query: 84 RHPNIVQLFEVMATKS--KIYFVMEYV---------RGGELFNKVAKGRLKEDLARKYFQ 132
+HPN++ L +V + + K++ + +Y +L + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 133 QLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLS-AVSDQIRQDGLFHTF 187
Q++ + + HA V HRDLKP N+L+ E G +K++D G + + ++ L
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LADLD 193
Query: 188 CG--TPAYVAPEVL--SRKGYDAAKVDIWSCGVILFVLMAG--------------YLPFQ 229
T Y APE+L +R Y A +DIW+ G I L+
Sbjct: 194 PVVVTFWYRAPELLLGARH-YTKA-IDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 230 DQ-------------------NIMVMYKKIYKGEFRSPR--------------WFSPDLI 256
DQ M + + K R+
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311
Query: 257 RLLTKLLDTNPDKRITIPEIMENRWFR 283
LL KLL +P KRIT + M++ +F
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-45
Identities = 65/253 (25%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKILKSGLVAHIKREISILRR 82
+ G+YE+ + HG +Y A + +G V +K + + A E L
Sbjct: 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAE 135
Query: 83 VRHPNIVQLFEV-----MATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
V HP+IVQ+F Y VMEYV G L + +L A Y +++ A
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAIAYLLEILPA 194
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
+ + H+ G+ + DLKPEN++L E LK+ D G + + F GTP + APE
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINS------FGYLYGTPGFQAPE 247
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257
++ A DI++ G L L + + + + + + R
Sbjct: 248 IVRTGPTVAT--DIYTVGRTLAALTLDLPTRNGRYVDGLPE-----DDPVLK-TYDSYGR 299
Query: 258 LLTKLLDTNPDKR 270
LL + +D +P +R
Sbjct: 300 LLRRAIDPDPRQR 312
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 7e-45
Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 11/263 (4%)
Query: 11 STTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLV 70
+ K + +E LG G V+ + SG +A K+I E +K +
Sbjct: 18 EAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIR 75
Query: 71 AHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLAR 128
I RE+ +L P IV + + +I ME++ GG L ++V K GR+ E +
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILG 134
Query: 129 KYFQQLISAVGFCHARG-VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187
K +I + + + + HRD+KP N+L++ G++K+ DFG VS Q+ D + ++F
Sbjct: 135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQL-IDSMANSF 190
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS 247
GT +Y++PE L Y + DIWS G+ L + G P + +
Sbjct: 191 VGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249
Query: 248 PRWFSPDLIRLLTKLLDTNPDKR 270
P L D R
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSR 272
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 47/291 (16%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
+ + +G G + +V+ GE+VA+K+ KS + E+ +RH NI
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-EKS---WFRETELYNTVMLRHENI 64
Query: 89 VQLF----EVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR 144
+ + ++++ + Y G L++ + L + + S + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 145 --------GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGLFHTFCGTPAYV 194
+ HRDLK +N+L+ +NG ++D GL+ + Q D + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 195 APEVLSRKGYDAA-----KVDIWSCGVIL---------FVLMAGY-LPFQDQN-----IM 234
APEVL +VDIW+ G++L ++ Y PF D
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 235 VMYKKIYKGEFR---SPRWFSPDLIRLLTKLL----DTNPDKRITIPEIME 278
M K + + R RWFS + L KL+ NP R+T I +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 77/287 (26%), Positives = 120/287 (41%), Gaps = 42/287 (14%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
RY +G G + V A + + VAIK I REI IL R RH
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHE 85
Query: 87 NIVQLFEVMATKSK-----IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
NI+ + +++ + +Y V + + +L+ + L D + Q++ + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT-FCGTPAYVAPEV-L 199
H+ V HRDLKP NLLL+ DLK+ DFGL+ V+D F T + T Y APE+ L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK----------GEFRSPR 249
+ KGY + +DIWS G IL +++ F ++ + I + +
Sbjct: 205 NSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 250 ---------------------WFSPDLIRLLTKLLDTNPDKRITIPE 275
+ LL K+L NP KRI + +
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-44
Identities = 77/332 (23%), Positives = 133/332 (40%), Gaps = 77/332 (23%)
Query: 9 STSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG 68
+ +++ D+ + R+++ ++ G GTF V + +G SVAIK + ++ +
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-- 63
Query: 69 LVAHIKREISI---LRRVRHPNIVQLFEVMATKSK-------IYFVMEYVRGGELFNKVA 118
RE+ I L + HPNIVQL T + + VMEYV + ++
Sbjct: 64 -----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCC 116
Query: 119 K--GRLKEDLARKYFQ----QLISAVGFCHAR--GVYHRDLKPENLLLD-ENGDLKVSDF 169
+ R + + QLI ++G H V HRD+KP N+L++ +G LK+ DF
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 170 GLSAVSDQIRQDGLFHTFCGTPAYV------APEV-LSRKGYDAAKVDIWSCGVILFVLM 222
G + + AY+ APE+ + Y A VDIWS G I +M
Sbjct: 177 GSAKKLSPSE----PNV-----AYICSRYYRAPELIFGNQHYTTA-VDIWSVGCIFAEMM 226
Query: 223 AGYLPFQ-----DQ--------------NIMVM---YKKIYKGEFRSPRW---------- 250
G F+ Q + + + + + W
Sbjct: 227 LGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLK 286
Query: 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
+ + LL+ LL P++R+ E + + +F
Sbjct: 287 DAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-43
Identities = 43/123 (34%), Positives = 68/123 (55%), Gaps = 5/123 (4%)
Query: 340 PASLNAFDLISFSPGFDLSGLFEEGGEG----ARFVSGAPVSKIITKLEEIAKVVSFTVR 395
P +NAF++I+ S G +LS LF+ + RFVS S+II +E +A + F
Sbjct: 4 PLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSH 63
Query: 396 KKDCRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLE 455
++ + LEG G L + EI+E+ P L +V+V+K G+ EY +F K+L LE
Sbjct: 64 TRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFY-KKLCSKLE 122
Query: 456 NLM 458
N++
Sbjct: 123 NII 125
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 25/273 (9%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISI-LRRVRHP 86
E LG G + V R+V SG+ +A+K I + S + ++ I +R V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGG--ELFNKVAK--GRLKEDLARKYFQQLISAVGFCH 142
V + + + ++ ME + + + +V + ED+ K ++ A+ H
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 143 A-RGVYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEV-- 198
+ V HRD+KP N+L++ G +K+ DFG+S + D + +D G Y+APE
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD----IDAGCKPYMAPERIN 182
Query: 199 --LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRSPR----WF 251
L++KGY K DIWS G+ + L P+ K++ + SP+ F
Sbjct: 183 PELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP--SPQLPADKF 239
Query: 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
S + + ++ L N +R T PE+M++ +F
Sbjct: 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 49/291 (16%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVRH 85
Y +G G + V A + +SGE VAIK + + +S + A RE+ +L+ ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 86 PNIVQLFEVMATKSK------IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG 139
N++ L +V S Y VM ++ +L K+ + E+ + Q++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQMLKGLK 140
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV- 198
+ H+ GV HRDLKP NL ++E+ +LK+ DFGL+ +D + T Y APEV
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVI 195
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK----------GEFRSP 248
LS Y+ VDIWS G I+ ++ G F+ ++ + +I K +
Sbjct: 196 LSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 249 R---------------------WFSPDLIRLLTKLLDTNPDKRITIPEIME 278
SP LL K+L+ + DKR+T + +
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-43
Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 27/295 (9%)
Query: 9 STSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG 68
S+ S +Q+ + +G G + V + SG+ +A+K I +
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEK 62
Query: 69 LVAHIKREISILRR-VRHPNIVQLFEVMATKSKIYFVMEYVRGG-----ELFNKVAKGRL 122
+ ++ ++ R P IVQ + + + + ME + + V +
Sbjct: 63 EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVI 122
Query: 123 KEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQ 180
E++ K + A+ + HRD+KP N+LLD +G++K+ DFG+S + D I +
Sbjct: 123 PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182
Query: 181 DGLFHTFCGTPAYVAPEVL----SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-- 234
G Y+APE + SR+GYD + D+WS G+ L+ L G P+ N +
Sbjct: 183 ----TRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFD 237
Query: 235 VMYKKIYKGE-----FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
+ ++ KG+ R FSP I + L + KR E++++ +
Sbjct: 238 QL-TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 82/301 (27%), Positives = 128/301 (42%), Gaps = 56/301 (18%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILR 81
L RY K LG G V+ A + + VAIK KI+ V H REI I+R
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIR 63
Query: 82 RVRHPNIVQLFEVMATKSK--------------IYFVMEYVRGGELFNKVAKGRLKEDLA 127
R+ H NIV++FE++ +Y V EY+ +L N + +G L E+ A
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHA 122
Query: 128 RKYFQQLISAVGFCHARGVYHRDLKPENLLLD-ENGDLKVSDFGLSAVSDQIRQDGLFHT 186
R + QL+ + + H+ V HRDLKP NL ++ E+ LK+ DFGL+ + D +
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 187 -FCGTPAYVAPEV-LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ-----DQNIMVM--- 236
T Y +P + LS Y A +D+W+ G I ++ G F +Q +++
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 237 ---------------YKKIYKGEFRSPRWF-------SPDLIRLLTKLLDTNPDKRITIP 274
I + S + + L ++L +P R+T
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301
Query: 275 E 275
E
Sbjct: 302 E 302
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-42
Identities = 43/124 (34%), Positives = 65/124 (52%), Gaps = 8/124 (6%)
Query: 339 RPASLNAFDLISFSPGFDLSGLFEE---GGEGARFVSGAPVSKIITKLEEIAKVVSFTVR 395
+NAFD+IS SPGF+LSGLF + RFVS +++ +LEEI + TV
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 396 KKD-CRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGL 454
KK+ + +EG KG + EI +LT +LV++EV+K+ + L+P
Sbjct: 62 KKETWGMKIEGQ----KGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFF 117
Query: 455 ENLM 458
L+
Sbjct: 118 VELV 121
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 91/300 (30%), Positives = 131/300 (43%), Gaps = 54/300 (18%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVRH 85
+++ LLG G + V A + +GE VAIK I+ L A REI IL+ +H
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKH 68
Query: 86 PNIVQLFEVMATKSK-----IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ-QLISAVG 139
NI+ +F + S +Y + E + +L ++V ++ D +YF Q + AV
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP--AYV--- 194
H V HRDLKP NLL++ N DLKV DFGL+ + D+ D T + +V
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 195 ---APEV-LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------- 242
APEV L+ Y A +D+WSCG IL L F ++ I+
Sbjct: 187 WYRAPEVMLTSAKYSRA-MDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 243 ---GEFRSPR---------------------WFSPDLIRLLTKLLDTNPDKRITIPEIME 278
SPR +P I LL ++L +P KRIT E +E
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-42
Identities = 78/336 (23%), Positives = 130/336 (38%), Gaps = 98/336 (29%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+Y +GK LG G+F V +++SG+ A+K + ++ K RE+ I++ + H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLDHV 60
Query: 87 NIVQLFEVMATKSK--------------------------------------IYFVMEYV 108
NI++L + T + +MEYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 109 -----RGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD-ENG 162
+ + F + + + +L Y QL AVGF H+ G+ HRD+KP+NLL++ ++
Sbjct: 121 PDTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV------APEV-LSRKGYDAAKVDIWSCG 215
LK+ DFG + AY+ APE+ L Y + +D+WS G
Sbjct: 180 TLKLCDFGSAKKLIP----SEPSV-----AYICSRFYRAPELMLGATEYTPS-IDLWSIG 229
Query: 216 VILFVLMAGYLPFQDQNIMVMYKKIYK-----------------GEFRSPRW----FS-- 252
+ L+ G F + + +I + E R P +
Sbjct: 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI 289
Query: 253 ------PDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
I LL ++L PD RI E M + +F
Sbjct: 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-42
Identities = 82/296 (27%), Positives = 134/296 (45%), Gaps = 50/296 (16%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVRH 85
Y + +G G + V A + ++G VAIK + + +S L A RE+ +L+ +RH
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 86 PNIVQLFEVMATKSK------IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG 139
N++ L +V Y VM ++ G +L + +L ED + Q++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 142
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT-FCGTPAYVAPEV 198
+ HA G+ HRDLKP NL ++E+ +LK+ DFGL+ RQ T + T Y APEV
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMTGYVVTRWYRAPEV 196
Query: 199 -LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK----------GEFRS 247
L+ Y VDIWS G I+ ++ G F+ + + K+I K +S
Sbjct: 197 ILNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 248 PR---------------------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
SP + LL K+L + ++R+T E + + +F
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 52/299 (17%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVRH 85
RY+ +G G + V A + K+G VA+K + + +S + A RE+ +L+ ++H
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 86 PNIVQLFEVMATKSK------IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ-QLISAV 138
N++ L +V +Y V + G +L N + K + D ++ Q++ +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT-FCGTPAYVAPE 197
+ H+ + HRDLKP NL ++E+ +LK+ DFGL+ R T + T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------RHTADEMTGYVATRWYRAPE 199
Query: 198 V-LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK----------GEFR 246
+ L+ Y+ VDIWS G I+ L+ G F + + K I + +
Sbjct: 200 IMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 247 SPR---------------------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
S +P + LL K+L + DKRIT + + + +F +
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 45/273 (16%), Positives = 91/273 (33%), Gaps = 39/273 (14%)
Query: 6 APTSTSTTSSSKDQNQSPLL-GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI 64
S++ + + + GRY + G + + A + VA+ +D + +
Sbjct: 10 DRESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV 69
Query: 65 LKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKE 124
L ++ L R+ P + ++ +V+ T++ V E++RGG L +VA
Sbjct: 70 LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSPSP 128
Query: 125 DLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184
A + Q L +A H GV P + + +GD+ +
Sbjct: 129 VGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVL------------------ 170
Query: 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-- 242
PA + + DI G L+ L+ P + + +
Sbjct: 171 ----AYPATMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT 218
Query: 243 -GEFRSPRWFSPD----LIRLLTKLLDTNPDKR 270
G+ P D + + + + + R
Sbjct: 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 64/291 (21%), Positives = 119/291 (40%), Gaps = 47/291 (16%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
+ + +G G F +V+ + GE VA+K+ + + EI +RH NI
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENI 98
Query: 89 VQLF----EVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR 144
+ + T ++++ V +Y G LF+ + + + + K S + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 145 --------GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGLFHTFCGTPAYV 194
+ HRDLK +N+L+ +NG ++D GL+ D D + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 195 APEVLSRKGYDAA-----KVDIWSCGVILFVLMAGY----------LPFQDQ-----NIM 234
APEVL + DI++ G++ + + LP+ D ++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 235 VMYKKIYKGEFR---SPRWFSPDLIRLLTKLL----DTNPDKRITIPEIME 278
M K + + + R RW S + +R++ K++ N R+T I +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 68/305 (22%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVRH 85
RY+ K +G G V A + +VAIK + + ++ A RE+ +++ V H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 86 PNIVQLFEVMATKSK------IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG 139
NI+ L V + +Y VME + L +V + L + Q++ +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK 178
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
H+ G+ HRDLKP N+++ + LK+ DFGL+ + + + T Y APEV+
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 235
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI------------------- 240
GY VDIWS G I+ ++ + F ++ + + K+
Sbjct: 236 LGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 241 -----------------------YKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIM 277
+ + + + LL+K+L +P KRI++ + +
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 278 ENRWF 282
++ +
Sbjct: 355 QHPYI 359
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 8e-41
Identities = 66/253 (26%), Positives = 105/253 (41%), Gaps = 45/253 (17%)
Query: 3 HATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKE 62
+S T S + + + RYEI L+G G++ V A + VAIK
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----- 84
Query: 63 KIL----KSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-----KIYFVMEYVRGGEL 113
KIL I REI+IL R+ H ++V++ +++ K ++Y V+E +
Sbjct: 85 KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF 143
Query: 114 FNKV--AKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171
K+ L E + L+ V + H+ G+ HRDLKP N L++++ +KV DFGL
Sbjct: 144 -KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202
Query: 172 SAVSDQIRQDGLFHTFCGTPA-------------------YV------APEV-LSRKGYD 205
+ D +V APE+ L ++ Y
Sbjct: 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262
Query: 206 AAKVDIWSCGVIL 218
A +D+WS G I
Sbjct: 263 EA-IDVWSIGCIF 274
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 72/333 (21%), Positives = 131/333 (39%), Gaps = 64/333 (19%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVRH 85
RY+ K +G G V A + +VAIK + + ++ A RE+ +++ V H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 86 PNIVQLFEVMATKSK------IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG 139
NI+ L V + +Y VME + L +V + L + Q++ +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK 141
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
H+ G+ HRDLKP N+++ + LK+ DFGL+ + + + T Y APEV+
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 198
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI------------------- 240
GY VDIWS G I+ ++ G + F + + + K+
Sbjct: 199 LGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 241 -----------------------YKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIM 277
+ + + + LL+K+L + KRI++ E +
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317
Query: 278 ENRWFRKGFKHIKFY-IEDDKMCNVEDVDHTDD 309
++ + +Y + + + D D
Sbjct: 318 QHPYIN------VWYDPSEAEAPPPKIPDKQLD 344
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 83/359 (23%), Positives = 141/359 (39%), Gaps = 86/359 (23%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA-HIKREISILRRVR- 84
+YE+ K LG G + V+ + + ++GE VA+K I ++ A REI IL +
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSG 67
Query: 85 HPNIVQLFEVMATKSK--IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ-QLISAVGFC 141
H NIV L V+ + +Y V +Y+ +L + V + + E + ++Y QLI + +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA--------- 192
H+ G+ HRD+KP N+LL+ +KV+DFGLS IR+
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 193 ----YV------APEV-LSRKGYDAAKVDIWSCGVILFVLMAG----------------- 224
YV APE+ L Y +D+WS G IL ++ G
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKG-IDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 225 ---------------------YL---------PFQDQNIMVMYKKIYKGEFRSPRWFSPD 254
+ ++ + K + + +
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK---------HIKFYIEDDKMCNVEDV 304
+ LL KLL NP+KRI+ + +++ + I I D+ +++D
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDY 363
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-40
Identities = 66/291 (22%), Positives = 116/291 (39%), Gaps = 47/291 (16%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
++ K +G G + +V+ + GE VA+KV + + EI +RH NI
Sbjct: 40 QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEAS----WFRETEIYQTVLMRHENI 93
Query: 89 VQLF----EVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR 144
+ + + +++Y + +Y G L++ + L K +S + H
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 145 --------GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGLFHTFCGTPAYV 194
+ HRDLK +N+L+ +NG ++D GL+ D +T GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 195 APEVLSRKGYDAA-----KVDIWSCGVIL---------FVLMAGY-LPFQDQN-----IM 234
PEVL D++S G+IL ++ Y LP+ D
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 235 VMYKKIYKGEFR---SPRWFSPDLIRLLTKLL----DTNPDKRITIPEIME 278
M + + + R RW S + +R + KL+ NP R+T + +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 64/306 (20%), Positives = 113/306 (36%), Gaps = 54/306 (17%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA--------HIKREIS 78
Y + + + G++ V + G VAIK + + + REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 79 ILRRVRHPNIVQLFEVMATKSK-----IYFVMEYVRGGELFN--KVAKGRLKEDLARKYF 131
+L HPNI+ L ++ + +Y V E + +L + + + +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140
Query: 132 QQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP 191
++ + H GV HRDL P N+LL +N D+ + DF L+ D +
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT---ADANKTHYVTHR 197
Query: 192 AYVAPEV-LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------- 242
Y APE+ + KG+ VD+WS G ++ + F+ KI +
Sbjct: 198 WYRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 243 --GEFRSPR----------------------WFSPDLIRLLTKLLDTNPDKRITIPEIME 278
F SP P + L+ K+L+ NP +RI+ + +
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
Query: 279 NRWFRK 284
+ +F
Sbjct: 317 HPYFES 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 64/320 (20%), Positives = 130/320 (40%), Gaps = 51/320 (15%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
M H S+ +++ + ++ ++ G F V+ A+ E VA+K+
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSM--PLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFP 56
Query: 61 KEKILKSGLVAHIKREISILRRVRHPNIVQLF----EVMATKSKIYFVMEYVRGGELF-- 114
+ K + E+ L ++H NI+Q + ++ + + G L
Sbjct: 57 IQD--KQSWQN--EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112
Query: 115 ---NKVA-KGRLK--EDLAR--KYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166
N V+ E +AR Y + I + H + HRD+K +N+LL N +
Sbjct: 113 LKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172
Query: 167 SDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLS-----RKGYDAAKVDIWSCGVILFVL 221
+DFGL+ + + G H GT Y+APEVL ++ ++D+++ G++L+ L
Sbjct: 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF-LRIDMYAMGLVLWEL 231
Query: 222 MAG-----------YLPFQDQ-----NIMVMYKKIYKGEFR---SPRWFSPDLIRLLTKL 262
+ LPF+++ ++ M + + + R W + +L +
Sbjct: 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCET 291
Query: 263 L----DTNPDKRITIPEIME 278
+ D + + R++ + E
Sbjct: 292 IEECWDHDAEARLSAGCVGE 311
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 61/252 (24%), Positives = 107/252 (42%), Gaps = 32/252 (12%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVID 60
M H +S + + Y I L+G G++ VY A + + ++VAIK +
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV- 59
Query: 61 KEKILKSGLVA-HIKREISILRRVRHPNIVQLFEVMATKSK-----IYFVMEYVRGGELF 114
++ + + I REI+IL R++ I++L++++ +Y V+E +L
Sbjct: 60 -NRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLK 117
Query: 115 NKVAKGRLKEDLARKYFQ-QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173
+ K L+ F H G+ HRDLKP N LL+++ +KV DFGL+
Sbjct: 118 KLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 174 VSDQIRQDGLFHTFCGTPA--------------YV------APEV-LSRKGYDAAKVDIW 212
+ + + + +V APE+ L ++ Y + +DIW
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS-IDIW 236
Query: 213 SCGVILFVLMAG 224
S G I L+
Sbjct: 237 STGCIFAELLNM 248
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 71/299 (23%), Positives = 122/299 (40%), Gaps = 34/299 (11%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI-DKEKILKSGLVAHIKREISILRR 82
+ RYE+ K++G G+F +V A + K + VA+K++ ++++ + EI IL
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEH 149
Query: 83 VRH------PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR---LKEDLARKYFQQ 133
+R N++ + E ++ I E + L+ + K + L RK+
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 134 LISAVGFCHARGVYHRDLKPENLLLDENG--DLKVSDFGLSAVSDQIRQDGLFHTFCGTP 191
++ + H + H DLKPEN+LL + G +KV DFG S Q +T+ +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSR 263
Query: 192 AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI--YKGEF---- 245
Y APEV+ Y +D+WS G IL L+ GY ++ + G
Sbjct: 264 FYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322
Query: 246 --RSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCN 300
S R F + T D + + R +G + + K C+
Sbjct: 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCD 381
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-35
Identities = 59/304 (19%), Positives = 105/304 (34%), Gaps = 62/304 (20%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISI--LRRVRHP 86
++ +L+G G + VY VA+K + + E +I + + H
Sbjct: 16 KLLELIGRGRYGAVYKGS--LDERPVAVK------VFSFANRQNFINEKNIYRVPLMEHD 67
Query: 87 NIVQLF-----EVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
NI + + + VMEY G L ++ + + + + +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 142 HA---------RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR------QDGLFHT 186
H + HRDL N+L+ +G +SDFGLS R +D +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 187 FCGTPAYVAPEVL------SRKGYDAAKVDIWSCGVIL------------FVLMAGY-LP 227
GT Y+APEVL +VD+++ G+I + Y +
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 228 FQDQ-----NIMVMYKKIYKGEFR---SPRWFS-PDLIRLLTKLL----DTNPDKRITIP 274
FQ + M + + + R W +R L + + D + + R+T
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
Query: 275 EIME 278
E
Sbjct: 308 XAEE 311
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 65/347 (18%), Positives = 127/347 (36%), Gaps = 86/347 (24%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI-DKEKILKSGLVAHIKREISILRRVR 84
RY + + LG G F+ V+ A+++ + VA+K++ + ++ EI +L+RV
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-----EIKLLQRVN 73
Query: 85 -----------HPNIVQL---FEVMATKSK-IYFVMEYVRGGELFNKVAK---GRLKEDL 126
+I++L F + V E V G L + K +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIY 132
Query: 127 ARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGD------LKVSDFGLSAVSDQIR 179
++ +QL+ + + H R G+ H D+KPEN+L++ +K++D G + D+
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH- 191
Query: 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN------- 232
+ T Y +PEVL + DIWS ++F L+ G F+
Sbjct: 192 ----YTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 233 ------IM-----------------------------VMYKKIYKGEFRSPRWFS----- 252
I+ + K + E +
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 253 -PDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKM 298
++ L+ +L +P KR ++ + W + + + D ++
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL 353
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 79/342 (23%), Positives = 125/342 (36%), Gaps = 96/342 (28%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI-DKEKILKSGLVAHIKREISILRR 82
+ RYEI L+G G+F +V A + E VAIK+I +K+ L + E+ +L
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----EVRLLEL 106
Query: 83 VRHP------NIVQLFEVMATKSKIYFVME------YVRGGELFNKVAKGRLKEDLARKY 130
+ IV L ++ + V E Y +L + +L RK+
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY----DLLRNTNFRGVSLNLTRKF 162
Query: 131 FQQLISAVGFCHAR--GVYHRDLKPENLLL--DENGDLKVSDFGLSAVSDQIRQDGLFHT 186
QQ+ +A+ F + H DLKPEN+LL + +K+ DFG S Q +
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQ 217
Query: 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI------ 240
+ + Y +PEVL YD A +D+WS G IL + G F N + KI
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276
Query: 241 -------------------------------YKGEFRSPRWFSPD--------------- 254
K E++ P
Sbjct: 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRA 336
Query: 255 ------------LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
L+ ++LD +P RI +++ +F+K
Sbjct: 337 GESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 61/342 (17%), Positives = 121/342 (35%), Gaps = 98/342 (28%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI-DKEKILKSGLVAHIKREISILRR 82
L + + + +G GTF +V +++ + + A+KV+ + +K +S + E IL++
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EADILKK 87
Query: 83 VRH-----PNIVQLFEVMATKSKIYFVME------YVRGGELFNKVAKGRLKEDLARKYF 131
+++ NIV+ + + E Y E+ + + + Y
Sbjct: 88 IQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY----EIITRNNYNGFHIEDIKLYC 143
Query: 132 QQLISAVGFCHARGVYHRDLKPENLLLDENG-------------------------DLKV 166
+++ A+ + + H DLKPEN+LLD+ +K+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 167 SDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYL 226
DFG A + T Y APEV+ G+D + D+WS G +L L G L
Sbjct: 204 IDFG-CATFKSDY----HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSL 257
Query: 227 PFQ-----DQNIMVM-------YKKIYKGEFRSPRWF----------------------- 251
F+ + M+ +Y+ + +
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 252 -----------SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282
L +L +P R + E++++++
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 84/343 (24%), Positives = 128/343 (37%), Gaps = 92/343 (26%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSG-ESVAIKVI-DKEKILKSGLVAHIKREISILR 81
L RYEI LG G F KV + K+G VA+K++ + ++ ++ EI +L
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-----EIQVLE 66
Query: 82 RVRHP------NIVQLFEVMATKSKIYFVME------YVRGGELFNKVAKGRLKEDLARK 129
+ VQ+ E I V E Y + + + D RK
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY----DFIKENGFLPFRLDHIRK 122
Query: 130 YFQQLISAVGFCHARGVYHRDLKPENLLLDENG-------------------DLKVSDFG 170
Q+ +V F H+ + H DLKPEN+L ++ D+KV DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD 230
SA D T T Y APEV+ G+ D+WS G IL G+ F
Sbjct: 183 -SATYDDEHH----STLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPT 236
Query: 231 QN-------IMV--------MYKKIYKGEF------------RSPRWFSPD--------- 254
+ + M +K K ++ + R+ S
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 255 --------LIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHI 289
L L+ K+L+ +P KRIT+ E +++ +F K I
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 69/259 (26%), Positives = 117/259 (45%), Gaps = 17/259 (6%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
+G+ +G G F +V+ R VA+K +E + ++ E IL++ HPNI
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQ-EARILKQYSHPNI 174
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
V+L V K IY VME V+GG+ + RL+ + + + + ++
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAY----VAPEVLSRK 202
HRDL N L+ E LK+SDFG+S + DG++ G APE L+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 203 GYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLL 259
Y +++ D+WS G++L+ G P+ + + + + KG R P + RL+
Sbjct: 291 RY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFRLM 348
Query: 260 TKLLDTNPDKRITIPEIME 278
+ P +R + I +
Sbjct: 349 EQCWAYEPGQRPSFSTIYQ 367
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 73/344 (21%), Positives = 117/344 (34%), Gaps = 92/344 (26%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHAR-NVKSGESVAIKVI-DKEKILKSGLVAHIKREISILR 81
L RYEI LG GTF KV + + VA+K+I + K ++ + EI++L+
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-----EINVLK 71
Query: 82 RVRHP------NIVQLFEVMATKSKIYFVME------YVRGGELFNKVAKGRLKEDLARK 129
+++ V + + + E + E + R
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF----EFLKENNFQPYPLPHVRH 127
Query: 130 YFQQLISAVGFCHARGVYHRDLKPENLLLDENG-------------------DLKVSDFG 170
QL A+ F H + H DLKPEN+L + ++V+DFG
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ- 229
SA D T T Y PEV+ G+ D+WS G ILF G+ FQ
Sbjct: 188 -SATFDHEHH----TTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQT 241
Query: 230 ----DQNIMVM---------------------------------------YKKIYKGEFR 246
+ +M+ K K
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIK 290
L L+ ++L+ +P +RIT+ E + + +F +
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEER 345
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 68/283 (24%), Positives = 125/283 (44%), Gaps = 31/283 (10%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVI-----DKEKILKSGLVAHIKREISILRRV 83
+ LG G + +VY K +VA+K + + E+ LK E ++++ +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---------EAAVMKEI 273
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFN---KVAKGRLKEDLARKYFQQLISAVGF 140
+HPN+VQL V + Y + E++ G L + + + + + Q+ SA+ +
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV---APE 197
+ HR+L N L+ EN +KV+DFGLS ++ + G + APE
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 198 VLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPD 254
L+ + + K D+W+ GV+L+ + G P+ ++ +Y+ + K +R P
Sbjct: 390 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEK 447
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDK 297
+ L+ NP R + EI + F F+ E +K
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVEK 488
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-27
Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 26 GRYEI-------GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK--RE 76
G++ I + +G G F V+ + + VAIK ++ G ++ E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKT------IREGAMSEEDFIEE 53
Query: 77 ISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQL 134
++ ++ HP +VQL+ V ++ I V E++ G L + + +G + +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 135 ISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI---RQDGLFHTFCGT 190
+ + V HRDL N L+ EN +KVSDFG++ V D F
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------ 167
Query: 191 PA-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR-- 246
P + +PEV S Y ++K D+WS GV+++ V G +P+++++ + + I G FR
Sbjct: 168 PVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLY 225
Query: 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME--NRWFRKGF 286
PR S + +++ P+ R ++ G
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/286 (22%), Positives = 116/286 (40%), Gaps = 44/286 (15%)
Query: 18 DQNQSPLLGRYEI--GKLLGHGTFAKVYHARNVKSGESVAIKV-IDKEKILKSGLVAHIK 74
+Q +L E K+LG G F VY + GE V I V I K L+
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKAN 61
Query: 75 ----REISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLAR 128
E ++ V +P++ +L + S + + + + G L + + K +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIG----- 115
Query: 129 KYFQQLISAVGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178
Q L + +C A+G Y HRDL N+L+ +K++DFGL + +
Sbjct: 116 --SQYL---LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLL 167
Query: 179 RQDGLFHTFCGT--P-AYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIM 234
+ + G P ++A E + + Y + D+WS GV ++ ++ G P+
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 235 VMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ + KGE R P + D+ ++ K + D R E++
Sbjct: 227 EISSILEKGE-RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 62/261 (23%), Positives = 110/261 (42%), Gaps = 15/261 (5%)
Query: 29 EIGKLLGHGTFAKVYHAR-NVKSGES--VAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
+ + LG G+F V + SG++ VA+K + + + + + RE++ + + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHA 143
N+++L+ V + V E G L + + +G +Y Q+ +G+ +
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT--P-AYVAPEVLS 200
+ HRDL NLLL +K+ DFGL Q D + P A+ APE L
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAPESLK 197
Query: 201 RKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIR 257
+ + + D W GV L+ + G P+ N + KI K R P D+
Sbjct: 198 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 256
Query: 258 LLTKLLDTNPDKRITIPEIME 278
++ + P+ R T + +
Sbjct: 257 VMVQCWAHKPEDRPTFVALRD 277
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 73/299 (24%), Positives = 130/299 (43%), Gaps = 42/299 (14%)
Query: 22 SPLLGRYEI-------GKLLGHGTFAKVYHARNVKSGESVAIKVI-----DKEKILKSGL 69
SP ++E+ LG G + +VY K +VA+K + + E+ LK
Sbjct: 2 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK--- 58
Query: 70 VAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN---KVAKGRLKEDL 126
E ++++ ++HPN+VQL V + Y + E++ G L + + + + +
Sbjct: 59 ------EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 127 ARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI---RQDG 182
Q+ SA+ + + HRDL N L+ EN +KV+DFGLS ++
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 183 LFHTFCGTPA-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKI 240
F P + APE L+ + + K D+W+ GV+L+ + G P+ ++ +Y+ +
Sbjct: 173 KF------PIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 241 YKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDK 297
K +R P + L+ NP R + EI + F F+ E +K
Sbjct: 226 EKD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVEK 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 72/348 (20%), Positives = 135/348 (38%), Gaps = 51/348 (14%)
Query: 18 DQNQSPLLGRYEI--GKLLGHGTFAKVYHARNVKSGESVAIKV-IDKEKILKSGLVAHIK 74
+Q +L E K+LG G F VY + GE V I V I K L+
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKAN 61
Query: 75 ----REISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLAR 128
E ++ V +P++ +L + S + + + + G L + + K +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIG----- 115
Query: 129 KYFQQLISAVGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178
Q L + +C A+G Y HRDL N+L+ +K++DFGL + +
Sbjct: 116 --SQYL---LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLL 167
Query: 179 RQDGLFHTFCGT--P-AYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIM 234
+ + G P ++A E + + Y + D+WS GV ++ ++ G P+
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 235 VMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFY 292
+ + KGE R P + D+ ++ K + D R E++ F K + + Y
Sbjct: 227 EISSILEKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE--FSKMARDPQRY 283
Query: 293 IEDDKMCNVEDVDHTDDVGPCSDDHSLSEPEPEPELETKRKLTSLPRP 340
+ + E + + E + + ++ L +P+
Sbjct: 284 LV---IQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYL--IPQQ 326
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 65/261 (24%), Positives = 116/261 (44%), Gaps = 27/261 (10%)
Query: 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK--REISILRRVRHPN 87
+ K LG G F V + K VA+K+ +K G ++ + +E + ++ HP
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKM------IKEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARG 145
+V+ + V + + IY V EY+ G L N + L+ + + + F +
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI---RQDGLFHTFCGTPA-YVAPEVLS 200
HRDL N L+D + +KVSDFG++ V D F P + APEV
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF------PVKWSAPEVFH 178
Query: 201 RKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIR 257
Y ++K D+W+ G++++ V G +P+ + K+ +G R P S + +
Sbjct: 179 YFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYRPHLASDTIYQ 236
Query: 258 LLTKLLDTNPDKRITIPEIME 278
++ P+KR T +++
Sbjct: 237 IMYSCWHELPEKRPTFQQLLS 257
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 48/289 (16%)
Query: 16 SKDQNQSPLLGRYEI-------GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG 68
SK Q Q +EI LG G F +V+ VAIK LK G
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKT------LKPG 219
Query: 69 LVAHIK--REISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDL 126
++ +E +++++RH +VQL+ V ++ IY V EY+ G L + LK +
Sbjct: 220 TMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLD-----FLKGE- 272
Query: 127 ARKYFQQLISAVGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS-AVS 175
+ +L V A G Y HRDL+ N+L+ EN KV+DFGL+ +
Sbjct: 273 -TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331
Query: 176 DQI---RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQ 231
D RQ F + APE + K D+WS G++L + G +P+
Sbjct: 332 DNEYTARQGAKFPIK-----WTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 232 NIMVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ ++ +G +R P L L+ + P++R T +
Sbjct: 386 VNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK--REISILRRVRHP 86
+ LG G F +V+ VAIK LK G ++ +E +++++RH
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKT------LKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH--AR 144
+VQL+ V ++ IY V EY+ G L LK + + +L V A
Sbjct: 323 KLVQLYAV-VSEEPIYIVTEYMSKGSL-----LDFLKGE--TGKYLRLPQLVDMAAQIAS 374
Query: 145 G-VY-------HRDLKPENLLLDENGDLKVSDFGLS-AVSDQI---RQDGLFHTFCGTP- 191
G Y HRDL+ N+L+ EN KV+DFGL+ + D RQ F P
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF------PI 428
Query: 192 AYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SP 248
+ APE + K D+WS G++L + G +P+ + ++ +G +R P
Sbjct: 429 KWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCP 486
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
L L+ + P++R T +
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFEYLQA 516
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 66/320 (20%), Positives = 124/320 (38%), Gaps = 57/320 (17%)
Query: 2 AHATAPTSTSTTSSSKDQNQSPLLGRYEI-------GKLLGHGTFAKVYHAR----NVKS 50
PT+ + + + + LG G F V R +
Sbjct: 10 HDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNT 69
Query: 51 GESVAIKVIDKEKILKSGLVAHIK---REISILRRVRHPNIVQLFEV--MATKSKIYFVM 105
GE VA+K L+ H++ REI IL+ ++H NIV+ V A + + +M
Sbjct: 70 GEVVAVKK------LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123
Query: 106 EYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD 163
EY+ G L + + K R+ +Y Q+ + + + HRDL N+L++
Sbjct: 124 EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 183
Query: 164 LKVSDFGLS-AVSD-----QIRQDGLFHTFCGTP-AYVAPEVLSRKGYDAAKVDIWSCGV 216
+K+ DFGL+ + ++++ G P + APE L+ + D+WS GV
Sbjct: 184 VKIGDFGLTKVLPQDKEYYKVKEPGES------PIFWYAPESLTESKFS-VASDVWSFGV 236
Query: 217 IL----------------FVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRL 258
+L F+ M G + + + + R P ++ +
Sbjct: 237 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG-RLPRPDGCPDEIYMI 295
Query: 259 LTKLLDTNPDKRITIPEIME 278
+T+ + N ++R + ++
Sbjct: 296 MTECWNNNVNQRPSFRDLAL 315
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 66/262 (25%), Positives = 115/262 (43%), Gaps = 31/262 (11%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH-IKREISILRRVRHPN 87
++ + +G G F V G VA+K +K+ A E S++ ++RH N
Sbjct: 24 KLLQTIGKGEFGDVMLG--DYRGNKVAVKC------IKNDATAQAFLAEASVMTQLRHSN 75
Query: 88 IVQLFEVMATKSK--IYFVMEYVRGGELFN---KVAKGRLKEDLARKYFQQLISAVGFCH 142
+VQL V + K +Y V EY+ G L + + L D K+ + A+ +
Sbjct: 76 LVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV---APEVL 199
HRDL N+L+ E+ KVSDFGL+ + + G P V APE L
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEAL 186
Query: 200 SRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLI 256
K + K D+WS G++L+ + G +P+ + + ++ KG ++ +P P +
Sbjct: 187 REKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVY 244
Query: 257 RLLTKLLDTNPDKRITIPEIME 278
++ + R + ++ E
Sbjct: 245 EVMKNCWHLDAAMRPSFLQLRE 266
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 43/293 (14%)
Query: 14 SSSKDQNQSPLLGRYEI-------GKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKE 62
+ D NQ+ L EI K++G G F +VY + K VAIK
Sbjct: 25 AMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---- 80
Query: 63 KILKSGLVAHIK----REISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNK 116
LK+G + E I+ + H NI++L V++ + + EY+ G L F +
Sbjct: 81 --LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
Query: 117 VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS---- 172
G + + + + + HRDL N+L++ N KVSDFGLS
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198
Query: 173 --AVSDQIRQDGLFHTFCGTPA-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPF 228
+ G P + APE +S + + + D+WS G++++ V+ G P+
Sbjct: 199 DDPEATYTTSGGKI------PIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPY 251
Query: 229 QD-QNIMVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ N VM K I G FR +P + +L+ + +R +I+
Sbjct: 252 WELSNHEVM-KAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 65/262 (24%), Positives = 116/262 (44%), Gaps = 27/262 (10%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK--REISILRRVRHP 86
K LG G F V + + + VAIK+ +K G ++ + E ++ + H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKM------IKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHAR 144
+VQL+ V + I+ + EY+ G L N + + R + + + + A+ + ++
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI---RQDGLFHTFCGTPA-YVAPEVL 199
HRDL N L+++ G +KVSDFGLS V D F P + PEVL
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF------PVRWSPPEVL 193
Query: 200 SRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLI 256
+ ++K DIW+ GV+++ + G +P++ + I +G R P S +
Sbjct: 194 MYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVY 251
Query: 257 RLLTKLLDTNPDKRITIPEIME 278
++ D+R T ++
Sbjct: 252 TIMYSCWHEKADERPTFKILLS 273
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 66/259 (25%), Positives = 114/259 (44%), Gaps = 25/259 (9%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
++ + +G G F V G VA+K I K + E S++ ++RH N+
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCI-KNDATAQAFL----AEASVMTQLRHSNL 248
Query: 89 VQLFEVMATKSK--IYFVMEYVRGGELFN---KVAKGRLKEDLARKYFQQLISAVGFCHA 143
VQL V + K +Y V EY+ G L + + L D K+ + A+ +
Sbjct: 249 VQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA-YVAPEVLSRK 202
HRDL N+L+ E+ KVSDFGL+ + + G P + APE L K
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREK 361
Query: 203 GYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLL 259
+ K D+WS G++L+ + G +P+ + + ++ KG ++ +P P + ++
Sbjct: 362 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYDVM 419
Query: 260 TKLLDTNPDKRITIPEIME 278
+ R T ++ E
Sbjct: 420 KNCWHLDAATRPTFLQLRE 438
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 61/271 (22%), Positives = 115/271 (42%), Gaps = 45/271 (16%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVI-----DKEKILKSGLVAHIKREISILRRV 83
++ + LG G F +V+ VA+K + + L E ++++++
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLA---------EANLMKQL 65
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKY-FQQLIS-AVGFC 141
+H +V+L+ V T+ IY + EY+ G L + LK K +L+ A
Sbjct: 66 QHQRLVRLYAV-VTQEPIYIITEYMENGSLVD-----FLKTPSGIKLTINKLLDMAAQIA 119
Query: 142 HA------RGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI---RQDGLFHTFCGTP 191
R HRDL+ N+L+ + K++DFGL+ + D R+ F P
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF------P 173
Query: 192 A-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--S 247
+ APE ++ + K D+WS G++L ++ G +P+ + + + +G +R
Sbjct: 174 IKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVR 231
Query: 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
P +L +L+ P+ R T +
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 70/321 (21%), Positives = 130/321 (40%), Gaps = 26/321 (8%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKV-IDKEKILKSGLVAHIK----REISILRRV 83
K+LG G F V+ + GES+ I V I K+++ + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCI---KVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFC 141
H +IV+L + S + V +Y+ G L + +G L L + Q+ + +
Sbjct: 73 DHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT--P-AYVAPEV 198
G+ HR+L N+LL ++V+DFG+ +D + D + P ++A E
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGV---ADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 199 LSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDL 255
+ Y + D+WS GV ++ ++ G P+ + + + KGE R P+ + D+
Sbjct: 189 IHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLAQPQICTIDV 246
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSD 315
++ K + + R T E+ F + + Y+ +
Sbjct: 247 YMVMVKCWMIDENIRPTFKELANE--FTRMARDPPRYLVIKR--ESGPGIAPGPEPHGLT 302
Query: 316 DHSLSEPEPEPELETKRKLTS 336
+ L E E EPEL+ L +
Sbjct: 303 NKKLEEVELEPELDLDLDLEA 323
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 70/270 (25%), Positives = 117/270 (43%), Gaps = 35/270 (12%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIK----REISILR 81
I K++G G +V + R G+ VAIK LK+G + E SI+
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA------LKAGYTERQRRDFLSEASIMG 105
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVG 139
+ HPNI++L V+ V EY+ G L + G+ + + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI-----RQDGLFHTFCGTPA- 192
+ G HRDL N+L+D N KVSDFGLS + D G P
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI------PIR 219
Query: 193 YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQD-QNIMVMYKKIYKGEFR--SP 248
+ APE ++ + + ++ D+WS GV+++ VL G P+ + N V+ + +G +R +P
Sbjct: 220 WTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-SSVEEG-YRLPAP 276
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
L +L+ + +R +I+
Sbjct: 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 34/268 (12%)
Query: 29 EIGKLLGHGTFAKVYHAR-NVKSGES--VAIKVIDKEKILKSGLVAHIK----REISILR 81
+ ++LG G F +VY GE VA+K K K E I++
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT------CKKDCTLDNKEKFMSEAVIMK 68
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVG 139
+ HP+IV+L ++ + + +ME GEL + + K LK Y Q+ A+
Sbjct: 69 NLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI---RQDGLFHTFCGTP-AYV 194
+ + HRD+ N+L+ +K+ DFGLS + D+ P ++
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL------PIKWM 181
Query: 195 APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQD-QNIMVMYKKIYKGEFR--SPRW 250
+PE ++ + + D+W V ++ +L G PF +N V+ + KG+ R P
Sbjct: 182 SPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVI-GVLEKGD-RLPKPDL 238
Query: 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278
P L L+T+ D +P R E++
Sbjct: 239 CPPVLYTLMTRCWDYDPSDRPRFTELVC 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 37/276 (13%)
Query: 30 IGKLLGHGTFAKVYHAR-NVKSGE--SVAIKVIDKEKILKSGLVAHIKR----EISILRR 82
I K++G G F +V R + S + SVAIK LK G +R E SI+ +
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT------LKVGYTEKQRRDFLGEASIMGQ 102
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGF 140
HPNI++L V+ + V EY+ G L F + + + + S + +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQ-----IRQDGLFHTFCGTPA-Y 193
G HRDL N+L++ N KVSDFGL + D + G P +
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI------PIRW 216
Query: 194 VAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQD-QNIMVMYKKIYKGEFR--SPR 249
+PE ++ + + + D+WS G++L+ V+ G P+ + N V+ K + +G +R P
Sbjct: 217 TSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEG-YRLPPPM 273
Query: 250 WFSPDLIRLLTKLLDTNPDKRITIPEIME--NRWFR 283
L +L+ + + R +I+ ++ R
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 50/286 (17%)
Query: 29 EIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIK---REISILR 81
+ + LG G F V R +GE VA+K L+ H++ REI IL+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK------LQHSTEEHLRDFEREIEILK 66
Query: 82 RVRHPNIVQLFEV--MATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISA 137
++H NIV+ V A + + +MEY+ G L + + K R+ +Y Q+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSD-----QIRQDGLFHTFCGTP 191
+ + + HRDL N+L++ +K+ DFGL+ + ++++ G P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES------P 180
Query: 192 -AYVAPEVLSRKGYDAAKVDIWSCGVIL----------------FVLMAGYLPFQDQNIM 234
+ APE L+ + D+WS GV+L F+ M G +
Sbjct: 181 IFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 235 VMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ + + R P ++ ++T+ + N ++R + ++
Sbjct: 240 HLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 75/268 (27%), Positives = 124/268 (46%), Gaps = 34/268 (12%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIK----REISILR 81
E+G+ +G G F V+ + +VAIK K+ ++ +E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT------CKNCTSDSVREKFLQEALTMR 71
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVG 139
+ HP+IV+L V T++ ++ +ME GEL F +V K L Y QL +A+
Sbjct: 72 QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI---RQDGLFHTFCGTPA-YV 194
+ ++ HRD+ N+L+ N +K+ DFGLS + D G P ++
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PIKWM 184
Query: 195 APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQD-QNIMVMYKKIYKGEFR--SPRW 250
APE ++ + + + D+W GV ++ +LM G PFQ +N V+ +I G R P
Sbjct: 185 APESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-GRIENG-ERLPMPPN 241
Query: 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278
P L L+TK +P +R E+
Sbjct: 242 CPPTLYSLMTKCWAYDPSRRPRFTELKA 269
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 63/280 (22%), Positives = 112/280 (40%), Gaps = 44/280 (15%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
+G++LG G F V A+ + S VA+K++ K I+ S + RE + ++ H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84
Query: 86 PNIVQLFEV------MATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG 139
P++ +L V ++ +++ G+L + R+ E+ Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR--- 141
Query: 140 FCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS---AVSD--QIRQDGLF 184
F A G Y HRDL N +L E+ + V+DFGLS D +
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 185 HTFCGTPAYV---APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKI 240
P V A E L+ Y D+W+ GV ++ ++ G P+ +Y +
Sbjct: 202 ------P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
Query: 241 YKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
G R P ++ L+ + +P +R + +
Sbjct: 253 IGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 57/257 (22%), Positives = 107/257 (41%), Gaps = 15/257 (5%)
Query: 31 GKLLGHGTFAKVYHA--RNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88
K LG G F V + K ++VA+K++ K + L + E ++++++ +P I
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVY 147
V++ + VME G L + + R +K+ + Q+ + +
Sbjct: 81 VRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 148 HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT--P-AYVAPEVLSRKGY 204
HRDL N+LL K+SDFGLS + + P + APE ++ +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 205 DAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLTK 261
++K D+WS GV+++ G P++ + + KGE R P ++ L+
Sbjct: 198 -SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDLMNL 255
Query: 262 LLDTNPDKRITIPEIME 278
+ + R +
Sbjct: 256 CWTYDVENRPGFAAVEL 272
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 70/372 (18%), Positives = 120/372 (32%), Gaps = 122/372 (32%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
GRY + + LG G F+ V+ + +++ + VA+KV+ EI +L+ V
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKSV 90
Query: 84 R-----HPN---IVQL---FEVMATKSK-IYFVMEYVRG--GELFNKVAKGRLKEDLARK 129
R PN +VQL F++ I V E + + K L +K
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 130 YFQQLISAVGFCHAR-GVYHRDLKPENLLL------------------------------ 158
QQ++ + + H + + H D+KPEN+LL
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 159 -------------------DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
E +K++D G + + + T Y + EVL
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVL 265
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI------------MV-----MYKKIYK 242
GY+ DIWS + F L G F+ + ++ + +K+
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 243 GEFRSPRWFSPD-------------------------------LIRLLTKLLDTNPDKRI 271
S +F+ L +L+ P+KR
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 272 TIPEIMENRWFR 283
T E + + W
Sbjct: 385 TAAECLRHPWLN 396
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 66/270 (24%), Positives = 119/270 (44%), Gaps = 43/270 (15%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIK--REISILRRVRHP 86
++ K LG G F +V+ A VA+K +K G ++ E ++++ ++H
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKT------MKPGSMSVEAFLAEANVMKTLQHD 243
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH--AR 144
+V+L V TK IY + E++ G L LK D Q L + F A
Sbjct: 244 KLVKLHAV-VTKEPIYIITEFMAKGSL-----LDFLKSD--EGSKQPLPKLIDFSAQIAE 295
Query: 145 G-VY-------HRDLKPENLLLDENGDLKVSDFGLS-AVSDQI---RQDGLFHTFCGTPA 192
G + HRDL+ N+L+ + K++DFGL+ + D R+ F P
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF------PI 349
Query: 193 -YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SP 248
+ APE ++ + K D+WS G++L ++ G +P+ + + + + +G +R P
Sbjct: 350 KWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRP 407
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+L ++ + P++R T I
Sbjct: 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 39/285 (13%)
Query: 18 DQNQSPLLGRYEI-------GKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKS 67
D P YEI G+ +G G F V+ + +VAIK K+
Sbjct: 375 DTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT------CKN 428
Query: 68 GLVAHIK----REISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGR 121
++ +E +R+ HP+IV+L V T++ ++ +ME GEL F +V K
Sbjct: 429 CTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFS 487
Query: 122 LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQI-- 178
L Y QL +A+ + ++ HRD+ N+L+ N +K+ DFGLS + D
Sbjct: 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547
Query: 179 -RQDGLFHTFCGTPA-YVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMV 235
G P ++APE ++ + + +A D+W GV ++ +LM G PFQ
Sbjct: 548 KASKGKL------PIKWMAPESINFRRFTSAS-DVWMFGVCMWEILMHGVKPFQGVKNND 600
Query: 236 MYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ +I GE R P P L L+TK +P +R E+
Sbjct: 601 VIGRIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-23
Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 25/259 (9%)
Query: 34 LGHGTFAKVYHAR-NVKSGE-SVAIKVIDKEKILKSGLVAHIK----REISILRRVRHPN 87
LG G F V ++ + VAIKV LK G RE I+ ++ +P
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV------LKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCHARG 145
IV+L V + VME GG L F + + + Q+ + + +
Sbjct: 72 IVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT--P-AYVAPEVLSRK 202
HRDL N+LL K+SDFGLS D + P + APE ++ +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFR 188
Query: 203 GYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLL 259
+ +++ D+WS GV ++ L G P++ + I +G+ R P P+L L+
Sbjct: 189 KF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYALM 246
Query: 260 TKLLDTNPDKRITIPEIME 278
+ + R + +
Sbjct: 247 SDCWIYKWEDRPDFLTVEQ 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 62/276 (22%), Positives = 110/276 (39%), Gaps = 45/276 (16%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGLVAHIK----REISILR 81
+++G G F VYH + + A+K L E I++
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS------LNRITDIGEVSQFLTEGIIMK 81
Query: 82 RVRHPNIVQLFEVMA-TKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140
HPN++ L + ++ V+ Y++ G+L + ++ + + LI F
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIG---F 133
Query: 141 CH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190
A+G Y HRDL N +LDE +KV+DFGL+ + + T
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEYYSVHNKT 190
Query: 191 PAYV-----APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGE 244
A + A E L + + K D+WS GV+L+ ++ G P+ D N + + +G
Sbjct: 191 GAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249
Query: 245 FR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
R P + L ++ K + R + E++
Sbjct: 250 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 72/314 (22%), Positives = 124/314 (39%), Gaps = 56/314 (17%)
Query: 29 EIGKLLGHGTFAKVY--HARNVKSGES---VAIKVIDKEKILKSGLVAHIK----REISI 79
+ + LG G+F VY A+ V E VAIK + + E S+
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT------VNEAASMRERIEFLNEASV 81
Query: 80 LRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN----KVAKGRLKEDLARKYFQQLI 135
++ ++V+L V++ +ME + G+L + LA ++I
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 136 SAVGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS---AVSDQIRQ-- 180
A G Y HRDL N ++ E+ +K+ DFG++ +D R+
Sbjct: 142 Q---MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 181 DGLFHTFCGTPAYV---APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVM 236
GL P V +PE L + D+WS GV+L+ + P+Q + +
Sbjct: 199 KGLL------P--VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 237 YKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN--RWFRKGFKHIKFY 292
+ + +G P L L+ NP R + EI+ + GF+ + FY
Sbjct: 250 LRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308
Query: 293 -IEDDKMCNVEDVD 305
E++K+ E++D
Sbjct: 309 YSEENKLPEPEELD 322
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 62/276 (22%), Positives = 111/276 (40%), Gaps = 45/276 (16%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGL----VAHIKREISILR 81
+++G G F VYH + + A+K L V+ E I++
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS------LNRITDIGEVSQFLTEGIIMK 145
Query: 82 RVRHPNIVQLFEVMA-TKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140
HPN++ L + ++ V+ Y++ G+L + ++ + + LI F
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIG---F 197
Query: 141 CH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190
A+G + HRDL N +LDE +KV+DFGL+ + T
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEFDSVHNKT 254
Query: 191 PAYV-----APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGE 244
A + A E L + + K D+WS GV+L+ ++ G P+ D N + + +G
Sbjct: 255 GAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313
Query: 245 FR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
R P + L ++ K + R + E++
Sbjct: 314 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-22
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 32/209 (15%)
Query: 29 EIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIK----REISIL 80
+ + LG G F KV R +GE VA+K LK + +EI IL
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS------LKPESGGNHIADLKKEIEIL 77
Query: 81 RRVRHPNIVQLFEV--MATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLIS 136
R + H NIV+ + + I +ME++ G L + K ++ KY Q+
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSD-----QIRQDGLFHTFCGT 190
+ + +R HRDL N+L++ +K+ DFGL+ A+ ++ D
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------ 191
Query: 191 P-AYVAPEVLSRKGYDAAKVDIWSCGVIL 218
P + APE L + + D+WS GV L
Sbjct: 192 PVFWYAPECLMQSKFY-IASDVWSFGVTL 219
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 29 EIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIK---REISILR 81
+ LG G F V R +G VA+K L+ + REI IL+
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ------LQHSGPDQQRDFQREIQILK 79
Query: 82 RVRHPNIVQLFEV-MATKSK-IYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISA 137
+ IV+ V + + VMEY+ G L F + + RL Y Q+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ------IRQDGLFHTFCGTP 191
+ + +R HRDL N+L++ +K++DFGL+ + +R+ G P
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------P 193
Query: 192 -AYVAPEVLSRKGYDAAKVDIWSCGVIL 218
+ APE LS + + D+WS GV+L
Sbjct: 194 IFWYAPESLSDNIFS-RQSDVWSFGVVL 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 8e-22
Identities = 64/263 (24%), Positives = 103/263 (39%), Gaps = 25/263 (9%)
Query: 30 IGKLLGHGTFAKVYHA--RNVKSGESVAIKVIDKEKILKSGLVAHIK----REISILRRV 83
LG G F V R K VAIKV LK G RE I+ ++
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKV------LKQGTEKADTEEMMREAQIMHQL 393
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFC 141
+P IV+L V + VME GG L + + + Q+ + +
Sbjct: 394 DNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT--P-AYVAPEV 198
+ HR+L N+LL K+SDFGLS D + P + APE
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPEC 510
Query: 199 LSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDL 255
++ + + +++ D+WS GV ++ L G P++ + I +G+ R P P+L
Sbjct: 511 INFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPEL 568
Query: 256 IRLLTKLLDTNPDKRITIPEIME 278
L++ + R + +
Sbjct: 569 YALMSDCWIYKWEDRPDFLTVEQ 591
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 56/279 (20%), Positives = 102/279 (36%), Gaps = 50/279 (17%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGES-------VAIKVIDKEKILKSGLVAHIK---REIS 78
+ LG GTF K++ + G+ V +KV L + + S
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV------LDKAHRNYSESFFEAAS 64
Query: 79 ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLIS 136
++ ++ H ++V + V + V E+V+ G L + K K + + +QL +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDL--------KVSDFGLS-AVSDQ------IRQD 181
A+ F + H ++ +N+LL D K+SD G+S V + I
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-- 182
Query: 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQD-QNIMVMYKK 239
+V PE + D WS G L+ + G P + + +
Sbjct: 183 -----------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QF 230
Query: 240 IYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ P + +L L+ +D PD R + I+
Sbjct: 231 YEDR-HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 29 EIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+ + LG G F KV N +GE VA+K + + + + K+EI ILR +
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--RSGWKQEIDILRTLY 91
Query: 85 HPNIVQLFEV--MATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH 142
H +I++ A + + VMEYV G L + + + + + QQ+ + + H
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSD-----QIRQDGLFHTFCGTP-AYVA 195
A+ HRDL N+LLD + +K+ DFGL+ AV + ++R+DG P + A
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PVFWYA 205
Query: 196 PEVLSRKGYDAAKVDIWSCGVIL 218
PE L + D+WS GV L
Sbjct: 206 PECLKEYKFY-YASDVWSFGVTL 227
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 66/279 (23%), Positives = 109/279 (39%), Gaps = 43/279 (15%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
+GK+LG G F V + + VA+K + K + E + ++ H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 86 PNIVQLFEV-----MATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140
PN+++L V K ++ +++ G+L + RL+ Q L+ F
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK---F 152
Query: 141 CH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS---AVSDQIRQDGLFHTF 187
A G Y HRDL N +L ++ + V+DFGLS D RQ
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ------- 205
Query: 188 CGTPAYV-----APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIY 241
G A + A E L+ + Y +K D+W+ GV ++ + G P+ MY +
Sbjct: 206 -GRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 242 KGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
G R P +L ++ T+P R T +
Sbjct: 264 HG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 65/276 (23%), Positives = 114/276 (41%), Gaps = 45/276 (16%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGL----VAHIKREISILR 81
+++G G F VYH + ++ AIK L V RE ++R
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS------LSRITEMQQVEAFLREGLLMR 77
Query: 82 RVRHPNIVQLFEV-MATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140
+ HPN++ L + + + + ++ Y+ G+L ++ + LIS F
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL-----LQFIRSPQRNPTVKDLIS---F 129
Query: 141 CH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190
ARG Y HRDL N +LDE+ +KV+DFGL+ I +
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQHR 186
Query: 191 PAYV-----APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGE 244
A + A E L + K D+WS GV+L+ +L G P++ + + + +G
Sbjct: 187 HARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG- 244
Query: 245 FR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
R P + L +++ + + +P R T ++
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 72/281 (25%), Positives = 116/281 (41%), Gaps = 48/281 (17%)
Query: 30 IGKLLGHGTFAKVYHARNVKSGES--VAIKVIDKEKILKSGLVAHIK----REISILRRV 83
++G G F +V AR K G AIK +K E+ +L ++
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIK------RMKEYASKDDHRDFAGELEVLCKL 82
Query: 84 -RHPNIVQLFEVMATKSKIYFVMEYVRGGEL--F---NKVAKGRLKEDLARKYFQQLISA 137
HPNI+ L + +Y +EY G L F ++V + +A L S
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 138 --VGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLSAVSD--QIRQDGL 183
+ F ARG Y HRDL N+L+ EN K++DFGLS + + G
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 184 FHTFCGTPAYV---APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKK 239
P V A E L+ Y D+WS GV+L+ +++ G P+ +Y+K
Sbjct: 203 L------P--VRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 240 IYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ +G +R P ++ L+ + P +R + +I+
Sbjct: 254 LPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 65/287 (22%), Positives = 104/287 (36%), Gaps = 53/287 (18%)
Query: 29 EIGKLLGHGTFAKVY--HARNVKSGES---VAIKVIDKEKILKSGLVAHIK----REISI 79
+ LG F KVY H GE VAIK LK ++ E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT------LKDKAEGPLREEFRHEAML 65
Query: 80 LRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN-------KVAKGRLKEDLARKYFQ 132
R++HPN+V L V+ + + Y G+L G +D K
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 133 QLISAVGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS---AVSD--Q 177
+ V A G Y H+DL N+L+ + ++K+SD GL +D +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 178 IRQDGLFHTFCGTPAYV---APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNI 233
+ + L P + APE + + DIWS GV+L+ V G P+ +
Sbjct: 186 LLGNSLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 234 MVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ + I P + L+ + + P +R +I
Sbjct: 237 QDVVEMIRNR-QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 282
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 66/285 (23%), Positives = 110/285 (38%), Gaps = 69/285 (24%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRY----EIGK---------LLGHGTFAKVYHARN 47
M + + S + P ++ + L+GHG F KVY
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV- 59
Query: 48 VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107
++ G VA+K E G+ + EI L RHP++V L ++++ + +Y
Sbjct: 60 LRDGAKVALKRRTPES--SQGI-EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116
Query: 108 VRGGELFNKVAKGRLKEDLARKYFQQLI------------SAVG--FCHARGVYHRDLKP 153
+ G LK L + +A G + H R + HRD+K
Sbjct: 117 M---------ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS 167
Query: 154 ENLLLDENGDLKVSDFGLSA---------VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
N+LLDEN K++DFG+S +S ++ GT Y+ PE + G
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVK---------GTLGYIDPEYFIK-GR 217
Query: 205 DAAKVDIWSCGVILFVLMAG------YLPFQDQNI----MVMYKK 239
K D++S GV+LF ++ LP + N+ + +
Sbjct: 218 LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 53/285 (18%)
Query: 29 EIGKLLGHGTFAKVY--HARNVKSGES---VAIKVIDKEKILKSGLVAHIK----REISI 79
+ + LGHG F +VY + + S VA+K L + E I
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT------LPEVCSEQDELDFLMEALI 86
Query: 80 LRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARK-YFQQLISAV 138
+ + H NIV+ V + +ME + GG+L + + + R + L+
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-- 144
Query: 139 GFCH--ARG-VY-------HRDLKPENLLLDENGD---LKVSDFGLS---AVSDQIRQDG 182
A G Y HRD+ N LL G K+ DFG++ + R+
Sbjct: 145 -VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK-- 201
Query: 183 LFHTFCGTPAYV-----APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVM 236
G A + PE + +K D WS GV+L+ + + GY+P+ ++ +
Sbjct: 202 ------GGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 237 YKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279
+ + G R P+ + R++T+ P+ R I+E
Sbjct: 255 LEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 57/247 (23%), Positives = 102/247 (41%), Gaps = 51/247 (20%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
+ +GK +G G F ++ +N+ + E VAIK+ E + + E +++
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRA--PQLHLEYRFYKQLGS 63
Query: 86 -PNIVQLFEVMATKSKIYFVMEYVRGG----ELFNKVAKGR---LKE--DLARKYFQQLI 135
I Q++ V+E + G +LF+ R LK +A QLI
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAI----QLI 115
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVS-----DFGLSAVSDQIRQDGLFH----- 185
S + + H++ + +RD+KPEN L+ G+ DF L+ + I + H
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA--KEYIDPETKKHIPYRE 173
Query: 186 --TFCGTPAYVAP-----EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ---DQNIMV 235
+ GT Y++ + SR+ D D+ + G + + G LP+Q +
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRR--D----DLEALGHMFMYFLRGSLPWQGLKADTLKE 227
Query: 236 MYKKIYK 242
Y+KI
Sbjct: 228 RYQKIGD 234
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 81/332 (24%), Positives = 127/332 (38%), Gaps = 86/332 (25%)
Query: 18 DQNQSPLLGRYEI-------GKLLGHGTFAKVY--HARNVKSGES---VAIKVIDKEKIL 65
D Q P ++E GK LG G F KV A + ++ VA+K+ L
Sbjct: 8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM------L 61
Query: 66 KSGLVAHIK------REISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGEL----- 113
K AH+ E+ +L + H NIV L + EY G+L
Sbjct: 62 KPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119
Query: 114 -------FNKVAKGRLKEDLARKYFQQLISAVGFCH--ARG-VY-------HRDLKPENL 156
+K + +++D + L+S F + A+G + HRDL N+
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLS---FSYQVAKGMAFLASKNCIHRDLAARNI 176
Query: 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV------------APEVLSRKGY 204
LL K+ DFGL+ I+ D YV APE + Y
Sbjct: 177 LLTHGRITKICDFGLA---RDIKNDS---------NYVVKGNARLPVKWMAPESIFNCVY 224
Query: 205 DAAKVDIWSCGVILFVLMA-GYLPFQ--DQNIMVMYKKIYKGEFR--SPRWFSPDLIRLL 259
+ D+WS G+ L+ L + G P+ + K I +G FR SP ++ ++
Sbjct: 225 TF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-KMIKEG-FRMLSPEHAPAEMYDIM 281
Query: 260 TKLLDTNPDKRITIPEIME--NRWFRKGFKHI 289
D +P KR T +I++ + + HI
Sbjct: 282 KTCWDADPLKRPTFKQIVQLIEKQISESTNHI 313
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 33/237 (13%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
RY +G+ +G G+F +Y ++ +GE VAIK ++ K L E I + ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQL----HIESKIYKMMQG 63
Query: 86 -PNIVQLFEVMATKSKIYFVMEYVRG---GELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
I + A VME + G +LFN ++ + Q+IS + +
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYI 121
Query: 142 HARGVYHRDLKPENLLLDENGD---LKVSDFGLS-----AVSDQIRQDGLFHTFCGTPAY 193
H++ HRD+KP+N L+ + + DFGL+ A + Q GT Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 194 VAP-----EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ---DQNIMVMYKKIYK 242
+ SR+ D D+ S G +L G LP+Q Y++I +
Sbjct: 182 ASINTHLGIEQSRR--D----DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 53/284 (18%)
Query: 29 EIGKLLGHGTFAKVY--HARNVKSGES---VAIKVIDKEKILKSGLVAHIK----REISI 79
+ + LGHG F +VY + + S VA+K L + E I
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT------LPEVCSEQDELDFLMEALI 127
Query: 80 LRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKY-FQQLISAV 138
+ + H NIV+ V + ++E + GG+L + + + R + L+
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-- 185
Query: 139 GFCH--ARG-VY-------HRDLKPENLLLDENGD---LKVSDFGLS---AVSDQIRQDG 182
A G Y HRD+ N LL G K+ DFG++ + R+
Sbjct: 186 -VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK-- 242
Query: 183 LFHTFCGTPAYV-----APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVM 236
G A + PE + +K D WS GV+L+ + + GY+P+ ++ +
Sbjct: 243 ------GGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
Query: 237 YKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ + G R P+ + R++T+ P+ R I+E
Sbjct: 296 LEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 73/326 (22%), Positives = 128/326 (39%), Gaps = 69/326 (21%)
Query: 3 HATAPTSTSTTSSSKDQNQSPLLGRYEI-------GKLLGHGTFAKVYHAR-------NV 48
H S + + + P ++E GK LG G F +V A
Sbjct: 5 HHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKP 64
Query: 49 KSGESVAIKVIDKEKILKSGLVAHIK----REISILRRV-RHPNIVQLFEVMATKSKIYF 103
K +VA+K +LK E+ +++ + +H NI+ L +Y
Sbjct: 65 KEAVTVAVK------MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118
Query: 104 VMEYVRGGEL----------FNKVAKGRLKEDLARKYFQQLISAVGFCH--ARG-VY--- 147
++EY G L + + + + F+ L+S + ARG Y
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS---CTYQLARGMEYLAS 175
Query: 148 ----HRDLKPENLLLDENGDLKVSDFGLS---AVSD--QIRQDGLFHTFCGTPAYV---A 195
HRDL N+L+ EN +K++DFGL+ D + +G P V A
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL------P--VKWMA 227
Query: 196 PEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFR--SPRWFS 252
PE L + Y + D+WS GV+++ + G P+ + ++K + +G R P +
Sbjct: 228 PEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKPANCT 285
Query: 253 PDLIRLLTKLLDTNPDKRITIPEIME 278
+L ++ P +R T +++E
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVE 311
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 58/289 (20%)
Query: 29 EIGKLLGHGTFAKVY--HARNVKSGES---VAIKVIDKEKILKSG---LVAHIKREISIL 80
+ + LG G F KV+ N+ + VA+K LK +RE +L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK------ALKDPTLAARKDFQREAELL 71
Query: 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL----------FNKVAKGRLKEDLARKY 130
++H +IV+ + V + V EY++ G+L + G+ ++
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 131 FQQLISAVGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS-AVSDQ-- 177
Q++ A G VY HRDL N L+ N +K+ DFG+S V
Sbjct: 132 LSQMLH---IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 178 --IRQDGLFHTFCGTPAYV---APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQ 231
+ + P + PE + + + + D+WS GVIL+ + G P+
Sbjct: 189 YRVGGHTML------P--IRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 232 NIMVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ + + I +G PR ++ ++ P +R+ I EI +
Sbjct: 240 SNTEVIECITQG-RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 74/320 (23%), Positives = 122/320 (38%), Gaps = 68/320 (21%)
Query: 7 PTSTSTTSSSKDQNQSPLLGRYEI-------GKLLGHGTFAKVY--HARNVKSGES---V 54
+ + + D Q P ++E GK LG G F KV A + ++ V
Sbjct: 20 ESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV 79
Query: 55 AIKVIDKEKILKSGLVAHIK------REISILRRV-RHPNIVQLFEVMATKSKIYFVMEY 107
A+K +LKS AH E+ I+ + +H NIV L + + EY
Sbjct: 80 AVK------MLKST--AHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
Query: 108 VRGGELFN--KVAKGRLKEDLARKYFQQLISA---VGFCH--ARG-VY-------HRDLK 152
G+L N + L+ D A S + F A+G + HRD+
Sbjct: 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191
Query: 153 PENLLLDENGDLKVSDFGLS---AVSD--QIRQDGLFHTFCGTPAYV---APEVLSRKGY 204
N+LL K+ DFGL+ ++ + P V APE + Y
Sbjct: 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL------P--VKWMAPESIFDCVY 243
Query: 205 DAAKVDIWSCGVILFVLMA-GYLPFQDQNIMV---MYKKIYKGEFR--SPRWFSPDLIRL 258
+ D+WS G++L+ + + G P+ I+V YK + G ++ P + ++ +
Sbjct: 244 T-VQSDVWSYGILLWEIFSLGLNPY--PGILVNSKFYKLVKDG-YQMAQPAFAPKNIYSI 299
Query: 259 LTKLLDTNPDKRITIPEIME 278
+ P R T +I
Sbjct: 300 MQACWALEPTHRPTFQQICS 319
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 47/217 (21%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLF 92
+LG G F KVY R + G VA+K + +E+ G + E+ ++ H N+++L
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 93 EVMATKSKIYFVMEYVRGG----ELFNKVAKG-------RLKEDLARKYFQQLISAVGFC 141
T ++ V Y+ G L + R + I A+G
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR-----------I-ALGS- 140
Query: 142 HARG-----------VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH---TF 187
ARG + HRD+K N+LLDE + V DFGL+ + D H
Sbjct: 141 -ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTAV 195
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG 224
GT ++APE LS G + K D++ GV+L L+ G
Sbjct: 196 RGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITG 231
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 72/328 (21%), Positives = 131/328 (39%), Gaps = 69/328 (21%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEI-------GKLLGHGTFAKVYHAR------- 46
+ + T+ + + + + P ++E GK LG G F +V A
Sbjct: 49 ITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKD 108
Query: 47 NVKSGESVAIKVIDKEKILKSGLVAHIK----REISILRRV-RHPNIVQLFEVMATKSKI 101
K +VA+K +LK E+ +++ + +H NI+ L +
Sbjct: 109 KPKEAVTVAVK------MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162
Query: 102 YFVMEYVRGGEL----------FNKVAKGRLKEDLARKYFQQLISAVGFCH--ARG-VY- 147
Y ++EY G L + + + + F+ L+S + ARG Y
Sbjct: 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS---CTYQLARGMEYL 219
Query: 148 ------HRDLKPENLLLDENGDLKVSDFGLS---AVSD--QIRQDGLFHTFCGTPAYV-- 194
HRDL N+L+ EN +K++DFGL+ D + +G P V
Sbjct: 220 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL------P--VKW 271
Query: 195 -APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRW 250
APE L + Y + D+WS GV+++ + G P+ + ++K + +G R P
Sbjct: 272 MAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKPAN 329
Query: 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ +L ++ P +R T +++E
Sbjct: 330 CTNELYMMMRDCWHAVPSQRPTFKQLVE 357
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 40/227 (17%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR- 84
++ +G+ +G G+F ++Y N+++ E VAIK ++ K L E I R ++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL----LYESKIYRILQG 61
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRG---GELFNKVAKGR---LK--EDLARKYFQQLIS 136
I + VM+ + G +LFN R LK LA Q+I+
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF--CSRKLSLKTVLMLA----DQMIN 114
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFGLS-----AVSDQIRQDGLFHTFC 188
V F H++ HRD+KP+N L+ + + DFGL+ + Q
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 189 GTPAYVAPEV-----LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD 230
GT Y + SR+ D D+ S G +L + G LP+Q
Sbjct: 175 GTARYASVNTHLGIEQSRR--D----DLESLGYVLMYFLRGSLPWQG 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 73/334 (21%), Positives = 121/334 (36%), Gaps = 83/334 (24%)
Query: 5 TAPTSTSTTSSSKDQNQSPLLGRYEI-------GKLLGHGTFAKVY--HARNVKSGES-- 53
S+ D + ++E GK+LG G F KV A +
Sbjct: 17 QVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI 76
Query: 54 -VAIKVIDKEKILKSGLVAHIK----REISILRRV-RHPNIVQLFEVMATKSKIYFVMEY 107
VA+K +LK + + E+ ++ ++ H NIV L IY + EY
Sbjct: 77 QVAVK------MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 130
Query: 108 VRGGEL-----------------FNKVAKGRLKEDLARKYFQQLISAVGFCH--ARG-VY 147
G+L + + +EDL F+ L+ F + A+G +
Sbjct: 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC---FAYQVAKGMEF 187
Query: 148 -------HRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV------ 194
HRDL N+L+ +K+ DFGL+ D + YV
Sbjct: 188 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLA--RDIMSDS----------NYVVRGNAR 235
Query: 195 ------APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQD-QNIMVMYKKIYKGEFR 246
APE L Y K D+WS G++L+ + + G P+ YK I G F+
Sbjct: 236 LPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG-FK 293
Query: 247 --SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
P + + ++ ++ + KR + P +
Sbjct: 294 MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 77/324 (23%), Positives = 125/324 (38%), Gaps = 82/324 (25%)
Query: 14 SSSKDQNQSPLLGRYEI-------GKLLGHGTFAKVY--HARNVKSGES---VAIKVIDK 61
S S D + ++E GK LG G F KV A ++K VA+K
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---- 59
Query: 62 EKILKSGLVAHIK----REISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL---- 113
+LK E ++L++V HP++++L+ + + ++EY + G L
Sbjct: 60 --MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL 117
Query: 114 --------------FNKVAKGRLKEDLARKYFQQLISAVGFCH--ARG-VY-------HR 149
++ + D LIS F ++G Y HR
Sbjct: 118 RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS---FAWQISQGMQYLAEMKLVHR 174
Query: 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV------------APE 197
DL N+L+ E +K+SDFGLS D +D +YV A E
Sbjct: 175 DLAARNILVAEGRKMKISDFGLS--RDVYEED----------SYVKRSQGRIPVKWMAIE 222
Query: 198 VLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPD 254
L Y + D+WS GV+L+ ++ G P+ ++ + G R P S +
Sbjct: 223 SLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG-HRMERPDNCSEE 280
Query: 255 LIRLLTKLLDTNPDKRITIPEIME 278
+ RL+ + PDKR +I +
Sbjct: 281 MYRLMLQCWKQEPDKRPVFADISK 304
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 62/285 (21%), Positives = 108/285 (37%), Gaps = 51/285 (17%)
Query: 29 EIGKLLGHGTFAKVY--HARNVKSGES---VAIKVIDKEKILKSGLVAHIK---REISIL 80
+ LG G F KV+ N+ + VA+K LK + + RE +L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK------ALKEASESARQDFQREAELL 97
Query: 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA--- 137
++H +IV+ F V + V EY+R G+L + L
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 138 ---VGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS---AVSD--QIR 179
+ A G VY HRDL N L+ + +K+ DFG+S +D ++
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 180 QDGLFHTFCGTPAYV---APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMV 235
+ P + PE + + + + D+WS GV+L+ + G P+ +
Sbjct: 218 GRTML------P--IRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268
Query: 236 MYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
I +G PR P++ ++ P +R +I ++
Sbjct: 269 AIDCITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 49/244 (20%), Positives = 95/244 (38%), Gaps = 45/244 (18%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
Y++G+ +G G+F ++ N+ + + VAIK + + L + E + +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQL----RDEYRTYKLLAG 64
Query: 86 -PNIVQLFEVMATKSKIYFVMEYVRG---GELFNKVAKGR---LKE--DLARKYFQQLIS 136
I ++ V++ + G +L + GR +K A +Q+++
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--CGRKFSVKTVAMAA----KQMLA 117
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLK-----VSDFGLS-----AVSDQIRQDGLFHT 186
V H + + +RD+KP+N L+ V DFG+ V+ Q
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 187 FCGTPAYVAP-----EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ---DQNIMVMYK 238
GT Y++ SR+ D D+ + G + + G LP+Q Y+
Sbjct: 178 LSGTARYMSINTHLGREQSRR--D----DLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231
Query: 239 KIYK 242
+I +
Sbjct: 232 RIGE 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 51/278 (18%), Positives = 92/278 (33%), Gaps = 64/278 (23%)
Query: 1 MAHATAPTSTSTTSSSKDQNQSPLL-----------GRYEIGKLLGHGTFAKVYHARNVK 49
M H +S + QS ++ +GK +G G F +Y A
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTN 60
Query: 50 SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK------IYF 103
E A V+ K + ++G + E+ +RV + ++ +
Sbjct: 61 KPEKDARHVV-KVEYQENG---PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116
Query: 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQ---------------QLISAVGFCHARGVYH 148
+ +G + + RL DL K +++ + + H H
Sbjct: 117 GLTEFKGRS-YRFMVMERLGIDLQ-KISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVH 174
Query: 149 RDLKPENLLLDENGDLKV--SDFGLS------AVSDQIRQDGLFHTFCGTPAY------- 193
D+K NLLL +V +D+GLS Q +++ GT +
Sbjct: 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP-RKGHNGTIEFTSLDAHK 233
Query: 194 -VAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD 230
VA SR+ D+ G + + G LP++
Sbjct: 234 GVAL---SRRS------DVEILGYCMLRWLCGKLPWEQ 262
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 49/217 (22%)
Query: 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR----EISILRRVRHPNI 88
+G G F VY + + +VA+K + + + +K+ EI ++ + +H N+
Sbjct: 38 KMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHENL 92
Query: 89 VQLFEVMATKSKIYFVMEYVRGG----ELFNKVAKG------RLK--EDLARKYFQQLIS 136
V+L + + V Y+ G L R K + A
Sbjct: 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN-------- 144
Query: 137 AVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL---------SAVSDQIRQDGLFHTF 187
+ F H HRD+K N+LLDE K+SDFGL + ++ +I
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV-------- 196
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG 224
GT AY+APE L G K DI+S GV+L ++ G
Sbjct: 197 -GTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITG 230
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 63/295 (21%), Positives = 105/295 (35%), Gaps = 61/295 (20%)
Query: 29 EIGKLLGHGTFAKVY--HARNVKSGES---VAIKVIDKEKILKSGLVAHIK----REISI 79
E + +G G F +V+ A + E VA+K +LK A ++ RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK------MLKEEASADMQADFQREAAL 103
Query: 80 LRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL------------FNKVAKGRLKEDLA 127
+ +PNIV+L V A + + EY+ G+L +
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 128 RKYFQQLISA---VGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS-- 172
+S + A G Y HRDL N L+ EN +K++DFGLS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 173 -AVSD--QIRQDGLFHTFCGTPAYV---APEVLSRKGYDAAKVDIWSCGVILF-VLMAGY 225
+D + + P + PE + Y + D+W+ GV+L+ + G
Sbjct: 224 IYSADYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGL 274
Query: 226 LPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
P+ + + G P +L L+ P R + I
Sbjct: 275 QPYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 80.7 bits (198), Expect = 8e-17
Identities = 33/191 (17%), Positives = 57/191 (29%), Gaps = 47/191 (24%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVI-----DKEKILKSGLVAHIKREISILR 81
+ + + +G G F +V+ VAIK+I D I EI I +
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 82 RV---------RHPNIVQLFEV------------------------------MATKSKIY 102
+ R + L V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDEN 161
V+E+ GG ++ A+ QL +++ A HRDL N+LL +
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 162 GDLKVSDFGLS 172
K+
Sbjct: 199 SLKKLHYTLNG 209
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 68/293 (23%), Positives = 119/293 (40%), Gaps = 62/293 (21%)
Query: 29 EIGKLLGHGTFAKVY--HARNVKSGES-----VAIKVIDKEKILKSGLVAHIK----REI 77
+GK LG G F +V A + + VA+K +LKS E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK------MLKSDATEKDLSDLISEM 125
Query: 78 SILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGEL----------FNKVAKGRLKEDL 126
+++ + +H NI+ L +Y ++EY G L + +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 127 ARKYFQQLISAVGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS---A 173
+ + L+S + ARG Y HRDL N+L+ E+ +K++DFGL+
Sbjct: 186 EQLSSKDLVS---CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 174 VSD--QIRQDGLFHTFCGTPAYV---APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLP 227
D + +G P V APE L + Y + D+WS GV+L+ + G P
Sbjct: 243 HIDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSP 293
Query: 228 FQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ + ++K + +G R P + +L ++ P +R T +++E
Sbjct: 294 YPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 66/294 (22%), Positives = 114/294 (38%), Gaps = 64/294 (21%)
Query: 29 EIGKLLGHGTFAKVYHA--RNVKSGES---VAIKVIDKEKILKSGLVAHIK----REISI 79
++GK LG G F +V A + + VA+K +LK G E+ I
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK------MLKEGATHSEHRALMSELKI 83
Query: 80 LRRV-RHPNIVQLFEV-MATKSKIYFVMEYVRGGEL----------FNKVAKGRLKEDLA 127
L + H N+V L + ++E+ + G L F
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 128 RKYFQQLISAVGFCH--ARG-VY-------HRDLKPENLLLDENGDLKVSDFGLS--AVS 175
+ LI + A+G + HRDL N+LL E +K+ DFGL+
Sbjct: 144 FLTLEHLIC---YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 176 DQI---RQDGLFHTFCGTPAYV---APEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPF 228
D + D P + APE + + Y + D+WS GV+L+ + G P+
Sbjct: 201 DPDYVRKGDARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 251
Query: 229 Q--DQNIMVMYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ +++ +G R +P + +P++ + + P +R T E++E
Sbjct: 252 PGVKIDEEFC-RRLKEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 53/255 (20%), Positives = 90/255 (35%), Gaps = 53/255 (20%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
+++G +G G F +Y A S ESV K+ S + E+ +R
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADM-NSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAK 92
Query: 86 PNIVQLFEVMATKS-----KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ-------- 132
P +Q + K + + + G+ + + R DL K ++
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRFSR 151
Query: 133 --------QLISAVGFCHARGVYHRDLKPENLLLDENGDLKV--SDFGLS------AVSD 176
+++ + + H H D+K NLLL+ +V D+GL+ V
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 177 QIRQDGLFHTFCGTPAY--------VAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF 228
D GT + VAP SR+G D+ G + + G+LP+
Sbjct: 212 AYAADP-KRCHDGTIEFTSIDAHNGVAP---SRRG------DLEILGYCMIQWLTGHLPW 261
Query: 229 QD---QNIMVMYKKI 240
+D V KI
Sbjct: 262 EDNLKDPKYVRDSKI 276
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 35/252 (13%), Positives = 78/252 (30%), Gaps = 47/252 (18%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSG--------ESVAIKV-------IDKEKILKSGLV 70
++++ +Y A + + ++K+ +++ +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 71 AHIKREISILRRVRHPNIVQLFEVMATKSKIYF-VMEYVRG---GELFNKVAKGRLKEDL 126
+ L I + K F V+ + G + K L E
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERS 160
Query: 127 ARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV--SDFGLSAV----SDQIR- 179
+ +L+ A+ F H H ++ EN+ +D +V + +G + +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 180 QDGLFHTFCGTPAY--------VAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD- 230
+G G + P SR+ D+ S G + + G+LP+ +
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGP---SRRS------DLQSLGYCMLKWLYGFLPWTNC 271
Query: 231 --QNIMVMYKKI 240
+M +K
Sbjct: 272 LPNTEDIMKQKQ 283
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV---AP 196
F +R HRDL N+LL E +K+ DFGL+ I +D + + AP
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDARLPLKWMAP 264
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQD-QNIMVMYKKIYKGEFR--SPRWFS 252
E + + Y + D+WS GV+L+ + + G P+ + +++ +G R +P + +
Sbjct: 265 ETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRMRAPDYTT 322
Query: 253 PDLIRLLTKLLDTNPDKRITIPEIME 278
P++ + + P +R T E++E
Sbjct: 323 PEMYQTMLDCWHGEPSQRPTFSELVE 348
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 22/93 (23%), Positives = 39/93 (41%), Gaps = 7/93 (7%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGL----VAHIKREISILRRV- 83
++GK LG G F +V A ++ + + K+LK G + E+ IL +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 84 RHPNIVQLFEVMATKSK-IYFVMEYVRGGELFN 115
H N+V L + ++E+ + G L
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 34/168 (20%), Positives = 60/168 (35%), Gaps = 27/168 (16%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGE--SVAIKV-------IDKEKILKSGLVAHIKREIS 78
+G ++ G A V++A V G+ ++A+K+ DK G R IS
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 79 ILRRVR------HPNIVQLFEVMATKSKIYF------VMEYVRGGELFN---KVAKGRLK 123
+V N+ + E + + Y +ME++ EL LK
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 124 EDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFG 170
E F ++ V + + H DL N++ + + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK--VYFIDMG 214
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 26/164 (15%), Positives = 59/164 (35%), Gaps = 27/164 (16%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKV---------------IDKEKILKSGLVAH 72
IGKL+G G + V++ + + +K + +
Sbjct: 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 73 IKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ 132
+ E L++++ + +++ +ME + EL+ R++ + +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELY------RVRVENPDEVLD 200
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176
++ V + RG+ H DL N+L+ + + DF S
Sbjct: 201 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 243
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 4e-05
Identities = 55/351 (15%), Positives = 97/351 (27%), Gaps = 111/351 (31%)
Query: 59 IDKEKILKSGLVAHIKREIS--ILRRVRHPNIVQLFE----VMAT---KSKIYFVMEYVR 109
I + L+ E +L V++ F ++ T K F+
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 110 GGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169
+ + L D + + + +DL E L +
Sbjct: 287 THISLDHHSMT-LTPDEVKSLLLKYL---------DCRPQDLPRE--------VLTTNPR 328
Query: 170 GLSAVSDQIRQ-------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGV 216
LS +++ IR D L + + P RK +D
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY-RKMFDR---------- 377
Query: 217 ILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSP---DLIRLLTK-----LLDTNPD 268
L V +I + + WF D++ ++ K L++ P
Sbjct: 378 -LSVFP------PSAHIPTILLSLI--------WFDVIKSDVMVVVNKLHKYSLVEKQPK 422
Query: 269 K-RITIPEI-------MENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDD---- 316
+ I+IP I +EN H ++ N+ +DD+ P D
Sbjct: 423 ESTISIPSIYLELKVKLENE----YALHRSI-VDHY---NIPKTFDSDDLIPPYLDQYFY 474
Query: 317 ----HSLSEPEPEPE-------------LETKRKLTSLPRPASLNAFDLIS 350
H L E LE K + S AS + + +
Sbjct: 475 SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ 525
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 80/513 (15%), Positives = 157/513 (30%), Gaps = 145/513 (28%)
Query: 27 RYEIGKLLGH--GTFAKVYHARNVKSGESVAIKVIDKEKILKSG-LVAHIKREISILRRV 83
+Y+ +L F + ++V+ + + + I+ S V+ R L
Sbjct: 15 QYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS- 73
Query: 84 RHPNIVQLFEVMATKSKIYFVME---------------YV-------RGGELFNKVAKGR 121
+ +VQ F + F+M Y+ ++F K R
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 122 LKEDLARKYFQQLISAVGFCHARGVYHRDLKPE-NLLLDENGDL---KVSDFGLSAVSDQ 177
L+ + +L A+ +L+P N+L+D G L K + L
Sbjct: 134 LQP------YLKLRQAL----------LELRPAKNVLID--GVLGSGK-TWVALDVCLSY 174
Query: 178 IRQDGL-FHTF------CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD 230
Q + F F C +P V E+L + +L+ + + D
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETV-LEMLQK---------------LLYQIDPNWTSRSD 218
Query: 231 QNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIK 290
+ + + L +LL + P + + ++ N K +
Sbjct: 219 H-------------SSNIKLRIHSIQAELRRLLKSKPYENCLL--VLLNVQNAKAWNA-- 261
Query: 291 FYIEDDKMCNV----EDVDHTDDVGPCSDDHSLSEPEPEP--ELETKR--------KLTS 336
F + C + TD + + H + E K +
Sbjct: 262 F----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 337 LPRPASLNAFDLISFSPGFDLSGLFEEGGEGA------RFVSGAPVSKII-TKLEEIAKV 389
LPR ++ +P LS + E +G + V+ ++ II + L +
Sbjct: 318 LPREV-------LTTNP-RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE-- 367
Query: 390 VSFTVRK--KDCRVSLEGSREGVKGP---LTIA-TEIFELTPKLVVVEVKKKG-GDKGEY 442
RK V P L++ ++ + +VV ++ K +K
Sbjct: 368 -PAEYRKMFDRLSV----FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-- 420
Query: 443 EEFCNKELKPGLENLMLDESESAVVAAVDDALH 475
KE + ++ L+ + ALH
Sbjct: 421 ----PKESTISIPSIYLELKVK---LENEYALH 446
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 481 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.84 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.46 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.23 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 97.99 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 97.99 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.8 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.77 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.5 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.37 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.19 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.13 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.1 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.9 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.5 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.23 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.76 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.71 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-68 Score=525.04 Aligned_cols=261 Identities=34% Similarity=0.637 Sum_probs=242.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999998776555556678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||||+||+|++++.+ +.++|.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999976 78999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
....+.|||+.|||||++.+.+| +.++|||||||++|+|++|.+||.+.+...++.+|.++.+..|..+|+++++||.+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 55678899999999999998888 57899999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCCHhH------HHhCccccc
Q 011628 262 LLDTNPDKRITIPE------IMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~~e------il~h~~f~~ 284 (481)
||++||++|||++| |++||||+.
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 99999999999988 688999964
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-67 Score=509.77 Aligned_cols=259 Identities=46% Similarity=0.869 Sum_probs=222.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 35899999999999999999999999999999999988766555666789999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||| +|+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---CC
Confidence 99999 6799998865 7899999999999999999999999999999999999999999999999999986433 23
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
...+.+||+.|||||++.+..|++.++|||||||++|+|++|+.||.+.+...++..+..+.+..|..+|+++++||.+|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 34578999999999999998888889999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCCCHhHHHhCcccccCc
Q 011628 263 LDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
|++||++|||++|+++||||+...
T Consensus 247 L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp SCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred ccCChhHCcCHHHHHcCcccccCC
Confidence 999999999999999999997653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-66 Score=516.96 Aligned_cols=281 Identities=29% Similarity=0.524 Sum_probs=234.2
Q ss_pred CCCCCCCCCCCccCCCCCCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH
Q 011628 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL 80 (481)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il 80 (481)
|.|...-+|+.+.++.....+ -+++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|
T Consensus 1 ~~~~~~~ssgvd~gten~~f~--sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il 77 (350)
T 4b9d_A 1 MHHHHHHSSGVDLGTENLYFQ--SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVL 77 (350)
T ss_dssp ---CCCC-------CCCCBCS--CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHH
T ss_pred CCCcCCCCCCccCCCcccCCC--cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHH
Confidence 444444445555444333322 268999999999999999999999999999999999876543 34567899999999
Q ss_pred HhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 011628 81 RRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLL 157 (481)
Q Consensus 81 ~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NIL 157 (481)
++|+|||||++++++.+.+.+|||||||+||+|++++.. ..+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 78 ~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 157 (350)
T 4b9d_A 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 157 (350)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEE
T ss_pred HHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEE
Confidence 999999999999999999999999999999999999964 35799999999999999999999999999999999999
Q ss_pred EccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHH
Q 011628 158 LDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY 237 (481)
Q Consensus 158 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~ 237 (481)
++.+|++||+|||+|+..... .....+.+||+.|||||++.+.+| +.++|||||||++|+|++|+.||.+.+...++
T Consensus 158 l~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 234 (350)
T 4b9d_A 158 LTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234 (350)
T ss_dssp ECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 999999999999999865432 123356789999999999999888 56899999999999999999999999999999
Q ss_pred HHHhhCCC-CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 238 KKIYKGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 238 ~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
.++..+.+ +.+..+|+++++||.+||++||++|||++|+++||||++...
T Consensus 235 ~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 235 LKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 99998875 457789999999999999999999999999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-65 Score=509.23 Aligned_cols=255 Identities=29% Similarity=0.495 Sum_probs=231.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++++.||+|+||+||+|+++.+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998664332 345789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
|||+||+|++++.++++++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ......
T Consensus 151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~ 228 (346)
T 4fih_A 151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRK 228 (346)
T ss_dssp CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBC
T ss_pred eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999986543 223456
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHHHHHHHHHh
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~ 262 (481)
+.|||+.|||||++.+.+| +.++|||||||++|+|++|.+||.+.+....+..+..+.. ..+..+|+++++||.+|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 7899999999999998888 6789999999999999999999999998888888877643 33456899999999999
Q ss_pred cccCcCCCCCHhHHHhCcccccCc
Q 011628 263 LDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
|++||++|||++|+++||||++..
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999998653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-64 Score=498.01 Aligned_cols=256 Identities=36% Similarity=0.668 Sum_probs=226.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++++.||+|+||+||+|++. .+++.||||++++....... ...+.+|+.+|++++|||||++++++.+++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 478999999999999999999984 46889999999876543322 23577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|||||||+||+|++++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--H 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--C
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999999985432 2
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
.....+.+||+.|||||++.+.+| +.++|||||||++|+|++|..||.+.+..+++.++.++.+..|..+|+++++||.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 234467899999999999998888 5689999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCcCCCCC-----HhHHHhCccccc
Q 011628 261 KLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
+||++||++||| ++|+++||||+.
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999998 589999999964
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-63 Score=510.45 Aligned_cols=254 Identities=29% Similarity=0.511 Sum_probs=231.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++++.||+|+||+||+|+++.+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998764332 345789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
|||+||+|.+++..+++++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... ......
T Consensus 228 Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~ 305 (423)
T 4fie_A 228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRK 305 (423)
T ss_dssp ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCBC
T ss_pred eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCcccc
Confidence 999999999999989999999999999999999999999999999999999999999999999999986533 223456
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHHHHHHh
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~~ 262 (481)
+.|||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+....+..+..+. +..+..+|+++++||.+|
T Consensus 306 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 7899999999999998888 578999999999999999999999999888888887763 334567899999999999
Q ss_pred cccCcCCCCCHhHHHhCcccccC
Q 011628 263 LDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|++||++|||++|+|+||||++.
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCCChhHCcCHHHHhcCHHhcCC
Confidence 99999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-62 Score=480.71 Aligned_cols=253 Identities=24% Similarity=0.516 Sum_probs=221.6
Q ss_pred cCCe-eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CC
Q 011628 25 LGRY-EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----KS 99 (481)
Q Consensus 25 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~ 99 (481)
.+|| ++.+.||+|+||+||+|++..++..||+|++...... ....+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 5677 8889999999999999999999999999999876543 3446779999999999999999999999865 35
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEcc-CCCEEEEecCCcccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDE-NGDLKVSDFGLSAVS 175 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~-~g~lkl~DFGla~~~ 175 (481)
.+|||||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999976 68999999999999999999999998 999999999999985 799999999999753
Q ss_pred cccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-hHHHHHHHHhhCCC--CCCCCCC
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NIMVMYKKIYKGEF--RSPRWFS 252 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~~~~~i~~~~~--~~~~~~s 252 (481)
. .....+.+|||.|||||++.+ +| +.++|||||||++|+|++|..||.+. +...++..+..+.. ..+..++
T Consensus 183 ~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred C----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 2 234567899999999999865 56 67899999999999999999999765 45566677766643 2456688
Q ss_pred HHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+++++||.+||++||++|||++|+++||||++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=484.93 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=220.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.+.|++.+.||+|+||+||+|+++.+|+.||||+++.+... .+|+.+++.++|||||++++++.+++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999875432 3699999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~~~~~ 182 (481)
||||+||+|.+++.+ +.+++..++.|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+.........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999999976 7899999999999999999999999999999999999999988 69999999998654322111
Q ss_pred ---cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHHHH
Q 011628 183 ---LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPDLI 256 (481)
Q Consensus 183 ---~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~ 256 (481)
.....+||+.|||||++.+.+| +.++|||||||++|+|++|+.||.+.+...++.++..+.. ..|+.+|+++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 1234689999999999999888 5689999999999999999999998877777778877654 35778999999
Q ss_pred HHHHHhcccCcCCCCCHhHHH-------------hCccccc
Q 011628 257 RLLTKLLDTNPDKRITIPEIM-------------ENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil-------------~h~~f~~ 284 (481)
+||.+||++||.+|||+.||+ +|||+.+
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 999999999999999999984 5788754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=500.16 Aligned_cols=424 Identities=31% Similarity=0.571 Sum_probs=309.6
Q ss_pred CCCCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011628 16 SKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVM 95 (481)
Q Consensus 16 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (481)
.....+....++|++++.||+|+||+||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp ---CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 33455667789999999999999999999999999999999999876544334567789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
.+.+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 999999999999999999999976 6799999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHH
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPD 254 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 254 (481)
... .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++..+.+..|..++++
T Consensus 166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 242 (476)
T 2y94_A 166 MSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPS 242 (476)
T ss_dssp CCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHH
T ss_pred ccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHH
Confidence 432 23456779999999999998887777899999999999999999999999988889999999988889999999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccCccccceeecccc---------ccCc-CCCCCC-CCCCCC--C---CCCC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDK---------MCNV-EDVDHT-DDVGPC--S---DDHS 318 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~~~~~~~~~~~---------~~~~-~~~~~~-~~~~~~--~---~~~~ 318 (481)
+.+||.+||+.||.+|||++|+++||||++......+...... .... +..... ++...+ . .++.
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 322 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPL 322 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC---------------------
T ss_pred HHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHH
Confidence 9999999999999999999999999999875432211100000 0000 000000 000000 0 0000
Q ss_pred ------C-CC---CCCCchh--hh--hh---hccC--CCCCCCcc------chhhhccCC--CCCCCCCcccCc-cccce
Q 011628 319 ------L-SE---PEPEPEL--ET--KR---KLTS--LPRPASLN------AFDLISFSP--GFDLSGLFEEGG-EGARF 370 (481)
Q Consensus 319 ------~-~~---~~~~~~~--~~--~~---~~~~--~~~~~~~~------~~~~~~~~~--~~~l~~~~~~~~-~~~~f 370 (481)
+ .. .....+. .. .. .... .+.|.... .-...+.++ .......+.... ...++
T Consensus 323 ~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi 402 (476)
T 2y94_A 323 AVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGI 402 (476)
T ss_dssp ----------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESE
T ss_pred HHHHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecC
Confidence 0 00 0000000 00 00 0000 00000000 000000000 000111121111 35688
Q ss_pred ecCCCHHHHHHHHHHHHHHcCcEEEEec-ceEEEEeecCCCcccEEEEEEEEEEcCceEEEEeEecCCCchhH
Q 011628 371 VSGAPVSKIITKLEEIAKVVSFTVRKKD-CRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGEY 442 (481)
Q Consensus 371 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~k~~l~~~~~v~~~~~~~~lVe~~~~~Gd~le~ 442 (481)
.|+.++.+|+..|..+++.+||.|++.+ +.|++..........+.|.+++|++.++.+||||++..|+.++|
T Consensus 403 ~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 403 RSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp EECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred ccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 8999999999999999999999998755 44887643322234577999999999999999999999999886
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-60 Score=484.28 Aligned_cols=260 Identities=26% Similarity=0.399 Sum_probs=224.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT------ 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 97 (481)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 45789999999999999999999999999999999976543 23445778899999999999999999999764
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...+|||||||. |+|++++.. +++++..++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367999999996 679999976 689999999999999999999999999999999999999999999999999998643
Q ss_pred cc--ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-------
Q 011628 177 QI--RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS------- 247 (481)
Q Consensus 177 ~~--~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~------- 247 (481)
.. .......+.+||+.|||||++.+..+.+.++||||+||++|+|++|++||.+.+....+..|.......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 223345678999999999999887777889999999999999999999999998887777775431111
Q ss_pred ------------------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 ------------------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+.+|+++.+||.+||.+||.+|||++|+|+||||++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 12368899999999999999999999999999999753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-59 Score=461.46 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=203.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS----- 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 99 (481)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 457999999999999999999999999999999997653 3345577899999999999999999999987644
Q ss_pred -------EEEEEEeccCCCchHHHHHcC-C---CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 100 -------KIYFVMEYVRGGELFNKVAKG-R---LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 100 -------~~~lv~Ey~~gg~L~~~i~~~-~---l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
.+|+|||||+||+|.+++... . .++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 379999999999999999863 2 45677899999999999999999999999999999999999999999
Q ss_pred cCCcccccccccC----------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHH
Q 011628 169 FGLSAVSDQIRQD----------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMY 237 (481)
Q Consensus 169 FGla~~~~~~~~~----------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~ 237 (481)
||+|+........ ....+.+||+.|||||++.+..| +.++|||||||++|||++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999865432211 12245689999999999998888 578999999999999996 8876543 3444
Q ss_pred HHHhhCCCC-CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 238 KKIYKGEFR-SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 238 ~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+....++ .+...++.+.+||.+||++||.+|||+.|+++||||+.
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 444444432 12235677899999999999999999999999999964
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-59 Score=459.81 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=221.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|++++|||||++++++.+++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 468999999999999999999875 36789999999754 2345677999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 011628 100 KIYFVMEYVRGGELFNKVAK--------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lk 165 (481)
.+|||||||+||+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 99999999999999999964 2599999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC
Q 011628 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 166 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 244 (481)
|+|||+|+..............+||+.|||||++.+..| +.++|||||||++|||+| |+.||.+.+..++...+..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986443222222334579999999999998888 578999999999999998 999999999888888888876
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 -FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+.|..+|+++.+||.+||+.||++|||+.|| ++|+++
T Consensus 248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 56788899999999999999999999999999 457653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-58 Score=494.96 Aligned_cols=256 Identities=31% Similarity=0.539 Sum_probs=227.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG---LVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
-+++|+++++||+|+||+||+|+++.+|+.||||++++....... .....++++.+++.++|||||++++++.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 478999999999999999999999999999999999876543322 22333455777788899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+|||||||+||+|++++.+ +.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~-- 344 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 344 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999986432
Q ss_pred cCCcccccCCCCcccccccccc-CCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhCCCCCCCCCCHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSR-KGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGEFRSPRWFSPDL 255 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~ 255 (481)
....+.|||+.|||||++.+ .+| +.++|||||||++|+|++|.+||.+. +...+...+.......|..+|+++
T Consensus 345 --~~~~t~~GTp~YmAPEvl~~~~~y-~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a 421 (689)
T 3v5w_A 345 --KKPHASVGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421 (689)
T ss_dssp --CCCCSCCSCGGGCCHHHHSTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred --CCCCCccCCcCccCHHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHH
Confidence 23467899999999999965 456 67899999999999999999999764 345677788888889999999999
Q ss_pred HHHHHHhcccCcCCCCC-----HhHHHhCccccc
Q 011628 256 IRLLTKLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
++||.+||++||.+|++ ++||++||||+.
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 99999999999999998 799999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-58 Score=464.25 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=209.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
+.++|++++.||+|+||+||+|+++ .+++.||||++.+.. ...++.+|+.+|+.+ +||||+++++++.+.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 5689999999999999999999875 467899999986543 234578999999998 6999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~~~ 178 (481)
.+|+|||||+||+|.+++. .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 9999999999999999984 59999999999999999999999999999999999999877 79999999999753221
Q ss_pred c--------------------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-
Q 011628 179 R--------------------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ- 231 (481)
Q Consensus 179 ~--------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~- 231 (481)
. ......+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1 1122345789999999999988765578899999999999999999999543
Q ss_pred hHHHHHHHHhh--------------------------------------CC----------------CCCCCCCCHHHHH
Q 011628 232 NIMVMYKKIYK--------------------------------------GE----------------FRSPRWFSPDLIR 257 (481)
Q Consensus 232 ~~~~~~~~i~~--------------------------------------~~----------------~~~~~~~s~~~~~ 257 (481)
+.......|.. .. ......+|+++++
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 33333222211 00 0112347899999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||.+||++||++|||++|+|+||||+.
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999964
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=456.22 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=214.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
..+|.+.+.||+|+||+||+|++. .+++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357899999999999999999864 36889999999754 2345677999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC
Q 011628 100 KIYFVMEYVRGGELFNKVAK----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD 163 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~ 163 (481)
.+|||||||+||+|.+++.. +++++.++..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 99999999999999999864 35899999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhh
Q 011628 164 LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYK 242 (481)
Q Consensus 164 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~ 242 (481)
+||+|||+|+..............+||+.|||||++.+..| +.++|||||||+||||+| |+.||.+.+..+....+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999986544333333456789999999999998887 678999999999999999 9999999988888888887
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 243 GE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 243 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+. ++.|..+|+++.+||.+||+.||++|||+.||+++
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 74 66788899999999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=452.37 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=223.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (481)
.-.+.+++.+.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.++++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 34678999999999999999999863 467899999997543 23345779999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE 160 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~ 160 (481)
.+.+|||||||++|+|.+++.. +.+++..+..++.||+.||+|||+++|+||||||+|||+++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 9999999999999999999953 35899999999999999999999999999999999999999
Q ss_pred CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHH
Q 011628 161 NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKK 239 (481)
Q Consensus 161 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 239 (481)
++++||+|||+|+..............+||+.|||||++.+..| +.++|||||||+||||+| |..||.+.+..++...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986554333444566789999999999988887 678999999999999998 8999999998888888
Q ss_pred HhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 240 IYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 240 i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+..+. .+.|..+|+++.+|+.+||+.||++|||+.||+++
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88775 56688899999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-57 Score=485.11 Aligned_cols=256 Identities=30% Similarity=0.548 Sum_probs=232.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.+.++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.|+|||||++++++.+...+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 456899999999999999999999999999999999976542 23467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC--CCEEEEecCCccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN--GDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~--g~lkl~DFGla~~~~~~ 178 (481)
||||||+||+|++++.. +.+++.+++.|++||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+....
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~- 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence 99999999999999964 579999999999999999999999999999999999999864 8999999999986542
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 254 (481)
.....+.|||+.|||||++.+.+| +.++|||||||++|+|++|..||.+.+....+..+..+.+..+ ..+|++
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred --CCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 334567899999999999999888 5789999999999999999999999999999999988876543 468999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++||.+||++||.+|||++|+|+||||+..
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 9999999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=448.96 Aligned_cols=250 Identities=22% Similarity=0.406 Sum_probs=205.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.+++++++.||+|+||+||+|++. ..||||+++.... .....+.+.+|+.+|++++|||||++++++.. +.+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 468899999999999999999863 3599999975442 33456789999999999999999999998754 568999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||+||+|.+++.. +++++..+..++.|++.||+|||+++|+||||||+|||++.++++||+|||+|+.........
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 999999999999964 579999999999999999999999999999999999999999999999999998755433344
Q ss_pred cccccCCCCccccccccccCC--CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH-HHHHhhCCC-----CCCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKG--YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM-YKKIYKGEF-----RSPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i~~~~~-----~~~~~~s~~ 254 (481)
...+.+||+.|||||++.+.. ..+.++|||||||+||||+||+.||.+.+.... ...+..+.. ..+..+|++
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 456779999999999996432 236789999999999999999999988654433 333333321 235568999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+.+||.+||+.||++|||+.||+++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999998765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=437.83 Aligned_cols=261 Identities=44% Similarity=0.841 Sum_probs=240.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..+..++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 34568999999999999999999999999999999999987653 33456778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+|+||||++||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 9999999999999999865 7899999999999999999999999999999999999999999999999999975432
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLL 259 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li 259 (481)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+..+.+..|..+++++.+||
T Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 245 (328)
T 3fe3_A 167 -GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL 245 (328)
T ss_dssp -SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 2345677999999999999988887788999999999999999999999999999999999999999999999999999
Q ss_pred HHhcccCcCCCCCHhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+||..||.+|||++|+++||||+..
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 99999999999999999999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=445.03 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=215.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRVRH-PNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||+||+|++..+ ++.||||++.... .....+.+.+|+.+|++++| ||||+++++|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 46899999999999999999998654 3679999997653 22345678999999999965 9999999999764
Q ss_pred -CEEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc
Q 011628 99 -SKIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE 160 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~ 160 (481)
..+|||||||+||+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 578999999999999999964 23889999999999999999999999999999999999999
Q ss_pred CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchH-HHHHH
Q 011628 161 NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNI-MVMYK 238 (481)
Q Consensus 161 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~-~~~~~ 238 (481)
++.+||+|||+|+............+.+||+.|||||++.+..| +.++|||||||+||||+| |..||.+.+. ..+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986543222223345689999999999998887 678999999999999998 9999988654 34455
Q ss_pred HHhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 239 KIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 239 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+..+ .++.|..+++++.+||.+||+.||++|||+.||++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 55555 367788999999999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=439.37 Aligned_cols=261 Identities=35% Similarity=0.635 Sum_probs=231.0
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
...-.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|..+++.+ +||||+++++++.+..
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 344578999999999999999999999999999999999876544445567788999999998 6999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 99999999999999999976 7899999999999999999999999999999999999999999999999999975322
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRL 258 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 258 (481)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++.++..+....|.++++++.+|
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 2223456799999999999988777 57899999999999999999999999999999999999999999999999999
Q ss_pred HHHhcccCcCCCCCH------hHHHhCccccc
Q 011628 259 LTKLLDTNPDKRITI------PEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps~------~eil~h~~f~~ 284 (481)
|.+||++||.+||++ ++|++||||+.
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999999999998 89999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=429.24 Aligned_cols=257 Identities=39% Similarity=0.697 Sum_probs=235.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 67899999999999999999999999999999999876443334456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ....
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CCCc
Confidence 999999999999875 6899999999999999999999999999999999999999999999999999975322 2233
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 263 (481)
..+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+..+....|..+++++.+||.+||
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 456789999999999988877 5789999999999999999999999998899999999988999999999999999999
Q ss_pred ccCcCCCC-----CHhHHHhCccccc
Q 011628 264 DTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 264 ~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
+.||.+|| +++|+++||||..
T Consensus 241 ~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 241 KKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 99999999 8999999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=433.97 Aligned_cols=261 Identities=41% Similarity=0.812 Sum_probs=233.2
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
....++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34679999999999999999999999999999999999865443334456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+ +|+|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 9999999 7889888764 7899999999999999999999999999999999999999999999999999976432
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+......+.++..+....|..+|+++.+||.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 23345678999999999998888777889999999999999999999998776666666666677788899999999999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccCc
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
+||+.||.+|||++|+++||||+...
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHHhChhhccCC
Confidence 99999999999999999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=422.08 Aligned_cols=255 Identities=36% Similarity=0.721 Sum_probs=234.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
-.++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 36789999999999999999999999999999999987654333445678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----- 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence 9999999999999976 6799999999999999999999999999999999999999999999999999975432
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++..+....|..+++++.+||.+|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 2346789999999999988877 568999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCC-----CHhHHHhCccccc
Q 011628 263 LDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 263 L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
|..||.+|| +++++++||||+.
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hccCHHHcCCCcCCCHHHHhcCccccC
Confidence 999999999 9999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=429.35 Aligned_cols=263 Identities=30% Similarity=0.577 Sum_probs=234.8
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT 97 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (481)
.....-.++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|..+++.+ +||||+++++++.+
T Consensus 13 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 92 (353)
T ss_dssp ------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred CcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence 33445688999999999999999999999999999999999876543344456788999999988 79999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...+|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999999999976 789999999999999999999999999999999999999999999999999997532
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLI 256 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 256 (481)
. ......+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.+.+...++.++..+....|..+++++.
T Consensus 173 ~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 173 W--DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 249 (353)
T ss_dssp C--TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred c--CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 2 2223456799999999999988887 678999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCcCCCCC-----HhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
+||.+||..||.+||+ +++|++||||+.
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999999995 699999999964
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=428.38 Aligned_cols=259 Identities=34% Similarity=0.627 Sum_probs=234.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
.-.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|..+++.+ +||||+++++++.+...+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 4578999999999999999999999999999999999876543334456678899999877 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... .
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~ 171 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--G 171 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--T
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--C
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999999975322 2
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..+..+....|.++++++.+||.
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 250 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 223456799999999999988877 6789999999999999999999999999999999999988899999999999999
Q ss_pred HhcccCcCCCCCHh-HHHhCccccc
Q 011628 261 KLLDTNPDKRITIP-EIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps~~-eil~h~~f~~ 284 (481)
+||..||.+||++. +|++||||+.
T Consensus 251 ~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 251 KLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHhcCCHhHcCCChHHHHcCccccC
Confidence 99999999999998 9999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=424.77 Aligned_cols=261 Identities=33% Similarity=0.564 Sum_probs=233.7
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
....+.++|++++.||+|+||+||+|++..+|+.||+|++.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 345678899999999999999999999999999999999987643221 13467889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEecCC
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG----DLKVSDFGL 171 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g----~lkl~DFGl 171 (481)
+...+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999999999976 5799999999999999999999999999999999999998877 799999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC---
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP--- 248 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--- 248 (481)
+..... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+..+.+..+
T Consensus 166 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (361)
T 2yab_A 166 AHEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241 (361)
T ss_dssp CEECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred ceEcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 976433 223456789999999999988777 6789999999999999999999999998888999988876554
Q ss_pred -CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 -RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 -~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+++.+++||.+||.+||.+|||++|+++||||+.
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 568999999999999999999999999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=431.51 Aligned_cols=259 Identities=32% Similarity=0.617 Sum_probs=229.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
.-.++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+++++ +||||+++++++.+...+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 3478999999999999999999999999999999999887655545556688899999887 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||++||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... .
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 206 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--P 206 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--T
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--C
Confidence 999999999999999876 7899999999999999999999999999999999999999999999999999975221 2
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---------hHHHHHHHHhhCCCCCCCCC
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---------NIMVMYKKIYKGEFRSPRWF 251 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~ 251 (481)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||... ....++..+.......|..+
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 285 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred CCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence 334567899999999999998887 67899999999999999999999632 23457788888889999999
Q ss_pred CHHHHHHHHHhcccCcCCCCCH------hHHHhCccccc
Q 011628 252 SPDLIRLLTKLLDTNPDKRITI------PEIMENRWFRK 284 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~------~eil~h~~f~~ 284 (481)
++++++||.+||+.||.+||++ +||++||||+.
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999999985 79999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=424.04 Aligned_cols=256 Identities=38% Similarity=0.692 Sum_probs=236.2
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45789999999999999999999999999999999998765444445677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---- 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC----
Confidence 99999999999999976 7899999999999999999999999999999999999999999999999999975432
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++..+....|..+++++.+||.+
T Consensus 194 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 194 -RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 2345689999999999988877 57899999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCC-----HhHHHhCccccc
Q 011628 262 LLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
||+.||.+||+ +++|++||||..
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999999998 999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=420.96 Aligned_cols=258 Identities=33% Similarity=0.626 Sum_probs=232.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (481)
-.++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+++.+ +||||+++++++.+...+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 367899999999999999999999999999999999887666666677889999999988 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... ..
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~~ 164 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PG 164 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--CC
Confidence 99999999999999876 6899999999999999999999999999999999999999999999999999975322 22
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC---------chHHHHHHHHhhCCCCCCCCCC
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD---------QNIMVMYKKIYKGEFRSPRWFS 252 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s 252 (481)
....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.. .....++..+.......|..++
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 243 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred CcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence 33456799999999999988877 6789999999999999999999975 2345667788888888899999
Q ss_pred HHHHHHHHHhcccCcCCCCCH------hHHHhCccccc
Q 011628 253 PDLIRLLTKLLDTNPDKRITI------PEIMENRWFRK 284 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps~------~eil~h~~f~~ 284 (481)
+++.+||.+||+.||.+||++ +++++||||+.
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 999999999999999999995 89999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=426.25 Aligned_cols=261 Identities=35% Similarity=0.603 Sum_probs=227.1
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISI-LRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~ 99 (481)
.....++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 34557899999999999999999999999999999999988765544455667777776 57789999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 99999999999999999976 6799999999999999999999999999999999999999999999999999975322
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRL 258 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 258 (481)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++.++.......|..+++++++|
T Consensus 192 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 -HNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 269 (373)
T ss_dssp -CCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHH
T ss_pred -CCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Confidence 2233456799999999999988877 57899999999999999999999999999999999999888899999999999
Q ss_pred HHHhcccCcCCCCCH----hHHHhCccccc
Q 011628 259 LTKLLDTNPDKRITI----PEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps~----~eil~h~~f~~ 284 (481)
|.+||+.||.+||++ ++|++||||+.
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 999999999999986 69999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=430.89 Aligned_cols=260 Identities=31% Similarity=0.526 Sum_probs=228.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 36799999999999999999999999999999999976443222223457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||++||+|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... ...
T Consensus 147 V~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~ 225 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVR 225 (410)
T ss_dssp EECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEE
T ss_pred EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-ccc
Confidence 9999999999999998899999999999999999999999999999999999999999999999999997543211 112
Q ss_pred ccccCCCCccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCC--CCCCCHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKG---YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRS--PRWFSPDLI 256 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~--~~~~s~~~~ 256 (481)
..+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|..||.+.+....+.++..+. +.. +..+|++++
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 305 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHH
Confidence 34679999999999997655 13578999999999999999999999999988888887652 333 446999999
Q ss_pred HHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
+||.+||..+|.+ |++++||++||||+.
T Consensus 306 ~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 306 NLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 9999999999998 999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=410.69 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=227.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||+||+|++..+++.||||++....... .+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 4679999999999999999999999999999999997654332 3567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||+.||+|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--ccc
Confidence 999999999999999888999999999999999999999999999999999999999999999999998764432 223
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~ 260 (481)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... ....|..+++.+.+||.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 445789999999999988877 67899999999999999999999988776655555433 23456678999999999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccC
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+||+.||.+|||++|+++||||+..
T Consensus 252 ~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHccCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=412.42 Aligned_cols=262 Identities=36% Similarity=0.665 Sum_probs=222.9
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc-----------------------hhHHHHHHHHH
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK-----------------------SGLVAHIKREI 77 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----------------------~~~~~~~~~Ei 77 (481)
.....++|++.+.||+|+||.||+|++..+++.||||++....... ....+.+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 3455789999999999999999999999999999999997654221 11235688999
Q ss_pred HHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCc
Q 011628 78 SILRRVRHPNIVQLFEVMAT--KSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPEN 155 (481)
Q Consensus 78 ~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~N 155 (481)
.+++.++||||+++++++.. ...+|+||||+++++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999999986 6789999999999999998777889999999999999999999999999999999999
Q ss_pred EEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCchH
Q 011628 156 LLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY--DAAKVDIWSCGVILFVLMAGYLPFQDQNI 233 (481)
Q Consensus 156 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~ 233 (481)
||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999976432 1223345689999999999976542 35679999999999999999999999888
Q ss_pred HHHHHHHhhCCCCCC--CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 234 MVMYKKIYKGEFRSP--RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 234 ~~~~~~i~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
......+.......| ..+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 777777777655443 468999999999999999999999999999999963
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=417.21 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=196.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS----K 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~ 100 (481)
..+|.+.+.||+|+||+||+|++ +|+.||||+++.... ......+|+..+.+++|||||++++++...+ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 35799999999999999999987 689999999975431 1122345777778899999999999997653 6
Q ss_pred EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 101 IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR--------GVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~--------gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
+|||||||+||+|.+++...+++++.+.+++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 89999999999999999998999999999999999999999987 9999999999999999999999999999
Q ss_pred cccccccc--CCcccccCCCCccccccccccCCC-----CCCcchHHHHHHHHHHHhcCCCCCCC---------------
Q 011628 173 AVSDQIRQ--DGLFHTFCGTPAYVAPEVLSRKGY-----DAAKVDIWSCGVILFVLMAGYLPFQD--------------- 230 (481)
Q Consensus 173 ~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiwSlGvil~elltg~~Pf~~--------------- 230 (481)
+....... .......+||+.|||||++.+... .+.++|||||||+||||+||..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86543221 112335689999999999975421 24589999999999999999776532
Q ss_pred chHHHHHHHHhhCCC--CCCCC-----CCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 231 QNIMVMYKKIYKGEF--RSPRW-----FSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 231 ~~~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.....+...+..... ..|.. .++.+.+|+.+||+.||++|||+.||++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122344444444432 22322 22467899999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=414.12 Aligned_cols=263 Identities=37% Similarity=0.656 Sum_probs=223.5
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCcceEEEE
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKILK-SGLVAHIKREISILRRVRHPNIVQLFEV 94 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 94 (481)
.......++|++++.||+|+||.||+|++. .+|+.||+|++.+..... ......+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp ---CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 344556789999999999999999999985 689999999998654322 2234567889999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 95 MATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 95 ~~~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
+...+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999999999975 679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCH
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSP 253 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 253 (481)
.... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++..+....|..+++
T Consensus 170 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 246 (327)
T 3a62_A 170 ESIH--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ 246 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCH
T ss_pred cccc--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence 5332 1223456789999999999988777 678999999999999999999999999888889999998889999999
Q ss_pred HHHHHHHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 254 DLIRLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
++.+||.+||+.||.+|| +++|+++||||+.
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 999999999999999999 8899999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=417.05 Aligned_cols=263 Identities=36% Similarity=0.674 Sum_probs=225.6
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++.++|++++.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp CTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 35789999999999999999999999999999999999765432 2335678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999999999976 4799999999999999999999999999999999999999999999999999986544333
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCCCC--CCCCCHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFRS--PRWFSPDLIR 257 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~--~~~~s~~~~~ 257 (481)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+....... ...+++.+.+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence 444557789999999999988777677899999999999999999999876543 3333333333222 3458999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
||.+||+.||.+|||++|+++||||++..
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 99999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=413.89 Aligned_cols=255 Identities=25% Similarity=0.487 Sum_probs=229.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.+.++|++++.||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 36789999999999999999999999999999999987542 23456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc--CCCEEEEecCCccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE--NGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~--~g~lkl~DFGla~~~~~~ 178 (481)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~- 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC-
Confidence 99999999999999976 36999999999999999999999999999999999999997 78999999999976432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 254 (481)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....+ ..+|++
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 223456789999999999987666 5789999999999999999999999988888888888876654 368999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+||.+||..||.+|||+.|+++||||++.
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=420.21 Aligned_cols=259 Identities=36% Similarity=0.712 Sum_probs=231.0
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
...+.++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+...
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 345567999999999999999999999999999999999876543 3345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEecCCccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---DLKVSDFGLSAVSD 176 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---~lkl~DFGla~~~~ 176 (481)
.|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999999875 5799999999999999999999999999999999999998654 59999999997654
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC----CCC
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFS 252 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s 252 (481)
. .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+..+.+..|. .++
T Consensus 183 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 183 D---SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp T---CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred C---CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 2 223456789999999999988777 57899999999999999999999999888888888888765543 479
Q ss_pred HHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+++.+||.+||+.||.+|||+.|+++||||..
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=421.86 Aligned_cols=261 Identities=27% Similarity=0.560 Sum_probs=233.2
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
......++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 44556799999999999999999999999999999999998765444445677889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 167 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR- 167 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence 99999999999999999986 5799999999999999999999999999999999999999999999999999976432
Q ss_pred ccCCcccccCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCC---chHHHHHHHHhhCCCCCCCCCC
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSR---KGYDAAKVDIWSCGVILFVLMAGYLPFQD---QNIMVMYKKIYKGEFRSPRWFS 252 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~---~~~~~~~~~i~~~~~~~~~~~s 252 (481)
.....+.+||+.|+|||++.+ .+| +.++|||||||++|+|++|..||.. .........+.......|..++
T Consensus 168 --~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 168 --ETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp --TCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred --CCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 334567899999999999864 235 6789999999999999999999974 3445667777777888899999
Q ss_pred HHHHHHHHHhcccCcCCCCC-HhHHHhCccccc
Q 011628 253 PDLIRLLTKLLDTNPDKRIT-IPEIMENRWFRK 284 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps-~~eil~h~~f~~ 284 (481)
+.+.+||.+||+.||.+||+ ++++++||||..
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999999999999998 999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=430.17 Aligned_cols=259 Identities=36% Similarity=0.695 Sum_probs=229.9
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+.++|++++.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 34678999999999999999999999999999999999876543 23456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc---cCCCEEEEecCCcccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD---ENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~---~~g~lkl~DFGla~~~~~ 177 (481)
|+||||+.||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999999875 6799999999999999999999999999999999999998 457899999999976443
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 253 (481)
........+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+..+.+..+ ..+++
T Consensus 166 --~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 166 --EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp --TCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred --CCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 2223356789999999999988777 5789999999999999999999999999999999988876543 35799
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999999999999965
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=432.05 Aligned_cols=259 Identities=39% Similarity=0.685 Sum_probs=225.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++++.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++...+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999998765444445567789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+||||++||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.... .
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~ 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--C
Confidence 99999999999999875 679999999999999999999998 9999999999999999999999999999975322 2
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
.......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+.......|..+++++.+||.
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 223456789999999999988777 6789999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCcCCCC-----CHhHHHhCccccc
Q 011628 261 KLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
+||++||.+|| |++|+++||||..
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 99999999999 9999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=417.20 Aligned_cols=260 Identities=40% Similarity=0.696 Sum_probs=216.2
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
+.....++|++++.||+|+||+||+|++..+++.||||++...... ...+.+|+.+++.++||||+++++++.+..
T Consensus 14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 3344578999999999999999999999999999999999765432 245779999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--EEEEecCCccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD--LKVSDFGLSAVSD 176 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~--lkl~DFGla~~~~ 176 (481)
.+|+||||+.||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999999999865 78999999999999999999999999999999999999987765 9999999987432
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCCCCC--C
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFRSPR--W 250 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~--~ 250 (481)
. .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+. ......+.......|. .
T Consensus 170 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 170 L---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred c---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence 2 22234568999999999998888866669999999999999999999987543 4455556666555544 5
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
+++++.+||.+||+.||.+|||++|+++||||.+..
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 799999999999999999999999999999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=408.65 Aligned_cols=261 Identities=32% Similarity=0.570 Sum_probs=230.6
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (481)
+..+.++|++++.||+|+||.||+|++..+|+.||+|++........ .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp CSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34567899999999999999999999999999999999986543221 134678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEecCCc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG----DLKVSDFGLS 172 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g----~lkl~DFGla 172 (481)
...+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999999975 5799999999999999999999999999999999999999887 8999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP---- 248 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 248 (481)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 166 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 166 HKIDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp EECCT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred eECCC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 76532 223345689999999999987776 6789999999999999999999999888877777777665543
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 4678999999999999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=415.73 Aligned_cols=260 Identities=32% Similarity=0.633 Sum_probs=224.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS--GLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
...+.++|++++.||+|+||+||+|++..+|+.||||++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34567899999999999999999999999999999999976432211 1346788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEecC
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFG 170 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~---lkl~DFG 170 (481)
..+|+|||||+||+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999999887753 24899999999999999999999999999999999999987665 9999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC--
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP-- 248 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-- 248 (481)
++...... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ...+..+..+....+
T Consensus 179 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 179 VAIQLGES--GLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp TCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred ceeEecCC--CeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence 99765431 222345689999999999988777 678999999999999999999998865 456666777665543
Q ss_pred --CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 --RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 --~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+++++.+||.+||..||.+|||+.|+++||||+.
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 468999999999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=425.49 Aligned_cols=259 Identities=28% Similarity=0.505 Sum_probs=226.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|..+++.++||||+++++++.+...+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 35799999999999999999999999999999999976543333333447889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... .
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~ 230 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-T 230 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-C
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-C
Confidence 9999999999999976 689999999999999999999999999999999999999999999999999997543211 1
Q ss_pred CcccccCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCCC---CC
Q 011628 182 GLFHTFCGTPAYVAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPR---WF 251 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~---~~ 251 (481)
......+||+.|+|||++. ...| +.++|||||||++|+|++|..||.+.+....+.++... .+..|. .+
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred cccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 1223468999999999986 3334 67899999999999999999999999988888888754 244444 48
Q ss_pred CHHHHHHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 252 SPDLIRLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
|+++++||++||..+|++ |++++|+++||||+.
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 999999999999999988 999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=399.80 Aligned_cols=258 Identities=30% Similarity=0.509 Sum_probs=217.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4689999999999999999999999999999999987653 334557788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~-~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||+.|+.+..+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 157 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCSC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--cccc
Confidence 99998744444444 36899999999999999999999999999999999999999999999999999976532 2223
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC-CCCchHHHHHHHHhhCC--C---------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLP-FQDQNIMVMYKKIYKGE--F--------------- 245 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~P-f~~~~~~~~~~~i~~~~--~--------------- 245 (481)
....+||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+.......+.... .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 35568999999999998776557899999999999999987777 56666555555554310 0
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 ------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 ------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...+.+++++++||.+||+.||++|||++|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1123478899999999999999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=397.35 Aligned_cols=265 Identities=44% Similarity=0.830 Sum_probs=229.5
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.+....++|++++.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++....
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 45566899999999999999999999999899999999997654433345677899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
..|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~- 163 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 163 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence 99999999999999999975 6899999999999999999999999999999999999999999999999999876432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRL 258 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 258 (481)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+..+....|..+++.+.++
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 164 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence 222345679999999999987776567899999999999999999999998888888888888888888999999999
Q ss_pred HHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
|.+||+.||.+|||++++++||||++...
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHccCChhhCCCHHHHHhChhhccCch
Confidence 99999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=406.59 Aligned_cols=263 Identities=30% Similarity=0.489 Sum_probs=216.3
Q ss_pred CCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011628 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 18 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (481)
...+..+.++|++++.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp --CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 3455678999999999999999999999984 699999999976542 23345678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
...+|+||||+.| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 9999999999985 78877765 45999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCC-------
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFR------- 246 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~------- 246 (481)
... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ...
T Consensus 170 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 170 GIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp TSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred CCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 321 223345689999999999977555578999999999999999999999876554444444321 000
Q ss_pred ---------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 247 ---------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 247 ---------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+.+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 012367899999999999999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=398.23 Aligned_cols=259 Identities=34% Similarity=0.681 Sum_probs=232.0
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
....++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34578999999999999999999999999999999999766544444457788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+++|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc---
Confidence 999999999999999876 6899999999999999999999999999999999999999999999999998864332
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..+++.+.+||.
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred -ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 12245689999999999987666 5789999999999999999999999998888889988888889999999999999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccC
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+||+.||.+|||++|+++||||+..
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHhccChhhCCCHHHHhhCccccCC
Confidence 9999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=396.52 Aligned_cols=262 Identities=33% Similarity=0.674 Sum_probs=234.6
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
+......++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 34455678999999999999999999999999999999999765443334456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
...|+||||+++|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999999999875 6899999999999999999999999999999999999999999999999999865432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 257 (481)
......+|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..+++++.+
T Consensus 167 ----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 167 ----LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241 (284)
T ss_dssp ----SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred ----cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHH
Confidence 12245689999999999988776 5689999999999999999999999888888888888888888999999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||.+||+.||.+|||++++++||||+..
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 9999999999999999999999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=417.39 Aligned_cols=260 Identities=30% Similarity=0.487 Sum_probs=211.8
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKS-- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-- 99 (481)
.+.++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 46789999999999999999999999999999999996543 23345567889999999997 999999999997554
Q ss_pred EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc-
Q 011628 100 KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI- 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~- 178 (481)
.+|+||||+. ++|.+.+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 7999999998 58999998889999999999999999999999999999999999999999999999999999754321
Q ss_pred ------------------ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHH
Q 011628 179 ------------------RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI 240 (481)
Q Consensus 179 ------------------~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 240 (481)
.........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11223455789999999999987544478899999999999999999999998877666665
Q ss_pred hhCC-C----------------------------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 011628 241 YKGE-F----------------------------------------------RSPRWFSPDLIRLLTKLLDTNPDKRITI 273 (481)
Q Consensus 241 ~~~~-~----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~ 273 (481)
.... . ..+..+++++.+||.+||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 4210 0 0122578899999999999999999999
Q ss_pred hHHHhCccccc
Q 011628 274 PEIMENRWFRK 284 (481)
Q Consensus 274 ~eil~h~~f~~ 284 (481)
+|+++||||+.
T Consensus 324 ~e~l~Hp~~~~ 334 (388)
T 3oz6_A 324 NDALKHPFVSI 334 (388)
T ss_dssp HHHTTSTTTTT
T ss_pred HHHhCCHHHHH
Confidence 99999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=402.35 Aligned_cols=261 Identities=34% Similarity=0.600 Sum_probs=237.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 46799999999999999999999999999999999987765555667788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--cc
Confidence 9999999999999876 67999999999999999999999999999999999999999999999999999764321 12
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........+..+..+....|..+++.+.+||.+|
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 2345689999999999987776 678999999999999999999999988888888888888888999999999999999
Q ss_pred cccCcCCCCCHhHHHhCcccccCcc
Q 011628 263 LDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
|+.||.+|||++|+++||||...+.
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ccCChhHCcCHHHHhcCccccCCCc
Confidence 9999999999999999999987643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=421.01 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=224.4
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|..++..++||||+++++++.+...+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 36899999999999999999999999999999999986543333334557899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||++||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~- 217 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT- 217 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-
Confidence 9999999999999976 4799999999999999999999999999999999999999999999999999976432111
Q ss_pred CcccccCCCCcccccccccc-------CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC---C
Q 011628 182 GLFHTFCGTPAYVAPEVLSR-------KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP---R 249 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~-------~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~---~ 249 (481)
......+||+.|+|||++.. ..| +.++|||||||++|+|++|..||.+.+....+.++.... ...| .
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 11235689999999999873 334 678999999999999999999999999888888887532 3333 5
Q ss_pred CCCHHHHHHHHHhcccCcCCC---CCHhHHHhCccccc
Q 011628 250 WFSPDLIRLLTKLLDTNPDKR---ITIPEIMENRWFRK 284 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~R---ps~~eil~h~~f~~ 284 (481)
.+|+++++||.+||. +|.+| ++++||++||||+.
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 799999999999999 99998 59999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=414.18 Aligned_cols=260 Identities=24% Similarity=0.408 Sum_probs=218.0
Q ss_pred ccCCeeEEeEeccc--CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 24 LLGRYEIGKLLGHG--TFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 24 ~~~~y~i~~~LG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
-.++|++++.||+| +||+||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 37899999999999 999999999999999999999987653 345667888999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999999875 57999999999999999999999999999999999999999999999999988643221
Q ss_pred c-----cCCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC------
Q 011628 179 R-----QDGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF------ 245 (481)
Q Consensus 179 ~-----~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------ 245 (481)
. ........+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.......+..+..
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 1 1112234589999999999977 345 6789999999999999999999987544333322222111
Q ss_pred ----------------------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 ----------------------------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 ----------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 1345578999999999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=389.26 Aligned_cols=259 Identities=36% Similarity=0.711 Sum_probs=230.6
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 34678999999999999999999999999999999999876543 34457788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEecCCcccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~---lkl~DFGla~~~~~ 177 (481)
|+||||+.|++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999888865 67999999999999999999999999999999999999987665 99999999975432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 253 (481)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..+....| ..+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 ---SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ---SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 223345689999999999988777 6789999999999999999999999988888888887765443 35799
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++.+||.+||+.||.+|||++|+++||||.+.
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=397.59 Aligned_cols=255 Identities=33% Similarity=0.545 Sum_probs=214.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++++.||+|+||+||+|++ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999998 78999999999765422 22346678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence 999986 89988875 67999999999999999999999999999999999999999999999999999764321 12
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CC---------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EF--------------- 245 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~--------------- 245 (481)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2345678999999999976554578999999999999999999999988766655555431 00
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 246 ------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 246 ------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+..+++++.+||.+||+.||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012347889999999999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=425.55 Aligned_cols=261 Identities=35% Similarity=0.632 Sum_probs=228.3
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch----------hHHHHHHHHHHHHHhCCCCCcce
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS----------GLVAHIKREISILRRVRHPNIVQ 90 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~HpnIv~ 90 (481)
...+.++|++++.||+|+||+||+|++..+++.||||++.+...... .....+.+|+.+++.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34578899999999999999999999999999999999986543221 23567889999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEE
Q 011628 91 LFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---DLKV 166 (481)
Q Consensus 91 l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---~lkl 166 (481)
+++++.+...+|+|||||+||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999998865 7899999999999999999999999999999999999999876 6999
Q ss_pred EecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC
Q 011628 167 SDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR 246 (481)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 246 (481)
+|||++..... .......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+.......+..+.+.
T Consensus 191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999986533 223456789999999999864 45 67899999999999999999999999999999999888765
Q ss_pred CC----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 247 SP----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 247 ~~----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.+ ..+|+++++||.+||++||.+|||++|+++||||++..
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 54 56899999999999999999999999999999998653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=392.54 Aligned_cols=261 Identities=34% Similarity=0.601 Sum_probs=237.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++...+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45789999999999999999999999999999999998776555566678899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 99999999999999876 67999999999999999999999999999999999999999999999999999764321 1
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||........+..+..+....|..+++.+.++|.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 22345679999999999987766 67899999999999999999999999888888888888888889999999999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccCc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
||+.||++|||++|+++||||....
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HcccChhhCcCHHHHhhChheecCC
Confidence 9999999999999999999997653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=409.17 Aligned_cols=255 Identities=34% Similarity=0.615 Sum_probs=222.0
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
....+.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ..+|+.++.++ +||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 3446788999999999999999999999999999999999765422 24688888888 799999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-C---CEEEEecCCcc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-G---DLKVSDFGLSA 173 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g---~lkl~DFGla~ 173 (481)
..+|+||||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+..+ + .+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999999999876 579999999999999999999999999999999999998543 3 49999999998
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC---chHHHHHHHHhhCCCCCC--
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD---QNIMVMYKKIYKGEFRSP-- 248 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~---~~~~~~~~~i~~~~~~~~-- 248 (481)
.... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+ .+...+...+..+.+..+
T Consensus 169 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 169 QLRA--ENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp ECBC--TTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred cCcC--CCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 6433 2234456799999999999987777 5689999999999999999999986 456677888888776543
Q ss_pred --CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 --RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 --~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+|+++.+||.+||..||.+|||+.++++||||..
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 468999999999999999999999999999999965
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=395.11 Aligned_cols=259 Identities=31% Similarity=0.662 Sum_probs=206.4
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++......|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 46789999999999999999999999999999999976544334445778999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 9999999999999976 579999999999999999999999999999999999999999999999999997644221
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..+++++.+||.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence 12235679999999999987666 67899999999999999999999887665556666666677788899999999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||+.||.+|||++++++||||...
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=427.17 Aligned_cols=263 Identities=37% Similarity=0.649 Sum_probs=229.6
Q ss_pred CCCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 17 KDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 17 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
+...++.+.++|++++.||+|+||+||+|++..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp -CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 34455678999999999999999999999999999999999997654322 23467889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc---cCCCEEEEecCCc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD---ENGDLKVSDFGLS 172 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~---~~g~lkl~DFGla 172 (481)
....+|+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999999999999998865 7899999999999999999999999999999999999995 4567999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC--C--
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS--P-- 248 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~-- 248 (481)
+.... .......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+.......+..+.+.. |
T Consensus 172 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (486)
T 3mwu_A 172 TCFQQ---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246 (486)
T ss_dssp TTBCC---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred eECCC---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 76433 223456789999999999976 35 678999999999999999999999999888888888876543 2
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+|+++++||.+||+.||.+|||+.|+++||||++.
T Consensus 247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 3479999999999999999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=402.40 Aligned_cols=257 Identities=32% Similarity=0.546 Sum_probs=206.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||+||+|++..+|+.||+|++..... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 4689999999999999999999999999999999976542 22335678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 105 MEYVRGGELFNKVAK-------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
|||+.| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999984 89888854 2589999999999999999999999999999999999999999999999999976532
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CC----------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EF---------- 245 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~---------- 245 (481)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 161 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 P--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp C--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred C--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 1 223345689999999999976544478999999999999999999999988876666655431 00
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 246 ----------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 246 ----------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
..+..+++++.+||.+||+.||++|||++|+++||||++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 01224788999999999999999999999999999998643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=405.76 Aligned_cols=263 Identities=31% Similarity=0.477 Sum_probs=211.5
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
.......++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 3445678999999999999999999999999999999999976542 233456677999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-----cCCCEEEEecCCc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD-----ENGDLKVSDFGLS 172 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~-----~~g~lkl~DFGla 172 (481)
..+|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999999985 99999876 5799999999999999999999999999999999999995 4455999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCC---
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRS--- 247 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~--- 247 (481)
...... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.... ...
T Consensus 185 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 765422 2233456789999999999876655789999999999999999999999887766666654321 100
Q ss_pred ------C-------------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 ------P-------------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ------~-------------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+ ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0 1167899999999999999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=441.71 Aligned_cols=258 Identities=31% Similarity=0.591 Sum_probs=235.7
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (481)
-.++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 468999999999999999999999999999999999876543344456778899999988 6999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||||++||+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--TT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--CC
Confidence 99999999999999976 7899999999999999999999999999999999999999999999999999975322 22
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..|..+....|..+++++.+||.+
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 575 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 33467899999999999988888 67899999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCCH-----hHHHhCccccc
Q 011628 262 LLDTNPDKRITI-----PEIMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~-----~eil~h~~f~~ 284 (481)
||++||.+||++ +||++||||+.
T Consensus 576 lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 576 LMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 999999999998 99999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=396.04 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=215.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++......++
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 4689999999999999999999999999999999987654 233455678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SD 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--cc
Confidence 9999999999999875 57999999999999999999999999999999999999999999999999999764421 22
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------- 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------- 243 (481)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3345689999999999977555578999999999999999999999887765544433221
Q ss_pred --CCCCC----------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 --EFRSP----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 --~~~~~----------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+.+ +.+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 01111 3478889999999999999999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=427.18 Aligned_cols=261 Identities=34% Similarity=0.630 Sum_probs=232.8
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.+..+.++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34567889999999999999999999999999999999998765544445677899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEecCCcccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVS 175 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl---~~~g~lkl~DFGla~~~ 175 (481)
.+|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999999875 689999999999999999999999999999999999999 56789999999999754
Q ss_pred cccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC--C--CCC
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS--P--RWF 251 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~--~~~ 251 (481)
.. .......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+.......+..+.+.. | ..+
T Consensus 180 ~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 180 EA---SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CC---CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred cc---ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 32 223456789999999999976 45 678999999999999999999999999988888988886543 2 348
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|+++++||.+||++||.+|||+.|+++||||+..
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=426.58 Aligned_cols=259 Identities=28% Similarity=0.443 Sum_probs=231.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34689999999999999999999999999999999998765444444567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 103 FVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999999864 2599999999999999999999999999999999999999999999999999976432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc----hHHHHHHHHhhCCCCCCCCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ----NIMVMYKKIYKGEFRSPRWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~ 253 (481)
. .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+. ....+...+.......|..+|+
T Consensus 342 ~--~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 342 G--QTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp T--CCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C--CcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 1 122345699999999999988877 57899999999999999999999875 3567778888888888999999
Q ss_pred HHHHHHHHhcccCcCCCCC-----HhHHHhCccccc
Q 011628 254 DLIRLLTKLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
.+.+||.+||++||.+||+ +++|++||||+.
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999999999999999996 489999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=393.05 Aligned_cols=262 Identities=31% Similarity=0.592 Sum_probs=222.6
Q ss_pred CCCCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011628 16 SKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVM 95 (481)
Q Consensus 16 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (481)
.+...++.+.++|++.+.||+|+||.||+|++..++..||+|++...... ...+.+.+|+.+++.++||||+++++++
T Consensus 12 ~~~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 89 (285)
T 3is5_A 12 ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVF 89 (285)
T ss_dssp -CCEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHhe
Confidence 34445667889999999999999999999999999999999999876432 2356788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEE
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVS 167 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl---~~~g~lkl~ 167 (481)
......|+||||++||+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEE
Confidence 999999999999999999998843 579999999999999999999999999999999999999 456789999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS 247 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 247 (481)
|||++..... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 170 Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 170 DFGLAELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred eeecceecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc
Confidence 9999976433 222345689999999999864 44 678999999999999999999999988877777666554333
Q ss_pred ---CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 248 ---PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 248 ---~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
...+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 245 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 2347899999999999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=428.38 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=230.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 44688999999999999999999999999999999998765444344566889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 103 FVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~-- 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-- 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc--
Confidence 999999999999999752 499999999999999999999999999999999999999999999999999975432
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc----hHHHHHHHHhhCCCCCCCCCCHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ----NIMVMYKKIYKGEFRSPRWFSPDL 255 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~ 255 (481)
.......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+. ....+...+.......|..+|+++
T Consensus 339 -~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 339 -GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416 (576)
T ss_dssp -TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred -CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence 223456799999999999988777 57899999999999999999999875 345667777777777888999999
Q ss_pred HHHHHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 256 IRLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
++||.+||+.||.+|| +++|+++||||+.
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999999 7899999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=408.91 Aligned_cols=257 Identities=26% Similarity=0.526 Sum_probs=227.5
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+.++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+...+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 3467899999999999999999999999999999999976532 2235688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc--CCCEEEEecCCcccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE--NGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~--~g~lkl~DFGla~~~~~ 177 (481)
|+||||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999999999975 36999999999999999999999999999999999999974 46799999999986432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC----CCCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS----PRWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~ 253 (481)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....... +..+++
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 204 ---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 233455689999999999988777 578999999999999999999999988888888887765443 345899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 99999999999999999999999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=414.32 Aligned_cols=283 Identities=27% Similarity=0.406 Sum_probs=217.1
Q ss_pred CCCCCCCCCCCccCCCCCCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH
Q 011628 1 MAHATAPTSTSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL 80 (481)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il 80 (481)
|-|-...++.......+......+.++|++++.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.++
T Consensus 1 ~~~~~~~~~~~~~~~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l 79 (432)
T 3n9x_A 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITIL 79 (432)
T ss_dssp ----------CCCCCTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHH
T ss_pred CCccccccccchhhhhcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHH
Confidence 334444444444555555556678999999999999999999999999999999999997643 2334557789999999
Q ss_pred HhCCCCCcceEEEEEEeC-----CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCC
Q 011628 81 RRVRHPNIVQLFEVMATK-----SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPE 154 (481)
Q Consensus 81 ~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~ 154 (481)
+.++||||+++++++... ..+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 ~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~ 158 (432)
T 3n9x_A 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPA 158 (432)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999999776 57999999997 599999987 46999999999999999999999999999999999
Q ss_pred cEEEccCCCEEEEecCCcccccccccC--------------------CcccccCCCCccccccccccCCCCCCcchHHHH
Q 011628 155 NLLLDENGDLKVSDFGLSAVSDQIRQD--------------------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSC 214 (481)
Q Consensus 155 NILl~~~g~lkl~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSl 214 (481)
|||++.++.+||+|||+++........ ......+||+.|+|||++......+.++|||||
T Consensus 159 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl 238 (432)
T 3n9x_A 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238 (432)
T ss_dssp GEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred HeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence 999999999999999999865432211 234678999999999997554444789999999
Q ss_pred HHHHHHHhcCC-----------CCCCCch-----------------HHHHHHHHh------------------------h
Q 011628 215 GVILFVLMAGY-----------LPFQDQN-----------------IMVMYKKIY------------------------K 242 (481)
Q Consensus 215 Gvil~elltg~-----------~Pf~~~~-----------------~~~~~~~i~------------------------~ 242 (481)
||++|+|++|. ++|.+.+ .......+. .
T Consensus 239 G~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 318 (432)
T 3n9x_A 239 GCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318 (432)
T ss_dssp HHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred HHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh
Confidence 99999999854 4443321 111111111 1
Q ss_pred CCCCC-------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 GEFRS-------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 ~~~~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..... .+.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 319 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred CCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 11111 13479999999999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=406.98 Aligned_cols=263 Identities=32% Similarity=0.543 Sum_probs=222.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.+.++|++++.||+|+||+||+|++..+++.||+|++...... .......+.+|+.+++.++||||+++++++.+...
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 4578999999999999999999999999999999999765432 22345778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 011628 101 IYFVMEYVRGGELFNKVAK-----------------------------------------GRLKEDLARKYFQQLISAVG 139 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-----------------------------------------~~l~e~~~~~~~~ql~~al~ 139 (481)
.|+||||++||+|.+++.. ..+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998851 12467889999999999999
Q ss_pred HHHHcCceecCCCCCcEEEccCC--CEEEEecCCcccccccccCC--cccccCCCCccccccccccC-CCCCCcchHHHH
Q 011628 140 FCHARGVYHRDLKPENLLLDENG--DLKVSDFGLSAVSDQIRQDG--LFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSC 214 (481)
Q Consensus 140 yLH~~gi~HrDLKp~NILl~~~g--~lkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSl 214 (481)
|||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998777 89999999998653322211 23456899999999998652 333678999999
Q ss_pred HHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC----CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 215 GVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 215 Gvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||++|+|++|..||.+.+.......+.......+. .+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 99999999999999998888888888776644322 378999999999999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=388.06 Aligned_cols=256 Identities=37% Similarity=0.644 Sum_probs=229.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.+.++|++.+.||+|+||.||+|++..++..||+|++...... ..+.+.+|+.+++.++||||+++++++......|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 4678999999999999999999999999999999999765432 2466889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEecCCccccccc
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl---~~~g~lkl~DFGla~~~~~~ 178 (481)
+||||++|++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~- 161 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP- 161 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT-
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC-
Confidence 99999999999998865 679999999999999999999999999999999999999 7889999999999976432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC----CCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~ 254 (481)
........||+.|+|||++.+. + +.++||||||+++|+|++|..||...+.......+..+....|. .+++.
T Consensus 162 --~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 162 --GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp --TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred --ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 2234566899999999998654 4 67899999999999999999999999888888888888776654 58999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
+.+||.+||+.||.+|||+.++++||||++..
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999999997643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=396.70 Aligned_cols=260 Identities=33% Similarity=0.555 Sum_probs=230.5
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (481)
+..+.++|++++.||+|+||.||+|++..+|+.||+|++........ .....+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45577899999999999999999999999999999999986543221 135678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEecCCc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG----DLKVSDFGLS 172 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g----~lkl~DFGla 172 (481)
...+|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999976 5799999999999999999999999999999999999999888 7999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP---- 248 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 248 (481)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 76433 223345679999999999987776 6789999999999999999999999888888888877765543
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+++.+.+||.+||+.||.+|||++|+++||||..
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 468899999999999999999999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=403.05 Aligned_cols=254 Identities=23% Similarity=0.417 Sum_probs=217.9
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcceEEE
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-----HPNIVQLFE 93 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~ 93 (481)
..+..+.++|++++.||+|+||+||+|++..+++.||||++.... .......+|+.+++.+. ||||+++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 345567899999999999999999999999999999999996432 34456778999999996 999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc----------
Q 011628 94 VMATKSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---------- 160 (481)
Q Consensus 94 ~~~~~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---------- 160 (481)
++...+..|+||||+ |++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 99999999763 4999999999999999999999999999999999999975
Q ss_pred ---------------CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCC
Q 011628 161 ---------------NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGY 225 (481)
Q Consensus 161 ---------------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~ 225 (481)
++.+||+|||+++.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSS
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCC
Confidence 78999999999975332 2245689999999999988877 57899999999999999999
Q ss_pred CCCCCchHHHHHHHHhhCCCCCCC----------------------------------------------CCCHHHHHHH
Q 011628 226 LPFQDQNIMVMYKKIYKGEFRSPR----------------------------------------------WFSPDLIRLL 259 (481)
Q Consensus 226 ~Pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~s~~~~~li 259 (481)
.||...+.......+.....+.|. ..++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 999987766655555432221110 1236788999
Q ss_pred HHhcccCcCCCCCHhHHHhCcccc
Q 011628 260 TKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.+||+.||.+|||++|+++||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999995
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=403.57 Aligned_cols=255 Identities=36% Similarity=0.652 Sum_probs=208.6
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.....+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 346788999999999999999999999999999999997643 234577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEecCCcccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---NGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---~g~lkl~DFGla~~~~~ 177 (481)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999999976 57999999999999999999999999999999999999975 88999999999976432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCCC----CCCCC
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFRS----PRWFS 252 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~----~~~~s 252 (481)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ...+..+..+.... ...++
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 204 ---QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp ------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ---ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 223345789999999999988776 6789999999999999999999977654 34666777665433 24578
Q ss_pred HHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++.+||.+||+.||++|||+.|+++||||...
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=394.37 Aligned_cols=253 Identities=29% Similarity=0.517 Sum_probs=224.5
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.|+..+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 488999999999999999999889999999999765422 34567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccc
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT 186 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 186 (481)
|++|++|.+++...++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--cccccc
Confidence 999999999998888999999999999999999999999999999999999999999999999998764331 122345
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHHHHHHHHHhc
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~L 263 (481)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..... ..+..+++.+.+||.+||
T Consensus 201 ~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred ccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 689999999999987766 5789999999999999999999998887777777766543 233457899999999999
Q ss_pred ccCcCCCCCHhHHHhCcccccC
Q 011628 264 DTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 264 ~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.||.+|||++|+++||||.+.
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGGC
T ss_pred cCChhhCcCHHHHhcChhhccC
Confidence 9999999999999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=403.06 Aligned_cols=256 Identities=37% Similarity=0.689 Sum_probs=204.6
Q ss_pred CCCccCCeeEE---eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEE
Q 011628 21 QSPLLGRYEIG---KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMA 96 (481)
Q Consensus 21 ~~~~~~~y~i~---~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 96 (481)
..++.++|++. +.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+. ||||+++++++.
T Consensus 3 ~~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~ 76 (325)
T 3kn6_A 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFH 76 (325)
T ss_dssp CCHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CCcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 34567889986 8899999999999999999999999999654 2355778999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEecCCc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---DLKVSDFGLS 172 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---~lkl~DFGla 172 (481)
+....|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred cCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 99999999999999999999976 5799999999999999999999999999999999999998766 7999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch-------HHHHHHHHhhCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-------IMVMYKKIYKGEF 245 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~ 245 (481)
+..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ .......+..+.+
T Consensus 157 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 157 RLKPPD--NQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp EECCC------------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred eecCCC--CCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 754332 223456789999999999988777 568999999999999999999998643 3566777777776
Q ss_pred CCC----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 RSP----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 ~~~----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+ ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 554 2489999999999999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=407.27 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=216.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 45789999999999999999999999999999999996643 3344567789999999999999999999999765
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..+|+||||+ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3469999999 8899999998899999999999999999999999999999999999999999999999999998643
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-----------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF----------- 245 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------- 245 (481)
. .....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 234568999999999997744447789999999999999999999998877666555543110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 --------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 --------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
......++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 1124568999999999999999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=389.61 Aligned_cols=262 Identities=36% Similarity=0.684 Sum_probs=226.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
++.++|++++.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 3578999999999999999999999999999999999765432 34577889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999999876 47999999999999999999999999999999999999999999999999999765433333
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCC--CCCCCCCHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEF--RSPRWFSPDLIRL 258 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~--~~~~~~s~~~~~l 258 (481)
......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...... ..+..+..... ..+..+++.+.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 34456789999999999988776667899999999999999999999876532 23333333322 2234589999999
Q ss_pred HHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
|.+||+.||.+|||++|+++||||++..
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=422.61 Aligned_cols=258 Identities=35% Similarity=0.616 Sum_probs=223.1
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+.++|++++.||+|+||+||+|++..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3456789999999999999999999999999999999987643222 246688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEecCCcccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~DFGla~~~~~ 177 (481)
|+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999999998865 689999999999999999999999999999999999999764 4599999999976543
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 253 (481)
. ......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+.......+..+.+..+ ..+|+
T Consensus 192 ~---~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 192 Q---KKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp T---BCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred C---ccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 2 23456789999999999864 45 6789999999999999999999999999899999988865543 35899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+++||.+||+.||.+|||+.|+++||||++.
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999999999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=395.20 Aligned_cols=260 Identities=32% Similarity=0.469 Sum_probs=213.2
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhCC---CCCcceEEEEE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK--SGLVAHIKREISILRRVR---HPNIVQLFEVM 95 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~ 95 (481)
+..+.++|++++.||+|+||+||+|++..+++.||||++....... ......+.+|+.+++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 4456789999999999999999999999999999999997543211 112244667888777775 99999999999
Q ss_pred EeCC-----EEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEE
Q 011628 96 ATKS-----KIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVS 167 (481)
Q Consensus 96 ~~~~-----~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~ 167 (481)
.... .+++||||+.| +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 8765 58999999974 999999763 39999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--C
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--F 245 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~ 245 (481)
|||+++.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++.... .
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999976432 223456789999999999988777 678999999999999999999999988777666665421 0
Q ss_pred C-------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 R-------------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 ~-------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. ..+.+++.+.+||.+||+.||.+|||+.|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0 012478899999999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=421.42 Aligned_cols=257 Identities=26% Similarity=0.467 Sum_probs=213.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4689999999999999999999999999999999998653 3334567788999999999999999999999654
Q ss_pred -CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 -SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+|+||||+.++ |.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 139 ~~~~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 139 FQDVYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CCEEEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CCeEEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 4689999999864 6666644 599999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF------------ 245 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------ 245 (481)
.......+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+....+.++.....
T Consensus 217 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 217 ---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred ---CcccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 233456799999999999998887 5689999999999999999999999887766666643210
Q ss_pred ----------C-----CCCC---------------CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 246 ----------R-----SPRW---------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 246 ----------~-----~~~~---------------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
. .+.. .++++++||.+||..||.+|||++|+++||||+....
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 0 0000 1467899999999999999999999999999986543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=394.67 Aligned_cols=261 Identities=30% Similarity=0.577 Sum_probs=218.0
Q ss_pred CCCCccCCeeEE-eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011628 20 NQSPLLGRYEIG-KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT 97 (481)
Q Consensus 20 ~~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (481)
....+.++|++. +.||+|+||+||+|++..+++.||||++..... .....+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp SCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 345678899995 889999999999999999999999999976532 2346688999999985 79999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEecCCcc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFGLSA 173 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~---lkl~DFGla~ 173 (481)
.+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999999999999999975 67999999999999999999999999999999999999998876 9999999987
Q ss_pred ccccccc-----CCcccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCch-----------
Q 011628 174 VSDQIRQ-----DGLFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQN----------- 232 (481)
Q Consensus 174 ~~~~~~~-----~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----------- 232 (481)
....... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 5432111 112335679999999999865 334 568999999999999999999997643
Q ss_pred ----HHHHHHHHhhCCCCCC----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 233 ----IMVMYKKIYKGEFRSP----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 233 ----~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
....+..+..+....| ..+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 2345666777766655 358999999999999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=418.05 Aligned_cols=261 Identities=30% Similarity=0.450 Sum_probs=199.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++++.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 45689999999999999999999999999999999997543 2334567788999999999999999999998443
Q ss_pred -CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 -SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 5799999998 4699999886 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccc-------------------------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--------
Q 011628 177 QIRQ-------------------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-------- 223 (481)
Q Consensus 177 ~~~~-------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-------- 223 (481)
.... .......+||+.|+|||++......+.++|||||||++|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 2111 1134567899999999987544444788999999999999998
Q ss_pred ---CCCCCCCchH--------------------HHHHHHHhh--C--------------------CC---------CCCC
Q 011628 224 ---GYLPFQDQNI--------------------MVMYKKIYK--G--------------------EF---------RSPR 249 (481)
Q Consensus 224 ---g~~Pf~~~~~--------------------~~~~~~i~~--~--------------------~~---------~~~~ 249 (481)
|.++|.+.+. ......+.. + .+ ...+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6777765431 111111111 0 00 0123
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..++++.+||.+||..||++|||++|+|+||||+..
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 468999999999999999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=401.20 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=210.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++++.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 47899999999999999999999999999999999754321 1112345799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence 999985 88888865 35999999999999999999999999999999999999999999999999998754321 22
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CC--------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FR-------------- 246 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~-------------- 246 (481)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 33456889999999999775555789999999999999999999999988766665554311 00
Q ss_pred --------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 247 --------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 247 --------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.+..+++++.+||.+||+.||.+|||++|+++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0124688999999999999999999999999999997653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=400.84 Aligned_cols=265 Identities=27% Similarity=0.448 Sum_probs=223.3
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
..+..+.++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 34566789999999999999999999999999999999999876655556677899999999999999999999998764
Q ss_pred C----EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 99 S----KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 99 ~----~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
. ..|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3 45999999999999999975 689999999999999999999999999999999999999999999999999997
Q ss_pred ccccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC----C
Q 011628 174 VSDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS----P 248 (481)
Q Consensus 174 ~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----~ 248 (481)
....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....... +
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 6443221 122334679999999999988776 568999999999999999999999988877766666654433 3
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+++++.+||.+||+.||.+||++.+++.|+|++.
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 458999999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=389.03 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=222.3
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.+..+.++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 35567899999999999999999999999999999999997766555666788999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999999976 67999999999999999999999999999999999999999999999999999765432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-----CCCCCCH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-----SPRWFSP 253 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~ 253 (481)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......+......+ .+..+++
T Consensus 165 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 165 S-LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred c-ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 1 122345679999999999988776 57899999999999999999999998877666565555432 2456899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+.++|.+||++||.+||+..+.+.+.|.
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 99999999999999999966666666664
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=397.74 Aligned_cols=261 Identities=30% Similarity=0.464 Sum_probs=218.7
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
....++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 345889999999999999999999999999999999997654 2334556788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 999999999999988764 67999999999999999999999999999999999999999999999999999754332
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-----------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG----------------- 243 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~----------------- 243 (481)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 223345689999999999987645578899999999999999999999987765544443321
Q ss_pred --CCCC------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 --EFRS------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 --~~~~------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.... .+.+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0011 12468999999999999999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=403.29 Aligned_cols=255 Identities=29% Similarity=0.517 Sum_probs=219.2
Q ss_pred ccCCeeE--EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 24 LLGRYEI--GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 24 ~~~~y~i--~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
+.+.|++ .+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3456666 6789999999999999999999999999976532 2346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE--ccCCCEEEEecCCcccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL--DENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl--~~~g~lkl~DFGla~~~~~ 177 (481)
|+||||++|++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999999998865 369999999999999999999999999999999999999 5567899999999986543
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 253 (481)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+..+ ..+++
T Consensus 242 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 242 ---REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp ---TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ---ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 223345689999999999977666 6789999999999999999999999988888888887765443 45899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++.+||.+||+.||.+|||++|+++||||...
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=403.84 Aligned_cols=257 Identities=33% Similarity=0.602 Sum_probs=224.8
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----GLVAHIKREISILRRVRHPNIVQLFEVM 95 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (481)
...+.++|++++.||+|+||+||+|++..+++.||||++........ .....+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34567899999999999999999999999999999999987643221 1233466899999999999999999999
Q ss_pred EeCCEEEEEEeccCCC-chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 96 ATKSKIYFVMEYVRGG-ELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg-~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
.....+++||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999999777 99999986 479999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCH
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSP 253 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 253 (481)
.... .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..+++
T Consensus 179 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~ 249 (335)
T 3dls_A 179 YLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSK 249 (335)
T ss_dssp ECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCH
T ss_pred ECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCH
Confidence 6432 23345678999999999998888767789999999999999999999987432 23344566777999
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
++.+||.+||++||.+|||++++++||||++..
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 999999999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=407.75 Aligned_cols=251 Identities=33% Similarity=0.622 Sum_probs=208.6
Q ss_pred CccCCeeEE-eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEe---
Q 011628 23 PLLGRYEIG-KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL-RRVRHPNIVQLFEVMAT--- 97 (481)
Q Consensus 23 ~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~--- 97 (481)
.+.++|.+. +.||+|+||+||+|++..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 456788887 7999999999999999999999999998642 2356788887 45589999999999876
Q ss_pred -CCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEecC
Q 011628 98 -KSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---NGDLKVSDFG 170 (481)
Q Consensus 98 -~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---~g~lkl~DFG 170 (481)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 56799999999999999999763 5999999999999999999999999999999999999998 7889999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH----HHHHHHhhCCCC
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM----VMYKKIYKGEFR 246 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~~ 246 (481)
+++.... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.. .....+..+.+.
T Consensus 210 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 210 FAKETTS---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cccccCC---CCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 9975432 223456789999999999988777 57899999999999999999999775432 244555566554
Q ss_pred CC----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 247 SP----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 247 ~~----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+ ..+++++.+||.+||+.||.+|||++|+++||||.+.
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 43 4589999999999999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=392.84 Aligned_cols=262 Identities=37% Similarity=0.673 Sum_probs=226.2
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK-SGLVAHIKREISILRRVRHPNIVQLFEVMA--TKS 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~ 99 (481)
.+.++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++. ...
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 36789999999999999999999999999999999997654321 234567889999999999999999999984 456
Q ss_pred EEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..|+||||+.++ |.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 799999999987 6666653 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDL 255 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 255 (481)
............||+.|+|||++.+.. +.+.++||||||+++|+|++|..||.+.+.......+..+....+..+++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 333333445667999999999987543 3356899999999999999999999999888888889888888888999999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+||.+||+.||.+|||++|+++||||++.
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999999999764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=398.55 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=218.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT------ 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 97 (481)
..++|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 468999999999999999999999999999999999765432 2234567799999999999999999999977
Q ss_pred --CCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 98 --KSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 98 --~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
.+.+|+||||+.| +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4568999999986 77777765 579999999999999999999999999999999999999999999999999997
Q ss_pred cccccc--cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCC-
Q 011628 174 VSDQIR--QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW- 250 (481)
Q Consensus 174 ~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~- 250 (481)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......+..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 654221 22234556899999999999775555789999999999999999999999988776666654421111110
Q ss_pred -------------------------------CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 251 -------------------------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 251 -------------------------------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 26779999999999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=399.54 Aligned_cols=259 Identities=28% Similarity=0.459 Sum_probs=220.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK-----S 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 99 (481)
.++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 479999999999999999999999999999999997533 334557788999999999999999999999765 4
Q ss_pred EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
..|+||||+.| +|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 68999999975 99999998899999999999999999999999999999999999999999999999999998654332
Q ss_pred c-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--C------------
Q 011628 180 Q-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--E------------ 244 (481)
Q Consensus 180 ~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~------------ 244 (481)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 2 223456789999999999766554478899999999999999999999887655444444321 0
Q ss_pred --------CC---------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 245 --------FR---------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 245 --------~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.+ ....+++++.+||.+||+.||.+|||++|+++||||++.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00 1245789999999999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=388.94 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=208.1
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
+..+.++|++.+.||+|+||+||+|++..+|+.||||++.......... ....+|+..+..+ +||||+++++++.+..
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 3445588999999999999999999999999999999987654333333 3344555555444 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
.+|+||||+ +++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999999999 6688888764 4699999999999999999999999999999999999999999999999999876433
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--CCCCCCHHH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDL 255 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~ 255 (481)
. ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+..... ...+..+..+ .+..+++++
T Consensus 210 ~---~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 210 A---GAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSEL 281 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHH
T ss_pred C---CCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHH
Confidence 2 23345679999999999876 45 6789999999999999999766655433 2233333222 245689999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+||.+||++||++|||++|+++||||++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=384.64 Aligned_cols=264 Identities=32% Similarity=0.560 Sum_probs=227.0
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc------chhHHHHHHHHHHHHHhCC-CCCcceE
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL------KSGLVAHIKREISILRRVR-HPNIVQL 91 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-HpnIv~l 91 (481)
.....+.++|++.+.||+|+||.||+|++..+|+.||||++...... .......+.+|+.+++++. ||||+++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 33456789999999999999999999999999999999999765311 1234566889999999995 9999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecC
Q 011628 92 FEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 92 ~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFG 170 (481)
++++......|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999999999976 689999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCcccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF 245 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 245 (481)
++..... .......+||+.|+|||++.+ ....+.++||||||+++|+|++|..||...+.......+..+..
T Consensus 170 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 170 FSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred chhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 9976432 223455689999999999852 22236789999999999999999999999888888888877765
Q ss_pred CCC----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 RSP----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 ~~~----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+ ..+++.+.+||.+||+.||.+|||++|+++||||++.
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 443 3478999999999999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=398.19 Aligned_cols=257 Identities=33% Similarity=0.632 Sum_probs=225.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-----KSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++.+.||+|+||.||+|++..+|+.||||++...... .......+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 47899999999999999999999889999999999765321 123356788999999999 799999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
...|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 999999999999999999875 6899999999999999999999999999999999999999999999999999876432
Q ss_pred cccCCcccccCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRK-----GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP---- 248 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 248 (481)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+....+
T Consensus 253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 2234567899999999998632 1235689999999999999999999999888888888877765543
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+++.+.+||.+||+.||.+|||++++++||||++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 457899999999999999999999999999999963
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=395.73 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=211.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
.+.++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 45689999999999999999999999999999999997654 2335577899999999999999999999986543
Q ss_pred ------------------------------------------------------EEEEEEeccCCCchHHHHHcC----C
Q 011628 100 ------------------------------------------------------KIYFVMEYVRGGELFNKVAKG----R 121 (481)
Q Consensus 100 ------------------------------------------------------~~~lv~Ey~~gg~L~~~i~~~----~ 121 (481)
.+|+|||||+||+|.+++... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 389999999999999999863 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc----------CCcccccCCCC
Q 011628 122 LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ----------DGLFHTFCGTP 191 (481)
Q Consensus 122 l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~----------~~~~~~~~gt~ 191 (481)
.++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 56677999999999999999999999999999999999999999999999986543221 11234568999
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-CCCCCHHHHHHHHHhcccCcCCC
Q 011628 192 AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 192 ~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R 270 (481)
.|+|||++.+..+ +.++|||||||++|+|++|..|+... ......+.....+. +...++++.+||.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999999988777 67899999999999999998775332 23333333333221 23357789999999999999999
Q ss_pred CCHhHHHhCccccc
Q 011628 271 ITIPEIMENRWFRK 284 (481)
Q Consensus 271 ps~~eil~h~~f~~ 284 (481)
||++|+++||||++
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=386.31 Aligned_cols=259 Identities=26% Similarity=0.487 Sum_probs=230.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
....+|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.....+|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 3467899999999999999999999999999999999866432 34577889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
+||||++|++|.+++..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 99999999999999998899999999999999999999999999999999999999999999999999997644321 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 261 (481)
......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+. ...+..+++.+.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 2345689999999999987776 568999999999999999999999887777666666554 34566789999999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccCc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
||+.||.+|||++++++||||.+..
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCC
Confidence 9999999999999999999997653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=388.75 Aligned_cols=256 Identities=36% Similarity=0.681 Sum_probs=224.9
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+.++|++.+.||+|+||.||+|++..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.....+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 45678999999999999999999999999999999999865322 235678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEecCCcccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl---~~~g~lkl~DFGla~~~~~ 177 (481)
|+||||++|++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999999999865 689999999999999999999999999999999999999 7889999999999875332
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC----CCCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS----PRWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~ 253 (481)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+.... +..+++
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 162 ----GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp ----BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ----CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 22345679999999999987766 578999999999999999999999988888888888775443 346889
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++.+||.+||+.||.+|||++|+++||||...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=382.74 Aligned_cols=257 Identities=33% Similarity=0.609 Sum_probs=224.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
+.++|++++.||+|+||.||+|++..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 45789999999999999999999999999999999976543221 135678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEecCCcccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG----DLKVSDFGLSAVS 175 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g----~lkl~DFGla~~~ 175 (481)
.|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999999975 6799999999999999999999999999999999999999877 8999999999754
Q ss_pred cccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCC
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWF 251 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 251 (481)
... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+ ..+
T Consensus 163 ~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 163 EAG---NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp C-----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred cCC---CcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 321 22345679999999999987766 6789999999999999999999999888877777776655443 467
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=394.35 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=221.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||+||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++......|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45699999999999999999999999999999999876544445567789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+. |+|.+.+. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 99998 57877775 36799999999999999999999999999999999999999999999999999976432
Q ss_pred cccccCCCCccccccccc---cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--CCCCCCHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLS---RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIR 257 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~ 257 (481)
....+||+.|+|||++. ...+ +.++|||||||++|+|++|..||.+.+.......+..+..+ .+..+++.+.+
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 284 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 284 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 23468999999999985 3344 67899999999999999999999988777666666665432 24568999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||.+||+.||.+|||++++++||||...
T Consensus 285 li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 285 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=404.37 Aligned_cols=256 Identities=28% Similarity=0.441 Sum_probs=202.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 45789999999999999999999999999999999997643 2334557788999999999999999999998654
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..+|++|||+ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 7899999988889999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--C----------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--E---------- 244 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~---------- 244 (481)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2345689999999999987444477899999999999999999999988776655555431 0
Q ss_pred -----------CCC--------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 245 -----------FRS--------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 245 -----------~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
... ....++.+.+||.+||..||.+|||++|+++||||...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 000 12468889999999999999999999999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=379.95 Aligned_cols=254 Identities=20% Similarity=0.307 Sum_probs=216.6
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSK 100 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 100 (481)
..+.++|++++.||+|+||+||+|++..+++.||||++....... .....+.+|+.++..+ +||||+++++++.+.+.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 446789999999999999999999999999999999998654333 3456678999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC--------------
Q 011628 101 IYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-------------- 161 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-------------- 161 (481)
.|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999999864 569999999999999999999999999999999999999854
Q ss_pred -----CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH
Q 011628 162 -----GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM 236 (481)
Q Consensus 162 -----g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 236 (481)
..+||+|||++...... ....||+.|+|||++.+....+.++|||||||++|+|++|..|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 47999999998764321 2346999999999997764545689999999999999999988766543
Q ss_pred HHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 237 YKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 237 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...+..+. ...|..+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 33344444 34577899999999999999999999999999999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=405.61 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=216.2
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC------CCCCcceEEE
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV------RHPNIVQLFE 93 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~ 93 (481)
....+..+|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+ +|+||+++++
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 34566789999999999999999999999999999999997543 3445677888888887 5779999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--EEEEe
Q 011628 94 VMATKSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD--LKVSD 168 (481)
Q Consensus 94 ~~~~~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~--lkl~D 168 (481)
++.....+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 9999999999999996 5899988753 4999999999999999999999999999999999999999987 99999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-- 246 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-- 246 (481)
||+++.... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......
T Consensus 246 FG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 246 FGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp CTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cccceecCC-----cccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999975332 2345789999999999988877 67899999999999999999999988766555544321000
Q ss_pred ---------------------------------------------------------CCCCCCHHHHHHHHHhcccCcCC
Q 011628 247 ---------------------------------------------------------SPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 247 ---------------------------------------------------------~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
.+...++.+.+||.+||+.||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 01123788999999999999999
Q ss_pred CCCHhHHHhCcccccC
Q 011628 270 RITIPEIMENRWFRKG 285 (481)
Q Consensus 270 Rps~~eil~h~~f~~~ 285 (481)
|||++|+++||||++.
T Consensus 400 Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRR 415 (429)
T ss_dssp SCCHHHHHTSTTTC--
T ss_pred CCCHHHHhCChhhccC
Confidence 9999999999999865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=393.06 Aligned_cols=263 Identities=29% Similarity=0.476 Sum_probs=225.6
Q ss_pred CCCCCCccCCeeEE-eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEE
Q 011628 18 DQNQSPLLGRYEIG-KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVM 95 (481)
Q Consensus 18 ~~~~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~ 95 (481)
-+....+.++|.+. +.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+++.+. ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 33445678899998 89999999999999999999999999998754322 33567889999999995 79999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEec
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---NGDLKVSDF 169 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---~g~lkl~DF 169 (481)
.....+|+||||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999999999854 57999999999999999999999999999999999999998 789999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC--
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-- 247 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-- 247 (481)
|++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......
T Consensus 179 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 179 GMSRKIGHA---CELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred ccccccCCc---cccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 999865432 22345689999999999987776 578999999999999999999999988877777776654333
Q ss_pred --CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 --PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 --~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 34588999999999999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=392.35 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=212.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH--PNIVQLFEVMATKSKI 101 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~ 101 (481)
..++|++++.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+++.++| |||+++++++.....+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 467899999999999999999987 5689999999986643 33455778999999999976 9999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.......
T Consensus 85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99999 567899999976 5799999999999999999999999999999999999996 67899999999986544333
Q ss_pred CCcccccCCCCcccccccccc----------CCCCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhC--CCCC
Q 011628 181 DGLFHTFCGTPAYVAPEVLSR----------KGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG--EFRS 247 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~----------~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~--~~~~ 247 (481)
.......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+.. .......+... ....
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence 333456789999999999864 1233678999999999999999999998743 33344444433 3456
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|...++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 243 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 77788999999999999999999999999999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=378.31 Aligned_cols=253 Identities=24% Similarity=0.495 Sum_probs=218.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----KSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~ 100 (481)
...|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 45689999999999999999999999999999999866533 3446778999999999999999999999875 456
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEc-cCCCEEEEecCCccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLD-ENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~-~~g~lkl~DFGla~~~~ 176 (481)
+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999986 78999999999999999999999999 99999999999998 78999999999997533
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-hHHHHHHHHhhCCC--CCCCCCCH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NIMVMYKKIYKGEF--RSPRWFSP 253 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~~~~~i~~~~~--~~~~~~s~ 253 (481)
. ......+||+.|+|||++.+. + +.++|||||||++|+|++|..||... +....+..+..+.. ..+...++
T Consensus 184 ~----~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 184 A----SFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred c----cccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 2 233456899999999998643 4 67899999999999999999999874 44455555555432 23556789
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
++.+||.+||+.||.+|||++++++||||+.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=400.93 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=214.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR--HPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~ 102 (481)
..+|++++.||+|+||+||+|.+.. ++.||||++..... .......+.+|+.+++.+. ||||+++++++.....+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 4569999999999999999999854 89999999987643 3345677899999999996 599999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++........
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9999 568899999976 5799999999999999999999999999999999999995 589999999999865433222
Q ss_pred CcccccCCCCccccccccccC----------CCCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhCC--CCCC
Q 011628 182 GLFHTFCGTPAYVAPEVLSRK----------GYDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKGE--FRSP 248 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~----------~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~--~~~~ 248 (481)
......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+.... ...|
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 234567899999999998652 233678999999999999999999998753 334455555443 4567
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+.++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 7889999999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=397.88 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=210.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
.+.++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 35789999999999999999999999999999999997653 23345577889999999999999999999997665
Q ss_pred ---EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 100 ---KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 100 ---~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
.+|+||||+.| +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 7888775 459999999999999999999999999999999999999999999999999997643
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC---------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS--------- 247 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~--------- 247 (481)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 223345689999999999988777 578999999999999999999999988777666665431100
Q ss_pred ----------CC-----------------------CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 248 ----------PR-----------------------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 248 ----------~~-----------------------~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
|. ..++++++||.+||+.||.+|||++|+++||||...+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 0146789999999999999999999999999997653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=396.37 Aligned_cols=260 Identities=30% Similarity=0.455 Sum_probs=213.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK--SGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
...++|++++.||+|+||.||+|++..+|+.||||++....... ......+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 35689999999999999999999999999999999997543221 1223467799999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.|+||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~- 164 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS- 164 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC-
Confidence 9999999986 88888875 3689999999999999999999999999999999999999999999999999976532
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCC---------
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRS--------- 247 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~--------- 247 (481)
........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+.... ...
T Consensus 165 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 -PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp -CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 22234567899999999999765544778999999999999999999999988777766665421 000
Q ss_pred -----------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 -----------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 -----------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...+++++.+||.+||+.||.+|||++|+++||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13457899999999999999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=395.98 Aligned_cols=259 Identities=32% Similarity=0.578 Sum_probs=222.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
.++|++++.||+|+||+||+|++. .+++.||||++.+.... .......+.+|+.+++.+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 479999999999999999999984 58999999999764321 112234466899999999 6999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999999999975 68999999999999999999999999999999999999999999999999999754322
Q ss_pred ccCCcccccCCCCccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCc----hHHHHHHHHhhCCCCCCCCCCH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSCGVILFVLMAGYLPFQDQ----NIMVMYKKIYKGEFRSPRWFSP 253 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~ 253 (481)
. .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+.......|..+++
T Consensus 213 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (355)
T 1vzo_A 213 E-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291 (355)
T ss_dssp G-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCH
Confidence 1 1223456899999999999753 22367899999999999999999999743 3455666777777788888999
Q ss_pred HHHHHHHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 254 DLIRLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.+.+||.+||..||.+|| |++|+++||||++
T Consensus 292 ~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999999999999 9999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=386.90 Aligned_cols=262 Identities=30% Similarity=0.443 Sum_probs=214.8
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA-- 96 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-- 96 (481)
..+..+.++|++++.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 4 IHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp --CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred cccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 455677899999999999999999999999999999999987542 345677889999999999999999999873
Q ss_pred ------------eCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-cCCC
Q 011628 97 ------------TKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD-ENGD 163 (481)
Q Consensus 97 ------------~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~-~~g~ 163 (481)
.....|+||||+. |+|.+++..+++++..++.++.|++.||+|||++||+||||||+|||++ .++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence 4468999999998 5999999988999999999999999999999999999999999999997 5678
Q ss_pred EEEEecCCcccccccc-cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh
Q 011628 164 LKVSDFGLSAVSDQIR-QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK 242 (481)
Q Consensus 164 lkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~ 242 (481)
+||+|||++....... .........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999998654221 122334567899999999987644447789999999999999999999998877666555543
Q ss_pred CCCC------------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 243 GEFR------------------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 243 ~~~~------------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.... .+..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 2110 12457999999999999999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=385.13 Aligned_cols=257 Identities=30% Similarity=0.517 Sum_probs=215.8
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe---
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT--- 97 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--- 97 (481)
....++|++++.||+|+||.||+|++..+|+.||||++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 4468899999999999999999999999999999999976532 235678999999999 79999999999977
Q ss_pred ---CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 98 ---KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 98 ---~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
...+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 5689999999999999999975 4699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR 246 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 246 (481)
+...... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+.....+
T Consensus 176 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 176 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred ceecCcC--ccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 8764321 12234567999999999986 3334 67899999999999999999999988776666666554432
Q ss_pred --CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 247 --SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 247 --~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 245689999999999999999999999999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=389.88 Aligned_cols=262 Identities=31% Similarity=0.484 Sum_probs=218.8
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK-- 98 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-- 98 (481)
...+.++|++++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 4456889999999999999999999999999999999996432 334556788999999999999999999998664
Q ss_pred ---CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 99 ---SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 99 ---~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
...|+||||+. ++|.+.+..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 67999999997 59999998889999999999999999999999999999999999999999999999999999764
Q ss_pred cccccC--------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--C-
Q 011628 176 DQIRQD--------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--E- 244 (481)
Q Consensus 176 ~~~~~~--------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~- 244 (481)
...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 422111 11234589999999999866444577899999999999999999999987765444433210 0
Q ss_pred ---------------------CC--------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 245 ---------------------FR--------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 245 ---------------------~~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.. .++.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00 023578999999999999999999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=396.79 Aligned_cols=250 Identities=30% Similarity=0.477 Sum_probs=210.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT------ 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 97 (481)
..++|++++.||+|+||+||+|++..+|+.||||++..+... ..+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 457899999999999999999999999999999998765322 2379999999999999999999844
Q ss_pred --------------------------------CCEEEEEEeccCCCchHHHHH----c-CCCCHHHHHHHHHHHHHHHHH
Q 011628 98 --------------------------------KSKIYFVMEYVRGGELFNKVA----K-GRLKEDLARKYFQQLISAVGF 140 (481)
Q Consensus 98 --------------------------------~~~~~lv~Ey~~gg~L~~~i~----~-~~l~e~~~~~~~~ql~~al~y 140 (481)
...+++||||++| +|.+.+. . +.+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3348999999985 7766654 2 579999999999999999999
Q ss_pred HHHcCceecCCCCCcEEEc-cCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHH
Q 011628 141 CHARGVYHRDLKPENLLLD-ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF 219 (481)
Q Consensus 141 LH~~gi~HrDLKp~NILl~-~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ 219 (481)
||++||+||||||+|||++ .++.+||+|||+++.... .......+||+.|+|||++.+....+.++||||+||++|
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999998 688999999999985432 223345688999999999887664578999999999999
Q ss_pred HHhcCCCCCCCchHHHHHHHHhhC-----------------CCC------------CCCCCCHHHHHHHHHhcccCcCCC
Q 011628 220 VLMAGYLPFQDQNIMVMYKKIYKG-----------------EFR------------SPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 220 elltg~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
+|++|..||.+.+.......+... ... .|..+++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999988776666655431 000 245578999999999999999999
Q ss_pred CCHhHHHhCccccc
Q 011628 271 ITIPEIMENRWFRK 284 (481)
Q Consensus 271 ps~~eil~h~~f~~ 284 (481)
||+.|+++||||+.
T Consensus 314 ~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 314 INPYEAMAHPFFDH 327 (383)
T ss_dssp CCHHHHHTSGGGHH
T ss_pred CCHHHHhcCHHHHH
Confidence 99999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=392.72 Aligned_cols=258 Identities=27% Similarity=0.450 Sum_probs=220.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
+....++|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 4456789999999999999999999999999999999998653 33456778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
+|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999999976 6899999999999999999999996 9999999999999999999999999998754321
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHH---------------------
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY--------------------- 237 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~--------------------- 237 (481)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.....
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 2245689999999999988776 57899999999999999999999876543322
Q ss_pred ---------------------HHHhhCCCC--CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 238 ---------------------KKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 238 ---------------------~~i~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+...... .+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 222222211 123478899999999999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=382.72 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=214.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++.+.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.++++++||||+++++++.....+|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 3468999999999999999999987 688999999976543 3345577889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 103 FVMEYVRGGELFNKVAKGR----LKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~----l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
+||||++||+|.+++.... +++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999998643 999999999999999999999999 9999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh--hCCCCCCCCCCHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY--KGEFRSPRWFSPD 254 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~~~~~s~~ 254 (481)
.. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+. ......|..+++.
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 191 ST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp -------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 21 122345689999999999988777 678999999999999999999999988776666653 3345678889999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHh--Ccccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIME--NRWFR 283 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~--h~~f~ 283 (481)
+.+||.+||+.||.+|||+.++++ ++++.
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999988 45543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=383.85 Aligned_cols=250 Identities=27% Similarity=0.476 Sum_probs=210.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMAT--KSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~ 101 (481)
.++|++++.||+|+||+||+|++..+++.||||++.... .+.+.+|+.+++.++ ||||+++++++.. ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 579999999999999999999999999999999986432 356789999999997 9999999999988 6789
Q ss_pred EEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~~~ 180 (481)
++||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 109 ~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--- 183 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--- 183 (330)
T ss_dssp EEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT---
T ss_pred EEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC---
Confidence 999999999999998854 89999999999999999999999999999999999999777 899999999976433
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-hHHHHHH-------------HHhhCCCC
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NIMVMYK-------------KIYKGEFR 246 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~~~~-------------~i~~~~~~ 246 (481)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +...... .+......
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 223455689999999999977555578999999999999999999999432 1111111 11111111
Q ss_pred C------------------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 247 S------------------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 247 ~------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. +..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 1 12278999999999999999999999999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=404.20 Aligned_cols=257 Identities=38% Similarity=0.683 Sum_probs=209.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK-----SGLVAHIKREISILRRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (481)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.+..... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999999999999999998754321 112234789999999999999999999975
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEecCCcc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---DLKVSDFGLSA 173 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---~lkl~DFGla~ 173 (481)
....|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 4568999999999999998875 6799999999999999999999999999999999999997654 59999999998
Q ss_pred cccccccCCcccccCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCCCC-
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSR---KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFRSP- 248 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~- 248 (481)
.... .....+.+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||..... ......+..+....+
T Consensus 291 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 291 ILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp SCC--------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred ecCC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 6543 233456789999999999854 333 5689999999999999999999986543 234445555554432
Q ss_pred ---CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 ---RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 ---~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 457999999999999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=378.86 Aligned_cols=258 Identities=33% Similarity=0.590 Sum_probs=224.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKI 101 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 101 (481)
..++|++++.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 367999999999999999999999999999999999876432 3446778999999999999999999998754 6789
Q ss_pred EEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-----ceecCCCCCcEEEccCCCEEEEecCC
Q 011628 102 YFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARG-----VYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~g-----i~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999999864 24999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCC
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRW 250 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 250 (481)
+...... ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+.. ..|..
T Consensus 163 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNHD--TSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeeccc--cccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 8754321 112234579999999999987766 5789999999999999999999999888888888877765 55778
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++++.++|.+||+.||.+|||++|+++|+|+...
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 99999999999999999999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=379.96 Aligned_cols=257 Identities=27% Similarity=0.498 Sum_probs=217.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.....++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 34557899999999999999999999999999999999976532 3557899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
+|+||||+.|++|.+++. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999999986 367999999999999999999999999999999999999999999999999999764332
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDL 255 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~ 255 (481)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.... +..+..+++.+
T Consensus 179 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (314)
T 3com_A 179 --MAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255 (314)
T ss_dssp --BSCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred --ccccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence 122345679999999999988776 568999999999999999999999877665555554442 23355679999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+||.+||..||.+|||+.++++||||+..
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=393.94 Aligned_cols=261 Identities=25% Similarity=0.493 Sum_probs=227.1
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh--------------HHHHHHHHHHHHHhCC
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG--------------LVAHIKREISILRRVR 84 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~ 84 (481)
..+....++|++++.||+|+||.||+|++ +|+.||||++......... ....+.+|+.+++.++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 34456679999999999999999999998 8999999999765432211 1267889999999999
Q ss_pred CCCcceEEEEEEeCCEEEEEEeccCCCchHHH------HHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCC
Q 011628 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNK------VAK---GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPE 154 (481)
Q Consensus 85 HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~------i~~---~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~ 154 (481)
||||+++++++...+.+|+||||++||+|.++ +.. +.+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999998 653 579999999999999999999999 99999999999
Q ss_pred cEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCchH
Q 011628 155 NLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSCGVILFVLMAGYLPFQDQNI 233 (481)
Q Consensus 155 NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 233 (481)
|||++.++.+||+|||++...... ......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||.....
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999764322 33456899999999999876 4533389999999999999999999988766
Q ss_pred -HHHHHHHhhCCCCCC-------------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 234 -MVMYKKIYKGEFRSP-------------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 234 -~~~~~~i~~~~~~~~-------------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
......+..+....| ..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 677777777766666 6689999999999999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=393.00 Aligned_cols=252 Identities=23% Similarity=0.432 Sum_probs=219.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-------KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMA 96 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 96 (481)
.++|++++.||+|+||+||+|++. .++..||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 578999999999999999999975 345679999997653 334567789999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD 159 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~ 159 (481)
..+.+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 999999999999999999999752 378999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHH
Q 011628 160 ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYK 238 (481)
Q Consensus 160 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 238 (481)
.++.+||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999986543322223344567899999999988776 678999999999999999 999999887777777
Q ss_pred HHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 239 KIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 239 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+..+. ...|..+++++.+||.+||+.||.+|||+.|++++
T Consensus 317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 776664 45677899999999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=398.85 Aligned_cols=254 Identities=31% Similarity=0.473 Sum_probs=209.6
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS- 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 99 (481)
+.....+|++++.||+|+||+||+|++..+++ ||+|++...... ..+|+.+++.++||||+++++++....
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 44567799999999999999999999876665 888888654322 237999999999999999999986543
Q ss_pred -----EEEEEEeccCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-cCCCEEEEec
Q 011628 100 -----KIYFVMEYVRGGELFNKVA----KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD-ENGDLKVSDF 169 (481)
Q Consensus 100 -----~~~lv~Ey~~gg~L~~~i~----~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~-~~g~lkl~DF 169 (481)
.+|+||||+.++.+..... .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 3889999998864443332 35799999999999999999999999999999999999999 7899999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC------
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------ 243 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------ 243 (481)
|+++.... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.+.
T Consensus 187 G~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 187 GSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp TTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99976432 222345689999999999977654578999999999999999999999998776655555431
Q ss_pred -----------CCC------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 -----------EFR------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 -----------~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
... .+..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 000 133478999999999999999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=407.05 Aligned_cols=248 Identities=18% Similarity=0.267 Sum_probs=205.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH---HHHhCCCCCcceEE-------EE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS---ILRRVRHPNIVQLF-------EV 94 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~ 94 (481)
.++|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999998899999999998665555556788999995 55555799999998 77
Q ss_pred EEeCCE-----------------EEEEEeccCCCchHHHHHc-CCCCH-------HHHHHHHHHHHHHHHHHHHcCceec
Q 011628 95 MATKSK-----------------IYFVMEYVRGGELFNKVAK-GRLKE-------DLARKYFQQLISAVGFCHARGVYHR 149 (481)
Q Consensus 95 ~~~~~~-----------------~~lv~Ey~~gg~L~~~i~~-~~l~e-------~~~~~~~~ql~~al~yLH~~gi~Hr 149 (481)
+...+. .|++|||+ +|+|.+++.. +.+++ ..++.++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 766542 89999999 6799999975 34555 7888899999999999999999999
Q ss_pred CCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccC-----------CCCCCcchHHHHHHHH
Q 011628 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK-----------GYDAAKVDIWSCGVIL 218 (481)
Q Consensus 150 DLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-----------~~~~~~~DiwSlGvil 218 (481)
||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .+ +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 9999999999999999999999975322 3345678 999999999876 55 6789999999999
Q ss_pred HHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 219 FVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 219 ~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
|+|++|..||.+.+.......+. ..+..+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999998766443333332 334678999999999999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=397.52 Aligned_cols=260 Identities=21% Similarity=0.316 Sum_probs=223.8
Q ss_pred CCccCCeeEEeEecccCceEEEEEE-----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHAR-----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
....++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3446899999999999999999999 44578899999996543 2334567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEE
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK--------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---DLK 165 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~--------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---~lk 165 (481)
.....|+||||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999999975 2489999999999999999999999999999999999999655 499
Q ss_pred EEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC
Q 011628 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 166 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 244 (481)
|+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999975543333333445678999999999988777 578999999999999998 999999998888888887765
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 -FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
...+..+++.+.+||.+||+.||.+|||+.+|+++.|+..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4567789999999999999999999999999999988653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=377.11 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=202.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.++...++.++||||+++++++...+..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 346899999999999999999999999999999999976532 2233344555666688889999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 103 FVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
+||||++| +|.+++.. +.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999985 77766542 5799999999999999999999998 99999999999999999999999999997643
Q ss_pred ccccCCcccccCCCCcccccccc----ccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhC-CCCC-CC
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVL----SRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKG-EFRS-PR 249 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl----~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~-~~~~-~~ 249 (481)
.. .......||+.|+|||++ .+..+ +.++|||||||++|+|++|..||.. ............. .... +.
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 32 222345799999999997 33334 6789999999999999999999985 3333333333333 3332 34
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+++++.+||.+||+.||++|||++|+++||||+..
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 689999999999999999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=378.32 Aligned_cols=259 Identities=37% Similarity=0.651 Sum_probs=226.8
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
+..+.++|++++.||+|+||.||+|++..+++.||+|++....... .....+.+|+.++++++||||+++++++.....
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 5567889999999999999999999999999999999997654322 235678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEecCCccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVSDFGLSAVSD 176 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~DFGla~~~~ 176 (481)
+|+||||+.|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999999998864 689999999999999999999999999999999999999764 469999999987643
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCCC
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFS 252 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 252 (481)
.. .......||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+....+ ..++
T Consensus 176 ~~---~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 176 QN---TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp CC---SSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred CC---CccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 32 222345689999999998754 4 6789999999999999999999999888888888877765432 4589
Q ss_pred HHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++.++|.+||..||.+|||+.|+++||||++.
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=385.35 Aligned_cols=263 Identities=28% Similarity=0.502 Sum_probs=197.9
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.....++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 345578999999999999999999999889999999998765322 234667899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 101 IYFVMEYVRGGELFNKVAK---------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~---------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
.|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999862 4599999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--
Q 011628 172 SAVSDQIR---QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-- 246 (481)
Q Consensus 172 a~~~~~~~---~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-- 246 (481)
+....... .........||+.|+|||++.+....+.++|||||||++|+|++|..||..................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 87543221 1122345679999999999876333467899999999999999999999886655444444433221
Q ss_pred --------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 247 --------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 247 --------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 234578899999999999999999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=378.98 Aligned_cols=259 Identities=31% Similarity=0.489 Sum_probs=219.5
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.....++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 34567899999999999999999999999999999999875432 234678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999998864 67999999999999999999999999999999999999999999999999987643221
Q ss_pred ccCCcccccCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC---CCCC
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR---SPRW 250 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---~~~~ 250 (481)
.. ......||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+..+..+ .+..
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 171 LQ--KRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp HH--C-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred cc--ccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccc
Confidence 11 123457999999999984 3344 67899999999999999999999998877777777665432 3566
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 88999999999999999999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=387.25 Aligned_cols=257 Identities=31% Similarity=0.606 Sum_probs=221.9
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCC--CCCcceEEE
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRVR--HPNIVQLFE 93 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--HpnIv~l~~ 93 (481)
.....+.++|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++.++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3455678999999999999999999999999999999999977643221 11234567999999996 599999999
Q ss_pred EEEeCCEEEEEEeccCC-CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-cCCCEEEEecC
Q 011628 94 VMATKSKIYFVMEYVRG-GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD-ENGDLKVSDFG 170 (481)
Q Consensus 94 ~~~~~~~~~lv~Ey~~g-g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~-~~g~lkl~DFG 170 (481)
++...+..++||||+.+ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999999987 899999875 7899999999999999999999999999999999999999 77899999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW 250 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 250 (481)
++..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+..+....+..
T Consensus 196 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~ 265 (320)
T 3a99_A 196 SGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQR 265 (320)
T ss_dssp TCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSC
T ss_pred ccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccccc
Confidence 9976442 233456799999999999877776778999999999999999999998754 344556667788
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 99999999999999999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=385.78 Aligned_cols=260 Identities=37% Similarity=0.658 Sum_probs=214.0
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-----KSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
..+.++|++.+.||+|+||.||+|++..+++.||||++...... .......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 44678999999999999999999999999999999999765321 1122345789999999999999999999987
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEecCCc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFGLS 172 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~---lkl~DFGla 172 (481)
... .|+||||++|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 665 8999999999999999875 57999999999999999999999999999999999999987665 999999999
Q ss_pred ccccccccCCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCCCC--
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFRS-- 247 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~-- 247 (481)
..... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...... .....+..+....
T Consensus 165 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 165 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp EECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred eeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 76432 122345679999999999742 223367899999999999999999999765432 3344445554433
Q ss_pred --CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 --PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 --~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 24578999999999999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=390.86 Aligned_cols=253 Identities=29% Similarity=0.473 Sum_probs=214.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE--
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI-- 101 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-- 101 (481)
+.++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 5689999999999999999999999999999999997654 3344567788999999999999999999999877654
Q ss_pred ----EEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 102 ----YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ----~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred ceeEEEEEcccc-ccHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999997 58887774 3599999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------- 244 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------- 244 (481)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 197 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 197 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred -----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 23456899999999999874444778999999999999999999999887666555553310
Q ss_pred ----------C--------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 ----------F--------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 ----------~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
. ..+..+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 0 012346899999999999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=395.64 Aligned_cols=250 Identities=30% Similarity=0.475 Sum_probs=207.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
...+|++++.||+|+||+||+|++..+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 345799999999999999999999999999999998764321 23799999999999999999988542
Q ss_pred -CEEEEEEeccCCCchHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCC
Q 011628 99 -SKIYFVMEYVRGGELFNKVA-----KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGL 171 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~-----~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGl 171 (481)
..+++||||+.+ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 246799999986 5555543 2579999999999999999999999999999999999999965 5689999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--------
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-------- 243 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------- 243 (481)
++.... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+.++.+.
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 985432 222345689999999999977644477899999999999999999999988766555554331
Q ss_pred ---------CCC------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 244 ---------EFR------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 244 ---------~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+. .+..+++++.+||.+||..||.+|||+.|+++||||..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 111 12346899999999999999999999999999999965
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=383.34 Aligned_cols=256 Identities=30% Similarity=0.473 Sum_probs=215.2
Q ss_pred CCCCCCccCCeeEEeEecccCceEEEEEEE-cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC------Ccce
Q 011628 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARN-VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP------NIVQ 90 (481)
Q Consensus 18 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~ 90 (481)
.+.+..+.++|++.+.||+|+||+||+|.+ ..+++.||||++.... .....+.+|+.+++.++|+ +|++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 456677889999999999999999999998 4588999999996532 3456788999999998765 4999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------
Q 011628 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE------- 160 (481)
Q Consensus 91 l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~------- 160 (481)
+++++...+.+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 88999998753 5899999999999999999999999999999999999987
Q ss_pred ------------CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q 011628 161 ------------NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF 228 (481)
Q Consensus 161 ------------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf 228 (481)
++.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCC
Confidence 67899999999975332 2245689999999999988777 67899999999999999999999
Q ss_pred CCchHHHHHHHHhhCCCC--------------------------------------------CCCCCCHHHHHHHHHhcc
Q 011628 229 QDQNIMVMYKKIYKGEFR--------------------------------------------SPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 229 ~~~~~~~~~~~i~~~~~~--------------------------------------------~~~~~s~~~~~li~~~L~ 264 (481)
...+.......+.....+ .+...++++.+||.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 887655443333221111 011234678999999999
Q ss_pred cCcCCCCCHhHHHhCccccc
Q 011628 265 TNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps~~eil~h~~f~~ 284 (481)
.||.+|||+.|+++||||+.
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGG
T ss_pred cCcccccCHHHHhcCHHHHH
Confidence 99999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=384.43 Aligned_cols=254 Identities=27% Similarity=0.478 Sum_probs=211.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-- 99 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 99 (481)
..+.++|++++.||+|+||+||+|++..+++.||||++....... ....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 345789999999999999999999999999999999997654322 2466789999999999999999999998765
Q ss_pred EEEEEEeccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEecCC
Q 011628 100 KIYFVMEYVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGL 171 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl----~~~g~lkl~DFGl 171 (481)
..|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 789999999999999999752 39999999999999999999999999999999999999 7777899999999
Q ss_pred cccccccccCCcccccCCCCccccccccc--------cCCCCCCcchHHHHHHHHHHHhcCCCCCCCc----hHHHHHHH
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLS--------RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ----NIMVMYKK 239 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~--------~~~~~~~~~DiwSlGvil~elltg~~Pf~~~----~~~~~~~~ 239 (481)
++.... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||... .......+
T Consensus 163 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 163 ARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred ceecCC---CCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 976433 22334568999999999986 3344 67899999999999999999999632 23444555
Q ss_pred HhhCCC---------------------CCC----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 240 IYKGEF---------------------RSP----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 240 i~~~~~---------------------~~~----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
+..+.. +.+ ..+++.+.+||.+||+.||++|||++|+++||-
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 544332 111 123456889999999999999999999999973
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=383.81 Aligned_cols=261 Identities=20% Similarity=0.355 Sum_probs=201.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
...++|++++.||+|+||.||+|++..++. .||||++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 446799999999999999999999877665 89999997654333 34677899999999999999999999998776
Q ss_pred EE------EEEEeccCCCchHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 011628 100 KI------YFVMEYVRGGELFNKVAKG-------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 100 ~~------~lv~Ey~~gg~L~~~i~~~-------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
.. ++||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 55 9999999999999998541 5999999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-
Q 011628 167 SDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE- 244 (481)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~- 244 (481)
+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 99999976543322222334567889999999988776 678999999999999999 999999887777777776654
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCC-------HhHHHhCcccccC
Q 011628 245 FRSPRWFSPDLIRLLTKLLDTNPDKRIT-------IPEIMENRWFRKG 285 (481)
Q Consensus 245 ~~~~~~~s~~~~~li~~~L~~dP~~Rps-------~~eil~h~~f~~~ 285 (481)
...+..+++++.+||.+||+.||.+||| +++++.|||+...
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 5667789999999999999999999999 7788889998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=381.47 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=218.9
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
....++|++.+.||+|+||+||+|++..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3457899999999999999999999986555 59999997543 334457788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|+||||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999999964 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCC-cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCH
Q 011628 177 QIRQDG-LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSP 253 (481)
Q Consensus 177 ~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 253 (481)
...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ..+.+..+++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence 322111 1223456788999999987777 568999999999999999 99999998888887777766 3566778999
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+.+||.+||..||.+|||+.++++
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=383.71 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=221.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
..++|++++.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3589999999999999999999987 455899999997653 334567789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCC
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-------------------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKP 153 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp 153 (481)
+..|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 999999999999999999875 4689999999999999999999999999999999
Q ss_pred CcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCch
Q 011628 154 ENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQN 232 (481)
Q Consensus 154 ~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~ 232 (481)
+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999976543322223345678999999999987776 578999999999999999 999999988
Q ss_pred HHHHHHHHhhCCC-CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 233 IMVMYKKIYKGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 233 ~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.......+..+.. ..|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 8888877777654 5678899999999999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=392.95 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=208.4
Q ss_pred CCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--------CCCcc
Q 011628 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR--------HPNIV 89 (481)
Q Consensus 18 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv 89 (481)
...+..+.++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 3445667899999999999999999999999999999999997542 34567889999999995 78899
Q ss_pred eEEEEEE----eCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccC
Q 011628 90 QLFEVMA----TKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDEN 161 (481)
Q Consensus 90 ~l~~~~~----~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~ 161 (481)
++++++. ....+|+||||+ +++|.+.+.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 9999987 556899999999 5566665543 4699999999999999999999999 99999999999999977
Q ss_pred C-------------------------------------------------CEEEEecCCcccccccccCCcccccCCCCc
Q 011628 162 G-------------------------------------------------DLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192 (481)
Q Consensus 162 g-------------------------------------------------~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 192 (481)
+ .+||+|||+++.... .....+||+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~ 258 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQ 258 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCc
Confidence 5 799999999976432 1345689999
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch------HHHHHHHHhh--CC--------------------
Q 011628 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN------IMVMYKKIYK--GE-------------------- 244 (481)
Q Consensus 193 y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~------~~~~~~~i~~--~~-------------------- 244 (481)
|+|||++.+..+ +.++|||||||++|+|++|..||...+ .......+.. +.
T Consensus 259 y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 259 YRSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred ccCChhhcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 999999988777 578999999999999999999997532 1222222211 10
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 245 --------------------FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 245 --------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
...+...++.+.+||.+||+.||++|||++|+++||||+
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 011122345688999999999999999999999999996
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=374.28 Aligned_cols=255 Identities=28% Similarity=0.500 Sum_probs=208.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT------ 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 97 (481)
+.++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 467899999999999999999999999999999999643 2345778899999999999999999998865
Q ss_pred -------CCEEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 98 -------KSKIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 98 -------~~~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
...+|+||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 45789999999999999999753 578899999999999999999999999999999999999999999999
Q ss_pred cCCcccccccc------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-hHHH
Q 011628 169 FGLSAVSDQIR------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NIMV 235 (481)
Q Consensus 169 FGla~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~ 235 (481)
||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||... +...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987543211 01223456799999999999876555789999999999999998 66543 3445
Q ss_pred HHHHHhhCCCCCC----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 236 MYKKIYKGEFRSP----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 236 ~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
....+.......| ...++.+.++|.+||+.||.+|||++++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 5556655544433 3456779999999999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=382.53 Aligned_cols=258 Identities=32% Similarity=0.634 Sum_probs=211.5
Q ss_pred CCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhC----CCCCcce
Q 011628 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRV----RHPNIVQ 90 (481)
Q Consensus 18 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~HpnIv~ 90 (481)
......+.++|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++++ +||||++
T Consensus 23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 33456778999999999999999999999999999999999976543221 1123355799999999 8999999
Q ss_pred EEEEEEeCCEEEEEEec-cCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc-cCCCEEEE
Q 011628 91 LFEVMATKSKIYFVMEY-VRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD-ENGDLKVS 167 (481)
Q Consensus 91 l~~~~~~~~~~~lv~Ey-~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~-~~g~lkl~ 167 (481)
+++++...+..++|||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999999999 789999999975 6799999999999999999999999999999999999999 78999999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS 247 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 247 (481)
|||++..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+.......
T Consensus 183 dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~ 252 (312)
T 2iwi_A 183 DFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHF 252 (312)
T ss_dssp CCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCC
T ss_pred Ecchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCC
Confidence 9999976543 223456799999999999877776668999999999999999999998754 344556677
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+..+++.+.+||.+||+.||++|||++|+++||||+..
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 88899999999999999999999999999999999754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=386.59 Aligned_cols=254 Identities=23% Similarity=0.412 Sum_probs=222.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKS-------GESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEV 94 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 94 (481)
...++|++++.||+|+||+||+|++..+ +..||||++.... .......+.+|+.+++.+ +||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3468999999999999999999997543 3579999997653 334557788999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 011628 95 MATKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLL 157 (481)
Q Consensus 95 ~~~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NIL 157 (481)
+...+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 99999999999999999999999753 3899999999999999999999999999999999999
Q ss_pred EccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHH
Q 011628 158 LDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVM 236 (481)
Q Consensus 158 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 236 (481)
++.++.+||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999986544333233445677899999999987766 678999999999999999 9999999888888
Q ss_pred HHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 237 YKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 237 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
...+..+. ...|..+++++.+||.+||+.||.+|||+.|++++
T Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87777664 45677899999999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=384.10 Aligned_cols=254 Identities=29% Similarity=0.479 Sum_probs=214.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK-- 100 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 100 (481)
.+.++|++.+.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 35689999999999999999999999999999999997653 334456778899999999999999999999987654
Q ss_pred ----EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 101 ----IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 101 ----~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
+|+||||+. ++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999998 588887754 59999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------- 243 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 243 (481)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 178 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 178 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred C-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2 1235678999999999877444477899999999999999999999987765555444321
Q ss_pred -----------------C-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 244 -----------------E-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 244 -----------------~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
. ...+..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0 1123457899999999999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=384.39 Aligned_cols=258 Identities=30% Similarity=0.557 Sum_probs=187.7
Q ss_pred CCCCCCCCccCCeeEEe-EecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE
Q 011628 16 SKDQNQSPLLGRYEIGK-LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEV 94 (481)
Q Consensus 16 ~~~~~~~~~~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 94 (481)
.+......+.++|++.+ .||+|+||+||+|++..+|+.||||++.... .. ..+....++.+.||||++++++
T Consensus 18 ~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~---~~e~~~~~~~~~h~~i~~~~~~ 90 (336)
T 3fhr_A 18 GPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KA---RQEVDHHWQASGGPHIVCILDV 90 (336)
T ss_dssp --CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HH---HHHHHHHHHHTTSTTBCCEEEE
T ss_pred CCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HH---HHHHHHHHHhcCCCChHHHHHH
Confidence 34455567899999965 6999999999999999999999999986532 11 1223334667799999999999
Q ss_pred EEe----CCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCE
Q 011628 95 MAT----KSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDL 164 (481)
Q Consensus 95 ~~~----~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~l 164 (481)
+.. ...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence 876 45689999999999999999763 59999999999999999999999999999999999999864 459
Q ss_pred EEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH----HHHH
Q 011628 165 KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM----YKKI 240 (481)
Q Consensus 165 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i 240 (481)
||+|||++..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ...+
T Consensus 171 kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (336)
T 3fhr_A 171 KLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245 (336)
T ss_dssp EECCCTTCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEeccccceeccc----cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh
Confidence 9999999975432 22345688999999999977766 5689999999999999999999977654332 2223
Q ss_pred hhCCCCC----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 241 YKGEFRS----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 241 ~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+.... ...+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 246 RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 2332222 24689999999999999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=369.17 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=218.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+....|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 478999999999999999999985 5788999999765432 25578999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 999999999999975 4699999999999999999999999999999999999999999999999999975433211 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 260 (481)
......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+ ....|..+++.+.+++.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 2234567889999999987776 578999999999999999 99999999888888888776 34557778999999999
Q ss_pred HhcccCcCCCCCHhHHHhC
Q 011628 261 KLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h 279 (481)
+||+.||.+|||+.++++|
T Consensus 242 ~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHH
Confidence 9999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=384.00 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=220.7
Q ss_pred CCCCCCCCccCCeeEEeEecccCceEEEEEE-----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcce
Q 011628 16 SKDQNQSPLLGRYEIGKLLGHGTFAKVYHAR-----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQ 90 (481)
Q Consensus 16 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 90 (481)
+.........++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.++||||++
T Consensus 20 s~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~ 97 (327)
T 2yfx_A 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVR 97 (327)
T ss_dssp CGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred chhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCe
Confidence 3344455668999999999999999999999 55678899999996443 2344567889999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-
Q 011628 91 LFEVMATKSKIYFVMEYVRGGELFNKVAKG--------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN- 161 (481)
Q Consensus 91 l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~- 161 (481)
+++++......|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 98 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred EEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC
Confidence 999999999999999999999999999753 38999999999999999999999999999999999999954
Q ss_pred --CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHH
Q 011628 162 --GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYK 238 (481)
Q Consensus 162 --g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 238 (481)
..+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+......
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 256 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence 4699999999875433222222344578999999999987766 578999999999999998 999999888777777
Q ss_pred HHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 239 KIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 239 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+..+. ...+..+++.+.++|.+||+.||.+|||+.+++++.|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 776654 4557788999999999999999999999999999988753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=383.66 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=209.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc--------cchhHHHHHHHHHHHHHhCCCCCcceEEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI--------LKSGLVAHIKREISILRRVRHPNIVQLFEV 94 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 94 (481)
.+.++|++++.||+|+||.||+|.+. +|+.||||++..... ......+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 45789999999999999999999985 499999999865432 122345778999999999999999999999
Q ss_pred EEe-----CCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEE
Q 011628 95 MAT-----KSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVS 167 (481)
Q Consensus 95 ~~~-----~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~ 167 (481)
+.. ...+|+||||+. |+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 854 347899999998 588888765 369999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--- 244 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--- 244 (481)
|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 177 Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 177 DFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999975332 2223456899999999999774445788999999999999999999999887666555553210
Q ss_pred --------------------C---------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 245 --------------------F---------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 245 --------------------~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
. ..+..+++.+.+||.+||+.||.+|||+.|+++||||+..+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 0 012346888999999999999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=388.39 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=213.8
Q ss_pred ccCCeeEEeEecccCceEEEEEE-----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHAR-----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (481)
..++|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 46899999999999999999999 44567899999997643 233456789999999999 79999999999987
Q ss_pred CC-EEEEEEeccCCCchHHHHHcCC-------------------------------------------------------
Q 011628 98 KS-KIYFVMEYVRGGELFNKVAKGR------------------------------------------------------- 121 (481)
Q Consensus 98 ~~-~~~lv~Ey~~gg~L~~~i~~~~------------------------------------------------------- 121 (481)
.+ .+++||||++||+|.+++....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 65 4899999999999999997532
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 122 ------------LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 122 ------------l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++................|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 89999999999999999999999999999999999999999999999999975433222223345678
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHH-HHHHHHhhC-CCCCCCCCCHHHHHHHHHhcccC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIM-VMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTN 266 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~d 266 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.... .....+..+ ....|..+++++.++|.+||+.|
T Consensus 258 t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 336 (359)
T 3vhe_A 258 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 336 (359)
T ss_dssp CGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 999999999987776 578999999999999998 99999876543 333333333 45667889999999999999999
Q ss_pred cCCCCCHhHHHhC
Q 011628 267 PDKRITIPEIMEN 279 (481)
Q Consensus 267 P~~Rps~~eil~h 279 (481)
|.+|||+.|+++|
T Consensus 337 P~~Rps~~ell~~ 349 (359)
T 3vhe_A 337 PSQRPTFSELVEH 349 (359)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=372.76 Aligned_cols=257 Identities=23% Similarity=0.394 Sum_probs=210.4
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
......++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 44556899999999999999999999999999999999998765555556688999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999999976 67999999999999999999999999999999999999999999999999998764432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPDL 255 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~ 255 (481)
. ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..... ..+..+++.+
T Consensus 188 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 188 K-LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred c-cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 1 122345679999999999987766 5789999999999999999999999887655554443322 2356789999
Q ss_pred HHHHHHhcccCcCCCC-CHhHHHh
Q 011628 256 IRLLTKLLDTNPDKRI-TIPEIME 278 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rp-s~~eil~ 278 (481)
.++|.+||+.||++|| |++++++
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999 7888775
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=387.31 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=214.7
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CC-----CcceEE
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HP-----NIVQLF 92 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~ 92 (481)
..+..+.++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ |+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 445667899999999999999999999999999999999997532 34566788999998885 55 499999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH--HcCceecCCCCCcEEEc--cCCCEE
Q 011628 93 EVMATKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCH--ARGVYHRDLKPENLLLD--ENGDLK 165 (481)
Q Consensus 93 ~~~~~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH--~~gi~HrDLKp~NILl~--~~g~lk 165 (481)
+++.....+|+||||+.| +|.+++.. +.+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 999999999999999965 99999875 35999999999999999999999 57999999999999995 477899
Q ss_pred EEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC
Q 011628 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF 245 (481)
Q Consensus 166 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 245 (481)
|+|||+++.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 202 L~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 202 IVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp ECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeccCceeccc-----ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999976432 2345789999999999988777 5789999999999999999999998877666665543210
Q ss_pred CC-------------------------------------CCC---------------------------CCHHHHHHHHH
Q 011628 246 RS-------------------------------------PRW---------------------------FSPDLIRLLTK 261 (481)
Q Consensus 246 ~~-------------------------------------~~~---------------------------~s~~~~~li~~ 261 (481)
.. |.. .++++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 00 000 01368999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||+.||++|||++|+|+||||++.
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hcCCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=395.76 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=196.1
Q ss_pred CCccCCeeE-EeEecccCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 011628 22 SPLLGRYEI-GKLLGHGTFAKVYHARNV--KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT- 97 (481)
Q Consensus 22 ~~~~~~y~i-~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~- 97 (481)
..+.+.|++ +++||+|+||+||+|++. .+++.||||++..... ...+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 345678888 678999999999999976 4789999999975532 2357789999999999999999999954
Q ss_pred -CCEEEEEEeccCCCchHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCC
Q 011628 98 -KSKIYFVMEYVRGGELFNKVAK----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL----DENG 162 (481)
Q Consensus 98 -~~~~~lv~Ey~~gg~L~~~i~~----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl----~~~g 162 (481)
...+|+||||+.| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 6789999999975 78777642 149999999999999999999999999999999999999 6778
Q ss_pred CEEEEecCCcccccccc-cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH--------
Q 011628 163 DLKVSDFGLSAVSDQIR-QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-------- 233 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-------- 233 (481)
.+||+|||+++...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 99999999998654321 112345678999999999998766557889999999999999999999975432
Q ss_pred -HHHHHHHhhC--CCCC------------------------------------CCCCCHHHHHHHHHhcccCcCCCCCHh
Q 011628 234 -MVMYKKIYKG--EFRS------------------------------------PRWFSPDLIRLLTKLLDTNPDKRITIP 274 (481)
Q Consensus 234 -~~~~~~i~~~--~~~~------------------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ 274 (481)
......+... .... ....++.+.+||.+||+.||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 1222222211 1100 011267899999999999999999999
Q ss_pred HHHhCcccccC
Q 011628 275 EIMENRWFRKG 285 (481)
Q Consensus 275 eil~h~~f~~~ 285 (481)
|+|+||||...
T Consensus 330 e~L~hp~f~~~ 340 (405)
T 3rgf_A 330 QAMQDPYFLED 340 (405)
T ss_dssp HHHTSGGGTSS
T ss_pred HHhcChhhccC
Confidence 99999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=380.71 Aligned_cols=261 Identities=28% Similarity=0.409 Sum_probs=214.7
Q ss_pred CCCCCCCCCCccCCeeEEeEecccCceEEEEEEEcCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-----
Q 011628 14 SSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSG-ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN----- 87 (481)
Q Consensus 14 ~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn----- 87 (481)
+......+..+.++|++++.||+|+||+||+|++..++ +.||+|++.... .....+.+|+.+++.++|++
T Consensus 7 ~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 7 GHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp SCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred CCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCce
Confidence 33445566778899999999999999999999998776 689999996532 34566788999999997665
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE-----
Q 011628 88 -IVQLFEVMATKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL----- 158 (481)
Q Consensus 88 -Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl----- 158 (481)
++.+++++.....+|+||||+ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 999999999999999999999 5566666654 369999999999999999999999999999999999999
Q ss_pred --------------ccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC
Q 011628 159 --------------DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG 224 (481)
Q Consensus 159 --------------~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg 224 (481)
+.++.+||+|||+++.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g 235 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRG 235 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHS
T ss_pred cccccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhC
Confidence 6678999999999975332 2245689999999999988777 5789999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhCCCCCC--------------------------------------------CCCCHHHHHHHH
Q 011628 225 YLPFQDQNIMVMYKKIYKGEFRSP--------------------------------------------RWFSPDLIRLLT 260 (481)
Q Consensus 225 ~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------------------------~~~s~~~~~li~ 260 (481)
..||...+.......+.......| ...++++.+||.
T Consensus 236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 315 (355)
T 2eu9_A 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315 (355)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence 999988765544333322111111 112457889999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccC
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+||+.||.+|||++|+++||||+..
T Consensus 316 ~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 316 RMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HHhcCChhhCcCHHHHhcChhhcCC
Confidence 9999999999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=387.87 Aligned_cols=256 Identities=28% Similarity=0.379 Sum_probs=201.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK-- 100 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 100 (481)
...++|++.+.||+|+||+||+|++..+|+.||||++....... ....+|+..++.++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45789999999999999999999999999999999986653222 335578888899999999999999866433
Q ss_pred -----EEEEEeccCCCchHHH---HHc-CCCCHHHHHHHHHHHHHHHHHHH--HcCceecCCCCCcEEEcc-CCCEEEEe
Q 011628 101 -----IYFVMEYVRGGELFNK---VAK-GRLKEDLARKYFQQLISAVGFCH--ARGVYHRDLKPENLLLDE-NGDLKVSD 168 (481)
Q Consensus 101 -----~~lv~Ey~~gg~L~~~---i~~-~~l~e~~~~~~~~ql~~al~yLH--~~gi~HrDLKp~NILl~~-~g~lkl~D 168 (481)
+++||||+.|+.+..+ ... ..+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 8899999997533322 222 57999999999999999999999 999999999999999997 89999999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC----
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---- 244 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---- 244 (481)
||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 176 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 176 FGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999865432 223456799999999999776655789999999999999999999999887766666554310
Q ss_pred ----------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 245 ----------------------------FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 245 ----------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...+...++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 01112256789999999999999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=394.88 Aligned_cols=254 Identities=17% Similarity=0.187 Sum_probs=195.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEE-------EEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV--RHPNIVQLF-------EVM 95 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~ 95 (481)
..+|++++.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999887654445567788886555555 699988755 555
Q ss_pred EeC-----------------CEEEEEEeccCCCchHHHHHc--CCCCHHHH------HHHHHHHHHHHHHHHHcCceecC
Q 011628 96 ATK-----------------SKIYFVMEYVRGGELFNKVAK--GRLKEDLA------RKYFQQLISAVGFCHARGVYHRD 150 (481)
Q Consensus 96 ~~~-----------------~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~------~~~~~ql~~al~yLH~~gi~HrD 150 (481)
... ..+|+||||++ |+|.+++.. ..+++... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 34899999999 899999975 24554445 56779999999999999999999
Q ss_pred CCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCC
Q 011628 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPF 228 (481)
Q Consensus 151 LKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf 228 (481)
|||+|||++.+|.+||+|||+++..... .....||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCST
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999854321 124567799999999976 455 67899999999999999999999
Q ss_pred CCchHHH--HHHH-----HhhCC--CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 229 QDQNIMV--MYKK-----IYKGE--FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 229 ~~~~~~~--~~~~-----i~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+..... .+.. ..... ++.+..+++.+.+||.+||+.||++|||+.++++||||++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 8764221 0100 00112 22235789999999999999999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=369.85 Aligned_cols=255 Identities=28% Similarity=0.474 Sum_probs=211.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|.....||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 33444459999999999999999999999999997653 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCccccccccc
Q 011628 106 EYVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~~~ 180 (481)
||++|++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-- 176 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence 999999999999753 4678999999999999999999999999999999999998 899999999999764321
Q ss_pred CCcccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchH--HHHHH-HHhhCCCCCCCCCCHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNI--MVMYK-KIYKGEFRSPRWFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~-~i~~~~~~~~~~~s~~~~ 256 (481)
........||+.|+|||++.+.. ..+.++||||||+++|+|++|..||..... ..... .........|..+++++.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHH
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHH
Confidence 12234567999999999986543 236789999999999999999999975432 22222 222334556778999999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+||.+||+.||++|||++++++||||+..
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=376.33 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=219.5
Q ss_pred CccCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (481)
...++|++++.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 34689999999999999999999984 456899999997543 33456778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCC
Q 011628 98 KSKIYFVMEYVRGGELFNKVAKG-------------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLK 152 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~~-------------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLK 152 (481)
.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 99999999999999999999752 28999999999999999999999999999999
Q ss_pred CCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCc
Q 011628 153 PENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQ 231 (481)
Q Consensus 153 p~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~ 231 (481)
|+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999976433222112234567889999999987766 578999999999999999 99999988
Q ss_pred hHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 232 NIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 232 ~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+.......+..+. ...+..+++++.++|.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7776776666654 45677899999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=368.81 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=216.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.-.++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.....+|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 34679999999999999999999874 6788999999765432 255789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+||||+.|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999999976 5799999999999999999999999999999999999999999999999999976433211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
.......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+. ...|..+++.+.++
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 11234457888999999987776 678999999999999998 999999988888887777764 45577789999999
Q ss_pred HHHhcccCcCCCCCHhHHHhC
Q 011628 259 LTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h 279 (481)
|.+||+.||.+|||+.++++|
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=389.63 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=217.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 578999999999999999999998899999999987542 233455678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 999999999999975 369999999999999999999999999999999999999999999999999997533211111
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 260 (481)
......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++++.+||.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1112235678999999987766 578999999999999998 99999998877776666655 35667889999999999
Q ss_pred HhcccCcCCCCCHhHHHh
Q 011628 261 KLLDTNPDKRITIPEIME 278 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~ 278 (481)
+||+.||++|||+++|++
T Consensus 350 ~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=374.57 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=221.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
....++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 345689999999999999999999876 357889999997543 2234566889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lk 165 (481)
.....|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 99999999999999999999864 3579999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC
Q 011628 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 166 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 244 (481)
|+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 999999976543222222334567899999999987766 578999999999999999 899999988887777777665
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 245 -FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 245 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
...+..+++.+.+||.+||+.||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 35577899999999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=364.72 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=217.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||.||+|++. ++..||+|++...... ...+.+|+.+++.++||||+++++++......|+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 3679999999999999999999874 6778999999765432 2557899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence 9999999999999975 3599999999999999999999999999999999999999999999999999975433211
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
.......||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+. ...|..+++.+.++|
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM 238 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred hcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence 11233456778999999987777 568999999999999999 999999988877777777664 445777899999999
Q ss_pred HHhcccCcCCCCCHhHHHhC
Q 011628 260 TKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h 279 (481)
.+||+.||.+|||+.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=365.19 Aligned_cols=248 Identities=26% Similarity=0.499 Sum_probs=206.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK-SGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
.++|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+.+|+.+++.++||||+++++++......|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 57999999999999999999997 48999999987654322 2335678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---ceecCCCCCcEEEcc--------CCCEEEEecCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARG---VYHRDLKPENLLLDE--------NGDLKVSDFGLS 172 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~g---i~HrDLKp~NILl~~--------~g~lkl~DFGla 172 (481)
||||++|++|.+++..+++++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|||++
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 999999999999998889999999999999999999999999 999999999999986 778999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRW 250 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~ 250 (481)
....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.... ...+..
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 164 REWHRTT----KMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred ccccccc----ccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 7543321 234579999999999987766 678999999999999999999999887776666665554 455778
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+++.+.++|.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=373.85 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=214.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEc-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEE--
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNV-KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMA-- 96 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-- 96 (481)
...++|++++.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34689999999999999999999995 678999999997654221 1123355777777766 8999999999987
Q ss_pred ---eCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecC
Q 011628 97 ---TKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 97 ---~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFG 170 (481)
.....++||||+. |+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5568999999998 599999875 349999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------ 244 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------ 244 (481)
++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 166 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 166 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ccccccCCC---CccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 997654321 2345689999999999987776 678999999999999999999999887766666654310
Q ss_pred -C--------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 245 -F--------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 245 -~--------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+ ..+..+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0 1234578899999999999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=375.92 Aligned_cols=248 Identities=22% Similarity=0.425 Sum_probs=210.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 68999999999999999999999999999999998543 334567789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD- 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~- 181 (481)
|||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999999976 57999999999999999999999999999999999999999999999999999764332111
Q ss_pred -----------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH-----HHHHHhhCCC
Q 011628 182 -----------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV-----MYKKIYKGEF 245 (481)
Q Consensus 182 -----------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-----~~~~i~~~~~ 245 (481)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ....... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--~ 242 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD--R 242 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--H
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--c
Confidence 01125689999999999988777 578999999999999999999986532110 0111111 1
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..|..+++.+.++|.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 245678899999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=378.90 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=208.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESV----AIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
..++|++.+.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 4689999999999999999999998887765 777665432 2234567889999999999999999999998765
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
.++++||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 7899999999999999875 5799999999999999999999999999999999999999999999999999986544
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDL 255 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 255 (481)
...........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...+..++.++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred CcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 333323344567889999999988777 578999999999999999 999999877666666665553 56677899999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+++.+||+.||.+|||+.+++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=368.36 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=206.7
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
....++|++++.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 34578999999999999999999998654 4579999986542 3345677889999999999999999999984 5
Q ss_pred CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
+..|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 678999999999999999975 369999999999999999999999999999999999999999999999999997654
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPD 254 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 254 (481)
.... .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .+.+..+++.
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 168 DSTY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred cccc-cccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 3211 11234467889999999987776 568999999999999996 999999877666666776654 5567789999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+.++|.+||+.||.+|||+.+++++
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=370.79 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=210.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR--HPNIVQLFEVMATKSKI 101 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~ 101 (481)
..++|++++.||+|+||.||+|++. +++.||||++..... .......+.+|+.+++.++ ||||+++++++......
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3568999999999999999999984 589999999976543 3345677899999999997 59999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||| +.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 99999 568899999976 6799999999999999999999999999999999999996 48999999999986543332
Q ss_pred CCcccccCCCCccccccccccC----------CCCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhCC--CCC
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRK----------GYDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKGE--FRS 247 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~----------~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~--~~~ 247 (481)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+.... ...
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence 2233456899999999998652 233568999999999999999999998753 333344444332 445
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|...++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 67788999999999999999999999999999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=367.92 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=209.2
Q ss_pred CCCccCCeeEEeEecccCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
+....++|++++.||+|+||+||+|+ +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 44567899999999999999999998 56689999999987542 344577889999999999999999999985
Q ss_pred e--CCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 97 T--KSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 97 ~--~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
. ...+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 5 3568999999999999999976 35999999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH----------------H
Q 011628 173 AVSDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM----------------V 235 (481)
Q Consensus 173 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----------------~ 235 (481)
........ ........|++.|+|||++.+..+ +.++|||||||++|+|++|..||...... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 86543221 112234567888999999988777 67899999999999999999998764322 1
Q ss_pred HHHHHhh-CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 236 MYKKIYK-GEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 236 ~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
....+.. ...+.|..+++++.+||.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2222222 245667789999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=377.01 Aligned_cols=248 Identities=20% Similarity=0.300 Sum_probs=210.8
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
.+.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.+ +||||+++++++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 3568899999999999999999999999999999998765422 3467899999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-----EEEEecCCccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD-----LKVSDFGLSAV 174 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~-----lkl~DFGla~~ 174 (481)
|+||||+ |++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 9999999974 68999999999999999999999999999999999999998887 99999999986
Q ss_pred ccccccCC-----cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC---chHHHHHHHHhhCCCC
Q 011628 175 SDQIRQDG-----LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD---QNIMVMYKKIYKGEFR 246 (481)
Q Consensus 175 ~~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~---~~~~~~~~~i~~~~~~ 246 (481)
........ .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ ......+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 43322111 1246789999999999988777 6789999999999999999999987 3444555555443322
Q ss_pred CC-----CCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 247 SP-----RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 247 ~~-----~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+ ..++ ++.++|.+||+.||.+||++++|++
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22 2234 9999999999999999999999876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=365.49 Aligned_cols=253 Identities=16% Similarity=0.261 Sum_probs=213.1
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.+..+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+ +|+||+++++++...
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 3456788999999999999999999999999999999998754322 3467899999999 799999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-----EEEEecCC
Q 011628 99 SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD-----LKVSDFGL 171 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~-----lkl~DFGl 171 (481)
...|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999999999 9999999985 46999999999999999999999999999999999999988776 99999999
Q ss_pred cccccccccC-----CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhC
Q 011628 172 SAVSDQIRQD-----GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKG 243 (481)
Q Consensus 172 a~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~ 243 (481)
++........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. .....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9865432221 12345689999999999988776 67899999999999999999999873 334444444332
Q ss_pred CC-----CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 244 EF-----RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 244 ~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.. ..+..+++++.+||.+||+.||.+|||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 21 1234689999999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=373.54 Aligned_cols=253 Identities=23% Similarity=0.429 Sum_probs=218.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEc-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNV-------KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVM 95 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 95 (481)
..++|++++.||+|+||.||+|++. .++..||||++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 3689999999999999999999985 457789999997653 334467788999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL 158 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl 158 (481)
...+.+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 9999999999999999999999753 38999999999999999999999999999999999999
Q ss_pred ccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHH
Q 011628 159 DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMY 237 (481)
Q Consensus 159 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~ 237 (481)
+.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999976443221112234467889999999987766 578999999999999999 99999998888777
Q ss_pred HHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 238 KKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 238 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+..+. ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7776664 45677899999999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=378.90 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=213.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGES----VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
-.++|++++.||+|+||+||+|++..+++. ||+|.+...... .....+.+|+.+++.++||||+++++++. ..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 367999999999999999999999888876 677776443211 12244668999999999999999999886 45
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..++||||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 68999999999999999975 4799999999999999999999999999999999999999999999999999987554
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDL 255 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 255 (481)
...........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred ccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence 333334456678889999999987776 678999999999999999 999999887767766666653 56677889999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.++|.+||+.||.+|||+.+++++
T Consensus 247 ~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=378.78 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=213.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||.||+|++. .++..||||++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 579999999999999999999973 366789999997543 223346788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCC
Q 011628 99 SKIYFVMEYVRGGELFNKVAKG------------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPE 154 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~------------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~ 154 (481)
+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 9999999999999999999753 2789999999999999999999999999999999
Q ss_pred cEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchH
Q 011628 155 NLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNI 233 (481)
Q Consensus 155 NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~ 233 (481)
|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+...
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999976543322222344567889999999987776 578999999999999998 9999988664
Q ss_pred HHHHHHHhhC--CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 234 MVMYKKIYKG--EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 234 ~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
......+... ....|..+++++.+||.+||+.||.+|||+.+++++..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 4333343333 34557788999999999999999999999999998643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=363.57 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=211.6
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhH----HHHHHHHHHHHHhCCCCCcceEEEE
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGL----VAHIKREISILRRVRHPNIVQLFEV 94 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~ 94 (481)
..+....++|++.+.||+|+||+||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 344456789999999999999999999999999999999997654332221 1678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCC-----EE
Q 011628 95 MATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGD-----LK 165 (481)
Q Consensus 95 ~~~~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~-----lk 165 (481)
+.+.. ++||||++||+|.+.+.. ..+++..++.++.|++.||.|||++| |+||||||+|||++.++. +|
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 97766 799999999999998865 47999999999999999999999999 999999999999988876 99
Q ss_pred EEecCCcccccccccCCcccccCCCCccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCchH--HHHHHHHhh
Q 011628 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSCGVILFVLMAGYLPFQDQNI--MVMYKKIYK 242 (481)
Q Consensus 166 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~ 242 (481)
|+|||+++.... ......||+.|+|||++... ...+.++|||||||++|+|++|..||...+. ......+..
T Consensus 170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 999999974322 23456899999999998432 2225689999999999999999999986542 222333333
Q ss_pred C--CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 243 G--EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 243 ~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
. ....+..+++.+.+||.+||+.||.+|||++++++
T Consensus 245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3 34567789999999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=366.56 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=220.3
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
-....++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3445789999999999999999999999999999999997543 235678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
.|+||||+.|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999999975 3599999999999999999999999999999999999999999999999999976442
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDL 255 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 255 (481)
.. ........||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|..+++.+
T Consensus 164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 164 DT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241 (288)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred Cc-cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence 21 112234457889999999987776 578999999999999999 99999987766666666555 355677899999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHh
Q 011628 256 IRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+||.+||..||.+|||++++++
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=372.84 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=215.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARN-----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (481)
..++|++++.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 357999999999999999999985 3577899999997653 223457788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE
Q 011628 98 KSKIYFVMEYVRGGELFNKVAKG-------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL 158 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~~-------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl 158 (481)
.+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 99999999999999999999753 38999999999999999999999999999999999999
Q ss_pred ccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHH
Q 011628 159 DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMY 237 (481)
Q Consensus 159 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~ 237 (481)
+.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 9999999999999976544322222334567889999999987766 578999999999999999 99999876543333
Q ss_pred HHHhh-C-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 238 KKIYK-G-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 238 ~~i~~-~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..... + ....+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 33333 2 234467789999999999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=367.51 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=211.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSG-------ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVM 95 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (481)
...++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34679999999999999999999998877 479999986543 23456788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--------EE
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD--------LK 165 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~--------lk 165 (481)
...+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999999764 3999999999999999999999999999999999999999887 99
Q ss_pred EEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC
Q 011628 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 166 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 244 (481)
|+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++ |.+||...+.... .......
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDR 234 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhcc
Confidence 999999865322 1234688999999999874444779999999999999999 5566665554433 3444455
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 245 FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 245 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
...|...++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66677789999999999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=360.29 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=215.9
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK-- 98 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-- 98 (481)
...-.++|++.+.||+|+||.||+|++ +++.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 344578999999999999999999998 488999999987543 234456789999999999999999999999887
Q ss_pred CEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
...++||||++||+|.+++... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 7889999999999999999864 4899999999999999999999999 9999999999999999999999998875
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCC--cchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCC
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAA--KVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR 249 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~--~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~ 249 (481)
... .....||+.|+|||++.+..+... ++|||||||++|+|++|..||.+.+.......+.... ...|.
T Consensus 162 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3kmu_A 162 SFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234 (271)
T ss_dssp TTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred eec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence 321 134578999999999987655432 7999999999999999999999888777666665543 45677
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+++++.++|.+||+.||.+|||++++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=371.90 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=215.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEE--EEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESV--AIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
.-.++|++.+.||+|+||.||+|++..++..+ |+|.+.... .......+.+|+.+++++ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 34689999999999999999999998888865 999887532 223446688999999999 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 100 KIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
.+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999999753 589999999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.+||+|||+++...... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCccccccc---cccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 99999999987433211 1233467889999999987766 578999999999999998 999999988888877777
Q ss_pred hCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+. ...+..+++.+.+||.+||+.||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 663 45677789999999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=374.17 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=203.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS----K 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~ 100 (481)
.++|++++.||+|+||+||+|++ .++.||||++.... .......+|+.+++.++||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 57999999999999999999987 48999999996543 22344567999999999999999999998744 4
Q ss_pred EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc----------CceecCCCCCcEEEccCCCEEEEecC
Q 011628 101 IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR----------GVYHRDLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~----------gi~HrDLKp~NILl~~~g~lkl~DFG 170 (481)
+|+||||+++|+|.+++..+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 79999999999999999988899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCC----CCCcchHHHHHHHHHHHhcCCCCCCCc---------------
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY----DAAKVDIWSCGVILFVLMAGYLPFQDQ--------------- 231 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~----~~~~~DiwSlGvil~elltg~~Pf~~~--------------- 231 (481)
+++..............+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9976554333333455789999999999976322 235789999999999999999999753
Q ss_pred -hHHHHHHHHhhCCCCC--CCC-----CCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 232 -NIMVMYKKIYKGEFRS--PRW-----FSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 232 -~~~~~~~~i~~~~~~~--~~~-----~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
........+....... +.. .++++.+||.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222333333322211 111 23459999999999999999999999873
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=380.65 Aligned_cols=252 Identities=25% Similarity=0.462 Sum_probs=206.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCcceEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-----------HPNIVQLF 92 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~ 92 (481)
..++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.++++++ ||||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 3679999999999999999999999999999999997543 23456788999999886 89999999
Q ss_pred EEEEeCC----EEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccC---
Q 011628 93 EVMATKS----KIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDEN--- 161 (481)
Q Consensus 93 ~~~~~~~----~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~--- 161 (481)
+++.... .++++|||+ |++|.+++.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9987654 789999999 8999999875 4599999999999999999999998 99999999999999543
Q ss_pred ---CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-----
Q 011628 162 ---GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----- 233 (481)
Q Consensus 162 ---g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----- 233 (481)
+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4799999999976433 2234589999999999988777 6789999999999999999999986431
Q ss_pred -HHHHHHHh------------------------------------------hCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 234 -MVMYKKIY------------------------------------------KGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 234 -~~~~~~i~------------------------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
......+. ......+..+++++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111111 11122333456778999999999999999
Q ss_pred CCHhHHHhCcccccCc
Q 011628 271 ITIPEIMENRWFRKGF 286 (481)
Q Consensus 271 ps~~eil~h~~f~~~~ 286 (481)
||++|+++||||+...
T Consensus 326 pt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTL 341 (373)
T ss_dssp BCHHHHHTCGGGTTCT
T ss_pred CCHHHHhhChhhhccc
Confidence 9999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=374.09 Aligned_cols=253 Identities=22% Similarity=0.363 Sum_probs=209.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESV----AIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
...++|++++.||+|+||+||+|++..+++.| |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 34689999999999999999999998888765 555554332 223456788999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
. .++++||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 8899999999999999875 579999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPD 254 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 254 (481)
............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .+.+..++++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 4333333344567889999999988777 578999999999999999 999999887766666666554 5667789999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+.++|.+||+.||.+|||+.|+++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999973
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=358.61 Aligned_cols=248 Identities=23% Similarity=0.394 Sum_probs=217.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 468999999999999999999985 6789999999765432 25678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 999999999999975 4699999999999999999999999999999999999999999999999999875432111 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLT 260 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 260 (481)
......|++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+. ...|..+++.+.++|.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 1234567889999999987766 578999999999999999 999999988888777777763 4457778999999999
Q ss_pred HhcccCcCCCCCHhHHHhC
Q 011628 261 KLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h 279 (481)
+||+.||.+|||+.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 240 HCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=369.10 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=206.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-- 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 99 (481)
.++|++++.||+|+||.||+|.+.. ++..||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 5799999999999999999998765 556899999976543 2344577889999999999999999999997755
Q ss_pred ---EEEEEEeccCCCchHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 100 ---KIYFVMEYVRGGELFNKVAK-------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 100 ---~~~lv~Ey~~gg~L~~~i~~-------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
..|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 35999999999999999842 45999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCC
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRS 247 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~ 247 (481)
|++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence 99976543222222234567889999999987766 578999999999999999 999999887777777776663 556
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77899999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=362.77 Aligned_cols=255 Identities=29% Similarity=0.552 Sum_probs=207.9
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
....++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++......
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34578999999999999999999999999999999999875544555667889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
++||||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998863 469999999999999999999999999999999999999999999999999987643
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc--hHHHHHHHHhhCCCCC--CCCCC
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ--NIMVMYKKIYKGEFRS--PRWFS 252 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~--~~~~~~~~i~~~~~~~--~~~~s 252 (481)
.. ........|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+. +.......+..+..+. +..++
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp -------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred CC--CccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence 32 122345679999999999987766 57899999999999999999999764 3344555555554332 35689
Q ss_pred HHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 253 PDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+++.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=366.67 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=199.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
-.++|++++.||+|+||.||+|++..+|+.||||++...... ......+.++..+++.++||||+++++++...+.+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 468999999999999999999999999999999999765422 2233445555667888899999999999999999999
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||+ ++.+..+... +.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-- 178 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--
Confidence 99999 5566655543 6799999999999999999999995 9999999999999999999999999998754321
Q ss_pred CCcccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCCCC-C--CCCCC
Q 011628 181 DGLFHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFR-S--PRWFS 252 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~-~--~~~~s 252 (481)
.......||+.|+|||++.. ....+.++|||||||++|+|++|..||.. .........+..+... . ...++
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 2dyl_A 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCC
T ss_pred -ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCC
Confidence 22345679999999999852 22236789999999999999999999987 3445555566555432 2 23579
Q ss_pred HHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+++.+||.+||+.||.+|||++++++||||+.
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 99999999999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=372.37 Aligned_cols=256 Identities=24% Similarity=0.402 Sum_probs=192.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS-ILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.-.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+. +++.++||||+++++++...+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 34689999999999999999999999999999999997653 2233345556665 77888999999999999999999
Q ss_pred EEEEeccCCCchHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 102 YFVMEYVRGGELFNKVA------KGRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~------~~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
|+||||+.| +|.+++. .+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999999986 7777765 35799999999999999999999999 999999999999999999999999999976
Q ss_pred ccccccCCcccccCCCCccccccccc----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCCC-C-
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLS----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFR-S- 247 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~-~- 247 (481)
.... .......||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.. .....+..+... .
T Consensus 176 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 176 LVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp ---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred cccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 4322 1223447999999999983 3444 67899999999999999999999875432 223233333221 1
Q ss_pred ---CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 ---PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ---~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 23588999999999999999999999999999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.69 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=209.7
Q ss_pred CccCCeeEEeEecccCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
....+|++++.||+|+||.||+|+ +..+++.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 345779999999999999999999 567899999999976542 23456788999999999999999999999876
Q ss_pred --CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
..+|+||||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 678999999999999999954 5799999999999999999999999999999999999999999999999999976
Q ss_pred cccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch---------------HHHHHH
Q 011628 175 SDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN---------------IMVMYK 238 (481)
Q Consensus 175 ~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---------------~~~~~~ 238 (481)
...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..|+.... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 543211 112335678899999999987776 568999999999999999999864331 222333
Q ss_pred HHhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 239 KIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 239 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..+ ....|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 33333 35567789999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=370.76 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=213.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (481)
..++|++++.||+|+||+||+|++. .+++.||||++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 4689999999999999999999853 467899999997653 233456788999999999 69999999999877
Q ss_pred CC-EEEEEEeccCCCchHHHHHcCC-----------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc
Q 011628 98 KS-KIYFVMEYVRGGELFNKVAKGR-----------------LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD 159 (481)
Q Consensus 98 ~~-~~~lv~Ey~~gg~L~~~i~~~~-----------------l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~ 159 (481)
.+ .+|+||||++||+|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 5899999999999999997632 88999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchH-HHHH
Q 011628 160 ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNI-MVMY 237 (481)
Q Consensus 160 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~-~~~~ 237 (481)
.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+... ....
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 999999999999976433222222334567899999999987776 578999999999999998 9999987653 2333
Q ss_pred HHHhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 238 KKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 238 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+..+ ....+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444444 355677899999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=361.10 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=216.8
Q ss_pred cCCeeEEe-EecccCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGK-LLGHGTFAKVYHARNV--KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 56788876 9999999999999864 468889999997653 334567789999999999999999999999 55669
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999999964 469999999999999999999999999999999999999999999999999997653221
Q ss_pred c-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 180 Q-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 180 ~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..+++++.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 243 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHH
Confidence 1 112233467899999999987766 568999999999999998 999999887777777776664 456778999999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
++|.+||+.||.+|||+.+++++.+
T Consensus 244 ~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 244 ALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=370.71 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=214.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGE-----SVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (481)
..++|++++.||+|+||.||+|.+..+++ .||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 36789999999999999999999977664 79999997653 233457788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK---------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~---------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
.+.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 9999999999999999999863 3579999999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 999999999986543222222334567889999999987776 578999999999999998 999998765443333443
Q ss_pred hC--CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KG--EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.. ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 33 234577789999999999999999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=363.51 Aligned_cols=253 Identities=25% Similarity=0.489 Sum_probs=199.3
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.+....++|++++.||+|+||+||+|++. ..||+|++..... .....+.+.+|+.+++.++||||++++++. ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 34556789999999999999999999863 3599999976543 334567789999999999999999999965 556
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..++||||+.|++|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 68999999999999999964 5799999999999999999999999999999999999999999999999999976544
Q ss_pred cccCCcccccCCCCccccccccc---cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCCC-----CC
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLS---RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFR-----SP 248 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~-----~~ 248 (481)
...........||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.. .....+..+... .+
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred ccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 33333445668999999999986 3334 56899999999999999999999875443 344444444322 23
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+++.+.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 467899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=378.05 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=206.7
Q ss_pred ccCCeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
-.++|++.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.++++++||||+++++++.....
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 3578999999999999999999986 467789999997643 33455778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999999999976 36999999999999999999999999999999999999999999999999999865432
Q ss_pred ccCC-cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHH
Q 011628 179 RQDG-LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDL 255 (481)
Q Consensus 179 ~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 255 (481)
.... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .+.+..+++.+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 279 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279 (373)
T ss_dssp -------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 2111 1122345788999999987777 568999999999999998 999999888777777776653 45567789999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHh
Q 011628 256 IRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+||.+||+.||.+|||+.++++
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=361.11 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=212.9
Q ss_pred cCCeeEEe-EecccCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGK-LLGHGTFAKVYHARN--VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~-~LG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++.+ .||+|+||.||+|.+ ..+++.||||++.... ......+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 46899998 999999999999954 4578899999997654 2334567789999999999999999999999 56778
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 999999999999999976 5699999999999999999999999999999999999999999999999999976432211
Q ss_pred C-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 181 D-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 181 ~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
. .......|++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+. ...|..+++.+.+
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 251 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 0 11123456789999999987766 568999999999999999 999999988877777776664 4567789999999
Q ss_pred HHHHhcccCcCCCCCHhHHHh
Q 011628 258 LLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~ 278 (481)
+|.+||+.||.+|||+.++++
T Consensus 252 li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=366.33 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=212.2
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSG----ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
....+|++.+.||+|+||+||+|++..++ ..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 34679999999999999999999987553 459999997543 233456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999999999975 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCC-cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCH
Q 011628 177 QIRQDG-LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSP 253 (481)
Q Consensus 177 ~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 253 (481)
...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.+..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 322111 1223456789999999987766 568999999999999998 99999988877777777766 3556777899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+.++|.+||+.||.+|||+.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=382.75 Aligned_cols=247 Identities=22% Similarity=0.407 Sum_probs=214.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. ...+|+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3678999999999999999999984 578899999976542 2467889999999999999999999986 567899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999999975 2699999999999999999999999999999999999999999999999999986432111
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
.......+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.+|
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred -eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11223456789999999987776 678999999999999999 99999998887777777665 356678899999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
|.+||+.||++|||+++|++
T Consensus 418 i~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHH
Confidence 99999999999999999976
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=357.04 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=211.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
...++|++.+.||+|+||+||+|++.. ++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 346899999999999999999999754 34469999997653 234457789999999999999999999998654
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..|+||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 56899999999999999975 4699999999999999999999999999999999999999999999999999976443
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDL 255 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 255 (481)
.. ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..+ ..+.+..+++.+
T Consensus 166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (281)
T 3cc6_A 166 ED-YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL 243 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred cc-ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHH
Confidence 21 112234567889999999987766 578999999999999998 99999876555555555554 355677899999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.++|.+||+.||.+|||+.+++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 244 YTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=358.26 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=206.8
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVM-ATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~ 101 (481)
.+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+..+ ......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 3578999999999999999999999999999999998765422 3477899999999988866655554 677889
Q ss_pred EEEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEecCCccccc
Q 011628 102 YFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl---~~~g~lkl~DFGla~~~~ 176 (481)
++||||+ +++|.+++. .+.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 999999997 3579999999999999999999999999999999999999 588999999999998654
Q ss_pred ccccC-----CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch---HHHHHHHHhhCCCCC-
Q 011628 177 QIRQD-----GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN---IMVMYKKIYKGEFRS- 247 (481)
Q Consensus 177 ~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~- 247 (481)
..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ....+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 32221 11245689999999999988776 678999999999999999999998632 122233333222222
Q ss_pred ----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 248 ----PRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 248 ----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+..+|+++.+||.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 3668999999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=357.98 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=213.5
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--- 97 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--- 97 (481)
+..+.++|++++.||+|+||.||+|++..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 3456789999999999999999999999899999999997653 235689999999999999999998864
Q ss_pred -------------CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC
Q 011628 98 -------------KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 98 -------------~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~ 161 (481)
...+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4568999999999999999964 479999999999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh
Q 011628 162 GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 162 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 241 (481)
+.+||+|||++...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.... .....+.
T Consensus 159 ~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~ 232 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR 232 (284)
T ss_dssp TEEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH
T ss_pred CCEEECcchhheecccc---ccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh
Confidence 99999999998764332 22345679999999999987766 678999999999999999999885432 2333333
Q ss_pred hCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 242 KGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 242 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+ ..+..+++.+.++|.+||+.||.+|||+.|++++.|..+
T Consensus 233 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 DG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 33 345668999999999999999999999999999988654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=388.31 Aligned_cols=248 Identities=24% Similarity=0.424 Sum_probs=217.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||.||+|++..++..||||++..... ..+.+.+|+.+|++++||||+++++++.....+|+|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 5689999999999999999999998899999999976532 246688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence 999999999999975 3589999999999999999999999999999999999999999999999999986432111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 259 (481)
.......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+||
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 452 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11223456789999999987776 578999999999999999 99999988776666666555 3556788999999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.||.+|||+.+|++
T Consensus 453 ~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 453 RACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCcChhHCcCHHHHHH
Confidence 9999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=361.38 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=206.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVK-SGE--SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
...++|++++.||+|+||+||+|++.. +++ .||||++...........+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 346799999999999999999998654 333 69999998765444556778999999999999999999999998765
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
.++||||+.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 8899999999999999875 5699999999999999999999999999999999999999999999999999976433
Q ss_pred cccC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC--CCCCCCCCH
Q 011628 178 IRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE--FRSPRWFSP 253 (481)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~ 253 (481)
.... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+.... .+.+..+++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2111 12234567889999999987766 578999999999999999 999999988887777776653 445667899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++.++|.+||+.||.+|||+.++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999997
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=358.59 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=202.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVM-ATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~ 101 (481)
.+.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+..+ ......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 3578999999999999999999999999999999987655432 2367899999999988876665554 778889
Q ss_pred EEEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEecCCccccc
Q 011628 102 YFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl---~~~g~lkl~DFGla~~~~ 176 (481)
++||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 999999997 3579999999999999999999999999999999999999 889999999999998654
Q ss_pred ccccC-----CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---HHHHHHHhhCCCCC-
Q 011628 177 QIRQD-----GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYKGEFRS- 247 (481)
Q Consensus 177 ~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~~- 247 (481)
..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+. ...+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 32221 12245689999999999988776 6789999999999999999999976421 12222322222222
Q ss_pred ----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 248 ----PRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 248 ----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+..+++++.+||.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 2567999999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=357.61 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=212.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI- 101 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 101 (481)
-+|++++.||+|+||+||+|++..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 367788999999999999999766554 79999986533 334567788999999999999999999999876655
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+++|||+.+|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999999986 568999999999999999999999999999999999999999999999999997543221
Q ss_pred --cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHH
Q 011628 180 --QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDL 255 (481)
Q Consensus 180 --~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 255 (481)
.........||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+.......+..+. ...+..+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence 1222345678899999999987776 578999999999999999 566677666666666665554 55677899999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHh
Q 011628 256 IRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.++|.+||+.||.+|||+.++++
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=363.79 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=212.0
Q ss_pred CCccCCe-eEEeEecccCceEEEEEEE----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 22 SPLLGRY-EIGKLLGHGTFAKVYHARN----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 22 ~~~~~~y-~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
..+.++| ++++.||+|+||+||++.. ..+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 3467777 9999999999999988764 3578999999997653 3345677899999999999999999999998
Q ss_pred e--CCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 97 T--KSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 97 ~--~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
. ...+|+||||+++|+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 7 46899999999999999999988899999999999999999999999999999999999999999999999999976
Q ss_pred cccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---------------HHHH
Q 011628 175 SDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---------------VMYK 238 (481)
Q Consensus 175 ~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---------------~~~~ 238 (481)
...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 543211 112234568889999999987776 46899999999999999999999765321 1222
Q ss_pred HHhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 239 KIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 239 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..+ ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22222 34567789999999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=381.06 Aligned_cols=241 Identities=27% Similarity=0.474 Sum_probs=210.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-KIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~l 103 (481)
.++|++++.||+|+||.||+|.+ +|+.||||+++... ..+.+.+|+.+|++++||||+++++++.... .+|+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 57899999999999999999987 47899999997653 2356889999999999999999999987765 7999
Q ss_pred EEeccCCCchHHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||+++|+|.+++.. + .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999999975 3 3799999999999999999999999999999999999999999999999999743221
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
.....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+|
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 418 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV 418 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ---ccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 123467899999999988777 578999999999999998 99999987776666777666 356788899999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
|.+||+.||.+|||+.++++
T Consensus 419 i~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 419 MKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=372.18 Aligned_cols=252 Identities=14% Similarity=0.202 Sum_probs=200.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchh---H-----HHHHHHHHHHHHhCCCCCcceE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSG---L-----VAHIKREISILRRVRHPNIVQL 91 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~---~-----~~~~~~Ei~il~~l~HpnIv~l 91 (481)
.++|++++.||+|+||.||+|.+..+ ++.||||++......... . ...+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34999999999999999999998764 588999998765321100 0 1123456777888899999999
Q ss_pred EEEEEeC----CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc--cCCC
Q 011628 92 FEVMATK----SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD--ENGD 163 (481)
Q Consensus 92 ~~~~~~~----~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~--~~g~ 163 (481)
++++... ...|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998764 5689999999 9999999975 5799999999999999999999999999999999999999 8899
Q ss_pred EEEEecCCcccccccccC-----CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHH
Q 011628 164 LKVSDFGLSAVSDQIRQD-----GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK 238 (481)
Q Consensus 164 lkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 238 (481)
+||+|||+++........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+.
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999765432221 11234569999999999988776 678999999999999999999998642211111
Q ss_pred HH----hhCC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 239 KI----YKGE-------FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 239 ~i----~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.. .... ...+..+++++.+++.+||..||.+||++.+|++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 10 0000 0112567899999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=359.05 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=210.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSG---ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVM-ATKS 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~ 99 (481)
-..+|++.+.||+|+||+||+|++..++ ..||+|.+.... .......+.+|+.++++++||||+++++++ ....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 4568999999999999999999975433 368999987533 334567788999999999999999999986 4566
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..|+||||+.||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 88999999999999999975 4689999999999999999999999999999999999999999999999999976433
Q ss_pred ccc--CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCH
Q 011628 178 IRQ--DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSP 253 (481)
Q Consensus 178 ~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~ 253 (481)
... ........||+.|+|||++.+..+ +.++||||||+++|+|++ |.+||.+.+.......+..+. ...|..+++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence 221 122334577889999999987776 578999999999999999 778888777666666666654 345777899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+.++|.+||+.||.+|||+.++++
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=365.45 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=205.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----KSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~ 100 (481)
.++|++++.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 578999999999999999999999999999999986532 3445678899999999999999999999863 447
Q ss_pred EEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
.|+||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999999999998864 56999999999999999999999999999999999999999999999999998754
Q ss_pred cccccC-------CcccccCCCCccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCchHH--HHHHHHhh-C
Q 011628 176 DQIRQD-------GLFHTFCGTPAYVAPEVLSRKGY--DAAKVDIWSCGVILFVLMAGYLPFQDQNIM--VMYKKIYK-G 243 (481)
Q Consensus 176 ~~~~~~-------~~~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~-~ 243 (481)
...... .......||+.|+|||++.+... .+.++|||||||++|+|++|..||...... .....+.. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 321111 01123468999999999875432 257899999999999999999999643211 11112222 2
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 244 EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 244 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+.+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 234456789999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=356.51 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=199.7
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEe-
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRR--VRHPNIVQLFEVMAT- 97 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~- 97 (481)
+..+.++|++++.||+|+||+||+|++ +++.||||++.... .....+|.+++.. ++||||+++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 345788999999999999999999987 78999999986542 2344567777666 789999999998654
Q ss_pred ---CCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceecCCCCCcEEEccCCCEEE
Q 011628 98 ---KSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH--------ARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 98 ---~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH--------~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
...+|+||||+++|+|.+++..+.+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred cCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 356899999999999999998889999999999999999999999 999999999999999999999999
Q ss_pred EecCCccccccccc--CCcccccCCCCccccccccccCCCC-----CCcchHHHHHHHHHHHhcC----------CCCCC
Q 011628 167 SDFGLSAVSDQIRQ--DGLFHTFCGTPAYVAPEVLSRKGYD-----AAKVDIWSCGVILFVLMAG----------YLPFQ 229 (481)
Q Consensus 167 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~-----~~~~DiwSlGvil~elltg----------~~Pf~ 229 (481)
+|||+++....... .......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999975433211 1112345899999999999765322 2579999999999999999 88885
Q ss_pred Cch----HHHHHHHHhhCC---CCCCC-----CCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 230 DQN----IMVMYKKIYKGE---FRSPR-----WFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 230 ~~~----~~~~~~~i~~~~---~~~~~-----~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
... ............ ...|. ..++.+.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 531 122222322221 12221 13467999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=371.74 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=209.8
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 3578999999999999999999996 578999999987653 234567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 103 FVMEYVRGGELFNKVAKG-----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~-----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
+||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999998652 489999999999999999999999999999999999999999999999999976443
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH-------HHHHHhhCCC-----
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV-------MYKKIYKGEF----- 245 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i~~~~~----- 245 (481)
...........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..... .......+..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 333333345679999999999987776 678999999999999999999997643211 1111111111
Q ss_pred -CC----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 246 -RS----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 246 -~~----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
.. +...+..+.+++.+||+.||++|||+.|++++..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 1123456899999999999999999999998743
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=354.24 Aligned_cols=247 Identities=21% Similarity=0.390 Sum_probs=213.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.. +..|+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 3579999999999999999999974 677899999976532 23568899999999999999999999864 55899
Q ss_pred EEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||+.|++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999999999752 699999999999999999999999999999999999999999999999999976533211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
.......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+. ...+..+++.+.++
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 165 -TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -ccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence 11234467889999999987666 578999999999999999 999999888777777776653 45577889999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
|.+||+.||++|||++++++
T Consensus 243 i~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHH
Confidence 99999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=363.72 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=212.4
Q ss_pred cCCeeEEeEecccCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA--TK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~ 98 (481)
.++|++++.||+|+||.||+|+ +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++. ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 5799999999999999999999 46789999999997643 344567899999999999999999999986 45
Q ss_pred CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..+|+||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 679999999999999999975 569999999999999999999999999999999999999999999999999998653
Q ss_pred cccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---------------HHHHHH
Q 011628 177 QIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---------------VMYKKI 240 (481)
Q Consensus 177 ~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---------------~~~~~i 240 (481)
.... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 3211 112234568889999999987766 57899999999999999999999765432 222333
Q ss_pred hhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 241 YKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 241 ~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+ ....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333 345677899999999999999999999999999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=369.20 Aligned_cols=252 Identities=17% Similarity=0.212 Sum_probs=199.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC---CCcEEEEEEeecccccch---h-----HHHHHHHHHHHHHhCCCCCcceEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKS---G-----LVAHIKREISILRRVRHPNIVQLFE 93 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~---~-----~~~~~~~Ei~il~~l~HpnIv~l~~ 93 (481)
.++|++++.||+|+||.||+|++.. ++..||||++........ . ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 788999999976532110 0 1123568899999999999999999
Q ss_pred EEEe----CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC--CEEE
Q 011628 94 VMAT----KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG--DLKV 166 (481)
Q Consensus 94 ~~~~----~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g--~lkl 166 (481)
++.. ....|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 78899999999 9999999975 5799999999999999999999999999999999999999887 9999
Q ss_pred EecCCccccccccc-----CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc--hHHHHHHH
Q 011628 167 SDFGLSAVSDQIRQ-----DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ--NIMVMYKK 239 (481)
Q Consensus 167 ~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~--~~~~~~~~ 239 (481)
+|||+++....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999976543221 112245689999999999987766 67899999999999999999999652 22211111
Q ss_pred H--hhCCCC-------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 240 I--YKGEFR-------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 240 i--~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
. .....+ .+..+++++.++|.+||+.||++|||+++|++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1 111111 12268899999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=356.08 Aligned_cols=243 Identities=26% Similarity=0.451 Sum_probs=205.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-CEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK-SKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~ 101 (481)
.-.++|++.+.||+|+||.||+|.+ +|+.||||++.... ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 3468999999999999999999987 58899999987543 346688999999999999999999997554 478
Q ss_pred EEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 102 YFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
|+||||++|++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 9999999999999999753 3899999999999999999999999999999999999999999999999998754321
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 256 (481)
.....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+ ....+..+++.+.
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred -----ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence 223467899999999987766 578999999999999998 99999987766666666655 3456778999999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
++|.+||+.||.+|||+.++++
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHH
Confidence 9999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=378.45 Aligned_cols=252 Identities=27% Similarity=0.475 Sum_probs=208.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-- 99 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 99 (481)
..+.++|++++.||+|+||+||+|++..+|+.||||++...... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 34678999999999999999999999999999999999765432 22466789999999999999999999998765
Q ss_pred EEEEEEeccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEecCC
Q 011628 100 KIYFVMEYVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGL 171 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl----~~~g~lkl~DFGl 171 (481)
..|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 789999999999999999752 39999999999999999999999999999999999999 7777899999999
Q ss_pred cccccccccCCcccccCCCCcccccccccc--------CCCCCCcchHHHHHHHHHHHhcCCCCCCCc----hHHHHHHH
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSR--------KGYDAAKVDIWSCGVILFVLMAGYLPFQDQ----NIMVMYKK 239 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~--------~~~~~~~~DiwSlGvil~elltg~~Pf~~~----~~~~~~~~ 239 (481)
++..... ......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||... .......+
T Consensus 163 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 163 ARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred ceEccCC---CccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 9765432 22345689999999999864 233 56899999999999999999999642 23344555
Q ss_pred HhhCCCC---------------------CC----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 240 IYKGEFR---------------------SP----RWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 240 i~~~~~~---------------------~~----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+..+... .+ ..+++.+.++|.+||+.||++|||+++++++
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 5544321 11 1134568899999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=376.81 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=209.7
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
-.++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.. ..+|+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 35789999999999999999999854 567999999765422 3567899999999999999999999876 67899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 334 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 334 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence 9999999999999964 469999999999999999999999999999999999999999999999999998643211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ..+.|..+++.+.+|
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp --------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 112233457889999999987766 678999999999999999 99999998887777777666 356678899999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
|.+||+.||++|||+++|++
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=377.76 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=196.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv 104 (481)
.+|++.+.||+|+||+||.. ...+|+.||||++..+... .+.+|+.+++.+ +||||+++++++.+....|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 35999999999999997643 4468999999999765422 245799999999 799999999999999999999
Q ss_pred EeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---C--CCEEEEecCCcccccc
Q 011628 105 MEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---N--GDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---~--g~lkl~DFGla~~~~~ 177 (481)
||||. |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. + ..+||+|||+++....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99996 5999999764 4666678899999999999999999999999999999953 2 3588999999976543
Q ss_pred ccc-CCcccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCCCC---CCCC
Q 011628 178 IRQ-DGLFHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFR---SPRW 250 (481)
Q Consensus 178 ~~~-~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~---~~~~ 250 (481)
... .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+...... .+..
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 211 1223457899999999999742 223568999999999999999 99999776544333222221211 1222
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.++.+.+||.+||+.||.+|||++++++||||...
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 35568999999999999999999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=363.49 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=199.9
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEEEEEEeC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV--RHPNIVQLFEVMATK 98 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~ 98 (481)
+..+.++|++++.||+|+||.||+|++ +++.||||++.... .....+|..++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 455678999999999999999999987 48999999986442 12334555555554 899999999999887
Q ss_pred ----CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCcEEEccCCCEEE
Q 011628 99 ----SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR--------GVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 99 ----~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~--------gi~HrDLKp~NILl~~~g~lkl 166 (481)
..+|+||||++||+|.+++....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999988999999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccccccCC--cccccCCCCccccccccccCCCCCC-----cchHHHHHHHHHHHhcC----------CCCCC
Q 011628 167 SDFGLSAVSDQIRQDG--LFHTFCGTPAYVAPEVLSRKGYDAA-----KVDIWSCGVILFVLMAG----------YLPFQ 229 (481)
Q Consensus 167 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~APEvl~~~~~~~~-----~~DiwSlGvil~elltg----------~~Pf~ 229 (481)
+|||++.......... .....+||+.|+|||++.+..+... ++|||||||++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997543322111 1235689999999999977665432 38999999999999999 77775
Q ss_pred Cch-----HHHHHHHHhhCC--CCCCC-----CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 230 DQN-----IMVMYKKIYKGE--FRSPR-----WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 230 ~~~-----~~~~~~~i~~~~--~~~~~-----~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
... .......+.... ...|. .+++++.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 431 122222222221 22222 345669999999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=373.65 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=198.5
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
...+.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ...+.+|+.+++.+ +||||+++++++.+..
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 34567788889999999999998764 4689999999986542 34567899999876 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcCCC--------CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC----------
Q 011628 100 KIYFVMEYVRGGELFNKVAKGRL--------KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---------- 161 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~~l--------~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---------- 161 (481)
.+|+|||||. |+|.+++..... ++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999996 599999986432 233457899999999999999999999999999999754
Q ss_pred ---CCEEEEecCCccccccccc--CCcccccCCCCcccccccccc------CCCCCCcchHHHHHHHHHHHhc-CCCCCC
Q 011628 162 ---GDLKVSDFGLSAVSDQIRQ--DGLFHTFCGTPAYVAPEVLSR------KGYDAAKVDIWSCGVILFVLMA-GYLPFQ 229 (481)
Q Consensus 162 ---g~lkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~------~~~~~~~~DiwSlGvil~ellt-g~~Pf~ 229 (481)
+.+||+|||++........ .......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 4799999999986543211 112345689999999999965 1234678999999999999999 999998
Q ss_pred CchHHHHHHHHhhCCCCCCC-------CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 230 DQNIMVMYKKIYKGEFRSPR-------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 230 ~~~~~~~~~~i~~~~~~~~~-------~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+..... ..+..+....+. .+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 764332 234444332221 235789999999999999999999999999999754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=360.71 Aligned_cols=250 Identities=30% Similarity=0.461 Sum_probs=187.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEE-------
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMA------- 96 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~------- 96 (481)
..+|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 458999999999999999999999999999999985542 334567889999999996 999999999984
Q ss_pred -eCCEEEEEEeccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEec
Q 011628 97 -TKSKIYFVMEYVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 97 -~~~~~~lv~Ey~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~lkl~DF 169 (481)
....++++|||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 3446899999996 688887753 57999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccccC----------CcccccCCCCccccccccc---cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH
Q 011628 170 GLSAVSDQIRQD----------GLFHTFCGTPAYVAPEVLS---RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM 236 (481)
Q Consensus 170 Gla~~~~~~~~~----------~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 236 (481)
|++......... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 999765432111 0112457999999999983 3344 5689999999999999999999987655433
Q ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 237 YKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 237 ~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
..... ....+...++.+.+||.+||+.||.+|||+.|++++-+
T Consensus 262 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 262 VNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hcCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 32221 23345567888999999999999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=365.69 Aligned_cols=244 Identities=15% Similarity=0.217 Sum_probs=201.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC--------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcce------
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS--------GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQ------ 90 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~------ 90 (481)
.++|++++.||+|+||.||+|++..+ ++.||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47999999999999999999999874 889999998754 23678999999999999887
Q ss_pred ---------EEEEEEe-CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 011628 91 ---------LFEVMAT-KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLL 157 (481)
Q Consensus 91 ---------l~~~~~~-~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NIL 157 (481)
+++++.. ....|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777766 78899999999 9999999975 57999999999999999999999999999999999999
Q ss_pred EccCC--CEEEEecCCcccccccccC-----CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC
Q 011628 158 LDENG--DLKVSDFGLSAVSDQIRQD-----GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD 230 (481)
Q Consensus 158 l~~~g--~lkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 230 (481)
++.++ .+||+|||+++........ .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 8999999999765432211 12234589999999999988766 6789999999999999999999987
Q ss_pred ch--HHHHHH---HHhhCCCCCC------CCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 231 QN--IMVMYK---KIYKGEFRSP------RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 231 ~~--~~~~~~---~i~~~~~~~~------~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.. ...... .+.......+ ..+++++.+||.+||+.||.+|||++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 53 222222 2222222221 246899999999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=353.00 Aligned_cols=233 Identities=30% Similarity=0.601 Sum_probs=193.2
Q ss_pred CCCCccCCeeEE-eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEe
Q 011628 20 NQSPLLGRYEIG-KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL-RRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 20 ~~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~ 97 (481)
....+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 345678888887 8899999999999999999999999998642 2356788888 66689999999999987
Q ss_pred ----CCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEE
Q 011628 98 ----KSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---NGDLKVS 167 (481)
Q Consensus 98 ----~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---~g~lkl~ 167 (481)
...+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 67899999999999999999753 5999999999999999999999999999999999999998 7889999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHH----hhC
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI----YKG 243 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i----~~~ 243 (481)
|||++.... +..+ +.++|||||||++|+|++|..||.+.+.......+ ..+
T Consensus 163 Dfg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp CCTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred ccccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence 999986421 1223 45899999999999999999999876654332211 122
Q ss_pred CCCCC----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 EFRSP----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
....+ ..+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 22233 4689999999999999999999999999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=370.77 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=202.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSG---ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA-TKSKI 101 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~ 101 (481)
.+|++.+.||+|+||+||+|++..++ ..||+|.+.... .......+.+|+.++++++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 46899999999999999999976433 468999986532 3345678899999999999999999999875 45688
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999999976 468999999999999999999999999999999999999999999999999997543221
Q ss_pred cC--CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHH
Q 011628 180 QD--GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDL 255 (481)
Q Consensus 180 ~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 255 (481)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+.......+..+. ...|..+++.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 11 11234567889999999987776 578999999999999999 789998776655555665554 45577899999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.++|.+||+.||++|||+.+++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=367.70 Aligned_cols=244 Identities=17% Similarity=0.283 Sum_probs=200.2
Q ss_pred cCCeeEEeEecccCceEEEEE-----EEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHA-----RNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR---HPNIVQLFEVMA 96 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~ 96 (481)
.++|++.+.||+|+||+||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 578999999999999999999 466789999999997543 245677888888887 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc----------
Q 011628 97 TKSKIYFVMEYVRGGELFNKVA------KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---------- 160 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~------~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---------- 160 (481)
..+..|+||||++||+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 9999999999999999999996 246999999999999999999999999999999999999998
Q ss_pred -CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHH
Q 011628 161 -NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKK 239 (481)
Q Consensus 161 -~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 239 (481)
++.+||+|||+|+..............+||+.|+|||++.+..| +.++|||||||++|+|++|..||.........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 89999999999976543333444566789999999999988877 67899999999999999999999654321000
Q ss_pred HhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 240 IYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 240 i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
....+ ...+.++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 295 -~~~~~-~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 295 -PEGLF-RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp -ECSCC-TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred -echhc-cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 00111 122456789999999999999999765544443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=353.71 Aligned_cols=240 Identities=30% Similarity=0.504 Sum_probs=198.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||+||+|++ .++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..|+|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 57899999999999999999987 4789999998643 234678899999999999999999998774 47999
Q ss_pred EeccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCceecCCCCCcEEEccCCC-EEEEecCCccccc
Q 011628 105 MEYVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHA---RGVYHRDLKPENLLLDENGD-LKVSDFGLSAVSD 176 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~---~gi~HrDLKp~NILl~~~g~-lkl~DFGla~~~~ 176 (481)
|||++||+|.+++... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999999999863 37899999999999999999999 89999999999999999887 7999999987543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch--HHHHHHHHhhC-CCCCCCCCCH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN--IMVMYKKIYKG-EFRSPRWFSP 253 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~-~~~~~~~~s~ 253 (481)
. ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .......+..+ ....+..+++
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
T 2eva_A 158 T-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCH
T ss_pred c-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCH
Confidence 2 1234579999999999987766 678999999999999999999997532 23333333333 3455677899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+.++|.+||+.||.+|||+++++++
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=362.14 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=205.5
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++.+.||+|+||.||+|++ .+|+.||||++........ ...+.+|+.+++.++||||+++++++......+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 3468999999999999999999985 5789999999976543221 235789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHc---CceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 103 FVMEYVRGGELFNKVAKG-----RLKEDLARKYFQQLISAVGFCHAR---GVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~-----~l~e~~~~~~~~ql~~al~yLH~~---gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
+||||+.||+|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 999999999999999752 399999999999999999999999 999999999999999999999999999986
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH----HHHHHHhhCCC-----
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM----VMYKKIYKGEF----- 245 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~----- 245 (481)
.... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ........+..
T Consensus 184 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 184 MDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp CCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 5432 2223345679999999999987776 67899999999999999999999632210 01111111100
Q ss_pred ----------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 246 ----------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 246 ----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
..+...++.+.+++.+||+.||.+|||+.|+++|-+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 011112357899999999999999999999999754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=383.53 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=208.9
Q ss_pred CCeeEEe-EecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 26 GRYEIGK-LLGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 26 ~~y~i~~-~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
++|.+.+ .||+|+||+||+|.+.. ++..||||++.... .....+.+.+|+.+|+.++||||+++++++.. +.+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 4566666 89999999999998763 56679999997653 22345778999999999999999999999976 5699
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+||||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999999964 4699999999999999999999999999999999999999999999999999986532211
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 111123346789999999987777 578999999999999998 999999988777777777764 5667889999999
Q ss_pred HHHHhcccCcCCCCCHhHHHh
Q 011628 258 LLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~ 278 (481)
||.+||+.||++|||+.+|++
T Consensus 571 li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=384.36 Aligned_cols=245 Identities=22% Similarity=0.329 Sum_probs=207.9
Q ss_pred EeEecccCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 31 GKLLGHGTFAKVYHARN--VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
.+.||+|+||.||+|.+ ..+++.||||++.... ......+.+.+|+.+++.++||||+++++++.. ..+++||||+
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 35899999999999965 3567899999997653 233456779999999999999999999999965 4588999999
Q ss_pred CCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc-CCcccc
Q 011628 109 RGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ-DGLFHT 186 (481)
Q Consensus 109 ~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~-~~~~~~ 186 (481)
.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 99999999976 5799999999999999999999999999999999999999999999999999976533211 112233
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcc
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 264 (481)
..||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++++.+||.+||+
T Consensus 532 ~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp ---CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 457889999999988777 578999999999999998 999999988888888777764 55688899999999999999
Q ss_pred cCcCCCCCHhHHHh
Q 011628 265 TNPDKRITIPEIME 278 (481)
Q Consensus 265 ~dP~~Rps~~eil~ 278 (481)
.||++|||+++|++
T Consensus 611 ~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 611 YDVENRPGFAAVEL 624 (635)
T ss_dssp SSTTTSCCHHHHHH
T ss_pred CCHhHCcCHHHHHH
Confidence 99999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.07 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=204.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-LKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..|..++.||+|+||.||+|.+ +++.||||++..... ........+.+|+.+++.++||||+++++++......|+|
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 3466679999999999999986 688999999975432 2334567789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 105 MEYVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 999999999999863 4599999999999999999999999999999999999999999999999999976543222
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH----HHHHHHhhCC----------C-
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM----VMYKKIYKGE----------F- 245 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~----------~- 245 (481)
........||+.|+|||++.+. + +.++||||||+++|+|++|..||...... .....+.... .
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 2223446799999999998653 4 67899999999999999999999764321 1222222111 1
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1122245678999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.65 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=209.9
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEE----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARN----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
.....++|++++.||+|+||.||+|+. ..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 344577899999999999999999984 5689999999997642 344577899999999999999999999986
Q ss_pred eCC--EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 97 TKS--KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 97 ~~~--~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..+ .+++||||++|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 644 78999999999999999976 45999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH----------------H
Q 011628 173 AVSDQIRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM----------------V 235 (481)
Q Consensus 173 ~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----------------~ 235 (481)
......... .......+++.|+|||++.+..+ +.++|||||||++|+|++|..||...... .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 865432111 11233467888999999987766 57899999999999999999998754211 1
Q ss_pred HHHHHhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 236 MYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 236 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+...+..+ ..+.|..+++++.+||.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12222222 35567789999999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=378.36 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=213.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.. ..+|+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 35789999999999999999999854 567999999765422 3568899999999999999999999876 67899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999999964 4699999999999999999999999999999999999999999999999999976432111
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
.......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ....|..+++.+.+|
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11123457789999999987766 678999999999999999 99999998887777777666 356678899999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
|.+||+.||++|||+++|++
T Consensus 497 i~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=356.57 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=191.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----- 97 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----- 97 (481)
.-.++|++++.||+|+||.||+|++ +++.||||++...... .....+|+..++.++||||+++++.+..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 4478999999999999999999976 7899999999754311 1112244444556899999999986543
Q ss_pred CCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---------CceecCCCCCcEEEccCCCEEEEe
Q 011628 98 KSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR---------GVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~---------gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
...+|+||||++||+|.+++.....++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 23679999999999999999988889999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccccc------cCCcccccCCCCccccccccccC------CCCCCcchHHHHHHHHHHHhcCCCCCCCc-h---
Q 011628 169 FGLSAVSDQIR------QDGLFHTFCGTPAYVAPEVLSRK------GYDAAKVDIWSCGVILFVLMAGYLPFQDQ-N--- 232 (481)
Q Consensus 169 FGla~~~~~~~------~~~~~~~~~gt~~y~APEvl~~~------~~~~~~~DiwSlGvil~elltg~~Pf~~~-~--- 232 (481)
||++....... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... .
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99997643211 11223356799999999998762 12245799999999999999997765321 1
Q ss_pred --------------HHHHHHHHhhC--CCCCCCC------CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 233 --------------IMVMYKKIYKG--EFRSPRW------FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 233 --------------~~~~~~~i~~~--~~~~~~~------~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.......+... ....|.. +++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11111111111 1222322 3347999999999999999999999965
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=359.40 Aligned_cols=252 Identities=26% Similarity=0.447 Sum_probs=208.9
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
....++|++++.||+|+||.||+|++.. .||+|++....... ...+.+.+|+.+++.++||||+++++++.....+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3447899999999999999999999843 49999997653222 2234567899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
++||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999999999863 599999999999999999999999999999999999998 6899999999987543211
Q ss_pred ---cCCcccccCCCCccccccccccC--------CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-
Q 011628 180 ---QDGLFHTFCGTPAYVAPEVLSRK--------GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS- 247 (481)
Q Consensus 180 ---~~~~~~~~~gt~~y~APEvl~~~--------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~- 247 (481)
.........||+.|+|||++.+. ...+.++|||||||++|+|++|..||...........+..+..+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 12233455799999999998652 223668999999999999999999999988877777776664332
Q ss_pred -CCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 248 -PRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 248 -~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+..+++++.++|.+||..||.+|||+.++++
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3357889999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=356.11 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=204.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC-
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRR--VRHPNIVQLFEVMATKS- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~- 99 (481)
.+.++|++.+.||+|+||.||+|++ +|+.||||++.... ...+.+|..+++. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 4468999999999999999999998 68999999986432 3456788999888 78999999999998876
Q ss_pred ---EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceecCCCCCcEEEccCCCEEEEe
Q 011628 100 ---KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH--------ARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 100 ---~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH--------~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
.+|+||||+++|+|.+++...++++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 8999999999999999999888999999999999999999999 89999999999999999999999999
Q ss_pred cCCcccccccccC--CcccccCCCCccccccccccCCCC-----CCcchHHHHHHHHHHHhcC----------CCCCCCc
Q 011628 169 FGLSAVSDQIRQD--GLFHTFCGTPAYVAPEVLSRKGYD-----AAKVDIWSCGVILFVLMAG----------YLPFQDQ 231 (481)
Q Consensus 169 FGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~-----~~~~DiwSlGvil~elltg----------~~Pf~~~ 231 (481)
||++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9999764432211 022456899999999998765322 1579999999999999999 8899764
Q ss_pred -----hHHHHHHHHhhCCCC--CCC-----CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 232 -----NIMVMYKKIYKGEFR--SPR-----WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 232 -----~~~~~~~~i~~~~~~--~~~-----~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
........+...... .|. ..++.+.+||.+||+.||++|||+.++++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 233444444433222 222 123468999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=368.69 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=208.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH-PNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~ 101 (481)
.+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.| ++|..+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 4578999999999999999999999999999999998765432 236789999999986 5666677777888999
Q ss_pred EEEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE---ccCCCEEEEecCCccccc
Q 011628 102 YFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL---DENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl---~~~g~lkl~DFGla~~~~ 176 (481)
|+||||+ |++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 999999997 4679999999999999999999999999999999999999 688999999999998654
Q ss_pred ccccC-----CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch---HHHHHHHHhhCCC---
Q 011628 177 QIRQD-----GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN---IMVMYKKIYKGEF--- 245 (481)
Q Consensus 177 ~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~--- 245 (481)
..... ......+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.. ....+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 32221 11236789999999999988777 678999999999999999999998743 2333444333221
Q ss_pred --CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 246 --RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 246 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+..+++++.+||.+||+.||++||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 123567899999999999999999999998876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=381.29 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=213.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..++|++++.||+|+||+||+|++..+ +..||||++.... .....+.+.+|+.+++.++||||+++++++. .+.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 357899999999999999999998653 4679999986542 3345577899999999999999999999985 456
Q ss_pred EEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.|+||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 89999999999999999753 6899999999999999999999999999999999999999999999999999865332
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .+.|..+++.+.
T Consensus 545 ~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 622 (656)
T 2j0j_A 545 TY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 622 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred cc-eeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence 11 11233467889999999987776 578999999999999997 999999988887777777664 567888999999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h 279 (481)
+||.+||+.||.+|||+.++++.
T Consensus 623 ~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 623 SLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999863
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=347.39 Aligned_cols=230 Identities=17% Similarity=0.227 Sum_probs=194.2
Q ss_pred CCCCC-CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 18 DQNQS-PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 18 ~~~~~-~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
...+. .+.++|++.+.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 34444 56789999999999999999999999999999999998776555566688899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..+..|+||||++|++|.+++..+. ...++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred ECCcEEEEEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999999999997664 566788999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHH---HHHhhCCCC----CCC
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY---KKIYKGEFR----SPR 249 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~~i~~~~~~----~~~ 249 (481)
|++| + +.++|||||||++|+|++|..||.+.+..... .+...+... .+.
T Consensus 175 ----------------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T 3uqc_A 175 ----------------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR 230 (286)
T ss_dssp ----------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCT
T ss_pred ----------------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhccc
Confidence 3333 2 56899999999999999999999876532211 011122221 135
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+++++.+||.+||+.||.+| |+.|+++.
T Consensus 231 ~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 231 DIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp TSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 689999999999999999999 99999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=371.60 Aligned_cols=248 Identities=19% Similarity=0.243 Sum_probs=195.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCc---------ce-----
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH-PNI---------VQ----- 90 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnI---------v~----- 90 (481)
..|++++.||+|+||+||+|++..+|+.||||++...........+.+++|+.+++.+.| +|+ +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999999975443333345778999999999987 221 11
Q ss_pred -------EEEEEEe-----CCEEEEEEeccCCCchHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecC
Q 011628 91 -------LFEVMAT-----KSKIYFVMEYVRGGELFNKVA--------KGRLKEDLARKYFQQLISAVGFCHARGVYHRD 150 (481)
Q Consensus 91 -------l~~~~~~-----~~~~~lv~Ey~~gg~L~~~i~--------~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrD 150 (481)
+..++.. ...++++|+++ +++|.+++. .+.+++..+..++.||+.||+|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 22467777766 579998885 23477889999999999999999999999999
Q ss_pred CCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCcccccccc----------ccCCCCCCcchHHHHHHHHHH
Q 011628 151 LKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL----------SRKGYDAAKVDIWSCGVILFV 220 (481)
Q Consensus 151 LKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl----------~~~~~~~~~~DiwSlGvil~e 220 (481)
|||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..+ +.++|||||||++|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHH
Confidence 9999999999999999999998764432 355688 999999999 33334 568999999999999
Q ss_pred HhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 221 LMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 221 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|++|+.||...+.......+. .....+|+++.+||.+||+.||++|||+.++++||||+.-
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 999999998876544333332 2334678999999999999999999999999999999764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=357.85 Aligned_cols=243 Identities=18% Similarity=0.285 Sum_probs=199.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC---------CCCcce
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-----KSGLVAHIKREISILRRVR---------HPNIVQ 90 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------HpnIv~ 90 (481)
.++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 58999999999999999999998 7899999999876421 2233467889999999886 888888
Q ss_pred EEEEEE------------------------------eCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 011628 91 LFEVMA------------------------------TKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF 140 (481)
Q Consensus 91 l~~~~~------------------------------~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~y 140 (481)
+++++. ....+|+|||||++|++.+.+.++.+++..++.++.||+.||.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 888753 26789999999999988777777789999999999999999999
Q ss_pred HH-HcCceecCCCCCcEEEccCC--------------------CEEEEecCCcccccccccCCcccccCCCCcccccccc
Q 011628 141 CH-ARGVYHRDLKPENLLLDENG--------------------DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199 (481)
Q Consensus 141 LH-~~gi~HrDLKp~NILl~~~g--------------------~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl 199 (481)
|| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||++
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGG
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhh
Confidence 99 99999999999999999987 899999999986542 235899999999999
Q ss_pred ccCCCCCCcchHHHHHHH-HHHHhcCCCCCCCchH-HHHHHHHhhC-CCC--C----CCCCCHHHHHHHHHhcccCcCCC
Q 011628 200 SRKGYDAAKVDIWSCGVI-LFVLMAGYLPFQDQNI-MVMYKKIYKG-EFR--S----PRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 200 ~~~~~~~~~~DiwSlGvi-l~elltg~~Pf~~~~~-~~~~~~i~~~-~~~--~----~~~~s~~~~~li~~~L~~dP~~R 270 (481)
.+.. +.++||||+|++ .+++++|..||.+... ......+... ... . +..+|+++++||.+||+.|
T Consensus 250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 8665 568999998777 7889999999966432 2223333322 111 1 1236788999999999977
Q ss_pred CCHhHHH-hCcccc
Q 011628 271 ITIPEIM-ENRWFR 283 (481)
Q Consensus 271 ps~~eil-~h~~f~ 283 (481)
|++|++ +||||+
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999994
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=388.95 Aligned_cols=257 Identities=32% Similarity=0.469 Sum_probs=206.6
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT---- 97 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---- 97 (481)
....++|++++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 345689999999999999999999999999999999987642 33456778899999999999999999999755
Q ss_pred --CCEEEEEEeccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEe
Q 011628 98 --KSKIYFVMEYVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSD 168 (481)
Q Consensus 98 --~~~~~lv~Ey~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~---lkl~D 168 (481)
....|+||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 67789999999999999999762 5999999999999999999999999999999999999998775 89999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHH---------
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKK--------- 239 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~--------- 239 (481)
||++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........+..
T Consensus 168 FG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 168 LGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred ccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 999986533 223355789999999999987777 5789999999999999999999976432211100
Q ss_pred -----HhhCCC------CCCC----CCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 240 -----IYKGEF------RSPR----WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 240 -----i~~~~~------~~~~----~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
...+.. +.|. .+++.+.+||.+||..||.+|||++++++||||+.
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 011111 1121 24678999999999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=382.02 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=203.4
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
.+..+.++|++.+.||+|+||+||+|++.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 345567999999999999999999999976 78999999986542 334556788999999999999999999999876
Q ss_pred CE-----EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 99 SK-----IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 99 ~~-----~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
+. .|+||||++|++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 55 7999999999999988765 79999999999999999999999999999999999999885 99999999997
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCH
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSP 253 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 253 (481)
..... ...+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+...... .........++
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~ 295 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYD 295 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCH
T ss_pred hcccC------CccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCH
Confidence 54321 456799999999998764 3 6789999999999999999999876321000 00000011357
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.+.+||.+||++||.+||+..+.+.|+|+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 899999999999999999999999999874
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=272.34 Aligned_cols=126 Identities=35% Similarity=0.619 Sum_probs=115.5
Q ss_pred CCCCccchhhhccCCCCCCCCCcccC----ccccceecCCCHHHHHHHHHHHHHHcCcEEEEecceEEEEeecCCCcccE
Q 011628 339 RPASLNAFDLISFSPGFDLSGLFEEG----GEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPL 414 (481)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~l~~~~~~~----~~~~~f~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~l 414 (481)
.|..+|||||||+|+|||||+||+.. .|+|||+|+.|+++|+++||++|+++||+|+++++.|++++..+|+||+|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 46679999999999999999999864 37999999999999999999999999999999888899999999999999
Q ss_pred EEEEEEEEEcCceEEEEeEecCCCchhHHHHhhhccccccccceecccccc
Q 011628 415 TIATEIFELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLDESESA 465 (481)
Q Consensus 415 ~~~~~v~~~~~~~~lVe~~~~~Gd~le~~~~~~~~l~~~l~~~v~~~~~~~ 465 (481)
++.+|||||+|+++||||||++||++||++||++ ||++|+||||+|+++.
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~-Lr~~L~diV~~~~~~~ 132 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKK-LCSKLENIIWRATEGI 132 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHH-HHHHSTTTBCC-----
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHH-HHHHhhcceecCCCCC
Confidence 9999999999999999999999999999998886 9999999999999865
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=252.22 Aligned_cols=118 Identities=36% Similarity=0.562 Sum_probs=105.7
Q ss_pred CCCccchhhhccCCCCCCCCCccc--C-ccccceecCCCHHHHHHHHHHHHHHcCcEEEEecceEEEEeecCCCcccEEE
Q 011628 340 PASLNAFDLISFSPGFDLSGLFEE--G-GEGARFVSGAPVSKIITKLEEIAKVVSFTVRKKDCRVSLEGSREGVKGPLTI 416 (481)
Q Consensus 340 ~~~~~~~~~~~~~~~~~l~~~~~~--~-~~~~~f~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~l~~ 416 (481)
|..+|||||||+|+|||||+||++ . .|+|||+|+.|+++|+++||++|+++||+|++++++ +++.+|+||+|++
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~v 79 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFAM 79 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEEE
T ss_pred cccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEEE
Confidence 456999999999999999999975 2 268999999999999999999999999999988775 6678899999999
Q ss_pred EEEEEEEcCceEEEEeEecCCCchhHHHHhhhccccccccceec
Q 011628 417 ATEIFELTPKLVVVEVKKKGGDKGEYEEFCNKELKPGLENLMLD 460 (481)
Q Consensus 417 ~~~v~~~~~~~~lVe~~~~~Gd~le~~~~~~~~l~~~l~~~v~~ 460 (481)
.+|||||+|+++||||||++||++||++||.++||++|+||||+
T Consensus 80 ~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 80 VVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 99999999999999999999999999998877799999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.71 Aligned_cols=232 Identities=15% Similarity=0.141 Sum_probs=161.3
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-------KSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 103 (481)
..++.|++|.+..++..-.|+.||+|++.+.... .....+.+.+|+++|+++ +|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3467888888888888788999999999865321 123346689999999999 69999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||++|++|.+++.. +++++. +++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Cc
Confidence 9999999999999987 567654 58999999999999999999999999999999999999999999865432 23
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
...+.+||+.|+|||++.+.. ..++|+||+|+++++|.++..|+. ..+... +. ....+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~~----~~-~~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQE----PV-ERWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHTS----CG-GGCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhcC----CC-CCCcHHHHHHHH
Confidence 345679999999999997653 457999999999998877644431 111111 10 011255677777
Q ss_pred cccCcCCCCCHhHHHhCcccc
Q 011628 263 LDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f~ 283 (481)
+..+|..|+.......++|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 888888888777776777653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=270.76 Aligned_cols=189 Identities=21% Similarity=0.238 Sum_probs=146.3
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG-----LVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
...+.||+|+||+||+|. ..++.+++|........... ..+++.+|+.++++++||||+++..++......|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 446799999999999994 46789999987654332221 24567899999999999999955555557777899
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC-
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG- 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~- 182 (481)
||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. ++||+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999876 6789999999999999999999999999999998 99999999998754422111
Q ss_pred ----cccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCC
Q 011628 183 ----LFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQ 229 (481)
Q Consensus 183 ----~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~ 229 (481)
...+.+||+.|+|||++.. .+| +..+|+||..+-..+-..++.+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhccccC
Confidence 1246789999999999976 556 456899999988888777766663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=226.04 Aligned_cols=146 Identities=21% Similarity=0.264 Sum_probs=117.1
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch---------------hHHHHHHHHHHHHHhCCCCCcceEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---------------GLVAHIKREISILRRVRHPNIVQLF 92 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnIv~l~ 92 (481)
|.+++.||+|+||.||+|++ .+|+.||||++........ .....+.+|+.+++.++| ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 44559999999999999999 8899999999965432110 134668899999999994 5555
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 93 EVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 93 ~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
+++.. +..|+||||++||+|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a 239 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence 54443 44699999999999998 422 33557999999999999999999999999999999 999999999998
Q ss_pred ccccccccCCcccccCCCCccccccccc
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLS 200 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~ 200 (481)
+. +..+.|||++.
T Consensus 240 ~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 240 VE---------------VGEEGWREILE 252 (282)
T ss_dssp EE---------------TTSTTHHHHHH
T ss_pred eE---------------CCCCCHHHHHH
Confidence 62 45578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=194.78 Aligned_cols=140 Identities=21% Similarity=0.278 Sum_probs=110.2
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcE--EEEEEeecccccc---------------------hhHHHHHHHHHHHHHhC
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGES--VAIKVIDKEKILK---------------------SGLVAHIKREISILRRV 83 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l 83 (481)
-|++++.||+|+||.||+|.+..+|+. ||||++....... ......+.+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778999 9999975432110 01123678999999999
Q ss_pred CCCCc--ceEEEEEEeCCEEEEEEeccCC-C----chHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCc
Q 011628 84 RHPNI--VQLFEVMATKSKIYFVMEYVRG-G----ELFNKVAKGRLKEDLARKYFQQLISAVGFCH-ARGVYHRDLKPEN 155 (481)
Q Consensus 84 ~HpnI--v~l~~~~~~~~~~~lv~Ey~~g-g----~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH-~~gi~HrDLKp~N 155 (481)
.|+++ ..++.. ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| ++||+||||||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 88864 444442 246899999942 3 66665432 345678899999999999999 9999999999999
Q ss_pred EEEccCCCEEEEecCCccc
Q 011628 156 LLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 156 ILl~~~g~lkl~DFGla~~ 174 (481)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2e-19 Score=181.67 Aligned_cols=138 Identities=15% Similarity=0.220 Sum_probs=103.5
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc---------------chhH----HHHHHHHHHHHHhCCCCCc
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL---------------KSGL----VAHIKREISILRRVRHPNI 88 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------------~~~~----~~~~~~Ei~il~~l~HpnI 88 (481)
|+++..||.|+||.||+|.+ .+|+.||||+++..... .... .....+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999997 57999999998643211 0000 1123568888888866554
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-----
Q 011628 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD----- 163 (481)
Q Consensus 89 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~----- 163 (481)
....-+.... .+|||||++|++|.++.. .+.+..++.||+.+|.|||++||+||||||.|||++.+|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 3322222222 279999999998876532 2345678999999999999999999999999999998873
Q ss_pred -----EEEEecCCcc
Q 011628 164 -----LKVSDFGLSA 173 (481)
Q Consensus 164 -----lkl~DFGla~ 173 (481)
+.|+||+-+-
T Consensus 249 ~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 249 SITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECCCTTCE
T ss_pred ccccceEEEEeCCcc
Confidence 8999998653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=5.2e-13 Score=128.09 Aligned_cols=142 Identities=17% Similarity=0.180 Sum_probs=114.4
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 102 (481)
..+.|++...+|.|+.+.||++.. .++.+++|+........ ...+.+|+.+++.+. +..+.+++++....+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 356799999999999999999974 47899999986532111 134778999999995 677889999999999999
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA--------------------------------------- 143 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~--------------------------------------- 143 (481)
+||||++|.+|.+.+. +......++.++..++..||+
T Consensus 87 lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 9999999999887632 222345788999999999998
Q ss_pred --------------------cCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 144 --------------------RGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 144 --------------------~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
.+++|+|++|.|||+++++.+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765567999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=3.5e-12 Score=121.48 Aligned_cols=136 Identities=15% Similarity=0.176 Sum_probs=102.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEVMATKSKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~ 102 (481)
...|.+....+.|+.+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 55678766656777799999964 567889999976431 134678999999986544 556888888888899
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARG------------------------------------- 145 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~g------------------------------------- 145 (481)
+||||++|.+|. .. ... ...++.++...+..||+..
T Consensus 92 ~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999999999884 21 112 2356677777777777643
Q ss_pred ---------------------ceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 146 ---------------------VYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 146 ---------------------i~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=4.4e-11 Score=120.18 Aligned_cols=143 Identities=16% Similarity=0.344 Sum_probs=108.4
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEee--cccccchhHHHHHHHHHHHHHhCC--CCCcceEEEEEEeC---CE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVID--KEKILKSGLVAHIKREISILRRVR--HPNIVQLFEVMATK---SK 100 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~ 100 (481)
..-.+.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 34567899999999999875 35678899875 33211 11245778999999997 45578888888776 45
Q ss_pred EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 011628 101 IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA------------------------------------- 143 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~------------------------------------- 143 (481)
.|+||||++|..+.+... ..++......++.+++..|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CEEEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred eEEEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 899999999988754221 347788889999999999999997
Q ss_pred ---------------------cCceecCCCCCcEEEccCCC--EEEEecCCcccc
Q 011628 144 ---------------------RGVYHRDLKPENLLLDENGD--LKVSDFGLSAVS 175 (481)
Q Consensus 144 ---------------------~gi~HrDLKp~NILl~~~g~--lkl~DFGla~~~ 175 (481)
.+++|+|++|.|||++.++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999998764 689999998753
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.15 E-value=2.1e-10 Score=96.15 Aligned_cols=85 Identities=12% Similarity=0.157 Sum_probs=73.4
Q ss_pred eecCCCHHHHHHHHHHHHHHcCcEEEEec-ceEEEEeecCCCcccEEEEEEEEEEc-CceEEEEeEecCCCchhHHHHhh
Q 011628 370 FVSGAPVSKIITKLEEIAKVVSFTVRKKD-CRVSLEGSREGVKGPLTIATEIFELT-PKLVVVEVKKKGGDKGEYEEFCN 447 (481)
Q Consensus 370 f~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~k~~l~~~~~v~~~~-~~~~lVe~~~~~Gd~le~~~~~~ 447 (481)
-+|.++|++|+..|+.++..+|+.|++++ +.+++.....+.++.+.+.+||+++. +++++|+|+|.+||.+.|+++|.
T Consensus 33 tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~ 112 (120)
T 3ose_A 33 TTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (120)
T ss_dssp CEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHH
Confidence 36889999999999999999999998876 45888754334567899999999996 89999999999999999999999
Q ss_pred hccccccc
Q 011628 448 KELKPGLE 455 (481)
Q Consensus 448 ~~l~~~l~ 455 (481)
+ |.+.|+
T Consensus 113 ~-il~~L~ 119 (120)
T 3ose_A 113 K-IANELK 119 (120)
T ss_dssp H-HHHHCC
T ss_pred H-HHHHhc
Confidence 7 766654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=3.9e-11 Score=117.72 Aligned_cols=187 Identities=18% Similarity=0.233 Sum_probs=123.9
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCC--cceEEEEEEeCC---EEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPN--IVQLFEVMATKS---KIYFV 104 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lv 104 (481)
.+.++.|....||++. ..+++|+.... .....+.+|..+++.+. +.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3558999999999863 46889986432 23467889999998884 433 345554443333 35899
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA----------------------------------------- 143 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~----------------------------------------- 143 (481)
||+++|.+|.+... ..++.++...++.|++..+..||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999998875433 347788888888899888888886
Q ss_pred -----------------cCceecCCCCCcEEEcc--CCCEEEEecCCcccccccccCCcccccCCCCcccccccccc--C
Q 011628 144 -----------------RGVYHRDLKPENLLLDE--NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR--K 202 (481)
Q Consensus 144 -----------------~gi~HrDLKp~NILl~~--~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~ 202 (481)
..++|+|++|.||+++. ++.+.|+||+.+...+....-....... .-..|+.... .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---EEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---TSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---cccCHHHHHHHHH
Confidence 13799999999999998 4567899999987543211100000000 0022222110 0
Q ss_pred CCCCC-----------cchHHHHHHHHHHHhcCCCCCCCc
Q 011628 203 GYDAA-----------KVDIWSCGVILFVLMAGYLPFQDQ 231 (481)
Q Consensus 203 ~~~~~-----------~~DiwSlGvil~elltg~~Pf~~~ 231 (481)
.|... ..+.|++|.++|.+.+|..+|-..
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~ 290 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEE 290 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHH
Confidence 11111 268999999999999998877443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=5e-07 Score=88.54 Aligned_cols=135 Identities=21% Similarity=0.216 Sum_probs=95.9
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEE-eCCEEEEEEe
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP---NIVQLFEVMA-TKSKIYFVME 106 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lv~E 106 (481)
.+.++.|....||+. |..+++|+... ......+.+|..+|+.+.+. .+.+++.+.. ..+..|++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456788999999987 56788998422 23456788999999999753 2556666664 4456789999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR------------------------------------------ 144 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~------------------------------------------ 144 (481)
|++|..|.+..- ..++......+..|+...|..||+.
T Consensus 94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999988876321 2345555555556666555555532
Q ss_pred ------------------CceecCCCCCcEEEcc---CCCE-EEEecCCccccc
Q 011628 145 ------------------GVYHRDLKPENLLLDE---NGDL-KVSDFGLSAVSD 176 (481)
Q Consensus 145 ------------------gi~HrDLKp~NILl~~---~g~l-kl~DFGla~~~~ 176 (481)
.++|+|++|.|||++. ++.+ .|+||+.+...+
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999997 4565 899999887543
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.66 E-value=3.4e-08 Score=82.57 Aligned_cols=84 Identities=11% Similarity=0.160 Sum_probs=70.1
Q ss_pred ecCCCHHHHHHHHHHHHHHcCcEEEEec-ceEEEEeecCCCcccEEEEEEEEEEc-CceEEEEeEecCCCchhHHHHhhh
Q 011628 371 VSGAPVSKIITKLEEIAKVVSFTVRKKD-CRVSLEGSREGVKGPLTIATEIFELT-PKLVVVEVKKKGGDKGEYEEFCNK 448 (481)
Q Consensus 371 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~k~~l~~~~~v~~~~-~~~~lVe~~~~~Gd~le~~~~~~~ 448 (481)
+|.+++++|+..|..+++.+|+.|++++ +.+++.......+..+.|.+||++|. .+++.|+|+|.+||...|+++|.+
T Consensus 34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~~ 113 (126)
T 1v5s_A 34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK 113 (126)
T ss_dssp CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHHH
T ss_pred ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHHH
Confidence 4688999999999999999999998744 44777543223356799999999994 789999999999999999999998
Q ss_pred ccccccc
Q 011628 449 ELKPGLE 455 (481)
Q Consensus 449 ~l~~~l~ 455 (481)
|-..|+
T Consensus 114 -IL~eLk 119 (126)
T 1v5s_A 114 -IANELK 119 (126)
T ss_dssp -HHHHTT
T ss_pred -HHHHHh
Confidence 666665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=5.9e-07 Score=85.88 Aligned_cols=137 Identities=16% Similarity=0.225 Sum_probs=97.3
Q ss_pred eeEEeEecccCc-eEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 011628 28 YEIGKLLGHGTF-AKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 28 y~i~~~LG~G~f-g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 105 (481)
|+... +..|.. +.||+......+..+.+|+-... ....+.+|..+|+.+. +--+.+++.++.+.+..|+||
T Consensus 27 ~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 27 YRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp CEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred CeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 44433 333444 47998877667788999986532 3456788999999885 333678888999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA------------------------------------------ 143 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~------------------------------------------ 143 (481)
|+++|.++.+..... ......+..++...|.-||+
T Consensus 100 e~l~G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp ECCCSEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred EeeCCccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 999998877665432 12223445555555555553
Q ss_pred ----------------cCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 144 ----------------RGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 144 ----------------~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
..++|+|++|.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1278999999999999877778999998764
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.6e-06 Score=69.94 Aligned_cols=79 Identities=8% Similarity=0.193 Sum_probs=66.4
Q ss_pred eecCCCHHHHHHHHHHHHHHcCcEEEEec-ceEEEEeecCCCcccEEEEEEEEEEcCceEEEEeEecCCC--------ch
Q 011628 370 FVSGAPVSKIITKLEEIAKVVSFTVRKKD-CRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGD--------KG 440 (481)
Q Consensus 370 f~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~k~~l~~~~~v~~~~~~~~lVe~~~~~Gd--------~l 440 (481)
..|...+.+|+..|..+++.+|+.|++.+ +.|++.....-....+.|.+++|++.+..+|+||++..|| ++
T Consensus 12 IrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~~ 91 (106)
T 4eai_A 12 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHTI 91 (106)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHHH
T ss_pred ceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCcE
Confidence 35678899999999999999999998765 5588875432223468999999999999999999999995 89
Q ss_pred hHHHHhhh
Q 011628 441 EYEEFCNK 448 (481)
Q Consensus 441 e~~~~~~~ 448 (481)
+|-.+|..
T Consensus 92 ~F~d~ca~ 99 (106)
T 4eai_A 92 EFFEMCAN 99 (106)
T ss_dssp HHHHHHHH
T ss_pred eHHHHHHH
Confidence 99999987
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.2e-06 Score=88.99 Aligned_cols=81 Identities=19% Similarity=0.197 Sum_probs=51.2
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhCCC--CC-cceEEEEEEeCCEEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-LKS---GLVAHIKREISILRRVRH--PN-IVQLFEVMATKSKIY 102 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~H--pn-Iv~l~~~~~~~~~~~ 102 (481)
-.+.||.|.++.||++....+++.++||....... ... ....++.+|..+++.+.. |. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35789999999999997655678999998653211 000 112446779999988742 33 4456544 344568
Q ss_pred EEEeccCCCc
Q 011628 103 FVMEYVRGGE 112 (481)
Q Consensus 103 lv~Ey~~gg~ 112 (481)
+||||++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=8.4e-07 Score=88.53 Aligned_cols=86 Identities=12% Similarity=0.126 Sum_probs=56.7
Q ss_pred eEEeEe-cccCceEEEEEEEc--C----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-C--CCcceEEEEEEeC
Q 011628 29 EIGKLL-GHGTFAKVYHARNV--K----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-H--PNIVQLFEVMATK 98 (481)
Q Consensus 29 ~i~~~L-G~G~fg~Vy~a~~~--~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~ 98 (481)
...+.| +.|....+|+.... . +++.+++|+..............+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445778 88999999988753 1 26789999865432000000133668899888884 3 3467788777655
Q ss_pred ---CEEEEEEeccCCCchH
Q 011628 99 ---SKIYFVMEYVRGGELF 114 (481)
Q Consensus 99 ---~~~~lv~Ey~~gg~L~ 114 (481)
+..|+||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999986543
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.23 E-value=5.7e-06 Score=70.74 Aligned_cols=71 Identities=6% Similarity=0.129 Sum_probs=57.2
Q ss_pred ecCCCHHHHHHHHHHHHHHcCcEEEEecc-eEEEEeecCCCcccEEEEEEEEEEcCceEEEEeEecCCCchh
Q 011628 371 VSGAPVSKIITKLEEIAKVVSFTVRKKDC-RVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGE 441 (481)
Q Consensus 371 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~k~~l~~~~~v~~~~~~~~lVe~~~~~Gd~le 441 (481)
-|..++.+|+..|..+++.+|+.|++.+. .|++.....-....+.|.+++|+|.++.+||||++..||+-|
T Consensus 10 rSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 10 RSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 46778999999999999999999998664 488875433222368999999999999999999999999866
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=9.7e-06 Score=70.22 Aligned_cols=72 Identities=6% Similarity=0.132 Sum_probs=57.5
Q ss_pred eecCCCHHHHHHHHHHHHHHcCcEEEEecce-EEEEeecCCCcccEEEEEEEEEEcCceEEEEeEecCCCchh
Q 011628 370 FVSGAPVSKIITKLEEIAKVVSFTVRKKDCR-VSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGE 441 (481)
Q Consensus 370 f~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~k~~l~~~~~v~~~~~~~~lVe~~~~~Gd~le 441 (481)
.-|+..+.+|+..|..+++.+|+.|++.+.. |++.....-....+.|.+++|+|.++.+||||++..||+-|
T Consensus 23 IrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 23 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 3567789999999999999999999986654 88875432122358999999999999999999999999866
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=3.1e-05 Score=76.11 Aligned_cols=134 Identities=15% Similarity=0.157 Sum_probs=77.9
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-----HPNIVQLF-E--VMATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-~--~~~~~~~~~ 102 (481)
.+.|+.|..+.||++.. .+..+++|+..... ..+..|..+++.|. .|.++... + +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 45667778899999875 33458999986521 22334555555543 34444310 0 123467889
Q ss_pred EEEeccCCCchH--------------HHHHc--CCC--C-----------HH--------H-------------------
Q 011628 103 FVMEYVRGGELF--------------NKVAK--GRL--K-----------ED--------L------------------- 126 (481)
Q Consensus 103 lv~Ey~~gg~L~--------------~~i~~--~~l--~-----------e~--------~------------------- 126 (481)
++|||++|..+. ..+.. ..+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999996431 11111 111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------cCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 127 ----ARKYFQQLISAVGFCHA-------------RGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 127 ----~~~~~~ql~~al~yLH~-------------~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
...+..++..++.+|++ .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112223345666652 479999999999999888899999999765
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.3e-05 Score=63.99 Aligned_cols=73 Identities=12% Similarity=0.159 Sum_probs=55.0
Q ss_pred ecCCCHHHHHHHHHHHHHHcCcEEEEec-ceEEEEeecCCCcccEEEEEEEEEEcCceEEEEeEecCCCchhHH
Q 011628 371 VSGAPVSKIITKLEEIAKVVSFTVRKKD-CRVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGEYE 443 (481)
Q Consensus 371 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~k~~l~~~~~v~~~~~~~~lVe~~~~~Gd~le~~ 443 (481)
-|...+.+|+..|..+++.+|+.|++.+ +.|++..........+.|.+++|++.+..+|+||++..||-.|+.
T Consensus 13 rS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~ 86 (130)
T 4eag_A 13 RSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQG 86 (130)
T ss_dssp CCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-------
T ss_pred ecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhcc
Confidence 3567799999999999999999998765 458887544333346889999999999999999999999966543
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=8.1e-06 Score=69.22 Aligned_cols=78 Identities=12% Similarity=0.162 Sum_probs=63.0
Q ss_pred ecCCCHHHHHHHHHHHHHHcCcEEEEe---------cc-eEEEEeecCCC-----cccEEEEEEEEEEcCceEEEEeEec
Q 011628 371 VSGAPVSKIITKLEEIAKVVSFTVRKK---------DC-RVSLEGSREGV-----KGPLTIATEIFELTPKLVVVEVKKK 435 (481)
Q Consensus 371 ~~~~~~~~~~~~l~~~~~~~~~~~~~~---------~~-~~~~~~~~~~~-----k~~l~~~~~v~~~~~~~~lVe~~~~ 435 (481)
-|+.++.+|+..|..+++.+|+.|++. +. .|++....+.. ...+.|.+++|+|.++.+||||+..
T Consensus 18 RSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLlDFk~~ 97 (137)
T 2qrd_A 18 RCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKSN 97 (137)
T ss_dssp EEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEEEE
T ss_pred ccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEEEEEec
Confidence 467789999999999999999999876 43 37776543211 2358899999999999999999999
Q ss_pred CCC---------------c----hhHHHHhhh
Q 011628 436 GGD---------------K----GEYEEFCNK 448 (481)
Q Consensus 436 ~Gd---------------~----le~~~~~~~ 448 (481)
.|+ . .+|-.+|..
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~ 129 (137)
T 2qrd_A 98 GYKDIYSHPERTADHGMDDLKSSFPFLDLCAM 129 (137)
T ss_dssp EEEESCC-------------CCCTTHHHHHHH
T ss_pred CCccccccCccccccCCccccccccHHHHHHH
Confidence 999 5 788888876
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.80 E-value=7.2e-05 Score=76.36 Aligned_cols=80 Identities=16% Similarity=0.096 Sum_probs=45.6
Q ss_pred HHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCC--CCCcchHHHHHHHHH
Q 011628 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY--DAAKVDIWSCGVILF 219 (481)
Q Consensus 142 H~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~ 219 (481)
+...++|+|++|.|||++.++ ++|+||+.+........-...-. .-...|++|+....... .....++.++...+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 345799999999999998876 99999998875332111000000 00134566654421110 011244456777777
Q ss_pred HHhc
Q 011628 220 VLMA 223 (481)
Q Consensus 220 ellt 223 (481)
..+.
T Consensus 308 ~~y~ 311 (420)
T 2pyw_A 308 NLFN 311 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00026 Score=69.36 Aligned_cols=76 Identities=11% Similarity=0.224 Sum_probs=60.3
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEe
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR---HPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~E 106 (481)
-.+.|+.|....+|+... ++..+++|+.... ....+.+|...|+.|. ...+.+++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 357789999999999874 5678889987543 2355778999998884 3567888888888889999999
Q ss_pred ccCCCch
Q 011628 107 YVRGGEL 113 (481)
Q Consensus 107 y~~gg~L 113 (481)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9999754
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00013 Score=63.87 Aligned_cols=77 Identities=12% Similarity=0.149 Sum_probs=61.3
Q ss_pred ecCCCHHHHHHHHHHHHHHcCcEEEEec----ceEEEEeecC---------CCcccEEEEEEEEEEcCceEEEEeEecCC
Q 011628 371 VSGAPVSKIITKLEEIAKVVSFTVRKKD----CRVSLEGSRE---------GVKGPLTIATEIFELTPKLVVVEVKKKGG 437 (481)
Q Consensus 371 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~---------~~k~~l~~~~~v~~~~~~~~lVe~~~~~G 437 (481)
-|...+.+|+..|..+++.+|+.|++.+ +.|++....+ +....+.|.+++|++.++.+||||+ ..|
T Consensus 56 rS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDfk-~~G 134 (179)
T 3t4n_A 56 RSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK-FDG 134 (179)
T ss_dssp EECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEEE-EEE
T ss_pred ccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEEE-ecc
Confidence 5678899999999999999999998763 4478764321 1123489999999999999999999 778
Q ss_pred ----------------------CchhHHHHhhh
Q 011628 438 ----------------------DKGEYEEFCNK 448 (481)
Q Consensus 438 ----------------------d~le~~~~~~~ 448 (481)
.+..|-.+|.+
T Consensus 135 ~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~ 167 (179)
T 3t4n_A 135 WESSYGDDTTVSNISEDEMSTFSAYPFLHLTTK 167 (179)
T ss_dssp EECC----------------CCCCHHHHHHHHH
T ss_pred ccccccccccccccccccccccCCccHHHHHHH
Confidence 66778888876
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00012 Score=71.06 Aligned_cols=131 Identities=15% Similarity=0.172 Sum_probs=76.4
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecc-
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYFVMEYV- 108 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~- 108 (481)
.+.|+.|....+|++ +.+++|+....... .....+|+.+++.+...++ .+++.. ..+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 788999999999998 56889987643211 1123468888887753333 455544 333347899999
Q ss_pred CCCchHH---------------HH---HcCC--CC-----HHHHHHHHHH--------------HHHHHHHHH-------
Q 011628 109 RGGELFN---------------KV---AKGR--LK-----EDLARKYFQQ--------------LISAVGFCH------- 142 (481)
Q Consensus 109 ~gg~L~~---------------~i---~~~~--l~-----e~~~~~~~~q--------------l~~al~yLH------- 142 (481)
+|.+|.. .+ .... ++ ...+..+..+ +...+..+.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6654421 01 1100 11 1122222111 111122221
Q ss_pred -HcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 143 -ARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 143 -~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
...++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 124899999999999 6677899999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00022 Score=70.17 Aligned_cols=134 Identities=12% Similarity=0.170 Sum_probs=71.2
Q ss_pred eEecccCceE-EEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAK-VYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP--NIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~-Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.|+.|+... +|+... .+|+.+++|....... ..+..|+.+++.+... .+.+++.+....+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 4565555544 566642 2367787876543210 1234677777777422 2456666543333 7899999
Q ss_pred CCCchHHHHHcCC---------------------------CCHHHHH-------HHH-------------HHHHHHHHHH
Q 011628 109 RGGELFNKVAKGR---------------------------LKEDLAR-------KYF-------------QQLISAVGFC 141 (481)
Q Consensus 109 ~gg~L~~~i~~~~---------------------------l~e~~~~-------~~~-------------~ql~~al~yL 141 (481)
.|..+.+.+.... ++..... .++ ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 7766654332110 1121110 000 0111122222
Q ss_pred ------HHcCceecCCCCCcEEEccC----CCEEEEecCCccc
Q 011628 142 ------HARGVYHRDLKPENLLLDEN----GDLKVSDFGLSAV 174 (481)
Q Consensus 142 ------H~~gi~HrDLKp~NILl~~~----g~lkl~DFGla~~ 174 (481)
+...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 12469999999999999875 6799999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00087 Score=61.48 Aligned_cols=120 Identities=19% Similarity=0.171 Sum_probs=80.1
Q ss_pred chHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccC
Q 011628 112 ELFNKVAK--GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188 (481)
Q Consensus 112 ~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 188 (481)
+|.+.+.. ++++|+++|.+..|.+.+|.-+-. +.-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 78898874 689999999999999999876521 2222344567999999999988763 2111 1
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhccc
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 265 (481)
....+.|||... ...+.+.=|||||+++|.-+--.+| ...+..+|+.+.+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 233466888763 2224678999999999987753333 122445899999999999866
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0005 Score=67.09 Aligned_cols=138 Identities=12% Similarity=0.150 Sum_probs=77.6
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-----HPNIVQLF-E--VMATKSK 100 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-~--~~~~~~~ 100 (481)
.-.+.|+.|....+|+... .+| .+++|+..... . ...+..|+.+++.+. -|.++... + +....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 3456788888899999875 333 68899986531 1 123456777777664 23333210 0 1123467
Q ss_pred EEEEEeccCCCchH-----------H---HHHc--CCC--------CHHHHHHHH---------------HHHHHHHHHH
Q 011628 101 IYFVMEYVRGGELF-----------N---KVAK--GRL--------KEDLARKYF---------------QQLISAVGFC 141 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~-----------~---~i~~--~~l--------~e~~~~~~~---------------~ql~~al~yL 141 (481)
.+++|+|++|..+. . .+.. ..+ ....-...+ ..+...++++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 89999999986431 0 1111 011 101000000 1133445555
Q ss_pred HH-------cCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 142 HA-------RGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 142 H~-------~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
++ .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 42 469999999999999887656899998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0019 Score=61.97 Aligned_cols=79 Identities=14% Similarity=0.091 Sum_probs=55.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEEeCCEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP---NIVQLFEVMATKSKIY 102 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~~~~~ 102 (481)
.+..-.+.+|.|..+.||+... .+|+.|.+|+........ ...+.+|...|+.|.-. -+.+++.+. . -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence 3456678899999999999985 678999999865443222 23367899999988421 244555442 2 37
Q ss_pred EEEeccCCCc
Q 011628 103 FVMEYVRGGE 112 (481)
Q Consensus 103 lv~Ey~~gg~ 112 (481)
+||||+.++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.001 Score=68.15 Aligned_cols=74 Identities=14% Similarity=0.183 Sum_probs=50.1
Q ss_pred EEeEecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEE
Q 011628 30 IGKLLGHGTFAKVYHARNVK-------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKI 101 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~ 101 (481)
-.+.|+.|-...||++.... +++.+++|+..... . ...+.+|..+++.+...++ .++++.+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678889899999998642 25789999884321 1 1234479999988853344 566665542
Q ss_pred EEEEeccCCCc
Q 011628 102 YFVMEYVRGGE 112 (481)
Q Consensus 102 ~lv~Ey~~gg~ 112 (481)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998744
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00094 Score=67.15 Aligned_cols=136 Identities=17% Similarity=0.165 Sum_probs=82.7
Q ss_pred EeEecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVK-------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 102 (481)
.+.|..|-...+|++.... +++.+.+|+..... .....+.+|..+++.|. +.-..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567778888899987632 35789999863311 12344568999998885 3223566666543 2
Q ss_pred EEEeccCCCchH--------------HHHH---cCC------CC--HHHHHHHHHHHHH-------------------HH
Q 011628 103 FVMEYVRGGELF--------------NKVA---KGR------LK--EDLARKYFQQLIS-------------------AV 138 (481)
Q Consensus 103 lv~Ey~~gg~L~--------------~~i~---~~~------l~--e~~~~~~~~ql~~-------------------al 138 (481)
+||||++|..|. +.+. .-. .. ...+.+|+.|+-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999986542 1111 111 11 3456666655532 23
Q ss_pred HHHHH--------cCceecCCCCCcEEEccC----CCEEEEecCCccc
Q 011628 139 GFCHA--------RGVYHRDLKPENLLLDEN----GDLKVSDFGLSAV 174 (481)
Q Consensus 139 ~yLH~--------~gi~HrDLKp~NILl~~~----g~lkl~DFGla~~ 174 (481)
..|.+ ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33322 258999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0018 Score=63.20 Aligned_cols=75 Identities=13% Similarity=0.201 Sum_probs=47.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE-----EEeCCEEEEE
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEV-----MATKSKIYFV 104 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~-----~~~~~~~~lv 104 (481)
..|+ |....||++.. .+|+.+++|+...... . ...+..|..+++.+...+ +.+++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 77889998754 4566899999864321 1 234567888887774212 3333332 2235677899
Q ss_pred EeccCCCc
Q 011628 105 MEYVRGGE 112 (481)
Q Consensus 105 ~Ey~~gg~ 112 (481)
|+|++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99999854
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00097 Score=66.56 Aligned_cols=74 Identities=12% Similarity=0.146 Sum_probs=45.0
Q ss_pred EeEecccCceEEEEEEEcC--------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 011628 31 GKLLGHGTFAKVYHARNVK--------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN-IVQLFEVMATKSKI 101 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~ 101 (481)
.+.|+.|....+|++.... .++.+++|+...... . .....+|..+++.+...+ +.++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 5677888888999997642 136889998754321 1 112357888888885334 34666544 22
Q ss_pred EEEEeccCCCc
Q 011628 102 YFVMEYVRGGE 112 (481)
Q Consensus 102 ~lv~Ey~~gg~ 112 (481)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999999854
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0035 Score=64.67 Aligned_cols=75 Identities=13% Similarity=0.239 Sum_probs=49.0
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~ 109 (481)
.+.|+.|-...+|++.....+..+++|+..... .... ...+|..+++.|...++ .++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 567888888999999874445789999875421 1111 12579999999975555 46776663 2 24999999
Q ss_pred CCch
Q 011628 110 GGEL 113 (481)
Q Consensus 110 gg~L 113 (481)
|..|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0049 Score=60.78 Aligned_cols=32 Identities=16% Similarity=0.343 Sum_probs=28.2
Q ss_pred cCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 144 ~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
.+++|+|+.|.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998889999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.50 E-value=0.029 Score=57.06 Aligned_cols=75 Identities=15% Similarity=0.202 Sum_probs=48.6
Q ss_pred EeEecccCceEEEEEEEcCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKS-------GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN-IVQLFEVMATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~ 102 (481)
.+.|..|-...+|+...... ++.+++|+..... .. .-...+|..+++.+.-.+ ..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 46677788889999986421 5789999864422 11 112357899888885323 34555533 22 7
Q ss_pred EEEeccCCCch
Q 011628 103 FVMEYVRGGEL 113 (481)
Q Consensus 103 lv~Ey~~gg~L 113 (481)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999999653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.72 E-value=0.2 Score=50.35 Aligned_cols=29 Identities=34% Similarity=0.506 Sum_probs=25.2
Q ss_pred ceecCCCCCcEEE------ccCCCEEEEecCCccc
Q 011628 146 VYHRDLKPENLLL------DENGDLKVSDFGLSAV 174 (481)
Q Consensus 146 i~HrDLKp~NILl------~~~g~lkl~DFGla~~ 174 (481)
++|+|+.+.|||+ +.++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999999875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.23 E-value=3.2 Score=37.78 Aligned_cols=114 Identities=15% Similarity=0.156 Sum_probs=80.0
Q ss_pred CCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHHcCceecCCCCCcEEEccCC
Q 011628 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVG-FCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 84 ~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~-yLH~~gi~HrDLKp~NILl~~~g 162 (481)
.||+. -..+-.+.+.+.+.++.-+++.-+..++. ++..+.++++.+|+.... ++ ..-+|--|+|+||+++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~--~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK--TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT--SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh--cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence 57888 45566788888888887766655555543 788889999998888666 44 4456677999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHH-HHHHHHHHHhcCCCCCC
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW-SCGVILFVLMAGYLPFQ 229 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~Diw-SlGvil~elltg~~Pf~ 229 (481)
.++|.-.|+-. -++|.-+ ...|.| +.=|++..++.++..|.
T Consensus 122 ~p~i~hRGi~~-------------------~lpP~e~-------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 122 EPFFLHVGVKE-------------------SLPPDEW-------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CEEESCCEETT-------------------TBSSCSC-------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred cEEEEEcCCcc-------------------cCCCCCC-------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99997666421 2333221 234444 36778888888877763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.76 E-value=0.078 Score=54.54 Aligned_cols=64 Identities=9% Similarity=0.168 Sum_probs=18.2
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEE------EEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAI------KVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAv------K~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
.+.+.|| ||.||+|........||+ |....... ..+....+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 3445566 999999998665568888 65543222 2223345678999999999999999988764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.71 E-value=2.2 Score=38.75 Aligned_cols=115 Identities=13% Similarity=0.249 Sum_probs=79.7
Q ss_pred CCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC
Q 011628 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD 163 (481)
Q Consensus 84 ~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~ 163 (481)
.||+.+.. .+-.+.+.+.+.++.-+.+.=+..+.+ ++....++++.+|+....++ ..-+|--|+|+||+++.++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~--~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~~ 117 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS--FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDGL 117 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG--SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTSC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh--cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCCC
Confidence 58988876 677777877777776654433444443 68888999999998877444 44567779999999999999
Q ss_pred EEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHH-HHHHHHHHHhcCCCCCC
Q 011628 164 LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIW-SCGVILFVLMAGYLPFQ 229 (481)
Q Consensus 164 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~Diw-SlGvil~elltg~~Pf~ 229 (481)
+++.-.|+-. -++|. .....|.| ..=|++..+++++..|.
T Consensus 118 p~i~~RGik~-------------------~l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 118 PIAKTRGLQN-------------------VVDPL-------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEESCCEETT-------------------TBSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEEEccCcc-------------------CCCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9997666422 12232 11234444 36788888999988863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 481 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-92 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-91 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-91 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-86 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-85 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-84 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-84 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-83 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-83 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-82 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-81 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-80 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-80 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-79 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-78 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-78 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-78 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-77 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-77 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-77 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-75 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-74 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-74 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-73 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-72 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-69 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-69 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-68 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-67 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-67 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-67 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-67 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-66 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-65 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-65 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-64 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-63 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-60 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-60 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-59 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-58 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-53 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-46 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-25 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 2e-06 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 279 bits (715), Expect = 2e-92
Identities = 90/261 (34%), Positives = 150/261 (57%), Gaps = 6/261 (2%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
L +EIG+ LG G F VY AR +S +A+KV+ K ++ K+G+ ++RE+ I +R
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA 143
HPNI++L+ +++Y ++EY G ++ ++ K + E Y +L +A+ +CH+
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
+ V HRD+KPENLLL G+LK++DFG S + T CGT Y+ PE++ +
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRM 180
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
+D KVD+WS GV+ + + G PF+ YK+I + EF P + + L+++LL
Sbjct: 181 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 264 DTNPDKRITIPEIMENRWFRK 284
NP +R + E++E+ W
Sbjct: 240 KHNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (708), Expect = 2e-91
Identities = 98/269 (36%), Positives = 158/269 (58%), Gaps = 6/269 (2%)
Query: 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRR 82
P + +++ + LG G + +V A N + E+VA+K++D ++ + +IK+EI I +
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKM 59
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFC 141
+ H N+V+ + + Y +EY GGELF+++ + E A+++F QL++ V +
Sbjct: 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
H G+ HRD+KPENLLLDE +LK+SDFGL+ V ++ L + CGT YVAPE+L R
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPF-QDQNIMVMYKKIYKGEFRSPRW--FSPDLIRL 258
+ + A VD+WSCG++L ++AG LP+ Q + Y + + W + L
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 259 LTKLLDTNPDKRITIPEIMENRWFRKGFK 287
L K+L NP RITIP+I ++RW+ K K
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 277 bits (709), Expect = 4e-91
Identities = 87/259 (33%), Positives = 146/259 (56%), Gaps = 2/259 (0%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
++ GK+LG G+F+ V AR + + AIK+++K I+K V ++ RE ++ R+ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARG 145
V+L+ K+YF + Y + GEL + K G E R Y +++SA+ + H +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+ HRDLKPEN+LL+E+ ++++DFG + V + ++F GT YV+PE+L+ K
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265
D+W+ G I++ L+AG PF+ N ++++KI K E+ P F P L+ KLL
Sbjct: 189 -KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 266 NPDKRITIPEIMENRWFRK 284
+ KR+ E+ +
Sbjct: 248 DATKRLGCEEMEGYGPLKA 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 264 bits (677), Expect = 2e-86
Identities = 77/262 (29%), Positives = 138/262 (52%), Gaps = 9/262 (3%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
+Y + +G G VY A +V +G+ VAI+ ++ ++ K I EI ++R ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKN 76
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARG 145
PNIV + +++ VMEY+ GG L + V + + E ++ + A+ F H+
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
V HRD+K +N+LL +G +K++DFG A + T GTP ++APEV++RK Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLLTKL 262
KVDIWS G++ ++ G P+ ++N + I E ++P S L +
Sbjct: 195 -PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 263 LDTNPDKRITIPEIMENRWFRK 284
LD + +KR + E++++++ +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKI 275
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 263 bits (673), Expect = 6e-85
Identities = 77/340 (22%), Positives = 152/340 (44%), Gaps = 26/340 (7%)
Query: 18 DQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI 77
+ Q + Y+I + LG G F V+ +G K I+ L +K EI
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEI 77
Query: 78 SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLI 135
SI+ ++ HP ++ L + K ++ ++E++ GGELF+++A ++ E Y +Q
Sbjct: 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 136 SAVGFCHARGVYHRDLKPENLLLD--ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAY 193
+ H + H D+KPEN++ + + +K+ DFGL+ ++ D + T +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEF 194
Query: 194 VAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR---- 249
APE++ R+ D+W+ GV+ +VL++G PF ++ + + + + ++
Sbjct: 195 AAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDD 309
SP+ + LL P KR+T+ + +E+ W + ++ I + +
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRY---------NK 304
Query: 310 VGPCSDDHSLSEPEPEPELETKRKLTSL--PRPASLNAFD 347
+ + P P+P + +SL RP +D
Sbjct: 305 IRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYD 344
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 259 bits (664), Expect = 3e-84
Identities = 72/263 (27%), Positives = 123/263 (46%), Gaps = 11/263 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+ + +GHG+F VY AR+V++ E VAIK + + I +E+ L+++RHP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELF-NKVAKGRLKEDLARKYFQQLISAVGFCHARG 145
N +Q + + VMEY G +V K L+E + + + H+
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL--SRKG 203
+ HRD+K N+LL E G +K+ DFG +++ ++F GTP ++APEV+ +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEG 189
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW--FSPDLIRLLTK 261
KVD+WS G+ L P + N M I + E + + +S +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 262 LLDTNPDKRITIPEIMENRWFRK 284
L P R T ++++R+ +
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (661), Expect = 5e-84
Identities = 86/282 (30%), Positives = 138/282 (48%), Gaps = 17/282 (6%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+EI LG G F KVY A+N ++ A KVID + + EI IL HP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHP 69
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHAR 144
NIV+L + ++ ++ ++E+ GG + + + L E + +Q + A+ + H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL----- 199
+ HRDLK N+L +GD+K++DFG+SA + R +F GTP ++APEV+
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLI 256
+ YD K D+WS G+ L + P + N M + KI K E P +S +
Sbjct: 188 KDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246
Query: 257 RLLTKLLDTNPDKRITIPEIMENRWFRKGF-KHIKFYIEDDK 297
L K L+ N D R T +++++ + K I+ I + K
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAK 288
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 260 bits (665), Expect = 1e-83
Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 15/270 (5%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
+L Y+I + LG G F V+ +G + A K + +++EI + +
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVL 80
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFC 141
RHP +V L + +++ + E++ GGELF KVA ++ ED A +Y +Q+ +
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 142 HARGVYHRDLKPENLLL--DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
H H DLKPEN++ + +LK+ DFGL+A + GT + APEV
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVA 197
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSPDL 255
K D+WS GV+ ++L++G PF +N + + ++ S D
Sbjct: 198 EGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285
+ KLL +P+ R+TI + +E+ W G
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 256 bits (656), Expect = 6e-83
Identities = 101/266 (37%), Positives = 156/266 (58%), Gaps = 14/266 (5%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
Y+ +LG G F++V A + ++ + VAIK I K+ + G ++ EI++L +++HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHP 67
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARG 145
NIV L ++ + +Y +M+ V GGELF+++ KG E A + Q++ AV + H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 146 VYHRDLKPENLLL---DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
+ HRDLKPENLL DE+ + +SDFGLS + D + T CGTP YVAPEVL++K
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---PGSVLSTACGTPGYVAPEVLAQK 184
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRW--FSPDLIRL 258
Y VD WS GVI ++L+ GY PF D+N ++++I K E F SP W S
Sbjct: 185 PYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 259 LTKLLDTNPDKRITIPEIMENRWFRK 284
+ L++ +P+KR T + +++ W
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAG 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (650), Expect = 1e-82
Identities = 84/267 (31%), Positives = 141/267 (52%), Gaps = 17/267 (6%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
YE+ +G G++ + R G+ + K +D + ++ + E+++LR ++HPN
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHPN 64
Query: 88 IVQLFEVM--ATKSKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGF 140
IV+ ++ + T + +Y VMEY GG+L + + K L E+ + QL A+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 141 CHARG-----VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195
CH R V HRDLKP N+ LD ++K+ DFGL+ + + F GTP Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMS 182
Query: 196 PEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-PRWFSPD 254
PE ++R Y+ K DIWS G +L+ L A PF + + KI +G+FR P +S +
Sbjct: 183 PEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRW 281
L ++T++L+ R ++ EI+EN
Sbjct: 242 LNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 249 bits (638), Expect = 9e-81
Identities = 90/275 (32%), Positives = 145/275 (52%), Gaps = 20/275 (7%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS------GLVAHIKREISIL 80
YE ++LG G + V + + + A+K+ID L +E+ IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 81 RRVR-HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAV 138
R+V HPNI+QL + T + + V + ++ GELF+ + K L E RK + L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 198
H + HRDLKPEN+LLD++ ++K++DFG S Q+ CGTP+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 199 LSRKGYDA-----AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRW- 250
+ D +VD+WS GVI++ L+AG PF + M+M + I G +F SP W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 251 -FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
+S + L+++ L P KR T E + + +F++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 2e-80
Identities = 87/261 (33%), Positives = 144/261 (55%), Gaps = 6/261 (2%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RH 85
+ + K+LG G+F KV+ A K+ + AIK + K+ +L V E +L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHAR 144
P + +F TK ++FVMEY+ GG+L + + + A Y ++I + F H++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
G+ +RDLK +N+LLD++G +K++DFG+ + + D +TFCGTP Y+APE+L + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264
+ VD WS GV+L+ ++ G PF Q+ ++ I PRW + LL KL
Sbjct: 181 NH-SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239
Query: 265 TNPDKRITIP-EIMENRWFRK 284
P+KR+ + +I ++ FR+
Sbjct: 240 REPEKRLGVRGDIRQHPLFRE 260
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 5e-80
Identities = 66/275 (24%), Positives = 125/275 (45%), Gaps = 16/275 (5%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
L +Y I + LG G F V+ S ++ K + + + +K+EISIL
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIA 58
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFC 141
RH NI+ L E + ++ + E++ G ++F ++ L E Y Q+ A+ F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 142 HARGVYHRDLKPENLLLD--ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199
H+ + H D++PEN++ + +K+ +FG + Q++ F P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVH 175
Query: 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFSPDL 255
D+WS G +++VL++G PF + + + I E+ + S +
Sbjct: 176 QHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIK 290
+ + +LL R+T E +++ W ++ + +
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 5e-79
Identities = 80/269 (29%), Positives = 132/269 (49%), Gaps = 18/269 (6%)
Query: 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH---IKREISI 79
PL +Y++G LLG G F VY V VAIK ++K++I G + + + E+ +
Sbjct: 1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 80 LRRVR--HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV--AKGRLKEDLARKYFQQLI 135
L++V +++L + ++E + +G L+E+LAR +F Q++
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 136 SAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV 194
AV CH GV HRD+K EN+L+D N G+LK+ DFG A+ D ++ F GT Y
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYS 176
Query: 195 APEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPD 254
PE + Y +WS G++L+ ++ G +PF+ +I +G+ + S +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 230
Query: 255 LIRLLTKLLDTNPDKRITIPEIMENRWFR 283
L+ L P R T EI + W +
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 246 bits (628), Expect = 1e-78
Identities = 89/263 (33%), Positives = 156/263 (59%), Gaps = 12/263 (4%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
++I + LG G+F +V+ R+ +G A+KV+ KE +++ V H E +L V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLISAVGFCHARGV 146
I++++ +I+ +M+Y+ GGELF+ R +A+ Y ++ A+ + H++ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA 206
+RDLKPEN+LLD+NG +K++DFG + + +T CGTP Y+APEV+S K Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYN- 179
Query: 207 AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTN 266
+D WS G++++ ++AGY PF D N M Y+KI E R P +F+ D+ LL++L+ +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 267 PDKRI-----TIPEIMENRWFRK 284
+R+ ++ + WF++
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (629), Expect = 1e-78
Identities = 109/335 (32%), Positives = 165/335 (49%), Gaps = 11/335 (3%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+ ++ KLLG GTF KV R +G A+K++ KE I+ VAH E +L+ R
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHA 143
HP + L T ++ FVMEY GGELF +++ E+ AR Y +++SA+ + H+
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
R V +RD+K ENL+LD++G +K++DFGL + I TFCGTP Y+APEVL
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 204 YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263
Y VD W GV+++ +M G LPF +Q+ +++ I E R PR SP+ LL LL
Sbjct: 182 YG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 264 DTNPDKRI-----TIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHS 318
+P +R+ E+ME+R+F + V D D+ +
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFF-LSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFT 299
Query: 319 LSEPEPEP-ELETKRKLTSLPRPASLNAFDLISFS 352
P + L L + F+ +
Sbjct: 300 AQSITITPPDRYDSLGLLELDQREEQEMFEDFDYI 334
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 5e-78
Identities = 66/270 (24%), Positives = 133/270 (49%), Gaps = 19/270 (7%)
Query: 26 GRY-EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
GR+ + +G G+F VY + ++ VA + K+ KS K E +L+ ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 66
Query: 85 HPNIVQLFEVMATKSK----IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVG 139
HPNIV+ ++ + K I V E + G L + + +K + R + +Q++ +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 140 FCHARG--VYHRDLKPENLLL-DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP 196
F H R + HRDLK +N+ + G +K+ D GL+ +++ GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEFMAP 182
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRS--PRWFSP 253
E+ K YD VD+++ G+ + + P+ + QN +Y+++ G + + P
Sbjct: 183 EMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFR 283
++ ++ + N D+R +I +++ + +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 1e-77
Identities = 64/263 (24%), Positives = 122/263 (46%), Gaps = 15/263 (5%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
G+ +G+ +G G+F VY + VA+K+++ L K E+ +LR+ RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRH 63
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHA 143
NI+ T ++ V ++ G L++ + + + + +Q + + HA
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
+ + HRDLK N+ L E+ +K+ DFGL+ V + F G+ ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 204 YDA--AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW------FSPDL 255
+ + D+++ G++L+ LM G LP+ + N + + SP +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 256 IRLLTKLLDTNPDKRITIPEIME 278
RL+ + L D+R P+I+
Sbjct: 243 KRLMAECLKKKRDERPLFPQILA 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 2e-77
Identities = 71/304 (23%), Positives = 126/304 (41%), Gaps = 53/304 (17%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+E LG G V+ + SG +A K+I E +K + I RE+ +L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR- 144
IV + + +I ME++ GG L + K GR+ E + K +I + + +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
+ HRD+KP N+L++ G++K+ DFG+S D + ++F GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHY 180
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQN---IMVMYKKIYKGEFRSPRW----------- 250
+ DIWS G+ L + G P + + +M+ +G+
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 251 ------------------------------FSPDLIRLLTKLLDTNPDKRITIPEIMENR 280
FS + + K L NP +R + ++M +
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 281 WFRK 284
+ ++
Sbjct: 300 FIKR 303
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 3e-77
Identities = 84/277 (30%), Positives = 141/277 (50%), Gaps = 16/277 (5%)
Query: 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG---LVAHIKRE 76
Q + Y+ G+ LG G FA V R +G A K I K + S I+RE
Sbjct: 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 77 ISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLI 135
+SIL+ ++HPN++ L EV K+ + ++E V GGELF+ K L E+ A ++ +Q++
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGD----LKVSDFGLSAVSDQIRQDGLFHTFCGTP 191
+ V + H+ + H DLKPEN++L + +K+ DFGL + +I F GTP
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKIDFGNEFKNIFGTP 180
Query: 192 AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF 251
+VAPE+++ + + D+WS GVI ++L++G PF + + +
Sbjct: 181 EFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 252 ----SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
S + +LL +P KR+TI + +++ W +
Sbjct: 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 235 bits (599), Expect = 7e-75
Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 11/270 (4%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
L RYE+G++LG G ++V+ AR+++ VA+KV+ + +RE +
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 84 RHPNIVQLFEVMATKSK----IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAV 138
HP IV +++ ++ Y VMEYV G L + V G + A + A+
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPE 197
F H G+ HRD+KP N+++ +KV DFG++ ++D GT Y++PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSP 253
D A+ D++S G +L+ ++ G PF + + + + + + P S
Sbjct: 185 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFR 283
DL ++ K L NP+ R M R
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 235 bits (599), Expect = 6e-74
Identities = 99/275 (36%), Positives = 153/275 (55%), Gaps = 12/275 (4%)
Query: 16 SKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKR 75
+ L +++ K LG G+F +V ++ +SG A+K++DK+K++K + H
Sbjct: 31 ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 76 EISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQL 134
E IL+ V P +V+L S +Y VMEYV GGE+F+ + + GR E AR Y Q+
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 135 ISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV 194
+ + H+ + +RDLKPENLL+D+ G ++V+DFG + R G T CGTP +
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEAL 205
Query: 195 APEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPD 254
APE++ KGY+ VD W+ GV+++ + AGY PF + +Y+KI G+ R P FS D
Sbjct: 206 APEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264
Query: 255 LIRLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284
L LL LL + KR + +I ++WF
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 235 bits (599), Expect = 9e-74
Identities = 78/271 (28%), Positives = 136/271 (50%), Gaps = 16/271 (5%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKRE---ISILR 81
+ + + +++G G F +VY R +G+ A+K +DK++I E +S++
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGF 140
P IV + T K+ F+++ + GG+L +++ G E R Y ++I +
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLS 200
H R V +RDLKP N+LLDE+G +++SD GL+ + + H GT Y+APEVL
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQ 178
Query: 201 RKGYDAAKVDIWSCGVILFVLMAGYLPFQD---QNIMVMYKKIYKGEFRSPRWFSPDLIR 257
+ + D +S G +LF L+ G+ PF+ ++ + + P FSP+L
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 258 LLTKLLDTNPDKRITIP-----EIMENRWFR 283
LL LL + ++R+ E+ E+ +FR
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 2e-73
Identities = 80/284 (28%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 21 QSPLLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISI 79
++ ++ Y++ ++LG G KV N ++ E A+K++ +RE+ +
Sbjct: 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------ARREVEL 57
Query: 80 LRRV-RHPNIVQLFEV----MATKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYF 131
R + P+IV++ +V A + + VME + GGELF+++ E A +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 132 QQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTP 191
+ + A+ + H+ + HRD+KPENLL + + + T C TP
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177
Query: 192 AYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------EF 245
YVAPEVL + YD D+WS GVI+++L+ GY PF + + + + EF
Sbjct: 178 YYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 246 RSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287
+P W S ++ L+ LL T P +R+TI E M + W + K
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (586), Expect = 4e-72
Identities = 73/298 (24%), Positives = 121/298 (40%), Gaps = 38/298 (12%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
RY +G G + V A + + VAIK I + REI IL R RH
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 86 PNIVQLFEVMATKS----KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
NI+ + +++ + K +++ ++ G +L+ + L D + Q++ + +
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR-QDGLFHTFCGTPAYVAPEVLS 200
H+ V HRDLKP NLLL+ DLK+ DFGL+ V+D G + T Y APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 201 RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI-------------------- 240
+DIWS G IL +++ F ++ + I
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 241 YKGEFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287
P + LL K+L NP KRI + + + + + + +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-69
Identities = 79/286 (27%), Positives = 118/286 (41%), Gaps = 33/286 (11%)
Query: 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI--LKSGLVAHIKREISILRRVRHP 86
E LG G FA VY AR+ + + VAIK I K G+ REI +L+ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARG 145
NI+ L + KS I V +++ L + Y + + + H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
+ HRDLKP NLLLDENG LK++DFGL+ + + T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEFRSPRW------------- 250
VD+W+ G IL L+ + + +I++ G +W
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 251 -------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283
DL+ L+ L NP RIT + ++ ++F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 3e-69
Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 19/258 (7%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
++ + +G G F V G VA+K I + + E S++ ++RH
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 60
Query: 87 NIVQLFEVMA-TKSKIYFVMEYVRGGELFN---KVAKGRLKEDLARKYFQQLISAVGFCH 142
N+VQL V+ K +Y V EY+ G L + + L D K+ + A+ +
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
HRDL N+L+ E+ KVSDFGL+ + + T + APE L K
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 175
Query: 203 GYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLT 260
+ K D+WS G++L+ + + G +P+ + + ++ KG +P P + ++
Sbjct: 176 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 261 KLLDTNPDKRITIPEIME 278
+ R + ++ E
Sbjct: 235 NCWHLDAAMRPSFLQLRE 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-68
Identities = 62/261 (23%), Positives = 107/261 (40%), Gaps = 11/261 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
+ + LG G+F V SVA+K + + + + + RE++ + +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFC 141
H N+++L+ V+ T + V E G L +++ K G +Y Q+ +G+
Sbjct: 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT-FCGTPAYVAPEVLS 200
++ HRDL NLLL +K+ DFGL Q + A+ APE L
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 201 RKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFRSPRW--FSPDLIR 257
+ + D W GV L+ + G P+ N + KI K R PR D+
Sbjct: 188 TRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 258 LLTKLLDTNPDKRITIPEIME 278
++ + P+ R T + +
Sbjct: 247 VMVQCWAHKPEDRPTFVALRD 267
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-67
Identities = 68/303 (22%), Positives = 117/303 (38%), Gaps = 44/303 (14%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+ +YE +G GTF +V+ AR+ K+G+ VA+K + E K G REI IL+ ++
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLK 67
Query: 85 HPNIVQLFEVMAT--------KSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLI 135
H N+V L E+ T K IY V ++ + ++ Q L+
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD--GLFHTFCGTPAY 193
+ + + H + HRD+K N+L+ +G LK++DFGL+ + + T Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 194 VAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR---- 249
PE+L + +D+W G I+ + Q I +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 250 ----------------------------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281
P + L+ KLL +P +RI + + + +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 282 FRK 284
F
Sbjct: 308 FWS 310
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 215 bits (549), Expect = 2e-67
Identities = 87/288 (30%), Positives = 143/288 (49%), Gaps = 34/288 (11%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+Y + +G GT+ VY A+N GE+ A+K I EK G+ + REISIL+ ++H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLISAVGFCHARG 145
NIV+L++V+ TK ++ V E++ V +G L+ A+ + QL++ + +CH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
V HRDLKP+NLL++ G+LK++DFGL+ + T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 206 AAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEFRSPRW------------- 250
+ +DIWS G I ++ G F + +I++ G S W
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 251 --------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
I LL+K+L +P++RIT + +E+ +F++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-67
Identities = 90/362 (24%), Positives = 150/362 (41%), Gaps = 63/362 (17%)
Query: 10 TSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGL 69
T+ ++ P Y K++G+G+F VY A+ SGE VAIK + ++K K
Sbjct: 4 TTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--- 60
Query: 70 VAHIKREISILRRVRHPNIVQLFEVMATKSK------IYFVMEYVRGGEL----FNKVAK 119
RE+ I+R++ H NIV+L + + + V++YV AK
Sbjct: 61 ----NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 120 GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQI 178
L + Y QL ++ + H+ G+ HRD+KP+NLLLD + LK+ DFG + Q+
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QL 173
Query: 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK 238
+ ++ + Y APE++ + +D+WS G +L L+ G F + +
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 239 KIYK-----------------GEFRSPRW------------FSPDLIRLLTKLLDTNPDK 269
+I K EF+ P+ P+ I L ++LL+ P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 270 RITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHSLSEPEPEPELE 329
R+T E + +F + + K+ N D + LS P L
Sbjct: 294 RLTPLEACAHSFFD------ELRDPNVKLPNGRDTPALFNF----TTQELSS---NPPLA 340
Query: 330 TK 331
T
Sbjct: 341 TI 342
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 8e-67
Identities = 83/289 (28%), Positives = 140/289 (48%), Gaps = 34/289 (11%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
++ + +G GT+ VY ARN +GE VA+K I + G+ + REIS+L+ + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHP 61
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR 144
NIV+L +V+ T++K+Y V E++ + + A + L + Y QL+ + FCH+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
V HRDLKP+NLL++ G +K++DFGL+ + T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 205 DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------EFR 246
+ VDIWS G I ++ F + + +I++ +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 247 SPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
P+W D LL+++L +P+KRI+ + + +F+
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 1e-66
Identities = 60/285 (21%), Positives = 112/285 (39%), Gaps = 36/285 (12%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGES-----VAIKVIDKEKILKSGLVAHIKREISILR 81
E GK+LG G F KV +A ++ VA+K++ ++ S + E+ ++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 82 RV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--------------------- 119
++ H NIV L IY + EY G+L N +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 120 ---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176
L + + Q+ + F + HRDL N+L+ +K+ DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMV 235
+ ++APE L Y K D+WS G++L+ + + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 236 MYKKIYKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ K+ + F+ P + + ++ ++ + KR + P +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-66
Identities = 60/256 (23%), Positives = 111/256 (43%), Gaps = 11/256 (4%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN 87
K LG G F V + + + VAIK+I + + + E ++ + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED----EFIEEAKVMMNLSHEK 60
Query: 88 IVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFCHARG 145
+VQL+ V + I+ + EY+ G L N + + R + + + + A+ + ++
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD 205
HRDL N L+++ G +KVSDFGLS + + PEVL +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 206 AAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLL 263
+K DIW+ GV+++ + + G +P++ + I +G P S + ++
Sbjct: 180 -SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 264 DTNPDKRITIPEIMEN 279
D+R T ++ N
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-65
Identities = 55/253 (21%), Positives = 103/253 (40%), Gaps = 9/253 (3%)
Query: 32 KLLGHGTFAKVYHA--RNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV 89
K LG G F V + K ++VA+K++ E L + E ++++++ +P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 90 QLFEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYH 148
++ + VME G L + + +K+ + Q+ + + H
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 149 RDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAA 207
RDL N+LL K+SDFGLS A+ + APE ++ + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189
Query: 208 KVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDT 265
K D+WS GV+++ + G P++ + + KGE P ++ L+
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 266 NPDKRITIPEIME 278
+ + R +
Sbjct: 250 DVENRPGFAAVEL 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-65
Identities = 60/260 (23%), Positives = 104/260 (40%), Gaps = 12/260 (4%)
Query: 27 RYEIGKL-LGHGTFAKVYHA--RNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
I + LG G F V R K VAIKV+ + + + RE I+ ++
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL 66
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFN--KVAKGRLKEDLARKYFQQLISAVGFC 141
+P IV+L V + VME GG L + + + Q+ + +
Sbjct: 67 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLS-AVSDQIRQDGLFHTFCGTPAYVAPEVLS 200
+ HRDL N+LL K+SDFGLS A+ + APE ++
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 201 RKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258
+ + ++ D+WS GV ++ ++ G P++ + I +G+ P P+L L
Sbjct: 186 FRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244
Query: 259 LTKLLDTNPDKRITIPEIME 278
++ + R + +
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQ 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (536), Expect = 3e-65
Identities = 57/264 (21%), Positives = 109/264 (41%), Gaps = 13/264 (4%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGLVAHIKREISILR 81
+ +I +++G G F +V G+ VAIK + K E SI+
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMG 82
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVG 139
+ HPN++ L V+ + + + E++ G L F + G+ + + + +
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 140 FCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT---FCGTPAYVAP 196
+ HRDL N+L++ N KVSDFGLS + D + + + AP
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 197 EVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPD 254
E + + + + D+WS G++++ +M+ G P+ D + I + P
Sbjct: 203 EAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261
Query: 255 LIRLLTKLLDTNPDKRITIPEIME 278
L +L+ + + R +I+
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 4e-65
Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 44/298 (14%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
+ Y + +G G + V A + ++G VAIK + + RE+ +L+ +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM 74
Query: 84 RHPNIVQLFEVMATKSK------IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
RH N++ L +V Y VM ++ G +L + +L ED + Q++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKG 133
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
+ + HA G+ HRDLKP NL ++E+ +LK+ DFGL+ +D + T Y APE
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPE 188
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF------ 251
V+ VDIWS G I+ ++ G F+ + + K+I K P F
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 252 -------------------------SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
SP + LL K+L + ++R+T E + + +F
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 9e-65
Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
RY+ +G G + V A + K+G VA+K + + RE+ +L+ ++H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 87 NIVQLFEVMATKSKI-----YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
N++ L +V + +++ ++ G +L N V +L +D + Q++ + +
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
H+ + HRDLKP NL ++E+ +LK+ DFGL+ +D + T Y APE++
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN 192
Query: 202 KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF---------- 251
+ VDIWS G I+ L+ G F + + K I +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 252 ---------------------SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
+P + LL K+L + DKRIT + + + +F +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-64
Identities = 58/256 (22%), Positives = 111/256 (43%), Gaps = 11/256 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+ +G G F V+ + + VAIK I + + + E ++ ++ HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEE----DFIEEAEVMMKLSHP 60
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGEL--FNKVAKGRLKEDLARKYFQQLISAVGFCHAR 144
+VQL+ V ++ I V E++ G L + + +G + + + +
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 145 GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY 204
V HRDL N L+ EN +KVSDFG++ Q + +PEV S Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 205 DAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKL 262
+K D+WS GV+++ + + G +P+++++ + + I G PR S + +++
Sbjct: 180 S-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 263 LDTNPDKRITIPEIME 278
P+ R ++
Sbjct: 239 WKERPEDRPAFSRLLR 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (531), Expect = 1e-64
Identities = 61/257 (23%), Positives = 113/257 (43%), Gaps = 11/257 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
+ LG G + +VY K +VA+K + ++ + V +E ++++ ++HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFN---KVAKGRLKEDLARKYFQQLISAVGFCHA 143
N+VQL V + Y + E++ G L + + + + + Q+ SA+ +
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
+ HRDL N L+ EN +KV+DFGLS + + APE L+
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 204 YDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTK 261
+ K D+W+ GV+L+ + G P+ ++ +Y+ + K P + L+
Sbjct: 193 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 262 LLDTNPDKRITIPEIME 278
NP R + EI +
Sbjct: 252 CWQWNPSDRPSFAEIHQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-64
Identities = 62/306 (20%), Positives = 122/306 (39%), Gaps = 8/306 (2%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKE--KILKSGLVAHIKREISILRRVRH 85
++ K+LG G F VY + GE V I V KE + I E ++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK--EDLARKYFQQLISAVGFCHA 143
P++ +L + T S + + + + G L + V + + + Q+ + +
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
R + HRDL N+L+ +K++DFGL+ + ++ ++A E + +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 204 YDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261
Y + D+WS GV ++ LM G P+ + + KGE P + D+ ++ K
Sbjct: 190 YT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 262 LLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKMCNVEDVDHTDDVGPCSDDHSLSE 321
+ D R E++ I+ D+ ++ ++ D+ + +
Sbjct: 249 CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDD 308
Query: 322 PEPEPE 327
E
Sbjct: 309 VVDADE 314
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-64
Identities = 78/275 (28%), Positives = 135/275 (49%), Gaps = 15/275 (5%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISIL 80
+ +E+ K+LG G + KV+ R + +G+ A+KV+ K I+ K+ H + E +L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 81 RRVRH-PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG-RLKEDLARKYFQQLISAV 138
+R P +V L T++K++ +++Y+ GGELF +++ R E + Y +++ A+
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 139 GFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 198
H G+ +RD+K EN+LLD NG + ++DFGLS + + V
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 199 LSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKGEFRSPRWFSPD 254
VD WS GV+++ L+ G PF + ++I K E P+ S
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 255 LIRLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284
L+ +LL +P KR+ EI E+ +F+K
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 6e-64
Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 21/278 (7%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGES---VAIKVIDKEKILKSGLVAHIKREISILRRV 83
R E+G+ +G G F V+ + VAIK + +E +R+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65
Query: 84 RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFC 141
HP+IV+L V+ T++ ++ +ME GEL + + L Y QL +A+ +
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSR 201
++ HRD+ N+L+ N +K+ DFGLS + ++APE ++
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 183
Query: 202 KGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259
+ + + D+W GV ++ +LM G PFQ + +I GE P P L L+
Sbjct: 184 RRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242
Query: 260 TKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDK 297
TK +P +R E+ + +E++K
Sbjct: 243 TKCWAYDPSRRPRFTELK---------AQLSTILEEEK 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-63
Identities = 79/291 (27%), Positives = 137/291 (47%), Gaps = 34/291 (11%)
Query: 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR 84
+ +YE + +G GT+ V+ A+N ++ E VA+K + + G+ + REI +L+ ++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 85 HPNIVQLFEVMATKSKIYFVMEYVRGGEL-FNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
H NIV+L +V+ + K+ V E+ + G L ++ + + QL+ +GFCH+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
R V HRDLKP+NLL++ NG+LK+++FGL+ + T Y P+VL
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 204 YDAAKVDIWSCGVILFVLMAGYLP-FQDQNIMVMYKKIYK--GEFRSPRW---------- 250
+ +D+WS G I L P F ++ K+I++ G +W
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 251 -----------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284
+ LL LL NP +RI+ E +++ +F
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-63
Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 43/295 (14%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKS-GESVAIKVIDKEKILKSGLVAHIKREISILRR--- 82
+YE +G G + KV+ AR++K+ G VA+K + + + G+ RE+++LR
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLET 66
Query: 83 VRHPNIVQLFEVMAT-----KSKIYFVMEYVRGG--ELFNKVAKGRLKEDLARKYFQQLI 135
HPN+V+LF+V ++K+ V E+V +KV + + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 136 SAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195
+ F H+ V HRDLKP+N+L+ +G +K++DFGL+ + + T Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRA 183
Query: 196 PEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---------- 245
PEVL + Y VD+WS G I + F+ + + KI
Sbjct: 184 PEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 246 -----------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283
+ LL K L NP KRI+ + + +F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-63
Identities = 53/257 (20%), Positives = 112/257 (43%), Gaps = 13/257 (5%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP 86
++ + LG G F +V+ VA+K + + + E +++++++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQ 68
Query: 87 NIVQLFEVMATKSKIYFVMEYVRGGELFN---KVAKGRLKEDLARKYFQQLISAVGFCHA 143
+V+L+ V+ T+ IY + EY+ G L + + +L + Q+ + F
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG 203
R HRDL+ N+L+ + K++DFGL+ + + + + APE ++
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 204 YDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTK 261
+ K D+WS G++L ++ G +P+ + + + +G P +L +L+
Sbjct: 187 FT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 262 LLDTNPDKRITIPEIME 278
P+ R T +
Sbjct: 246 CWKERPEDRPTFDYLRS 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 3e-63
Identities = 62/273 (22%), Positives = 111/273 (40%), Gaps = 14/273 (5%)
Query: 11 STTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLV 70
T +KD + P + LG G F +V+ VAIK + +
Sbjct: 3 QTQGLAKDAWEIPR-ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPE--- 57
Query: 71 AHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK---EDLA 127
+E +++++RH +VQL+ V+ ++ IY V EY+ G L + + K
Sbjct: 58 -AFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 115
Query: 128 RKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187
Q+ S + + HRDL+ N+L+ EN KV+DFGL+ + + +
Sbjct: 116 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGA 174
Query: 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKG-EF 245
+ APE + K D+WS G++L + G +P+ + ++ +G
Sbjct: 175 KFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 233
Query: 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
P L L+ + P++R T +
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-62
Identities = 55/272 (20%), Positives = 104/272 (38%), Gaps = 24/272 (8%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RH 85
+ ++G G F +V AR K G + + ++ E+ +L ++ H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 86 PNIVQLFEVMATKSKIYFVMEYVRGGELFN-----------------KVAKGRLKEDLAR 128
PNI+ L + +Y +EY G L + L
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 129 KYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188
+ + + + + HRDL N+L+ EN K++DFGLS + +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGR 187
Query: 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKIYKGE-FR 246
++A E L+ Y D+WS GV+L+ ++ G P+ +Y+K+ +G
Sbjct: 188 LPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
P ++ L+ + P +R + +I+
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 2e-61
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 35/284 (12%)
Query: 27 RYEIGKLLGHGTFAKVYHAR-----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILR 81
E + +G G F +V+ AR + VA+K++ +E + + A +RE +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFN-------------------------K 116
+PNIV+L V A + + EY+ G+L
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 117 VAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176
L +Q+ + + + R HRDL N L+ EN +K++DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYL-PFQDQNIMV 235
++ PE + Y + D+W+ GV+L+ + + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 236 MYKKIYKGEFRS-PRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ + G + P +L L+ P R + I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 201 bits (511), Expect = 3e-61
Identities = 73/299 (24%), Positives = 129/299 (43%), Gaps = 53/299 (17%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-H 85
Y++ + LG G +++V+ A N+ + E V +K++ K IKREI IL +R
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGG 89
Query: 86 PNIVQLFEVMATKSK--IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA 143
PNI+ L +++ V E+V + L + R Y +++ A+ +CH+
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHS 147
Query: 144 RGVYHRDLKPENLLLD-ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202
G+ HRD+KP N+++D E+ L++ D+GL ++ ++ + + PE+L
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGL---AEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 203 GYDAAKVDIWSCGVILFVLMAGYLPF------QDQNIMV--------MYKKIYKGEFRSP 248
+D+WS G +L ++ PF DQ + + +Y I K
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 249 RWF------------------------SPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283
F SP+ + L KLL + R+T E ME+ +F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-60
Identities = 64/280 (22%), Positives = 107/280 (38%), Gaps = 31/280 (11%)
Query: 27 RYEIGKLLGHGTFAKVYHAR-----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILR 81
R GK LG G F KV A + +VA+K++ L + E+ +L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLS 81
Query: 82 RV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK-------------------GR 121
+ H NIV L + EY G+L N + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 122 LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181
L + + Q+ + F ++ HRDL N+LL K+ DFGL+
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKI 240
+ ++APE + + D+WS G+ L+ L + G P+ + + K+
Sbjct: 202 VVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 241 YKGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
K FR SP ++ ++ D +P KR T +I++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 4e-60
Identities = 56/283 (19%), Positives = 104/283 (36%), Gaps = 27/283 (9%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
RY +G+ +G G+F +Y ++ +GE VAIK+ + + E I + ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQG 61
Query: 86 PNIVQLFE-VMATKSKIYFVMEYVRGGELF-NKVAKGRLKEDLARKYFQQLISAVGFCHA 143
+ A VME + + Q+IS + + H+
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 144 RGVYHRDLKPENLL---LDENGDLKVSDFGLS-----AVSDQIRQDGLFHTFCGTPAYVA 195
+ HRD+KP+N L + + + DFGL+ A + Q GT Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 196 PEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ---DQNIMVMYKKIYKGEFRSP---- 248
+ D+ S G +L G LP+Q Y++I + + +P
Sbjct: 182 INTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 -RWFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRKGFK 287
+ + + L D + + ++ N + R+GF
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-59
Identities = 55/290 (18%), Positives = 111/290 (38%), Gaps = 23/290 (7%)
Query: 27 RYEIGKLLGHGTFAKVYHARN-----VKSGESVAIKVIDKEKILKSGLVAHIKREISILR 81
+ + + LG G+F VY + VAIK +++ ++ E S+++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVMK 78
Query: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVRGGELF-----------NKVAKGRLKEDLARKY 130
++V+L V++ +ME + G+L N +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 131 FQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190
++ + + +A HRDL N ++ E+ +K+ DFG++ +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIMVMYKKIYKGEFRS-P 248
+++PE L + D+WS GV+L+ + P+Q + + + + +G P
Sbjct: 199 VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME--NRWFRKGFKHIKFYIEDD 296
L L+ NP R + EI+ GF+ + FY ++
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 3e-59
Identities = 59/279 (21%), Positives = 116/279 (41%), Gaps = 30/279 (10%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGES-------VAIKVIDKEKILKSGLVAHIKREISI 79
R +GK LG G F +V A + + VA+K++ + K ++ + E+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEM 71
Query: 80 LRRV-RHPNIVQLFEVMATKSKIYFVMEYVRGGELFN-----------------KVAKGR 121
++ + +H NI+ L +Y ++EY G L + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 122 LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181
L Q+ + + ++ HRDL N+L+ E+ +K++DFGL+ I
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF-VLMAGYLPFQDQNIMVMYKKI 240
++APE L + Y + D+WS GV+L+ + G P+ + ++K +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 241 YKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+G P + +L ++ P +R T +++E
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 194 bits (493), Expect = 4e-59
Identities = 45/290 (15%), Positives = 100/290 (34%), Gaps = 28/290 (9%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
Y++G+ +G G+F ++ N+ + + VAIK + ++ E + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAG 59
Query: 86 -PNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHA 143
I ++ V++ + GR +Q+++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 144 RGVYHRDLKPENLLLDE-----NGDLKVSDFGLSAVSD-----QIRQDGLFHTFCGTPAY 193
+ + +RD+KP+N L+ + V DFG+ Q GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 194 VAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD---QNIMVMYKKIYKGEFRSPRW 250
++ + + D+ + G + + G LP+Q Y++I + + +P
Sbjct: 180 MSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 251 -----FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIED 295
F + + + + D + F K + + ++
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERLNTTEDE 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-58
Identities = 58/261 (22%), Positives = 105/261 (40%), Gaps = 12/261 (4%)
Query: 27 RYEIGKLLGHGTFAKVYHARNVKSGES----VAIKVIDKEKILKSGLVAHIKREISILRR 82
K++G G F +VY S VAIK + K E I+ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQ 65
Query: 83 VRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGF 140
H NI++L V++ + + EY+ G L + + G + + + + +
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 141 CHARGVYHRDLKPENLLLDENGDLKVSDFGLSA-VSDQIRQDGLFHTFCGTPAYVAPEVL 199
HRDL N+L++ N KVSDFGLS + D + APE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 200 SRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIR 257
S + + + D+WS G++++ +M G P+ + + + K I G +P + +
Sbjct: 186 SYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244
Query: 258 LLTKLLDTNPDKRITIPEIME 278
L+ + +R +I+
Sbjct: 245 LMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-58
Identities = 60/280 (21%), Positives = 114/280 (40%), Gaps = 13/280 (4%)
Query: 9 STSTTSSSKDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKIL 65
+ + + P +++G G F VYH + + A+K +++
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-- 67
Query: 66 KSGLVAHIKREISILRRVRHPNIVQLFEV-MATKSKIYFVMEYVRGGEL--FNKVAKGRL 122
G V+ E I++ HPN++ L + + ++ V+ Y++ G+L F +
Sbjct: 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 127
Query: 123 KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS--AVSDQIRQ 180
+ Q+ + F ++ HRDL N +LDE +KV+DFGL+ +
Sbjct: 128 TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187
Query: 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKK 239
++A E L + + K D+WS GV+L+ LM G P+ D N +
Sbjct: 188 VHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246
Query: 240 IYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
+ +G P + L ++ K + R + E++
Sbjct: 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-56
Identities = 68/312 (21%), Positives = 123/312 (39%), Gaps = 55/312 (17%)
Query: 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV 83
+L RY+ K +G G V A + +VAIK + + RE+ +++ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV 73
Query: 84 RHPNIVQLFEVMATKSK------IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISA 137
H NI+ L V + +Y VME + +V + L + Q++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLYQMLCG 131
Query: 138 VGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPE 197
+ H+ G+ HRDLKP N+++ + LK+ DFGL+ + + + T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPE 188
Query: 198 VLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF------ 251
V+ GY VDIWS G I+ ++ + F ++ + + K+ + F
Sbjct: 189 VILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 252 ------------------------------------SPDLIRLLTKLLDTNPDKRITIPE 275
+ LL+K+L +P KRI++ +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 276 IMENRWFRKGFK 287
+++ + +
Sbjct: 308 ALQHPYINVWYD 319
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-56
Identities = 60/294 (20%), Positives = 114/294 (38%), Gaps = 47/294 (15%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
+ + +G G F +V+ + GE VA+K+ + + EI +RH
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERS----WFREAEIYQTVMLRH 56
Query: 86 PNIVQLFEVM----ATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFC 141
NI+ T ++++ V +Y G LF+ + + + + K S +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 142 HA--------RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGLFHTFCGTP 191
H + HRDLK +N+L+ +NG ++D GL+ D D + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 192 AYVAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPF---------------QDQ 231
Y+APEVL + + DI++ G++ + + D
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 232 NIMVMYKKIYKGEFR---SPRWFSPD----LIRLLTKLLDTNPDKRITIPEIME 278
++ M K + + + R RW S + + +++ + N R+T I +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 2e-53
Identities = 61/278 (21%), Positives = 112/278 (40%), Gaps = 28/278 (10%)
Query: 27 RYEIGKLLGHGTFAKVYHAR-----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILR 81
R ++GK LG G F +V A + +VA+K++ + S A + ++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIH 72
Query: 82 RVRHPNIVQLFEVMA-TKSKIYFVMEYVRGGELF-----------------NKVAKGRLK 123
H N+V L + ++E+ + G L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 124 EDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183
+ Y Q+ + F +R HRDL N+LL E +K+ DFGL+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGY-LPFQDQNIMVMYKKIYK 242
++APE + + Y + D+WS GV+L+ + + P+ I + + K
Sbjct: 193 KGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 243 G--EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278
R+P + +P++ + + P +R T E++E
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (411), Expect = 2e-46
Identities = 55/340 (16%), Positives = 118/340 (34%), Gaps = 72/340 (21%)
Query: 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH 85
RY + + LG G F+ V+ A+++ + VA+K++ +K+ + EI +L+RV
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----AAEDEIKLLQRVND 68
Query: 86 PNIVQL--------------FEVMATKSKIYFVMEYVRGG---ELFNKVAKGRLKEDLAR 128
+ + F ++ V G L K + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 129 KYFQQLISAVGFC-HARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQDGLFHT 186
+ +QL+ + + G+ H D+KPEN+L++ + ++ + + D +
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK-------- 238
T Y +PEVL + DIWS ++F L+ G F+ K
Sbjct: 189 SIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 239 ----------------------------------------KIYKGEFRSPRWFSPDLIRL 258
+ +++ + + ++
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 259 LTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIEDDKM 298
L+ +L +P KR ++ + W + + + D ++
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL 347
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.5 bits (247), Expect = 6e-25
Identities = 33/212 (15%), Positives = 70/212 (33%), Gaps = 41/212 (19%)
Query: 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI---------------LKSGLVAH 72
IGKL+G G + V++ + + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 73 IKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQ 132
+ E L++++ + +++ +ME + EL+ + + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRV------RVENPDEVLD 110
Query: 133 QLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192
++ V + RG+ H DL N+L+ E G + + DF S + +
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV---- 165
Query: 193 YVAPEVLS---RKGYDAAKVDIWSCGVILFVL 221
+ + Y + DI S I +L
Sbjct: 166 ----RNIITYFSRTYR-TEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 44.0 bits (104), Expect = 2e-06
Identities = 9/82 (10%), Positives = 28/82 (34%), Gaps = 2/82 (2%)
Query: 372 SGAPVSKIITKLEEIAKVVSFTVRKKDC-RVSLEGSREGVKGPLTIATEIFEL-TPKLVV 429
S S ++ ++ ++ + +++ + + + E+ +L L
Sbjct: 17 SSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNG 76
Query: 430 VEVKKKGGDKGEYEEFCNKELK 451
V K+ G ++ +K
Sbjct: 77 VRFKRISGTSIAFKNIASKIAN 98
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 481 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.45 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.62 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.17 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.01 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.44 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.64 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.14 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-64 Score=484.41 Aligned_cols=255 Identities=35% Similarity=0.702 Sum_probs=237.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||+||+|+++.+++.||+|++.+....+......+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876555555667889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||+||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..... ..
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----CC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----Cc
Confidence 999999999999976 7899999999999999999999999999999999999999999999999999975432 23
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 263 (481)
....+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+....+.++.++.+..|..+|+++++||.+||
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 456789999999999998887 5789999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCCHhHHHhCccccc
Q 011628 264 DTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 264 ~~dP~~Rps~~eil~h~~f~~ 284 (481)
++||++|||++|+++||||+.
T Consensus 240 ~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 240 KHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CSSGGGSCCHHHHHTCHHHHH
T ss_pred cCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-64 Score=489.02 Aligned_cols=263 Identities=37% Similarity=0.682 Sum_probs=227.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
|+.++|++++.||+|+||+||+|+++.+|+.||||+++..... +..+.+.+|+.++++++|||||++++++.+++.+|
T Consensus 2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 4678999999999999999999999999999999999875432 23456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|||||+||+|++++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999999875 57999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCCC--CCCCCCHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFR--SPRWFSPDLIRL 258 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~--~~~~~s~~~~~l 258 (481)
....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+.. ..+..+...... .+..+|+++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 45567899999999999998888777899999999999999999999776533 333334333322 234589999999
Q ss_pred HHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
|.+||+.||++|||++|+++||||++.++
T Consensus 240 i~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 99999999999999999999999987543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-63 Score=487.75 Aligned_cols=261 Identities=34% Similarity=0.643 Sum_probs=234.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34578999999999999999999999999999999998765544555678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|||||+||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999999875 78999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++.++.++.+..|..+|+++++||.+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 45567799999999999998887 56899999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCCHhH------HHhCccccc
Q 011628 262 LLDTNPDKRITIPE------IMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~~e------il~h~~f~~ 284 (481)
||++||++|||++| |++||||+.
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999988 578888854
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-62 Score=478.68 Aligned_cols=254 Identities=30% Similarity=0.545 Sum_probs=228.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 358999999999999999999999999999999998654332 35688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||||+||+|.+++.++.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .....
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR 173 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCB
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999986532 22334
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~ 261 (481)
...+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.......+... .+..|..+|+++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 56789999999999998888 56899999999999999999999988876666555544 234567799999999999
Q ss_pred hcccCcCCCCCHhHHHhCccccc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||++||++|||++|+++||||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-61 Score=483.67 Aligned_cols=257 Identities=39% Similarity=0.695 Sum_probs=238.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 67899999999999999999999999999999999877654445567889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||+||+|++++.+ +.++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ....
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTCC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CCcc
Confidence 999999999999976 7899999999999999999999999999999999999999999999999999985432 2234
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 263 (481)
..+.+||+.|+|||++.+.+| +.++|||||||++|+|++|++||.+.+...++..+..+.+..|..+|+++++||.+||
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 240 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhc
Confidence 567899999999999999988 5789999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCC-----HhHHHhCccccc
Q 011628 264 DTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 264 ~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
++||.+|++ ++|+++||||+.
T Consensus 241 ~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 241 KKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred cCCchhhcccccccHHHHHcCccccc
Confidence 999999994 899999999965
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-60 Score=473.55 Aligned_cols=254 Identities=36% Similarity=0.726 Sum_probs=235.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46799999999999999999999999999999999876554445567889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||.||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence 999999999999876 5799999999999999999999999999999999999999999999999999986432 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 263 (481)
..+.+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+....+.++..+....|..+|+++.++|.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 346799999999999998888 4689999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCC-----CHhHHHhCccccc
Q 011628 264 DTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 264 ~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.+||.+|+ |+++|++||||+.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhCHHhccccchhhHHHHHcCccccc
Confidence 99999996 9999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-61 Score=464.96 Aligned_cols=254 Identities=33% Similarity=0.609 Sum_probs=217.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 102 (481)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ....+.+.+|+.++++++|||||++++++.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 46899999999999999999999999999999999876543 3446778999999999999999999999864 45689
Q ss_pred EEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-----ceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 103 FVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARG-----VYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~g-----i~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
+|||||+||+|.+++.+ +.+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998853 46999999999999999999999987 999999999999999999999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWF 251 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 251 (481)
+.... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..++..++..+.+ ..|..+
T Consensus 162 ~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNH--DTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccc--CCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 86543 2223456789999999999988877 5789999999999999999999999999899999988875 457789
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
|+++.+||.+||+.||++|||++||++|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-61 Score=469.25 Aligned_cols=254 Identities=31% Similarity=0.506 Sum_probs=225.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+.|++++.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 579999999999999999999999999999999976532 23456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...... ..
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 99999999998754 569999999999999999999999999999999999999999999999999997543321 12
Q ss_pred ccccCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHHH
Q 011628 184 FHTFCGTPAYVAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPDL 255 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~ 255 (481)
..+.+||+.|+|||++. +..| +.++|||||||++|+|++|..||.+.+..+.+.++..+.. ..|..+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 34678999999999984 3334 5789999999999999999999999888888888887753 3356789999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++||.+||++||++|||++|+++||||+..
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-60 Score=471.60 Aligned_cols=256 Identities=37% Similarity=0.689 Sum_probs=213.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45678999999999999999999999999999999998765332 2356789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc---cCCCEEEEecCCccccccc
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD---ENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~---~~g~lkl~DFGla~~~~~~ 178 (481)
+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence 99999999999999975 6899999999999999999999999999999999999995 578999999999986432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC----CCCCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS----PRWFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~~ 254 (481)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.......+..+.... +..+|++
T Consensus 163 --~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 239 (307)
T d1a06a_ 163 --GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239 (307)
T ss_dssp ------------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred --CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence 234456789999999999998887 578999999999999999999999999888888998876544 3468999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+.+||.+||++||++|||++|+++||||+.
T Consensus 240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999999964
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-59 Score=462.33 Aligned_cols=260 Identities=32% Similarity=0.574 Sum_probs=232.9
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS---GLVAHIKREISILRRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (481)
+..+.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 33467899999999999999999999999999999999986543321 235778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEecCCc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG----DLKVSDFGLS 172 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g----~lkl~DFGla 172 (481)
.+.+|+|||||+||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999999999975 6899999999999999999999999999999999999998877 5999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP---- 248 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 248 (481)
..... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+..+....+
T Consensus 165 ~~~~~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 165 HKIDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp EECTT---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhcCC---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 76432 233456789999999999988777 6789999999999999999999999999888999988876543
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+|+++++||.+||++||++|||++|+++||||+.
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 568999999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-60 Score=467.29 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=227.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999998776555566678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||.||+|..++.. +++++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------B
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------C
Confidence 99999999877654 6899999999999999999999999999999999999999999999999999975432 2
Q ss_pred cccCCCCccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--CCCCCCHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRK---GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIRLL 259 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li 259 (481)
...+||+.|+|||++.+. .| +.++|||||||++|+|++|..||.+.+......++..+..+ .+..+|+++++||
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y-~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCc-CchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 456899999999998643 34 57899999999999999999999998888777777776543 3456899999999
Q ss_pred HHhcccCcCCCCCHhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+||++||.+|||++|+++||||.+.
T Consensus 248 ~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 99999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=455.58 Aligned_cols=253 Identities=24% Similarity=0.510 Sum_probs=220.0
Q ss_pred ccCCe-eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----C
Q 011628 24 LLGRY-EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----K 98 (481)
Q Consensus 24 ~~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~ 98 (481)
..+|| ++.+.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+++|++++|||||++++++.+ .
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 34567 7888999999999999999999999999999876543 3445778999999999999999999999865 4
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEc-cCCCEEEEecCCccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLD-ENGDLKVSDFGLSAV 174 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~-~~g~lkl~DFGla~~ 174 (481)
..+|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+.
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 568999999999999999976 68999999999999999999999998 99999999999997 478999999999975
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-hHHHHHHHHhhCCCC--CCCCC
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NIMVMYKKIYKGEFR--SPRWF 251 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~~~~~i~~~~~~--~~~~~ 251 (481)
.. .....+.+||+.|+|||++.+ +| +.++|||||||++|+|++|+.||.+. +...++..+..+..+ .+..+
T Consensus 165 ~~----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 165 KR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238 (270)
T ss_dssp CC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred cc----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccC
Confidence 32 233457799999999999865 46 67899999999999999999999765 455666777665432 34568
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
++++.+||.+||++||++|||++|+++||||+
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-60 Score=473.62 Aligned_cols=254 Identities=38% Similarity=0.699 Sum_probs=236.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.....+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 68999999999999999999999999999999999876554445567789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||+.||+|.+.+.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... .
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-----~ 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----R 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----C
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-----c
Confidence 999999999999875 7899999999999999999999999999999999999999999999999999986432 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 263 (481)
..+.+||+.|+|||++.+.+| +.++|||||||++|+|++|..||.+.+....+.++..+.+..|..+|+++.+||++||
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHS
T ss_pred cccccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHh
Confidence 346789999999999998888 5789999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCC-----CHhHHHhCccccc
Q 011628 264 DTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 264 ~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
++||.+|+ |+++|++||||+.
T Consensus 274 ~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred hhCHHhccccccccHHHHHcCccccC
Confidence 99999995 9999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-59 Score=471.98 Aligned_cols=257 Identities=30% Similarity=0.546 Sum_probs=231.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..++++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4567899999999999999999999999999999999976532 3346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc--CCCEEEEecCCcccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE--NGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~--~g~lkl~DFGla~~~~~ 177 (481)
|+|||||+||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||+|+....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999999999953 57999999999999999999999999999999999999964 57899999999986432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 253 (481)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+..+....+ ..+|+
T Consensus 179 ---~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 179 ---KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp ---TSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred ---ccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 234456799999999999998888 5789999999999999999999999999999999988776543 35899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++++||.+||++||++|||++|+++||||+..
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-59 Score=472.46 Aligned_cols=257 Identities=26% Similarity=0.532 Sum_probs=231.8
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+.++|++++.||+|+||+||+|++..+|+.||||+++.... .....+.+|+.+|++++|||||++++++.++..+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467899999999999999999999999999999999976542 2245688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc--cCCCEEEEecCCcccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD--ENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~--~~g~lkl~DFGla~~~~~ 177 (481)
|+|||||+||+|++.+.. .++++.+++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+|+....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999999999998765 3699999999999999999999999999999999999998 578999999999986542
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC----CCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP----RWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 253 (481)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+.++..+.+..| ..+|+
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 182 ---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 334567799999999999998888 5789999999999999999999999999889999988876543 46899
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++.+||.+||++||.+|||++|+++||||+..
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=466.43 Aligned_cols=257 Identities=34% Similarity=0.636 Sum_probs=232.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILR-RVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|..++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 468999999999999999999999999999999998765443444555667777654 6899999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||||+||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 9999999999999976 7899999999999999999999999999999999999999999999999999985432 223
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
.....+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+...++.++..+.+..|..+|+++.+||.+|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 3456789999999999999888 578999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCCCHh-HHHhCccccc
Q 011628 263 LDTNPDKRITIP-EIMENRWFRK 284 (481)
Q Consensus 263 L~~dP~~Rps~~-eil~h~~f~~ 284 (481)
|++||.+|||+. ++++||||++
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999996 8999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-60 Score=470.14 Aligned_cols=255 Identities=27% Similarity=0.474 Sum_probs=217.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||+||+|+++.+|+.||+|+++... ......++.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999997653 33456788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||||+||+|.+++.+ +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+....
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 157 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----
Confidence 9999999999999975 789999999999999999999997 5999999999999999999999999999986433
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH-------------------------
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM------------------------- 236 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~------------------------- 236 (481)
....+.+||+.|+|||++.+..| +.++||||+||++|||++|+.||.+.+....
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 22346799999999999998888 5689999999999999999999976432111
Q ss_pred -----------------HHHHhhCCC-CCC-CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 237 -----------------YKKIYKGEF-RSP-RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 237 -----------------~~~i~~~~~-~~~-~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...+..... ..| ..+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 111111111 111 2368899999999999999999999999999999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-58 Score=451.48 Aligned_cols=258 Identities=33% Similarity=0.580 Sum_probs=229.4
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhCC-CCCcceEEEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK------SGLVAHIKREISILRRVR-HPNIVQLFEVMA 96 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 96 (481)
+.++|++++.||+|+||+||+|++..+|+.||||++++..... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 4579999999999999999999999999999999998764322 223456889999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
+++.+|||||||+||+|.+++.. +.++++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999965 78999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCCcccccCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC-
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRK-----GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR- 249 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~- 249 (481)
.. .......+||+.|+|||++.+. ...+.++||||+||++|+|++|+.||.+.+.......+..+....+.
T Consensus 161 ~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 161 DP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 43 2234567899999999998632 22367899999999999999999999999998888888888654432
Q ss_pred ---CCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 250 ---WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 250 ---~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+|+++++||.+||++||.+|||++|+++||||++
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-59 Score=462.21 Aligned_cols=255 Identities=25% Similarity=0.491 Sum_probs=230.5
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.+.+||++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 478999999999999999999999999999999999976542 2345789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-C-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC--CCEEEEecCCccccccc
Q 011628 103 FVMEYVRGGELFNKVAK-G-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN--GDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~--g~lkl~DFGla~~~~~~ 178 (481)
+|||||+||+|++++.. + .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence 99999999999999975 3 69999999999999999999999999999999999999854 4799999999976432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC----CCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~ 254 (481)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+.++.++.+..+. .+|++
T Consensus 157 --~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 157 --GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 233456789999999999988877 57899999999999999999999999999999999988876653 68999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++||.+||.+||++|||++|+++||||++.
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-59 Score=452.51 Aligned_cols=253 Identities=32% Similarity=0.620 Sum_probs=223.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh---HHHHHHHHHHHHHhCC--CCCcceEEEEEEe
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG---LVAHIKREISILRRVR--HPNIVQLFEVMAT 97 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~ 97 (481)
|+.++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.++++++ |||||++++++.+
T Consensus 1 pl~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 5788999999999999999999999999999999999865433211 1233568999999997 8999999999999
Q ss_pred CCEEEEEEeccCC-CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCccc
Q 011628 98 KSKIYFVMEYVRG-GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAV 174 (481)
Q Consensus 98 ~~~~~lv~Ey~~g-g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~ 174 (481)
.+..|+||||+.+ +++.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999999987 578888765 789999999999999999999999999999999999999854 7899999999976
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHH
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPD 254 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 254 (481)
... ....+.+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+ .+..+....+..+|++
T Consensus 161 ~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~ 230 (273)
T d1xwsa_ 161 LKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 230 (273)
T ss_dssp CCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred ccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHH
Confidence 432 334567899999999999888877778999999999999999999998754 4567778888899999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++||.+||++||++|||++|+++||||++.
T Consensus 231 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-58 Score=465.98 Aligned_cols=256 Identities=30% Similarity=0.507 Sum_probs=222.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGL---VAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
+++|++++.||+|+||+||+|++..+|+.||||++.+........ .....+|+.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 578999999999999999999999999999999997654432222 22334457778888899999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS---
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC---
Confidence 999999999999999875 6899999999999999999999999999999999999999999999999999986433
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch---HHHHHHHHhhCCCCCCCCCCHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN---IMVMYKKIYKGEFRSPRWFSPDLIR 257 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~~~~ 257 (481)
......+||+.|+|||++......+.++|||||||++|+|++|..||.+.+ ...+...+.......|..+|+++++
T Consensus 160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 233567899999999999754444678999999999999999999998654 3344555556667778889999999
Q ss_pred HHHHhcccCcCCCCC-----HhHHHhCccccc
Q 011628 258 LLTKLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
||.+||++||++||| ++||++||||+.
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 999999999999999 799999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-57 Score=444.78 Aligned_cols=258 Identities=31% Similarity=0.506 Sum_probs=218.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++++.||+|+||+||+|++..+|+.||||++..... ......++.+|+.++++++|||||++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4789999999999999999999999999999999976542 223456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.|+.+...... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Ccc
Confidence 999987655444333 5799999999999999999999999999999999999999999999999999976433 223
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-----------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF----------------- 245 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------------- 245 (481)
.....+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......++.....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 345668999999999998888888899999999999999999999998877666555543100
Q ss_pred -CC-----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 -RS-----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 -~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.. ...+|+++.+||++||++||++|||++|+++||||++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00 12367889999999999999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=447.61 Aligned_cols=254 Identities=30% Similarity=0.431 Sum_probs=214.4
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK--SGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
|.++.||+|+||+||+|+++.+|+.||||+++...... ....+.+.+|+.+++.++|||||++++++..++.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 35789999999999999999999999999997654322 1234568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 107 YVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 107 y~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
|+.|+++..+... +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--ccccc
Confidence 9999888877764 57999999999999999999999999999999999999999999999999999764432 22345
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-------------------
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR------------------- 246 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------------------- 246 (481)
+.+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+..+...++.+....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 6789999999999876665578999999999999999999999998887777666532000
Q ss_pred ---------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 247 ---------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 247 ---------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
....+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 01246889999999999999999999999999999964
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-56 Score=435.81 Aligned_cols=261 Identities=27% Similarity=0.452 Sum_probs=219.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-- 99 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 99 (481)
..+.+||++++.||+|+||+||+|++..+|+.||||++.+....+......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 456789999999999999999999999999999999998876666667788999999999999999999999997654
Q ss_pred --EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 100 --KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 100 --~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
.+|+|||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++..+|+|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 48999999999999998865 689999999999999999999999999999999999999999999999999986543
Q ss_pred ccc-cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC----CCCC
Q 011628 177 QIR-QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS----PRWF 251 (481)
Q Consensus 177 ~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----~~~~ 251 (481)
... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+...++..+.... +..+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ----------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred cccccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 222 2223456789999999999988777 568999999999999999999999998888877777765433 3568
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999999544445567754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-57 Score=449.93 Aligned_cols=253 Identities=32% Similarity=0.622 Sum_probs=214.1
Q ss_pred CCCccCCeeEE-eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEe-
Q 011628 21 QSPLLGRYEIG-KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRR-VRHPNIVQLFEVMAT- 97 (481)
Q Consensus 21 ~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~- 97 (481)
...+.++|++. +.||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ ++|||||++++++.+
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 44567899986 5699999999999999999999999998643 346689998755 489999999999876
Q ss_pred ---CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CCCEEEEe
Q 011628 98 ---KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---NGDLKVSD 168 (481)
Q Consensus 98 ---~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---~g~lkl~D 168 (481)
...+|+|||||+||+|++++.. .++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 4679999999999999999975 26999999999999999999999999999999999999986 46799999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH----HHHHhhCC
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM----YKKIYKGE 244 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~ 244 (481)
||+|+.... .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.... ...+..+.
T Consensus 158 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 158 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred cceeeeccC---CCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence 999986433 233456789999999999998888 5689999999999999999999987654333 33344444
Q ss_pred CCCCC----CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 245 FRSPR----WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 245 ~~~~~----~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...|. .+|+++.+||.+||++||++|||++|+++||||.+.
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 44443 479999999999999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.3e-56 Score=434.29 Aligned_cols=256 Identities=32% Similarity=0.514 Sum_probs=218.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
++||++++.||+|+||+||+|+++ +|+.||||++..... .....+++.+|+.+|++++||||+++++++...+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999984 889999999977643 233457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||+.++.+..+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 999998888888764 68999999999999999999999999999999999999999999999999999764332 122
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--C----------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--F---------------- 245 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~---------------- 245 (481)
.....|++.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+......++.... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3455799999999999877777889999999999999999999999887766666554310 0
Q ss_pred -----------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 246 -----------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 246 -----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+..+++++.+||++||++||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112346889999999999999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=433.31 Aligned_cols=255 Identities=30% Similarity=0.440 Sum_probs=213.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEe---
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-GESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMAT--- 97 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~--- 97 (481)
.++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47999999999999999999999765 6779999997654322 2223455788877766 79999999999853
Q ss_pred --CCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 98 --KSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 98 --~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
...+|++|||+.++.+...... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3478999999999877655543 579999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---------
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--------- 244 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--------- 244 (481)
..... ......+||+.|+|||++.+.+| +.++||||+||++|+|++|..||.+.+......++....
T Consensus 165 ~~~~~---~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhccc---ccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 64332 23456789999999999998888 578999999999999999999999988777766664310
Q ss_pred ------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 ------------------FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 ------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
...+..+++.+.+||.+||++||++|||++|+++||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0123457889999999999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-56 Score=430.30 Aligned_cols=250 Identities=24% Similarity=0.469 Sum_probs=205.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||+||+|+. +..||||+++..... ....+.+.+|+.++++++|||||++++++.. +.+|+|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 57899999999999999999975 346999999765433 3456788999999999999999999998754 568999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||+||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999999999999964 569999999999999999999999999999999999999999999999999998765444444
Q ss_pred cccccCCCCccccccccccCC--CCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCC-----CCCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKG--YDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEF-----RSPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~-----~~~~~~s~~ 254 (481)
...+.+||+.|+|||++.+.. ..+.++|||||||++|||++|+.||.+.+.. .....+..+.. ..+..+|++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 456778999999999986432 2367899999999999999999999886544 33344444422 235668999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+.+||.+||+.||++|||++||+++
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=439.90 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=214.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGE-----SVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
++|++++.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+++++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 689999999999999999999876544 699999865432 23345688999999998 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCc
Q 011628 100 KIYFVMEYVRGGELFNKVAKG------------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPEN 155 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~------------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~N 155 (481)
.+|+|||||+||+|.+++... .+++..++.++.|++.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999999999999642 38899999999999999999999999999999999
Q ss_pred EEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHH
Q 011628 156 LLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIM 234 (481)
Q Consensus 156 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~ 234 (481)
||++.++++||+|||+|+............+.+||+.|+|||++.+..| +.++|||||||++|||++ |..||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999986554333333446678999999999988777 578999999999999998 89999887655
Q ss_pred HHHHHHhhCC--CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 235 VMYKKIYKGE--FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 235 ~~~~~i~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
....++.... ++.|..+|+++++||.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5555555443 45678899999999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=439.36 Aligned_cols=254 Identities=29% Similarity=0.466 Sum_probs=215.8
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS---- 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 99 (481)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 6789999999999999999999999999999999997654 34456678899999999999999999999997654
Q ss_pred --EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 --KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 --~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
.+|+||||+ |.+|...+..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|+....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 67888888888999999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------- 244 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------- 244 (481)
.....+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 174 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 174 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 23567899999999999877776889999999999999999999998876655444332210
Q ss_pred ------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 ------------------FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 ------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
......+++++.+||.+||..||.+|||++|+|+||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0123457899999999999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-55 Score=426.40 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=218.8
Q ss_pred CCeeEEeE-ecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 26 GRYEIGKL-LGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 26 ~~y~i~~~-LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 56888885 9999999999998754 45579999997653 33456778999999999999999999999875 4589
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||||+||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999999854 5799999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
.......+||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..++...+.++. +..|+.+|+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 122335678999999999988777 578999999999999998 999999988778888887775 5678899999999
Q ss_pred HHHHhcccCcCCCCCHhHH---HhCcccc
Q 011628 258 LLTKLLDTNPDKRITIPEI---MENRWFR 283 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~ei---l~h~~f~ 283 (481)
||.+||+.||++|||+.+| |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999888 5678764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=422.23 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=209.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++++.||+|+||+||+|++. +++.||||+++..... .+.+.+|+.++++++|||||++++++..++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 57999999999999999999974 6788999999765432 356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||++|+|.+++.. ..++++.+..++.|++.||+|||+++|+||||||+|||++.++++||+|||+|+....... ..
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 99999999999865 4689999999999999999999999999999999999999999999999999986543221 22
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 261 (481)
.....||+.|+|||++.+..| +.++|||||||++|||+| |.+||...+...+...+..+. ...|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 344679999999999988887 578999999999999999 688888888888888887764 45677889999999999
Q ss_pred hcccCcCCCCCHhHHHhC
Q 011628 262 LLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h 279 (481)
||+.||++|||++||++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-55 Score=430.19 Aligned_cols=248 Identities=24% Similarity=0.413 Sum_probs=216.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||+||+|++..+|+.||||+++.+.. ..+++.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 4689999999999999999999999999999999976542 245688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~ 170 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 170 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-S
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC-c
Confidence 999999999999864 468999999999999999999999999999999999999999999999999998654321 1
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCC-CCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYL-PFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~-Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 259 (481)
.......||+.|+|||++.+..| +.++|||||||++|||++|.. ||.+.+...++..+..+ .+..|..+|+++.+||
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 249 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence 12233468899999999988887 578999999999999999654 55666666666666555 3566788999999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.||++|||++||++
T Consensus 250 ~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 250 RACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-55 Score=429.82 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=209.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+.+|++++|||||++++++...+.+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 5789999999999999999999977665 58899886543 334457789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+|||||+||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999999999998875 469999999999999999999999999999999999999999999999999998654322
Q ss_pred cCCc---ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHH
Q 011628 180 QDGL---FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPD 254 (481)
Q Consensus 180 ~~~~---~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 254 (481)
.... .....||+.|+|||++.+..| +.++|||||||++|||+| |..||.+.+...+...+..+. .+.|..++++
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261 (299)
T ss_dssp -------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence 2111 123467999999999988777 568999999999999998 899999998888888887764 5667789999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+.+||.+||+.||++|||+.||+++
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=426.40 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=210.3
Q ss_pred eEecccCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHGTFAKVYHARNV--KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
+.||+|+||+||+|.+. .+++.||||++.... ......+.+.+|+.+|++++|||||++++++..+ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999864 356789999997654 3344567899999999999999999999998654 5789999999
Q ss_pred CCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc-CCccccc
Q 011628 110 GGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ-DGLFHTF 187 (481)
Q Consensus 110 gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~-~~~~~~~ 187 (481)
||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999976 6799999999999999999999999999999999999999999999999999986432211 1122345
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhccc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 265 (481)
.||+.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+..++...+.++. ++.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 79999999999988777 578999999999999998 899999988888888887764 567888999999999999999
Q ss_pred CcCCCCCHhHHH---hCccc
Q 011628 266 NPDKRITIPEIM---ENRWF 282 (481)
Q Consensus 266 dP~~Rps~~eil---~h~~f 282 (481)
||++|||+++|+ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 55554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=431.25 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=213.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-------
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT------- 97 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------- 97 (481)
.+||++++.||+|+||+||+|++..+|+.||||++..+... .....++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 68999999999999999999999999999999999776533 3345678899999999999999999999855
Q ss_pred -CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 98 -KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 98 -~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
...+|+||||+.++.+...... ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999988777655544 57999999999999999999999999999999999999999999999999999754
Q ss_pred cccc--cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC----
Q 011628 176 DQIR--QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR---- 249 (481)
Q Consensus 176 ~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~---- 249 (481)
.... ......+.+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+.......+.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 4221 2233455789999999999977655578999999999999999999999988776665555432111100
Q ss_pred ----------------------------CCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 250 ----------------------------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 250 ----------------------------~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..++++.+||.+||++||++|||++|+++||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 02667899999999999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=434.13 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=216.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS---- 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 99 (481)
+..||++++.||+|+||+||+|++..+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 4579999999999999999999999999999999997643 3455678899999999999999999999997653
Q ss_pred EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
..+++++|+.||+|++++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 23445566779999999998899999999999999999999999999999999999999999999999999997654332
Q ss_pred c-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---------------
Q 011628 180 Q-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--------------- 243 (481)
Q Consensus 180 ~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------------- 243 (481)
. .......+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+...........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2 233456789999999999866666678899999999999999999999887654443333210
Q ss_pred -------CC---------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 244 -------EF---------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 244 -------~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.. ...+.+|+++++||.+||+.||.+|||++|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 00 01234788999999999999999999999999999998654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-55 Score=424.18 Aligned_cols=251 Identities=21% Similarity=0.396 Sum_probs=217.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||+||+|++. +++.||||+++..... .+.+.+|+.++++++|||||++++++.+ +.+|+|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 468999999999999999999974 6788999999765422 3568899999999999999999998754 567999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||++|+|.+++.. .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... .
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~ 164 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y 164 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence 999999999998754 369999999999999999999999999999999999999999999999999998654321 1
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
.......||+.|+|||++.+..| +.++|||||||++|||+| |.+||...+.......+..+. ...|..+++++.+||
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHH
Confidence 22345679999999999987777 578999999999999999 566777777777888887764 566888999999999
Q ss_pred HHhcccCcCCCCCHhHHHh--Ccccc
Q 011628 260 TKLLDTNPDKRITIPEIME--NRWFR 283 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~--h~~f~ 283 (481)
.+||+.||++|||+++|++ |+||.
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999999999998 78885
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=416.36 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=221.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|+++++||+|+||+||+|++ .+++.||||++++.... .+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 5799999999999999999998 47889999999876533 256889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+++|+|.+++.. ..+++..+.+++.|+++||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence 99999999999754 579999999999999999999999999999999999999999999999999997654322 223
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 261 (481)
.....||+.|+|||++.+..| +.++|||||||++|||+| |+.||.+.+..++..++..+. ...|..+++++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 345679999999999988887 568999999999999998 899999999888888888874 56688899999999999
Q ss_pred hcccCcCCCCCHhHHHhC
Q 011628 262 LLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h 279 (481)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=418.27 Aligned_cols=257 Identities=30% Similarity=0.509 Sum_probs=221.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
++||++++.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999999999999999999977653 345678899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|++.|++|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+..... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Ccc
Confidence 999999999998876 58999999999999999999999999999999999999999999999999999865432 223
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCC-CCchHHHHHHHHhhC-------------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF-QDQNIMVMYKKIYKG------------------- 243 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf-~~~~~~~~~~~i~~~------------------- 243 (481)
.....+++.|+|||++.+..+.+.++||||+||++|+|++|..|| .+.+......++...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 344567899999999988776678999999999999999999885 445555544444321
Q ss_pred ----------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 244 ----------EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 244 ----------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
....+..+++.+.+||++||++||.+|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 01123346889999999999999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-54 Score=430.75 Aligned_cols=257 Identities=30% Similarity=0.441 Sum_probs=212.8
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
.+..+..-+|+.+++||+|+||+||+|++..+|+.||||++..+... ..+|+.+|++++||||+++++++...
T Consensus 13 ~p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~ 85 (350)
T d1q5ka_ 13 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSS 85 (350)
T ss_dssp SSCCCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred CCCCcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEec
Confidence 33344455899999999999999999999999999999999765422 23799999999999999999998543
Q ss_pred ------CEEEEEEeccCCCchHHHH---H-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEE
Q 011628 99 ------SKIYFVMEYVRGGELFNKV---A-KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVS 167 (481)
Q Consensus 99 ------~~~~lv~Ey~~gg~L~~~i---~-~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~ 167 (481)
..+|+|||||+++.+..+. . ...+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 86 ~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~ 165 (350)
T d1q5ka_ 86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 165 (350)
T ss_dssp --CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEEC
T ss_pred CccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEe
Confidence 3589999999876544333 2 24799999999999999999999999999999999999999875 89999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC----
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---- 243 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---- 243 (481)
|||+++.... .....+.+||+.|+|||++.+....+.++||||+||++|+|++|..||...+....+.++.+.
T Consensus 166 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 166 DFGSAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp CCTTCEECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cccchhhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999976432 233456789999999999876655578999999999999999999999888766655555321
Q ss_pred -------------CCC------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 -------------EFR------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 -------------~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
... ....+++++.+||.+||++||++|||+.|+++||||++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 001 123478999999999999999999999999999999753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-54 Score=426.12 Aligned_cols=260 Identities=32% Similarity=0.577 Sum_probs=223.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRVRH-PNIVQLFEVMATK 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~ 98 (481)
-.++|++++.||+|+||+||+|++. .+|+.||||++++.... +....+.+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 4689999999999999999999974 47899999999765432 22234567799999999976 8999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+|++|||+.||+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999999876 6899999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCcccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCch----HHHHHHHHhhCCCCCCCCCC
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKGEFRSPRWFS 252 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s 252 (481)
. ......+.+|++.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+ ...+.........+.|..+|
T Consensus 182 ~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 182 D-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp G-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred c-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 2 222345678999999999997644 34678999999999999999999997754 33455555666777888899
Q ss_pred HHHHHHHHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 253 PDLIRLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
+++.+||.+||++||.+|| |++|+++||||+.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=433.60 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=217.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK-----S 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 99 (481)
.+||++++.||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+.+|+.++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 6899999999999999999999999999999999986543 334456788999999999999999999998643 3
Q ss_pred EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
..+++|+|+.||+|.+++..+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 456677888899999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC------------
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS------------ 247 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~------------ 247 (481)
...+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 23456899999999998887777889999999999999999999999887766665554321110
Q ss_pred -------------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 -------------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 -------------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...+++++++||.+||+.||.+|||++|+|+||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 12478999999999999999999999999999999763
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=417.67 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=207.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSG---ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++++.||+|+||+||+|++..++ ..||||.++... .....+.+.+|+.++++++|||||++++++. .+.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 468999999999999999999986543 468888875433 3445677899999999999999999999985 4678
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~- 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-
Confidence 999999999999998754 57999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
.........||+.|+|||++.+..| +.++|||||||++|||++ |.+||.+.+..+++.++..+. .+.|+.+|+++.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1222345678999999999988777 568999999999999998 899999988888888888775 5678889999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhC
Q 011628 258 LLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h 279 (481)
||.+||+.||++|||+.||++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=421.97 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=211.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.+|++++.||+|+||+||+|++..+|+ .||+|.+.... .....+.+.+|+.++++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988876 57888775432 223457789999999999999999999999875 56
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
++++||+.+|+|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788899999999988764 479999999999999999999999999999999999999999999999999998755433
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
.........||+.|+|||++.+..| +.++|||||||++|||+| |.+||.+.+..++...+..+. ++.|..+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 3333445678999999999988877 678999999999999998 899999887777777777765 5678889999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENR 280 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~ 280 (481)
||.+||+.||.+|||+.||++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=410.34 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=208.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSG----ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.+.|++.++||+|+||+||+|.+..++ ..||||++.... .......+.+|+.++++++|||||++++++.+...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 467999999999999999999987654 469999997543 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.++||||+.+|+|.+.+.. +.+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999999999998865 57999999999999999999999999999999999999999999999999999865432
Q ss_pred ccC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCchHHHHHHHHhhCC-CCCCCCCCHHH
Q 011628 179 RQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDL 255 (481)
Q Consensus 179 ~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 255 (481)
... .......||+.|+|||++.+..+ +.++|||||||++|||++| .+||...+..+++..+..+. .+.|..+++.+
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence 221 12234578999999999988777 5689999999999999995 66666677777777777663 56677899999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHh
Q 011628 256 IRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+||.+||+.||++|||+.||++
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=418.77 Aligned_cols=249 Identities=27% Similarity=0.489 Sum_probs=208.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK--SKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~ 101 (481)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .+++.+|+.+|+.++ ||||+++++++... ..+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 578999999999999999999999999999999996542 356789999999995 99999999999754 569
Q ss_pred EEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~~~ 180 (481)
|+|||||.+++|.... +.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 108 ~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~--- 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--- 182 (328)
T ss_dssp EEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT---
T ss_pred eEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC---
Confidence 9999999999998764 4699999999999999999999999999999999999999765 589999999986443
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHh-------------hCCC-
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIY-------------KGEF- 245 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~-------------~~~~- 245 (481)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||..... ......+. ....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 22345678999999999988766557899999999999999999999975432 11111110 0000
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 246 -----------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 246 -----------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.....+|+++.+||++||.+||.+|||++|+|+||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011236889999999999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=411.86 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=211.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||+||+|++..+ +.||||++...... .+.+.+|+.++++++|||||++++++.+ +.+|+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 57899999999999999999998644 67999999765432 3568899999999999999999999854 568999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++|+|..++.. +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~ 168 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 168 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC-c
Confidence 999999999988753 579999999999999999999999999999999999999999999999999998653321 1
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 259 (481)
.......||+.|+|||++....+ +.++|||||||++|||++ |.+||......+....+..+ ..+.+..+|+++++||
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247 (285)
T ss_dssp -------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred eeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHH
Confidence 22344679999999999988777 578999999999999999 56666777777777777766 3567888999999999
Q ss_pred HHhcccCcCCCCCHhHHHh--Cccccc
Q 011628 260 TKLLDTNPDKRITIPEIME--NRWFRK 284 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~--h~~f~~ 284 (481)
.+||+.||++|||+++|++ ++||..
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999999987 778754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-52 Score=413.10 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=220.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++++.||+|+||+||+|+++ .+++.||||+++... .....+++.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 467999999999999999999975 356789999997653 3345677899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCC
Q 011628 100 KIYFVMEYVRGGELFNKVAKG-------------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPE 154 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~-------------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~ 154 (481)
..+++|||+.+|+|.+++... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 999999999999999998632 3788999999999999999999999999999999
Q ss_pred cEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCchH
Q 011628 155 NLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNI 233 (481)
Q Consensus 155 NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~ 233 (481)
|||++.++++||+|||+|+............+.+||+.|+|||++.+..| +.++|||||||++|||++| .+||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999986544444444556789999999999998887 5789999999999999998 578999998
Q ss_pred HHHHHHHhhCCC-CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 234 MVMYKKIYKGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 234 ~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.++...+..+.. ..|..+++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888888764 457789999999999999999999999999965
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=424.09 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=204.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT------ 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 97 (481)
+..+|++++.||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.++++++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 45799999999999999999999999999999999987653 34456778999999999999999999999954
Q ss_pred CCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
...+|+|||||.|+.+. .+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++....
T Consensus 94 ~~~~~iv~Ey~~~~l~~-~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQ-VI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHHH-HH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHHH-hh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 46899999999775544 43 35699999999999999999999999999999999999999999999999999876443
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-------------- 243 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------- 243 (481)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+......++...
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ---ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 223456689999999999988777 56899999999999999999999887765554444321
Q ss_pred --------CCCC--------------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 --------EFRS--------------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 --------~~~~--------------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.... +...|+++.+||++||..||++|||++|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 1000 00135678999999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=411.93 Aligned_cols=251 Identities=23% Similarity=0.425 Sum_probs=217.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSG-------ESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMA 96 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 96 (481)
.++|++++.||+|+||.||+|++..++ ..||||+++++. .......+.+|...+.++ +|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 579999999999999999999976554 479999997654 233456788899999888 7999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD 159 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~ 159 (481)
+...+|+|||||++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 999999999999999999999642 389999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHH
Q 011628 160 ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYK 238 (481)
Q Consensus 160 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 238 (481)
.++.+||+|||+++..............+||+.|+|||++.+..| +.++|||||||++|+|++ |.+||.+.+...++.
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 999999999999987665444445566789999999999988877 578999999999999998 799999998888888
Q ss_pred HHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 239 KIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 239 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..+. +..|.++++++.+||.+||+.||++|||+.||++
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 887764 5678889999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-53 Score=408.52 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=206.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-CC--cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-SG--ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++.+.||+|+||+||+|++.. ++ ..||||++.+.........+.+.+|+.+|++++||||+++++++.+ ..+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999998754 33 3689999987766566667889999999999999999999999976 467
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
++||||+++|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999988754 579999999999999999999999999999999999999999999999999998654332
Q ss_pred cCC-cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHH
Q 011628 180 QDG-LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDL 255 (481)
Q Consensus 180 ~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~ 255 (481)
... ......|++.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+...++.... ++.+..+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 221 2234567889999999988776 678999999999999998 899999999988888887764 34567799999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHh
Q 011628 256 IRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+||.+||+.||++|||+.||++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999964
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=412.45 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=203.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||+||+|++.. +++.||||++.... .....+.+.+|..++.++ +||||+.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3689999999999999999999754 45689999987543 223345677788877776 689999999998664
Q ss_pred -CEEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc
Q 011628 99 -SKIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE 160 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~ 160 (481)
..+++|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 468999999999999999863 23889999999999999999999999999999999999999
Q ss_pred CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCchHH-HHHH
Q 011628 161 NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIM-VMYK 238 (481)
Q Consensus 161 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~-~~~~ 238 (481)
++++||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||++| ..||.+.+.. ....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986554333334456789999999999988777 6789999999999999986 6788776543 3344
Q ss_pred HHhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 239 KIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 239 ~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+..+ .+..|..+++++.+||.+||+.||++|||++||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44444 356678899999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=409.41 Aligned_cols=249 Identities=23% Similarity=0.400 Sum_probs=214.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES--VAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++++.||+|+||+||+|+++.+|.. ||||.+.... .....+.+.+|+.+|+++ +|||||++++++.+.+.+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 46899999999999999999999888875 6677765432 223456688999999999 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCE
Q 011628 102 YFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~l 164 (481)
|+||||++||+|.+++.. ..+++..+.+++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 999999999999999853 358999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCchHHHHHHHHhhC
Q 011628 165 KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIMVMYKKIYKG 243 (481)
Q Consensus 165 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~ 243 (481)
||+|||+|+...... .....+||+.|+|||.+.+..| +.++|||||||++|||++| .+||.+.+..+++..+.++
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 999999997644322 2245579999999999988887 5789999999999999996 5689999988888888776
Q ss_pred -CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 244 -EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 244 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+..|..+++++.+||.+||+.||++|||+.||+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 456678899999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=401.23 Aligned_cols=242 Identities=26% Similarity=0.462 Sum_probs=206.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-KSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~l 103 (481)
.++|++++.||+|+||.||+|++ +|+.||||+++.+. ..+.+.+|+.++++++||||+++++++.+ .+.+|+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 56899999999999999999998 57899999997543 33568899999999999999999999854 466899
Q ss_pred EEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||+++|+|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--- 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC---
Confidence 99999999999998652 489999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
......+|+.|+|||++.+..+ +.++|||||||++|||+| |.+||...+...+...+.++ .++.|..+++++.+|
T Consensus 156 --~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 232 (262)
T d1byga_ 156 --TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232 (262)
T ss_dssp --------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred --CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 2345578999999999988777 678999999999999998 79999988887888888765 356788899999999
Q ss_pred HHHhcccCcCCCCCHhHHHhC
Q 011628 259 LTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h 279 (481)
|.+||+.||.+|||+.+|+++
T Consensus 233 i~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 233 MKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=407.83 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=220.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++++.||+|+||+||+|.+.. +++.||||+++... .......+.+|+.++++++||||+++++++....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 4899999999999999999998752 45789999997543 2334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 100 KIYFVMEYVRGGELFNKVAK-----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
..++||||+.+|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 99999999999999998753 1368899999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCchHHHHHHHHhhCC-CC
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIMVMYKKIYKGE-FR 246 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~~-~~ 246 (481)
||+|+..............+||+.|+|||.+.+..+ +.++|||||||++|||++| .+||.+.+..+.+..+.++. ..
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 999986654433333445678999999999988777 5689999999999999997 68999999888888888775 45
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.|..+++.+.+||.+||+.||++|||+++|++
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67889999999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=404.50 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=215.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+++.+ +|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 489999999999999999999863 467799999997654 234456788999999999 699999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKG-------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD 159 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~-------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~ 159 (481)
..+|+|||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 9999999999999999998642 489999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHH
Q 011628 160 ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYK 238 (481)
Q Consensus 160 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 238 (481)
.++.+||+|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987554333333445789999999999987666 678999999999999998 677777766555554
Q ss_pred HHhhC--CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 239 KIYKG--EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 239 ~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++... ....|..+|+++.+||.+||+.||++|||++||++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 54443 24456778999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=391.52 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=206.0
Q ss_pred eEEeEecccCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSG---ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-KSKIYFV 104 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv 104 (481)
.+.++||+|+||+||+|++..++ ..||||+++.. ......+++.+|+.+|++++||||+++++++.. +...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34689999999999999986643 36899998653 244556889999999999999999999999875 5689999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc--
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ-- 180 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~-- 180 (481)
||||++|+|.+++.. ..+++..+.+++.|++.||.|||++||+||||||+|||+++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999999876 3578899999999999999999999999999999999999999999999999986433211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
........||+.|+|||++.+..+ +.++||||||+++|||++|..||.. .+.......+..+. +..|..+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 122234578999999999987777 6789999999999999997666654 44455666666664 55678899999999
Q ss_pred HHHhcccCcCCCCCHhHHHhC
Q 011628 259 LTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h 279 (481)
|.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-49 Score=387.64 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=203.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN-IVQLFEVMATKSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~ 102 (481)
+.+||++++.||+|+||+||+|++..+|+.||||++..+... ..+.+|+++++.++|+| |+.+..++...+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 457899999999999999999999999999999998765422 23678999999998766 555566678889999
Q ss_pred EEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc---cCCCEEEEecCCcccccc
Q 011628 103 FVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD---ENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~---~~g~lkl~DFGla~~~~~ 177 (481)
+||||+.+ +|.+.+. .+.+++..+..++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|+....
T Consensus 80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99999954 5555554 35799999999999999999999999999999999999986 355799999999987543
Q ss_pred ccc-----CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHH---HhhCC--C--
Q 011628 178 IRQ-----DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKK---IYKGE--F-- 245 (481)
Q Consensus 178 ~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~---i~~~~--~-- 245 (481)
... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........... ..... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 221 112345689999999999988877 5789999999999999999999987544322221 11111 1
Q ss_pred -CCCCCCCHHHHHHHHHhcccCcCCCCCHhH---HHhCcccccCc
Q 011628 246 -RSPRWFSPDLIRLLTKLLDTNPDKRITIPE---IMENRWFRKGF 286 (481)
Q Consensus 246 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~e---il~h~~f~~~~ 286 (481)
..+..+|+++.+||.+||+.||++||++++ +++|+|.+.++
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 124568999999999999999999999874 56788765543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-48 Score=379.74 Aligned_cols=249 Identities=16% Similarity=0.259 Sum_probs=207.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH-PNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~ 101 (481)
.+.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.+.| +||+.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 4578999999999999999999999999999999998665322 236789999999975 8999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-----CCCEEEEecCCccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-----NGDLKVSDFGLSAV 174 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-----~g~lkl~DFGla~~ 174 (481)
|+||||+ |++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 6899988865 47999999999999999999999999999999999999974 57899999999986
Q ss_pred cccccc-----CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch---HHHHHHHHhhCCC-
Q 011628 175 SDQIRQ-----DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN---IMVMYKKIYKGEF- 245 (481)
Q Consensus 175 ~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~- 245 (481)
...... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ....+.++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 543211 122345689999999999988877 578999999999999999999997542 3333333332211
Q ss_pred ----CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 246 ----RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 246 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+..+|+++.+++..|+..+|++||+++.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123568899999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=381.61 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=195.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS----K 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~ 100 (481)
..+|.+.+.||+|+||.||+|+. +|+.||||+++.+.. ......+|+..+..++||||+++++++.... .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 45799999999999999999986 789999999865431 1122334666667789999999999997654 6
Q ss_pred EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------cCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 101 IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA--------RGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~--------~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
+|+|||||++|+|.+++.+..++++...+++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 8999999999999999998889999999999999999999996 59999999999999999999999999999
Q ss_pred cccccccc--CCcccccCCCCccccccccccCCC-----CCCcchHHHHHHHHHHHhcCCCCCCC---------------
Q 011628 173 AVSDQIRQ--DGLFHTFCGTPAYVAPEVLSRKGY-----DAAKVDIWSCGVILFVLMAGYLPFQD--------------- 230 (481)
Q Consensus 173 ~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiwSlGvil~elltg~~Pf~~--------------- 230 (481)
+....... .......+||+.|+|||++.+... .+.++|||||||+||||++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 86543221 123345789999999999865431 24579999999999999999887742
Q ss_pred chHHHHHHHHhhCCCC--CCCC-----CCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 231 QNIMVMYKKIYKGEFR--SPRW-----FSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 231 ~~~~~~~~~i~~~~~~--~~~~-----~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
............+..+ .|.. ....+.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1223333344333332 2221 12348899999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-46 Score=375.41 Aligned_cols=255 Identities=23% Similarity=0.437 Sum_probs=198.7
Q ss_pred CCCCcc-CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCC
Q 011628 20 NQSPLL-GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-----------HPN 87 (481)
Q Consensus 20 ~~~~~~-~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------Hpn 87 (481)
.+.++. +||+++++||+|+||+||+|+++.+|+.||||+++++. ...+.+.+|+.+++.++ |+|
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 355554 68999999999999999999999999999999997653 23456778999988875 478
Q ss_pred cceEEEEEEe--CCEEEEEEeccCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEcc
Q 011628 88 IVQLFEVMAT--KSKIYFVMEYVRGGELFNKVA----KGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDE 160 (481)
Q Consensus 88 Iv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~----~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~ 160 (481)
|+++++++.. ....+++|+++.++....... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 9999988754 456777777776665433322 2579999999999999999999998 89999999999999987
Q ss_pred CCC------EEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH
Q 011628 161 NGD------LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM 234 (481)
Q Consensus 161 ~g~------lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 234 (481)
++. ++++|||.|..... .....+||+.|+|||++.+..| +.++||||+||++++|++|+.||...+..
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCCccc
Confidence 764 99999999875432 2245689999999999998888 56899999999999999999999753211
Q ss_pred ------HHHHH---Hhh---------------------------------------CCCCCCCCCCHHHHHHHHHhcccC
Q 011628 235 ------VMYKK---IYK---------------------------------------GEFRSPRWFSPDLIRLLTKLLDTN 266 (481)
Q Consensus 235 ------~~~~~---i~~---------------------------------------~~~~~~~~~s~~~~~li~~~L~~d 266 (481)
..... +.. .....+...++++.+||.+||++|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 01110 000 000111123567999999999999
Q ss_pred cCCCCCHhHHHhCccccc
Q 011628 267 PDKRITIPEIMENRWFRK 284 (481)
Q Consensus 267 P~~Rps~~eil~h~~f~~ 284 (481)
|.+|||++|+|+||||++
T Consensus 316 P~~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKD 333 (362)
T ss_dssp TTTCBCHHHHHTCGGGTT
T ss_pred hhHCcCHHHHhcCcccCC
Confidence 999999999999999974
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=9.7e-27 Score=212.23 Aligned_cols=136 Identities=19% Similarity=0.306 Sum_probs=109.4
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc---------------chhHHHHHHHHHHHHHhCCCCCcceEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL---------------KSGLVAHIKREISILRRVRHPNIVQLF 92 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~HpnIv~l~ 92 (481)
|.+++.||+|+||+||+|++ .+|+.||||+++..... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999998 57899999987542210 011224456789999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 93 EVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 93 ~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
++.. .+++|||+++..+.+ +++..+..++.|++.++.|||++||+||||||+|||++++ .++|+|||+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred EecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 6632 279999999876543 4556678899999999999999999999999999999865 4899999998
Q ss_pred ccc
Q 011628 173 AVS 175 (481)
Q Consensus 173 ~~~ 175 (481)
...
T Consensus 150 ~~~ 152 (191)
T d1zara2 150 VEV 152 (191)
T ss_dssp EET
T ss_pred ccC
Confidence 653
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.45 E-value=1.5e-13 Score=109.57 Aligned_cols=84 Identities=12% Similarity=0.155 Sum_probs=76.2
Q ss_pred eecCCCHHHHHHHHHHHHHHcCcEEEEec-ceEEEEeecCCCcccEEEEEEEEEEc-CceEEEEeEecCCCchhHHHHhh
Q 011628 370 FVSGAPVSKIITKLEEIAKVVSFTVRKKD-CRVSLEGSREGVKGPLTIATEIFELT-PKLVVVEVKKKGGDKGEYEEFCN 447 (481)
Q Consensus 370 f~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~k~~l~~~~~v~~~~-~~~~lVe~~~~~Gd~le~~~~~~ 447 (481)
-+|.++|++|+.+|+++++.+|+.|++++ +.+++....+++++.+.|.+||+++. +++++|+|+|..||+++|+++|.
T Consensus 15 tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~~ 94 (102)
T d1ul7a_ 15 TTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 94 (102)
T ss_dssp CCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHHH
T ss_pred cCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHHH
Confidence 46899999999999999999999998765 56999988888999999999999995 79999999999999999999999
Q ss_pred hcccccc
Q 011628 448 KELKPGL 454 (481)
Q Consensus 448 ~~l~~~l 454 (481)
+ |-..|
T Consensus 95 ~-il~~l 100 (102)
T d1ul7a_ 95 K-IANEL 100 (102)
T ss_dssp H-HHHHC
T ss_pred H-HHHhc
Confidence 8 65554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.62 E-value=7.4e-08 Score=89.45 Aligned_cols=142 Identities=16% Similarity=0.168 Sum_probs=97.4
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 102 (481)
+...|++.+..+.++.+.||+.. ..++.+.+|+........ ...+.+|..+++.+. +--+.+++.+...++..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 46788888887777778999875 366778899876543222 234678888888774 333667888888899999
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA--------------------------------------- 143 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~--------------------------------------- 143 (481)
+||++++|..+.+......- ...+..++...+..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~~~----~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQS----PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEEECCSSEEHHHHTTTCSC----HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEEeccccccccccccccc----HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999999877554322211 11122333333333332
Q ss_pred --------------------cCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 144 --------------------RGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 144 --------------------~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1378999999999998776667999998764
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.17 E-value=4.3e-06 Score=68.83 Aligned_cols=72 Identities=6% Similarity=0.132 Sum_probs=58.8
Q ss_pred eecCCCHHHHHHHHHHHHHHcCcEEEEecc-eEEEEeecCCCcccEEEEEEEEEEcCceEEEEeEecCCCchh
Q 011628 370 FVSGAPVSKIITKLEEIAKVVSFTVRKKDC-RVSLEGSREGVKGPLTIATEIFELTPKLVVVEVKKKGGDKGE 441 (481)
Q Consensus 370 f~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~k~~l~~~~~v~~~~~~~~lVe~~~~~Gd~le 441 (481)
.-|+..+.+|+..+..+++.||+.|++.+. .+++.....-....+.|.+++|+|.++.+||||+...|+-.|
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 347789999999999999999999987664 488876544334578999999999999999999999998666
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=6.4e-06 Score=75.47 Aligned_cols=139 Identities=13% Similarity=0.139 Sum_probs=83.9
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH--PNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~ 105 (481)
++....-+..+-+.||+... ..+..+.+|....... ..+.+|...++.+.. -.+.+++.+..+++..++||
T Consensus 13 ~~~~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 13 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CceEEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence 44433333333478998874 5677788998654431 235678888887743 23567888888888999999
Q ss_pred eccCCCchHH--------------HHHc-CC-------C--CHHHHHHHHH--------------------HHHHHHHHH
Q 011628 106 EYVRGGELFN--------------KVAK-GR-------L--KEDLARKYFQ--------------------QLISAVGFC 141 (481)
Q Consensus 106 Ey~~gg~L~~--------------~i~~-~~-------l--~e~~~~~~~~--------------------ql~~al~yL 141 (481)
++++|.++.+ .+.+ .. + .......-.. .....+..+
T Consensus 86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 9999865422 1111 00 0 0000000000 011122333
Q ss_pred HHc-------CceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 142 HAR-------GVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 142 H~~-------gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
..+ .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 322 37999999999999987667899999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.01 E-value=9.2e-06 Score=79.98 Aligned_cols=81 Identities=19% Similarity=0.203 Sum_probs=50.7
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeeccc-ccc---hhHHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEK-ILK---SGLVAHIKREISILRRVR-H--PNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~---~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~l 103 (481)
.+.||.|....||++.+..+++.|+||.-...- ... .....+..+|...++.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999887778899999754311 000 011234567888887773 2 335566654 4445678
Q ss_pred EEeccCCCch
Q 011628 104 VMEYVRGGEL 113 (481)
Q Consensus 104 v~Ey~~gg~L 113 (481)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987643
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.44 E-value=0.00016 Score=58.09 Aligned_cols=63 Identities=14% Similarity=0.190 Sum_probs=50.7
Q ss_pred ecCCCHHHHHHHHHHHHHHcCcEEEEec----------ceEEEEee-----cCCCcccEEEEEEEEEEcCceEEEEeE
Q 011628 371 VSGAPVSKIITKLEEIAKVVSFTVRKKD----------CRVSLEGS-----REGVKGPLTIATEIFELTPKLVVVEVK 433 (481)
Q Consensus 371 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~-----~~~~k~~l~~~~~v~~~~~~~~lVe~~ 433 (481)
-|+..+-+|+..|..|++++|+.|++-+ +.+++... ..+....+.|.+++|+|.++.+|||||
T Consensus 8 RSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK 85 (127)
T d2qrda1 8 RCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVK 85 (127)
T ss_dssp EEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEE
T ss_pred ccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEc
Confidence 4778999999999999999999998655 33777633 122234588899999999999999998
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.16 E-value=0.00055 Score=57.77 Aligned_cols=65 Identities=11% Similarity=0.129 Sum_probs=47.6
Q ss_pred eecCCCHHHHHHHHHHHHHHcCcEEEEec----ceEEEEeecC---------CCcccEEEEEEEEEEcCceEEEEeEe
Q 011628 370 FVSGAPVSKIITKLEEIAKVVSFTVRKKD----CRVSLEGSRE---------GVKGPLTIATEIFELTPKLVVVEVKK 434 (481)
Q Consensus 370 f~~~~~~~~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~---------~~k~~l~~~~~v~~~~~~~~lVe~~~ 434 (481)
.-|+.++-+|+..|..|++++|+.|++.+ +.+++....+ .....+.|.+++|+|.++.+|||||-
T Consensus 50 IRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDFK~ 127 (171)
T d2qlva1 50 IRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFKF 127 (171)
T ss_dssp EEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEEEE
T ss_pred cccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEEec
Confidence 35889999999999999999999998754 3477764321 11124789999999999999999984
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.07 E-value=0.00058 Score=64.74 Aligned_cols=67 Identities=13% Similarity=0.233 Sum_probs=44.7
Q ss_pred eEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc--ceEE-----EEEEeCCEEEEEEeccCCC
Q 011628 40 AKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI--VQLF-----EVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 40 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----~~~~~~~~~~lv~Ey~~gg 111 (481)
-.||++.. ++|+.|++|+.+.... ...++..|...+..|...+| +... .........+.+++++.|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 48999975 6789999999876532 23557778888887752222 1111 1234567789999999884
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.64 E-value=0.0041 Score=60.23 Aligned_cols=74 Identities=15% Similarity=0.203 Sum_probs=50.7
Q ss_pred EeEecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVK-------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~ 102 (481)
++.|+.|--=.+|++.... ..+.|.+++.-... .. ....+|..+++.+.-.++ .++++++.. .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678888889999998643 24568788764211 12 345689999998863344 477776643 6
Q ss_pred EEEeccCCCch
Q 011628 103 FVMEYVRGGEL 113 (481)
Q Consensus 103 lv~Ey~~gg~L 113 (481)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 88999988543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.14 E-value=0.008 Score=55.95 Aligned_cols=136 Identities=14% Similarity=0.159 Sum_probs=72.0
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC-----CCcceEE---EEEEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH-----PNIVQLF---EVMATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-----pnIv~l~---~~~~~~~~~~ 102 (481)
.+.|..|---+.|+... .+ ..+++|+...... ...+..|+.++..|.. |..+... .+........
T Consensus 23 ~~~i~~G~~N~ny~v~t-~~-g~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHT-TK-DPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEECC---EEEEEEEE-SS-CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eecCCCCcccCeEEEEE-CC-CcEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 34455666678899875 33 4589999865321 1234567777777642 2222210 1123345667
Q ss_pred EEEeccCCCchH--------------HHHH---cC---C----CCHH------------------HHHHHHHHHHHHHHH
Q 011628 103 FVMEYVRGGELF--------------NKVA---KG---R----LKED------------------LARKYFQQLISAVGF 140 (481)
Q Consensus 103 lv~Ey~~gg~L~--------------~~i~---~~---~----l~e~------------------~~~~~~~ql~~al~y 140 (481)
.++.+..|.... ..+. .. . .... .....+..+...+.-
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 777777774321 0110 00 0 0111 111122222222222
Q ss_pred HH----HcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 141 CH----ARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 141 LH----~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
.+ ..|++|+|+.+.||+++.+...-|.||+.++
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 22 2479999999999999988777899999775
|